<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>AE</th>
      <th>Target</th>
      <th>Ligand</th>
      <th>GENERIC_NAME</th>
      <th>INCHI_KEY</th>
      <th>Note</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>-14.7</td>
      <td>6w9c</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-13.6</td>
      <td>6crv</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-12.8</td>
      <td>6m3m</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-12.5</td>
      <td>6m2n</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-12.4</td>
      <td>6m3m</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-12.4</td>
      <td>6crv</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-12.3</td>
      <td>6crv</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-12.2</td>
      <td>6crv</td>
      <td>DB14859</td>
      <td>Fosifloxuridine nafalbenamide</td>
      <td>BIOWRMNRHMERIO-ZVAHOJSLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-12.2</td>
      <td>6crv</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-12.1</td>
      <td>6crv</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-12.1</td>
      <td>6w9c</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-12.1</td>
      <td>6w9c</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-12.0</td>
      <td>6m3m</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-12.0</td>
      <td>6crv</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.9</td>
      <td>6crv</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.9</td>
      <td>6vxx</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.9</td>
      <td>6crv</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.9</td>
      <td>6crv</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.9</td>
      <td>6vxx</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.8</td>
      <td>6lxt</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-11.8</td>
      <td>6crv</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.8</td>
      <td>6w9c</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.8</td>
      <td>6w4b</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-11.8</td>
      <td>6crv</td>
      <td>DB04760</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)</td>
      <td>PYFRREJCFXFNRR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6crv</td>
      <td>DB15232</td>
      <td>Telaglenastat</td>
      <td>PRAAPINBUWJLGA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6cs2</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6m2n</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6crv</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6m2n</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6crv</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6crv</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6crv</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6m2n</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6crv</td>
      <td>DB03268</td>
      <td>RU82197</td>
      <td>WKTQBTSOHBKBRW-VMPREFPWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6m3m</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.7</td>
      <td>6crv</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.6</td>
      <td>6w9q</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-11.6</td>
      <td>6crv</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.6</td>
      <td>6m3m</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.6</td>
      <td>6crv</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.6</td>
      <td>6m2n</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.6</td>
      <td>6w9c</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.6</td>
      <td>6crv</td>
      <td>DB06515</td>
      <td>Resiniferatoxin</td>
      <td>DSDNAKHZNJAGHN-MXTYGGKSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.6</td>
      <td>6vxx</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.6</td>
      <td>6m3m</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6crv</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6m2n</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6crv</td>
      <td>DB02483</td>
      <td>Etheno-Nad</td>
      <td>JCDBQDNBEQHDHK-BSLNIGMPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6m2n</td>
      <td>DB12198</td>
      <td>Fosdagrocorat</td>
      <td>BVXLAHSJXXSWFF-KEKPKEOLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6m2n</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6cs2</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6m2n</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6crv</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6crv</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6m3m</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.5</td>
      <td>6cs2</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6crv</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6vxx</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6cs2</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6w9c</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6crv</td>
      <td>DB03642</td>
      <td>Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</td>
      <td>VBPPNJCVXGAZDD-PMACEKPBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6crv</td>
      <td>DB04759</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)</td>
      <td>GTBUZLPQANSGGE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6vxx</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6m2n</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6w9c</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6m3m</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6m2n</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.4</td>
      <td>6crv</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6vxs</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6m3m</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6m3m</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6crv</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6vxx</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6w9c</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6m3m</td>
      <td>DB13640</td>
      <td>Acetoxolone</td>
      <td>FTQDJVZNPJRVPG-XWEVEMRCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6crv</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6w4h</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6m3m</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6cs2</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6m3m</td>
      <td>DB12550</td>
      <td>Taladegib</td>
      <td>SZBGQDXLNMELTB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6crv</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.3</td>
      <td>6m2n</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m2n</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6crv</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m2n</td>
      <td>DB15367</td>
      <td>LY-2623091</td>
      <td>YPCLDHGBEKZGEB-RUDKWAFVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m71</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m3m</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m2n</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m2n</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6crv</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m2n</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m3m</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6crv</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m3m</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m2n</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6crv</td>
      <td>DB15269</td>
      <td>ALK-4290</td>
      <td>DWKNOLCXIFYNFV-HSZRJFAPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6crv</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m3m</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6crv</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m2n</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6crv</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m3m</td>
      <td>DB08220</td>
      <td>(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid</td>
      <td>RPNNXCYIESWDSC-JRZBRKEGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m2n</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.2</td>
      <td>6m2n</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6crv</td>
      <td>DB08749</td>
      <td>3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</td>
      <td>KTRFBFMYAJOXLG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6crv</td>
      <td>DB13095</td>
      <td>JTK-853</td>
      <td>JQLOVYLALGSISI-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m2n</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB07716</td>
      <td>(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL</td>
      <td>VDRIXSJOPKVWKM-HXGIDPQASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6w9c</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6crv</td>
      <td>DB15356</td>
      <td>SLV-334</td>
      <td>LOFDNSDPZTVIIO-VPUSJEBWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6crv</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6cs2</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6crv</td>
      <td>DB04190</td>
      <td>Inhibitor Bea425</td>
      <td>AHAVBKNGKPWROK-UMFPTGFGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m2n</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6w9c</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6crv</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6crv</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m2n</td>
      <td>DB02009</td>
      <td>L-756,423</td>
      <td>AOMZDQMIOCTPQP-QHQMVRJISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6crv</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB14664</td>
      <td>Difluocortolone pivalate</td>
      <td>UWGRWFCLGQWKPR-GSTUPEFVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6cs2</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6m3m</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.1</td>
      <td>6crv</td>
      <td>DB06817</td>
      <td>Raltegravir</td>
      <td>CZFFBEXEKNGXKS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m3m</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6w9c</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m2n</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6w9c</td>
      <td>DB02152</td>
      <td>K-252a</td>
      <td>KOZFSFOOLUUIGY-SOLYNIJKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m3m</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6cs2</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m3m</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB14895</td>
      <td>Vibegron</td>
      <td>DJXRIQMCROIRCZ-XOEOCAAJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB12127</td>
      <td>Sultamicillin</td>
      <td>OPYGFNJSCUDTBT-PMLPCWDUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB00966</td>
      <td>Telmisartan</td>
      <td>RMMXLENWKUUMAY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m3m</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m2n</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m3m</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m3m</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB06311</td>
      <td>Darapladib</td>
      <td>WDPFJWLDPVQCAJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m3m</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m3m</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6w4h</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6vxx</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB15385</td>
      <td>Acebilustat</td>
      <td>GERJIEKMNDGSCS-DQEYMECFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>7bv1</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m2n</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m3m</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6w4h</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6w9c</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB04875</td>
      <td>Pralnacasan</td>
      <td>CXAGHAZMQSCAKJ-WAHHBDPQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6vxx</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m2n</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m2n</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6crv</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m2n</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-11.0</td>
      <td>6m2n</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6vxx</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m2n</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6cs2</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m2n</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m2n</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m2n</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m2n</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6lxt</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m2n</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m2n</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6w9c</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6w9c</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6cs2</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6vxs</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB06229</td>
      <td>Ocaperidone</td>
      <td>ZZQNEJILGNNOEP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6w9c</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6cs2</td>
      <td>DB07834</td>
      <td>N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide</td>
      <td>FOHZGCHKLPIBBX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6w9c</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB01831</td>
      <td>Tryptophanyl-5'amp</td>
      <td>IFQVDHDRFCKAAW-SQIXAUHQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB15177</td>
      <td>VX-659</td>
      <td>IGEOJNMYRZUKIK-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB13814</td>
      <td>Talampicillin</td>
      <td>SOROUYSPFADXSN-SUWVAFIASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB11652</td>
      <td>Tucatinib</td>
      <td>SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB02033</td>
      <td>N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide</td>
      <td>GDRNWAKVNIROCG-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m2n</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6m3m</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6w4h</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6w9c</td>
      <td>DB06888</td>
      <td>(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</td>
      <td>KBLPHMRCKHFBJB-OLZOCXBDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.9</td>
      <td>6crv</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6w4h</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6w9c</td>
      <td>DB05129</td>
      <td>Elsamitrucin</td>
      <td>MGQRRMONVLMKJL-KWJIQSIXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB01147</td>
      <td>Cloxacillin</td>
      <td>LQOLIRLGBULYKD-JKIFEVAISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6w9c</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB14679</td>
      <td>Quingestanol acetate</td>
      <td>FLGJKPPXEKYCBY-AKCFYGDASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6w9c</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB13095</td>
      <td>JTK-853</td>
      <td>JQLOVYLALGSISI-HXUWFJFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6w9c</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB08237</td>
      <td>2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)</td>
      <td>COMPKRGNHXOXMN-GVDBMIGSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB02009</td>
      <td>L-756,423</td>
      <td>AOMZDQMIOCTPQP-QHQMVRJISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6cs2</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6cs2</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6w4h</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB12996</td>
      <td>Acteoside</td>
      <td>FBSKJMQYURKNSU-ZLSOWSIRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB15444</td>
      <td>Elexacaftor</td>
      <td>MVRHVFSOIWFBTE-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB04708</td>
      <td>(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>SYNSHNDQFWMLJW-YZGRCXSVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6w9c</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB11618</td>
      <td>Zorubicin</td>
      <td>FBTUMDXHSRTGRV-BJISBDEGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6cs2</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6w9c</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6lxt</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB13307</td>
      <td>Proscillaridin</td>
      <td>MYEJFUXQJGHEQK-ALRJYLEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6vxx</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6vxx</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6cs2</td>
      <td>DB12693</td>
      <td>Ritanserin</td>
      <td>JUQLTPCYUFPYKE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB04632</td>
      <td>4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE</td>
      <td>JHHBGNIRSUTQAS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB08738</td>
      <td>1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one</td>
      <td>KWCKZIJGKMCYCI-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6cs2</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m2n</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6m3m</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.8</td>
      <td>6crv</td>
      <td>DB06634</td>
      <td>Casopitant</td>
      <td>XGGTZCKQRWXCHW-WMTVXVAQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m2n</td>
      <td>DB00224</td>
      <td>Indinavir</td>
      <td>CBVCZFGXHXORBI-PXQQMZJSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB04983</td>
      <td>Denufosol</td>
      <td>FPNPSEMJLALQSA-MIYUEGBISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m2n</td>
      <td>DB00966</td>
      <td>Telmisartan</td>
      <td>RMMXLENWKUUMAY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB11984</td>
      <td>Letaxaban</td>
      <td>GEHAEMCVKDPMKO-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB00878</td>
      <td>Chlorhexidine</td>
      <td>GHXZTYHSJHQHIJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB04703</td>
      <td>Hesperidin</td>
      <td>QUQPHWDTPGMPEX-QJBIFVCTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m2n</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6cs2</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6cs2</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB13953</td>
      <td>Estradiol benzoate</td>
      <td>UYIFTLBWAOGQBI-BZDYCCQFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6w4h</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB11870</td>
      <td>RG-4733</td>
      <td>OJPLJFIFUQPSJR-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6cs2</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6w9c</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB11652</td>
      <td>Tucatinib</td>
      <td>SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB11577</td>
      <td>Indigotindisulfonic Acid</td>
      <td>CFZXDJWFRVEWSR-BUHFOSPRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6w9c</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m2n</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB06581</td>
      <td>Bevirimat</td>
      <td>YJEJKUQEXFSVCJ-WRFMNRASSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6w9c</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB15046</td>
      <td>LY-2881835</td>
      <td>FHRWHNJJQGSCQC-LJAQVGFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m2n</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB14766</td>
      <td>Etrasimod</td>
      <td>MVGWUTBTXDYMND-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6w9c</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m2n</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB09291</td>
      <td>Rolapitant</td>
      <td>FIVSJYGQAIEMOC-ZGNKEGEESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB12134</td>
      <td>Gepotidacin</td>
      <td>PZFAZQUREQIODZ-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6w9c</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB12843</td>
      <td>Oleandrin</td>
      <td>JLPDBLFIVFSOCC-XYXFTTADSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m2n</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB06589</td>
      <td>Pazopanib</td>
      <td>CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6vxs</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m2n</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB11804</td>
      <td>AZD-5672</td>
      <td>SCXSQUUTGCWHFU-WJOKGBTCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m2n</td>
      <td>DB07629</td>
      <td>N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-DLBZAZTESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6crv</td>
      <td>DB13093</td>
      <td>TAK-593</td>
      <td>DZFZXPPHBWCXPQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6m3m</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.7</td>
      <td>6w9c</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB00693</td>
      <td>Fluorescein</td>
      <td>GNBHRKFJIUUOQI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w9c</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB14822</td>
      <td>SB-649868</td>
      <td>ZJXIUGNEAIHSBI-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w9c</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6cs2</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w9c</td>
      <td>DB08220</td>
      <td>(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid</td>
      <td>RPNNXCYIESWDSC-JRZBRKEGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w9c</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB04689</td>
      <td>2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID</td>
      <td>ZXWVCCFKIRBLDP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB08400</td>
      <td>4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid</td>
      <td>KUEKMTNOUPAOBS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB12130</td>
      <td>Lorlatinib</td>
      <td>IIXWYSCJSQVBQM-LLVKDONJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB08822</td>
      <td>Azilsartan medoxomil</td>
      <td>QJFSABGVXDWMIW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB07326</td>
      <td>6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</td>
      <td>FEGRQUWSKADGSP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB01459</td>
      <td>Bezitramide</td>
      <td>FLKWNFFCSSJANB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6vxx</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6vxx</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6vxs</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6cs2</td>
      <td>DB12571</td>
      <td>Rimacalib</td>
      <td>MYTIJGWONQOOLC-HNNXBMFYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m71</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w9c</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB11829</td>
      <td>Ruboxistaurin</td>
      <td>ZCBUQCWBWNUWSU-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB05470</td>
      <td>VX-702</td>
      <td>FYSRKRZDBHOFAY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB09291</td>
      <td>Rolapitant</td>
      <td>FIVSJYGQAIEMOC-ZGNKEGEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6cs2</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB08164</td>
      <td>(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</td>
      <td>GOBIXGZJSMAOFV-QRWLVFNGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB05038</td>
      <td>Anatibant</td>
      <td>XUHBBTKJWIBQMY-MHZLTWQESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6cs2</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB06510</td>
      <td>Muraglitazar</td>
      <td>IRLWJILLXJGJTD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6vxx</td>
      <td>DB15257</td>
      <td>Milademetan</td>
      <td>RYAYYVTWKAOAJF-QISPRATLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB00324</td>
      <td>Fluorometholone</td>
      <td>FAOZLTXFLGPHNG-KNAQIMQKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB12550</td>
      <td>Taladegib</td>
      <td>SZBGQDXLNMELTB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB06558</td>
      <td>Tezosentan</td>
      <td>TUYWTLTWNJOZNY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB13931</td>
      <td>Netarsudil</td>
      <td>OURRXQUGYQRVML-AREMUKBSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB04006</td>
      <td>[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone</td>
      <td>WUGJIPFLBOATGL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6cs2</td>
      <td>DB13095</td>
      <td>JTK-853</td>
      <td>JQLOVYLALGSISI-HXUWFJFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w9c</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB11487</td>
      <td>Dexamethasone isonicotinate</td>
      <td>BQTXJHAJMDGOFI-NJLPOHDGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6vxx</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6vxx</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB00700</td>
      <td>Eplerenone</td>
      <td>JUKPWJGBANNWMW-VWBFHTRKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB11611</td>
      <td>Lifitegrast</td>
      <td>JFOZKMSJYSPYLN-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB09095</td>
      <td>Difluocortolone</td>
      <td>OGPWIDANBSLJPC-RFPWEZLHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6lxt</td>
      <td>DB14729</td>
      <td>Rebeccamycin</td>
      <td>QEHOIJJIZXRMAN-QZQSLCQPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB04690</td>
      <td>Camptothecin</td>
      <td>VSJKWCGYPAHWDS-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w9c</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB07549</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE</td>
      <td>WOYBPRBUPLYTPY-UHFFFAOYSA-P</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB12137</td>
      <td>GSK-256066</td>
      <td>JFHROPTYMMSOLG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w9c</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB02354</td>
      <td>4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine</td>
      <td>IRKPNOLLMNHSOU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB12929</td>
      <td>JNJ-39220675</td>
      <td>IQOWHZHNGJXGHG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m3m</td>
      <td>DB06997</td>
      <td>2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</td>
      <td>BMPOCDJEXAXXEZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w9c</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6m2n</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6w4h</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6crv</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.6</td>
      <td>6cs2</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6lzg</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6w9c</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB08429</td>
      <td>N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide</td>
      <td>QRGBOABBMKYMLG-UXHICEINSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6w9c</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB06455</td>
      <td>Meclinertant</td>
      <td>DYLJVOXRWLXDIG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB12355</td>
      <td>Netazepide</td>
      <td>YDZYKNJZCVIKPP-VWLOTQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB04408</td>
      <td>Ncs-Chromophore</td>
      <td>QZGIWPZCWHMVQL-UIYAJPBUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB13867</td>
      <td>Fluticasone</td>
      <td>MGNNYOODZCAHBA-GQKYHHCASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB07265</td>
      <td>3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID</td>
      <td>JDARUOOLJCFUOY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB07692</td>
      <td>1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine</td>
      <td>SHWNKRPMUBFWKE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxs</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxx</td>
      <td>DB01830</td>
      <td>{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid</td>
      <td>SPSGYTWOIGAABK-DQEYMECFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6cs2</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB03268</td>
      <td>RU82197</td>
      <td>WKTQBTSOHBKBRW-VMPREFPWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxx</td>
      <td>DB04703</td>
      <td>Hesperidin</td>
      <td>QUQPHWDTPGMPEX-QJBIFVCTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB11883</td>
      <td>SB-705498</td>
      <td>JYILLRHXRVTRSH-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6cs2</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB14555</td>
      <td>Ursadiol</td>
      <td>RTLXJEJRLWILSU-GWNGJUQLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB12491</td>
      <td>Fasiglifam</td>
      <td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB07031</td>
      <td>3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid</td>
      <td>AANFHDFOMFRLLR-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB13685</td>
      <td>Quingestanol</td>
      <td>PCJFRMOEZQQSAX-AIOSZGMZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB13307</td>
      <td>Proscillaridin</td>
      <td>MYEJFUXQJGHEQK-ALRJYLEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB11618</td>
      <td>Zorubicin</td>
      <td>FBTUMDXHSRTGRV-BJISBDEGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB07570</td>
      <td>3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID</td>
      <td>ZKEZEXYKYHYIMQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxx</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxs</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB04408</td>
      <td>Ncs-Chromophore</td>
      <td>QZGIWPZCWHMVQL-UIYAJPBUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB12186</td>
      <td>SRT-2104</td>
      <td>LAMQVIQMVKWXOC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxx</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxs</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxs</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB12480</td>
      <td>Betulinic Acid</td>
      <td>QGJZLNKBHJESQX-FZFNOLFKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6w9c</td>
      <td>DB11818</td>
      <td>Retosiban</td>
      <td>PLVGDGRBPMVYPB-FDUHJNRSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxx</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB12198</td>
      <td>Fosdagrocorat</td>
      <td>BVXLAHSJXXSWFF-KEKPKEOLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB12385</td>
      <td>10-hydroxycamptothecin</td>
      <td>HAWSQZCWOQZXHI-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB13042</td>
      <td>Fenoverine</td>
      <td>UBAJTZKNDCEGKL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6w9c</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6w9c</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB11819</td>
      <td>ASP-4058</td>
      <td>NJNXCJPSMWKXHO-VIFPVBQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB15414</td>
      <td>CM-4307</td>
      <td>MLDQJTXFUGDVEO-FIBGUPNXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6lxt</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB13490</td>
      <td>Hidrosmin</td>
      <td>XYFLWVOTXWXNAM-WTNNCJBMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6vxx</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB01514</td>
      <td>Furazabol</td>
      <td>RGLLOUBXMOGLDQ-IVEVATEUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6lxt</td>
      <td>DB13078</td>
      <td>KOSN-1724</td>
      <td>JAYGOFBXDFAXBW-CYEKYUJNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB09003</td>
      <td>Clocapramine</td>
      <td>QAZKXHSIKKNOHH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB00301</td>
      <td>Flucloxacillin</td>
      <td>UIOFUWFRIANQPC-JKIFEVAISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB02830</td>
      <td>FR236913</td>
      <td>KCCUBLLGAMGDJL-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB00596</td>
      <td>Ulobetasol</td>
      <td>LEHFPXVYPMWYQD-XHIJKXOTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB00663</td>
      <td>Flumethasone</td>
      <td>WXURHACBFYSXBI-GQKYHHCASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB13422</td>
      <td>Nicofuranose</td>
      <td>FUWFSXZKBMCSKF-ZASNTINBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB15450</td>
      <td>PF-05105679</td>
      <td>BXNMZRPTQFVRFA-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6w9c</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB04030</td>
      <td>1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole</td>
      <td>ADXYEWMDAGIULV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB11772</td>
      <td>Pilaralisib</td>
      <td>QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m2n</td>
      <td>DB01690</td>
      <td>Bis(Adenosine)-5'-Triphosphate</td>
      <td>QCICUPZZLIQAPA-XPWFQUROSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6w9c</td>
      <td>DB07629</td>
      <td>N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-DLBZAZTESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB02259</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide</td>
      <td>VSYGXLAJQDAWCZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB15057</td>
      <td>NUC-1031</td>
      <td>NHTKGYOMICWFQZ-KKQYNPQSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB14982</td>
      <td>Miransertib</td>
      <td>HNFMVVHMKGFCMB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6crv</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6w9c</td>
      <td>DB02194</td>
      <td>8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>ULLMMKZQNNBLRN-SANMLTNESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.5</td>
      <td>6m3m</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB11616</td>
      <td>Pirarubicin</td>
      <td>KMSKQZKKOZQFFG-YXRRJAAWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07041</td>
      <td>N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide</td>
      <td>FDJWFDQRPKKBFA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w4h</td>
      <td>DB11611</td>
      <td>Lifitegrast</td>
      <td>JFOZKMSJYSPYLN-QHCPKHFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6vxx</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6cs2</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07333</td>
      <td>N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE</td>
      <td>KRGKAARWVPUWSY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07362</td>
      <td>1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>UOLCZAFAGDOUFX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB01792</td>
      <td>Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate</td>
      <td>FZCSEXOMUJFOHQ-KPKSGTNCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w4h</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB11424</td>
      <td>Lufenuron</td>
      <td>PWPJGUXAGUPAHP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB04373</td>
      <td>4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</td>
      <td>WQUBEIMCFHCJCO-AWCRTANDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB02519</td>
      <td>Indirubin-5-Sulphonate</td>
      <td>IHBOEHLUIBMBMY-YPKPFQOOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB15403</td>
      <td>Ziritaxestat</td>
      <td>REQQVBGILUTQNN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6vxx</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6vxx</td>
      <td>DB03161</td>
      <td>Thymidine-5'-Diphospho-Beta-D-Xylose</td>
      <td>AJUADKZRQSBUAK-KDGZBOQCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB08005</td>
      <td>4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide</td>
      <td>ARMFMDYRYOKSOW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07026</td>
      <td>(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</td>
      <td>PPLDARNGJSQINK-OKZBNKHCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB12221</td>
      <td>Canrenone</td>
      <td>UJVLDDZCTMKXJK-WNHSNXHDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07190</td>
      <td>3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide</td>
      <td>JGFCNVHEEMBVJG-MOPGFXCFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB08497</td>
      <td>(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>NKBDSMREMMRFSI-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB07794</td>
      <td>5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</td>
      <td>XVECMUKVOMUNLE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB15183</td>
      <td>Fosmanogepix</td>
      <td>JQONJQKKVAHONF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6cs2</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB12207</td>
      <td>Verdinexor</td>
      <td>OPAKEJZFFCECPN-XQRVVYSFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07548</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE</td>
      <td>JXHWVKOKYDAROD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB15319</td>
      <td>VM4-037</td>
      <td>QGYZPMXIVNIGKA-GMAHTHKFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB08389</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UPTQSRGSSJRBKJ-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB13610</td>
      <td>Flumedroxone</td>
      <td>CDZJOBWKHSYNMO-SCUQKFFVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6cs2</td>
      <td>DB05835</td>
      <td>NS-3728</td>
      <td>OQRAKHDEGGGWQO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB01406</td>
      <td>Danazol</td>
      <td>POZRVZJJTULAOH-LHZXLZLDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB11794</td>
      <td>Berzosertib</td>
      <td>JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB12185</td>
      <td>Exatecan</td>
      <td>ZVYVPGLRVWUPMP-FYSMJZIKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB15197</td>
      <td>RSV-604</td>
      <td>MTPVBMVUENFFLL-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB06176</td>
      <td>Romidepsin</td>
      <td>OHRURASPPZQGQM-GCCNXGTGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB04764</td>
      <td>[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</td>
      <td>CCLHROFBSWWOQO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6cs2</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB00966</td>
      <td>Telmisartan</td>
      <td>RMMXLENWKUUMAY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB01003</td>
      <td>Cromoglicic acid</td>
      <td>IMZMKUWMOSJXDT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6vxx</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB06922</td>
      <td>2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>CZNPWASYMRBJCX-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB11750</td>
      <td>Clobetasol</td>
      <td>FCSHDIVRCWTZOX-DVTGEIKXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w4h</td>
      <td>DB13003</td>
      <td>Cortivazol</td>
      <td>RKHQGWMMUURILY-UHRZLXHJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6vxx</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB14675</td>
      <td>Temsavir</td>
      <td>QRPZBKAMSFHVRW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB12622</td>
      <td>Lupeol</td>
      <td>MQYXUWHLBZFQQO-QGTGJCAVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB03207</td>
      <td>2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid</td>
      <td>BNVMUDXGABBWGP-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB04608</td>
      <td>9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</td>
      <td>IAUZTOZLTFSMIE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB14649</td>
      <td>Dexamethasone acetate</td>
      <td>AKUJBENLRBOFTD-RPRRAYFGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6lzg</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6vxs</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB09003</td>
      <td>Clocapramine</td>
      <td>QAZKXHSIKKNOHH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB08487</td>
      <td>3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>PRMSFVUWLBPPLY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6cs2</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB12580</td>
      <td>Tradipitant</td>
      <td>CAVRKWRKTNINFF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6vxx</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB13003</td>
      <td>Cortivazol</td>
      <td>RKHQGWMMUURILY-UHRZLXHJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB08772</td>
      <td>3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID</td>
      <td>BCSVCWVQNOXFGL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w4h</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB08930</td>
      <td>Dolutegravir</td>
      <td>RHWKPHLQXYSBKR-BMIGLBTASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w4h</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m71</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB04724</td>
      <td>(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE</td>
      <td>COVPLULNDBDXTN-KYJUHHDHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB13040</td>
      <td>Gandotinib</td>
      <td>SQSZANZGUXWJEA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB04238</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid</td>
      <td>GNANSBQAIRJZPA-XZOQPEGZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB12725</td>
      <td>TD-8954</td>
      <td>MZOITCJKGUIQEI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB06888</td>
      <td>(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</td>
      <td>KBLPHMRCKHFBJB-OLZOCXBDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6cs2</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m3m</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6w9c</td>
      <td>DB11923</td>
      <td>Decoglurant</td>
      <td>DMJHZVARRXJSEG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6crv</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.4</td>
      <td>6m2n</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB15137</td>
      <td>VK-2809</td>
      <td>LGGPZDRLTDGYSQ-JADSYQMUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB12426</td>
      <td>Bitopertin</td>
      <td>YUUGYIUSCYNSQR-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB14214</td>
      <td>Rose bengal lactone</td>
      <td>IICCLYANAQEHCI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB14889</td>
      <td>Derazantinib</td>
      <td>KPJDVVCDVBFRMU-AREMUKBSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB12138</td>
      <td>PF-03715455</td>
      <td>VGEXRDWWPSGZDH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB05087</td>
      <td>Ganaxolone</td>
      <td>PGTVWKLGGCQMBR-FLBATMFCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w4h</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB12260</td>
      <td>Radiprodil</td>
      <td>GKGRZLGAQZPEHO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB01092</td>
      <td>Ouabain</td>
      <td>LPMXVESGRSUGHW-HBYQJFLCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB14034</td>
      <td>Darglitazone</td>
      <td>QQKNSPHAFATFNQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB06786</td>
      <td>Halcinonide</td>
      <td>MUQNGPZZQDCDFT-JNQJZLCISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB08164</td>
      <td>(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</td>
      <td>GOBIXGZJSMAOFV-QRWLVFNGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m71</td>
      <td>DB03632</td>
      <td>Argifin</td>
      <td>UHBHXSDKGLPPGO-HTDHLNIYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6lxt</td>
      <td>DB04408</td>
      <td>Ncs-Chromophore</td>
      <td>QZGIWPZCWHMVQL-UIYAJPBUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB07226</td>
      <td>N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE</td>
      <td>JWZVNUNTFNELHL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB11995</td>
      <td>Avatrombopag</td>
      <td>OFZJKCQENFPZBH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB14729</td>
      <td>Rebeccamycin</td>
      <td>QEHOIJJIZXRMAN-QZQSLCQPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB06920</td>
      <td>Eribaxaban</td>
      <td>QQBKAVAGLMGMHI-WIYYLYMNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m71</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB01289</td>
      <td>Glisoxepide</td>
      <td>ZKUDBRCEOBOWLF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB11870</td>
      <td>RG-4733</td>
      <td>OJPLJFIFUQPSJR-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB13053</td>
      <td>CP-195543</td>
      <td>NZQDWKCNBOELAI-KSFYIVLOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB14652</td>
      <td>Clocortolone acetate</td>
      <td>ARPLCFGLEYFDCN-CDACMRRYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB04177</td>
      <td>4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>XZTUSOXSLKTKJQ-CESUGQOBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB01745</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester</td>
      <td>JJLGQWCKMHPBEB-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB02432</td>
      <td>RU90395</td>
      <td>RLLAUERCSKPFGD-VMPREFPWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB08731</td>
      <td>2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>GPOKTQCDBPECSS-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6cs2</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB14942</td>
      <td>BMS-986141</td>
      <td>KEEBLYWBELVGPQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB11965</td>
      <td>SJG-136</td>
      <td>RWZVMMQNDHPRQD-SFTDATJTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB01690</td>
      <td>Bis(Adenosine)-5'-Triphosphate</td>
      <td>QCICUPZZLIQAPA-XPWFQUROSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB12002</td>
      <td>AZD-4818</td>
      <td>HVTUHSABWJPWNK-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB03311</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</td>
      <td>SXKBTDJJEQQEGE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB14568</td>
      <td>Ivosidenib</td>
      <td>WIJZXSAJMHAVGX-DHLKQENFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB02360</td>
      <td>Bis-Napthyl Beta-Ketophosphonic Acid</td>
      <td>OFHMUASCSJJNNA-JOCHJYFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w4h</td>
      <td>DB13053</td>
      <td>CP-195543</td>
      <td>NZQDWKCNBOELAI-KSFYIVLOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6vxs</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w9c</td>
      <td>DB12138</td>
      <td>PF-03715455</td>
      <td>VGEXRDWWPSGZDH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB15393</td>
      <td>Telatinib</td>
      <td>QFCXANHHBCGMAS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w9c</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w9c</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>7bv1</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB03311</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</td>
      <td>SXKBTDJJEQQEGE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w9c</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB03268</td>
      <td>RU82197</td>
      <td>WKTQBTSOHBKBRW-VMPREFPWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6lzg</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB04107</td>
      <td>[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester</td>
      <td>RNOYCNIZOAIUSV-LSWMGQQCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB08738</td>
      <td>1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one</td>
      <td>KWCKZIJGKMCYCI-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w9c</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6lzg</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB06677</td>
      <td>Clazosentan</td>
      <td>LFWCJABOXHSRGC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6vxx</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6lzg</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6vxs</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB15245</td>
      <td>Olorofim</td>
      <td>SUFPWYYDCOKDLL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB08971</td>
      <td>Fluocortolone</td>
      <td>GAKMQHDJQHZUTJ-ULHLPKEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB06945</td>
      <td>N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide</td>
      <td>FOSWRYKPHVPIDJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6vxx</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w9c</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB06497</td>
      <td>Aplaviroc</td>
      <td>GWNOTCOIYUNTQP-FQLXRVMXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB11645</td>
      <td>PF-4191834</td>
      <td>DVNQWYLVSNPCJZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6cs2</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6cs2</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB07993</td>
      <td>N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>LPQUIIHPUGDHJK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB00547</td>
      <td>Desoximetasone</td>
      <td>VWVSBHGCDBMOOT-IIEHVVJPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB00288</td>
      <td>Amcinonide</td>
      <td>ILKJAFIWWBXGDU-MOGDOJJUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB11878</td>
      <td>Filibuvir</td>
      <td>SLVAPEZTBDBAPI-GDLZYMKVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB09298</td>
      <td>Silibinin</td>
      <td>SEBFKMXJBCUCAI-HKTJVKLFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6cs2</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB06367</td>
      <td>Relacatib</td>
      <td>BWYBBMQLUKXECQ-GIVPXCGWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6cs2</td>
      <td>DB13029</td>
      <td>MK-0873</td>
      <td>JJWKQXNHYDJXKF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w9c</td>
      <td>DB04960</td>
      <td>Tipifarnib</td>
      <td>PLHJCIYEEKOWNM-HHHXNRCGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB09319</td>
      <td>Carindacillin</td>
      <td>JIRBAUWICKGBFE-MNRDOXJOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6lxt</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB04125</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine</td>
      <td>ZUWBXGHMVKDMQO-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB13138</td>
      <td>Neladenoson bialanate</td>
      <td>WESNEIGKOAXSGX-VXKWHMMOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB00845</td>
      <td>Clofazimine</td>
      <td>WDQPAMHFFCXSNU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB12225</td>
      <td>Beclabuvir</td>
      <td>ZTTKEBYSXUCBSE-QDFUAKMASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB00485</td>
      <td>Dicloxacillin</td>
      <td>YFAGHNZHGGCZAX-JKIFEVAISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6lxt</td>
      <td>DB12225</td>
      <td>Beclabuvir</td>
      <td>ZTTKEBYSXUCBSE-QDFUAKMASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB02033</td>
      <td>N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide</td>
      <td>GDRNWAKVNIROCG-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB04575</td>
      <td>Quinestrol</td>
      <td>PWZUUYSISTUNDW-VAFBSOEGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB05038</td>
      <td>Anatibant</td>
      <td>XUHBBTKJWIBQMY-MHZLTWQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB11614</td>
      <td>Rupatadine</td>
      <td>WUZYKBABMWJHDL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w4h</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB15442</td>
      <td>Trilaciclib</td>
      <td>PDGKHKMBHVFCMG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6w9c</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB06589</td>
      <td>Pazopanib</td>
      <td>CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m3m</td>
      <td>DB08906</td>
      <td>Fluticasone furoate</td>
      <td>XTULMSXFIHGYFS-VLSRWLAYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6vxx</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB04042</td>
      <td>2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol</td>
      <td>XLJNZONSWKENRP-VABIIVNOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6vxx</td>
      <td>DB12410</td>
      <td>Sabarubicin</td>
      <td>VQHRZZISQVWPLK-UIRGBLDSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6m2n</td>
      <td>DB15407</td>
      <td>Acalisib</td>
      <td>DOCINCLJNAXZQF-LBPRGKRZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.3</td>
      <td>6crv</td>
      <td>DB01026</td>
      <td>Ketoconazole</td>
      <td>XMAYWYJOQHXEEK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB14657</td>
      <td>Paramethasone acetate</td>
      <td>HYRKAAMZBDSJFJ-LFDBJOOHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m71</td>
      <td>DB13095</td>
      <td>JTK-853</td>
      <td>JQLOVYLALGSISI-HXUWFJFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB07630</td>
      <td>N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-IAGOWNOFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB06409</td>
      <td>Morphine glucuronide</td>
      <td>GNJCUHZOSOYIEC-GAROZEBRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB04154</td>
      <td>N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</td>
      <td>ALBWBHNFOJJMCV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB13491</td>
      <td>Fluperolone</td>
      <td>SLVCCRYLKTYUQP-DVTGEIKXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB04154</td>
      <td>N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</td>
      <td>ALBWBHNFOJJMCV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB12774</td>
      <td>AZD-8055</td>
      <td>KVLFRAWTRWDEDF-IRXDYDNUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxs</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12055</td>
      <td>MK-0767</td>
      <td>ORZMUVMQJPGFOM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB09143</td>
      <td>Sonidegib</td>
      <td>VZZJRYRQSPEMTK-CALCHBBNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB04301</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate</td>
      <td>ZLAHDRAQCSQPOC-UHFFFAOYSA-P</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB11618</td>
      <td>Zorubicin</td>
      <td>FBTUMDXHSRTGRV-BJISBDEGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB15444</td>
      <td>Elexacaftor</td>
      <td>MVRHVFSOIWFBTE-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB11772</td>
      <td>Pilaralisib</td>
      <td>QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB12165</td>
      <td>Presatovir</td>
      <td>GOFXWTVKPWJNGD-UWJYYQICSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m71</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB05263</td>
      <td>Caprospinol</td>
      <td>VMOZFSWFUBLCNN-AAPULDEBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB00223</td>
      <td>Diflorasone</td>
      <td>WXURHACBFYSXBI-XHIJKXOTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB07193</td>
      <td>(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</td>
      <td>HJJAYSSCWGUPKO-ABAIWWIYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB15437</td>
      <td>Rocacetrapib</td>
      <td>GBHPDJQHZADVAA-SOKVYYICSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m71</td>
      <td>DB13814</td>
      <td>Talampicillin</td>
      <td>SOROUYSPFADXSN-SUWVAFIASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB01948</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One</td>
      <td>VXIYTVJEIXMAQF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB00990</td>
      <td>Exemestane</td>
      <td>BFYIZQONLCFLEV-DAELLWKTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB15437</td>
      <td>Rocacetrapib</td>
      <td>GBHPDJQHZADVAA-SOKVYYICSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB08867</td>
      <td>Ulipristal</td>
      <td>HKDLNTKNLJPAIY-WKWWZUSTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB01100</td>
      <td>Pimozide</td>
      <td>YVUQSNJEYSNKRX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB03671</td>
      <td>4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>SHIBSTMRCDJXLN-KCZCNTNESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB14640</td>
      <td>Isoflupredone acetate</td>
      <td>ZOCUOMKMBMEYQV-GSLJADNHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB04244</td>
      <td>(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide</td>
      <td>YCDHZDINQZLSRR-DNQXCXABSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxs</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB04232</td>
      <td>N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide</td>
      <td>DNGGPLKVDUPXFN-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB11925</td>
      <td>Vistusertib</td>
      <td>JUSFANSTBFGBAF-IRXDYDNUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB14766</td>
      <td>Etrasimod</td>
      <td>MVGWUTBTXDYMND-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB01289</td>
      <td>Glisoxepide</td>
      <td>ZKUDBRCEOBOWLF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB01047</td>
      <td>Fluocinonide</td>
      <td>WJOHZNCJWYWUJD-IUGZLZTKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB12006</td>
      <td>BMS-906024</td>
      <td>AYOUDDAETNMCBW-GSHUGGBRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB05835</td>
      <td>NS-3728</td>
      <td>OQRAKHDEGGGWQO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB06844</td>
      <td>4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE</td>
      <td>MBXKBJLIESPLIK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB00941</td>
      <td>Hexafluronium</td>
      <td>HDZAQYPYABGTCL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB05936</td>
      <td>CVT-6883</td>
      <td>KOYXXLLNCXWUNF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB03583</td>
      <td>(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</td>
      <td>AYOAIABDFUJDKQ-SQJPUDIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB13164</td>
      <td>Olmutinib</td>
      <td>FDMQDKQUTRLUBU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB15169</td>
      <td>H3B-6527</td>
      <td>MBWRLLRCTIYXDW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB11637</td>
      <td>Delamanid</td>
      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB07779</td>
      <td>N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE</td>
      <td>ANQHSFFUNMTTRS-MOPGFXCFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w4h</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB11663</td>
      <td>Pictilisib</td>
      <td>LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB08883</td>
      <td>Perampanel</td>
      <td>PRMWGUBFXWROHD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB00443</td>
      <td>Betamethasone</td>
      <td>UREBDLICKHMUKA-DVTGEIKXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB04064</td>
      <td>Nogalaviketone</td>
      <td>QHNJNOBWURJIEK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB06518</td>
      <td>R-1487</td>
      <td>KKKRKRMVJRHDMG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB03076</td>
      <td>AHA047</td>
      <td>CGBDAHCDSVOMCF-FYZVQMPESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB02152</td>
      <td>K-252a</td>
      <td>KOZFSFOOLUUIGY-SOLYNIJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB06178</td>
      <td>Talotrexin</td>
      <td>NYQPLPNEESYGNO-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB08912</td>
      <td>Dabrafenib</td>
      <td>BFSMGDJOXZAERB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB12355</td>
      <td>Netazepide</td>
      <td>YDZYKNJZCVIKPP-VWLOTQADSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w4h</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB01234</td>
      <td>Dexamethasone</td>
      <td>UREBDLICKHMUKA-CXSFZGCWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB01216</td>
      <td>Finasteride</td>
      <td>DBEPLOCGEIEOCV-WSBQPABSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w4h</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB05611</td>
      <td>Apilimod</td>
      <td>HSKAZIJJKRAJAV-KOEQRZSOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB14896</td>
      <td>Selitrectinib</td>
      <td>OEBIHOVSAMBXIB-SJKOYZFVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB04190</td>
      <td>Inhibitor Bea425</td>
      <td>AHAVBKNGKPWROK-UMFPTGFGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12598</td>
      <td>Nafamostat</td>
      <td>MQQNFDZXWVTQEH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB03907</td>
      <td>N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide</td>
      <td>UHHBFOLQOQSPLU-WGRQDFERSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB06916</td>
      <td>N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE</td>
      <td>LBCGUKCXRVUULK-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12649</td>
      <td>Ibipinabant</td>
      <td>AXJQVVLKUYCICH-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB03311</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</td>
      <td>SXKBTDJJEQQEGE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB02483</td>
      <td>Etheno-Nad</td>
      <td>JCDBQDNBEQHDHK-BSLNIGMPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB14895</td>
      <td>Vibegron</td>
      <td>DJXRIQMCROIRCZ-XOEOCAAJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB12515</td>
      <td>9-aminocamptothecin</td>
      <td>FUXVKZWTXQUGMW-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB12511</td>
      <td>Imiglitazar</td>
      <td>ULVDFHLHKNJICZ-QCWLDUFUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB08407</td>
      <td>PLATENSIMYCIN</td>
      <td>CSOMAHTTWTVBFL-OFBLZTNGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12776</td>
      <td>E-6005</td>
      <td>BBTFKAOFCSOZMB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB06844</td>
      <td>4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE</td>
      <td>MBXKBJLIESPLIK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB13874</td>
      <td>Enasidenib</td>
      <td>DYLUUSLLRIQKOE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB08822</td>
      <td>Azilsartan medoxomil</td>
      <td>QJFSABGVXDWMIW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB01691</td>
      <td>Indole Naphthyridinone</td>
      <td>VAZMNDXVXVUKFY-JXMROGBWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12562</td>
      <td>Setipiprant</td>
      <td>IHAXLPDVOWLUOS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB01067</td>
      <td>Glipizide</td>
      <td>ZJJXGWJIGJFDTL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB07943</td>
      <td>2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol</td>
      <td>CATQHDWESBRRQA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB07031</td>
      <td>3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid</td>
      <td>AANFHDFOMFRLLR-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB00972</td>
      <td>Azelastine</td>
      <td>MBUVEWMHONZEQD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB12269</td>
      <td>PF-06273340</td>
      <td>BPIWZDNVMQQBQX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB08731</td>
      <td>2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>GPOKTQCDBPECSS-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB08057</td>
      <td>N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine</td>
      <td>VWJPPYCULHDHBB-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12465</td>
      <td>Ketanserin</td>
      <td>FPCCSQOGAWCVBH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12467</td>
      <td>TU-100</td>
      <td>KAYRGFYBCCETPE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w4h</td>
      <td>DB07326</td>
      <td>6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</td>
      <td>FEGRQUWSKADGSP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB04983</td>
      <td>Denufosol</td>
      <td>FPNPSEMJLALQSA-MIYUEGBISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB04703</td>
      <td>Hesperidin</td>
      <td>QUQPHWDTPGMPEX-QJBIFVCTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB06963</td>
      <td>3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide</td>
      <td>ZFGCLYUGFRNYFE-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB02217</td>
      <td>Dpb-T</td>
      <td>WTZFKHNHHRPQOU-WSMBLCCSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12272</td>
      <td>Vidupiprant</td>
      <td>PFWVGKROPKKEDW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB11176</td>
      <td>Zeaxanthin</td>
      <td>JKQXZKUSFCKOGQ-QAYBQHTQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6lxt</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6lxt</td>
      <td>DB06515</td>
      <td>Resiniferatoxin</td>
      <td>DSDNAKHZNJAGHN-MXTYGGKSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB03157</td>
      <td>N,O-Didansyl-L-Tyrosine</td>
      <td>LUBOPDUYHWABFG-NDEPHWFRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB15092</td>
      <td>LY-2624803</td>
      <td>UEFWDVMEDFCHGW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6lxt</td>
      <td>DB05129</td>
      <td>Elsamitrucin</td>
      <td>MGQRRMONVLMKJL-KWJIQSIXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB05327</td>
      <td>Ranirestat</td>
      <td>QCVNMNYRNIMDKV-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB11751</td>
      <td>Cabotegravir</td>
      <td>WCWSTNLSLKSJPK-LKFCYVNXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6lxt</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB15460</td>
      <td>AGG-523</td>
      <td>JWQMTWCFNZSLNR-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB01933</td>
      <td>7-Hydroxystaurosporine</td>
      <td>PBCZSGKMGDDXIJ-HQCWYSJUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB15281</td>
      <td>Ravoxertinib</td>
      <td>RZUOCXOYPYGSKL-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB15246</td>
      <td>Salvianolic acid A</td>
      <td>YMGFTDKNIWPMGF-UCPJVGPRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB11892</td>
      <td>Prulifloxacin</td>
      <td>PWNMXPDKBYZCOO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB11984</td>
      <td>Letaxaban</td>
      <td>GEHAEMCVKDPMKO-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB02010</td>
      <td>Staurosporine</td>
      <td>HKSZLNNOFSGOKW-FYTWVXJKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>7bv1</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB14822</td>
      <td>SB-649868</td>
      <td>ZJXIUGNEAIHSBI-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB05667</td>
      <td>Levoketoconazole</td>
      <td>XMAYWYJOQHXEEK-ZEQKJWHPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB13764</td>
      <td>Monoxerutin</td>
      <td>MBHXKZDTQCSVPM-BDAFLREQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB11622</td>
      <td>Dehydrocholic acid</td>
      <td>OHXPGWPVLFPUSM-KLRNGDHRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w4h</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB13997</td>
      <td>Baloxavir marboxil</td>
      <td>RZVPBGBYGMDSBG-GGAORHGYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB08911</td>
      <td>Trametinib</td>
      <td>LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB06717</td>
      <td>Fosaprepitant</td>
      <td>BARDROPHSZEBKC-OITMNORJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6lxt</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12973</td>
      <td>Serlopitant</td>
      <td>FLNYCRJBCNNHRH-OIYLJQICSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6lxt</td>
      <td>DB15193</td>
      <td>BMS-955176</td>
      <td>XDMUFNNPLXHNKA-ZTESCHFWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB11995</td>
      <td>Avatrombopag</td>
      <td>OFZJKCQENFPZBH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB12973</td>
      <td>Serlopitant</td>
      <td>FLNYCRJBCNNHRH-OIYLJQICSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6lzg</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6lxt</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB03583</td>
      <td>(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</td>
      <td>AYOAIABDFUJDKQ-SQJPUDIVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB11450</td>
      <td>Pimobendan</td>
      <td>GLBJJMFZWDBELO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB13164</td>
      <td>Olmutinib</td>
      <td>FDMQDKQUTRLUBU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB07794</td>
      <td>5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</td>
      <td>XVECMUKVOMUNLE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB13078</td>
      <td>KOSN-1724</td>
      <td>JAYGOFBXDFAXBW-CYEKYUJNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxx</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB12260</td>
      <td>Radiprodil</td>
      <td>GKGRZLGAQZPEHO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxs</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB12101</td>
      <td>CC-220</td>
      <td>IXZOHGPZAQLIBH-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6vxs</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB07450</td>
      <td>(R)-minalrestat</td>
      <td>BMHZAHGTGIZZCT-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m2n</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB13003</td>
      <td>Cortivazol</td>
      <td>RKHQGWMMUURILY-UHRZLXHJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB15297</td>
      <td>Petesicatib</td>
      <td>KXAAIORSMACJSI-AEFFLSMTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6cs2</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6crv</td>
      <td>DB08444</td>
      <td>3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile</td>
      <td>YYGZQXRLQMFHDH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6w9c</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB07294</td>
      <td>3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid</td>
      <td>AANFHDFOMFRLLR-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB13158</td>
      <td>Clobetasone</td>
      <td>XXIFVOHLGBURIG-OZCCCYNHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.2</td>
      <td>6m3m</td>
      <td>DB07456</td>
      <td>3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>7bv1</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>7bv1</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m71</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB12858</td>
      <td>LY-377604</td>
      <td>RBSGUQYXRDKPAE-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB12798</td>
      <td>Relenopride</td>
      <td>KGMMSPVVHZGPHL-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12465</td>
      <td>Ketanserin</td>
      <td>FPCCSQOGAWCVBH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB14879</td>
      <td>Cefiderocol</td>
      <td>DBPPRLRVDVJOCL-FQRUVTKNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB06834</td>
      <td>N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide</td>
      <td>XZRYCTLOGNCQDG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB14669</td>
      <td>Betamethasone phosphate</td>
      <td>VQODGRNSFPNSQE-DVTGEIKXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>7bv1</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB03932</td>
      <td>LFA703</td>
      <td>WPVRNXUYVXQXPY-YFAYRSKXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB02008</td>
      <td>1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine</td>
      <td>JHSHXKJSPVHPCJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB07369</td>
      <td>N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide</td>
      <td>YMJLSOJLEXWATP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxx</td>
      <td>DB11853</td>
      <td>Relugolix</td>
      <td>AOMXMOCNKJTRQP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB02732</td>
      <td>Nicotinamide Adenine Dinucleotide Acetone Adduct</td>
      <td>SGHBFOOIAAJJMI-YDKVLQLQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB04971</td>
      <td>Reglitazar</td>
      <td>QBQLYIISSRXYKL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxx</td>
      <td>DB11431</td>
      <td>Moxidectin</td>
      <td>YZBLFMPOMVTDJY-LSGXYNIPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB04960</td>
      <td>Tipifarnib</td>
      <td>PLHJCIYEEKOWNM-HHHXNRCGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB15168</td>
      <td>Cilofexor</td>
      <td>KZSKGLFYQAYZCO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB07382</td>
      <td>N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine</td>
      <td>WJNBSTLIALIIEW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxs</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB01678</td>
      <td>RU84687</td>
      <td>SAFPHFWYRLLBFO-NSOVKSMOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB05812</td>
      <td>Abiraterone</td>
      <td>GZOSMCIZMLWJML-VJLLXTKPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB03632</td>
      <td>Argifin</td>
      <td>UHBHXSDKGLPPGO-HTDHLNIYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB14634</td>
      <td>Fluprednidene acetate</td>
      <td>DEFOZIFYUBUHHU-IYQKUMFPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB13104</td>
      <td>X-396</td>
      <td>ONPGOSVDVDPBCY-CQSZACIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB11614</td>
      <td>Rupatadine</td>
      <td>WUZYKBABMWJHDL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m71</td>
      <td>DB15367</td>
      <td>LY-2623091</td>
      <td>YPCLDHGBEKZGEB-RUDKWAFVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12644</td>
      <td>AZD-2066</td>
      <td>SXWHYTICXCLKDG-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB06117</td>
      <td>1alpha,24S-Dihydroxyvitamin D2</td>
      <td>ODZFJAXAEXQSKL-WRJREGAQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB13019</td>
      <td>Henatinib</td>
      <td>MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB15310</td>
      <td>Vactosertib</td>
      <td>FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB04875</td>
      <td>Pralnacasan</td>
      <td>CXAGHAZMQSCAKJ-WAHHBDPQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB11652</td>
      <td>Tucatinib</td>
      <td>SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB04882</td>
      <td>Edotecarin</td>
      <td>QMVPQBFHUJZJCS-NTKFZFFISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB07800</td>
      <td>N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE</td>
      <td>MIJGLXFQYBTIFY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB03186</td>
      <td>U-Pi-a-Pi</td>
      <td>JIAJERGOUFOENU-LNAOLWRRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB13607</td>
      <td>Picloxydine</td>
      <td>YNCLPFSAZFGQCD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB01830</td>
      <td>{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid</td>
      <td>SPSGYTWOIGAABK-DQEYMECFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12553</td>
      <td>Fluocinolone</td>
      <td>UUOUOERPONYGOS-CLCRDYEYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB06886</td>
      <td>N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL</td>
      <td>MACLRJNEKXUAJK-YDLSIGKMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB02432</td>
      <td>RU90395</td>
      <td>RLLAUERCSKPFGD-VMPREFPWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB02498</td>
      <td>Carba-Nicotinamide-Adenine-Dinucleotide</td>
      <td>DGPLSUKWXXSBCU-VGXGLJSLSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB02581</td>
      <td>5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</td>
      <td>VNZHOIDQBPFEJU-OAQYLSRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB13941</td>
      <td>Piperaquine</td>
      <td>UCRHFBCYFMIWHC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m71</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB12693</td>
      <td>Ritanserin</td>
      <td>JUQLTPCYUFPYKE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxx</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB04204</td>
      <td>[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid</td>
      <td>SRHSAABKYJDBDV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB12682</td>
      <td>Mubritinib</td>
      <td>ZTFBIUXIQYRUNT-MDWZMJQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB01177</td>
      <td>Idarubicin</td>
      <td>XDXDZDZNSLXDNA-TZNDIEGXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB09143</td>
      <td>Sonidegib</td>
      <td>VZZJRYRQSPEMTK-CALCHBBNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6lxt</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB06229</td>
      <td>Ocaperidone</td>
      <td>ZZQNEJILGNNOEP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB09233</td>
      <td>Cronidipine</td>
      <td>CNIJVNPIIHWRRP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB06248</td>
      <td>Amelubant</td>
      <td>SBVYURPQULDJTI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB14669</td>
      <td>Betamethasone phosphate</td>
      <td>VQODGRNSFPNSQE-DVTGEIKXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB02524</td>
      <td>2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)</td>
      <td>XFMMHXLUHKBKQE-UHEGPQQHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxs</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB02668</td>
      <td>Je-2147, Ag1776, Kni-764</td>
      <td>CUFQBQOBLVLKRF-RZDMPUFOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB03367</td>
      <td>PF-00356231</td>
      <td>VMTJQZUZINLEKC-JOCHJYFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB03893</td>
      <td>Thionicotinamide-Adenine-Dinucleotide</td>
      <td>UQYPZLRUJKCREN-NNYOXOHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB14859</td>
      <td>Fosifloxuridine nafalbenamide</td>
      <td>BIOWRMNRHMERIO-ZVAHOJSLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB03460</td>
      <td>Violaxanthin</td>
      <td>SZCBXWMUOPQSOX-WVJDLNGLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB05465</td>
      <td>Tandutinib</td>
      <td>UXXQOJXBIDBUAC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB07665</td>
      <td>N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>STHCHQXQLDMISY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB02483</td>
      <td>Etheno-Nad</td>
      <td>JCDBQDNBEQHDHK-BSLNIGMPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>7bv1</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB08730</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</td>
      <td>CPFBZMFUCGHBAP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB14929</td>
      <td>Elsulfavirine</td>
      <td>ULTDEARCBRNRGR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12041</td>
      <td>Mapracorat</td>
      <td>VJGFOYBQOIPQFY-XMMPIXPASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB15137</td>
      <td>VK-2809</td>
      <td>LGGPZDRLTDGYSQ-JADSYQMUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB15145</td>
      <td>Ziresovir</td>
      <td>GAAICKUTDBZCMT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB08520</td>
      <td>(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE</td>
      <td>VUCSBBBCFXBFFY-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB15367</td>
      <td>LY-2623091</td>
      <td>YPCLDHGBEKZGEB-RUDKWAFVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB14993</td>
      <td>Pyrotinib</td>
      <td>SADXACCFNXBCFY-IYNHSRRRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB11769</td>
      <td>Funapide</td>
      <td>NEBUOXBYNAHKFV-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB09073</td>
      <td>Palbociclib</td>
      <td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB07296</td>
      <td>(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE</td>
      <td>PLGHLEBIWUQEPR-PDGQHHTCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB01134</td>
      <td>Desoxycorticosterone pivalate</td>
      <td>VVOIQBFMTVCINR-WWMZEODYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB09319</td>
      <td>Carindacillin</td>
      <td>JIRBAUWICKGBFE-MNRDOXJOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxx</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB01948</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One</td>
      <td>VXIYTVJEIXMAQF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB08197</td>
      <td>(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime</td>
      <td>KYIXUSLGFINPTC-WVFAEZDRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB00288</td>
      <td>Amcinonide</td>
      <td>ILKJAFIWWBXGDU-MOGDOJJUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB09215</td>
      <td>Droxicam</td>
      <td>OEHFRZLKGRKFAS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB07991</td>
      <td>N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE</td>
      <td>APLJSSOXDWUNGV-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxx</td>
      <td>DB12394</td>
      <td>Eleclazine</td>
      <td>YNUAEEJQYHYLMS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB14568</td>
      <td>Ivosidenib</td>
      <td>WIJZXSAJMHAVGX-DHLKQENFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB06920</td>
      <td>Eribaxaban</td>
      <td>QQBKAVAGLMGMHI-WIYYLYMNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB08881</td>
      <td>Vemurafenib</td>
      <td>GPXBXXGIAQBQNI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxx</td>
      <td>DB12412</td>
      <td>Gemigliptin</td>
      <td>ZWPRRQZNBDYKLH-VIFPVBQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB13104</td>
      <td>X-396</td>
      <td>ONPGOSVDVDPBCY-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB00620</td>
      <td>Triamcinolone</td>
      <td>GFNANZIMVAIWHM-OBYCQNJPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB09063</td>
      <td>Ceritinib</td>
      <td>VERWOWGGCGHDQE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>2fxp</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>HR2</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w4b</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB08906</td>
      <td>Fluticasone furoate</td>
      <td>XTULMSXFIHGYFS-VLSRWLAYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB01030</td>
      <td>Topotecan</td>
      <td>UCFGDBYHRUNTLO-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB13371</td>
      <td>Difenpiramide</td>
      <td>PWHROYKAGRUWDQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w4h</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB07297</td>
      <td>5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE</td>
      <td>PTILEOLOGGMFCS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m71</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB03141</td>
      <td>3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril</td>
      <td>UYUWNNRWESUYOB-FIRIVFDPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB01573</td>
      <td>Benzylmorphine</td>
      <td>RDJGWRFTDZZXSM-RNWLQCGYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m71</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB07204</td>
      <td>(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</td>
      <td>DQIXTEDFNFZMCM-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB01148</td>
      <td>Flavoxate</td>
      <td>SPIUTQOUKAMGCX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB00796</td>
      <td>Candesartan cilexetil</td>
      <td>GHOSNRCGJFBJIB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB07254</td>
      <td>N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</td>
      <td>KQGTYXRWSIBDOZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB00687</td>
      <td>Fludrocortisone</td>
      <td>AAXVEMMRQDVLJB-BULBTXNYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m71</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxs</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB02338</td>
      <td>Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate</td>
      <td>ACFIXJIJDZMPPO-NNYOXOHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w4h</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB00838</td>
      <td>Clocortolone</td>
      <td>YMTMADLUXIRMGX-RFPWEZLHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB02519</td>
      <td>Indirubin-5-Sulphonate</td>
      <td>IHBOEHLUIBMBMY-YPKPFQOOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB13756</td>
      <td>Peruvoside</td>
      <td>PMTSPAGBAFCORP-HBUONDEYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB06364</td>
      <td>XR5944</td>
      <td>SFOADSRLCHRTKT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxs</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB06959</td>
      <td>(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine</td>
      <td>BUCZDJYEOAQTHL-KEKNWZKVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB04875</td>
      <td>Pralnacasan</td>
      <td>CXAGHAZMQSCAKJ-WAHHBDPQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9q</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB07008</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE</td>
      <td>XPXGYINSBORUMM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxs</td>
      <td>DB15403</td>
      <td>Ziritaxestat</td>
      <td>REQQVBGILUTQNN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB12420</td>
      <td>Diazepinomicin</td>
      <td>SALVHVNECODMJP-GNUCVDFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB08164</td>
      <td>(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</td>
      <td>GOBIXGZJSMAOFV-QRWLVFNGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxx</td>
      <td>DB01690</td>
      <td>Bis(Adenosine)-5'-Triphosphate</td>
      <td>QCICUPZZLIQAPA-XPWFQUROSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB12270</td>
      <td>Losmapimod</td>
      <td>KKYABQBFGDZVNQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB13954</td>
      <td>Estradiol cypionate</td>
      <td>UOACKFBJUYNSLK-XRKIENNPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6vxx</td>
      <td>DB02194</td>
      <td>8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>ULLMMKZQNNBLRN-SANMLTNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB06367</td>
      <td>Relacatib</td>
      <td>BWYBBMQLUKXECQ-GIVPXCGWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB06497</td>
      <td>Aplaviroc</td>
      <td>GWNOTCOIYUNTQP-FQLXRVMXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB06229</td>
      <td>Ocaperidone</td>
      <td>ZZQNEJILGNNOEP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB12394</td>
      <td>Eleclazine</td>
      <td>YNUAEEJQYHYLMS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB12186</td>
      <td>SRT-2104</td>
      <td>LAMQVIQMVKWXOC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB12410</td>
      <td>Sabarubicin</td>
      <td>VQHRZZISQVWPLK-UIRGBLDSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB04859</td>
      <td>Zanapezil</td>
      <td>PMBLXLOXUGVTGB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB12307</td>
      <td>Foretinib</td>
      <td>CXQHYVUVSFXTMY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB06962</td>
      <td>(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone</td>
      <td>YKTUSHSSKIWDRY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB12805</td>
      <td>Ataciguat</td>
      <td>PQHLRGARXNPFCF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB08448</td>
      <td>(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol</td>
      <td>PCBWLKUEKANDCL-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6crv</td>
      <td>DB07778</td>
      <td>FAMOXADONE</td>
      <td>PCCSBWNGDMYFCW-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB12721</td>
      <td>RO-5028442</td>
      <td>QZXVLRCMAHJVIP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m2n</td>
      <td>DB04685</td>
      <td>1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>GJNIPWYJQUGERM-BFLUCZKCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6m3m</td>
      <td>DB06212</td>
      <td>Tolvaptan</td>
      <td>GYHCTFXIZSNGJT-XMMPIXPASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB06469</td>
      <td>Lestaurtinib</td>
      <td>UIARLYUEJFELEN-DMVVYWCZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB07993</td>
      <td>N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>LPQUIIHPUGDHJK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6w9c</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.1</td>
      <td>6cs2</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB09383</td>
      <td>Meprednisone</td>
      <td>PIDANAQULIKBQS-RNUIGHNZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lxt</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB15011</td>
      <td>Avacopan</td>
      <td>PUKBOVABABRILL-YZNIXAGQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB03453</td>
      <td>(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester</td>
      <td>MRNGXYMKYHNMLV-PKTZIBPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB13919</td>
      <td>Candesartan</td>
      <td>HTQMVQVXFRQIKW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB12207</td>
      <td>Verdinexor</td>
      <td>OPAKEJZFFCECPN-XQRVVYSFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB03638</td>
      <td>Cytidyl-2'-5'-Phospho-Guanosine</td>
      <td>QZDUXDLOEVJGDG-VMIOUTBZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB07000</td>
      <td>N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide</td>
      <td>ILXJWLWSYAWJKZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB03642</td>
      <td>Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</td>
      <td>VBPPNJCVXGAZDD-PMACEKPBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB15121</td>
      <td>AT-001</td>
      <td>YRGPAXAVTDMKDK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB06624</td>
      <td>Taranabant</td>
      <td>QLYKJCMUNUWAGO-GAJHUEQPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lxt</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB03768</td>
      <td>N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3</td>
      <td>WRUVOSYKHXGAQN-GKRYNVPLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB13138</td>
      <td>Neladenoson bialanate</td>
      <td>WESNEIGKOAXSGX-VXKWHMMOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB09054</td>
      <td>Idelalisib</td>
      <td>IFSDAJWBUCMOAH-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB11529</td>
      <td>Melengestrol</td>
      <td>OKHAOBQKCCIRLO-IBVJIVQJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12996</td>
      <td>Acteoside</td>
      <td>FBSKJMQYURKNSU-ZLSOWSIRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB11522</td>
      <td>Isoflupredone</td>
      <td>WAIJIHDWAKJCBX-BULBTXNYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB00223</td>
      <td>Diflorasone</td>
      <td>WXURHACBFYSXBI-XHIJKXOTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB00823</td>
      <td>Ethynodiol diacetate</td>
      <td>ONKUMRGIYFNPJW-KIEAKMPYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB11371</td>
      <td>Alfaxalone</td>
      <td>DUHUCHOQIDJXAT-OLVMNOGESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB02567</td>
      <td>PD173955</td>
      <td>VAARYSWULJUGST-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lxt</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07124</td>
      <td>(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>CCIACUJJBPSOHE-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB13101</td>
      <td>4SC-202</td>
      <td>PRXXYMVLYKJITB-IZZDOVSWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07270</td>
      <td>N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE</td>
      <td>GAYYMURZGLJDCT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB07334</td>
      <td>N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</td>
      <td>HTIZPBXCJPQDEM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB04020</td>
      <td>4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol</td>
      <td>AIBKIFHSQQYXLG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxs</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB13094</td>
      <td>Pruvanserin</td>
      <td>AQRLDDAFYYAIJP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxs</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB12419</td>
      <td>HSD-016</td>
      <td>ZWASRJHIEFYJGL-BFUOFWGJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB12306</td>
      <td>Cipargamin</td>
      <td>CKLPLPZSUQEDRT-WPCRTTGESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m71</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB14856</td>
      <td>PF-05089771</td>
      <td>ZYSCOUXLBXGGIM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lxt</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB00251</td>
      <td>Terconazole</td>
      <td>BLSQLHNBWJLIBQ-OZXSUGGESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB02033</td>
      <td>N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide</td>
      <td>GDRNWAKVNIROCG-DEOSSOPVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB12996</td>
      <td>Acteoside</td>
      <td>FBSKJMQYURKNSU-ZLSOWSIRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lxt</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB00253</td>
      <td>Medrysone</td>
      <td>GZENKSODFLBBHQ-ILSZZQPISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m71</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lxt</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB00396</td>
      <td>Progesterone</td>
      <td>RJKFOVLPORLFTN-LEKSSAKUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB13215</td>
      <td>Sulfobromophthalein</td>
      <td>OHTXTCNTQJFRIG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB02033</td>
      <td>N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide</td>
      <td>GDRNWAKVNIROCG-DEOSSOPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB13040</td>
      <td>Gandotinib</td>
      <td>SQSZANZGUXWJEA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lzg</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08459</td>
      <td>3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>SVMHTBVIPYVDIL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB12467</td>
      <td>TU-100</td>
      <td>KAYRGFYBCCETPE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12024</td>
      <td>PF-04418948</td>
      <td>LWJGMYMNSNVCEM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB09199</td>
      <td>Netoglitazone</td>
      <td>PKWDZWYVIHVNKS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB14681</td>
      <td>Cortisone</td>
      <td>MFYSYFVPBJMHGN-ZPOLXVRWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB00910</td>
      <td>Paricalcitol</td>
      <td>BPKAHTKRCLCHEA-UBFJEZKGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB02241</td>
      <td>8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>HOSWCJDTHOAORT-SANMLTNESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB11965</td>
      <td>SJG-136</td>
      <td>RWZVMMQNDHPRQD-SFTDATJTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB08881</td>
      <td>Vemurafenib</td>
      <td>GPXBXXGIAQBQNI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB06302</td>
      <td>Glesatinib</td>
      <td>YRCHYHRCBXNYNU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB02008</td>
      <td>1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine</td>
      <td>JHSHXKJSPVHPCJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB15266</td>
      <td>TAK-580</td>
      <td>VWMJHAFYPMOMGF-ZCFIWIBFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9q</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB01384</td>
      <td>Paramethasone</td>
      <td>MKPDWECBUAZOHP-AFYJWTTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB01380</td>
      <td>Cortisone acetate</td>
      <td>ITRJWOMZKQRYTA-RFZYENFJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB11859</td>
      <td>Brexanolone</td>
      <td>AURFZBICLPNKBZ-SYBPFIFISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12910</td>
      <td>Emicerfont</td>
      <td>JFHJGXQFESYQGY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB02009</td>
      <td>L-756,423</td>
      <td>AOMZDQMIOCTPQP-QHQMVRJISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB06334</td>
      <td>Tucidinostat</td>
      <td>SZMJVTADHFNAIS-BJMVGYQFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB14723</td>
      <td>Larotrectinib</td>
      <td>NYNZQNWKBKUAII-KBXCAEBGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB06747</td>
      <td>ginkgolide-M</td>
      <td>KDKROYXEHCYLJQ-FJFAJXJPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxs</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07107</td>
      <td>(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE</td>
      <td>SGHXFHRRWFLILP-XJDXJNMNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB11878</td>
      <td>Filibuvir</td>
      <td>SLVAPEZTBDBAPI-GDLZYMKVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB03020</td>
      <td>5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</td>
      <td>UINNILASBHZOTM-KMXXXSRASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB06976</td>
      <td>1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA</td>
      <td>IWOOJEZSDPRYAZ-WFASDCNBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB01831</td>
      <td>Tryptophanyl-5'amp</td>
      <td>IFQVDHDRFCKAAW-SQIXAUHQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB03020</td>
      <td>5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</td>
      <td>UINNILASBHZOTM-KMXXXSRASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB08747</td>
      <td>(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one</td>
      <td>JJTPPGUNMJMPLY-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB01933</td>
      <td>7-Hydroxystaurosporine</td>
      <td>PBCZSGKMGDDXIJ-HQCWYSJUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB15403</td>
      <td>Ziritaxestat</td>
      <td>REQQVBGILUTQNN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB07630</td>
      <td>N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-IAGOWNOFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB07607</td>
      <td>4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>RXDZANYWRNIAOR-HHHXNRCGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB03157</td>
      <td>N,O-Didansyl-L-Tyrosine</td>
      <td>LUBOPDUYHWABFG-NDEPHWFRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB15437</td>
      <td>Rocacetrapib</td>
      <td>GBHPDJQHZADVAA-SOKVYYICSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB13607</td>
      <td>Picloxydine</td>
      <td>YNCLPFSAZFGQCD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08197</td>
      <td>(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime</td>
      <td>KYIXUSLGFINPTC-WVFAEZDRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB03076</td>
      <td>AHA047</td>
      <td>CGBDAHCDSVOMCF-FYZVQMPESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08174</td>
      <td>5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE</td>
      <td>QCPYHSAHOYXXQK-DLBZAZTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07143</td>
      <td>D-phenylalanyl-N-benzyl-L-prolinamide</td>
      <td>MEPJWLFTTFHOQO-MOPGFXCFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB13806</td>
      <td>Linopirdine</td>
      <td>YEJCDKJIEMIWRQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>7bv1</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB07084</td>
      <td>N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</td>
      <td>YHKGWOJTUMJPNW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB01336</td>
      <td>Metocurine</td>
      <td>JFXBEKISTKFVAB-AJQTZOPKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB13791</td>
      <td>Penfluridol</td>
      <td>MDLAAYDRRZXJIF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB12134</td>
      <td>Gepotidacin</td>
      <td>PZFAZQUREQIODZ-LJQANCHMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB01871</td>
      <td>[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester</td>
      <td>OACUXIVGLLCILS-ZEQRLZLVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxs</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lxt</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08930</td>
      <td>Dolutegravir</td>
      <td>RHWKPHLQXYSBKR-BMIGLBTASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB14625</td>
      <td>Meprednisone acetate</td>
      <td>RZAMUHXEOMZXET-ABQXZQTJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB12036</td>
      <td>Naquotinib</td>
      <td>QKDCLUARMDUUKN-XMMPIXPASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB01184</td>
      <td>Domperidone</td>
      <td>FGXWKSZFVQUSTL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB11870</td>
      <td>RG-4733</td>
      <td>OJPLJFIFUQPSJR-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB12336</td>
      <td>GDC-0917</td>
      <td>HSHPBORBOJIXSQ-HARLFGEKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB14942</td>
      <td>BMS-986141</td>
      <td>KEEBLYWBELVGPQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB04432</td>
      <td>ZK-805623</td>
      <td>ZXIHYCYAQUQHSG-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB09095</td>
      <td>Difluocortolone</td>
      <td>OGPWIDANBSLJPC-RFPWEZLHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB14207</td>
      <td>Fosinoprilat</td>
      <td>WOIWWYDXDVSWAZ-RTWAWAEBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m71</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08493</td>
      <td>5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID</td>
      <td>AKWKBACKRMYPRV-NQIIRXRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB12756</td>
      <td>TAK-901</td>
      <td>WKDACQVEJIVHMZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB12130</td>
      <td>Lorlatinib</td>
      <td>IIXWYSCJSQVBQM-LLVKDONJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12535</td>
      <td>AC-430</td>
      <td>DCRWIATZWHLIPN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB14675</td>
      <td>Temsavir</td>
      <td>QRPZBKAMSFHVRW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07844</td>
      <td>6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE</td>
      <td>PHLKBODTBJLXRD-WFASDCNBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB00641</td>
      <td>Simvastatin</td>
      <td>RYMZZMVNJRMUDD-HGQWONQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB11796</td>
      <td>Fostemsavir</td>
      <td>SWMDAPWAQQTBOG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB03268</td>
      <td>RU82197</td>
      <td>WKTQBTSOHBKBRW-VMPREFPWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB14152</td>
      <td>Ginsenosides</td>
      <td>NLHQJXWYMZLQJY-SWIZOJJJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB13055</td>
      <td>Oteseconazole</td>
      <td>IDUYJRXRDSPPRC-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07839</td>
      <td>N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE</td>
      <td>VFNWTXUFNNOQHD-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB13520</td>
      <td>Metergoline</td>
      <td>WZHJKEUHNJHDLS-QTGUNEKASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB06717</td>
      <td>Fosaprepitant</td>
      <td>BARDROPHSZEBKC-OITMNORJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12571</td>
      <td>Rimacalib</td>
      <td>MYTIJGWONQOOLC-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07848</td>
      <td>5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide</td>
      <td>BHNMMFGOJRIAEZ-LRDDRELGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB03213</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-P</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB04849</td>
      <td>Cediranib</td>
      <td>XXJWYDDUDKYVKI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB11804</td>
      <td>AZD-5672</td>
      <td>SCXSQUUTGCWHFU-WJOKGBTCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB00496</td>
      <td>Darifenacin</td>
      <td>HXGBXQDTNZMWGS-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB14673</td>
      <td>Flurandrenolide acetate</td>
      <td>AUDPKCCPWYXNEV-XTLNBZDDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB07029</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE</td>
      <td>QQBNDYARFVOEGW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB02498</td>
      <td>Carba-Nicotinamide-Adenine-Dinucleotide</td>
      <td>DGPLSUKWXXSBCU-VGXGLJSLSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m71</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB14859</td>
      <td>Fosifloxuridine nafalbenamide</td>
      <td>BIOWRMNRHMERIO-ZVAHOJSLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB04879</td>
      <td>Vatalanib</td>
      <td>YCOYDOIWSSHVCK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB11769</td>
      <td>Funapide</td>
      <td>NEBUOXBYNAHKFV-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB13060</td>
      <td>CEP-37440</td>
      <td>BCSHRERPHLTPEE-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m71</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12776</td>
      <td>E-6005</td>
      <td>BBTFKAOFCSOZMB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB14512</td>
      <td>Mometasone furoate</td>
      <td>WOFMFGQZHJDGCX-ZULDAHANSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB14637</td>
      <td>Fluprednisolone acetate</td>
      <td>CYMBAKFTWRNHPS-APRQOCPKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB05983</td>
      <td>Bardoxolone methyl</td>
      <td>WPTTVJLTNAWYAO-KPOXMGGZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB14631</td>
      <td>Prednisolone phosphate</td>
      <td>JDOZJEUDSLGTLU-VWUMJDOOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB06817</td>
      <td>Raltegravir</td>
      <td>CZFFBEXEKNGXKS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB14626</td>
      <td>Pregnenolone acetate</td>
      <td>CRRKVZVYZQXICQ-RJJCNJEVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB12887</td>
      <td>Tazemetostat</td>
      <td>NSQSAUGJQHDYNO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB12432</td>
      <td>CC-401</td>
      <td>XDJCLCLBSGGNKS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12693</td>
      <td>Ritanserin</td>
      <td>JUQLTPCYUFPYKE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB05423</td>
      <td>ORG-34517</td>
      <td>DFELGYQKEOCHOA-BZAFBGKRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07456</td>
      <td>3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m71</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07809</td>
      <td>4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>MBJYEMUMDMGQQC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB11818</td>
      <td>Retosiban</td>
      <td>PLVGDGRBPMVYPB-FDUHJNRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB12547</td>
      <td>LY-2886721</td>
      <td>NIDRNVHMMDAAIK-YPMLDQLKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB06306</td>
      <td>Onalespib</td>
      <td>IFRGXKKQHBVPCQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB12743</td>
      <td>Z-160</td>
      <td>VCPMZDWBEWTGNW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB08407</td>
      <td>PLATENSIMYCIN</td>
      <td>CSOMAHTTWTVBFL-OFBLZTNGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB13490</td>
      <td>Hidrosmin</td>
      <td>XYFLWVOTXWXNAM-WTNNCJBMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB08366</td>
      <td>3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid</td>
      <td>XADCWKSMHQPTGH-OFBLZTNGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB07583</td>
      <td>(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE</td>
      <td>RLNNFNGBXLTQOB-RBUKOAKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB13643</td>
      <td>Loprazolam</td>
      <td>UTEFBSAVJNEPTR-RGEXLXHISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB04350</td>
      <td>Argadin</td>
      <td>FOZYKTUSOWWQGR-KNPYFFGGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB13664</td>
      <td>Formocortal</td>
      <td>QNXUUBBKHBYRFW-QWAPGEGQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB13061</td>
      <td>MLN8054</td>
      <td>HHFBDROWDBDFBR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB14766</td>
      <td>Etrasimod</td>
      <td>MVGWUTBTXDYMND-QGZVFWFLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB04705</td>
      <td>(3BETA)-CHOLEST-5-ENE-3,25-DIOL</td>
      <td>INBGSXNNRGWLJU-ZHHJOTBYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB04708</td>
      <td>(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>SYNSHNDQFWMLJW-YZGRCXSVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08962</td>
      <td>Glibornuride</td>
      <td>RMTYNAPTNBJHQI-LLDVTBCESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB00421</td>
      <td>Spironolactone</td>
      <td>LXMSZDCAJNLERA-ZHYRCANASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB14822</td>
      <td>SB-649868</td>
      <td>ZJXIUGNEAIHSBI-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB08446</td>
      <td>3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile</td>
      <td>OHQMEDBYNUAVNE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB11934</td>
      <td>Epelsiban</td>
      <td>UWHCWRQFNKUYCG-QUZACWSFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB15047</td>
      <td>BMS-919373</td>
      <td>XGKULQQVQWCASY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB04842</td>
      <td>Fluspirilene</td>
      <td>QOYHHIBFXOOADH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxs</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB00973</td>
      <td>Ezetimibe</td>
      <td>OLNTVTPDXPETLC-XPWALMASSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB11965</td>
      <td>SJG-136</td>
      <td>RWZVMMQNDHPRQD-SFTDATJTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB08973</td>
      <td>Fluclorolone acetonide</td>
      <td>NJNWEGFJCGYWQT-VSXGLTOVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lzg</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB09053</td>
      <td>Ibrutinib</td>
      <td>XYFPWWZEPKGCCK-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m3m</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB07029</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE</td>
      <td>QQBNDYARFVOEGW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w4h</td>
      <td>DB11663</td>
      <td>Pictilisib</td>
      <td>LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6w9c</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6crv</td>
      <td>DB04841</td>
      <td>Flunarizine</td>
      <td>SMANXXCATUTDDT-QPJJXVBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB09238</td>
      <td>Manidipine</td>
      <td>ANEBWFXPVPTEET-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6cs2</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6m2n</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6lzg</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-10.0</td>
      <td>6vxx</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB02668</td>
      <td>Je-2147, Ag1776, Kni-764</td>
      <td>CUFQBQOBLVLKRF-RZDMPUFOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB05804</td>
      <td>Prasterone sulfate</td>
      <td>CZWCKYRVOZZJNM-USOAJAOKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB15102</td>
      <td>Pemigatinib</td>
      <td>HCDMJFOHIXMBOV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB13094</td>
      <td>Pruvanserin</td>
      <td>AQRLDDAFYYAIJP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB03461</td>
      <td>2'-Monophosphoadenosine 5'-Diphosphoribose</td>
      <td>XJLXINKUBYWONI-NNYOXOHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB13093</td>
      <td>TAK-593</td>
      <td>DZFZXPPHBWCXPQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB13528</td>
      <td>Chlormadinone</td>
      <td>VUHJZBBCZGVNDZ-TTYLFXKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12858</td>
      <td>LY-377604</td>
      <td>RBSGUQYXRDKPAE-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lzg</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB09272</td>
      <td>Eluxadoline</td>
      <td>QFNHIDANIVGXPE-FNZWTVRRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12419</td>
      <td>HSD-016</td>
      <td>ZWASRJHIEFYJGL-BFUOFWGJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB13931</td>
      <td>Netarsudil</td>
      <td>OURRXQUGYQRVML-AREMUKBSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB03325</td>
      <td>Tyrosyladenylate</td>
      <td>MJZAZMKENKZBAJ-QTOWJTHWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07126</td>
      <td>O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE</td>
      <td>OWXORKPNCHJYOF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB08708</td>
      <td>N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine</td>
      <td>XYYDXQCAYXOGQT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07026</td>
      <td>(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</td>
      <td>PPLDARNGJSQINK-OKZBNKHCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB02449</td>
      <td>3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid</td>
      <td>ULOTXPTWJAUGGE-MHZLTWQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB02466</td>
      <td>4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid</td>
      <td>ZXQHMEUGMCXKLO-KPKJPENVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB09079</td>
      <td>Nintedanib</td>
      <td>XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB15141</td>
      <td>Deutivacaftor</td>
      <td>PURKAOJPTOLRMP-ASMGOKTBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12015</td>
      <td>Alpelisib</td>
      <td>STUWGJZDJHPWGZ-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB06160</td>
      <td>Garenoxacin</td>
      <td>NJDRXTDGYFKORP-LLVKDONJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12673</td>
      <td>ATX-914</td>
      <td>ALANRBCCCQEPFZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB06159</td>
      <td>Rubitecan</td>
      <td>VHXNKPBCCMUMSW-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB15003</td>
      <td>PF-06700841</td>
      <td>BUWBRTXGQRBBHG-MJBXVCDLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB13856</td>
      <td>Fluclorolone</td>
      <td>VTWKPILBIUBMDS-OTJLYDAYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB01893</td>
      <td>N6-Benzyl Adenosine-5'-Diphosphate</td>
      <td>MRHGMAGSDAQUFH-LSCFUAHRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB00288</td>
      <td>Amcinonide</td>
      <td>ILKJAFIWWBXGDU-MOGDOJJUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB02691</td>
      <td>Glycocholic acid</td>
      <td>RFDAIACWWDREDC-FRVQLJSFSA-M</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB04350</td>
      <td>Argadin</td>
      <td>FOZYKTUSOWWQGR-KNPYFFGGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB06718</td>
      <td>Stanozolol</td>
      <td>LKAJKIOFIWVMDJ-IYRCEVNGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB08882</td>
      <td>Linagliptin</td>
      <td>LTXREWYXXSTFRX-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB13587</td>
      <td>Mesterolone</td>
      <td>UXYRZJKIQKRJCF-TZPFWLJSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB03605</td>
      <td>(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>LAJJKGIZTCCOHY-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB07024</td>
      <td>2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE</td>
      <td>CEXBEGBNDJVZPK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07369</td>
      <td>N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide</td>
      <td>YMJLSOJLEXWATP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB02128</td>
      <td>[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester</td>
      <td>QCUBCTPTNWPFBC-ZEQRLZLVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB08820</td>
      <td>Ivacaftor</td>
      <td>PURKAOJPTOLRMP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB07811</td>
      <td>N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide</td>
      <td>UBVTVSINEVHYSY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB07570</td>
      <td>3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID</td>
      <td>ZKEZEXYKYHYIMQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB05129</td>
      <td>Elsamitrucin</td>
      <td>MGQRRMONVLMKJL-KWJIQSIXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB03907</td>
      <td>N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide</td>
      <td>UHHBFOLQOQSPLU-WGRQDFERSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB08494</td>
      <td>S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate</td>
      <td>AWAKIULNKVOBKE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB14054</td>
      <td>Asiatic acid</td>
      <td>JXSVIVRDWWRQRT-UYDOISQJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB08520</td>
      <td>(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE</td>
      <td>VUCSBBBCFXBFFY-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB11429</td>
      <td>Mibolerone</td>
      <td>PTQMMNYJKCSPET-OMHQDGTGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB08822</td>
      <td>Azilsartan medoxomil</td>
      <td>QJFSABGVXDWMIW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB11730</td>
      <td>Ribociclib</td>
      <td>RHXHGRAEPCAFML-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB02873</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One</td>
      <td>YAWZIQKDHQIHOS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07879</td>
      <td>N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide</td>
      <td>SMSIXMLQOONOQQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB14034</td>
      <td>Darglitazone</td>
      <td>QQKNSPHAFATFNQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07793</td>
      <td>(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>ACSGSLPOHKRZCY-GXTWGEPZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB03005</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium</td>
      <td>ISUOMOOYAOQQPZ-UHFFFAOYSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07181</td>
      <td>4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</td>
      <td>JYKFWUXBFJJDTP-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB07390</td>
      <td>2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE</td>
      <td>RKWXKADYTDWZIJ-VIFPVBQESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB05039</td>
      <td>Indacaterol</td>
      <td>QZZUEBNBZAPZLX-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB06515</td>
      <td>Resiniferatoxin</td>
      <td>DSDNAKHZNJAGHN-MXTYGGKSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07507</td>
      <td>2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</td>
      <td>ROMNEYAQUBNRLR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB04125</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine</td>
      <td>ZUWBXGHMVKDMQO-DEOSSOPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB04038</td>
      <td>Ergosterol</td>
      <td>DNVPQKQSNYMLRS-APGDWVJJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w4h</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB08416</td>
      <td>(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE</td>
      <td>AQSNIXKAKUZPSI-SSTWWWIQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB11878</td>
      <td>Filibuvir</td>
      <td>SLVAPEZTBDBAPI-GDLZYMKVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB06307</td>
      <td>Apoptone</td>
      <td>CKAXZOYFIHQCBN-JRRMKBMNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB08351</td>
      <td>N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</td>
      <td>MNEXDVSJIUQQRH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB14821</td>
      <td>Macozinone</td>
      <td>BJDZBXGJNBMCAV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB05038</td>
      <td>Anatibant</td>
      <td>XUHBBTKJWIBQMY-MHZLTWQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB03157</td>
      <td>N,O-Didansyl-L-Tyrosine</td>
      <td>LUBOPDUYHWABFG-NDEPHWFRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB03363</td>
      <td>3-Acetylpyridine Adenine Dinucleotide</td>
      <td>KPVQNXLUPNWQHM-RBEMOOQDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB05412</td>
      <td>Talmapimod</td>
      <td>ZMELOYOKMZBMRB-DLBZAZTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12848</td>
      <td>PF-04217903</td>
      <td>PDMUGYOXRHVNMO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB07830</td>
      <td>(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE</td>
      <td>DIRIFWIKLRTNMB-DYVFJYSZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB06995</td>
      <td>N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide</td>
      <td>USBSTVPJNQLYEM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB08034</td>
      <td>(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</td>
      <td>TVOPERZEGKBKAY-RGVLZGJSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w4h</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12307</td>
      <td>Foretinib</td>
      <td>CXQHYVUVSFXTMY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB12020</td>
      <td>Tecovirimat</td>
      <td>CSKDFZIMJXRJGH-VWLPUNTISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB12234</td>
      <td>BMS-214662</td>
      <td>OLCWFLWEHWLBTO-HSZRJFAPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB11925</td>
      <td>Vistusertib</td>
      <td>JUSFANSTBFGBAF-IRXDYDNUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB14729</td>
      <td>Rebeccamycin</td>
      <td>QEHOIJJIZXRMAN-QZQSLCQPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB14895</td>
      <td>Vibegron</td>
      <td>DJXRIQMCROIRCZ-XOEOCAAJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB02732</td>
      <td>Nicotinamide Adenine Dinucleotide Acetone Adduct</td>
      <td>SGHBFOOIAAJJMI-YDKVLQLQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m71</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>7bv1</td>
      <td>DB04125</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine</td>
      <td>ZUWBXGHMVKDMQO-DEOSSOPVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB07847</td>
      <td>6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE</td>
      <td>ICLOZQFWTRAYPX-LIRRHRJNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB15367</td>
      <td>LY-2623091</td>
      <td>YPCLDHGBEKZGEB-RUDKWAFVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB09233</td>
      <td>Cronidipine</td>
      <td>CNIJVNPIIHWRRP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB09291</td>
      <td>Rolapitant</td>
      <td>FIVSJYGQAIEMOC-ZGNKEGEESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB12186</td>
      <td>SRT-2104</td>
      <td>LAMQVIQMVKWXOC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB15297</td>
      <td>Petesicatib</td>
      <td>KXAAIORSMACJSI-AEFFLSMTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB15307</td>
      <td>Atabecestat</td>
      <td>VLLFGVHGKLDDLW-SFHVURJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB09298</td>
      <td>Silibinin</td>
      <td>SEBFKMXJBCUCAI-HKTJVKLFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lzg</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB13874</td>
      <td>Enasidenib</td>
      <td>DYLUUSLLRIQKOE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB13814</td>
      <td>Talampicillin</td>
      <td>SOROUYSPFADXSN-SUWVAFIASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB03583</td>
      <td>(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</td>
      <td>AYOAIABDFUJDKQ-SQJPUDIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB07351</td>
      <td>O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE</td>
      <td>ICACWKLCNCPHAM-YJBOKZPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB14066</td>
      <td>Tetrandrine</td>
      <td>WVTKBKWTSCPRNU-KYJUHHDHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB09073</td>
      <td>Palbociclib</td>
      <td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB13003</td>
      <td>Cortivazol</td>
      <td>RKHQGWMMUURILY-UHRZLXHJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB11769</td>
      <td>Funapide</td>
      <td>NEBUOXBYNAHKFV-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m71</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB11775</td>
      <td>PF-03758309</td>
      <td>AYCPARAPKDAOEN-LJQANCHMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w4h</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB11816</td>
      <td>Omecamtiv Mecarbil</td>
      <td>RFUBTTPMWSKEIW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB15197</td>
      <td>RSV-604</td>
      <td>MTPVBMVUENFFLL-HXUWFJFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB04960</td>
      <td>Tipifarnib</td>
      <td>PLHJCIYEEKOWNM-HHHXNRCGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB06420</td>
      <td>Annamycin</td>
      <td>CIDNKDMVSINJCG-GKXONYSUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB07651</td>
      <td>N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE</td>
      <td>KPMMESISHWWXNM-ROUUACIJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB13135</td>
      <td>AGN-201904</td>
      <td>PPCGSVWOZKNPCX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB15163</td>
      <td>Selatogrel</td>
      <td>FYXHWMQPCJOJCH-GMAHTHKFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m71</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB14029</td>
      <td>Furafylline</td>
      <td>HMZQULPVMKITSP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w4h</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB15108</td>
      <td>Tipranavir C-14</td>
      <td>SUJUHGSWHZTSEU-MWQIXQBFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB13080</td>
      <td>Roluperidone</td>
      <td>RNRYULFRLCBRQS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB11751</td>
      <td>Cabotegravir</td>
      <td>WCWSTNLSLKSJPK-LKFCYVNXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB13074</td>
      <td>Macimorelin</td>
      <td>UJVDJAPJQWZRFR-DHIUTWEWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB00559</td>
      <td>Bosentan</td>
      <td>GJPICJJJRGTNOD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB12368</td>
      <td>AZD-3839</td>
      <td>MRXBCEQZNKUUIP-DEOSSOPVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB11923</td>
      <td>Decoglurant</td>
      <td>DMJHZVARRXJSEG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB08051</td>
      <td>(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>XXRHRPGYYNOBHO-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB08031</td>
      <td>N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</td>
      <td>LNQWELVSNCYKDU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB04098</td>
      <td>Balanol</td>
      <td>XYUFCXJZFZPEJD-PGRDOPGGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB12412</td>
      <td>Gemigliptin</td>
      <td>ZWPRRQZNBDYKLH-VIFPVBQESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB13648</td>
      <td>Alcuronium</td>
      <td>MUQUYTSLDVKIOF-CHJKCJHBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB11966</td>
      <td>BMS-986094</td>
      <td>YFXGICNMLCGLHJ-RSKRLRQZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB13640</td>
      <td>Acetoxolone</td>
      <td>FTQDJVZNPJRVPG-XWEVEMRCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB06922</td>
      <td>2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>CZNPWASYMRBJCX-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB12289</td>
      <td>Darexaban</td>
      <td>IJNIQYINMSGIPS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB12272</td>
      <td>Vidupiprant</td>
      <td>PFWVGKROPKKEDW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB11949</td>
      <td>Vestipitant</td>
      <td>SBBYBXSFWOLDDG-JLTOFOAXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB03363</td>
      <td>3-Acetylpyridine Adenine Dinucleotide</td>
      <td>KPVQNXLUPNWQHM-RBEMOOQDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB12665</td>
      <td>Isoquercetin</td>
      <td>OVSQVDMCBVZWGM-QSOFNFLRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w4h</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxs</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB12138</td>
      <td>PF-03715455</td>
      <td>VGEXRDWWPSGZDH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB13422</td>
      <td>Nicofuranose</td>
      <td>FUWFSXZKBMCSKF-ZASNTINBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB15414</td>
      <td>CM-4307</td>
      <td>MLDQJTXFUGDVEO-FIBGUPNXSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB02668</td>
      <td>Je-2147, Ag1776, Kni-764</td>
      <td>CUFQBQOBLVLKRF-RZDMPUFOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB07653</td>
      <td>N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE</td>
      <td>VXTCEUDVOCLEJG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB11844</td>
      <td>Pritelivir</td>
      <td>IVZKZONQVYTCKC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB00438</td>
      <td>Ceftazidime</td>
      <td>ORFOPKXBNMVMKC-DWVKKRMSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB12380</td>
      <td>GDC-0152</td>
      <td>WZRFLSDVFPIXOV-LRQRDZAKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w4h</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB06626</td>
      <td>Axitinib</td>
      <td>RITAVMQDGBJQJZ-FMIVXFBMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m71</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB00932</td>
      <td>Tipranavir</td>
      <td>SUJUHGSWHZTSEU-FYBSXPHGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB01029</td>
      <td>Irbesartan</td>
      <td>YOSHYTLCDANDAN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB04408</td>
      <td>Ncs-Chromophore</td>
      <td>QZGIWPZCWHMVQL-UIYAJPBUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB07507</td>
      <td>2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</td>
      <td>ROMNEYAQUBNRLR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB12580</td>
      <td>Tradipitant</td>
      <td>CAVRKWRKTNINFF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB12001</td>
      <td>Abemaciclib</td>
      <td>UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB12806</td>
      <td>GSK-1004723</td>
      <td>YANGEESWIGIKOP-UUWRZZSWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB01329</td>
      <td>Cefoperazone</td>
      <td>GCFBRXLSHGKWDP-XCGNWRKASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB12706</td>
      <td>Seletalisib</td>
      <td>LNLJHGXOFYUARS-OAQYLSRUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB11890</td>
      <td>Cilengitide</td>
      <td>AMLYAMJWYAIXIA-VWNVYAMZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxs</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxs</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxs</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB00559</td>
      <td>Bosentan</td>
      <td>GJPICJJJRGTNOD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB06831</td>
      <td>2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE</td>
      <td>UMMYTDJYDSTEMB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB12130</td>
      <td>Lorlatinib</td>
      <td>IIXWYSCJSQVBQM-LLVKDONJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB15229</td>
      <td>CNV-2197944</td>
      <td>BLFJGFDZMABYMY-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01591</td>
      <td>Solifenacin</td>
      <td>FBOUYBDGKBSUES-VXKWHMMOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB06212</td>
      <td>Tolvaptan</td>
      <td>GYHCTFXIZSNGJT-XMMPIXPASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>7bv1</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01471</td>
      <td>Bolasterone</td>
      <td>IVFYLRMMHVYGJH-VLOLGRDOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>7bv1</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9q</td>
      <td>DB03005</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium</td>
      <td>ISUOMOOYAOQQPZ-UHFFFAOYSA-O</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB15367</td>
      <td>LY-2623091</td>
      <td>YPCLDHGBEKZGEB-RUDKWAFVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lzg</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01690</td>
      <td>Bis(Adenosine)-5'-Triphosphate</td>
      <td>QCICUPZZLIQAPA-XPWFQUROSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB12158</td>
      <td>Filorexant</td>
      <td>NPFDWHQSDBWQLH-QZTJIDSGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB15295</td>
      <td>Tenalisib</td>
      <td>HDXDQPRPFRKGKZ-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB15448</td>
      <td>Acumapimod</td>
      <td>VGUSQKZDZHAAEE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB04708</td>
      <td>(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>SYNSHNDQFWMLJW-YZGRCXSVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB11942</td>
      <td>Selinexor</td>
      <td>DEVSOMFAQLZNKR-RJRFIUFISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB06429</td>
      <td>Talnetant</td>
      <td>BIAVGWDGIJKWRM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lzg</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01185</td>
      <td>Fluoxymesterone</td>
      <td>YLRFCQOZQXIBAB-RBZZARIASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB08213</td>
      <td>1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE</td>
      <td>PFAYCUAUBOGVDX-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxs</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB04685</td>
      <td>1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>GJNIPWYJQUGERM-BFLUCZKCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01763</td>
      <td>7-thionicotinamide-adenine-dinucleotide phosphate</td>
      <td>OJNFDOAQUXJWED-NNYOXOHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB02354</td>
      <td>4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine</td>
      <td>IRKPNOLLMNHSOU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB01768</td>
      <td>Methylumbelliferyl Sialic Acid</td>
      <td>KKDWIUJBUSOPGC-GKHMPSLRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB05913</td>
      <td>OSI-930</td>
      <td>FGTCROZDHDSNIO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB00137</td>
      <td>Lutein</td>
      <td>KBPHJBAIARWVSC-RGZFRNHPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB04708</td>
      <td>(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>SYNSHNDQFWMLJW-YZGRCXSVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB07081</td>
      <td>(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>FDEXEPZGMKFCTG-PSASIEDQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxs</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB02217</td>
      <td>Dpb-T</td>
      <td>WTZFKHNHHRPQOU-WSMBLCCSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01830</td>
      <td>{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid</td>
      <td>SPSGYTWOIGAABK-DQEYMECFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB02123</td>
      <td>Glycochenodeoxycholic Acid</td>
      <td>GHCZAUBVMUEKKP-GYPHWSFCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB06090</td>
      <td>Bradanicline</td>
      <td>OXKRFEWMSWPKKV-GHTZIAJQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB15367</td>
      <td>LY-2623091</td>
      <td>YPCLDHGBEKZGEB-RUDKWAFVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB01763</td>
      <td>7-thionicotinamide-adenine-dinucleotide phosphate</td>
      <td>OJNFDOAQUXJWED-NNYOXOHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB02010</td>
      <td>Staurosporine</td>
      <td>HKSZLNNOFSGOKW-FYTWVXJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB06178</td>
      <td>Talotrexin</td>
      <td>NYQPLPNEESYGNO-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB15173</td>
      <td>JNJ-42165279</td>
      <td>YWGYNGCRVZLMCS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB01941</td>
      <td>6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid</td>
      <td>SLXTWXQUEZSSTJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>7bv1</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w4h</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB06454</td>
      <td>Sarizotan</td>
      <td>HKFMQJUJWSFOLY-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB08043</td>
      <td>1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>DDDLGNOZDKDSEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB13061</td>
      <td>MLN8054</td>
      <td>HHFBDROWDBDFBR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxs</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9c</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB06817</td>
      <td>Raltegravir</td>
      <td>CZFFBEXEKNGXKS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB15193</td>
      <td>BMS-955176</td>
      <td>XDMUFNNPLXHNKA-ZTESCHFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB06962</td>
      <td>(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone</td>
      <td>YKTUSHSSKIWDRY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB00591</td>
      <td>Fluocinolone acetonide</td>
      <td>FEBLZLNTKCEFIT-VSXGLTOVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w4h</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB06962</td>
      <td>(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone</td>
      <td>YKTUSHSSKIWDRY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB08042</td>
      <td>N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>FLXGQDHYCWXTAI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB15046</td>
      <td>LY-2881835</td>
      <td>FHRWHNJJQGSCQC-LJAQVGFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lxt</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB00197</td>
      <td>Troglitazone</td>
      <td>GXPHKUHSUJUWKP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m71</td>
      <td>DB06515</td>
      <td>Resiniferatoxin</td>
      <td>DSDNAKHZNJAGHN-MXTYGGKSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB00959</td>
      <td>Methylprednisolone</td>
      <td>VHRSUDSXCMQTMA-PJHHCJLFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB06469</td>
      <td>Lestaurtinib</td>
      <td>UIARLYUEJFELEN-DMVVYWCZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m2n</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6lzg</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6w9q</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxs</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6crv</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6cs2</td>
      <td>DB03632</td>
      <td>Argifin</td>
      <td>UHBHXSDKGLPPGO-HTDHLNIYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6vxx</td>
      <td>DB13042</td>
      <td>Fenoverine</td>
      <td>UBAJTZKNDCEGKL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m3m</td>
      <td>DB00764</td>
      <td>Mometasone</td>
      <td>QLIIKPVHVRXHRI-CXSFZGCWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.9</td>
      <td>6m71</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12649</td>
      <td>Ibipinabant</td>
      <td>AXJQVVLKUYCICH-OAQYLSRUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12972</td>
      <td>Sepranolone</td>
      <td>AURFZBICLPNKBZ-FZCSVUEKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12574</td>
      <td>LY-295501</td>
      <td>VAMFSFIPDOODFH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB03777</td>
      <td>Rbt205 Inhibitor</td>
      <td>QMGUOJYZJKLOLH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB08068</td>
      <td>N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</td>
      <td>YQJVDUKATDECHF-ICSRJNTNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB06755</td>
      <td>Beta carotene</td>
      <td>OENHQHLEOONYIE-JLTXGRSLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB01831</td>
      <td>Tryptophanyl-5'amp</td>
      <td>IFQVDHDRFCKAAW-SQIXAUHQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB06347</td>
      <td>Cenisertib</td>
      <td>KSOVGRCOLZZTPF-QMKUDKLTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB03199</td>
      <td>4-Methoxy-E-Rhodomycin T</td>
      <td>XSSVYBYWQBNYOH-QJIXERIWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB04131</td>
      <td>10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione</td>
      <td>BLGDWFJQIHBUJY-NWJGULHDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB04724</td>
      <td>(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE</td>
      <td>COVPLULNDBDXTN-KYJUHHDHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB00377</td>
      <td>Palonosetron</td>
      <td>CPZBLNMUGSZIPR-NVXWUHKLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB00430</td>
      <td>Cefpiramide</td>
      <td>PWAUCHMQEXVFJR-PMAPCBKXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB06809</td>
      <td>Plerixafor</td>
      <td>YIQPUIGJQJDJOS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12285</td>
      <td>Verubecestat</td>
      <td>YHYKUSGACIYRML-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB06558</td>
      <td>Tezosentan</td>
      <td>TUYWTLTWNJOZNY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07084</td>
      <td>N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</td>
      <td>YHKGWOJTUMJPNW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12474</td>
      <td>Lynestrenol</td>
      <td>YNVGQYHLRCDXFQ-XGXHKTLJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB04392</td>
      <td>Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]</td>
      <td>HIZKPJUTKKJDGA-BETUJISGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08703</td>
      <td>12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</td>
      <td>FGKKIHITEICGMN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12523</td>
      <td>Mizolastine</td>
      <td>PVLJETXTTWAYEW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB04190</td>
      <td>Inhibitor Bea425</td>
      <td>AHAVBKNGKPWROK-UMFPTGFGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB04853</td>
      <td>Binodenoson</td>
      <td>XJFMHMFFBSOEPR-DNZQAUTHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08708</td>
      <td>N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine</td>
      <td>XYYDXQCAYXOGQT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB07786</td>
      <td>1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>SMFRBBHLVBWHGB-DJJJIMSYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08745</td>
      <td>4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE</td>
      <td>QLHUDNKWOSQSMK-CXUHLZMHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB12341</td>
      <td>LY-2456302</td>
      <td>ZHPMYDSXGRRERG-DEOSSOPVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08097</td>
      <td>2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE</td>
      <td>OGWSGDLIXOEZJG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB00948</td>
      <td>Mezlocillin</td>
      <td>YPBATNHYBCGSSN-VWPFQQQWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB05412</td>
      <td>Talmapimod</td>
      <td>ZMELOYOKMZBMRB-DLBZAZTESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB07814</td>
      <td>Gibberellic acid</td>
      <td>IXORZMNAPKEEDV-OBDJNFEBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12888</td>
      <td>Ezutromid</td>
      <td>KSGCNXAZROJSNW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB06677</td>
      <td>Clazosentan</td>
      <td>LFWCJABOXHSRGC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB01329</td>
      <td>Cefoperazone</td>
      <td>GCFBRXLSHGKWDP-XCGNWRKASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12385</td>
      <td>10-hydroxycamptothecin</td>
      <td>HAWSQZCWOQZXHI-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00773</td>
      <td>Etoposide</td>
      <td>VJJPUSNTGOMMGY-MRVIYFEKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB04421</td>
      <td>Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct</td>
      <td>BZJFKYRGSZWSLT-YLIVDTKOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08339</td>
      <td>6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE</td>
      <td>ZIQFYVPVJZEOFS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00796</td>
      <td>Candesartan cilexetil</td>
      <td>GHOSNRCGJFBJIB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB12394</td>
      <td>Eleclazine</td>
      <td>YNUAEEJQYHYLMS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB06212</td>
      <td>Tolvaptan</td>
      <td>GYHCTFXIZSNGJT-XMMPIXPASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12720</td>
      <td>Nivocasan</td>
      <td>VYFGDLGHHBUDTQ-ZLGUVYLKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08747</td>
      <td>(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one</td>
      <td>JJTPPGUNMJMPLY-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB07847</td>
      <td>6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE</td>
      <td>ICLOZQFWTRAYPX-LIRRHRJNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB05470</td>
      <td>VX-702</td>
      <td>FYSRKRZDBHOFAY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB06997</td>
      <td>2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</td>
      <td>BMPOCDJEXAXXEZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08058</td>
      <td>4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one</td>
      <td>HGEPGGJUGUMFHT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB06976</td>
      <td>1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA</td>
      <td>IWOOJEZSDPRYAZ-WFASDCNBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB08058</td>
      <td>4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one</td>
      <td>HGEPGGJUGUMFHT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB13040</td>
      <td>Gandotinib</td>
      <td>SQSZANZGUXWJEA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00687</td>
      <td>Fludrocortisone</td>
      <td>AAXVEMMRQDVLJB-BULBTXNYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB14218</td>
      <td>Telotristat</td>
      <td>NCLGDOBQAWBXRA-PGRDOPGGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB01933</td>
      <td>7-Hydroxystaurosporine</td>
      <td>PBCZSGKMGDDXIJ-HQCWYSJUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>7bv1</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB15009</td>
      <td>PF-04937319</td>
      <td>MASKQITXHVYVFL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB02152</td>
      <td>K-252a</td>
      <td>KOZFSFOOLUUIGY-SOLYNIJKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12185</td>
      <td>Exatecan</td>
      <td>ZVYVPGLRVWUPMP-FYSMJZIKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB15245</td>
      <td>Olorofim</td>
      <td>SUFPWYYDCOKDLL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB13919</td>
      <td>Candesartan</td>
      <td>HTQMVQVXFRQIKW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB13874</td>
      <td>Enasidenib</td>
      <td>DYLUUSLLRIQKOE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB11637</td>
      <td>Delamanid</td>
      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12207</td>
      <td>Verdinexor</td>
      <td>OPAKEJZFFCECPN-XQRVVYSFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB05212</td>
      <td>HE3286</td>
      <td>JJKOQZHWYLMASZ-FJWDNACWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12211</td>
      <td>PSI-697</td>
      <td>DIEPFYNZGUUVHD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00220</td>
      <td>Nelfinavir</td>
      <td>QAGYKUNXZHXKMR-HKWSIXNMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00227</td>
      <td>Lovastatin</td>
      <td>PCZOHLXUXFIOCF-BXMDZJJMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB13371</td>
      <td>Difenpiramide</td>
      <td>PWHROYKAGRUWDQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB06626</td>
      <td>Axitinib</td>
      <td>RITAVMQDGBJQJZ-FMIVXFBMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB09295</td>
      <td>Talniflumate</td>
      <td>ANMLJLFWUCQGKZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08519</td>
      <td>N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>SQQAPOSROFWHIB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB11773</td>
      <td>BMS-903452</td>
      <td>OGIAVRWXUPYGGC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB14845</td>
      <td>Filgotinib</td>
      <td>RIJLVEAXPNLDTC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB14876</td>
      <td>TAS-116</td>
      <td>NVVPMZUGELHVMH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB14896</td>
      <td>Selitrectinib</td>
      <td>OEBIHOVSAMBXIB-SJKOYZFVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB14898</td>
      <td>Retagliptin</td>
      <td>WIIAMRXFUJLYEF-SNVBAGLBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB14917</td>
      <td>Ceralasertib</td>
      <td>DTTJKLNXNZAVSM-JYCIKRDWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12001</td>
      <td>Abemaciclib</td>
      <td>UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB14937</td>
      <td>MK-8666</td>
      <td>CODQKEMYZZKQAE-QPVYNBJUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB15013</td>
      <td>TAK-243</td>
      <td>KJDAGXLMHXUAGV-DGWLBADLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB06011</td>
      <td>AMG-222</td>
      <td>NVSWJKWHLUTHLP-CPJSRVTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB15048</td>
      <td>Licogliflozin</td>
      <td>XFJAMQQAAMJFGB-ZQGJOIPISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB15063</td>
      <td>Inarigivir soproxil</td>
      <td>CJCYTUJOSMYXLE-JDLSZIHUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB15168</td>
      <td>Cilofexor</td>
      <td>KZSKGLFYQAYZCO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12134</td>
      <td>Gepotidacin</td>
      <td>PZFAZQUREQIODZ-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB14648</td>
      <td>Acetyl simvastatin</td>
      <td>OHVWRJDVJRNCPE-BIKFJBPRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB11796</td>
      <td>Fostemsavir</td>
      <td>SWMDAPWAQQTBOG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB11804</td>
      <td>AZD-5672</td>
      <td>SCXSQUUTGCWHFU-WJOKGBTCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>7bv1</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB06420</td>
      <td>Annamycin</td>
      <td>CIDNKDMVSINJCG-GKXONYSUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00278</td>
      <td>Argatroban</td>
      <td>KXNPVXPOPUZYGB-IOVMHBDKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB14661</td>
      <td>Loperamide oxide</td>
      <td>KXVSBTJVTUVNPM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB11845</td>
      <td>Lucitanib</td>
      <td>CUDVHEFYRIWYQD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB06409</td>
      <td>Morphine glucuronide</td>
      <td>GNJCUHZOSOYIEC-GAROZEBRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB11855</td>
      <td>Revefenacin</td>
      <td>FYDWDCIFZSGNBU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB15450</td>
      <td>PF-05105679</td>
      <td>BXNMZRPTQFVRFA-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9q</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB06635</td>
      <td>Otamixaban</td>
      <td>PFGVNLZDWRZPJW-OPAMFIHVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>7bv1</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>7bv1</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB01339</td>
      <td>Vecuronium</td>
      <td>BGSZAXLLHYERSY-XQIGCQGXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB12673</td>
      <td>ATX-914</td>
      <td>ALANRBCCCQEPFZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00547</td>
      <td>Desoximetasone</td>
      <td>VWVSBHGCDBMOOT-IIEHVVJPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6wiq</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08607</td>
      <td>(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE</td>
      <td>GXPHKUHSUJUWKP-NTKDMRAZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB01940</td>
      <td>Balanol Analog 2</td>
      <td>SQLYTJZXRRDERK-ISKFKSNPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB02033</td>
      <td>N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide</td>
      <td>GDRNWAKVNIROCG-DEOSSOPVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12523</td>
      <td>Mizolastine</td>
      <td>PVLJETXTTWAYEW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB01177</td>
      <td>Idarubicin</td>
      <td>XDXDZDZNSLXDNA-TZNDIEGXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB04882</td>
      <td>Edotecarin</td>
      <td>QMVPQBFHUJZJCS-NTKFZFFISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB02241</td>
      <td>8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>HOSWCJDTHOAORT-SANMLTNESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08489</td>
      <td>N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE</td>
      <td>GCBPAPVOMPJQHK-NQIIRXRSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB04685</td>
      <td>1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>GJNIPWYJQUGERM-BFLUCZKCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB02319</td>
      <td>5,6-Dihydroxy-Nadp</td>
      <td>LRAVAOPKUBJONV-IVCJQJMGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB02524</td>
      <td>2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)</td>
      <td>XFMMHXLUHKBKQE-UHEGPQQHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08664</td>
      <td>({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER</td>
      <td>QUQQVMVIWCUYFV-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12623</td>
      <td>Taprenepag</td>
      <td>MFFBXYNKZHTCEY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB07716</td>
      <td>(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL</td>
      <td>VDRIXSJOPKVWKM-HXGIDPQASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12542</td>
      <td>GSK-356278</td>
      <td>AWDJJMXJUOHGLC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08749</td>
      <td>3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</td>
      <td>KTRFBFMYAJOXLG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08561</td>
      <td>BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE</td>
      <td>PLBINCOCFGQAJM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08546</td>
      <td>4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE</td>
      <td>CETLUACQMGBMFH-ZALSBGIRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB13024</td>
      <td>MK-8245</td>
      <td>UJEAABFSXKCSGI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB11923</td>
      <td>Decoglurant</td>
      <td>DMJHZVARRXJSEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12998</td>
      <td>PF-00217830</td>
      <td>QGNOXTFZOLDODX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB05039</td>
      <td>Indacaterol</td>
      <td>QZZUEBNBZAPZLX-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00378</td>
      <td>Dydrogesterone</td>
      <td>JGMOKGBVKVMRFX-HQZYFCCVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08970</td>
      <td>Fluprednidene</td>
      <td>YVHXHNGGPURVOS-SBTDHBFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB01100</td>
      <td>Pimozide</td>
      <td>YVUQSNJEYSNKRX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lzg</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB00430</td>
      <td>Cefpiramide</td>
      <td>PWAUCHMQEXVFJR-PMAPCBKXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB06786</td>
      <td>Halcinonide</td>
      <td>MUQNGPZZQDCDFT-JNQJZLCISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12412</td>
      <td>Gemigliptin</td>
      <td>ZWPRRQZNBDYKLH-VIFPVBQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB00878</td>
      <td>Chlorhexidine</td>
      <td>GHXZTYHSJHQHIJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB00443</td>
      <td>Betamethasone</td>
      <td>UREBDLICKHMUKA-DVTGEIKXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lxt</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB04131</td>
      <td>10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione</td>
      <td>BLGDWFJQIHBUJY-NWJGULHDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB08882</td>
      <td>Linagliptin</td>
      <td>LTXREWYXXSTFRX-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB11424</td>
      <td>Lufenuron</td>
      <td>PWPJGUXAGUPAHP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB06178</td>
      <td>Talotrexin</td>
      <td>NYQPLPNEESYGNO-IBGZPJMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxx</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB11819</td>
      <td>ASP-4058</td>
      <td>NJNXCJPSMWKXHO-VIFPVBQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB07800</td>
      <td>N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE</td>
      <td>MIJGLXFQYBTIFY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB12540</td>
      <td>Lecozotan</td>
      <td>NRPQELCNMADTOZ-OAQYLSRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m71</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB14097</td>
      <td>13-cis-12-(3'-Carboxyphenyl)retinoic acid</td>
      <td>XKKDQOHDTASHCE-PAZAWXFKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08354</td>
      <td>2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>QCVULERVJOYHCP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB12706</td>
      <td>Seletalisib</td>
      <td>LNLJHGXOFYUARS-OAQYLSRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB14539</td>
      <td>Hydrocortisone acetate</td>
      <td>ALEXXDVDDISNDU-JZYPGELDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB00838</td>
      <td>Clocortolone</td>
      <td>YMTMADLUXIRMGX-RFPWEZLHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB12843</td>
      <td>Oleandrin</td>
      <td>JLPDBLFIVFSOCC-XYXFTTADSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB15191</td>
      <td>MAX-40279</td>
      <td>AVIOBQFPAGEICQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB14942</td>
      <td>BMS-986141</td>
      <td>KEEBLYWBELVGPQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB00699</td>
      <td>Nicergoline</td>
      <td>YSEXMKHXIOCEJA-FVFQAYNVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB00694</td>
      <td>Daunorubicin</td>
      <td>STQGQHZAVUOBTE-VGBVRHCVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB03723</td>
      <td>2'-Deoxy-Thymidine-Beta-L-Rhamnose</td>
      <td>ZOSQFDVXNQFKBY-CGAXJHMRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB11865</td>
      <td>Brivanib alaninate</td>
      <td>LTEJRLHKIYCEOX-OCCSQVGLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07786</td>
      <td>1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>SMFRBBHLVBWHGB-DJJJIMSYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6lzg</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB05990</td>
      <td>Obeticholic acid</td>
      <td>ZXERDUOLZKYMJM-ZWECCWDJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB13061</td>
      <td>MLN8054</td>
      <td>HHFBDROWDBDFBR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB14037</td>
      <td>Madecassic acid</td>
      <td>PRAUVHZJPXOEIF-AOLYGAPISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB01016</td>
      <td>Glyburide</td>
      <td>ZNNLBTZKUZBEKO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB13766</td>
      <td>Lidoflazine</td>
      <td>ZBIAKUMOEKILTF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB06879</td>
      <td>5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE</td>
      <td>QCFIRACCCDFXIP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB12002</td>
      <td>AZD-4818</td>
      <td>HVTUHSABWJPWNK-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB06229</td>
      <td>Ocaperidone</td>
      <td>ZZQNEJILGNNOEP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB13814</td>
      <td>Talampicillin</td>
      <td>SOROUYSPFADXSN-SUWVAFIASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB08730</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</td>
      <td>CPFBZMFUCGHBAP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07665</td>
      <td>N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>STHCHQXQLDMISY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB12180</td>
      <td>Apitolisib</td>
      <td>YOVVNQKCSKSHKT-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB04708</td>
      <td>(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>SYNSHNDQFWMLJW-YZGRCXSVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB06626</td>
      <td>Axitinib</td>
      <td>RITAVMQDGBJQJZ-FMIVXFBMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB08747</td>
      <td>(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one</td>
      <td>JJTPPGUNMJMPLY-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB01604</td>
      <td>Pivampicillin</td>
      <td>ZEMIJUDPLILVNQ-ZXFNITATSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB06558</td>
      <td>Tezosentan</td>
      <td>TUYWTLTWNJOZNY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB06543</td>
      <td>Astaxanthin</td>
      <td>MQZIGYBFDRPAKN-UWFIBFSHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB12371</td>
      <td>Siponimod</td>
      <td>KIHYPELVXPAIDH-HNSNBQBZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB01067</td>
      <td>Glipizide</td>
      <td>ZJJXGWJIGJFDTL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB15391</td>
      <td>Elenbecestat</td>
      <td>AACUJFVOHGRMTR-DPXNYUHVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m71</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB14632</td>
      <td>Prednisolone tebutate</td>
      <td>HUMXXHTVHHLNRO-KAJVQRHHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB04408</td>
      <td>Ncs-Chromophore</td>
      <td>QZGIWPZCWHMVQL-UIYAJPBUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB01471</td>
      <td>Bolasterone</td>
      <td>IVFYLRMMHVYGJH-VLOLGRDOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB15047</td>
      <td>BMS-919373</td>
      <td>XGKULQQVQWCASY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB15414</td>
      <td>CM-4307</td>
      <td>MLDQJTXFUGDVEO-FIBGUPNXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB11870</td>
      <td>RG-4733</td>
      <td>OJPLJFIFUQPSJR-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07872</td>
      <td>5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide</td>
      <td>IYGIXVNAMZPBDK-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB01501</td>
      <td>Difenoxin</td>
      <td>UFIVBRCCIRTJTN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB04764</td>
      <td>[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</td>
      <td>CCLHROFBSWWOQO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB11704</td>
      <td>Adomeglivant</td>
      <td>FASLTMSUPQDLIB-MHZLTWQESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB11732</td>
      <td>Lasmiditan</td>
      <td>XEDHVZKDSYZQBF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB07796</td>
      <td>(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE</td>
      <td>GJYCQHGTXMVIBG-MUGJNUQGSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB11814</td>
      <td>PF-03882845</td>
      <td>XNULRSOGWPFPBL-REWPJTCUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB15310</td>
      <td>Vactosertib</td>
      <td>FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB15295</td>
      <td>Tenalisib</td>
      <td>HDXDQPRPFRKGKZ-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB06834</td>
      <td>N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide</td>
      <td>XZRYCTLOGNCQDG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB04044</td>
      <td>4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>NAQUAVBNIYTIIS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB15273</td>
      <td>VS-4718</td>
      <td>IGUBBWJDMLCRIK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB15205</td>
      <td>Capromorelin</td>
      <td>KVLLHLWBPNCVNR-SKCUWOTOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB14876</td>
      <td>TAS-116</td>
      <td>NVVPMZUGELHVMH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m71</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB00137</td>
      <td>Lutein</td>
      <td>KBPHJBAIARWVSC-RGZFRNHPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB12185</td>
      <td>Exatecan</td>
      <td>ZVYVPGLRVWUPMP-FYSMJZIKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB04971</td>
      <td>Reglitazar</td>
      <td>QBQLYIISSRXYKL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB01410</td>
      <td>Ciclesonide</td>
      <td>LUKZNWIVRBCLON-GXOBDPJESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB13240</td>
      <td>Cymarin</td>
      <td>XQCGNURMLWFQJR-ZNDDOCHDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07789</td>
      <td>1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea</td>
      <td>KNTGXMNWVXZIMW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB00549</td>
      <td>Zafirlukast</td>
      <td>YEEZWCHGZNKEEK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB00522</td>
      <td>Bentiromide</td>
      <td>SPPTWHFVYKCNNK-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08031</td>
      <td>N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</td>
      <td>LNQWELVSNCYKDU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB13556</td>
      <td>Sulfamazone</td>
      <td>BGLHAKAJGYLSOX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB07321</td>
      <td>2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE</td>
      <td>KOKQLKWXOFRTHE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB11692</td>
      <td>Pavinetant</td>
      <td>QYTBBBAHNIWFOD-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB05511</td>
      <td>Piclidenoson</td>
      <td>HUJXGQILHAUCCV-MOROJQBDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB01357</td>
      <td>Mestranol</td>
      <td>IMSSROKUHAOUJS-MJCUULBUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB05470</td>
      <td>VX-702</td>
      <td>FYSRKRZDBHOFAY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m71</td>
      <td>DB13764</td>
      <td>Monoxerutin</td>
      <td>MBHXKZDTQCSVPM-BDAFLREQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07843</td>
      <td>5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE</td>
      <td>LTJNKFUIOOJXNJ-WFASDCNBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB12158</td>
      <td>Filorexant</td>
      <td>NPFDWHQSDBWQLH-QZTJIDSGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB12137</td>
      <td>GSK-256066</td>
      <td>JFHROPTYMMSOLG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m71</td>
      <td>DB13307</td>
      <td>Proscillaridin</td>
      <td>MYEJFUXQJGHEQK-ALRJYLEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB14774</td>
      <td>Balipodect</td>
      <td>KVHRYLNQDWXAGI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB12289</td>
      <td>Darexaban</td>
      <td>IJNIQYINMSGIPS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB07084</td>
      <td>N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</td>
      <td>YHKGWOJTUMJPNW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB06248</td>
      <td>Amelubant</td>
      <td>SBVYURPQULDJTI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11984</td>
      <td>Letaxaban</td>
      <td>GEHAEMCVKDPMKO-HXUWFJFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12116</td>
      <td>Epigallocatechin gallate</td>
      <td>WMBWREPUVVBILR-WIYYLYMNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12115</td>
      <td>AZD-9164</td>
      <td>FNYFFCOCVNTJCD-NNMXADRKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12095</td>
      <td>Telotristat ethyl</td>
      <td>MDSQOJYHHZBZKA-GBXCKJPGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB04623</td>
      <td>2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>CGBRFCVAMLJVEA-ZGURCIGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB08911</td>
      <td>Trametinib</td>
      <td>LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB14845</td>
      <td>Filgotinib</td>
      <td>RIJLVEAXPNLDTC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB14993</td>
      <td>Pyrotinib</td>
      <td>SADXACCFNXBCFY-IYNHSRRRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w4h</td>
      <td>DB13556</td>
      <td>Sulfamazone</td>
      <td>BGLHAKAJGYLSOX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB15099</td>
      <td>GW-468816</td>
      <td>XDKRVNKVAKCFGW-WXWBBQJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB15075</td>
      <td>4-demethyl-4-cholesteryloxycarbonylpenclomedine</td>
      <td>ZJUUIXYKTPSIOH-LEZJFEBPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB04608</td>
      <td>9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</td>
      <td>IAUZTOZLTFSMIE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB09295</td>
      <td>Talniflumate</td>
      <td>ANMLJLFWUCQGKZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB15356</td>
      <td>SLV-334</td>
      <td>LOFDNSDPZTVIIO-VPUSJEBWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08426</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</td>
      <td>PLXOQMHGHDZMSX-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08423</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE</td>
      <td>QKZZJXRGCHXIAI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB09272</td>
      <td>Eluxadoline</td>
      <td>QFNHIDANIVGXPE-FNZWTVRRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB13610</td>
      <td>Flumedroxone</td>
      <td>CDZJOBWKHSYNMO-SCUQKFFVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07404</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>YXQQNSYZOQHKHD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB01764</td>
      <td>Dalfopristin</td>
      <td>SUYRLXYYZQTJHF-VMBLUXKRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB15403</td>
      <td>Ziritaxestat</td>
      <td>REQQVBGILUTQNN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB02323</td>
      <td>EM-1745</td>
      <td>CKSDYJASHNGOOS-KTXOUVACSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB02319</td>
      <td>5,6-Dihydroxy-Nadp</td>
      <td>LRAVAOPKUBJONV-IVCJQJMGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB13019</td>
      <td>Henatinib</td>
      <td>MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB02360</td>
      <td>Bis-Napthyl Beta-Ketophosphonic Acid</td>
      <td>OFHMUASCSJJNNA-JOCHJYFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB02177</td>
      <td>1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine</td>
      <td>GKGJFUXSTSUKPB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB07435</td>
      <td>1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE</td>
      <td>GFANZDFKCCJYRF-NSISKUIASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB08237</td>
      <td>2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)</td>
      <td>COMPKRGNHXOXMN-GVDBMIGSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12137</td>
      <td>GSK-256066</td>
      <td>JFHROPTYMMSOLG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB13059</td>
      <td>PF-03814735</td>
      <td>RYYNGWLOYLRZLK-RBUKOAKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB08448</td>
      <td>(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol</td>
      <td>PCBWLKUEKANDCL-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB03802</td>
      <td>1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>ZGHFWBDHZZKWSI-LITSAYRRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB06677</td>
      <td>Clazosentan</td>
      <td>LFWCJABOXHSRGC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB13471</td>
      <td>Nalfurafine</td>
      <td>XGZZHZMWIXFATA-UEZBDDGYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB04652</td>
      <td>Corticosterone</td>
      <td>OMFXVFTZEKFJBZ-HJTSIMOOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11773</td>
      <td>BMS-903452</td>
      <td>OGIAVRWXUPYGGC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB07063</td>
      <td>{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID</td>
      <td>KYHVTMFADJNSGS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6w9c</td>
      <td>DB14555</td>
      <td>Ursadiol</td>
      <td>RTLXJEJRLWILSU-GWNGJUQLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07550</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE</td>
      <td>ZIGSBBKEPNQXRG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB07072</td>
      <td>(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</td>
      <td>CNKRZILQBKJWDS-WMFXKJRFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB03478</td>
      <td>2'-O-Acetyl Adenosine-5-Diphosphoribose</td>
      <td>BFNOPXRXIQJDHO-DLFWLGJNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6cs2</td>
      <td>DB11652</td>
      <td>Tucatinib</td>
      <td>SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB01392</td>
      <td>Yohimbine</td>
      <td>BLGXFZZNTVWLAY-SCYLSFHTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11871</td>
      <td>PF-00610355</td>
      <td>YPHDIMUXXABSSO-YTTGMZPUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB01426</td>
      <td>Ajmaline</td>
      <td>CJDRUOGAGYHKKD-HEFSZTOGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB15414</td>
      <td>CM-4307</td>
      <td>MLDQJTXFUGDVEO-FIBGUPNXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11694</td>
      <td>Ilorasertib</td>
      <td>WPHKIQPVPYJNAX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB04514</td>
      <td>Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester</td>
      <td>DFYLLEBFVZTKHD-VMIOUTBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11772</td>
      <td>Pilaralisib</td>
      <td>QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB07138</td>
      <td>Neflamapimod</td>
      <td>VEPKQEUBKLEPRA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08899</td>
      <td>Enzalutamide</td>
      <td>WXCXUHSOUPDCQV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07405</td>
      <td>1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</td>
      <td>GIZYIOOBBUHOBS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB07422</td>
      <td>(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide</td>
      <td>MMNRWNREMUMYQG-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB12036</td>
      <td>Naquotinib</td>
      <td>QKDCLUARMDUUKN-XMMPIXPASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6vxs</td>
      <td>DB06515</td>
      <td>Resiniferatoxin</td>
      <td>DSDNAKHZNJAGHN-MXTYGGKSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB13499</td>
      <td>Cefsulodin</td>
      <td>SYLKGLMBLAAGSC-QLVMHMETSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6crv</td>
      <td>DB08391</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UBIIFKJMNRPNMT-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11703</td>
      <td>Acalabrutinib</td>
      <td>WDENQIQQYWYTPO-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11769</td>
      <td>Funapide</td>
      <td>NEBUOXBYNAHKFV-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m3m</td>
      <td>DB01514</td>
      <td>Furazabol</td>
      <td>RGLLOUBXMOGLDQ-IVEVATEUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.8</td>
      <td>6m2n</td>
      <td>DB11775</td>
      <td>PF-03758309</td>
      <td>AYCPARAPKDAOEN-LJQANCHMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15257</td>
      <td>Milademetan</td>
      <td>RYAYYVTWKAOAJF-QISPRATLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15268</td>
      <td>Afabicin</td>
      <td>HFYMDQMXVPJNTH-VQHVLOKHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB04421</td>
      <td>Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct</td>
      <td>BZJFKYRGSZWSLT-YLIVDTKOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15009</td>
      <td>PF-04937319</td>
      <td>MASKQITXHVYVFL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB13040</td>
      <td>Gandotinib</td>
      <td>SQSZANZGUXWJEA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08241</td>
      <td>4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE</td>
      <td>RUUOIINPNMNPIU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14889</td>
      <td>Derazantinib</td>
      <td>KPJDVVCDVBFRMU-AREMUKBSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08248</td>
      <td>3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE</td>
      <td>BKDUVKJYBJDZQW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15013</td>
      <td>TAK-243</td>
      <td>KJDAGXLMHXUAGV-DGWLBADLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15029</td>
      <td>AZD-8186</td>
      <td>LMJFJIDLEAWOQJ-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15209</td>
      <td>MK-0736</td>
      <td>ORQZQBUNAMJFCY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15197</td>
      <td>RSV-604</td>
      <td>MTPVBMVUENFFLL-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06401</td>
      <td>Bazedoxifene</td>
      <td>UCJGJABZCDBEDK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15442</td>
      <td>Trilaciclib</td>
      <td>PDGKHKMBHVFCMG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB02483</td>
      <td>Etheno-Nad</td>
      <td>JCDBQDNBEQHDHK-BSLNIGMPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14896</td>
      <td>Selitrectinib</td>
      <td>OEBIHOVSAMBXIB-SJKOYZFVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB15169</td>
      <td>H3B-6527</td>
      <td>MBWRLLRCTIYXDW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12115</td>
      <td>AZD-9164</td>
      <td>FNYFFCOCVNTJCD-NNMXADRKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06169</td>
      <td>Indibulin</td>
      <td>SOLIIYNRSAWTSQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB05423</td>
      <td>ORG-34517</td>
      <td>DFELGYQKEOCHOA-BZAFBGKRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12141</td>
      <td>Gilteritinib</td>
      <td>GYQYAJJFPNQOOW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08051</td>
      <td>(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>XXRHRPGYYNOBHO-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08138</td>
      <td>{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide</td>
      <td>BDRDBXXWQDFXEC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08064</td>
      <td>N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA</td>
      <td>NTMADESEDXKNFZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06194</td>
      <td>Elocalcitol</td>
      <td>LRLWXBHFPGSUOX-GJQYOBCGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB03944</td>
      <td>5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One</td>
      <td>IZLRMTJLQCLMKF-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06494</td>
      <td>Sufugolix</td>
      <td>UCQSBGOFELXYIN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB14942</td>
      <td>BMS-986141</td>
      <td>KEEBLYWBELVGPQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15132</td>
      <td>AZD-8165</td>
      <td>YUHNXUAATAMVKD-PZJWPPBQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15108</td>
      <td>Tipranavir C-14</td>
      <td>SUJUHGSWHZTSEU-MWQIXQBFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14895</td>
      <td>Vibegron</td>
      <td>DJXRIQMCROIRCZ-XOEOCAAJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15408</td>
      <td>Silmitasertib</td>
      <td>MUOKSQABCJCOPU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB13556</td>
      <td>Sulfamazone</td>
      <td>BGLHAKAJGYLSOX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15120</td>
      <td>GSK-239512</td>
      <td>YFRBKEVUUCQYOW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12096</td>
      <td>PF-05175157</td>
      <td>BDXXSFOJPYSYOC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB14068</td>
      <td>Dexniguldipine</td>
      <td>SVJMLYUFVDMUHP-MGBGTMOVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06346</td>
      <td>Fiboflapon</td>
      <td>DFQGDHBGRSTTHX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB05255</td>
      <td>Ronacaleret</td>
      <td>FQJISUPNMFRIFZ-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB00590</td>
      <td>Doxazosin</td>
      <td>RUZYUOTYCVRMRZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06314</td>
      <td>SGX-523</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12114</td>
      <td>Poziotinib</td>
      <td>LPFWVDIFUFFKJU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14929</td>
      <td>Elsulfavirine</td>
      <td>ULTDEARCBRNRGR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB03159</td>
      <td>CRA_8696</td>
      <td>GAVRMVQHHVMXFD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07325</td>
      <td>N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE</td>
      <td>VCOKUBHAJVTVNG-FMIVXFBMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07024</td>
      <td>2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE</td>
      <td>CEXBEGBNDJVZPK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB13490</td>
      <td>Hidrosmin</td>
      <td>XYFLWVOTXWXNAM-WTNNCJBMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB04696</td>
      <td>4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN</td>
      <td>GFGZCXHXQCQRFP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB04609</td>
      <td>INHIBITOR Q8467 OF DUPONT MERCK</td>
      <td>HFLCERPZYCWLSZ-VKONIRKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12740</td>
      <td>CC-115</td>
      <td>GMYLVKUGJMYTFB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12719</td>
      <td>Turofexorate isopropyl</td>
      <td>INASOKQDNHHMRE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07537</td>
      <td>N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide</td>
      <td>CLEGTVIMOPPIBR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06942</td>
      <td>N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide</td>
      <td>RNZKCCPFUWHBFY-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB06732</td>
      <td>beta-Naphthoflavone</td>
      <td>OUGIDAPQYNCXRA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06908</td>
      <td>(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID</td>
      <td>PAWOPJKHTZCKMT-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB01092</td>
      <td>Ouabain</td>
      <td>LPMXVESGRSUGHW-HBYQJFLCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB04879</td>
      <td>Vatalanib</td>
      <td>YCOYDOIWSSHVCK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB07382</td>
      <td>N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine</td>
      <td>WJNBSTLIALIIEW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB13556</td>
      <td>Sulfamazone</td>
      <td>BGLHAKAJGYLSOX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB11614</td>
      <td>Rupatadine</td>
      <td>WUZYKBABMWJHDL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB02329</td>
      <td>Carbenoxolone</td>
      <td>OBZHEBDUNPOCJG-WBXJDKIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB13002</td>
      <td>HKI-357</td>
      <td>NERXPXBELDBEPZ-RMKNXTFCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB00693</td>
      <td>Fluorescein</td>
      <td>GNBHRKFJIUUOQI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB14895</td>
      <td>Vibegron</td>
      <td>DJXRIQMCROIRCZ-XOEOCAAJSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB04842</td>
      <td>Fluspirilene</td>
      <td>QOYHHIBFXOOADH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07181</td>
      <td>4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</td>
      <td>JYKFWUXBFJJDTP-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07183</td>
      <td>N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide</td>
      <td>CPVRYQAOUPSUDO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12887</td>
      <td>Tazemetostat</td>
      <td>NSQSAUGJQHDYNO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB04651</td>
      <td>BIOTINOL-5-AMP</td>
      <td>KBOGUFFJCBPJEH-SQGSUPJISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07219</td>
      <td>BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE</td>
      <td>OMQNYWZURFTFHE-MQBSTWLZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB00773</td>
      <td>Etoposide</td>
      <td>VJJPUSNTGOMMGY-MRVIYFEKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB01337</td>
      <td>Pancuronium</td>
      <td>GVEAYVLWDAFXET-XGHATYIMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB13095</td>
      <td>JTK-853</td>
      <td>JQLOVYLALGSISI-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07252</td>
      <td>3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide</td>
      <td>TZHCXOMEOHEZDX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB03383</td>
      <td>5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide</td>
      <td>YDCGVASFVACWKF-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07253</td>
      <td>N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</td>
      <td>QTFCKBFCXDAZIU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB01410</td>
      <td>Ciclesonide</td>
      <td>LUKZNWIVRBCLON-GXOBDPJESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB07457</td>
      <td>3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE</td>
      <td>APYXQTXFRIDSGE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB08444</td>
      <td>3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile</td>
      <td>YYGZQXRLQMFHDH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB13223</td>
      <td>Fluocortin</td>
      <td>PUWHHWCHAVXSIG-NCLPIGKXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB04793</td>
      <td>1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol</td>
      <td>DKBAWRNTUZFJKV-XMTFNYHQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB11694</td>
      <td>Ilorasertib</td>
      <td>WPHKIQPVPYJNAX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12627</td>
      <td>GSK-1292263</td>
      <td>AYJRTVVIBJSSKN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB12973</td>
      <td>Serlopitant</td>
      <td>FLNYCRJBCNNHRH-OIYLJQICSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB04405</td>
      <td>2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid</td>
      <td>AQYSXARQCHHHLK-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12590</td>
      <td>Indiplon</td>
      <td>CBIAWPMZSFFRGN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14646</td>
      <td>Prednisone acetate</td>
      <td>MOVRKLZUVNCBIP-RFZYENFJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07806</td>
      <td>(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID</td>
      <td>UDMBRVGTYILYDX-SVFBPWRDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14653</td>
      <td>Clocortolone caproate</td>
      <td>MMTRTBFDFNRBQO-ANHDKODLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14655</td>
      <td>Drostanolone propionate</td>
      <td>NOTIQUSPUUHHEH-UXOVVSIBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB13003</td>
      <td>Cortivazol</td>
      <td>RKHQGWMMUURILY-UHRZLXHJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB11934</td>
      <td>Epelsiban</td>
      <td>UWHCWRQFNKUYCG-QUZACWSFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07856</td>
      <td>6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE</td>
      <td>HPWBHQIUIBFTQC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB12368</td>
      <td>AZD-3839</td>
      <td>MRXBCEQZNKUUIP-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB04099</td>
      <td>Deamido-Nad+</td>
      <td>SENPVEZBRZQVST-HISDBWNOSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB03186</td>
      <td>U-Pi-a-Pi</td>
      <td>JIAJERGOUFOENU-LNAOLWRRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB04098</td>
      <td>Balanol</td>
      <td>XYUFCXJZFZPEJD-PGRDOPGGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB12550</td>
      <td>Taladegib</td>
      <td>SZBGQDXLNMELTB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB12368</td>
      <td>AZD-3839</td>
      <td>MRXBCEQZNKUUIP-DEOSSOPVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB12336</td>
      <td>GDC-0917</td>
      <td>HSHPBORBOJIXSQ-HARLFGEKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB01640</td>
      <td>(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One</td>
      <td>QNURTFDBHAQRSI-OAHLLOKOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB01669</td>
      <td>Virginiamycin M1</td>
      <td>DAIKHDNSXMZDCU-FQTGFAPKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB12054</td>
      <td>BQ-123</td>
      <td>VYCMAAOURFJIHD-PJNXIOHISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m71</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB07794</td>
      <td>5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</td>
      <td>XVECMUKVOMUNLE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB04373</td>
      <td>4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</td>
      <td>WQUBEIMCFHCJCO-AWCRTANDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12388</td>
      <td>Evocalcet</td>
      <td>RZNUIYPHQFXBAN-XLIONFOSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lzg</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB13981</td>
      <td>Nomegestrol acetate</td>
      <td>IIVBFTNIGYRNQY-YQLZSBIMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12522</td>
      <td>Toreforant</td>
      <td>FCRFVPZAXGJLPW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB03082</td>
      <td>6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide</td>
      <td>CSWQJKHBMACTGB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxx</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14152</td>
      <td>Ginsenosides</td>
      <td>NLHQJXWYMZLQJY-SWIZOJJJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB00966</td>
      <td>Telmisartan</td>
      <td>RMMXLENWKUUMAY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06837</td>
      <td>(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide</td>
      <td>VXDKQRWTOJFQKH-BJZITVGISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB04903</td>
      <td>Pagoclone</td>
      <td>HIUPRQPBWVEQJJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14624</td>
      <td>Nandrolone hydrogen sulfate</td>
      <td>SKZMVWBZTQNCKW-IZPLOLCNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14625</td>
      <td>Meprednisone acetate</td>
      <td>RZAMUHXEOMZXET-ABQXZQTJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08350</td>
      <td>5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE</td>
      <td>GYQRHHQPEMOLKH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w4h</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB06732</td>
      <td>beta-Naphthoflavone</td>
      <td>OUGIDAPQYNCXRA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6vxs</td>
      <td>DB15269</td>
      <td>ALK-4290</td>
      <td>DWKNOLCXIFYNFV-HSZRJFAPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB14633</td>
      <td>Prednisolone hemisuccinate</td>
      <td>APGDTXUMTIZLCJ-CGVGKPPMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12410</td>
      <td>Sabarubicin</td>
      <td>VQHRZZISQVWPLK-UIRGBLDSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB01177</td>
      <td>Idarubicin</td>
      <td>XDXDZDZNSLXDNA-TZNDIEGXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB15193</td>
      <td>BMS-955176</td>
      <td>XDMUFNNPLXHNKA-ZTESCHFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08003</td>
      <td>ISOTHIAZOLIDINONE ANALOG</td>
      <td>UILYPHAKDBTKQV-UFYCRDLUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB00896</td>
      <td>Rimexolone</td>
      <td>QTTRZHGPGKRAFB-OOKHYKNYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB00637</td>
      <td>Astemizole</td>
      <td>GXDALQBWZGODGZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB00932</td>
      <td>Tipranavir</td>
      <td>SUJUHGSWHZTSEU-FYBSXPHGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB00590</td>
      <td>Doxazosin</td>
      <td>RUZYUOTYCVRMRZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11562</td>
      <td>Bicuculline</td>
      <td>IYGYMKDQCDOMRE-ZWKOTPCHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB00288</td>
      <td>Amcinonide</td>
      <td>ILKJAFIWWBXGDU-MOGDOJJUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB01108</td>
      <td>Trilostane</td>
      <td>KVJXBPDAXMEYOA-CXANFOAXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB01260</td>
      <td>Desonide</td>
      <td>WBGKWQHBNHJJPZ-LECWWXJVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11591</td>
      <td>Bilastine</td>
      <td>ACCMWZWAEFYUGZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB01336</td>
      <td>Metocurine</td>
      <td>JFXBEKISTKFVAB-AJQTZOPKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00354</td>
      <td>Buclizine</td>
      <td>MOYGZHXDRJNJEP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB01410</td>
      <td>Ciclesonide</td>
      <td>LUKZNWIVRBCLON-GXOBDPJESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB01561</td>
      <td>Androstanedione</td>
      <td>RAJWOBJTTGJROA-WZNAKSSCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB01564</td>
      <td>Calusterone</td>
      <td>IVFYLRMMHVYGJH-PVPPCFLZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB01737</td>
      <td>Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester</td>
      <td>YAEIKQDHLCFGAA-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB02115</td>
      <td>Daidzin</td>
      <td>KYQZWONCHDNPDP-QNDFHXLGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB08407</td>
      <td>PLATENSIMYCIN</td>
      <td>CSOMAHTTWTVBFL-OFBLZTNGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB02118</td>
      <td>CP-271485</td>
      <td>CIUMOGWIMXNXSQ-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB01691</td>
      <td>Indole Naphthyridinone</td>
      <td>VAZMNDXVXVUKFY-JXMROGBWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB00741</td>
      <td>Hydrocortisone</td>
      <td>JYGXADMDTFJGBT-VWUMJDOOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB09215</td>
      <td>Droxicam</td>
      <td>OEHFRZLKGRKFAS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12085</td>
      <td>LCL-161</td>
      <td>UFPFGVNKHCLJJO-SSKFGXFMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB01661</td>
      <td>1-(5-phospho-D-ribosyl)-ATP</td>
      <td>RKNHJBVBFHDXGR-MRUDJCSFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB15102</td>
      <td>Pemigatinib</td>
      <td>HCDMJFOHIXMBOV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB15238</td>
      <td>Olinciguat</td>
      <td>YWQFJNWMWZMXRW-HXUWFJFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB09183</td>
      <td>Dasabuvir</td>
      <td>NBRBXGKOEOGLOI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB15269</td>
      <td>ALK-4290</td>
      <td>DWKNOLCXIFYNFV-HSZRJFAPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB11663</td>
      <td>Pictilisib</td>
      <td>LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11706</td>
      <td>Raxatrigine</td>
      <td>JESCETIFNOFKEU-SJORKVTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB00948</td>
      <td>Mezlocillin</td>
      <td>YPBATNHYBCGSSN-VWPFQQQWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00450</td>
      <td>Droperidol</td>
      <td>RMEDXOLNCUSCGS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11701</td>
      <td>Amenamevir</td>
      <td>MNHNIVNAFBSLLX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB00436</td>
      <td>Bendroflumethiazide</td>
      <td>HDWIHXWEUNVBIY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB00588</td>
      <td>Fluticasone propionate</td>
      <td>WMWTYOKRWGGJOA-CENSZEJFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB14822</td>
      <td>SB-649868</td>
      <td>ZJXIUGNEAIHSBI-IBGZPJMESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB02300</td>
      <td>Calcipotriol</td>
      <td>LWQQLNNNIPYSNX-UROSTWAQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB02329</td>
      <td>Carbenoxolone</td>
      <td>OBZHEBDUNPOCJG-WBXJDKIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB05838</td>
      <td>OPC-51803</td>
      <td>INGXCNVWWKKWOO-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>7bv1</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB13552</td>
      <td>Trifluperidol</td>
      <td>GPMXUUPHFNMNDH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB06446</td>
      <td>Dotarizine</td>
      <td>LRMJAFKKJLRDLE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB06469</td>
      <td>Lestaurtinib</td>
      <td>UIARLYUEJFELEN-DMVVYWCZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB13607</td>
      <td>Picloxydine</td>
      <td>YNCLPFSAZFGQCD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB06652</td>
      <td>Vicriviroc</td>
      <td>CNPVJJQCETWNEU-CYFREDJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB06660</td>
      <td>Saredutant</td>
      <td>PGKXDIMONUAMFR-AREMUKBSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB06677</td>
      <td>Clazosentan</td>
      <td>LFWCJABOXHSRGC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB13682</td>
      <td>Cefpirome</td>
      <td>DKOQGJHPHLTOJR-WHRDSVKCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB13685</td>
      <td>Quingestanol</td>
      <td>PCJFRMOEZQQSAX-AIOSZGMZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB02341</td>
      <td>Mdl 101,146</td>
      <td>XQAMVCHQGHAELT-YPAWHYETSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB06985</td>
      <td>2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid</td>
      <td>MEAQCLPMSVEOQF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07008</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE</td>
      <td>XPXGYINSBORUMM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07066</td>
      <td>2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>LJAHIGGEXIWVJG-LLVKDONJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07076</td>
      <td>6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</td>
      <td>FWTQOPWAMQXIMI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07081</td>
      <td>(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>FDEXEPZGMKFCTG-PSASIEDQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB05667</td>
      <td>Levoketoconazole</td>
      <td>XMAYWYJOQHXEEK-ZEQKJWHPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB14770</td>
      <td>Lanraplenib</td>
      <td>XCIGZBVOUQVIPI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB05212</td>
      <td>HE3286</td>
      <td>JJKOQZHWYLMASZ-FJWDNACWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB02331</td>
      <td>(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>YBULOUKTPCHXAL-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB02581</td>
      <td>5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</td>
      <td>VNZHOIDQBPFEJU-OAQYLSRUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB09371</td>
      <td>Norethynodrel</td>
      <td>ICTXHFFSOAJUMG-SLHNCBLASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>7bv1</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB03159</td>
      <td>CRA_8696</td>
      <td>GAVRMVQHHVMXFD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00301</td>
      <td>Flucloxacillin</td>
      <td>UIOFUWFRIANQPC-JKIFEVAISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB03480</td>
      <td>Brequinar Analog</td>
      <td>WYKKHJQZENLZID-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB13158</td>
      <td>Clobetasone</td>
      <td>XXIFVOHLGBURIG-OZCCCYNHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB03678</td>
      <td>(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine</td>
      <td>WVGZKPGUHOZIJQ-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB04099</td>
      <td>Deamido-Nad+</td>
      <td>SENPVEZBRZQVST-HISDBWNOSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB07794</td>
      <td>5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</td>
      <td>XVECMUKVOMUNLE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB04632</td>
      <td>4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE</td>
      <td>JHHBGNIRSUTQAS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB04698</td>
      <td>N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</td>
      <td>HJWYZPGYPZNDTN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB04704</td>
      <td>20-hydroxycholesterol</td>
      <td>MCKLJFJEQRYRQT-MGNSQDQZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB11431</td>
      <td>Moxidectin</td>
      <td>YZBLFMPOMVTDJY-LSGXYNIPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB04875</td>
      <td>Pralnacasan</td>
      <td>CXAGHAZMQSCAKJ-WAHHBDPQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB05171</td>
      <td>E-2012</td>
      <td>PUOAETJYKQITMO-LANLRWRYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lzg</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6wiq</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB14723</td>
      <td>Larotrectinib</td>
      <td>NYNZQNWKBKUAII-KBXCAEBGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12128</td>
      <td>Ulimorelin</td>
      <td>WGYPAJVJMXQXTR-ABNZCKJZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12149</td>
      <td>S-3304</td>
      <td>YWCLDDLVLSQGSZ-JOCHJYFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB11923</td>
      <td>Decoglurant</td>
      <td>DMJHZVARRXJSEG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB12320</td>
      <td>Palovarotene</td>
      <td>YTFHCXIPDIHOIA-DHZHZOJOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB15031</td>
      <td>Nemorexant</td>
      <td>NBGABHGMJVIVBW-QHCPKHFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12494</td>
      <td>SGI-1776</td>
      <td>MHXGEROHKGDZGO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB11870</td>
      <td>RG-4733</td>
      <td>OJPLJFIFUQPSJR-INIZCTEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB08708</td>
      <td>N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine</td>
      <td>XYYDXQCAYXOGQT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB08882</td>
      <td>Linagliptin</td>
      <td>LTXREWYXXSTFRX-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB08912</td>
      <td>Dabrafenib</td>
      <td>BFSMGDJOXZAERB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB04872</td>
      <td>Osanetant</td>
      <td>DZOJBGLFWINFBF-UMSFTDKQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12064</td>
      <td>BMS-777607</td>
      <td>VNBRGSXVFBYQNN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB14774</td>
      <td>Balipodect</td>
      <td>KVHRYLNQDWXAGI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12522</td>
      <td>Toreforant</td>
      <td>FCRFVPZAXGJLPW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12535</td>
      <td>AC-430</td>
      <td>DCRWIATZWHLIPN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB09230</td>
      <td>Azelnidipine</td>
      <td>ZKFQEACEUNWPMT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB08220</td>
      <td>(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid</td>
      <td>RPNNXCYIESWDSC-JRZBRKEGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB14675</td>
      <td>Temsavir</td>
      <td>QRPZBKAMSFHVRW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB05667</td>
      <td>Levoketoconazole</td>
      <td>XMAYWYJOQHXEEK-ZEQKJWHPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12371</td>
      <td>Siponimod</td>
      <td>KIHYPELVXPAIDH-HNSNBQBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12368</td>
      <td>AZD-3839</td>
      <td>MRXBCEQZNKUUIP-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12327</td>
      <td>Salvinorin A</td>
      <td>OBSYBRPAKCASQB-AGQYDFLVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB07396</td>
      <td>1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid</td>
      <td>KAJJGOCSAXKXBD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB06624</td>
      <td>Taranabant</td>
      <td>QLYKJCMUNUWAGO-GAJHUEQPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB07450</td>
      <td>(R)-minalrestat</td>
      <td>BMHZAHGTGIZZCT-LJQANCHMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00977</td>
      <td>Ethinylestradiol</td>
      <td>BFPYWIDHMRZLRN-SLHNCBLASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12282</td>
      <td>Defactinib</td>
      <td>FWLMVFUGMHIOAA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB06469</td>
      <td>Lestaurtinib</td>
      <td>UIARLYUEJFELEN-DMVVYWCZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12426</td>
      <td>Bitopertin</td>
      <td>YUUGYIUSCYNSQR-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00932</td>
      <td>Tipranavir</td>
      <td>SUJUHGSWHZTSEU-FYBSXPHGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB01100</td>
      <td>Pimozide</td>
      <td>YVUQSNJEYSNKRX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB07692</td>
      <td>1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine</td>
      <td>SHWNKRPMUBFWKE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB15450</td>
      <td>PF-05105679</td>
      <td>BXNMZRPTQFVRFA-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB07949</td>
      <td>({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID</td>
      <td>BFQRPTKOSYMPOL-LALPNIDTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12198</td>
      <td>Fosdagrocorat</td>
      <td>BVXLAHSJXXSWFF-KEKPKEOLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB15407</td>
      <td>Acalisib</td>
      <td>DOCINCLJNAXZQF-LBPRGKRZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12185</td>
      <td>Exatecan</td>
      <td>ZVYVPGLRVWUPMP-FYSMJZIKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB06178</td>
      <td>Talotrexin</td>
      <td>NYQPLPNEESYGNO-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07144</td>
      <td>5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>XZXVRKHUCSXVBM-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9q</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12025</td>
      <td>Triptolide</td>
      <td>DFBIRQPKNDILPW-CIVMWXNOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12724</td>
      <td>AZD-7295</td>
      <td>MAQDQJWCSSCURR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB02732</td>
      <td>Nicotinamide Adenine Dinucleotide Acetone Adduct</td>
      <td>SGHBFOOIAAJJMI-YDKVLQLQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12858</td>
      <td>LY-377604</td>
      <td>RBSGUQYXRDKPAE-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB02411</td>
      <td>2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2</td>
      <td>HOUHLOFMBSYNBO-KKUQBAQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11855</td>
      <td>Revefenacin</td>
      <td>FYDWDCIFZSGNBU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12419</td>
      <td>HSD-016</td>
      <td>ZWASRJHIEFYJGL-BFUOFWGJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12368</td>
      <td>AZD-3839</td>
      <td>MRXBCEQZNKUUIP-DEOSSOPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11832</td>
      <td>Crenolanib</td>
      <td>DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12306</td>
      <td>Cipargamin</td>
      <td>CKLPLPZSUQEDRT-WPCRTTGESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB02155</td>
      <td>Balanol Analog 8</td>
      <td>XVLMXAUKCDSMMW-YXLARRHKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12719</td>
      <td>Turofexorate isopropyl</td>
      <td>INASOKQDNHHMRE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00596</td>
      <td>Ulobetasol</td>
      <td>LEHFPXVYPMWYQD-XHIJKXOTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB13950</td>
      <td>WIN 55212-2</td>
      <td>HQVHOQAKMCMIIM-HXUWFJFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00591</td>
      <td>Fluocinolone acetonide</td>
      <td>FEBLZLNTKCEFIT-VSXGLTOVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12225</td>
      <td>Beclabuvir</td>
      <td>ZTTKEBYSXUCBSE-QDFUAKMASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12222</td>
      <td>Lurtotecan</td>
      <td>RVFGKBWWUQOIOU-NDEPHWFRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB14218</td>
      <td>Telotristat</td>
      <td>NCLGDOBQAWBXRA-PGRDOPGGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12198</td>
      <td>Fosdagrocorat</td>
      <td>BVXLAHSJXXSWFF-KEKPKEOLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12705</td>
      <td>Cenerimod</td>
      <td>KJKKMMMRWISKRF-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12041</td>
      <td>Mapracorat</td>
      <td>VJGFOYBQOIPQFY-XMMPIXPASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB02759</td>
      <td>4-Methylumbelliferyl Chitobiose</td>
      <td>UPSFMJHZUCSEHU-JYGUBCOQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB01357</td>
      <td>Mestranol</td>
      <td>IMSSROKUHAOUJS-MJCUULBUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB11616</td>
      <td>Pirarubicin</td>
      <td>KMSKQZKKOZQFFG-YXRRJAAWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lzg</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11995</td>
      <td>Avatrombopag</td>
      <td>OFZJKCQENFPZBH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB04158</td>
      <td>6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin</td>
      <td>ZKRKFZJAQKKHKL-SUGPNEFASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB11796</td>
      <td>Fostemsavir</td>
      <td>SWMDAPWAQQTBOG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB11855</td>
      <td>Revefenacin</td>
      <td>FYDWDCIFZSGNBU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB13728</td>
      <td>Halometasone</td>
      <td>GGXMRPUKBWXVHE-MIHLVHIWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lzg</td>
      <td>DB11618</td>
      <td>Zorubicin</td>
      <td>FBTUMDXHSRTGRV-BJISBDEGSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB11966</td>
      <td>BMS-986094</td>
      <td>YFXGICNMLCGLHJ-RSKRLRQZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB03962</td>
      <td>Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate</td>
      <td>MDKMTCCUJSRQGW-NAJQWHGHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12127</td>
      <td>Sultamicillin</td>
      <td>OPYGFNJSCUDTBT-PMLPCWDUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12165</td>
      <td>Presatovir</td>
      <td>GOFXWTVKPWJNGD-UWJYYQICSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB13307</td>
      <td>Proscillaridin</td>
      <td>MYEJFUXQJGHEQK-ALRJYLEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12222</td>
      <td>Lurtotecan</td>
      <td>RVFGKBWWUQOIOU-NDEPHWFRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12282</td>
      <td>Defactinib</td>
      <td>FWLMVFUGMHIOAA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB13164</td>
      <td>Olmutinib</td>
      <td>FDMQDKQUTRLUBU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB03642</td>
      <td>Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</td>
      <td>VBPPNJCVXGAZDD-PMACEKPBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12368</td>
      <td>AZD-3839</td>
      <td>MRXBCEQZNKUUIP-DEOSSOPVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12523</td>
      <td>Mizolastine</td>
      <td>PVLJETXTTWAYEW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m2n</td>
      <td>DB12548</td>
      <td>Sparsentan</td>
      <td>WRFHGDPIDHPWIQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB11903</td>
      <td>GW842166</td>
      <td>TWQYWUXBZHPIIV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB12756</td>
      <td>TAK-901</td>
      <td>WKDACQVEJIVHMZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB13866</td>
      <td>Etynodiol</td>
      <td>JYILPERKVHXLNF-QMNUTNMBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08039</td>
      <td>(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE</td>
      <td>LOGJQOUIVKBFGH-YBEGLDIGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15108</td>
      <td>Tipranavir C-14</td>
      <td>SUJUHGSWHZTSEU-MWQIXQBFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15106</td>
      <td>Surufatinib</td>
      <td>TTZSNFLLYPYKIL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>7bv1</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB06178</td>
      <td>Talotrexin</td>
      <td>NYQPLPNEESYGNO-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08739</td>
      <td>2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione</td>
      <td>ZSXNPAWXICXNGZ-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15071</td>
      <td>Omidenepag isopropyl</td>
      <td>VIQCWEGEHRBLAC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08997</td>
      <td>Dexetimide</td>
      <td>LQQIVYSCPWCSSD-HSZRJFAPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB03802</td>
      <td>1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>ZGHFWBDHZZKWSI-LITSAYRRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB09124</td>
      <td>Medrogestone</td>
      <td>HCFSGRMEEXUOSS-JXEXPEPMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08549</td>
      <td>(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER</td>
      <td>MFDBNNQUDZFSES-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07789</td>
      <td>1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea</td>
      <td>KNTGXMNWVXZIMW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15029</td>
      <td>AZD-8186</td>
      <td>LMJFJIDLEAWOQJ-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07728</td>
      <td>2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>XJJYJNMNYDNXNO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB14993</td>
      <td>Pyrotinib</td>
      <td>SADXACCFNXBCFY-IYNHSRRRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07692</td>
      <td>1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine</td>
      <td>SHWNKRPMUBFWKE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>7bv1</td>
      <td>DB14876</td>
      <td>TAS-116</td>
      <td>NVVPMZUGELHVMH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07678</td>
      <td>(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL</td>
      <td>ANAMDWGJXBYJEB-OPWFCKQNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08762</td>
      <td>O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID</td>
      <td>UPJNMOBJDSFRTI-FCEWJHQRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB14035</td>
      <td>Englitazone</td>
      <td>MVDXXGIBARMXSA-PYUWXLGESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08772</td>
      <td>3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID</td>
      <td>BCSVCWVQNOXFGL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB11645</td>
      <td>PF-4191834</td>
      <td>DVNQWYLVSNPCJZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB04190</td>
      <td>Inhibitor Bea425</td>
      <td>AHAVBKNGKPWROK-UMFPTGFGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6cs2</td>
      <td>DB13520</td>
      <td>Metergoline</td>
      <td>WZHJKEUHNJHDLS-QTGUNEKASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07252</td>
      <td>3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide</td>
      <td>TZHCXOMEOHEZDX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB04785</td>
      <td>Streptolydigin</td>
      <td>KVTPRMVXYZKLIG-NCAOFHFGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08426</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</td>
      <td>PLXOQMHGHDZMSX-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15254</td>
      <td>RO-5126766 free base</td>
      <td>LMMJFBMMJUMSJS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08449</td>
      <td>2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid</td>
      <td>IEVFQDJUDLCOQY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08459</td>
      <td>3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>SVMHTBVIPYVDIL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB04872</td>
      <td>Osanetant</td>
      <td>DZOJBGLFWINFBF-UMSFTDKQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15297</td>
      <td>Petesicatib</td>
      <td>KXAAIORSMACJSI-AEFFLSMTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lzg</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB04690</td>
      <td>Camptothecin</td>
      <td>VSJKWCGYPAHWDS-FQEVSTJZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08354</td>
      <td>2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>QCVULERVJOYHCP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15310</td>
      <td>Vactosertib</td>
      <td>FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08499</td>
      <td>N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide</td>
      <td>DQXBKUVWJSZHSI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>7bv1</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08510</td>
      <td>5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE</td>
      <td>UVTGFMKBPVLATL-DSOJQRAMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08561</td>
      <td>BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE</td>
      <td>PLBINCOCFGQAJM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15362</td>
      <td>LSZ-102</td>
      <td>SJXNPGGVGZXKKI-NYYWCZLTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB02621</td>
      <td>Latrunculin A</td>
      <td>DDVBPZROPPMBLW-IZGXTMSKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15222</td>
      <td>GS-6620</td>
      <td>YAAQYJCOIFNMKX-RSTNYOGXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15435</td>
      <td>BMS-986158</td>
      <td>KGERZPVQIRYWRK-GDLZYMKVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08703</td>
      <td>12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</td>
      <td>FGKKIHITEICGMN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08124</td>
      <td>3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>FTQYGMLRLRXBPT-IDUWFGFVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15157</td>
      <td>Voruciclib</td>
      <td>MRPGRAKIAJJGMM-OCCSQVGLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08710</td>
      <td>(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE</td>
      <td>BKZOQCGDCHOGOQ-MZLJFPOFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB15121</td>
      <td>AT-001</td>
      <td>YRGPAXAVTDMKDK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB14652</td>
      <td>Clocortolone acetate</td>
      <td>ARPLCFGLEYFDCN-CDACMRRYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08584</td>
      <td>6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08742</td>
      <td>1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)</td>
      <td>CEEUUHVULXTFGS-BQXVGYHGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>7bv1</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB06634</td>
      <td>Casopitant</td>
      <td>XGGTZCKQRWXCHW-WMTVXVAQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07422</td>
      <td>(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide</td>
      <td>MMNRWNREMUMYQG-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB06744</td>
      <td>ginkgolide-B</td>
      <td>SQOJOAFXDQDRGF-MMQTXUMRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB08834</td>
      <td>Tauroursodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-LBSADWJPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lzg</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6lxt</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12002</td>
      <td>AZD-4818</td>
      <td>HVTUHSABWJPWNK-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB13950</td>
      <td>WIN 55212-2</td>
      <td>HQVHOQAKMCMIIM-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB14844</td>
      <td>ONC-201</td>
      <td>VLULRUCCHYVXOH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB02466</td>
      <td>4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid</td>
      <td>ZXQHMEUGMCXKLO-KPKJPENVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB12006</td>
      <td>BMS-906024</td>
      <td>AYOUDDAETNMCBW-GSHUGGBRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB11968</td>
      <td>MK-7145</td>
      <td>OCKGFTQIICXDQW-ZEQRLZLVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB11921</td>
      <td>Deflazacort</td>
      <td>FBHSPRKOSMHSIF-GRMWVWQJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB11950</td>
      <td>Teneligliptin</td>
      <td>WGRQANOPCQRCME-PMACEKPBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6w9c</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB11814</td>
      <td>PF-03882845</td>
      <td>XNULRSOGWPFPBL-REWPJTCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6m3m</td>
      <td>DB11942</td>
      <td>Selinexor</td>
      <td>DEVSOMFAQLZNKR-RJRFIUFISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.7</td>
      <td>6crv</td>
      <td>DB14821</td>
      <td>Macozinone</td>
      <td>BJDZBXGJNBMCAV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB01690</td>
      <td>Bis(Adenosine)-5'-Triphosphate</td>
      <td>QCICUPZZLIQAPA-XPWFQUROSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB04408</td>
      <td>Ncs-Chromophore</td>
      <td>QZGIWPZCWHMVQL-UIYAJPBUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12693</td>
      <td>Ritanserin</td>
      <td>JUQLTPCYUFPYKE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12432</td>
      <td>CC-401</td>
      <td>XDJCLCLBSGGNKS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08588</td>
      <td>2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE</td>
      <td>OYNURZXTLNNKAP-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB11987</td>
      <td>GSK-2018682</td>
      <td>NFIGDBFIDKDNIG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB12719</td>
      <td>Turofexorate isopropyl</td>
      <td>INASOKQDNHHMRE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB01792</td>
      <td>Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate</td>
      <td>FZCSEXOMUJFOHQ-KPKSGTNCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07074</td>
      <td>6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER</td>
      <td>OUBRALHIKGRAMA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB00673</td>
      <td>Aprepitant</td>
      <td>ATALOFNDEOCMKK-OITMNORJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12806</td>
      <td>GSK-1004723</td>
      <td>YANGEESWIGIKOP-UUWRZZSWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12850</td>
      <td>Etalocib</td>
      <td>YFIZRWPXUYFCSN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB12580</td>
      <td>Tradipitant</td>
      <td>CAVRKWRKTNINFF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12904</td>
      <td>ZSTK-474</td>
      <td>HGVNLRPZOWWDKD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB00455</td>
      <td>Loratadine</td>
      <td>JCCNYMKQOSZNPW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12756</td>
      <td>TAK-901</td>
      <td>WKDACQVEJIVHMZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB03020</td>
      <td>5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</td>
      <td>UINNILASBHZOTM-KMXXXSRASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB13953</td>
      <td>Estradiol benzoate</td>
      <td>UYIFTLBWAOGQBI-BZDYCCQFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB04392</td>
      <td>Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]</td>
      <td>HIZKPJUTKKJDGA-BETUJISGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07088</td>
      <td>(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide</td>
      <td>ZWXWAYUCJVQHOR-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12269</td>
      <td>PF-06273340</td>
      <td>BPIWZDNVMQQBQX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08816</td>
      <td>Ticagrelor</td>
      <td>OEKWJQXRCDYSHL-FNOIDJSQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB06334</td>
      <td>Tucidinostat</td>
      <td>SZMJVTADHFNAIS-BJMVGYQFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB04099</td>
      <td>Deamido-Nad+</td>
      <td>SENPVEZBRZQVST-HISDBWNOSA-O</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07688</td>
      <td>4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>RPJIMTALCNCQLV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12295</td>
      <td>Evodenoson</td>
      <td>SQJXTUJMBYVDBB-RQXXJAGISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB04362</td>
      <td>Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid</td>
      <td>VGXBGQACJQRWLV-LKGUXBDMSA-K</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07697</td>
      <td>1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine</td>
      <td>HMGDKYUJSFVHIY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB12960</td>
      <td>INCB-9471</td>
      <td>ZMCJFJZOSKEMOM-DNKZPPIMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB03638</td>
      <td>Cytidyl-2'-5'-Phospho-Guanosine</td>
      <td>QZDUXDLOEVJGDG-VMIOUTBZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB06920</td>
      <td>Eribaxaban</td>
      <td>QQBKAVAGLMGMHI-WIYYLYMNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB03157</td>
      <td>N,O-Didansyl-L-Tyrosine</td>
      <td>LUBOPDUYHWABFG-NDEPHWFRSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12658</td>
      <td>AFN-1252</td>
      <td>QXTWSUQCXCWEHF-JXMROGBWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08730</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</td>
      <td>CPFBZMFUCGHBAP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB04342</td>
      <td>7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid</td>
      <td>JWCSIUVGFCSJCK-LIUKBUMOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB07456</td>
      <td>3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB03300</td>
      <td>Pterin Cytosine Dinucleotide</td>
      <td>WKSPNQYEWZEMMI-FEFZDOOUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB12843</td>
      <td>Oleandrin</td>
      <td>JLPDBLFIVFSOCC-XYXFTTADSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12082</td>
      <td>Vesnarinone</td>
      <td>ZVNYJIZDIRKMBF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB11871</td>
      <td>PF-00610355</td>
      <td>YPHDIMUXXABSSO-YTTGMZPUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB11789</td>
      <td>Hyodeoxycholic Acid</td>
      <td>DGABKXLVXPYZII-SIBKNCMHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12996</td>
      <td>Acteoside</td>
      <td>FBSKJMQYURKNSU-ZLSOWSIRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB06268</td>
      <td>Sitaxentan</td>
      <td>PHWXUGHIIBDVKD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB13093</td>
      <td>TAK-593</td>
      <td>DZFZXPPHBWCXPQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB06263</td>
      <td>Amrubicin</td>
      <td>VJZITPJGSQKZMX-XDPRQOKASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB12185</td>
      <td>Exatecan</td>
      <td>ZVYVPGLRVWUPMP-FYSMJZIKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9q</td>
      <td>DB03523</td>
      <td>Brequinar</td>
      <td>PHEZJEYUWHETKO-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB12054</td>
      <td>BQ-123</td>
      <td>VYCMAAOURFJIHD-PJNXIOHISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB06755</td>
      <td>Beta carotene</td>
      <td>OENHQHLEOONYIE-JLTXGRSLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB12221</td>
      <td>Canrenone</td>
      <td>UJVLDDZCTMKXJK-WNHSNXHDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07830</td>
      <td>(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE</td>
      <td>DIRIFWIKLRTNMB-DYVFJYSZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB11805</td>
      <td>Saracatinib</td>
      <td>OUKYUETWWIPKQR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB11995</td>
      <td>Avatrombopag</td>
      <td>OFZJKCQENFPZBH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lzg</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB11829</td>
      <td>Ruboxistaurin</td>
      <td>ZCBUQCWBWNUWSU-SFHVURJKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB12307</td>
      <td>Foretinib</td>
      <td>CXQHYVUVSFXTMY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB14937</td>
      <td>MK-8666</td>
      <td>CODQKEMYZZKQAE-QPVYNBJUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08400</td>
      <td>4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid</td>
      <td>KUEKMTNOUPAOBS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12781</td>
      <td>Balaglitazone</td>
      <td>IETKPTYAGKZLKY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB15011</td>
      <td>Avacopan</td>
      <td>PUKBOVABABRILL-YZNIXAGQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12764</td>
      <td>ABC-294640</td>
      <td>CAOTVXGYTWCKQE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB04092</td>
      <td>Apstatin</td>
      <td>YVUUZAPYLPWFHE-HXFGRODQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12562</td>
      <td>Setipiprant</td>
      <td>IHAXLPDVOWLUOS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB01705</td>
      <td>Bis(5-Amidino-Benzimidazolyl)Methane</td>
      <td>QZKOOEFIMWKZPK-UHFFFAOYSA-Q</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB07680</td>
      <td>[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</td>
      <td>HUJXISJLAPAFBO-IBGZPJMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07796</td>
      <td>(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE</td>
      <td>GJYCQHGTXMVIBG-MUGJNUQGSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB05616</td>
      <td>4'-Methylene-5,8,10-trideazaaminopterin</td>
      <td>NAWXUBYGYWOOIX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB02259</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide</td>
      <td>VSYGXLAJQDAWCZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lzg</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4b</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08556</td>
      <td>5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID</td>
      <td>CMHHNHDPPWDNAH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB07340</td>
      <td>N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine</td>
      <td>ZFLJHSQHILSNCM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB13126</td>
      <td>BMS-986115</td>
      <td>SRJNRAQUSAVENA-GSHUGGBRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB13074</td>
      <td>Macimorelin</td>
      <td>UJVDJAPJQWZRFR-DHIUTWEWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB13042</td>
      <td>Fenoverine</td>
      <td>UBAJTZKNDCEGKL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07686</td>
      <td>4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>VPOGRVWIIVMWRI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12505</td>
      <td>E-7820</td>
      <td>LWGUASZLXHYWIV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB02194</td>
      <td>8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>ULLMMKZQNNBLRN-SANMLTNESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB07326</td>
      <td>6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</td>
      <td>FEGRQUWSKADGSP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB13947</td>
      <td>Testosterone enantate benzilic acid hydrazone</td>
      <td>PTVXYACXDYZNID-JKXGKYMWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lzg</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12558</td>
      <td>AEE-788</td>
      <td>OONFNUWBHFSNBT-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07817</td>
      <td>1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea</td>
      <td>NJPVZSIGDRLLTD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08657</td>
      <td>2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID</td>
      <td>SSXCWVOQWRUMGN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB13791</td>
      <td>Penfluridol</td>
      <td>MDLAAYDRRZXJIF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08498</td>
      <td>(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>OVSAMUIBGQSLDC-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB06677</td>
      <td>Clazosentan</td>
      <td>LFWCJABOXHSRGC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB13764</td>
      <td>Monoxerutin</td>
      <td>MBHXKZDTQCSVPM-BDAFLREQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08500</td>
      <td>(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</td>
      <td>ZCJBDRSKHARECB-PYTCMNEWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08639</td>
      <td>Dapivirine</td>
      <td>ILAYIAGXTHKHNT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB12307</td>
      <td>Foretinib</td>
      <td>CXQHYVUVSFXTMY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB00549</td>
      <td>Zafirlukast</td>
      <td>YEEZWCHGZNKEEK-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB01405</td>
      <td>Temafloxacin</td>
      <td>QKDHBVNJCZBTMR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB11952</td>
      <td>Duvelisib</td>
      <td>SJVQHLPISAIATJ-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB14882</td>
      <td>CEP-9722</td>
      <td>CTLOSZHDGZLOQE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB00836</td>
      <td>Loperamide</td>
      <td>RDOIQAHITMMDAJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12507</td>
      <td>Atecegatran metoxil</td>
      <td>XSNMGLZVFNDDPW-ZWKOTPCHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB01003</td>
      <td>Cromoglicic acid</td>
      <td>IMZMKUWMOSJXDT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lzg</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB11176</td>
      <td>Zeaxanthin</td>
      <td>JKQXZKUSFCKOGQ-QAYBQHTQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07005</td>
      <td>D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide</td>
      <td>VZFTWWJAUZOJDH-MOPGFXCFSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9q</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08495</td>
      <td>4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>VXONTEUOQXFJJS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08730</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</td>
      <td>CPFBZMFUCGHBAP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB04121</td>
      <td>Guanosine-3'-Monophosphate-5'-Diphosphate</td>
      <td>HEYSFDAMRDTCJM-UUOKFMHZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB01678</td>
      <td>RU84687</td>
      <td>SAFPHFWYRLLBFO-NSOVKSMOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB01690</td>
      <td>Bis(Adenosine)-5'-Triphosphate</td>
      <td>QCICUPZZLIQAPA-XPWFQUROSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07294</td>
      <td>3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid</td>
      <td>AANFHDFOMFRLLR-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08816</td>
      <td>Ticagrelor</td>
      <td>OEKWJQXRCDYSHL-FNOIDJSQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB11841</td>
      <td>Entinostat</td>
      <td>INVTYAOGFAGBOE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB07743</td>
      <td>S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE</td>
      <td>VNGWUVBXUIDQTK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12511</td>
      <td>Imiglitazar</td>
      <td>ULVDFHLHKNJICZ-QCWLDUFUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08738</td>
      <td>1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one</td>
      <td>KWCKZIJGKMCYCI-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08772</td>
      <td>3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID</td>
      <td>BCSVCWVQNOXFGL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12432</td>
      <td>CC-401</td>
      <td>XDJCLCLBSGGNKS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB05936</td>
      <td>CVT-6883</td>
      <td>KOYXXLLNCXWUNF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07182</td>
      <td>(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID</td>
      <td>HFRHWTYCVGKGIE-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB12302</td>
      <td>CP-724714</td>
      <td>LLVZBTWPGQVVLW-SNAWJCMRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12186</td>
      <td>SRT-2104</td>
      <td>LAMQVIQMVKWXOC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB06159</td>
      <td>Rubitecan</td>
      <td>VHXNKPBCCMUMSW-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB02329</td>
      <td>Carbenoxolone</td>
      <td>OBZHEBDUNPOCJG-WBXJDKIVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB06248</td>
      <td>Amelubant</td>
      <td>SBVYURPQULDJTI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB11778</td>
      <td>Danusertib</td>
      <td>XKFTZKGMDDZMJI-HSZRJFAPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB11663</td>
      <td>Pictilisib</td>
      <td>LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB05470</td>
      <td>VX-702</td>
      <td>FYSRKRZDBHOFAY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lzg</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12436</td>
      <td>Vofopitant</td>
      <td>XILNRORTJVDYRH-HKUYNNGSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB11656</td>
      <td>Rebamipide</td>
      <td>ALLWOAVDORUJLA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB07789</td>
      <td>1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea</td>
      <td>KNTGXMNWVXZIMW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lzg</td>
      <td>DB07789</td>
      <td>1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea</td>
      <td>KNTGXMNWVXZIMW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB15435</td>
      <td>BMS-986158</td>
      <td>KGERZPVQIRYWRK-GDLZYMKVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB06263</td>
      <td>Amrubicin</td>
      <td>VJZITPJGSQKZMX-XDPRQOKASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB07845</td>
      <td>2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide</td>
      <td>VGYXXQRDIVRILX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB09235</td>
      <td>Efonidipine</td>
      <td>NSVFSAJIGAJDMR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB01185</td>
      <td>Fluoxymesterone</td>
      <td>YLRFCQOZQXIBAB-RBZZARIASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB04350</td>
      <td>Argadin</td>
      <td>FOZYKTUSOWWQGR-KNPYFFGGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB14068</td>
      <td>Dexniguldipine</td>
      <td>SVJMLYUFVDMUHP-MGBGTMOVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08391</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UBIIFKJMNRPNMT-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB11778</td>
      <td>Danusertib</td>
      <td>XKFTZKGMDDZMJI-HSZRJFAPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB11786</td>
      <td>Pefcalcitol</td>
      <td>SVCSMAZYWOQCBW-NVJMFHFGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB06364</td>
      <td>XR5944</td>
      <td>SFOADSRLCHRTKT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB13950</td>
      <td>WIN 55212-2</td>
      <td>HQVHOQAKMCMIIM-HXUWFJFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB09047</td>
      <td>Finafloxacin</td>
      <td>FYMHQCNFKNMJAV-HOTGVXAUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB06144</td>
      <td>Sertindole</td>
      <td>GZKLJWGUPQBVJQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB06809</td>
      <td>Plerixafor</td>
      <td>YIQPUIGJQJDJOS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB11951</td>
      <td>Lemborexant</td>
      <td>MUGXRYIUWFITCP-PGRDOPGGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12001</td>
      <td>Abemaciclib</td>
      <td>UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12010</td>
      <td>Fostamatinib</td>
      <td>GKDRMWXFWHEQQT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08931</td>
      <td>Riociguat</td>
      <td>WXXSNCNJFUAIDG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12073</td>
      <td>Albaconazole</td>
      <td>UHIXWHUVLCAJQL-MPBGBICISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12095</td>
      <td>Telotristat ethyl</td>
      <td>MDSQOJYHHZBZKA-GBXCKJPGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08833</td>
      <td>Taurochenodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-BJLOMENOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08834</td>
      <td>Tauroursodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-LBSADWJPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB03893</td>
      <td>Thionicotinamide-Adenine-Dinucleotide</td>
      <td>UQYPZLRUJKCREN-NNYOXOHSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB09298</td>
      <td>Silibinin</td>
      <td>SEBFKMXJBCUCAI-HKTJVKLFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB01254</td>
      <td>Dasatinib</td>
      <td>ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB11521</td>
      <td>Imidocarb</td>
      <td>SCEVFJUWLLRELN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9q</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12116</td>
      <td>Epigallocatechin gallate</td>
      <td>WMBWREPUVVBILR-WIYYLYMNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB05616</td>
      <td>4'-Methylene-5,8,10-trideazaaminopterin</td>
      <td>NAWXUBYGYWOOIX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB04064</td>
      <td>Nogalaviketone</td>
      <td>QHNJNOBWURJIEK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07642</td>
      <td>5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>GYKIQIOWVKCVBP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB12096</td>
      <td>PF-05175157</td>
      <td>BDXXSFOJPYSYOC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB06178</td>
      <td>Talotrexin</td>
      <td>NYQPLPNEESYGNO-IBGZPJMESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB07832</td>
      <td>4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde</td>
      <td>VKQPTVJDZIILPG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12006</td>
      <td>BMS-906024</td>
      <td>AYOUDDAETNMCBW-GSHUGGBRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12272</td>
      <td>Vidupiprant</td>
      <td>PFWVGKROPKKEDW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12048</td>
      <td>Savolitinib</td>
      <td>XYDNMOZJKOGZLS-NSHDSACASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12050</td>
      <td>LY-3039478</td>
      <td>YCBAQKQAINQRFW-UGSOOPFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12542</td>
      <td>GSK-356278</td>
      <td>AWDJJMXJUOHGLC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB04862</td>
      <td>Merimepodib</td>
      <td>JBPUGFODGPKTDW-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB09199</td>
      <td>Netoglitazone</td>
      <td>PKWDZWYVIHVNKS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB04623</td>
      <td>2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>CGBRFCVAMLJVEA-ZGURCIGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB09048</td>
      <td>Netupitant</td>
      <td>WAXQNWCZJDTGBU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB04201</td>
      <td>Histidyl-Adenosine Monophosphate</td>
      <td>XTFBSLZFYLGYAT-OPYVMVOTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB03632</td>
      <td>Argifin</td>
      <td>UHBHXSDKGLPPGO-HTDHLNIYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB09079</td>
      <td>Nintedanib</td>
      <td>XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB06995</td>
      <td>N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide</td>
      <td>USBSTVPJNQLYEM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB08499</td>
      <td>N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide</td>
      <td>DQXBKUVWJSZHSI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12302</td>
      <td>CP-724714</td>
      <td>LLVZBTWPGQVVLW-SNAWJCMRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB11611</td>
      <td>Lifitegrast</td>
      <td>JFOZKMSJYSPYLN-QHCPKHFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08490</td>
      <td>CTS-1027</td>
      <td>ROSNVSQTEGHUKU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07435</td>
      <td>1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE</td>
      <td>GFANZDFKCCJYRF-NSISKUIASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07434</td>
      <td>HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE</td>
      <td>TZWQPWGUQCSKDW-GUYCJALGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB05706</td>
      <td>13-deoxydoxorubicin</td>
      <td>RGVRUQHYQSORBY-JIGXQNLBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB09235</td>
      <td>Efonidipine</td>
      <td>NSVFSAJIGAJDMR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12027</td>
      <td>Serdemetan</td>
      <td>CEGSUKYESLWKJP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB04623</td>
      <td>2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>CGBRFCVAMLJVEA-ZGURCIGKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxs</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB01108</td>
      <td>Trilostane</td>
      <td>KVJXBPDAXMEYOA-CXANFOAXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07403</td>
      <td>4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE</td>
      <td>DTDZLJHKVNTQGZ-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12289</td>
      <td>Darexaban</td>
      <td>IJNIQYINMSGIPS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB04177</td>
      <td>4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>XZTUSOXSLKTKJQ-CESUGQOBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB15126</td>
      <td>IMG-7289</td>
      <td>KQKBMHGOHXOHTD-KKUQBAQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB12010</td>
      <td>Fostamatinib</td>
      <td>GKDRMWXFWHEQQT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB02010</td>
      <td>Staurosporine</td>
      <td>HKSZLNNOFSGOKW-FYTWVXJKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB13042</td>
      <td>Fenoverine</td>
      <td>UBAJTZKNDCEGKL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB11772</td>
      <td>Pilaralisib</td>
      <td>QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB03355</td>
      <td>5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine</td>
      <td>UPVAPSGKXAAHBG-CKTDUXNWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB09227</td>
      <td>Barnidipine</td>
      <td>VXMOONUMYLCFJD-DHLKQENFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB06281</td>
      <td>Torcetrapib</td>
      <td>CMSGWTNRGKRWGS-NQIIRXRSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07800</td>
      <td>N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE</td>
      <td>MIJGLXFQYBTIFY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB05608</td>
      <td>MKC-1</td>
      <td>OVSKGTONMLKNPZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB12505</td>
      <td>E-7820</td>
      <td>LWGUASZLXHYWIV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB03865</td>
      <td>6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine</td>
      <td>FEKRWNWZMOSVBX-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07689</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>NYNAFINLHQEHKU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB04703</td>
      <td>Hesperidin</td>
      <td>QUQPHWDTPGMPEX-QJBIFVCTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB14862</td>
      <td>PF-06815345</td>
      <td>QTBYVAZRKWOIDU-FUHWJXTLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07698</td>
      <td>3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine</td>
      <td>JDNMRPIWJIDDAY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB06401</td>
      <td>Bazedoxifene</td>
      <td>UCJGJABZCDBEDK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB07800</td>
      <td>N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE</td>
      <td>MIJGLXFQYBTIFY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB04392</td>
      <td>Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]</td>
      <td>HIZKPJUTKKJDGA-BETUJISGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB07147</td>
      <td>methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate</td>
      <td>HJWMYFBKJRVWJY-YKSBVNFPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB04023</td>
      <td>Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester</td>
      <td>DNBSDUDYNPJVCN-ZXTXFPBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB00700</td>
      <td>Eplerenone</td>
      <td>JUKPWJGBANNWMW-VWBFHTRKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB04006</td>
      <td>[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone</td>
      <td>WUGJIPFLBOATGL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB14898</td>
      <td>Retagliptin</td>
      <td>WIIAMRXFUJLYEF-SNVBAGLBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB14899</td>
      <td>Tavapadon</td>
      <td>AKQXQLUNFKDZBN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB04574</td>
      <td>Estrone sulfate</td>
      <td>JKKFKPJIXZFSSB-CBZIJGRNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB09286</td>
      <td>Pipamperone</td>
      <td>AXKPFOAXAHJUAG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB13950</td>
      <td>WIN 55212-2</td>
      <td>HQVHOQAKMCMIIM-HXUWFJFHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB08354</td>
      <td>2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>QCVULERVJOYHCP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15250</td>
      <td>Vercirnon</td>
      <td>JRWROCIMSDXGOZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15254</td>
      <td>RO-5126766 free base</td>
      <td>LMMJFBMMJUMSJS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB02196</td>
      <td>Uridine-Diphosphate-N-Acetylgalactosamine</td>
      <td>LFTYTUAZOPRMMI-NESSUJCYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07872</td>
      <td>5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide</td>
      <td>IYGIXVNAMZPBDK-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15292</td>
      <td>Foliglurax</td>
      <td>ZTEDNASHAWNBKQ-NCELDCMTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15310</td>
      <td>Vactosertib</td>
      <td>FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15317</td>
      <td>Posiphen</td>
      <td>PBHFNBQPZCRWQP-AZUAARDMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB03837</td>
      <td>Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide</td>
      <td>YUMYYTORLYHUFW-ZUDLOMHPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07945</td>
      <td>5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid</td>
      <td>GKBQRPKZHUFGOB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB01990</td>
      <td>Cholesterol sulfate</td>
      <td>BHYOQNUELFTYRT-DPAQBDIFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB01669</td>
      <td>Virginiamycin M1</td>
      <td>DAIKHDNSXMZDCU-FQTGFAPKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15245</td>
      <td>Olorofim</td>
      <td>SUFPWYYDCOKDLL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15238</td>
      <td>Olinciguat</td>
      <td>YWQFJNWMWZMXRW-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB14575</td>
      <td>Eslicarbazepine</td>
      <td>BMPDWHIDQYTSHX-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB02338</td>
      <td>Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate</td>
      <td>ACFIXJIJDZMPPO-NNYOXOHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB02673</td>
      <td>(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium</td>
      <td>VLGAHTYYCHWLNI-BHRZLAGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB08164</td>
      <td>(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</td>
      <td>GOBIXGZJSMAOFV-QRWLVFNGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB12371</td>
      <td>Siponimod</td>
      <td>KIHYPELVXPAIDH-HNSNBQBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB14568</td>
      <td>Ivosidenib</td>
      <td>WIJZXSAJMHAVGX-DHLKQENFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12885</td>
      <td>CF-102</td>
      <td>IPSYPUKKXMNCNQ-PFHKOEEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB02573</td>
      <td>2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate</td>
      <td>LYWWDKIADIGKTH-IDMWBNCISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB02799</td>
      <td>N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide</td>
      <td>OJBZDUMTXGGVSP-KTKRTIGZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB00324</td>
      <td>Fluorometholone</td>
      <td>FAOZLTXFLGPHNG-KNAQIMQKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15168</td>
      <td>Cilofexor</td>
      <td>KZSKGLFYQAYZCO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB02411</td>
      <td>2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2</td>
      <td>HOUHLOFMBSYNBO-KKUQBAQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07815</td>
      <td>GIBBERELLIN A4</td>
      <td>RSQSQJNRHICNNH-NFMPGMCNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB02388</td>
      <td>Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</td>
      <td>UQFRSHRWRKYNDE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB11219</td>
      <td>Enzacamene</td>
      <td>HEOCBCNFKCOKBX-SDNWHVSQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB03788</td>
      <td>GC-24</td>
      <td>JYHIGYLGYNCMGI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15151</td>
      <td>RO-6870810</td>
      <td>PKQXLRYFPSZKDU-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB01732</td>
      <td>(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One</td>
      <td>SQBOSZXDOHQFAA-ZRTHHSRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB04760</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)</td>
      <td>PYFRREJCFXFNRR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB04796</td>
      <td>Inecalcitol</td>
      <td>HHGRMHMXKPQNGF-WNSNRMDMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06837</td>
      <td>(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide</td>
      <td>VXDKQRWTOJFQKH-BJZITVGISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06817</td>
      <td>Raltegravir</td>
      <td>CZFFBEXEKNGXKS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07326</td>
      <td>6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</td>
      <td>FEGRQUWSKADGSP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB04703</td>
      <td>Hesperidin</td>
      <td>QUQPHWDTPGMPEX-QJBIFVCTSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB13939</td>
      <td>RAD-140</td>
      <td>XMBUPPIEVAFYHO-KPZWWZAWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB13943</td>
      <td>Testosterone cypionate</td>
      <td>HPFVBGJFAYZEBE-ZLQWOROUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB13947</td>
      <td>Testosterone enantate benzilic acid hydrazone</td>
      <td>PTVXYACXDYZNID-JKXGKYMWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB13950</td>
      <td>WIN 55212-2</td>
      <td>HQVHOQAKMCMIIM-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB14034</td>
      <td>Darglitazone</td>
      <td>QQKNSPHAFATFNQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06525</td>
      <td>Ganstigmine</td>
      <td>ZOBDWFRKFSPCRB-UNMCSNQZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06521</td>
      <td>Ertiprotafib</td>
      <td>FONCZICQWCUXEB-RUZDIDTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08366</td>
      <td>3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid</td>
      <td>XADCWKSMHQPTGH-OFBLZTNGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06515</td>
      <td>Resiniferatoxin</td>
      <td>DSDNAKHZNJAGHN-MXTYGGKSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB13710</td>
      <td>Metenolone</td>
      <td>ANJQEDFWRSLVBR-VHUDCFPWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07297</td>
      <td>5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE</td>
      <td>PTILEOLOGGMFCS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB02411</td>
      <td>2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2</td>
      <td>HOUHLOFMBSYNBO-KKUQBAQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB08242</td>
      <td>N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide</td>
      <td>OYTBZXSFNNAVKU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08883</td>
      <td>Perampanel</td>
      <td>PRMWGUBFXWROHD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB13422</td>
      <td>Nicofuranose</td>
      <td>FUWFSXZKBMCSKF-ZASNTINBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07124</td>
      <td>(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>CCIACUJJBPSOHE-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB15047</td>
      <td>BMS-919373</td>
      <td>XGKULQQVQWCASY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB00319</td>
      <td>Piperacillin</td>
      <td>IVBHGBMCVLDMKU-GXNBUGAJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB15177</td>
      <td>VX-659</td>
      <td>IGEOJNMYRZUKIK-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07053</td>
      <td>2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID</td>
      <td>TWVYNPULGKGJOS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07025</td>
      <td>3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</td>
      <td>KBIHHEGEALBUMT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB13766</td>
      <td>Lidoflazine</td>
      <td>ZBIAKUMOEKILTF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB06469</td>
      <td>Lestaurtinib</td>
      <td>UIARLYUEJFELEN-DMVVYWCZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07409</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>MPBUFKZCEBTBSK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08816</td>
      <td>Ticagrelor</td>
      <td>OEKWJQXRCDYSHL-FNOIDJSQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB03583</td>
      <td>(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</td>
      <td>AYOAIABDFUJDKQ-SQJPUDIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB05706</td>
      <td>13-deoxydoxorubicin</td>
      <td>RGVRUQHYQSORBY-JIGXQNLBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB07458</td>
      <td>3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-KRWDZBQOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB05653</td>
      <td>IRX-5183</td>
      <td>PNAWUIKCVQSLFG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB13059</td>
      <td>PF-03814735</td>
      <td>RYYNGWLOYLRZLK-RBUKOAKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4b</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07664</td>
      <td>5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE</td>
      <td>ARIOBGGRZJITQX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB14661</td>
      <td>Loperamide oxide</td>
      <td>KXVSBTJVTUVNPM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB04983</td>
      <td>Denufosol</td>
      <td>FPNPSEMJLALQSA-MIYUEGBISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB13053</td>
      <td>CP-195543</td>
      <td>NZQDWKCNBOELAI-KSFYIVLOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07680</td>
      <td>[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</td>
      <td>HUJXISJLAPAFBO-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB11618</td>
      <td>Zorubicin</td>
      <td>FBTUMDXHSRTGRV-BJISBDEGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB04859</td>
      <td>Zanapezil</td>
      <td>PMBLXLOXUGVTGB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB07430</td>
      <td>(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one</td>
      <td>CMWRPDHVGMHLSZ-GFCCVEGCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB14790</td>
      <td>BPN-14770</td>
      <td>KRRGWHSEDYQKDQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB13036</td>
      <td>Ramatroban</td>
      <td>LDXDSHIEDAPSSA-OAHLLOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07458</td>
      <td>3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB13997</td>
      <td>Baloxavir marboxil</td>
      <td>RZVPBGBYGMDSBG-GGAORHGYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06429</td>
      <td>Talnetant</td>
      <td>BIAVGWDGIJKWRM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06412</td>
      <td>Oxymetholone</td>
      <td>ICMWWNHDUZJFDW-DHODBPELSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06410</td>
      <td>Doxercalciferol</td>
      <td>HKXBNHCUPKIYDM-CGMHZMFXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB13607</td>
      <td>Picloxydine</td>
      <td>YNCLPFSAZFGQCD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06334</td>
      <td>Tucidinostat</td>
      <td>SZMJVTADHFNAIS-BJMVGYQFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB07471</td>
      <td>5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE</td>
      <td>UHCHLTQBLNUYRT-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08973</td>
      <td>Fluclorolone acetonide</td>
      <td>NJNWEGFJCGYWQT-VSXGLTOVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB13520</td>
      <td>Metergoline</td>
      <td>WZHJKEUHNJHDLS-QTGUNEKASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06250</td>
      <td>Fluasterone</td>
      <td>VHZXNQKVFDBFIK-NBBHSKLNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB13471</td>
      <td>Nalfurafine</td>
      <td>XGZZHZMWIXFATA-UEZBDDGYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06169</td>
      <td>Indibulin</td>
      <td>SOLIIYNRSAWTSQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB06163</td>
      <td>Plevitrexed</td>
      <td>IEJSCSAMMLUINT-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08971</td>
      <td>Fluocortolone</td>
      <td>GAKMQHDJQHZUTJ-ULHLPKEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB11424</td>
      <td>Lufenuron</td>
      <td>PWPJGUXAGUPAHP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB01070</td>
      <td>Dihydrotachysterol</td>
      <td>ILYCWAKSDCYMBB-OPCMSESCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB00966</td>
      <td>Telmisartan</td>
      <td>RMMXLENWKUUMAY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB09054</td>
      <td>Idelalisib</td>
      <td>IFSDAJWBUCMOAH-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB11652</td>
      <td>Tucatinib</td>
      <td>SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08121</td>
      <td>(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid</td>
      <td>TZTPJJNNACUQQR-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08174</td>
      <td>5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE</td>
      <td>QCPYHSAHOYXXQK-DLBZAZTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08125</td>
      <td>4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE</td>
      <td>BOMPRXSVSIPRDT-PTNGSMBKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB01026</td>
      <td>Ketoconazole</td>
      <td>XMAYWYJOQHXEEK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB07548</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE</td>
      <td>JXHWVKOKYDAROD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08126</td>
      <td>3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE</td>
      <td>DMCRNUMVSATRTP-LCYFTJDESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08166</td>
      <td>(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile</td>
      <td>LPFQFJAOMCGYCP-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB03907</td>
      <td>N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide</td>
      <td>UHHBFOLQOQSPLU-WGRQDFERSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08709</td>
      <td>2,3-diphenyl-1H-indole-7-carboxylic acid</td>
      <td>OLUDUXWVPIEHDA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB03076</td>
      <td>AHA047</td>
      <td>CGBDAHCDSVOMCF-FYZVQMPESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lzg</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB00496</td>
      <td>Darifenacin</td>
      <td>HXGBXQDTNZMWGS-RUZDIDTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB00977</td>
      <td>Ethinylestradiol</td>
      <td>BFPYWIDHMRZLRN-SLHNCBLASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>7bv1</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08355</td>
      <td>1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid</td>
      <td>ZOBRPBVIEUWYJR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB11645</td>
      <td>PF-4191834</td>
      <td>DVNQWYLVSNPCJZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12888</td>
      <td>Ezutromid</td>
      <td>KSGCNXAZROJSNW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08351</td>
      <td>N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</td>
      <td>MNEXDVSJIUQQRH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB06730</td>
      <td>Gestodene</td>
      <td>SIGSPDASOTUPFS-XUDSTZEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB00559</td>
      <td>Bosentan</td>
      <td>GJPICJJJRGTNOD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12869</td>
      <td>Eliprodil</td>
      <td>GGUSQTSTQSHJAH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB08350</td>
      <td>5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE</td>
      <td>GYQRHHQPEMOLKH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB12550</td>
      <td>Taladegib</td>
      <td>SZBGQDXLNMELTB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08057</td>
      <td>N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine</td>
      <td>VWJPPYCULHDHBB-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB00303</td>
      <td>Ertapenem</td>
      <td>JUZNIMUFDBIJCM-ANEDZVCMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB00678</td>
      <td>Losartan</td>
      <td>PSIFNNKUMBGKDQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB00773</td>
      <td>Etoposide</td>
      <td>VJJPUSNTGOMMGY-MRVIYFEKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB00224</td>
      <td>Indinavir</td>
      <td>CBVCZFGXHXORBI-PXQQMZJSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB00773</td>
      <td>Etoposide</td>
      <td>VJJPUSNTGOMMGY-MRVIYFEKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB11614</td>
      <td>Rupatadine</td>
      <td>WUZYKBABMWJHDL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB03962</td>
      <td>Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate</td>
      <td>MDKMTCCUJSRQGW-NAJQWHGHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB11592</td>
      <td>Nitrocefin</td>
      <td>LHNIIDJCEODSHA-OQRUQETBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB04930</td>
      <td>Permethrin</td>
      <td>RLLPVAHGXHCWKJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB00858</td>
      <td>Drostanolone</td>
      <td>IKXILDNPCZPPRV-RFMGOVQKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB00206</td>
      <td>Reserpine</td>
      <td>QEVHRUUCFGRFIF-MDEJGZGSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB08220</td>
      <td>(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid</td>
      <td>RPNNXCYIESWDSC-JRZBRKEGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB08772</td>
      <td>3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID</td>
      <td>BCSVCWVQNOXFGL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB05423</td>
      <td>ORG-34517</td>
      <td>DFELGYQKEOCHOA-BZAFBGKRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12952</td>
      <td>Methylprednisone</td>
      <td>SVYCRJXQZUCUND-PQXSVQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6lxt</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15444</td>
      <td>Elexacaftor</td>
      <td>MVRHVFSOIWFBTE-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB15456</td>
      <td>Vericiguat</td>
      <td>QZFHIXARHDBPBY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12985</td>
      <td>Quisinostat</td>
      <td>PAWIYAYFNXQGAP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB01339</td>
      <td>Vecuronium</td>
      <td>BGSZAXLLHYERSY-XQIGCQGXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w9c</td>
      <td>DB08911</td>
      <td>Trametinib</td>
      <td>LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB06307</td>
      <td>Apoptone</td>
      <td>CKAXZOYFIHQCBN-JRRMKBMNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB12823</td>
      <td>Tecarfarin</td>
      <td>QFLNTQDOVCLQKW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB12806</td>
      <td>GSK-1004723</td>
      <td>YANGEESWIGIKOP-UUWRZZSWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB02669</td>
      <td>RB106</td>
      <td>ZWDQTNWLXALTOV-QYZOEREBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6vxx</td>
      <td>DB11925</td>
      <td>Vistusertib</td>
      <td>JUSFANSTBFGBAF-IRXDYDNUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m2n</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB07181</td>
      <td>4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</td>
      <td>JYKFWUXBFJJDTP-HXUWFJFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB04908</td>
      <td>Flibanserin</td>
      <td>PPRRDFIXUUSXRA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6w4h</td>
      <td>DB05653</td>
      <td>IRX-5183</td>
      <td>PNAWUIKCVQSLFG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m3m</td>
      <td>DB01451</td>
      <td>1-Androstenedione</td>
      <td>WJIQCDPCDVWDDE-WZNAKSSCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB08204</td>
      <td>3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE</td>
      <td>FLWABCQDXUKNQY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB07945</td>
      <td>5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid</td>
      <td>GKBQRPKZHUFGOB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6crv</td>
      <td>DB00481</td>
      <td>Raloxifene</td>
      <td>GZUITABIAKMVPG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB06844</td>
      <td>4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE</td>
      <td>MBXKBJLIESPLIK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6cs2</td>
      <td>DB14895</td>
      <td>Vibegron</td>
      <td>DJXRIQMCROIRCZ-XOEOCAAJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.6</td>
      <td>6m71</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB13571</td>
      <td>Pentamycin</td>
      <td>AGJUUQSLGVCRQA-SWOUQTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB01831</td>
      <td>Tryptophanyl-5'amp</td>
      <td>IFQVDHDRFCKAAW-SQIXAUHQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB01016</td>
      <td>Glyburide</td>
      <td>ZNNLBTZKUZBEKO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB08500</td>
      <td>(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</td>
      <td>ZCJBDRSKHARECB-PYTCMNEWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB05944</td>
      <td>Varlitinib</td>
      <td>UWXSAYUXVSFDBQ-CYBMUJFWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07025</td>
      <td>3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</td>
      <td>KBIHHEGEALBUMT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB13490</td>
      <td>Hidrosmin</td>
      <td>XYFLWVOTXWXNAM-WTNNCJBMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB06609</td>
      <td>Odiparcil</td>
      <td>JRHNIQQUVJOPQC-AQNFWKISSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13499</td>
      <td>Cefsulodin</td>
      <td>SYLKGLMBLAAGSC-QLVMHMETSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB06888</td>
      <td>(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</td>
      <td>KBLPHMRCKHFBJB-OLZOCXBDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB06933</td>
      <td>N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide</td>
      <td>GJTCKUKIFXWJKG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB15157</td>
      <td>Voruciclib</td>
      <td>MRPGRAKIAJJGMM-OCCSQVGLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12848</td>
      <td>PF-04217903</td>
      <td>PDMUGYOXRHVNMO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4b</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB08423</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE</td>
      <td>QKZZJXRGCHXIAI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB15028</td>
      <td>MK-1064</td>
      <td>CKTWQGHVNRYNCM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB06414</td>
      <td>Etravirine</td>
      <td>PYGWGZALEOIKDF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4b</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15295</td>
      <td>Tenalisib</td>
      <td>HDXDQPRPFRKGKZ-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB14037</td>
      <td>Madecassic acid</td>
      <td>PRAUVHZJPXOEIF-AOLYGAPISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB02241</td>
      <td>8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>HOSWCJDTHOAORT-SANMLTNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB06871</td>
      <td>17-METHYL-17-ALPHA-DIHYDROEQUILENIN</td>
      <td>FQMQOMRDADWGJJ-GBESFXJTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13606</td>
      <td>Phenazocine</td>
      <td>ZQHYKVKNPWDQSL-KNXBSLHKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB12673</td>
      <td>ATX-914</td>
      <td>ALANRBCCCQEPFZ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB01047</td>
      <td>Fluocinonide</td>
      <td>WJOHZNCJWYWUJD-IUGZLZTKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB06847</td>
      <td>5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>YYCPXVRHQUEVAW-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB06590</td>
      <td>Ceftaroline fosamil</td>
      <td>ZCCUWMICIWSJIX-NQJJCJBVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13556</td>
      <td>Sulfamazone</td>
      <td>BGLHAKAJGYLSOX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15294</td>
      <td>SB-1578</td>
      <td>NNXDIGHYPZHXTR-ONEGZZNKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15287</td>
      <td>Elismetrep</td>
      <td>CWEFDWIKLABKBX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15282</td>
      <td>Fluorofuranylnorprogesterone F-18</td>
      <td>VJKRBRUNEOHPBS-JQKUZGBFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB01180</td>
      <td>Rescinnamine</td>
      <td>SZLZWPPUNLXJEA-LAFLMMDJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB08489</td>
      <td>N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE</td>
      <td>GCBPAPVOMPJQHK-NQIIRXRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB08861</td>
      <td>DPDPE</td>
      <td>MCMMCRYPQBNCPH-WMIMKTLMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB08521</td>
      <td>4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>CDMGBJANTYXAIV-HHHXNRCGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12412</td>
      <td>Gemigliptin</td>
      <td>ZWPRRQZNBDYKLH-VIFPVBQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB11949</td>
      <td>Vestipitant</td>
      <td>SBBYBXSFWOLDDG-JLTOFOAXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07022</td>
      <td>3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate</td>
      <td>PXERBGNIBOFZOW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB07630</td>
      <td>N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-IAGOWNOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB04298</td>
      <td>3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One</td>
      <td>ZEBFKFGJWHOOST-LJAQVGFWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB11867</td>
      <td>JNJ-39393406</td>
      <td>IURMHZBQEYNQOH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13053</td>
      <td>CP-195543</td>
      <td>NZQDWKCNBOELAI-KSFYIVLOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB00137</td>
      <td>Lutein</td>
      <td>KBPHJBAIARWVSC-RGZFRNHPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB04514</td>
      <td>Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester</td>
      <td>DFYLLEBFVZTKHD-VMIOUTBZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12579</td>
      <td>JNJ-37822681</td>
      <td>UVUYWJWYRLJHEN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB12412</td>
      <td>Gemigliptin</td>
      <td>ZWPRRQZNBDYKLH-VIFPVBQESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB13648</td>
      <td>Alcuronium</td>
      <td>MUQUYTSLDVKIOF-CHJKCJHBSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB07689</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>NYNAFINLHQEHKU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB00342</td>
      <td>Terfenadine</td>
      <td>GUGOEEXESWIERI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB04628</td>
      <td>Allosamidin</td>
      <td>MDWNFWDBQGOKNZ-XYUDZHFQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB05608</td>
      <td>MKC-1</td>
      <td>OVSKGTONMLKNPZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13055</td>
      <td>Oteseconazole</td>
      <td>IDUYJRXRDSPPRC-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB11878</td>
      <td>Filibuvir</td>
      <td>SLVAPEZTBDBAPI-GDLZYMKVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB12001</td>
      <td>Abemaciclib</td>
      <td>UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15047</td>
      <td>BMS-919373</td>
      <td>XGKULQQVQWCASY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB03797</td>
      <td>3-Aminomethyl-Pyridinium-Adenine-Dinucleotide</td>
      <td>HMCRLFVYYFBZEZ-PLEFRAQWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB15132</td>
      <td>AZD-8165</td>
      <td>YUHNXUAATAMVKD-PZJWPPBQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB14634</td>
      <td>Fluprednidene acetate</td>
      <td>DEFOZIFYUBUHHU-IYQKUMFPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13036</td>
      <td>Ramatroban</td>
      <td>LDXDSHIEDAPSSA-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB07193</td>
      <td>(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</td>
      <td>HJJAYSSCWGUPKO-ABAIWWIYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB06446</td>
      <td>Dotarizine</td>
      <td>LRMJAFKKJLRDLE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13048</td>
      <td>PAC-1</td>
      <td>YQNRVGJCPCNMKT-LFVJCYFKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB07252</td>
      <td>3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide</td>
      <td>TZHCXOMEOHEZDX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15062</td>
      <td>Inarigivir</td>
      <td>LYMICVBGNUEHGE-FUQPUAIBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB07144</td>
      <td>5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>XZXVRKHUCSXVBM-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB07537</td>
      <td>N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide</td>
      <td>CLEGTVIMOPPIBR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB04044</td>
      <td>4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>NAQUAVBNIYTIIS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB04099</td>
      <td>Deamido-Nad+</td>
      <td>SENPVEZBRZQVST-HISDBWNOSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB00421</td>
      <td>Spironolactone</td>
      <td>LXMSZDCAJNLERA-ZHYRCANASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15191</td>
      <td>MAX-40279</td>
      <td>AVIOBQFPAGEICQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13126</td>
      <td>BMS-986115</td>
      <td>SRJNRAQUSAVENA-GSHUGGBRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB13095</td>
      <td>JTK-853</td>
      <td>JQLOVYLALGSISI-HXUWFJFHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB06684</td>
      <td>Vilazodone</td>
      <td>SGEGOXDYSFKCPT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13347</td>
      <td>Diphenadione</td>
      <td>JYGLAHSAISAEAL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB05944</td>
      <td>Varlitinib</td>
      <td>UWXSAYUXVSFDBQ-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB05239</td>
      <td>Cobimetinib</td>
      <td>BSMCAPRUBJMWDF-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB02483</td>
      <td>Etheno-Nad</td>
      <td>JCDBQDNBEQHDHK-BSLNIGMPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB13055</td>
      <td>Oteseconazole</td>
      <td>IDUYJRXRDSPPRC-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB03157</td>
      <td>N,O-Didansyl-L-Tyrosine</td>
      <td>LUBOPDUYHWABFG-NDEPHWFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB00845</td>
      <td>Clofazimine</td>
      <td>WDQPAMHFFCXSNU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB15266</td>
      <td>TAK-580</td>
      <td>VWMJHAFYPMOMGF-ZCFIWIBFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB12743</td>
      <td>Z-160</td>
      <td>VCPMZDWBEWTGNW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB03642</td>
      <td>Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</td>
      <td>VBPPNJCVXGAZDD-PMACEKPBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB05653</td>
      <td>IRX-5183</td>
      <td>PNAWUIKCVQSLFG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB13246</td>
      <td>Quinupramine</td>
      <td>JCBQCKFFSPGEDY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15245</td>
      <td>Olorofim</td>
      <td>SUFPWYYDCOKDLL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB04760</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)</td>
      <td>PYFRREJCFXFNRR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB00445</td>
      <td>Epirubicin</td>
      <td>AOJJSUZBOXZQNB-VTZDEGQISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB13024</td>
      <td>MK-8245</td>
      <td>UJEAABFSXKCSGI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB06497</td>
      <td>Aplaviroc</td>
      <td>GWNOTCOIYUNTQP-FQLXRVMXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB04842</td>
      <td>Fluspirilene</td>
      <td>QOYHHIBFXOOADH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15238</td>
      <td>Olinciguat</td>
      <td>YWQFJNWMWZMXRW-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lxt</td>
      <td>DB12550</td>
      <td>Taladegib</td>
      <td>SZBGQDXLNMELTB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB00693</td>
      <td>Fluorescein</td>
      <td>GNBHRKFJIUUOQI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB13059</td>
      <td>PF-03814735</td>
      <td>RYYNGWLOYLRZLK-RBUKOAKNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB02354</td>
      <td>4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine</td>
      <td>IRKPNOLLMNHSOU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB15358</td>
      <td>JNJ-54175446</td>
      <td>CWFVVQFVGMFTBD-SECBINFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB12588</td>
      <td>AZD-1480</td>
      <td>PDOQBOJDRPLBQU-QMMMGPOBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB02323</td>
      <td>EM-1745</td>
      <td>CKSDYJASHNGOOS-KTXOUVACSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB06835</td>
      <td>(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID</td>
      <td>CTQDLSDUHUFBQW-LEWJYISDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12036</td>
      <td>Naquotinib</td>
      <td>QKDCLUARMDUUKN-XMMPIXPASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB06995</td>
      <td>N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide</td>
      <td>USBSTVPJNQLYEM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06011</td>
      <td>AMG-222</td>
      <td>NVSWJKWHLUTHLP-CPJSRVTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB08446</td>
      <td>3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile</td>
      <td>OHQMEDBYNUAVNE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB05288</td>
      <td>Anecortave acetate</td>
      <td>YUWPMEXLKGOSBF-GACAOOTBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14662</td>
      <td>Flunisolide acetate</td>
      <td>WEGNFRKBIKYVLC-XTLNBZDDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB05016</td>
      <td>Ataluren</td>
      <td>OOUGLTULBSNHNF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB04908</td>
      <td>Flibanserin</td>
      <td>PPRRDFIXUUSXRA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB04862</td>
      <td>Merimepodib</td>
      <td>JBPUGFODGPKTDW-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14681</td>
      <td>Cortisone</td>
      <td>MFYSYFVPBJMHGN-ZPOLXVRWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14726</td>
      <td>Dabigatran</td>
      <td>YBSJFWOBGCMAKL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB04785</td>
      <td>Streptolydigin</td>
      <td>KVTPRMVXYZKLIG-NCAOFHFGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB09070</td>
      <td>Tibolone</td>
      <td>WZDGZWOAQTVYBX-XOINTXKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14770</td>
      <td>Lanraplenib</td>
      <td>XCIGZBVOUQVIPI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14844</td>
      <td>ONC-201</td>
      <td>VLULRUCCHYVXOH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB08584</td>
      <td>6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB04158</td>
      <td>6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin</td>
      <td>ZKRKFZJAQKKHKL-SUGPNEFASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB03944</td>
      <td>5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One</td>
      <td>IZLRMTJLQCLMKF-CYBMUJFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06194</td>
      <td>Elocalcitol</td>
      <td>LRLWXBHFPGSUOX-GJQYOBCGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14584</td>
      <td>Segesterone</td>
      <td>SFLXYFZGKSGFKA-XUDSTZEESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14581</td>
      <td>CPI-1205</td>
      <td>HPODOLXTMDHLLC-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06888</td>
      <td>(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</td>
      <td>KBLPHMRCKHFBJB-OLZOCXBDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB13791</td>
      <td>Penfluridol</td>
      <td>MDLAAYDRRZXJIF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06781</td>
      <td>Difluprednate</td>
      <td>WYQPLTPSGFELIB-JTQPXKBDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06777</td>
      <td>Chenodeoxycholic acid</td>
      <td>RUDATBOHQWOJDD-BSWAIDMHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06755</td>
      <td>Beta carotene</td>
      <td>OENHQHLEOONYIE-JLTXGRSLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06721</td>
      <td>Gimatecan</td>
      <td>UIVFUQKYVFCEKJ-OPTOVBNMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB13866</td>
      <td>Etynodiol</td>
      <td>JYILPERKVHXLNF-QMNUTNMBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06622</td>
      <td>7-beta-Hydroxyepiandrosterone</td>
      <td>VFPMCLQMAUVEHD-UCPSWNCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB13951</td>
      <td>Stanolone acetate</td>
      <td>ILCTUFVQFCIIDS-NGFSFWIMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06605</td>
      <td>Apixaban</td>
      <td>QNZCBYKSOIHPEH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB13993</td>
      <td>MRK-409</td>
      <td>GOIFCXRIFSYPFG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14038</td>
      <td>beta-Sitosterol</td>
      <td>KZJWDPNRJALLNS-VJSFXXLFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06364</td>
      <td>XR5944</td>
      <td>SFOADSRLCHRTKT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06347</td>
      <td>Cenisertib</td>
      <td>KSOVGRCOLZZTPF-QMKUDKLTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06314</td>
      <td>SGX-523</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14541</td>
      <td>Hydrocortisone cypionate</td>
      <td>DLVOSEUFIRPIRM-KAQKJVHQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14569</td>
      <td>Tedizolid</td>
      <td>XFALPSLJIHVRKE-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB09181</td>
      <td>Trefentanil</td>
      <td>RJSCINHYBGMIFT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07006</td>
      <td>9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE</td>
      <td>AOGOZJCRIFBTTN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB14937</td>
      <td>MK-8666</td>
      <td>CODQKEMYZZKQAE-QPVYNBJUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB03507</td>
      <td>6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One</td>
      <td>UXGUZFZBZPPZGL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01772</td>
      <td>3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione</td>
      <td>RPGZQOOZHIEPJW-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01745</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester</td>
      <td>JJLGQWCKMHPBEB-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01678</td>
      <td>RU84687</td>
      <td>SAFPHFWYRLLBFO-NSOVKSMOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15385</td>
      <td>Acebilustat</td>
      <td>GERJIEKMNDGSCS-DQEYMECFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11429</td>
      <td>Mibolerone</td>
      <td>PTQMMNYJKCSPET-OMHQDGTGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01541</td>
      <td>Boldenone</td>
      <td>RSIHSRDYCUFFLA-DYKIIFRCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15418</td>
      <td>AZD-9977</td>
      <td>MBKYLPOPYYLTNW-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15431</td>
      <td>M-2698</td>
      <td>HXAUJHZZPCBFPN-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15287</td>
      <td>Elismetrep</td>
      <td>CWEFDWIKLABKBX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15435</td>
      <td>BMS-986158</td>
      <td>KGERZPVQIRYWRK-GDLZYMKVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01347</td>
      <td>Saprisartan</td>
      <td>DUEWVPTZCSAMNB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01337</td>
      <td>Pancuronium</td>
      <td>GVEAYVLWDAFXET-XGHATYIMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB01459</td>
      <td>Bezitramide</td>
      <td>FLKWNFFCSSJANB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01162</td>
      <td>Terazosin</td>
      <td>VCKUSRYTPJJLNI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15281</td>
      <td>Ravoxertinib</td>
      <td>RZUOCXOYPYGSKL-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB02241</td>
      <td>8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>HOSWCJDTHOAORT-SANMLTNESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15177</td>
      <td>VX-659</td>
      <td>IGEOJNMYRZUKIK-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB03461</td>
      <td>2'-Monophosphoadenosine 5'-Diphosphoribose</td>
      <td>XJLXINKUBYWONI-NNYOXOHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15003</td>
      <td>PF-06700841</td>
      <td>BUWBRTXGQRBBHG-MJBXVCDLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB03397</td>
      <td>Uridine-Diphosphate-N-Acetylglucosamine</td>
      <td>LFTYTUAZOPRMMI-CFRASDGPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB09215</td>
      <td>Droxicam</td>
      <td>OEHFRZLKGRKFAS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB03336</td>
      <td>BIA</td>
      <td>KVIVJQWOYSWCCZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB03207</td>
      <td>2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid</td>
      <td>BNVMUDXGABBWGP-OAQYLSRUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB09232</td>
      <td>Cilnidipine</td>
      <td>KJEBULYHNRNJTE-DHZHZOJOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB03084</td>
      <td>Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</td>
      <td>XCTKFTOEAKJMII-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15046</td>
      <td>LY-2881835</td>
      <td>FHRWHNJJQGSCQC-LJAQVGFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15055</td>
      <td>ABT-639</td>
      <td>AGPIHNZOZNKRGT-CYBMUJFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB09298</td>
      <td>Silibinin</td>
      <td>SEBFKMXJBCUCAI-HKTJVKLFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB02789</td>
      <td>Pregnenolone</td>
      <td>ORNBQBCIOKFOEO-QGVNFLHTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB09319</td>
      <td>Carindacillin</td>
      <td>JIRBAUWICKGBFE-MNRDOXJOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB02659</td>
      <td>Cholic Acid</td>
      <td>BHQCQFFYRZLCQQ-OELDTZBJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB07245</td>
      <td>6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE</td>
      <td>AEVBKBAFFJKFJZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB08738</td>
      <td>1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one</td>
      <td>KWCKZIJGKMCYCI-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15173</td>
      <td>JNJ-42165279</td>
      <td>YWGYNGCRVZLMCS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB09198</td>
      <td>Lobeglitazone</td>
      <td>CHHXEZSCHQVSRE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB13607</td>
      <td>Picloxydine</td>
      <td>YNCLPFSAZFGQCD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07041</td>
      <td>N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide</td>
      <td>FDJWFDQRPKKBFA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07084</td>
      <td>N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</td>
      <td>YHKGWOJTUMJPNW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12420</td>
      <td>Diazepinomicin</td>
      <td>SALVHVNECODMJP-GNUCVDFRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08709</td>
      <td>2,3-diphenyl-1H-indole-7-carboxylic acid</td>
      <td>OLUDUXWVPIEHDA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12467</td>
      <td>TU-100</td>
      <td>KAYRGFYBCCETPE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08486</td>
      <td>Efaproxiral</td>
      <td>BNFRJXLZYUTIII-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12474</td>
      <td>Lynestrenol</td>
      <td>YNVGQYHLRCDXFQ-XGXHKTLJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08607</td>
      <td>(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE</td>
      <td>GXPHKUHSUJUWKP-NTKDMRAZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12339</td>
      <td>Radezolid</td>
      <td>BTTNOGHPGJANSW-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08619</td>
      <td>Testosterone succinate</td>
      <td>CJQNBXFUHQZFOE-VYAQIDIUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08546</td>
      <td>4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE</td>
      <td>CETLUACQMGBMFH-ZALSBGIRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08504</td>
      <td>6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM</td>
      <td>ZNHVIJAGMFQGMS-IHPCNDPISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08448</td>
      <td>(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol</td>
      <td>PCBWLKUEKANDCL-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12597</td>
      <td>ABL-001</td>
      <td>VOVZXURTCKPRDQ-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12598</td>
      <td>Nafamostat</td>
      <td>MQQNFDZXWVTQEH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12612</td>
      <td>Ozanimod</td>
      <td>XRVDGNKRPOAQTN-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB07966</td>
      <td>[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile</td>
      <td>NVMCVWOODOWOLT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB07967</td>
      <td>9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE</td>
      <td>JJNKDTWKWYLERH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08584</td>
      <td>6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08488</td>
      <td>4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE</td>
      <td>PLWVUIRWJVKSSD-XBXARRHUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11994</td>
      <td>Diacerein</td>
      <td>TYNLGDBUJLVSMA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08498</td>
      <td>(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>OVSAMUIBGQSLDC-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11922</td>
      <td>Danirixin</td>
      <td>NGYNBSHYFOFVLS-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB07729</td>
      <td>3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide</td>
      <td>GAKOBKPDJJGRIL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11871</td>
      <td>PF-00610355</td>
      <td>YPHDIMUXXABSSO-YTTGMZPUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11832</td>
      <td>Crenolanib</td>
      <td>DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12149</td>
      <td>S-3304</td>
      <td>YWCLDDLVLSQGSZ-JOCHJYFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11759</td>
      <td>Pevonedistat</td>
      <td>MPUQHZXIXSTTDU-QXGSTGNESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11743</td>
      <td>Ipatasertib</td>
      <td>GRZXWCHAXNAUHY-NSISKUIASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11636</td>
      <td>Nomegestrol</td>
      <td>KZUIYQJTUIACIG-YBZCJVABSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11592</td>
      <td>Nitrocefin</td>
      <td>LHNIIDJCEODSHA-OQRUQETBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12219</td>
      <td>GSK-424887</td>
      <td>DRXBWLBZWAJIEF-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB07800</td>
      <td>N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE</td>
      <td>MIJGLXFQYBTIFY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB11443</td>
      <td>Orbifloxacin</td>
      <td>QIPQASLPWJVQMH-DTORHVGOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB09378</td>
      <td>Fluprednisolone</td>
      <td>MYYIMZRZXIQBGI-HVIRSNARSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12235</td>
      <td>Estetrol</td>
      <td>AJIPIJNNOJSSQC-NYLIRDPKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08543</td>
      <td>1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE</td>
      <td>BZJHCQBNFUNZPJ-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12282</td>
      <td>Defactinib</td>
      <td>FWLMVFUGMHIOAA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08423</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE</td>
      <td>QKZZJXRGCHXIAI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08365</td>
      <td>8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide</td>
      <td>XUAHLMVOYLUYSB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12933</td>
      <td>RO-4987655</td>
      <td>FIMYFEGKMOCQKT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07688</td>
      <td>4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>RPJIMTALCNCQLV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07663</td>
      <td>2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID</td>
      <td>QISJEFYTLZTWIQ-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08755</td>
      <td>N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide</td>
      <td>MQWUTQCRGGBPBT-WIOPSUGQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB13042</td>
      <td>Fenoverine</td>
      <td>UBAJTZKNDCEGKL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07405</td>
      <td>1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</td>
      <td>GIZYIOOBBUHOBS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07340</td>
      <td>N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine</td>
      <td>ZFLJHSQHILSNCM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07333</td>
      <td>N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE</td>
      <td>KRGKAARWVPUWSY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07253</td>
      <td>N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</td>
      <td>QTFCKBFCXDAZIU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07186</td>
      <td>4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE</td>
      <td>TYYNSDQVFIOSFH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07142</td>
      <td>5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>ATFDKOLABYIYCC-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07141</td>
      <td>5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>QVXYJVHNRPNRJL-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB13506</td>
      <td>Carfecillin</td>
      <td>NZDASSHFKWDBBU-KVMCETHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB14840</td>
      <td>Ripretinib</td>
      <td>CEFJVGZHQAGLHS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08746</td>
      <td>1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE</td>
      <td>ZOSSOFIFNGGDKG-GIJQJNRQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01137</td>
      <td>Levofloxacin</td>
      <td>GSDSWSVVBLHKDQ-JTQLQIEISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07765</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>UKCFUFHREWUXJJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07804</td>
      <td>5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE</td>
      <td>FKCQUVAGEOSYRU-QWRGUYRKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12658</td>
      <td>AFN-1252</td>
      <td>QXTWSUQCXCWEHF-JXMROGBWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12680</td>
      <td>Intepirdine</td>
      <td>JJZFWROHYSMCMU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08460</td>
      <td>3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile</td>
      <td>KXDIHAQCVNNLIB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08353</td>
      <td>2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>NCVMTHVSAJMOPI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08305</td>
      <td>(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>KQAGZLQCEURCKJ-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08303</td>
      <td>(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide</td>
      <td>CUMKMTBOHBENJI-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12724</td>
      <td>AZD-7295</td>
      <td>MAQDQJWCSSCURR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08242</td>
      <td>N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide</td>
      <td>OYTBZXSFNNAVKU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08143</td>
      <td>5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE</td>
      <td>SXIYSYYSKHUTQQ-RDJZCZTQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08096</td>
      <td>8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM</td>
      <td>ZWKOUFZHPNIQSH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12812</td>
      <td>Palomid 529</td>
      <td>YEAHTLOYHVWAKW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08094</td>
      <td>(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE</td>
      <td>JRNJNYBQQYBCLE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08092</td>
      <td>3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide</td>
      <td>VMLSXFMXUNVCSK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB14889</td>
      <td>Derazantinib</td>
      <td>KPJDVVCDVBFRMU-AREMUKBSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB08037</td>
      <td>(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide</td>
      <td>MYBGWENAVMIGMM-GIFXNVAJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07969</td>
      <td>3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol</td>
      <td>QNCYYRHIUFGGJX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07882</td>
      <td>4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID</td>
      <td>VFIZFTGABDUGCF-UPVHCHBVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB12877</td>
      <td>Oxatomide</td>
      <td>BAINIUMDFURPJM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB07770</td>
      <td>5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>DJPFUQBNQLKCAB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01029</td>
      <td>Irbesartan</td>
      <td>YOSHYTLCDANDAN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01026</td>
      <td>Ketoconazole</td>
      <td>XMAYWYJOQHXEEK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB09181</td>
      <td>Trefentanil</td>
      <td>RJSCINHYBGMIFT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07340</td>
      <td>N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine</td>
      <td>ZFLJHSQHILSNCM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12052</td>
      <td>Icariin</td>
      <td>TZJALUIVHRYQQB-XLRXWWTNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB09075</td>
      <td>Edoxaban</td>
      <td>HGVDHZBSSITLCT-JLJPHGGASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB09053</td>
      <td>Ibrutinib</td>
      <td>XYFPWWZEPKGCCK-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB11611</td>
      <td>Lifitegrast</td>
      <td>JFOZKMSJYSPYLN-QHCPKHFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB09034</td>
      <td>Suvorexant</td>
      <td>JYTNQNCOQXFQPK-MRXNPFEDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB09183</td>
      <td>Dasabuvir</td>
      <td>NBRBXGKOEOGLOI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB11832</td>
      <td>Crenolanib</td>
      <td>DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08745</td>
      <td>4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE</td>
      <td>QLHUDNKWOSQSMK-CXUHLZMHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08739</td>
      <td>2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione</td>
      <td>ZSXNPAWXICXNGZ-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB12134</td>
      <td>Gepotidacin</td>
      <td>PZFAZQUREQIODZ-LJQANCHMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB12269</td>
      <td>PF-06273340</td>
      <td>BPIWZDNVMQQBQX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08521</td>
      <td>4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>CDMGBJANTYXAIV-HHHXNRCGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07359</td>
      <td>3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide</td>
      <td>SJTQKYKXCYVFHX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB00568</td>
      <td>Cinnarizine</td>
      <td>DERZBLKQOCDDDZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB09239</td>
      <td>Niguldipine</td>
      <td>SVJMLYUFVDMUHP-XIFFEERXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12225</td>
      <td>Beclabuvir</td>
      <td>ZTTKEBYSXUCBSE-QDFUAKMASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12137</td>
      <td>GSK-256066</td>
      <td>JFHROPTYMMSOLG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB11952</td>
      <td>Duvelisib</td>
      <td>SJVQHLPISAIATJ-ZDUSSCGKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB11942</td>
      <td>Selinexor</td>
      <td>DEVSOMFAQLZNKR-RJRFIUFISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB11794</td>
      <td>Berzosertib</td>
      <td>JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB11743</td>
      <td>Ipatasertib</td>
      <td>GRZXWCHAXNAUHY-NSISKUIASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB07789</td>
      <td>1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea</td>
      <td>KNTGXMNWVXZIMW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB11637</td>
      <td>Delamanid</td>
      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07426</td>
      <td>[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)</td>
      <td>NWIARQRYIRVYCM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07410</td>
      <td>[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID</td>
      <td>BYVXAUZOTGITQZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB09319</td>
      <td>Carindacillin</td>
      <td>JIRBAUWICKGBFE-MNRDOXJOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB04190</td>
      <td>Inhibitor Bea425</td>
      <td>AHAVBKNGKPWROK-UMFPTGFGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08407</td>
      <td>PLATENSIMYCIN</td>
      <td>CSOMAHTTWTVBFL-OFBLZTNGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB15437</td>
      <td>Rocacetrapib</td>
      <td>GBHPDJQHZADVAA-SOKVYYICSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB15442</td>
      <td>Trilaciclib</td>
      <td>PDGKHKMBHVFCMG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12284</td>
      <td>LY-2608204</td>
      <td>QIIVJLHCZUTGSD-CUBQBAPOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07434</td>
      <td>HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE</td>
      <td>TZWQPWGUQCSKDW-GUYCJALGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07072</td>
      <td>(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</td>
      <td>CNKRZILQBKJWDS-WMFXKJRFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07404</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>YXQQNSYZOQHKHD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07333</td>
      <td>N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE</td>
      <td>KRGKAARWVPUWSY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07270</td>
      <td>N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE</td>
      <td>GAYYMURZGLJDCT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07054</td>
      <td>(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL</td>
      <td>OSCWQKTUILTARV-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07265</td>
      <td>3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID</td>
      <td>JDARUOOLJCFUOY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12341</td>
      <td>LY-2456302</td>
      <td>ZHPMYDSXGRRERG-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxx</td>
      <td>DB00522</td>
      <td>Bentiromide</td>
      <td>SPPTWHFVYKCNNK-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB12693</td>
      <td>Ritanserin</td>
      <td>JUQLTPCYUFPYKE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08366</td>
      <td>3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid</td>
      <td>XADCWKSMHQPTGH-OFBLZTNGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07193</td>
      <td>(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</td>
      <td>HJJAYSSCWGUPKO-ABAIWWIYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08031</td>
      <td>N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</td>
      <td>LNQWELVSNCYKDU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB13024</td>
      <td>MK-8245</td>
      <td>UJEAABFSXKCSGI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07162</td>
      <td>4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide</td>
      <td>KFJCXIOVAGJCKB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07159</td>
      <td>Tamatinib</td>
      <td>NHHQJBCNYHBUSI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB13953</td>
      <td>Estradiol benzoate</td>
      <td>UYIFTLBWAOGQBI-BZDYCCQFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB14766</td>
      <td>Etrasimod</td>
      <td>MVGWUTBTXDYMND-QGZVFWFLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB15011</td>
      <td>Avacopan</td>
      <td>PUKBOVABABRILL-YZNIXAGQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07136</td>
      <td>(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID</td>
      <td>WFFOOKSVFDUPDH-FCHUYYIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB15183</td>
      <td>Fosmanogepix</td>
      <td>JQONJQKKVAHONF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07126</td>
      <td>O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE</td>
      <td>OWXORKPNCHJYOF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12327</td>
      <td>Salvinorin A</td>
      <td>OBSYBRPAKCASQB-AGQYDFLVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00294</td>
      <td>Etonogestrel</td>
      <td>GCKFUYQCUCGESZ-BPIQYHPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00220</td>
      <td>Nelfinavir</td>
      <td>QAGYKUNXZHXKMR-HKWSIXNMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00218</td>
      <td>Moxifloxacin</td>
      <td>FABPRXSRWADJSP-MEDUHNTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00153</td>
      <td>Ergocalciferol</td>
      <td>MECHNRXZTMCUDQ-RKHKHRCZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB15456</td>
      <td>Vericiguat</td>
      <td>QZFHIXARHDBPBY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07982</td>
      <td>2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol</td>
      <td>PVTKDXZNSUHUMO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB15356</td>
      <td>SLV-334</td>
      <td>LOFDNSDPZTVIIO-VPUSJEBWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08013</td>
      <td>(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE</td>
      <td>UEIUDEUUVLYRFV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB06897</td>
      <td>3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol</td>
      <td>MMGKIHLBFPJYJL-HNNXBMFYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB15266</td>
      <td>TAK-580</td>
      <td>VWMJHAFYPMOMGF-ZCFIWIBFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB15257</td>
      <td>Milademetan</td>
      <td>RYAYYVTWKAOAJF-QISPRATLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07946</td>
      <td>N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>DZEJHPMTDNDECN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB15186</td>
      <td>GDC-0084</td>
      <td>LGWACEZVCMBSKW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB15177</td>
      <td>VX-659</td>
      <td>IGEOJNMYRZUKIK-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07974</td>
      <td>1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE</td>
      <td>BDLMBQRBNPDCSS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB06933</td>
      <td>N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide</td>
      <td>GJTCKUKIFXWJKG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11703</td>
      <td>Acalabrutinib</td>
      <td>WDENQIQQYWYTPO-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08022</td>
      <td>(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile</td>
      <td>RCYPVQCPYKNSTG-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB01013</td>
      <td>Clobetasol propionate</td>
      <td>CBGUOGMQLZIXBE-XGQKBEPLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00972</td>
      <td>Azelastine</td>
      <td>MBUVEWMHONZEQD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08154</td>
      <td>3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>WHCLIFOVZDANCU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB15145</td>
      <td>Ziresovir</td>
      <td>GAAICKUTDBZCMT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00950</td>
      <td>Fexofenadine</td>
      <td>RWTNPBWLLIMQHL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB04350</td>
      <td>Argadin</td>
      <td>FOZYKTUSOWWQGR-KNPYFFGGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB15151</td>
      <td>RO-6870810</td>
      <td>PKQXLRYFPSZKDU-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00948</td>
      <td>Mezlocillin</td>
      <td>YPBATNHYBCGSSN-VWPFQQQWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00901</td>
      <td>Bitolterol</td>
      <td>FZGVEKPRDOIXJY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00894</td>
      <td>Testolactone</td>
      <td>BPEWUONYVDABNZ-DZBHQSCQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00873</td>
      <td>Loteprednol</td>
      <td>YPZVAYHNBBHPTO-MXRBDKCISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB15183</td>
      <td>Fosmanogepix</td>
      <td>JQONJQKKVAHONF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB06888</td>
      <td>(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</td>
      <td>KBLPHMRCKHFBJB-OLZOCXBDSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00713</td>
      <td>Oxacillin</td>
      <td>UWYHMGVUTGAWSP-JKIFEVAISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00635</td>
      <td>Prednisone</td>
      <td>XOFYZVNMUHMLCC-ZPOLXVRWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00621</td>
      <td>Oxandrolone</td>
      <td>QSLJIVKCVHQPLV-PEMPUTJUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB00606</td>
      <td>Cyclothiazide</td>
      <td>BOCUKUHCLICSIY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB06963</td>
      <td>3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide</td>
      <td>ZFGCLYUGFRNYFE-INIZCTEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11750</td>
      <td>Clobetasol</td>
      <td>FCSHDIVRCWTZOX-DVTGEIKXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB12371</td>
      <td>Siponimod</td>
      <td>KIHYPELVXPAIDH-HNSNBQBZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB15145</td>
      <td>Ziresovir</td>
      <td>GAAICKUTDBZCMT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB00950</td>
      <td>Fexofenadine</td>
      <td>RWTNPBWLLIMQHL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12776</td>
      <td>E-6005</td>
      <td>BBTFKAOFCSOZMB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB01003</td>
      <td>Cromoglicic acid</td>
      <td>IMZMKUWMOSJXDT-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB01678</td>
      <td>RU84687</td>
      <td>SAFPHFWYRLLBFO-NSOVKSMOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB15358</td>
      <td>JNJ-54175446</td>
      <td>CWFVVQFVGMFTBD-SECBINFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12644</td>
      <td>AZD-2066</td>
      <td>SXWHYTICXCLKDG-GFCCVEGCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB02323</td>
      <td>EM-1745</td>
      <td>CKSDYJASHNGOOS-KTXOUVACSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07704</td>
      <td>6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</td>
      <td>UKRVQKUVWNDGMN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12571</td>
      <td>Rimacalib</td>
      <td>MYTIJGWONQOOLC-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11923</td>
      <td>Decoglurant</td>
      <td>DMJHZVARRXJSEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB12459</td>
      <td>Belotecan</td>
      <td>LNHWXBUNXOXMRL-VWLOTQADSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11939</td>
      <td>Henagliflozin</td>
      <td>HYTPDMFFHVZBOR-VNXMGFANSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11942</td>
      <td>Selinexor</td>
      <td>DEVSOMFAQLZNKR-RJRFIUFISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB03363</td>
      <td>3-Acetylpyridine Adenine Dinucleotide</td>
      <td>KPVQNXLUPNWQHM-RBEMOOQDSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6vxs</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB08173</td>
      <td>5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE</td>
      <td>UCKHUNHXYMAFQM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB15414</td>
      <td>CM-4307</td>
      <td>MLDQJTXFUGDVEO-FIBGUPNXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07875</td>
      <td>5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide</td>
      <td>ARAVOODWJJJNBY-IRXDYDNUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB15063</td>
      <td>Inarigivir soproxil</td>
      <td>CJCYTUJOSMYXLE-JDLSZIHUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07861</td>
      <td>(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide</td>
      <td>MMOUXLMPQFMDRD-JOCHJYFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11759</td>
      <td>Pevonedistat</td>
      <td>MPUQHZXIXSTTDU-QXGSTGNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07855</td>
      <td>(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE</td>
      <td>CWHMAWBXRCDOEB-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB14726</td>
      <td>Dabigatran</td>
      <td>YBSJFWOBGCMAKL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB07845</td>
      <td>2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide</td>
      <td>VGYXXQRDIVRILX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB14068</td>
      <td>Dexniguldipine</td>
      <td>SVJMLYUFVDMUHP-MGBGTMOVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB13993</td>
      <td>MRK-409</td>
      <td>GOIFCXRIFSYPFG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11816</td>
      <td>Omecamtiv Mecarbil</td>
      <td>RFUBTTPMWSKEIW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m71</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB13756</td>
      <td>Peruvoside</td>
      <td>PMTSPAGBAFCORP-HBUONDEYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB13648</td>
      <td>Alcuronium</td>
      <td>MUQUYTSLDVKIOF-CHJKCJHBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11828</td>
      <td>Neratinib</td>
      <td>JWNPDZNEKVCWMY-VQHVLOKHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m2n</td>
      <td>DB13093</td>
      <td>TAK-593</td>
      <td>DZFZXPPHBWCXPQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB06494</td>
      <td>Sufugolix</td>
      <td>UCQSBGOFELXYIN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6m3m</td>
      <td>DB15183</td>
      <td>Fosmanogepix</td>
      <td>JQONJQKKVAHONF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB05038</td>
      <td>Anatibant</td>
      <td>XUHBBTKJWIBQMY-MHZLTWQESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB06163</td>
      <td>Plevitrexed</td>
      <td>IEJSCSAMMLUINT-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB12364</td>
      <td>Betrixaban</td>
      <td>XHOLNRLADUSQLD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB12410</td>
      <td>Sabarubicin</td>
      <td>VQHRZZISQVWPLK-UIRGBLDSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB05608</td>
      <td>MKC-1</td>
      <td>OVSKGTONMLKNPZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB00367</td>
      <td>Levonorgestrel</td>
      <td>WWYNJERNGUHSAO-XUDSTZEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB13931</td>
      <td>Netarsudil</td>
      <td>OURRXQUGYQRVML-AREMUKBSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB03797</td>
      <td>3-Aminomethyl-Pyridinium-Adenine-Dinucleotide</td>
      <td>HMCRLFVYYFBZEZ-PLEFRAQWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB12693</td>
      <td>Ritanserin</td>
      <td>JUQLTPCYUFPYKE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB12764</td>
      <td>ABC-294640</td>
      <td>CAOTVXGYTWCKQE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB03005</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium</td>
      <td>ISUOMOOYAOQQPZ-UHFFFAOYSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB02581</td>
      <td>5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</td>
      <td>VNZHOIDQBPFEJU-OAQYLSRUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB13061</td>
      <td>MLN8054</td>
      <td>HHFBDROWDBDFBR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB12073</td>
      <td>Albaconazole</td>
      <td>UHIXWHUVLCAJQL-MPBGBICISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB00246</td>
      <td>Ziprasidone</td>
      <td>MVWVFYHBGMAFLY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB00153</td>
      <td>Ergocalciferol</td>
      <td>MECHNRXZTMCUDQ-RKHKHRCZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08708</td>
      <td>N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine</td>
      <td>XYYDXQCAYXOGQT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08738</td>
      <td>1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one</td>
      <td>KWCKZIJGKMCYCI-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB12644</td>
      <td>AZD-2066</td>
      <td>SXWHYTICXCLKDG-GFCCVEGCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB00197</td>
      <td>Troglitazone</td>
      <td>GXPHKUHSUJUWKP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB08124</td>
      <td>3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>FTQYGMLRLRXBPT-IDUWFGFVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB02354</td>
      <td>4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine</td>
      <td>IRKPNOLLMNHSOU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08973</td>
      <td>Fluclorolone acetonide</td>
      <td>NJNWEGFJCGYWQT-VSXGLTOVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB09233</td>
      <td>Cronidipine</td>
      <td>CNIJVNPIIHWRRP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB09235</td>
      <td>Efonidipine</td>
      <td>NSVFSAJIGAJDMR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB11487</td>
      <td>Dexamethasone isonicotinate</td>
      <td>BQTXJHAJMDGOFI-NJLPOHDGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB07270</td>
      <td>N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE</td>
      <td>GAYYMURZGLJDCT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB05424</td>
      <td>Canertinib</td>
      <td>OMZCMEYTWSXEPZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB11772</td>
      <td>Pilaralisib</td>
      <td>QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB11793</td>
      <td>Niraparib</td>
      <td>PCHKPVIQAHNQLW-CQSZACIVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB06558</td>
      <td>Tezosentan</td>
      <td>TUYWTLTWNJOZNY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB14895</td>
      <td>Vibegron</td>
      <td>DJXRIQMCROIRCZ-XOEOCAAJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB00485</td>
      <td>Dicloxacillin</td>
      <td>YFAGHNZHGGCZAX-JKIFEVAISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB12996</td>
      <td>Acteoside</td>
      <td>FBSKJMQYURKNSU-ZLSOWSIRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB14879</td>
      <td>Cefiderocol</td>
      <td>DBPPRLRVDVJOCL-FQRUVTKNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB02329</td>
      <td>Carbenoxolone</td>
      <td>OBZHEBDUNPOCJG-WBXJDKIVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6cs2</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9q</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB00549</td>
      <td>Zafirlukast</td>
      <td>YEEZWCHGZNKEEK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB03126</td>
      <td>Mant-Adp</td>
      <td>QPKUEBLEGWBRHC-BFHYXJOUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB03161</td>
      <td>Thymidine-5'-Diphospho-Beta-D-Xylose</td>
      <td>AJUADKZRQSBUAK-KDGZBOQCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB00796</td>
      <td>Candesartan cilexetil</td>
      <td>GHOSNRCGJFBJIB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB01459</td>
      <td>Bezitramide</td>
      <td>FLKWNFFCSSJANB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB01016</td>
      <td>Glyburide</td>
      <td>ZNNLBTZKUZBEKO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB06248</td>
      <td>Amelubant</td>
      <td>SBVYURPQULDJTI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9q</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB06163</td>
      <td>Plevitrexed</td>
      <td>IEJSCSAMMLUINT-NRFANRHFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB05835</td>
      <td>NS-3728</td>
      <td>OQRAKHDEGGGWQO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB01410</td>
      <td>Ciclesonide</td>
      <td>LUKZNWIVRBCLON-GXOBDPJESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB02581</td>
      <td>5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</td>
      <td>VNZHOIDQBPFEJU-OAQYLSRUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB02998</td>
      <td>Metribolone</td>
      <td>CCCIJQPRIXGQOE-XWSJACJDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB02873</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One</td>
      <td>YAWZIQKDHQIHOS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9q</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB03632</td>
      <td>Argifin</td>
      <td>UHBHXSDKGLPPGO-HTDHLNIYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB00549</td>
      <td>Zafirlukast</td>
      <td>YEEZWCHGZNKEEK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB00578</td>
      <td>Carbenicillin</td>
      <td>FPPNZSSZRUTDAP-UWFZAAFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB04098</td>
      <td>Balanol</td>
      <td>XYUFCXJZFZPEJD-PGRDOPGGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB13756</td>
      <td>Peruvoside</td>
      <td>PMTSPAGBAFCORP-HBUONDEYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB05239</td>
      <td>Cobimetinib</td>
      <td>BSMCAPRUBJMWDF-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB13856</td>
      <td>Fluclorolone</td>
      <td>VTWKPILBIUBMDS-OTJLYDAYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB13997</td>
      <td>Baloxavir marboxil</td>
      <td>RZVPBGBYGMDSBG-GGAORHGYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB02323</td>
      <td>EM-1745</td>
      <td>CKSDYJASHNGOOS-KTXOUVACSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB06876</td>
      <td>N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE</td>
      <td>YJWJKKXGAPWLGT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB03447</td>
      <td>Uridylyl-2'-5'-Phospho-Adenosine</td>
      <td>QARCCHXXGAIRFS-KPKSGTNCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB03300</td>
      <td>Pterin Cytosine Dinucleotide</td>
      <td>WKSPNQYEWZEMMI-FEFZDOOUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB04350</td>
      <td>Argadin</td>
      <td>FOZYKTUSOWWQGR-KNPYFFGGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9q</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB14723</td>
      <td>Larotrectinib</td>
      <td>NYNZQNWKBKUAII-KBXCAEBGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB00717</td>
      <td>Norethisterone</td>
      <td>VIKNJXKGJWUCNN-XGXHKTLJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB03496</td>
      <td>Alvocidib</td>
      <td>BIIVYFLTOXDAOV-YVEFUNNKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB04886</td>
      <td>Calanolide A</td>
      <td>NIDRYBLTWYFCFV-FMTVUPSXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB02827</td>
      <td>7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</td>
      <td>MDYIGSPVMWSFEZ-JTQLQIEISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08546</td>
      <td>4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE</td>
      <td>CETLUACQMGBMFH-ZALSBGIRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08239</td>
      <td>(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE</td>
      <td>NKLVBHMAIMEVEH-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB07872</td>
      <td>5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide</td>
      <td>IYGIXVNAMZPBDK-CQSZACIVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB02241</td>
      <td>8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>HOSWCJDTHOAORT-SANMLTNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB04158</td>
      <td>6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin</td>
      <td>ZKRKFZJAQKKHKL-SUGPNEFASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08080</td>
      <td>LATRUNCULIN B</td>
      <td>NSHPHXHGRHSMIK-JRIKCGFMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB12138</td>
      <td>PF-03715455</td>
      <td>VGEXRDWWPSGZDH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB11814</td>
      <td>PF-03882845</td>
      <td>XNULRSOGWPFPBL-REWPJTCUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB02049</td>
      <td>2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide</td>
      <td>QOPFTBAEAJQKSY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB07270</td>
      <td>N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE</td>
      <td>GAYYMURZGLJDCT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w4h</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB02102</td>
      <td>DMP450</td>
      <td>KYRSNWPSSXSNEP-ZRTHHSRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB08500</td>
      <td>(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</td>
      <td>ZCJBDRSKHARECB-PYTCMNEWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>7bv1</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6crv</td>
      <td>DB02155</td>
      <td>Balanol Analog 8</td>
      <td>XVLMXAUKCDSMMW-YXLARRHKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB07242</td>
      <td>(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile</td>
      <td>XGUIMGJMQKZRGM-LLVKDONJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6w9c</td>
      <td>DB07226</td>
      <td>N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE</td>
      <td>JWZVNUNTFNELHL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.5</td>
      <td>6lzg</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB03791</td>
      <td>(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid</td>
      <td>NAXSRXHZFIBFMI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01180</td>
      <td>Rescinnamine</td>
      <td>SZLZWPPUNLXJEA-LAFLMMDJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11424</td>
      <td>Lufenuron</td>
      <td>PWPJGUXAGUPAHP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11487</td>
      <td>Dexamethasone isonicotinate</td>
      <td>BQTXJHAJMDGOFI-NJLPOHDGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB08034</td>
      <td>(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</td>
      <td>TVOPERZEGKBKAY-RGVLZGJSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04115</td>
      <td>Berberine</td>
      <td>YBHILYKTIRIUTE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11793</td>
      <td>Niraparib</td>
      <td>PCHKPVIQAHNQLW-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB09219</td>
      <td>Bisoxatin</td>
      <td>BPKUDUSVDVLOPY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB11704</td>
      <td>Adomeglivant</td>
      <td>FASLTMSUPQDLIB-MHZLTWQESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12020</td>
      <td>Tecovirimat</td>
      <td>CSKDFZIMJXRJGH-VWLPUNTISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11732</td>
      <td>Lasmiditan</td>
      <td>XEDHVZKDSYZQBF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11176</td>
      <td>Zeaxanthin</td>
      <td>JKQXZKUSFCKOGQ-QAYBQHTQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11703</td>
      <td>Acalabrutinib</td>
      <td>WDENQIQQYWYTPO-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07393</td>
      <td>2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE</td>
      <td>GSKNNHAAFLPYHG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11698</td>
      <td>Ipragliflozin</td>
      <td>AHFWIQIYAXSLBA-RQXATKFSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB09003</td>
      <td>Clocapramine</td>
      <td>QAZKXHSIKKNOHH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07608</td>
      <td>N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</td>
      <td>JDGOPNUGILVNJZ-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB09231</td>
      <td>Benidipine</td>
      <td>QZVNQOLPLYWLHQ-ZEQKJWHPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB09038</td>
      <td>Empagliflozin</td>
      <td>OBWASQILIWPZMG-QZMOQZSNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07142</td>
      <td>5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>ATFDKOLABYIYCC-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB09274</td>
      <td>Artesunate</td>
      <td>FIHJKUPKCHIPAT-AHIGJZGOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB07800</td>
      <td>N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE</td>
      <td>MIJGLXFQYBTIFY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11440</td>
      <td>Norgestomet</td>
      <td>IWSXBCZCPVUWHT-VIFKTUCRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04014</td>
      <td>Alsterpaullone</td>
      <td>OLUKILHGKRVDCT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12043</td>
      <td>Sepetaprost</td>
      <td>BKVUSNOUTQMSBE-XCMGCKIWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB03383</td>
      <td>5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide</td>
      <td>YDCGVASFVACWKF-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB08092</td>
      <td>3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide</td>
      <td>VMLSXFMXUNVCSK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01708</td>
      <td>Prasterone</td>
      <td>FMGSKLZLMKYGDP-USOAJAOKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11730</td>
      <td>Ribociclib</td>
      <td>RHXHGRAEPCAFML-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB04154</td>
      <td>N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</td>
      <td>ALBWBHNFOJJMCV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12064</td>
      <td>BMS-777607</td>
      <td>VNBRGSXVFBYQNN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12085</td>
      <td>LCL-161</td>
      <td>UFPFGVNKHCLJJO-SSKFGXFMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB11637</td>
      <td>Delamanid</td>
      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07146</td>
      <td>2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE</td>
      <td>QUIQCYFSBGOBKE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08746</td>
      <td>1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE</td>
      <td>ZOSSOFIFNGGDKG-GIJQJNRQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08572</td>
      <td>4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE</td>
      <td>YBKLJTXDSBEVRV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB13490</td>
      <td>Hidrosmin</td>
      <td>XYFLWVOTXWXNAM-WTNNCJBMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01261</td>
      <td>Sitagliptin</td>
      <td>MFFMDFFZMYYVKS-SECBINFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12141</td>
      <td>Gilteritinib</td>
      <td>GYQYAJJFPNQOOW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12158</td>
      <td>Filorexant</td>
      <td>NPFDWHQSDBWQLH-QZTJIDSGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11951</td>
      <td>Lemborexant</td>
      <td>MUGXRYIUWFITCP-PGRDOPGGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07321</td>
      <td>2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE</td>
      <td>KOKQLKWXOFRTHE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07909</td>
      <td>(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL</td>
      <td>OBWILOKKNDYPLX-HBMCJLEFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01328</td>
      <td>Cefonicid</td>
      <td>DYAIAHUQIPBDIP-AXAPSJFSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12380</td>
      <td>GDC-0152</td>
      <td>WZRFLSDVFPIXOV-LRQRDZAKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08538</td>
      <td>N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>HQPVGVSQPQVZLD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB05532</td>
      <td>BMS-488043</td>
      <td>DBPMWRYLTBNCCE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08828</td>
      <td>Vismodegib</td>
      <td>BPQMGSKTAYIVFO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01222</td>
      <td>Budesonide</td>
      <td>VOVIALXJUBGFJZ-KWVAZRHASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB14054</td>
      <td>Asiatic acid</td>
      <td>JXSVIVRDWWRQRT-UYDOISQJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11742</td>
      <td>Ebastine</td>
      <td>MJJALKDDGIKVBE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB14037</td>
      <td>Madecassic acid</td>
      <td>PRAUVHZJPXOEIF-AOLYGAPISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB03363</td>
      <td>3-Acetylpyridine Adenine Dinucleotide</td>
      <td>KPVQNXLUPNWQHM-RBEMOOQDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08542</td>
      <td>3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione</td>
      <td>YUHVBHDSVLKFNI-NJSLBKSFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11814</td>
      <td>PF-03882845</td>
      <td>XNULRSOGWPFPBL-REWPJTCUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB07692</td>
      <td>1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine</td>
      <td>SHWNKRPMUBFWKE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07855</td>
      <td>(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE</td>
      <td>CWHMAWBXRCDOEB-HNNXBMFYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB08549</td>
      <td>(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER</td>
      <td>MFDBNNQUDZFSES-KRWDZBQOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11832</td>
      <td>Crenolanib</td>
      <td>DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB11663</td>
      <td>Pictilisib</td>
      <td>LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11886</td>
      <td>Infigratinib</td>
      <td>QADPYRIHXKWUSV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB03337</td>
      <td>1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea</td>
      <td>ZHCAYBOLUMAUQX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB13814</td>
      <td>Talampicillin</td>
      <td>SOROUYSPFADXSN-SUWVAFIASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11979</td>
      <td>Elagolix</td>
      <td>HEAUOKZIVMZVQL-VWLOTQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11921</td>
      <td>Deflazacort</td>
      <td>FBHSPRKOSMHSIF-GRMWVWQJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07507</td>
      <td>2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</td>
      <td>ROMNEYAQUBNRLR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08899</td>
      <td>Enzalutamide</td>
      <td>WXCXUHSOUPDCQV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08865</td>
      <td>Crizotinib</td>
      <td>KTEIFNKAUNYNJU-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB07629</td>
      <td>N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-DLBZAZTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01219</td>
      <td>Dantrolene</td>
      <td>OZOMQRBLCMDCEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB02703</td>
      <td>Fusidic acid</td>
      <td>IECPWNUMDGFDKC-MZJAQBGESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04573</td>
      <td>Estriol</td>
      <td>PROQIPRRNZUXQM-ZXXIGWHRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04471</td>
      <td>2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>FMWVCTJKLAVRPB-MUUNZHRXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB15192</td>
      <td>ABT-288</td>
      <td>GNIRITULTPTAQW-KNQAVFIVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07716</td>
      <td>(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL</td>
      <td>VDRIXSJOPKVWKM-HXGIDPQASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB03220</td>
      <td>FR233623</td>
      <td>OODDZQQDDOVCFD-SCLBCKFNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07789</td>
      <td>1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea</td>
      <td>KNTGXMNWVXZIMW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12229</td>
      <td>Cerlapirdine</td>
      <td>NXQGEDVQXVTCDA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB15444</td>
      <td>Elexacaftor</td>
      <td>MVRHVFSOIWFBTE-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12364</td>
      <td>Betrixaban</td>
      <td>XHOLNRLADUSQLD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12350</td>
      <td>Rostafuroxin</td>
      <td>AEAPORIZZWBIEX-DTBDINHYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12211</td>
      <td>PSI-697</td>
      <td>DIEPFYNZGUUVHD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12341</td>
      <td>LY-2456302</td>
      <td>ZHPMYDSXGRRERG-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB15431</td>
      <td>M-2698</td>
      <td>HXAUJHZZPCBFPN-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07966</td>
      <td>[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile</td>
      <td>NVMCVWOODOWOLT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07967</td>
      <td>9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE</td>
      <td>JJNKDTWKWYLERH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB01514</td>
      <td>Furazabol</td>
      <td>RGLLOUBXMOGLDQ-IVEVATEUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07741</td>
      <td>4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE</td>
      <td>VPNYXOTTXAXSIH-SXYSDOLCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB08950</td>
      <td>Indoramin</td>
      <td>JXZZEXZZKAWDSP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07653</td>
      <td>N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE</td>
      <td>VXTCEUDVOCLEJG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12394</td>
      <td>Eleclazine</td>
      <td>YNUAEEJQYHYLMS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB06212</td>
      <td>Tolvaptan</td>
      <td>GYHCTFXIZSNGJT-XMMPIXPASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07607</td>
      <td>4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>RXDZANYWRNIAOR-HHHXNRCGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07294</td>
      <td>3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid</td>
      <td>AANFHDFOMFRLLR-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB01329</td>
      <td>Cefoperazone</td>
      <td>GCFBRXLSHGKWDP-XCGNWRKASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB01337</td>
      <td>Pancuronium</td>
      <td>GVEAYVLWDAFXET-XGHATYIMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07297</td>
      <td>5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE</td>
      <td>PTILEOLOGGMFCS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07321</td>
      <td>2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE</td>
      <td>KOKQLKWXOFRTHE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12492</td>
      <td>Piritramide</td>
      <td>IHEHEFLXQFOQJO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06693</td>
      <td>Mevastatin</td>
      <td>AJLFOPYRIVGYMJ-INTXDZFKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12477</td>
      <td>Perfluoro tert-butylcyclohexane</td>
      <td>VLTXBOGHSBHSAC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB11871</td>
      <td>PF-00610355</td>
      <td>YPHDIMUXXABSSO-YTTGMZPUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07982</td>
      <td>2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol</td>
      <td>PVTKDXZNSUHUMO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12436</td>
      <td>Vofopitant</td>
      <td>XILNRORTJVDYRH-HKUYNNGSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04623</td>
      <td>2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>CGBRFCVAMLJVEA-ZGURCIGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9q</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07410</td>
      <td>[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID</td>
      <td>BYVXAUZOTGITQZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB15257</td>
      <td>Milademetan</td>
      <td>RYAYYVTWKAOAJF-QISPRATLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07488</td>
      <td>{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE</td>
      <td>XQKUGFIWKSKCDL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07458</td>
      <td>3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12408</td>
      <td>PF-03635659</td>
      <td>WGOJWDWKHJHXSV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07567</td>
      <td>(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL</td>
      <td>XPVKGTWRXBSJKO-LHXLBICKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07789</td>
      <td>1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea</td>
      <td>KNTGXMNWVXZIMW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11800</td>
      <td>Tivozanib</td>
      <td>SPMVMDHWKHCIDT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB15385</td>
      <td>Acebilustat</td>
      <td>GERJIEKMNDGSCS-DQEYMECFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04348</td>
      <td>Taurocholic Acid</td>
      <td>WBWWGRHZICKQGZ-HZAMXZRMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11992</td>
      <td>Omarigliptin</td>
      <td>MKMPWKUAHLTIBJ-ISTRZQFTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11949</td>
      <td>Vestipitant</td>
      <td>SBBYBXSFWOLDDG-JLTOFOAXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04244</td>
      <td>(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide</td>
      <td>YCDHZDINQZLSRR-DNQXCXABSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB08607</td>
      <td>(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE</td>
      <td>GXPHKUHSUJUWKP-NTKDMRAZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11925</td>
      <td>Vistusertib</td>
      <td>JUSFANSTBFGBAF-IRXDYDNUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB02411</td>
      <td>2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2</td>
      <td>HOUHLOFMBSYNBO-KKUQBAQOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11912</td>
      <td>Lanopepden</td>
      <td>SWHNZGMQMGFQGW-MSOLQXFVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB11903</td>
      <td>GW842166</td>
      <td>TWQYWUXBZHPIIV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB08709</td>
      <td>2,3-diphenyl-1H-indole-7-carboxylic acid</td>
      <td>OLUDUXWVPIEHDA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB14882</td>
      <td>CEP-9722</td>
      <td>CTLOSZHDGZLOQE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04240</td>
      <td>(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose</td>
      <td>XGORHSPGULYMCV-HHYQQTLHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07113</td>
      <td>(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE</td>
      <td>KHZQOXQOUCGGGA-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB08426</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</td>
      <td>PLXOQMHGHDZMSX-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB02621</td>
      <td>Latrunculin A</td>
      <td>DDVBPZROPPMBLW-IZGXTMSKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07076</td>
      <td>6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</td>
      <td>FWTQOPWAMQXIMI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04238</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid</td>
      <td>GNANSBQAIRJZPA-XZOQPEGZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB05611</td>
      <td>Apilimod</td>
      <td>HSKAZIJJKRAJAV-KOEQRZSOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04258</td>
      <td>Seocalcitol</td>
      <td>LVLLALCJVJNGQQ-SEODYNFXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08494</td>
      <td>S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate</td>
      <td>AWAKIULNKVOBKE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB04706</td>
      <td>(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL</td>
      <td>OYXZMSRRJOYLLO-KGZHIOMZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06780</td>
      <td>Desoxycorticosterone acetate</td>
      <td>VPGRYOFKCNULNK-ACXQXYJUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12180</td>
      <td>Apitolisib</td>
      <td>YOVVNQKCSKSHKT-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12167</td>
      <td>LY-3023414</td>
      <td>ACCFLVVUVBJNGT-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB08143</td>
      <td>5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE</td>
      <td>SXIYSYYSKHUTQQ-RDJZCZTQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12128</td>
      <td>Ulimorelin</td>
      <td>WGYPAJVJMXQXTR-ABNZCKJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB01948</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One</td>
      <td>VXIYTVJEIXMAQF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07450</td>
      <td>(R)-minalrestat</td>
      <td>BMHZAHGTGIZZCT-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12092</td>
      <td>Naftopidil</td>
      <td>HRRBJVNMSRJFHQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB15356</td>
      <td>SLV-334</td>
      <td>LOFDNSDPZTVIIO-VPUSJEBWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB08248</td>
      <td>3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE</td>
      <td>BKDUVKJYBJDZQW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12085</td>
      <td>LCL-161</td>
      <td>UFPFGVNKHCLJJO-SSKFGXFMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB09143</td>
      <td>Sonidegib</td>
      <td>VZZJRYRQSPEMTK-CALCHBBNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB15099</td>
      <td>GW-468816</td>
      <td>XDKRVNKVAKCFGW-WXWBBQJKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB02009</td>
      <td>L-756,423</td>
      <td>AOMZDQMIOCTPQP-QHQMVRJISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB08124</td>
      <td>3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>FTQYGMLRLRXBPT-IDUWFGFVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01138</td>
      <td>Sulfinpyrazone</td>
      <td>MBGGBVCUIVRRBF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB01876</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methanone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12055</td>
      <td>MK-0767</td>
      <td>ORZMUVMQJPGFOM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12052</td>
      <td>Icariin</td>
      <td>TZJALUIVHRYQQB-XLRXWWTNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB15029</td>
      <td>AZD-8186</td>
      <td>LMJFJIDLEAWOQJ-CQSZACIVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB08237</td>
      <td>2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)</td>
      <td>COMPKRGNHXOXMN-GVDBMIGSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB11778</td>
      <td>Danusertib</td>
      <td>XKFTZKGMDDZMJI-HSZRJFAPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12558</td>
      <td>AEE-788</td>
      <td>OONFNUWBHFSNBT-HXUWFJFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07456</td>
      <td>3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15362</td>
      <td>LSZ-102</td>
      <td>SJXNPGGVGZXKKI-NYYWCZLTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB11692</td>
      <td>Pavinetant</td>
      <td>QYTBBBAHNIWFOD-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07294</td>
      <td>3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid</td>
      <td>AANFHDFOMFRLLR-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04761</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]</td>
      <td>NHPBWKYFMTXWAA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07014</td>
      <td>2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole</td>
      <td>TUTZKAQTSPMEBI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB11666</td>
      <td>Buparlisib</td>
      <td>CWHUFRVAEUJCEF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06743</td>
      <td>Ginkgolide A</td>
      <td>FPUXKXIZEIDQKW-VKMVSBOZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15460</td>
      <td>AGG-523</td>
      <td>JWQMTWCFNZSLNR-DEOSSOPVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06745</td>
      <td>ginkgolide-C</td>
      <td>AMOGMTLMADGEOQ-DTDWCABLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB11611</td>
      <td>Lifitegrast</td>
      <td>JFOZKMSJYSPYLN-QHCPKHFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB11577</td>
      <td>Indigotindisulfonic Acid</td>
      <td>CFZXDJWFRVEWSR-BUHFOSPRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00246</td>
      <td>Ziprasidone</td>
      <td>MVWVFYHBGMAFLY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00253</td>
      <td>Medrysone</td>
      <td>GZENKSODFLBBHQ-ILSZZQPISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00307</td>
      <td>Bexarotene</td>
      <td>NAVMQTYZDKMPEU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07215</td>
      <td>2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID</td>
      <td>ILUPZUOBHCUBKB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB07321</td>
      <td>2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE</td>
      <td>KOKQLKWXOFRTHE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00378</td>
      <td>Dydrogesterone</td>
      <td>JGMOKGBVKVMRFX-HQZYFCCVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00430</td>
      <td>Cefpiramide</td>
      <td>PWAUCHMQEXVFJR-PMAPCBKXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04652</td>
      <td>Corticosterone</td>
      <td>OMFXVFTZEKFJBZ-HJTSIMOOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06718</td>
      <td>Stanozolol</td>
      <td>LKAJKIOFIWVMDJ-IYRCEVNGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07296</td>
      <td>(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE</td>
      <td>PLGHLEBIWUQEPR-PDGQHHTCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06717</td>
      <td>Fosaprepitant</td>
      <td>BARDROPHSZEBKC-OITMNORJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15297</td>
      <td>Petesicatib</td>
      <td>KXAAIORSMACJSI-AEFFLSMTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB04196</td>
      <td>Pteroic Acid</td>
      <td>JOAQINSXLLMRCV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15029</td>
      <td>AZD-8186</td>
      <td>LMJFJIDLEAWOQJ-CQSZACIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15031</td>
      <td>Nemorexant</td>
      <td>NBGABHGMJVIVBW-QHCPKHFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07550</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE</td>
      <td>ZIGSBBKEPNQXRG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15046</td>
      <td>LY-2881835</td>
      <td>FHRWHNJJQGSCQC-LJAQVGFWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15057</td>
      <td>NUC-1031</td>
      <td>NHTKGYOMICWFQZ-KKQYNPQSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06521</td>
      <td>Ertiprotafib</td>
      <td>FONCZICQWCUXEB-RUZDIDTESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07493</td>
      <td>(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE</td>
      <td>IEQQJQHHJMQETK-YPKPFQOOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07486</td>
      <td>3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline</td>
      <td>KLSZVPNVFKKIRD-FNORWQNLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15121</td>
      <td>AT-001</td>
      <td>YRGPAXAVTDMKDK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB13931</td>
      <td>Netarsudil</td>
      <td>OURRXQUGYQRVML-AREMUKBSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00590</td>
      <td>Doxazosin</td>
      <td>RUZYUOTYCVRMRZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07453</td>
      <td>2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE</td>
      <td>VFMMPHCGEFXGIP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01480</td>
      <td>Cyprenorphine</td>
      <td>VSKIOMHXEUHYSI-KNLIIKEYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15191</td>
      <td>MAX-40279</td>
      <td>AVIOBQFPAGEICQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15193</td>
      <td>BMS-955176</td>
      <td>XDMUFNNPLXHNKA-ZTESCHFWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB11796</td>
      <td>Fostemsavir</td>
      <td>SWMDAPWAQQTBOG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07410</td>
      <td>[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID</td>
      <td>BYVXAUZOTGITQZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07000</td>
      <td>N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide</td>
      <td>ILXJWLWSYAWJKZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07395</td>
      <td>4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid</td>
      <td>NWQGDIBCFLDHDO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB08366</td>
      <td>3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid</td>
      <td>XADCWKSMHQPTGH-OFBLZTNGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07375</td>
      <td>5-BETA-ANDROSTANE-3,17-DIONE</td>
      <td>RAJWOBJTTGJROA-QJISAEMRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07297</td>
      <td>5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE</td>
      <td>PTILEOLOGGMFCS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07430</td>
      <td>(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one</td>
      <td>CMWRPDHVGMHLSZ-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00624</td>
      <td>Testosterone</td>
      <td>MUMGGOZAMZWBJJ-DYKIIFRCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07159</td>
      <td>Tamatinib</td>
      <td>NHHQJBCNYHBUSI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB06401</td>
      <td>Bazedoxifene</td>
      <td>UCJGJABZCDBEDK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB08822</td>
      <td>Azilsartan medoxomil</td>
      <td>QJFSABGVXDWMIW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01212</td>
      <td>Ceftriaxone</td>
      <td>VAAUVRVFOQPIGI-SPQHTLEESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01222</td>
      <td>Budesonide</td>
      <td>VOVIALXJUBGFJZ-KWVAZRHASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB06963</td>
      <td>3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide</td>
      <td>ZFGCLYUGFRNYFE-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01328</td>
      <td>Cefonicid</td>
      <td>DYAIAHUQIPBDIP-AXAPSJFSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07267</td>
      <td>2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine</td>
      <td>JONFDFIXMPXTRH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB06916</td>
      <td>N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE</td>
      <td>LBCGUKCXRVUULK-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08970</td>
      <td>Fluprednidene</td>
      <td>YVHXHNGGPURVOS-SBTDHBFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB06876</td>
      <td>N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE</td>
      <td>YJWJKKXGAPWLGT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11385</td>
      <td>Cefalonium</td>
      <td>FMZXNVLFJHCSAF-DNVCBOLYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB13095</td>
      <td>JTK-853</td>
      <td>JQLOVYLALGSISI-HXUWFJFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01479</td>
      <td>BA-2664</td>
      <td>QGKQXZFZOIQFBI-XSWYFRFISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11450</td>
      <td>Pimobendan</td>
      <td>GLBJJMFZWDBELO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01540</td>
      <td>17alpha-methyl-4-hydroxynandrolone</td>
      <td>CLNUZOCYKSHICX-FAHHUNKHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01820</td>
      <td>Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide</td>
      <td>UESXELNYBIOROE-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01572</td>
      <td>Methyl-1-testosterone</td>
      <td>JRNSSSJKIGAFCT-YDSAWKJFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01573</td>
      <td>Benzylmorphine</td>
      <td>RDJGWRFTDZZXSM-RNWLQCGYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07175</td>
      <td>N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide</td>
      <td>CXQRKICWSCAUGW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01691</td>
      <td>Indole Naphthyridinone</td>
      <td>VAZMNDXVXVUKFY-JXMROGBWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01177</td>
      <td>Idarubicin</td>
      <td>XDXDZDZNSLXDNA-TZNDIEGXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04690</td>
      <td>Camptothecin</td>
      <td>VSJKWCGYPAHWDS-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB01975</td>
      <td>AMPCPR</td>
      <td>ZPZRETFSCSWNDT-DBXCYWGHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB06983</td>
      <td>(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol</td>
      <td>RBLKWWBHDUBPFN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07156</td>
      <td>(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione</td>
      <td>JFEKAVPMVOLVTH-UNOMPAQXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB02021</td>
      <td>Fidarestat</td>
      <td>WAAPEIZFCHNLKK-UFBFGSQYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB02698</td>
      <td>N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid</td>
      <td>NQOOJFXBGLOGTC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00693</td>
      <td>Fluorescein</td>
      <td>GNBHRKFJIUUOQI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB08143</td>
      <td>5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE</td>
      <td>SXIYSYYSKHUTQQ-RDJZCZTQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01569</td>
      <td>Formebolone</td>
      <td>AMVODTGMYSRMNP-GNIMZFFESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07080</td>
      <td>N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE</td>
      <td>SGIWFELWJPNFDH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07078</td>
      <td>(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>AYSXURJZVXBSRV-WJDWOHSUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00776</td>
      <td>Oxcarbazepine</td>
      <td>CTRLABGOLIVAIY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00637</td>
      <td>Astemizole</td>
      <td>GXDALQBWZGODGZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07006</td>
      <td>9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE</td>
      <td>AOGOZJCRIFBTTN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07021</td>
      <td>(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine</td>
      <td>SOSYXEPELJIJHZ-RNCFNFMXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00836</td>
      <td>Loperamide</td>
      <td>RDOIQAHITMMDAJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB09075</td>
      <td>Edoxaban</td>
      <td>HGVDHZBSSITLCT-JLJPHGGASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00957</td>
      <td>Norgestimate</td>
      <td>KIQQMECNKUGGKA-NMYWJIRASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB08448</td>
      <td>(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol</td>
      <td>PCBWLKUEKANDCL-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00973</td>
      <td>Ezetimibe</td>
      <td>OLNTVTPDXPETLC-XPWALMASSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB00984</td>
      <td>Nandrolone phenpropionate</td>
      <td>UBWXUGDQUBIEIZ-QNTYDACNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB06992</td>
      <td>(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone</td>
      <td>SIDDLTBLAQYZIZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07053</td>
      <td>2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID</td>
      <td>TWVYNPULGKGJOS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB08912</td>
      <td>Dabrafenib</td>
      <td>BFSMGDJOXZAERB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07019</td>
      <td>N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE</td>
      <td>QWDOKZPZLWNULU-MZNJEOGPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB15013</td>
      <td>TAK-243</td>
      <td>KJDAGXLMHXUAGV-DGWLBADLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB02505</td>
      <td>N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)</td>
      <td>JJVQUUYZGJWBPW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12743</td>
      <td>Z-160</td>
      <td>VCPMZDWBEWTGNW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB02882</td>
      <td>Cyanocinnoline</td>
      <td>CUWRVIIPSSUUDJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11885</td>
      <td>Anlotinib</td>
      <td>KSMZEXLVHXZPEF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB07126</td>
      <td>O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE</td>
      <td>OWXORKPNCHJYOF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB02877</td>
      <td>Arotinoid acid</td>
      <td>FOIVPCKZDPCJJY-JQIJEIRASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08237</td>
      <td>2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)</td>
      <td>COMPKRGNHXOXMN-GVDBMIGSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08191</td>
      <td>4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid</td>
      <td>KSFDVNIKNYXUIP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08170</td>
      <td>(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE</td>
      <td>AYFCYVLVRYQGME-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08123</td>
      <td>N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE</td>
      <td>GEWPSTLKJDIUHW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08111</td>
      <td>4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol</td>
      <td>ZGJYGQLGSXWEMY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04872</td>
      <td>Osanetant</td>
      <td>DZOJBGLFWINFBF-UMSFTDKQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB11263</td>
      <td>Polydatin</td>
      <td>HSTZMXCBWJGKHG-CUYWLFDKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB07404</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>YXQQNSYZOQHKHD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB06077</td>
      <td>Lumateperone</td>
      <td>HOIIHACBCFLJET-SFTDATJTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB12649</td>
      <td>Ibipinabant</td>
      <td>AXJQVVLKUYCICH-OAQYLSRUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB02790</td>
      <td>Phenyl-Uridine-5'-Diphosphate</td>
      <td>ZHUWBKDWWGKIEN-FMKGYKFTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08063</td>
      <td>1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE</td>
      <td>HLZMYWLMBBLASX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12973</td>
      <td>Serlopitant</td>
      <td>FLNYCRJBCNNHRH-OIYLJQICSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB08407</td>
      <td>PLATENSIMYCIN</td>
      <td>CSOMAHTTWTVBFL-OFBLZTNGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB12598</td>
      <td>Nafamostat</td>
      <td>MQQNFDZXWVTQEH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB06248</td>
      <td>Amelubant</td>
      <td>SBVYURPQULDJTI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12725</td>
      <td>TD-8954</td>
      <td>MZOITCJKGUIQEI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08304</td>
      <td>(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>QZBQVXXESPXFPZ-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB04608</td>
      <td>9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</td>
      <td>IAUZTOZLTFSMIE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB04623</td>
      <td>2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>CGBRFCVAMLJVEA-ZGURCIGKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08497</td>
      <td>(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>NKBDSMREMMRFSI-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB06997</td>
      <td>2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</td>
      <td>BMPOCDJEXAXXEZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07295</td>
      <td>2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID</td>
      <td>IGOULVZYQKJJKC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB04696</td>
      <td>4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN</td>
      <td>GFGZCXHXQCQRFP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB04698</td>
      <td>N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</td>
      <td>HJWYZPGYPZNDTN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB12571</td>
      <td>Rimacalib</td>
      <td>MYTIJGWONQOOLC-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12637</td>
      <td>Onapristone</td>
      <td>IEXUMDBQLIVNHZ-YOUGDJEHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB03041</td>
      <td>UDP-alpha-D-glucuronic acid</td>
      <td>HDYANYHVCAPMJV-LXQIFKJMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB07181</td>
      <td>4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</td>
      <td>JYKFWUXBFJJDTP-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB02998</td>
      <td>Metribolone</td>
      <td>CCCIJQPRIXGQOE-XWSJACJDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB00445</td>
      <td>Epirubicin</td>
      <td>AOJJSUZBOXZQNB-VTZDEGQISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08341</td>
      <td>4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide</td>
      <td>CAUFYHKGKDJMQG-HZPDHXFCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11892</td>
      <td>Prulifloxacin</td>
      <td>PWNMXPDKBYZCOO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07252</td>
      <td>3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide</td>
      <td>TZHCXOMEOHEZDX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB08031</td>
      <td>N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</td>
      <td>LNQWELVSNCYKDU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB12558</td>
      <td>AEE-788</td>
      <td>OONFNUWBHFSNBT-HXUWFJFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01434</td>
      <td>19-norandrostenedione</td>
      <td>JRIZOGLBRPZBLQ-QXUSFIETSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11795</td>
      <td>GSK-2636771</td>
      <td>XTKLTGBKIDQGQL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04630</td>
      <td>Aldosterone</td>
      <td>PQSUYGKTWSAVDQ-ZVIOFETBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB09295</td>
      <td>Talniflumate</td>
      <td>ANMLJLFWUCQGKZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB02547</td>
      <td>Guanosine-5'-Diphosphate-Rhamnose</td>
      <td>LQEBEXMHBLQMDB-GDJBGNAASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07783</td>
      <td>1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>GUYYFMCFEPDDFL-OAQYLSRUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB00834</td>
      <td>Mifepristone</td>
      <td>VKHAHZOOUSRJNA-GCNJZUOMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07778</td>
      <td>FAMOXADONE</td>
      <td>PCCSBWNGDMYFCW-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB14661</td>
      <td>Loperamide oxide</td>
      <td>KXVSBTJVTUVNPM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06362</td>
      <td>Becatecarin</td>
      <td>JSKFWUPVIZYJMR-UDOAKELVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB14034</td>
      <td>Darglitazone</td>
      <td>QQKNSPHAFATFNQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB14729</td>
      <td>Rebeccamycin</td>
      <td>QEHOIJJIZXRMAN-QZQSLCQPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07717</td>
      <td>(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE</td>
      <td>AJODXHGZHBERGJ-JLYQOUBASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11775</td>
      <td>PF-03758309</td>
      <td>AYCPARAPKDAOEN-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB08237</td>
      <td>2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)</td>
      <td>COMPKRGNHXOXMN-GVDBMIGSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB14876</td>
      <td>TAS-116</td>
      <td>NVVPMZUGELHVMH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB08124</td>
      <td>3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>FTQYGMLRLRXBPT-IDUWFGFVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11763</td>
      <td>Momelotinib</td>
      <td>ZVHNDZWQTBEVRY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06429</td>
      <td>Talnetant</td>
      <td>BIAVGWDGIJKWRM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB03642</td>
      <td>Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</td>
      <td>VBPPNJCVXGAZDD-PMACEKPBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06367</td>
      <td>Relacatib</td>
      <td>BWYBBMQLUKXECQ-GIVPXCGWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07157</td>
      <td>(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE</td>
      <td>RTFGEFWZCFCODU-RBUKOAKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB13953</td>
      <td>Estradiol benzoate</td>
      <td>UYIFTLBWAOGQBI-BZDYCCQFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07991</td>
      <td>N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE</td>
      <td>APLJSSOXDWUNGV-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB13059</td>
      <td>PF-03814735</td>
      <td>RYYNGWLOYLRZLK-RBUKOAKNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07265</td>
      <td>3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID</td>
      <td>JDARUOOLJCFUOY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB13072</td>
      <td>GDC-0349</td>
      <td>RGJOJUGRHPQXGF-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB12432</td>
      <td>CC-401</td>
      <td>XDJCLCLBSGGNKS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB13088</td>
      <td>AZD-0424</td>
      <td>MVWATCATLSSVBH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB08064</td>
      <td>N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA</td>
      <td>NTMADESEDXKNFZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB13101</td>
      <td>4SC-202</td>
      <td>PRXXYMVLYKJITB-IZZDOVSWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB02703</td>
      <td>Fusidic acid</td>
      <td>IECPWNUMDGFDKC-MZJAQBGESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB02668</td>
      <td>Je-2147, Ag1776, Kni-764</td>
      <td>CUFQBQOBLVLKRF-RZDMPUFOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11806</td>
      <td>VTP-194204</td>
      <td>BOOOLEGQBVUTKC-NVQSDHBMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB11841</td>
      <td>Entinostat</td>
      <td>INVTYAOGFAGBOE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB13491</td>
      <td>Fluperolone</td>
      <td>SLVCCRYLKTYUQP-DVTGEIKXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07848</td>
      <td>5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide</td>
      <td>BHNMMFGOJRIAEZ-LRDDRELGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06212</td>
      <td>Tolvaptan</td>
      <td>GYHCTFXIZSNGJT-XMMPIXPASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07845</td>
      <td>2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide</td>
      <td>VGYXXQRDIVRILX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB07843</td>
      <td>5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE</td>
      <td>LTJNKFUIOOJXNJ-WFASDCNBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06246</td>
      <td>Exisulind</td>
      <td>MVGSNCBCUWPVDA-MFOYZWKCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB06248</td>
      <td>Amelubant</td>
      <td>SBVYURPQULDJTI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB14034</td>
      <td>Darglitazone</td>
      <td>QQKNSPHAFATFNQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08735</td>
      <td>R,S-Warfarin alcohol</td>
      <td>ZUJMMGHIYSAEOU-SWLSCSKDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB13029</td>
      <td>MK-0873</td>
      <td>JJWKQXNHYDJXKF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB02827</td>
      <td>7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</td>
      <td>MDYIGSPVMWSFEZ-JTQLQIEISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB02329</td>
      <td>Carbenoxolone</td>
      <td>OBZHEBDUNPOCJG-WBXJDKIVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12743</td>
      <td>Z-160</td>
      <td>VCPMZDWBEWTGNW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB01792</td>
      <td>Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate</td>
      <td>FZCSEXOMUJFOHQ-KPKSGTNCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB01948</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One</td>
      <td>VXIYTVJEIXMAQF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07971</td>
      <td>5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE</td>
      <td>FQQVTDIBUYSVHM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14583</td>
      <td>Segesterone acetate</td>
      <td>CKFBRGLGTWAVLG-GOMYTPFNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB14029</td>
      <td>Furafylline</td>
      <td>HMZQULPVMKITSP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14570</td>
      <td>Hydroxyprogesterone</td>
      <td>DBPWSSGDRRHUNT-CEGNMAFCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04038</td>
      <td>Ergosterol</td>
      <td>DNVPQKQSNYMLRS-APGDWVJJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB05511</td>
      <td>Piclidenoson</td>
      <td>HUJXGQILHAUCCV-MOROJQBDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB03268</td>
      <td>RU82197</td>
      <td>WKTQBTSOHBKBRW-VMPREFPWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB01669</td>
      <td>Virginiamycin M1</td>
      <td>DAIKHDNSXMZDCU-FQTGFAPKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00554</td>
      <td>Piroxicam</td>
      <td>QYSPLQLAKJAUJT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07743</td>
      <td>S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE</td>
      <td>VNGWUVBXUIDQTK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06230</td>
      <td>Nalmefene</td>
      <td>WJBLNOPPDWQMCH-MBPVOVBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00490</td>
      <td>Buspirone</td>
      <td>QWCRAEMEVRGPNT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14859</td>
      <td>Fosifloxuridine nafalbenamide</td>
      <td>BIOWRMNRHMERIO-ZVAHOJSLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB01337</td>
      <td>Pancuronium</td>
      <td>GVEAYVLWDAFXET-XGHATYIMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB00266</td>
      <td>Dicoumarol</td>
      <td>DOBMPNYZJYQDGZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14856</td>
      <td>PF-05089771</td>
      <td>ZYSCOUXLBXGGIM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB01410</td>
      <td>Ciclesonide</td>
      <td>LUKZNWIVRBCLON-GXOBDPJESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00304</td>
      <td>Desogestrel</td>
      <td>RPLCPCMSCLEKRS-BPIQYHPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB06494</td>
      <td>Sufugolix</td>
      <td>UCQSBGOFELXYIN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB15029</td>
      <td>AZD-8186</td>
      <td>LMJFJIDLEAWOQJ-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6wiq</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB01573</td>
      <td>Benzylmorphine</td>
      <td>RDJGWRFTDZZXSM-RNWLQCGYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14674</td>
      <td>Estramustine phosphate</td>
      <td>ADFOJJHRTBFFOF-RBRWEJTLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07967</td>
      <td>9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE</td>
      <td>JJNKDTWKWYLERH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lzg</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14568</td>
      <td>Ivosidenib</td>
      <td>WIJZXSAJMHAVGX-DHLKQENFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9q</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14035</td>
      <td>Englitazone</td>
      <td>MVDXXGIBARMXSA-PYUWXLGESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB12535</td>
      <td>AC-430</td>
      <td>DCRWIATZWHLIPN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB15385</td>
      <td>Acebilustat</td>
      <td>GERJIEKMNDGSCS-DQEYMECFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB03126</td>
      <td>Mant-Adp</td>
      <td>QPKUEBLEGWBRHC-BFHYXJOUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14029</td>
      <td>Furafylline</td>
      <td>HMZQULPVMKITSP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08361</td>
      <td>2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide</td>
      <td>NZNTWOVDIXCHHS-LSDHHAIUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12666</td>
      <td>Emapunil</td>
      <td>NBMBIEOUVBHEBM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB08031</td>
      <td>N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</td>
      <td>LNQWELVSNCYKDU-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB03213</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-P</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB13551</td>
      <td>Cinchophen</td>
      <td>YTRMTPPVNRALON-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13958</td>
      <td>Trestolone acetate</td>
      <td>IVCRCPJOLWECJU-XQVQQVTHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB11487</td>
      <td>Dexamethasone isonicotinate</td>
      <td>BQTXJHAJMDGOFI-NJLPOHDGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14217</td>
      <td>Quinaprilat</td>
      <td>FLSLEGPOVLMJMN-YSSFQJQWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06237</td>
      <td>Avanafil</td>
      <td>WEAJZXNPAWBCOA-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07333</td>
      <td>N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE</td>
      <td>KRGKAARWVPUWSY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00622</td>
      <td>Nicardipine</td>
      <td>ZBBHBTPTTSWHBA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00635</td>
      <td>Prednisone</td>
      <td>XOFYZVNMUHMLCC-ZPOLXVRWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB12225</td>
      <td>Beclabuvir</td>
      <td>ZTTKEBYSXUCBSE-QDFUAKMASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB13600</td>
      <td>Deltamethrin</td>
      <td>OWZREIFADZCYQD-NSHGMRRFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08239</td>
      <td>(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE</td>
      <td>NKLVBHMAIMEVEH-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB13953</td>
      <td>Estradiol benzoate</td>
      <td>UYIFTLBWAOGQBI-BZDYCCQFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB13089</td>
      <td>Enoxolone</td>
      <td>MPDGHEJMBKOTSU-YKLVYJNSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB02331</td>
      <td>(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>YBULOUKTPCHXAL-DEOSSOPVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07000</td>
      <td>N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide</td>
      <td>ILXJWLWSYAWJKZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB14542</td>
      <td>Hydrocortisone phosphate</td>
      <td>BGSOJVFOEQLVMH-VWUMJDOOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06620</td>
      <td>Aplindore</td>
      <td>DYJIKHYBKVODAC-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB14635</td>
      <td>Curcumin sulfate</td>
      <td>NEJVQQBBTRFOHB-FCXRPNKRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07909</td>
      <td>(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL</td>
      <td>OBWILOKKNDYPLX-HBMCJLEFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB06677</td>
      <td>Clazosentan</td>
      <td>LFWCJABOXHSRGC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB06916</td>
      <td>N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE</td>
      <td>LBCGUKCXRVUULK-QGZVFWFLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4b</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB15273</td>
      <td>VS-4718</td>
      <td>IGUBBWJDMLCRIK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12966</td>
      <td>Falnidamol</td>
      <td>FTFRZXFNZVCRSK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB02581</td>
      <td>5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</td>
      <td>VNZHOIDQBPFEJU-OAQYLSRUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB15269</td>
      <td>ALK-4290</td>
      <td>DWKNOLCXIFYNFV-HSZRJFAPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB14896</td>
      <td>Selitrectinib</td>
      <td>OEBIHOVSAMBXIB-SJKOYZFVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06166</td>
      <td>Fosdevirine</td>
      <td>CGBYTKOSZYQOPV-CCEZBSFNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00377</td>
      <td>Palonosetron</td>
      <td>CPZBLNMUGSZIPR-NVXWUHKLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB15207</td>
      <td>Esaxerenone</td>
      <td>NOSNHVJANRODGR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB03678</td>
      <td>(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine</td>
      <td>WVGZKPGUHOZIJQ-HNNXBMFYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB13607</td>
      <td>Picloxydine</td>
      <td>YNCLPFSAZFGQCD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB00220</td>
      <td>Nelfinavir</td>
      <td>QAGYKUNXZHXKMR-HKWSIXNMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB06011</td>
      <td>AMG-222</td>
      <td>NVSWJKWHLUTHLP-CPJSRVTESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB15275</td>
      <td>GDC-0077</td>
      <td>SGEUNORSOZVTOL-CABZTGNLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB04785</td>
      <td>Streptolydigin</td>
      <td>KVTPRMVXYZKLIG-NCAOFHFGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB15011</td>
      <td>Avacopan</td>
      <td>PUKBOVABABRILL-YZNIXAGQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4b</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12563</td>
      <td>MK-0686</td>
      <td>WZZIQHIQMWJNLU-LLVKDONJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB15105</td>
      <td>PF-06751979</td>
      <td>ZLZUHACSRMOLLV-RAALSFIWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB04099</td>
      <td>Deamido-Nad+</td>
      <td>SENPVEZBRZQVST-HISDBWNOSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06506</td>
      <td>Repinotan</td>
      <td>YGYBFMRFXNDIPO-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lzg</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB04759</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)</td>
      <td>GTBUZLPQANSGGE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB04760</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)</td>
      <td>PYFRREJCFXFNRR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06521</td>
      <td>Ertiprotafib</td>
      <td>FONCZICQWCUXEB-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00203</td>
      <td>Sildenafil</td>
      <td>BNRNXUUZRGQAQC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB06634</td>
      <td>Casopitant</td>
      <td>XGGTZCKQRWXCHW-WMTVXVAQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB13022</td>
      <td>LY-2874455</td>
      <td>GKJCVYLDJWTWQU-CXLRFSCWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB15408</td>
      <td>Silmitasertib</td>
      <td>MUOKSQABCJCOPU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07229</td>
      <td>3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE</td>
      <td>MINVOLKUPZPDNX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB15346</td>
      <td>GLPG-1205</td>
      <td>IRBAWVGZNJIROV-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00436</td>
      <td>Bendroflumethiazide</td>
      <td>HDWIHXWEUNVBIY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB13059</td>
      <td>PF-03814735</td>
      <td>RYYNGWLOYLRZLK-RBUKOAKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB15145</td>
      <td>Ziresovir</td>
      <td>GAAICKUTDBZCMT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB12960</td>
      <td>INCB-9471</td>
      <td>ZMCJFJZOSKEMOM-DNKZPPIMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB13954</td>
      <td>Estradiol cypionate</td>
      <td>UOACKFBJUYNSLK-XRKIENNPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04014</td>
      <td>Alsterpaullone</td>
      <td>OLUKILHGKRVDCT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB06997</td>
      <td>2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</td>
      <td>BMPOCDJEXAXXEZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12867</td>
      <td>Benperidol</td>
      <td>FEBOTPHFXYHVPL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB00997</td>
      <td>Doxorubicin</td>
      <td>AOJJSUZBOXZQNB-TZSSRYMLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07175</td>
      <td>N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide</td>
      <td>CXQRKICWSCAUGW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB03723</td>
      <td>2'-Deoxy-Thymidine-Beta-L-Rhamnose</td>
      <td>ZOSQFDVXNQFKBY-CGAXJHMRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB03714</td>
      <td>4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid</td>
      <td>OWWCIKSGGKYNHT-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08003</td>
      <td>ISOTHIAZOLIDINONE ANALOG</td>
      <td>UILYPHAKDBTKQV-UFYCRDLUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04421</td>
      <td>Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct</td>
      <td>BZJFKYRGSZWSLT-YLIVDTKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00430</td>
      <td>Cefpiramide</td>
      <td>PWAUCHMQEXVFJR-PMAPCBKXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB00251</td>
      <td>Terconazole</td>
      <td>BLSQLHNBWJLIBQ-OZXSUGGESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB06959</td>
      <td>(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine</td>
      <td>BUCZDJYEOAQTHL-KEKNWZKVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lzg</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08058</td>
      <td>4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one</td>
      <td>HGEPGGJUGUMFHT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB15192</td>
      <td>ABT-288</td>
      <td>GNIRITULTPTAQW-KNQAVFIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lzg</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB15192</td>
      <td>ABT-288</td>
      <td>GNIRITULTPTAQW-KNQAVFIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08304</td>
      <td>(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>QZBQVXXESPXFPZ-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB15406</td>
      <td>GLPG-0974</td>
      <td>MPMKMQHJHDHPBE-RUZDIDTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07654</td>
      <td>(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC</td>
      <td>VDJWWYRYKMXMKA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07685</td>
      <td>4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>NMAZGYDYIYLSLJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13941</td>
      <td>Piperaquine</td>
      <td>UCRHFBCYFMIWHC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04097</td>
      <td>Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose</td>
      <td>OAPPZHVTNHJVAL-JZMIEXBBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB00694</td>
      <td>Daunorubicin</td>
      <td>STQGQHZAVUOBTE-VGBVRHCVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB07294</td>
      <td>3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid</td>
      <td>AANFHDFOMFRLLR-IBGZPJMESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08111</td>
      <td>4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol</td>
      <td>ZGJYGQLGSXWEMY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB03368</td>
      <td>5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione</td>
      <td>RTBMLCLTYAPKIF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12857</td>
      <td>NVP-LEQ-506</td>
      <td>POERAARDVFVDLO-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12416</td>
      <td>VTP-27999</td>
      <td>NXWASIVXQMMPLM-ZXMXYHOLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9q</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB06718</td>
      <td>Stanozolol</td>
      <td>LKAJKIOFIWVMDJ-IYRCEVNGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB06721</td>
      <td>Gimatecan</td>
      <td>UIVFUQKYVFCEKJ-OPTOVBNMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB03903</td>
      <td>Tmr</td>
      <td>KGFLZYXDJDOIEE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08112</td>
      <td>N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID</td>
      <td>IRJUSGUHNFMVCK-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB06844</td>
      <td>4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE</td>
      <td>MBXKBJLIESPLIK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07804</td>
      <td>5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE</td>
      <td>FKCQUVAGEOSYRU-QWRGUYRKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB00845</td>
      <td>Clofazimine</td>
      <td>WDQPAMHFFCXSNU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB15031</td>
      <td>Nemorexant</td>
      <td>NBGABHGMJVIVBW-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06660</td>
      <td>Saredutant</td>
      <td>PGKXDIMONUAMFR-AREMUKBSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB11965</td>
      <td>SJG-136</td>
      <td>RWZVMMQNDHPRQD-SFTDATJTSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13080</td>
      <td>Roluperidone</td>
      <td>RNRYULFRLCBRQS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB00984</td>
      <td>Nandrolone phenpropionate</td>
      <td>UBWXUGDQUBIEIZ-QNTYDACNSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13052</td>
      <td>Upamostat</td>
      <td>HUASEDVYRABWCV-NDEPHWFRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00901</td>
      <td>Bitolterol</td>
      <td>FZGVEKPRDOIXJY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB06163</td>
      <td>Plevitrexed</td>
      <td>IEJSCSAMMLUINT-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB06176</td>
      <td>Romidepsin</td>
      <td>OHRURASPPZQGQM-GCCNXGTGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB15055</td>
      <td>ABT-639</td>
      <td>AGPIHNZOZNKRGT-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08108</td>
      <td>N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID</td>
      <td>PUHRQSFXADUGJW-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB04190</td>
      <td>Inhibitor Bea425</td>
      <td>AHAVBKNGKPWROK-UMFPTGFGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB00663</td>
      <td>Flumethasone</td>
      <td>WXURHACBFYSXBI-GQKYHHCASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9q</td>
      <td>DB08220</td>
      <td>(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid</td>
      <td>RPNNXCYIESWDSC-JRZBRKEGSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07041</td>
      <td>N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide</td>
      <td>FDJWFDQRPKKBFA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00921</td>
      <td>Buprenorphine</td>
      <td>RMRJXGBAOAMLHD-IHFGGWKQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB14903</td>
      <td>Rovafovir etalafenamide</td>
      <td>OCJRRXHWPBXZSU-BJBBEUPESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB01029</td>
      <td>Irbesartan</td>
      <td>YOSHYTLCDANDAN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12350</td>
      <td>Rostafuroxin</td>
      <td>AEAPORIZZWBIEX-DTBDINHYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07064</td>
      <td>(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE</td>
      <td>HPVCRUIDFODATB-LJQANCHMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12580</td>
      <td>Tradipitant</td>
      <td>CAVRKWRKTNINFF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB15287</td>
      <td>Elismetrep</td>
      <td>CWEFDWIKLABKBX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07142</td>
      <td>5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>ATFDKOLABYIYCC-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12565</td>
      <td>Abexinostat</td>
      <td>MAUCONCHVWBMHK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12339</td>
      <td>Radezolid</td>
      <td>BTTNOGHPGJANSW-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB07629</td>
      <td>N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-DLBZAZTESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08462</td>
      <td>N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE</td>
      <td>JGWHILNNHLDARR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07041</td>
      <td>N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide</td>
      <td>FDJWFDQRPKKBFA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB01873</td>
      <td>Epothilone D</td>
      <td>XOZIUKBZLSUILX-GIQCAXHBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB06920</td>
      <td>Eribaxaban</td>
      <td>QQBKAVAGLMGMHI-WIYYLYMNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12388</td>
      <td>Evocalcet</td>
      <td>RZNUIYPHQFXBAN-XLIONFOSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9q</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12781</td>
      <td>Balaglitazone</td>
      <td>IETKPTYAGKZLKY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12756</td>
      <td>TAK-901</td>
      <td>WKDACQVEJIVHMZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12744</td>
      <td>CGI-1842</td>
      <td>ZXBFYBLSJMEBEP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB00522</td>
      <td>Bentiromide</td>
      <td>SPPTWHFVYKCNNK-FQEVSTJZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07519</td>
      <td>(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</td>
      <td>VDFBMQAUECXNKR-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04258</td>
      <td>Seocalcitol</td>
      <td>LVLLALCJVJNGQQ-SEODYNFXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB13791</td>
      <td>Penfluridol</td>
      <td>MDLAAYDRRZXJIF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB04703</td>
      <td>Hesperidin</td>
      <td>QUQPHWDTPGMPEX-QJBIFVCTSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB04882</td>
      <td>Edotecarin</td>
      <td>QMVPQBFHUJZJCS-NTKFZFFISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB00997</td>
      <td>Doxorubicin</td>
      <td>AOJJSUZBOXZQNB-TZSSRYMLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB07031</td>
      <td>3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid</td>
      <td>AANFHDFOMFRLLR-LJQANCHMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB12665</td>
      <td>Isoquercetin</td>
      <td>OVSQVDMCBVZWGM-QSOFNFLRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB12186</td>
      <td>SRT-2104</td>
      <td>LAMQVIQMVKWXOC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB12477</td>
      <td>Perfluoro tert-butylcyclohexane</td>
      <td>VLTXBOGHSBHSAC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB07507</td>
      <td>2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</td>
      <td>ROMNEYAQUBNRLR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9q</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9q</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB02329</td>
      <td>Carbenoxolone</td>
      <td>OBZHEBDUNPOCJG-WBXJDKIVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12553</td>
      <td>Fluocinolone</td>
      <td>UUOUOERPONYGOS-CLCRDYEYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB15317</td>
      <td>Posiphen</td>
      <td>PBHFNBQPZCRWQP-AZUAARDMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08191</td>
      <td>4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid</td>
      <td>KSFDVNIKNYXUIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13555</td>
      <td>Prajmaline</td>
      <td>UAUHEPXILIZYCU-ALHOSYKFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB13556</td>
      <td>Sulfamazone</td>
      <td>BGLHAKAJGYLSOX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9q</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB04724</td>
      <td>(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE</td>
      <td>COVPLULNDBDXTN-KYJUHHDHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB15307</td>
      <td>Atabecestat</td>
      <td>VLLFGVHGKLDDLW-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lzg</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB03005</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium</td>
      <td>ISUOMOOYAOQQPZ-UHFFFAOYSA-O</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB12380</td>
      <td>GDC-0152</td>
      <td>WZRFLSDVFPIXOV-LRQRDZAKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06249</td>
      <td>Arzoxifene</td>
      <td>MCGDSOGUHLTADD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06362</td>
      <td>Becatecarin</td>
      <td>JSKFWUPVIZYJMR-UDOAKELVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13682</td>
      <td>Cefpirome</td>
      <td>DKOQGJHPHLTOJR-WHRDSVKCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB07141</td>
      <td>5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>QVXYJVHNRPNRJL-HNNXBMFYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB00966</td>
      <td>Telmisartan</td>
      <td>RMMXLENWKUUMAY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB03837</td>
      <td>Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide</td>
      <td>YUMYYTORLYHUFW-ZUDLOMHPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lzg</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB15431</td>
      <td>M-2698</td>
      <td>HXAUJHZZPCBFPN-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB04006</td>
      <td>[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone</td>
      <td>WUGJIPFLBOATGL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lzg</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB11562</td>
      <td>Bicuculline</td>
      <td>IYGYMKDQCDOMRE-ZWKOTPCHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB15408</td>
      <td>Silmitasertib</td>
      <td>MUOKSQABCJCOPU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w4h</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9q</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08402</td>
      <td>2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID</td>
      <td>VNDRRWBKNSHALL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB07204</td>
      <td>(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</td>
      <td>DQIXTEDFNFZMCM-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13185</td>
      <td>Oxabolone cipionate</td>
      <td>KHKDIUPVDIEHAH-KXLSUQFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lxt</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12483</td>
      <td>Copanlisib</td>
      <td>PZBCKZWLPGJMAO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m71</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6w9c</td>
      <td>DB00445</td>
      <td>Epirubicin</td>
      <td>AOJJSUZBOXZQNB-VTZDEGQISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6lzg</td>
      <td>DB15310</td>
      <td>Vactosertib</td>
      <td>FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13126</td>
      <td>BMS-986115</td>
      <td>SRJNRAQUSAVENA-GSHUGGBRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13101</td>
      <td>4SC-202</td>
      <td>PRXXYMVLYKJITB-IZZDOVSWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB00843</td>
      <td>Donepezil</td>
      <td>ADEBPBSSDYVVLD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13097</td>
      <td>1alpha-Hydroxyvitamin D5</td>
      <td>NWFOBODUYTUMNC-VPSCEVSQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6cs2</td>
      <td>DB15448</td>
      <td>Acumapimod</td>
      <td>VGUSQKZDZHAAEE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m2n</td>
      <td>DB04882</td>
      <td>Edotecarin</td>
      <td>QMVPQBFHUJZJCS-NTKFZFFISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>7bv1</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6m3m</td>
      <td>DB13240</td>
      <td>Cymarin</td>
      <td>XQCGNURMLWFQJR-ZNDDOCHDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB15219</td>
      <td>Tomivosertib</td>
      <td>HKTBYUWLRDZAJK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxx</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB04471</td>
      <td>2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>FMWVCTJKLAVRPB-MUUNZHRXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6vxs</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB08407</td>
      <td>PLATENSIMYCIN</td>
      <td>CSOMAHTTWTVBFL-OFBLZTNGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB06250</td>
      <td>Fluasterone</td>
      <td>VHZXNQKVFDBFIK-NBBHSKLNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB15170</td>
      <td>Evobrutinib</td>
      <td>QUIWHXQETADMGN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB12515</td>
      <td>9-aminocamptothecin</td>
      <td>FUXVKZWTXQUGMW-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.4</td>
      <td>6crv</td>
      <td>DB03471</td>
      <td>6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid</td>
      <td>SMNHQYPORNSAQH-HSZRJFAPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06955</td>
      <td>3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid</td>
      <td>OAMCCJASDLMTOO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB07031</td>
      <td>3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid</td>
      <td>AANFHDFOMFRLLR-LJQANCHMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07162</td>
      <td>4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide</td>
      <td>KFJCXIOVAGJCKB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB05983</td>
      <td>Bardoxolone methyl</td>
      <td>WPTTVJLTNAWYAO-KPOXMGGZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB12756</td>
      <td>TAK-901</td>
      <td>WKDACQVEJIVHMZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08096</td>
      <td>8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM</td>
      <td>ZWKOUFZHPNIQSH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07140</td>
      <td>5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>JPENSYBRTSIYGO-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB06976</td>
      <td>1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA</td>
      <td>IWOOJEZSDPRYAZ-WFASDCNBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07203</td>
      <td>6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE</td>
      <td>OUEGMEMDEAOAEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08073</td>
      <td>(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>YWTBGJGMTBHQTM-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07014</td>
      <td>2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole</td>
      <td>TUTZKAQTSPMEBI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB15173</td>
      <td>JNJ-42165279</td>
      <td>YWGYNGCRVZLMCS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB06454</td>
      <td>Sarizotan</td>
      <td>HKFMQJUJWSFOLY-OAQYLSRUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB07294</td>
      <td>3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid</td>
      <td>AANFHDFOMFRLLR-IBGZPJMESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03925</td>
      <td>Freselestat</td>
      <td>HMPQTEPEMQZWQH-QZTJIDSGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07212</td>
      <td>N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE</td>
      <td>NNGZRCYXFBHMRM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06933</td>
      <td>N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide</td>
      <td>GJTCKUKIFXWJKG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07229</td>
      <td>3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE</td>
      <td>MINVOLKUPZPDNX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12548</td>
      <td>Sparsentan</td>
      <td>WRFHGDPIDHPWIQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB07794</td>
      <td>5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</td>
      <td>XVECMUKVOMUNLE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB05239</td>
      <td>Cobimetinib</td>
      <td>BSMCAPRUBJMWDF-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB05408</td>
      <td>Emricasan</td>
      <td>SCVHJVCATBPIHN-SJCJKPOMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB07544</td>
      <td>N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE</td>
      <td>ZLQBZYKAQQWOTK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB04180</td>
      <td>4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide</td>
      <td>NTDFJEKGSGSXME-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB05465</td>
      <td>Tandutinib</td>
      <td>UXXQOJXBIDBUAC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02123</td>
      <td>Glycochenodeoxycholic Acid</td>
      <td>GHCZAUBVMUEKKP-GYPHWSFCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB13997</td>
      <td>Baloxavir marboxil</td>
      <td>RZVPBGBYGMDSBG-GGAORHGYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB06558</td>
      <td>Tezosentan</td>
      <td>TUYWTLTWNJOZNY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB11804</td>
      <td>AZD-5672</td>
      <td>SCXSQUUTGCWHFU-WJOKGBTCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB04125</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine</td>
      <td>ZUWBXGHMVKDMQO-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB05830</td>
      <td>Trestolone</td>
      <td>YSGQGNQWBLYHPE-CFUSNLFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB05959</td>
      <td>ENMD-1198</td>
      <td>YQJWOUQGXATDAE-ACNBBOPNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB12134</td>
      <td>Gepotidacin</td>
      <td>PZFAZQUREQIODZ-LJQANCHMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB05992</td>
      <td>Plinabulin</td>
      <td>UNRCMCRRFYFGFX-TYPNBTCFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02194</td>
      <td>8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>ULLMMKZQNNBLRN-SANMLTNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08990</td>
      <td>Eprazinone</td>
      <td>BSHWLCACYCVCJE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06144</td>
      <td>Sertindole</td>
      <td>GZKLJWGUPQBVJQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06174</td>
      <td>Noscapine</td>
      <td>AKNNEGZIBPJZJG-MSOLQXFVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02197</td>
      <td>4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide</td>
      <td>NKORVPQBJCGYEC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB15310</td>
      <td>Vactosertib</td>
      <td>FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB11864</td>
      <td>Preladenant</td>
      <td>DTYWJKSSUANMHD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB15197</td>
      <td>RSV-604</td>
      <td>MTPVBMVUENFFLL-HXUWFJFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB15193</td>
      <td>BMS-955176</td>
      <td>XDMUFNNPLXHNKA-ZTESCHFWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04759</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)</td>
      <td>GTBUZLPQANSGGE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07793</td>
      <td>(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>ACSGSLPOHKRZCY-GXTWGEPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07127</td>
      <td>{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID</td>
      <td>SXDBFKLPNPUPRI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04850</td>
      <td>Posizolid</td>
      <td>HBUJYEUPIIJJOS-PBHICJAKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB06677</td>
      <td>Clazosentan</td>
      <td>LFWCJABOXHSRGC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04861</td>
      <td>Nebivolol</td>
      <td>KOHIRBRYDXPAMZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB07653</td>
      <td>N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE</td>
      <td>VXTCEUDVOCLEJG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07133</td>
      <td>D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide</td>
      <td>CHKWABXWPATIIG-UXHICEINSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04879</td>
      <td>Vatalanib</td>
      <td>YCOYDOIWSSHVCK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04942</td>
      <td>Tamibarotene</td>
      <td>MUTNCGKQJGXKEM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07813</td>
      <td>GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE</td>
      <td>KCELZXZDIUJGNM-GUYCJALGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07141</td>
      <td>5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>QVXYJVHNRPNRJL-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07814</td>
      <td>Gibberellic acid</td>
      <td>IXORZMNAPKEEDV-OBDJNFEBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB12222</td>
      <td>Lurtotecan</td>
      <td>RVFGKBWWUQOIOU-NDEPHWFRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB08354</td>
      <td>2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>QCVULERVJOYHCP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06732</td>
      <td>beta-Naphthoflavone</td>
      <td>OUGIDAPQYNCXRA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08012</td>
      <td>(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE</td>
      <td>KCHIOGFOPPOUJC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB13101</td>
      <td>4SC-202</td>
      <td>PRXXYMVLYKJITB-IZZDOVSWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB02155</td>
      <td>Balanol Analog 8</td>
      <td>XVLMXAUKCDSMMW-YXLARRHKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB14810</td>
      <td>AZD-1656</td>
      <td>FJEJHJINOKKDCW-INIZCTEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06847</td>
      <td>5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>YYCPXVRHQUEVAW-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06871</td>
      <td>17-METHYL-17-ALPHA-DIHYDROEQUILENIN</td>
      <td>FQMQOMRDADWGJJ-GBESFXJTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB11773</td>
      <td>BMS-903452</td>
      <td>OGIAVRWXUPYGGC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB12563</td>
      <td>MK-0686</td>
      <td>WZZIQHIQMWJNLU-LLVKDONJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06919</td>
      <td>D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide</td>
      <td>CJHLRGCXPGIPCB-MOPGFXCFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB12571</td>
      <td>Rimacalib</td>
      <td>MYTIJGWONQOOLC-HNNXBMFYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06921</td>
      <td>(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID</td>
      <td>FNZHLCNFXRRIIC-RBUKOAKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB13042</td>
      <td>Fenoverine</td>
      <td>UBAJTZKNDCEGKL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06945</td>
      <td>N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide</td>
      <td>FOSWRYKPHVPIDJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB02354</td>
      <td>4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine</td>
      <td>IRKPNOLLMNHSOU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08922</td>
      <td>Perospirone</td>
      <td>FBVFZWUMDDXLLG-HDICACEKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06972</td>
      <td>7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile</td>
      <td>TZCXQSNBTXDAJG-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB04698</td>
      <td>N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</td>
      <td>HJWYZPGYPZNDTN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06977</td>
      <td>(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine</td>
      <td>CAASENZOSQYNPX-HSTJUUNISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB02449</td>
      <td>3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid</td>
      <td>ULOTXPTWJAUGGE-MHZLTWQESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB02498</td>
      <td>Carba-Nicotinamide-Adenine-Dinucleotide</td>
      <td>DGPLSUKWXXSBCU-VGXGLJSLSA-O</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07728</td>
      <td>2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>XJJYJNMNYDNXNO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB08993</td>
      <td>Enviomycin</td>
      <td>HPWIIERXAFODPP-GHBBWTPBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB09063</td>
      <td>Ceritinib</td>
      <td>VERWOWGGCGHDQE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07765</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>UKCFUFHREWUXJJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB12260</td>
      <td>Radiprodil</td>
      <td>GKGRZLGAQZPEHO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06267</td>
      <td>Udenafil</td>
      <td>IYFNEFQTYQPVOC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB12523</td>
      <td>Mizolastine</td>
      <td>PVLJETXTTWAYEW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06268</td>
      <td>Sitaxentan</td>
      <td>PHWXUGHIIBDVKD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB07326</td>
      <td>6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</td>
      <td>FEGRQUWSKADGSP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02217</td>
      <td>Dpb-T</td>
      <td>WTZFKHNHHRPQOU-WSMBLCCSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06302</td>
      <td>Glesatinib</td>
      <td>YRCHYHRCBXNYNU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB07321</td>
      <td>2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE</td>
      <td>KOKQLKWXOFRTHE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08911</td>
      <td>Trametinib</td>
      <td>LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB13791</td>
      <td>Penfluridol</td>
      <td>MDLAAYDRRZXJIF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB06833</td>
      <td>1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE</td>
      <td>MMIJMYOYKAKQPN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB06521</td>
      <td>Ertiprotafib</td>
      <td>FONCZICQWCUXEB-RUZDIDTESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB11832</td>
      <td>Crenolanib</td>
      <td>DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02259</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide</td>
      <td>VSYGXLAJQDAWCZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07742</td>
      <td>N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE</td>
      <td>QASSMVGOSBNFQY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06597</td>
      <td>Estradiol sulfamate</td>
      <td>YXYXCSOJKUAPJI-ZBRFXRBCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB06311</td>
      <td>Darapladib</td>
      <td>WDPFJWLDPVQCAJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07263</td>
      <td>[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid</td>
      <td>WDTMVBQZDFMOIK-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02573</td>
      <td>2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate</td>
      <td>LYWWDKIADIGKTH-IDMWBNCISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03916</td>
      <td>4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine</td>
      <td>RHOOHUMOHVIXEF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13865</td>
      <td>Dehydroemetine</td>
      <td>XXLZPUYGHQWHRN-RPBOFIJWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB15442</td>
      <td>Trilaciclib</td>
      <td>PDGKHKMBHVFCMG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03495</td>
      <td>4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1-&gt;4)-Alpha-D-Threo-Hexopyranosyl-(1-&gt;6)-Alpha-L-Threo-Hexopyranose</td>
      <td>FZLCJZILHGFQLM-PISLJJGOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13793</td>
      <td>Vinburnine</td>
      <td>WYJAPUKIYAZSEM-MOPGFXCFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB00206</td>
      <td>Reserpine</td>
      <td>QEVHRUUCFGRFIF-MDEJGZGSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB11712</td>
      <td>Tezacaftor</td>
      <td>MJUVRTYWUMPBTR-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB00223</td>
      <td>Diflorasone</td>
      <td>WXURHACBFYSXBI-XHIJKXOTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02882</td>
      <td>Cyanocinnoline</td>
      <td>CUWRVIIPSSUUDJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07395</td>
      <td>4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid</td>
      <td>NWQGDIBCFLDHDO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08513</td>
      <td>[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID</td>
      <td>PAIQRYUOBBCBSE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB11795</td>
      <td>GSK-2636771</td>
      <td>XTKLTGBKIDQGQL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13667</td>
      <td>Cefozopran</td>
      <td>QDUIJCOKQCCXQY-WHJQOFBOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB02691</td>
      <td>Glycocholic acid</td>
      <td>RFDAIACWWDREDC-FRVQLJSFSA-M</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB07404</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>YXQQNSYZOQHKHD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13631</td>
      <td>Methoserpidine</td>
      <td>ULBNWNUHGJLQHO-VKMIBBQISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03005</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium</td>
      <td>ISUOMOOYAOQQPZ-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13563</td>
      <td>Norgestrienone</td>
      <td>GVDMJXQHPUYPHP-FYQPLNBISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB00324</td>
      <td>Fluorometholone</td>
      <td>FAOZLTXFLGPHNG-KNAQIMQKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03472</td>
      <td>Cyclohexyl-Hexyl-Beta-D-Maltoside</td>
      <td>WUCWJXGMSXTDAV-QKMCSOCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB11867</td>
      <td>JNJ-39393406</td>
      <td>IURMHZBQEYNQOH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB11901</td>
      <td>Apalutamide</td>
      <td>HJBWBFZLDZWPHF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07584</td>
      <td>N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine</td>
      <td>OKGCSZUKOGMZAL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB06163</td>
      <td>Plevitrexed</td>
      <td>IEJSCSAMMLUINT-NRFANRHFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB11694</td>
      <td>Ilorasertib</td>
      <td>WPHKIQPVPYJNAX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB11679</td>
      <td>Fruquintinib</td>
      <td>BALLNEJQLSTPIO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB03903</td>
      <td>Tmr</td>
      <td>KGFLZYXDJDOIEE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB09063</td>
      <td>Ceritinib</td>
      <td>VERWOWGGCGHDQE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB03791</td>
      <td>(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid</td>
      <td>NAXSRXHZFIBFMI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB07845</td>
      <td>2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide</td>
      <td>VGYXXQRDIVRILX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07337</td>
      <td>4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE</td>
      <td>SOKOHDQTKSROQZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08353</td>
      <td>2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>NCVMTHVSAJMOPI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02804</td>
      <td>A-98881</td>
      <td>PMBZSBGCSQGJAQ-GRKNLSHJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB07835</td>
      <td>N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide</td>
      <td>BOPSUAHGQHFKGG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13484</td>
      <td>Quinbolone</td>
      <td>IUVKMZGDUIUOCP-BTNSXGMBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB09230</td>
      <td>Azelnidipine</td>
      <td>ZKFQEACEUNWPMT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02833</td>
      <td>[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine</td>
      <td>DYTKVFHLKPDNRW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB09534</td>
      <td>Ecamsule</td>
      <td>HEAHZSUCFKFERC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB03460</td>
      <td>Violaxanthin</td>
      <td>SZCBXWMUOPQSOX-WVJDLNGLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB07362</td>
      <td>1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>UOLCZAFAGDOUFX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB06626</td>
      <td>Axitinib</td>
      <td>RITAVMQDGBJQJZ-FMIVXFBMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB06635</td>
      <td>Otamixaban</td>
      <td>PFGVNLZDWRZPJW-OPAMFIHVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07588</td>
      <td>3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID</td>
      <td>FZDVNXHYGMEEDT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02861</td>
      <td>4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide</td>
      <td>DEHMSTGBNAXEGX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB06809</td>
      <td>Plerixafor</td>
      <td>YIQPUIGJQJDJOS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13874</td>
      <td>Enasidenib</td>
      <td>DYLUUSLLRIQKOE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07409</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>MPBUFKZCEBTBSK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB11923</td>
      <td>Decoglurant</td>
      <td>DMJHZVARRXJSEG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03041</td>
      <td>UDP-alpha-D-glucuronic acid</td>
      <td>HDYANYHVCAPMJV-LXQIFKJMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB07369</td>
      <td>N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide</td>
      <td>YMJLSOJLEXWATP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB00836</td>
      <td>Loperamide</td>
      <td>RDOIQAHITMMDAJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12823</td>
      <td>Tecarfarin</td>
      <td>QFLNTQDOVCLQKW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12368</td>
      <td>AZD-3839</td>
      <td>MRXBCEQZNKUUIP-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12371</td>
      <td>Siponimod</td>
      <td>KIHYPELVXPAIDH-HNSNBQBZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB07519</td>
      <td>(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</td>
      <td>VDFBMQAUECXNKR-OAQYLSRUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12798</td>
      <td>Relenopride</td>
      <td>KGMMSPVVHZGPHL-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07471</td>
      <td>5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE</td>
      <td>UHCHLTQBLNUYRT-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB00948</td>
      <td>Mezlocillin</td>
      <td>YPBATNHYBCGSSN-VWPFQQQWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12345</td>
      <td>MBX-2982</td>
      <td>NFTMKHWBOINJGM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12706</td>
      <td>Seletalisib</td>
      <td>LNLJHGXOFYUARS-OAQYLSRUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12447</td>
      <td>Nadifloxacin</td>
      <td>JYJTVFIEFKZWCJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12461</td>
      <td>GLPG-0492</td>
      <td>VAJGULUVTFDTAS-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03239</td>
      <td>3',5'-Dinitro-N-Acetyl-L-Thyronine</td>
      <td>VZSQTOXQXPKQJX-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12494</td>
      <td>SGI-1776</td>
      <td>MHXGEROHKGDZGO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08481</td>
      <td>4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE</td>
      <td>MXAPQGDBWFYKKX-ZROIWOOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12567</td>
      <td>Camicinal</td>
      <td>RZKDEGZIFSJVNA-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07486</td>
      <td>3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline</td>
      <td>KLSZVPNVFKKIRD-FNORWQNLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB04030</td>
      <td>1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole</td>
      <td>ADXYEWMDAGIULV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07467</td>
      <td>4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide</td>
      <td>NDDAHWYSQHTHNT-JTQLQIEISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13386</td>
      <td>Epimestrol</td>
      <td>UHQGCIIQUZBJAE-RRQVMCLOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB11951</td>
      <td>Lemborexant</td>
      <td>MUGXRYIUWFITCP-PGRDOPGGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB02123</td>
      <td>Glycochenodeoxycholic Acid</td>
      <td>GHCZAUBVMUEKKP-GYPHWSFCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB07031</td>
      <td>3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid</td>
      <td>AANFHDFOMFRLLR-LJQANCHMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12010</td>
      <td>Fostamatinib</td>
      <td>GKDRMWXFWHEQQT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB08242</td>
      <td>N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide</td>
      <td>OYTBZXSFNNAVKU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13129</td>
      <td>Trimegestone</td>
      <td>JUNDJWOLDSCTFK-MTZCLOFQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12025</td>
      <td>Triptolide</td>
      <td>DFBIRQPKNDILPW-CIVMWXNOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12081</td>
      <td>Anecortave</td>
      <td>BCFCRXOJOFDUMZ-ONKRVSLGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07546</td>
      <td>[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid</td>
      <td>BBYRUZKRFAIQSR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13078</td>
      <td>KOSN-1724</td>
      <td>JAYGOFBXDFAXBW-CYEKYUJNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13074</td>
      <td>Macimorelin</td>
      <td>UJVDJAPJQWZRFR-DHIUTWEWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB00591</td>
      <td>Fluocinolone acetonide</td>
      <td>FEBLZLNTKCEFIT-VSXGLTOVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB07186</td>
      <td>4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE</td>
      <td>TYYNSDQVFIOSFH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB13029</td>
      <td>MK-0873</td>
      <td>JJWKQXNHYDJXKF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12222</td>
      <td>Lurtotecan</td>
      <td>RVFGKBWWUQOIOU-NDEPHWFRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB15046</td>
      <td>LY-2881835</td>
      <td>FHRWHNJJQGSCQC-LJAQVGFWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02046</td>
      <td>N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid</td>
      <td>WHPKSASOSKNDPY-PKOBYXMFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12252</td>
      <td>PG-701</td>
      <td>OKRSVUYYCJPECG-LFGMFVMYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12952</td>
      <td>Methylprednisone</td>
      <td>SVYCRJXQZUCUND-PQXSVQADSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03173</td>
      <td>CRA_10433</td>
      <td>CFSQPEBVGUSQII-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB12308</td>
      <td>Eltanolone</td>
      <td>AURFZBICLPNKBZ-YZRLXODZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB07181</td>
      <td>4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</td>
      <td>JYKFWUXBFJJDTP-HXUWFJFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB04040</td>
      <td>N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide</td>
      <td>MCMWCTMAKPQTPI-WGNYYXNJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB04042</td>
      <td>2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol</td>
      <td>XLJNZONSWKENRP-VABIIVNOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07697</td>
      <td>1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine</td>
      <td>HMGDKYUJSFVHIY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08233</td>
      <td>6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE</td>
      <td>RFSDQDHHBKYQOD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB13059</td>
      <td>PF-03814735</td>
      <td>RYYNGWLOYLRZLK-RBUKOAKNSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08242</td>
      <td>N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide</td>
      <td>OYTBZXSFNNAVKU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06314</td>
      <td>SGX-523</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB06314</td>
      <td>SGX-523</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07792</td>
      <td>(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>VUKPNWLGSLOHIF-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08272</td>
      <td>(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID</td>
      <td>YDWIUFASTTZKNI-UONOGXRCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07794</td>
      <td>5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</td>
      <td>XVECMUKVOMUNLE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06420</td>
      <td>Annamycin</td>
      <td>CIDNKDMVSINJCG-GKXONYSUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB15448</td>
      <td>Acumapimod</td>
      <td>VGUSQKZDZHAAEE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07813</td>
      <td>GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE</td>
      <td>KCELZXZDIUJGNM-GUYCJALGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB15393</td>
      <td>Telatinib</td>
      <td>QFCXANHHBCGMAS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07832</td>
      <td>4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde</td>
      <td>VKQPTVJDZIILPG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06229</td>
      <td>Ocaperidone</td>
      <td>ZZQNEJILGNNOEP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB15358</td>
      <td>JNJ-54175446</td>
      <td>CWFVVQFVGMFTBD-SECBINFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07861</td>
      <td>(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide</td>
      <td>MMOUXLMPQFMDRD-JOCHJYFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07680</td>
      <td>[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</td>
      <td>HUJXISJLAPAFBO-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07891</td>
      <td>4-{[(14beta,17alpha)-3-hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid</td>
      <td>YJPIDPAGJSWWBE-FNIAAEIWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07941</td>
      <td>PH-797804</td>
      <td>KCAJXIDMCNPGHZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07949</td>
      <td>({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID</td>
      <td>BFQRPTKOSYMPOL-LALPNIDTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06263</td>
      <td>Amrubicin</td>
      <td>VJZITPJGSQKZMX-XDPRQOKASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07965</td>
      <td>6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile</td>
      <td>OGODDSLNRULSMM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB01336</td>
      <td>Metocurine</td>
      <td>JFXBEKISTKFVAB-AJQTZOPKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07630</td>
      <td>N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-IAGOWNOFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07274</td>
      <td>N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide</td>
      <td>ZATGFXTWDKIEKC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06721</td>
      <td>Gimatecan</td>
      <td>UIVFUQKYVFCEKJ-OPTOVBNMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08860</td>
      <td>Pitavastatin</td>
      <td>VGYFMXBACGZSIL-MCBHFWOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB12694</td>
      <td>CE-326597</td>
      <td>UBNMGTSDHSQBEL-PMERELPUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB11652</td>
      <td>Tucatinib</td>
      <td>SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB04609</td>
      <td>INHIBITOR Q8467 OF DUPONT MERCK</td>
      <td>HFLCERPZYCWLSZ-VKONIRKNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06673</td>
      <td>Almorexant</td>
      <td>DKMACHNQISHMDN-RPLLCQBOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07354</td>
      <td>2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM</td>
      <td>LXDREMZQGAILJU-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07362</td>
      <td>1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>UOLCZAFAGDOUFX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB07076</td>
      <td>6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</td>
      <td>FWTQOPWAMQXIMI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB12644</td>
      <td>AZD-2066</td>
      <td>SXWHYTICXCLKDG-GFCCVEGCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07403</td>
      <td>4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE</td>
      <td>DTDZLJHKVNTQGZ-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB06455</td>
      <td>Meclinertant</td>
      <td>DYLJVOXRWLXDIG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07404</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>YXQQNSYZOQHKHD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB15137</td>
      <td>VK-2809</td>
      <td>LGGPZDRLTDGYSQ-JADSYQMUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07434</td>
      <td>HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE</td>
      <td>TZWQPWGUQCSKDW-GUYCJALGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07544</td>
      <td>N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE</td>
      <td>ZLQBZYKAQQWOTK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07546</td>
      <td>[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid</td>
      <td>BBYRUZKRFAIQSR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB12465</td>
      <td>Ketanserin</td>
      <td>FPCCSQOGAWCVBH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07578</td>
      <td>3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE</td>
      <td>WUOLYUKMMRCXGH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB02009</td>
      <td>L-756,423</td>
      <td>AOMZDQMIOCTPQP-QHQMVRJISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07588</td>
      <td>3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID</td>
      <td>FZDVNXHYGMEEDT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07608</td>
      <td>N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</td>
      <td>JDGOPNUGILVNJZ-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB07270</td>
      <td>N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE</td>
      <td>GAYYMURZGLJDCT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08493</td>
      <td>5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID</td>
      <td>AKWKBACKRMYPRV-NQIIRXRSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB04424</td>
      <td>RPR128515</td>
      <td>XFKVLKLCLYJKNF-MZNJEOGPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08572</td>
      <td>4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE</td>
      <td>YBKLJTXDSBEVRV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08622</td>
      <td>4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL</td>
      <td>KVDKNVPAAQKHKD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03701</td>
      <td>Vanoxerine</td>
      <td>NAUWTFJOPJWYOT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08597</td>
      <td>6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine</td>
      <td>XHBVYDAKJHETMP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB04514</td>
      <td>Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester</td>
      <td>DFYLLEBFVZTKHD-VMIOUTBZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB14866</td>
      <td>Amcasertib</td>
      <td>QDWKGEFGLQMDAM-ULJHMMPZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB14822</td>
      <td>SB-649868</td>
      <td>ZJXIUGNEAIHSBI-IBGZPJMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB14840</td>
      <td>Ripretinib</td>
      <td>CEFJVGZHQAGLHS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08739</td>
      <td>2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione</td>
      <td>ZSXNPAWXICXNGZ-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB14729</td>
      <td>Rebeccamycin</td>
      <td>QEHOIJJIZXRMAN-QZQSLCQPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB14716</td>
      <td>Clonazolam</td>
      <td>XJRGLCAWBRZUFC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08750</td>
      <td>1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE</td>
      <td>SFPCNWQWKOUNRT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB14644</td>
      <td>Methylprednisolone hemisuccinate</td>
      <td>IMBXEJJVJRTNOW-XYMSELFBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08864</td>
      <td>Rilpivirine</td>
      <td>YIBOMRUWOWDFLG-ONEGZZNKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB14641</td>
      <td>Estriol tripropionate</td>
      <td>ONMZMZJEZHMWQL-REUUDLSRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB15227</td>
      <td>Tirabrutinib</td>
      <td>SEJLPXCPMNSRAM-GOSISDBHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB07326</td>
      <td>6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</td>
      <td>FEGRQUWSKADGSP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08905</td>
      <td>Formestane</td>
      <td>OSVMTWJCGUFAOD-KZQROQTASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB14790</td>
      <td>BPN-14770</td>
      <td>KRRGWHSEDYQKDQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08300</td>
      <td>1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>UOKGZPYGRJDACN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB15031</td>
      <td>Nemorexant</td>
      <td>NBGABHGMJVIVBW-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB14821</td>
      <td>Macozinone</td>
      <td>BJDZBXGJNBMCAV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08005</td>
      <td>4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide</td>
      <td>ARMFMDYRYOKSOW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB15282</td>
      <td>Fluorofuranylnorprogesterone F-18</td>
      <td>VJKRBRUNEOHPBS-JQKUZGBFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB05611</td>
      <td>Apilimod</td>
      <td>HSKAZIJJKRAJAV-KOEQRZSOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07269</td>
      <td>(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID</td>
      <td>SFUOOKBZBVUDBC-VQTJNVASSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08043</td>
      <td>1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>DDDLGNOZDKDSEG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB15266</td>
      <td>TAK-580</td>
      <td>VWMJHAFYPMOMGF-ZCFIWIBFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB15246</td>
      <td>Salvianolic acid A</td>
      <td>YMGFTDKNIWPMGF-UCPJVGPRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB05482</td>
      <td>7-ethyl-10-hydroxycamptothecin</td>
      <td>FJHBVJOVLFPMQE-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB08710</td>
      <td>(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE</td>
      <td>BKZOQCGDCHOGOQ-MZLJFPOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB02616</td>
      <td>FR117016</td>
      <td>CKJGKHXCUDWFDC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB11923</td>
      <td>Decoglurant</td>
      <td>DMJHZVARRXJSEG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB04708</td>
      <td>(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>SYNSHNDQFWMLJW-YZGRCXSVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08197</td>
      <td>(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime</td>
      <td>KYIXUSLGFINPTC-WVFAEZDRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08241</td>
      <td>4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE</td>
      <td>RUUOIINPNMNPIU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08248</td>
      <td>3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE</td>
      <td>BKDUVKJYBJDZQW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03758</td>
      <td>Radicicol</td>
      <td>WYZWZEOGROVVHK-GTMNPGAYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03755</td>
      <td>Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate</td>
      <td>ARRGHMSEJJFDME-IOSLPCCCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB07991</td>
      <td>N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE</td>
      <td>APLJSSOXDWUNGV-GOSISDBHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07664</td>
      <td>5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE</td>
      <td>ARIOBGGRZJITQX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07663</td>
      <td>2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID</td>
      <td>QISJEFYTLZTWIQ-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB08389</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UPTQSRGSSJRBKJ-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB03744</td>
      <td>Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate</td>
      <td>RONLONYAIBUEKT-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB07969</td>
      <td>3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol</td>
      <td>QNCYYRHIUFGGJX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB11855</td>
      <td>Revefenacin</td>
      <td>FYDWDCIFZSGNBU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB00737</td>
      <td>Meclizine</td>
      <td>OCJYIGYOJCODJL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB15232</td>
      <td>Telaglenastat</td>
      <td>PRAAPINBUWJLGA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB15444</td>
      <td>Elexacaftor</td>
      <td>MVRHVFSOIWFBTE-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB11965</td>
      <td>SJG-136</td>
      <td>RWZVMMQNDHPRQD-SFTDATJTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB05351</td>
      <td>Dexlansoprazole</td>
      <td>MJIHNNLFOKEZEW-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB03311</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</td>
      <td>SXKBTDJJEQQEGE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB13791</td>
      <td>Penfluridol</td>
      <td>MDLAAYDRRZXJIF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB11949</td>
      <td>Vestipitant</td>
      <td>SBBYBXSFWOLDDG-JLTOFOAXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB11614</td>
      <td>Rupatadine</td>
      <td>WUZYKBABMWJHDL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB11968</td>
      <td>MK-7145</td>
      <td>OCKGFTQIICXDQW-ZEQRLZLVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12020</td>
      <td>Tecovirimat</td>
      <td>CSKDFZIMJXRJGH-VWLPUNTISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01238</td>
      <td>Aripiprazole</td>
      <td>CEUORZQYGODEFX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB11960</td>
      <td>Carboxyamidotriazole</td>
      <td>WNRZHQBJSXRYJK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13062</td>
      <td>ME-344</td>
      <td>QVCAATSEPLQVBX-FPOVZHCZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12303</td>
      <td>Motolimod</td>
      <td>QSPOQCXMGPDIHI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12320</td>
      <td>Palovarotene</td>
      <td>YTFHCXIPDIHOIA-DHZHZOJOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13088</td>
      <td>AZD-0424</td>
      <td>MVWATCATLSSVBH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB07270</td>
      <td>N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE</td>
      <td>GAYYMURZGLJDCT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB06558</td>
      <td>Tezosentan</td>
      <td>TUYWTLTWNJOZNY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB13089</td>
      <td>Enoxolone</td>
      <td>MPDGHEJMBKOTSU-YKLVYJNSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12432</td>
      <td>CC-401</td>
      <td>XDJCLCLBSGGNKS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB05414</td>
      <td>Pipendoxifene</td>
      <td>JICOGKJOQXTAIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB07254</td>
      <td>N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</td>
      <td>KQGTYXRWSIBDOZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB07253</td>
      <td>N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</td>
      <td>QTFCKBFCXDAZIU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB13874</td>
      <td>Enasidenib</td>
      <td>DYLUUSLLRIQKOE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13002</td>
      <td>HKI-357</td>
      <td>NERXPXBELDBEPZ-RMKNXTFCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB08068</td>
      <td>N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</td>
      <td>YQJVDUKATDECHF-ICSRJNTNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB08058</td>
      <td>4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one</td>
      <td>HGEPGGJUGUMFHT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB15197</td>
      <td>RSV-604</td>
      <td>MTPVBMVUENFFLL-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06578</td>
      <td>Tonabersat</td>
      <td>XLIIRNOPGJTBJD-ROUUACIJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB06817</td>
      <td>Raltegravir</td>
      <td>CZFFBEXEKNGXKS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB09291</td>
      <td>Rolapitant</td>
      <td>FIVSJYGQAIEMOC-ZGNKEGEESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB00396</td>
      <td>Progesterone</td>
      <td>RJKFOVLPORLFTN-LEKSSAKUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB08011</td>
      <td>(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DXIHOIDYHQSQKJ-HMMYKYKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12024</td>
      <td>PF-04418948</td>
      <td>LWJGMYMNSNVCEM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12937</td>
      <td>Quercetin-3'-O-phosphate</td>
      <td>UWJBYNLLMAPJMM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB15442</td>
      <td>Trilaciclib</td>
      <td>PDGKHKMBHVFCMG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB15265</td>
      <td>USL-311</td>
      <td>XNUNVQKARNSSEO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB11562</td>
      <td>Bicuculline</td>
      <td>IYGYMKDQCDOMRE-ZWKOTPCHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06518</td>
      <td>R-1487</td>
      <td>KKKRKRMVJRHDMG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB07993</td>
      <td>N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>LPQUIIHPUGDHJK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12015</td>
      <td>Alpelisib</td>
      <td>STUWGJZDJHPWGZ-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB15275</td>
      <td>GDC-0077</td>
      <td>SGEUNORSOZVTOL-CABZTGNLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB04154</td>
      <td>N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</td>
      <td>ALBWBHNFOJJMCV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB13953</td>
      <td>Estradiol benzoate</td>
      <td>UYIFTLBWAOGQBI-BZDYCCQFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB07698</td>
      <td>3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine</td>
      <td>JDNMRPIWJIDDAY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB11819</td>
      <td>ASP-4058</td>
      <td>NJNXCJPSMWKXHO-VIFPVBQESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB11845</td>
      <td>Lucitanib</td>
      <td>CUDVHEFYRIWYQD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB14793</td>
      <td>RO-5045337</td>
      <td>QBGKPEROWUKSBK-QPPIDDCLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12524</td>
      <td>BI-671800</td>
      <td>XEOSTBFUCNZKGS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB12760</td>
      <td>GW-493838</td>
      <td>ZQYJPMPXQLNTPQ-QCUYGVNKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB13212</td>
      <td>Phenolsulfonphthalein</td>
      <td>BELBBZDIHDAJOR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB11853</td>
      <td>Relugolix</td>
      <td>AOMXMOCNKJTRQP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB07141</td>
      <td>5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>QVXYJVHNRPNRJL-HNNXBMFYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB11829</td>
      <td>Ruboxistaurin</td>
      <td>ZCBUQCWBWNUWSU-SFHVURJKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB13422</td>
      <td>Nicofuranose</td>
      <td>FUWFSXZKBMCSKF-ZASNTINBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB05611</td>
      <td>Apilimod</td>
      <td>HSKAZIJJKRAJAV-KOEQRZSOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB13506</td>
      <td>Carfecillin</td>
      <td>NZDASSHFKWDBBU-KVMCETHSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB11794</td>
      <td>Berzosertib</td>
      <td>JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13418</td>
      <td>Moxestrol</td>
      <td>MTMZZIPTQITGCY-OLGWUGKESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB13931</td>
      <td>Netarsudil</td>
      <td>OURRXQUGYQRVML-AREMUKBSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB13089</td>
      <td>Enoxolone</td>
      <td>MPDGHEJMBKOTSU-YKLVYJNSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB11814</td>
      <td>PF-03882845</td>
      <td>XNULRSOGWPFPBL-REWPJTCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB05414</td>
      <td>Pipendoxifene</td>
      <td>JICOGKJOQXTAIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB14625</td>
      <td>Meprednisone acetate</td>
      <td>RZAMUHXEOMZXET-ABQXZQTJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB14627</td>
      <td>Oxyphenisatin acetate</td>
      <td>PHPUXYRXPHEJDF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB11794</td>
      <td>Berzosertib</td>
      <td>JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB09183</td>
      <td>Dasabuvir</td>
      <td>NBRBXGKOEOGLOI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13434</td>
      <td>Fenticonazole</td>
      <td>ZCJYUTQZBAIHBS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB11789</td>
      <td>Hyodeoxycholic Acid</td>
      <td>DGABKXLVXPYZII-SIBKNCMHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB14664</td>
      <td>Difluocortolone pivalate</td>
      <td>UWGRWFCLGQWKPR-GSTUPEFVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB04698</td>
      <td>N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</td>
      <td>HJWYZPGYPZNDTN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB14790</td>
      <td>BPN-14770</td>
      <td>KRRGWHSEDYQKDQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB14885</td>
      <td>PF-05180999</td>
      <td>CLGCHUKGBICQTE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB08730</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</td>
      <td>CPFBZMFUCGHBAP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB00991</td>
      <td>Oxaprozin</td>
      <td>OFPXSFXSNFPTHF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB13062</td>
      <td>ME-344</td>
      <td>QVCAATSEPLQVBX-FPOVZHCZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB13055</td>
      <td>Oteseconazole</td>
      <td>IDUYJRXRDSPPRC-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB11910</td>
      <td>MK-0249</td>
      <td>DDDZBLNULGDPGA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB07215</td>
      <td>2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID</td>
      <td>ILUPZUOBHCUBKB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12627</td>
      <td>GSK-1292263</td>
      <td>AYJRTVVIBJSSKN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12649</td>
      <td>Ibipinabant</td>
      <td>AXJQVVLKUYCICH-OAQYLSRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12659</td>
      <td>SJ-733</td>
      <td>VKCPFWKTFZAOTO-LEWJYISDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB12774</td>
      <td>AZD-8055</td>
      <td>KVLFRAWTRWDEDF-IRXDYDNUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01380</td>
      <td>Cortisone acetate</td>
      <td>ITRJWOMZKQRYTA-RFZYENFJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB13053</td>
      <td>CP-195543</td>
      <td>NZQDWKCNBOELAI-KSFYIVLOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB13060</td>
      <td>CEP-37440</td>
      <td>BCSHRERPHLTPEE-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12720</td>
      <td>Nivocasan</td>
      <td>VYFGDLGHHBUDTQ-ZLGUVYLKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01392</td>
      <td>Yohimbine</td>
      <td>BLGXFZZNTVWLAY-SCYLSFHTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12823</td>
      <td>Tecarfarin</td>
      <td>QFLNTQDOVCLQKW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB12368</td>
      <td>AZD-3839</td>
      <td>MRXBCEQZNKUUIP-DEOSSOPVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13327</td>
      <td>Picotamide</td>
      <td>KYWCWBXGRWWINE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB07064</td>
      <td>(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE</td>
      <td>HPVCRUIDFODATB-LJQANCHMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB11867</td>
      <td>JNJ-39393406</td>
      <td>IURMHZBQEYNQOH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4b</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB13002</td>
      <td>HKI-357</td>
      <td>NERXPXBELDBEPZ-RMKNXTFCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06281</td>
      <td>Torcetrapib</td>
      <td>CMSGWTNRGKRWGS-NQIIRXRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB12764</td>
      <td>ABC-294640</td>
      <td>CAOTVXGYTWCKQE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01149</td>
      <td>Nefazodone</td>
      <td>VRBKIVRKKCLPHA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB03583</td>
      <td>(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</td>
      <td>AYOAIABDFUJDKQ-SQJPUDIVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB00549</td>
      <td>Zafirlukast</td>
      <td>YEEZWCHGZNKEEK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB13029</td>
      <td>MK-0873</td>
      <td>JJWKQXNHYDJXKF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB01678</td>
      <td>RU84687</td>
      <td>SAFPHFWYRLLBFO-NSOVKSMOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB03671</td>
      <td>4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>SHIBSTMRCDJXLN-KCZCNTNESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB07025</td>
      <td>3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</td>
      <td>KBIHHEGEALBUMT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB03583</td>
      <td>(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</td>
      <td>AYOAIABDFUJDKQ-SQJPUDIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12644</td>
      <td>AZD-2066</td>
      <td>SXWHYTICXCLKDG-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9q</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9q</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12361</td>
      <td>Piclozotan</td>
      <td>URMTUEWUIGOJBW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB03447</td>
      <td>Uridylyl-2'-5'-Phospho-Adenosine</td>
      <td>QARCCHXXGAIRFS-KPKSGTNCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB12138</td>
      <td>PF-03715455</td>
      <td>VGEXRDWWPSGZDH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9q</td>
      <td>DB03480</td>
      <td>Brequinar Analog</td>
      <td>WYKKHJQZENLZID-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB03383</td>
      <td>5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide</td>
      <td>YDCGVASFVACWKF-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB00713</td>
      <td>Oxacillin</td>
      <td>UWYHMGVUTGAWSP-JKIFEVAISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB12120</td>
      <td>Avoralstat</td>
      <td>TUWMKPVJGGWGNL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB00700</td>
      <td>Eplerenone</td>
      <td>JUKPWJGBANNWMW-VWBFHTRKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB07369</td>
      <td>N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide</td>
      <td>YMJLSOJLEXWATP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12308</td>
      <td>Eltanolone</td>
      <td>AURFZBICLPNKBZ-YZRLXODZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB07393</td>
      <td>2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE</td>
      <td>GSKNNHAAFLPYHG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12306</td>
      <td>Cipargamin</td>
      <td>CKLPLPZSUQEDRT-WPCRTTGESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12302</td>
      <td>CP-724714</td>
      <td>LLVZBTWPGQVVLW-SNAWJCMRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB11855</td>
      <td>Revefenacin</td>
      <td>FYDWDCIFZSGNBU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB07430</td>
      <td>(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one</td>
      <td>CMWRPDHVGMHLSZ-GFCCVEGCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB07460</td>
      <td>2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE</td>
      <td>UYJNQQDJUOUFQJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB07253</td>
      <td>N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</td>
      <td>QTFCKBFCXDAZIU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB00737</td>
      <td>Meclizine</td>
      <td>OCJYIGYOJCODJL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB04698</td>
      <td>N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</td>
      <td>HJWYZPGYPZNDTN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB05171</td>
      <td>E-2012</td>
      <td>PUOAETJYKQITMO-LANLRWRYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB00834</td>
      <td>Mifepristone</td>
      <td>VKHAHZOOUSRJNA-GCNJZUOMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB05327</td>
      <td>Ranirestat</td>
      <td>QCVNMNYRNIMDKV-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB00844</td>
      <td>Nalbuphine</td>
      <td>NETZHAKZCGBWSS-CEDHKZHLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB05616</td>
      <td>4'-Methylene-5,8,10-trideazaaminopterin</td>
      <td>NAWXUBYGYWOOIX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12532</td>
      <td>Oxetacaine</td>
      <td>FTLDJPRFCGDUFH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB04760</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)</td>
      <td>PYFRREJCFXFNRR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB05835</td>
      <td>NS-3728</td>
      <td>OQRAKHDEGGGWQO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB12434</td>
      <td>Steviolbioside</td>
      <td>OMHUCGDTACNQEX-OSHKXICASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9q</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12447</td>
      <td>Nadifloxacin</td>
      <td>JYJTVFIEFKZWCJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB13019</td>
      <td>Henatinib</td>
      <td>MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12443</td>
      <td>Sonedenoson</td>
      <td>WUCQGGOGHZRELS-LSCFUAHRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB01705</td>
      <td>Bis(5-Amidino-Benzimidazolyl)Methane</td>
      <td>QZKOOEFIMWKZPK-UHFFFAOYSA-Q</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12434</td>
      <td>Steviolbioside</td>
      <td>OMHUCGDTACNQEX-OSHKXICASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB06346</td>
      <td>Fiboflapon</td>
      <td>DFQGDHBGRSTTHX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB12960</td>
      <td>INCB-9471</td>
      <td>ZMCJFJZOSKEMOM-DNKZPPIMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB06401</td>
      <td>Bazedoxifene</td>
      <td>UCJGJABZCDBEDK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB06518</td>
      <td>R-1487</td>
      <td>KKKRKRMVJRHDMG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB06543</td>
      <td>Astaxanthin</td>
      <td>MQZIGYBFDRPAKN-UWFIBFSHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB06589</td>
      <td>Pazopanib</td>
      <td>CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9q</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB06786</td>
      <td>Halcinonide</td>
      <td>MUQNGPZZQDCDFT-JNQJZLCISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB01067</td>
      <td>Glipizide</td>
      <td>ZJJXGWJIGJFDTL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB11450</td>
      <td>Pimobendan</td>
      <td>GLBJJMFZWDBELO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB07608</td>
      <td>N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</td>
      <td>JDGOPNUGILVNJZ-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB14982</td>
      <td>Miransertib</td>
      <td>HNFMVVHMKGFCMB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB01234</td>
      <td>Dexamethasone</td>
      <td>UREBDLICKHMUKA-CXSFZGCWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB14942</td>
      <td>BMS-986141</td>
      <td>KEEBLYWBELVGPQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12120</td>
      <td>Avoralstat</td>
      <td>TUWMKPVJGGWGNL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB14934</td>
      <td>GDC-0927</td>
      <td>KJAAPZIFCQQQKX-NDEPHWFRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12114</td>
      <td>Poziotinib</td>
      <td>LPFWVDIFUFFKJU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB01100</td>
      <td>Pimozide</td>
      <td>YVUQSNJEYSNKRX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB01089</td>
      <td>Deserpidine</td>
      <td>CVBMAZKKCSYWQR-WCGOZPBSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB08449</td>
      <td>2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid</td>
      <td>IEVFQDJUDLCOQY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08698</td>
      <td>1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL</td>
      <td>BKSGACYTXOQQNI-OAQYLSRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08731</td>
      <td>2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>GPOKTQCDBPECSS-MRXNPFEDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08494</td>
      <td>S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate</td>
      <td>AWAKIULNKVOBKE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB14866</td>
      <td>Amcasertib</td>
      <td>QDWKGEFGLQMDAM-ULJHMMPZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12885</td>
      <td>CF-102</td>
      <td>IPSYPUKKXMNCNQ-PFHKOEEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12085</td>
      <td>LCL-161</td>
      <td>UFPFGVNKHCLJJO-SSKFGXFMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB00796</td>
      <td>Candesartan cilexetil</td>
      <td>GHOSNRCGJFBJIB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB15141</td>
      <td>Deutivacaftor</td>
      <td>PURKAOJPTOLRMP-ASMGOKTBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB11819</td>
      <td>ASP-4058</td>
      <td>NJNXCJPSMWKXHO-VIFPVBQESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08883</td>
      <td>Perampanel</td>
      <td>PRMWGUBFXWROHD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB00694</td>
      <td>Daunorubicin</td>
      <td>STQGQHZAVUOBTE-VGBVRHCVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB14846</td>
      <td>Bimiralisib</td>
      <td>ADGGYDAFIHSYFI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08930</td>
      <td>Dolutegravir</td>
      <td>RHWKPHLQXYSBKR-BMIGLBTASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08834</td>
      <td>Tauroursodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-LBSADWJPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08460</td>
      <td>3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile</td>
      <td>KXDIHAQCVNNLIB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08437</td>
      <td>Puromycin</td>
      <td>RXWNCPJZOCPEPQ-NVWDDTSBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB00522</td>
      <td>Bentiromide</td>
      <td>SPPTWHFVYKCNNK-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB15456</td>
      <td>Vericiguat</td>
      <td>QZFHIXARHDBPBY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB15437</td>
      <td>Rocacetrapib</td>
      <td>GBHPDJQHZADVAA-SOKVYYICSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB02449</td>
      <td>3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid</td>
      <td>ULOTXPTWJAUGGE-MHZLTWQESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB02338</td>
      <td>Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate</td>
      <td>ACFIXJIJDZMPPO-NNYOXOHSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB08975</td>
      <td>Florantyrone</td>
      <td>QOBAOSCOLAGPKI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB02329</td>
      <td>Carbenoxolone</td>
      <td>OBZHEBDUNPOCJG-WBXJDKIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB02196</td>
      <td>Uridine-Diphosphate-N-Acetylgalactosamine</td>
      <td>LFTYTUAZOPRMMI-NESSUJCYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB00621</td>
      <td>Oxandrolone</td>
      <td>QSLJIVKCVHQPLV-PEMPUTJUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06743</td>
      <td>Ginkgolide A</td>
      <td>FPUXKXIZEIDQKW-VKMVSBOZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB02049</td>
      <td>2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide</td>
      <td>QOPFTBAEAJQKSY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB00611</td>
      <td>Butorphanol</td>
      <td>IFKLAQQSCNILHL-PWRODBHTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB15358</td>
      <td>JNJ-54175446</td>
      <td>CWFVVQFVGMFTBD-SECBINFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB04946</td>
      <td>Iloperidone</td>
      <td>XMXHEBAFVSFQEX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06747</td>
      <td>ginkgolide-M</td>
      <td>KDKROYXEHCYLJQ-FJFAJXJPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB04215</td>
      <td>CRA_9076</td>
      <td>BVTBOJXEAPSOEB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12731</td>
      <td>Daporinad</td>
      <td>KPBNHDGDUADAGP-VAWYXSNFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB01820</td>
      <td>Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide</td>
      <td>UESXELNYBIOROE-QHCPKHFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB08881</td>
      <td>Vemurafenib</td>
      <td>GPXBXXGIAQBQNI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08204</td>
      <td>3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE</td>
      <td>FLWABCQDXUKNQY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB08846</td>
      <td>Ellagic Acid</td>
      <td>AFSDNFLWKVMVRB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08241</td>
      <td>4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE</td>
      <td>RUUOIINPNMNPIU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08305</td>
      <td>(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>KQAGZLQCEURCKJ-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB08354</td>
      <td>2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>QCVULERVJOYHCP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB06515</td>
      <td>Resiniferatoxin</td>
      <td>DSDNAKHZNJAGHN-MXTYGGKSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB01459</td>
      <td>Bezitramide</td>
      <td>FLKWNFFCSSJANB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB12787</td>
      <td>Norethandrolone</td>
      <td>ZDHCJEIGTNNEMY-XGXHKTLJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB06543</td>
      <td>Astaxanthin</td>
      <td>MQZIGYBFDRPAKN-UWFIBFSHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB12048</td>
      <td>Savolitinib</td>
      <td>XYDNMOZJKOGZLS-NSHDSACASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4b</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB12410</td>
      <td>Sabarubicin</td>
      <td>VQHRZZISQVWPLK-UIRGBLDSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB08584</td>
      <td>6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB00769</td>
      <td>Hydrocortamate</td>
      <td>FWFVLWGEFDIZMJ-FOMYWIRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07027</td>
      <td>D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide</td>
      <td>JGZSVYZIJHGHMA-MOPGFXCFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB03213</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-P</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB02338</td>
      <td>Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate</td>
      <td>ACFIXJIJDZMPPO-NNYOXOHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB15143</td>
      <td>PF-06650833</td>
      <td>JKDGKIBAOAFRPJ-ZBINZKHDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB09231</td>
      <td>Benidipine</td>
      <td>QZVNQOLPLYWLHQ-ZEQKJWHPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB02323</td>
      <td>EM-1745</td>
      <td>CKSDYJASHNGOOS-KTXOUVACSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB08059</td>
      <td>Wortmannin</td>
      <td>QDLHCMPXEPAAMD-QAIWCSMKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB03082</td>
      <td>6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide</td>
      <td>CSWQJKHBMACTGB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB00881</td>
      <td>Quinapril</td>
      <td>JSDRRTOADPPCHY-HSQYWUDLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06134</td>
      <td>SNS-314</td>
      <td>FAYAUAZLLLJJGH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB09274</td>
      <td>Artesunate</td>
      <td>FIHJKUPKCHIPAT-AHIGJZGOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB02976</td>
      <td>Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester</td>
      <td>NGTCPFGWXMBZEP-KBQKSTHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB15193</td>
      <td>BMS-955176</td>
      <td>XDMUFNNPLXHNKA-ZTESCHFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB08930</td>
      <td>Dolutegravir</td>
      <td>RHWKPHLQXYSBKR-BMIGLBTASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01061</td>
      <td>Azlocillin</td>
      <td>JTWOMNBEOCYFNV-NFFDBFGFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB14152</td>
      <td>Ginsenosides</td>
      <td>NLHQJXWYMZLQJY-SWIZOJJJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB03035</td>
      <td>1,8-Di-Hydroxy-4-Nitro-Anthraquinone</td>
      <td>RIYCICFDXLNQPV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01155</td>
      <td>Gemifloxacin</td>
      <td>ZRCVYEYHRGVLOC-HYARGMPZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lzg</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB03619</td>
      <td>Deoxycholic Acid</td>
      <td>KXGVEGMKQFWNSR-LLQZFEROSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB00251</td>
      <td>Terconazole</td>
      <td>BLSQLHNBWJLIBQ-OZXSUGGESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB11562</td>
      <td>Bicuculline</td>
      <td>IYGYMKDQCDOMRE-ZWKOTPCHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB00304</td>
      <td>Desogestrel</td>
      <td>RPLCPCMSCLEKRS-BPIQYHPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB01678</td>
      <td>RU84687</td>
      <td>SAFPHFWYRLLBFO-NSOVKSMOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB03501</td>
      <td>Galactose-uridine-5'-diphosphate</td>
      <td>HSCJRCZFDFQWRP-ABVWGUQPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB03141</td>
      <td>3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril</td>
      <td>UYUWNNRWESUYOB-FIRIVFDPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB00342</td>
      <td>Terfenadine</td>
      <td>GUGOEEXESWIERI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB03186</td>
      <td>U-Pi-a-Pi</td>
      <td>JIAJERGOUFOENU-LNAOLWRRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB14717</td>
      <td>Nitrazolam</td>
      <td>OYRPNABWTHDOFK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01767</td>
      <td>Hemi-Babim</td>
      <td>KKJYVDXDZURHMA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB11176</td>
      <td>Zeaxanthin</td>
      <td>JKQXZKUSFCKOGQ-QAYBQHTQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB13422</td>
      <td>Nicofuranose</td>
      <td>FUWFSXZKBMCSKF-ZASNTINBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB11662</td>
      <td>Rabusertib</td>
      <td>SYYBDNPGDKKJDU-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01564</td>
      <td>Calusterone</td>
      <td>IVFYLRMMHVYGJH-PVPPCFLZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB03300</td>
      <td>Pterin Cytosine Dinucleotide</td>
      <td>WKSPNQYEWZEMMI-FEFZDOOUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB00303</td>
      <td>Ertapenem</td>
      <td>JUZNIMUFDBIJCM-ANEDZVCMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB09223</td>
      <td>Blonanserin</td>
      <td>XVGOZDAJGBALKS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB03583</td>
      <td>(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</td>
      <td>AYOAIABDFUJDKQ-SQJPUDIVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13936</td>
      <td>JNJ-28330835</td>
      <td>RYBKPGYFXRNMMU-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB08865</td>
      <td>Crizotinib</td>
      <td>KTEIFNKAUNYNJU-GFCCVEGCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06077</td>
      <td>Lumateperone</td>
      <td>HOIIHACBCFLJET-SFTDATJTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB12269</td>
      <td>PF-06273340</td>
      <td>BPIWZDNVMQQBQX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01501</td>
      <td>Difenoxin</td>
      <td>UFIVBRCCIRTJTN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB14646</td>
      <td>Prednisone acetate</td>
      <td>MOVRKLZUVNCBIP-RFZYENFJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB02432</td>
      <td>RU90395</td>
      <td>RLLAUERCSKPFGD-VMPREFPWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB08197</td>
      <td>(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime</td>
      <td>KYIXUSLGFINPTC-WVFAEZDRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB08204</td>
      <td>3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE</td>
      <td>FLWABCQDXUKNQY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01485</td>
      <td>4-Hydroxytestosterone</td>
      <td>BQOIJSIMMIDHMO-FBPKJDBXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01876</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methanone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB04703</td>
      <td>Hesperidin</td>
      <td>QUQPHWDTPGMPEX-QJBIFVCTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB02554</td>
      <td>Sulfoquinovose-Uridine-C1,5'-Diphosphate</td>
      <td>FQANCGQCBCUSMI-JZMIEXBBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01889</td>
      <td>16,17-Androstene-3-Ol</td>
      <td>KRVXMNNRSSQZJP-PHFHYRSDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01893</td>
      <td>N6-Benzyl Adenosine-5'-Diphosphate</td>
      <td>MRHGMAGSDAQUFH-LSCFUAHRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB02547</td>
      <td>Guanosine-5'-Diphosphate-Rhamnose</td>
      <td>LQEBEXMHBLQMDB-GDJBGNAASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB02498</td>
      <td>Carba-Nicotinamide-Adenine-Dinucleotide</td>
      <td>DGPLSUKWXXSBCU-VGXGLJSLSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB02432</td>
      <td>RU90395</td>
      <td>RLLAUERCSKPFGD-VMPREFPWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01198</td>
      <td>Zopiclone</td>
      <td>GBBSUAFBMRNDJC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB14542</td>
      <td>Hydrocortisone phosphate</td>
      <td>BGSOJVFOEQLVMH-VWUMJDOOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB15212</td>
      <td>Pemafibrate</td>
      <td>ZHKNLJLMDFQVHJ-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01830</td>
      <td>{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid</td>
      <td>SPSGYTWOIGAABK-DQEYMECFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB08707</td>
      <td>4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine</td>
      <td>AQVFETGXIRKVAQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB08708</td>
      <td>N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine</td>
      <td>XYYDXQCAYXOGQT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01329</td>
      <td>Cefoperazone</td>
      <td>GCFBRXLSHGKWDP-XCGNWRKASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07070</td>
      <td>(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid</td>
      <td>BDLLIPYDNFENMY-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01678</td>
      <td>RU84687</td>
      <td>SAFPHFWYRLLBFO-NSOVKSMOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01689</td>
      <td>Inhibitor Idd 384</td>
      <td>CJKKMQCZOLCXAM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB08710</td>
      <td>(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE</td>
      <td>BKZOQCGDCHOGOQ-MZLJFPOFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB01481</td>
      <td>1-Testosterone</td>
      <td>OKJCFMUGMSVJBG-ABEVXSGRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB08703</td>
      <td>12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</td>
      <td>FGKKIHITEICGMN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07064</td>
      <td>(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE</td>
      <td>HPVCRUIDFODATB-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB01410</td>
      <td>Ciclesonide</td>
      <td>LUKZNWIVRBCLON-GXOBDPJESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07063</td>
      <td>{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID</td>
      <td>KYHVTMFADJNSGS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01820</td>
      <td>Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide</td>
      <td>UESXELNYBIOROE-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB14581</td>
      <td>CPI-1205</td>
      <td>HPODOLXTMDHLLC-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB05532</td>
      <td>BMS-488043</td>
      <td>DBPMWRYLTBNCCE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB02759</td>
      <td>4-Methylumbelliferyl Chitobiose</td>
      <td>UPSFMJHZUCSEHU-JYGUBCOQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07043</td>
      <td>7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide</td>
      <td>CKLCIJCZOIDJQU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m71</td>
      <td>DB15435</td>
      <td>BMS-986158</td>
      <td>KGERZPVQIRYWRK-GDLZYMKVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB14029</td>
      <td>Furafylline</td>
      <td>HMZQULPVMKITSP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01513</td>
      <td>17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane</td>
      <td>QGKQXZFZOIQFBI-UYEYMFBJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB01940</td>
      <td>Balanol Analog 2</td>
      <td>SQLYTJZXRRDERK-ISKFKSNPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxs</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06228</td>
      <td>Rivaroxaban</td>
      <td>KGFYHTZWPPHNLQ-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB11853</td>
      <td>Relugolix</td>
      <td>AOMXMOCNKJTRQP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w4h</td>
      <td>DB07875</td>
      <td>5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide</td>
      <td>ARAVOODWJJJNBY-IRXDYDNUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB14810</td>
      <td>AZD-1656</td>
      <td>FJEJHJINOKKDCW-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01474</td>
      <td>17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene</td>
      <td>BNUOCVTVOYWNJC-DTMQFJJTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB03723</td>
      <td>2'-Deoxy-Thymidine-Beta-L-Rhamnose</td>
      <td>ZOSQFDVXNQFKBY-CGAXJHMRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB11795</td>
      <td>GSK-2636771</td>
      <td>XTKLTGBKIDQGQL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB07856</td>
      <td>6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE</td>
      <td>HPWBHQIUIBFTQC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04097</td>
      <td>Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose</td>
      <td>OAPPZHVTNHJVAL-JZMIEXBBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB15222</td>
      <td>GS-6620</td>
      <td>YAAQYJCOIFNMKX-RSTNYOGXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01944</td>
      <td>(S)-blebbistatin</td>
      <td>LZAXPYOBKSJSEX-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06190</td>
      <td>Solabegron</td>
      <td>LLDXOPKUNJTIRF-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13643</td>
      <td>Loprazolam</td>
      <td>UTEFBSAVJNEPTR-RGEXLXHISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB15062</td>
      <td>Inarigivir</td>
      <td>LYMICVBGNUEHGE-FUQPUAIBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB11942</td>
      <td>Selinexor</td>
      <td>DEVSOMFAQLZNKR-RJRFIUFISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04540</td>
      <td>Cholesterol</td>
      <td>HVYWMOMLDIMFJA-DPAQBDIFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04421</td>
      <td>Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct</td>
      <td>BZJFKYRGSZWSLT-YLIVDTKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB14982</td>
      <td>Miransertib</td>
      <td>HNFMVVHMKGFCMB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13491</td>
      <td>Fluperolone</td>
      <td>SLVCCRYLKTYUQP-DVTGEIKXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>7bv1</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB08164</td>
      <td>(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</td>
      <td>GOBIXGZJSMAOFV-QRWLVFNGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB15003</td>
      <td>PF-06700841</td>
      <td>BUWBRTXGQRBBHG-MJBXVCDLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB15009</td>
      <td>PF-04937319</td>
      <td>MASKQITXHVYVFL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB13563</td>
      <td>Norgestrienone</td>
      <td>GVDMJXQHPUYPHP-FYQPLNBISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB06992</td>
      <td>(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone</td>
      <td>SIDDLTBLAQYZIZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6w9c</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m3m</td>
      <td>DB04342</td>
      <td>7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid</td>
      <td>JWCSIUVGFCSJCK-LIUKBUMOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB15232</td>
      <td>Telaglenastat</td>
      <td>PRAAPINBUWJLGA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB14902</td>
      <td>JHU-75528 C-11</td>
      <td>MCNQUWLLXZZZAC-BJUDXGSMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB06888</td>
      <td>(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</td>
      <td>KBLPHMRCKHFBJB-OLZOCXBDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB04960</td>
      <td>Tipifarnib</td>
      <td>PLHJCIYEEKOWNM-HHHXNRCGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB07091</td>
      <td>(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide</td>
      <td>IWPMQJKXKKKSEY-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6cs2</td>
      <td>DB04760</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)</td>
      <td>PYFRREJCFXFNRR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB15385</td>
      <td>Acebilustat</td>
      <td>GERJIEKMNDGSCS-DQEYMECFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6lxt</td>
      <td>DB05903</td>
      <td>KOS-1584</td>
      <td>XAYAKDZVINDZGB-BMVMHAJPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6crv</td>
      <td>DB01933</td>
      <td>7-Hydroxystaurosporine</td>
      <td>PBCZSGKMGDDXIJ-HQCWYSJUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6vxx</td>
      <td>DB03671</td>
      <td>4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>SHIBSTMRCDJXLN-KCZCNTNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.3</td>
      <td>6m2n</td>
      <td>DB15292</td>
      <td>Foliglurax</td>
      <td>ZTEDNASHAWNBKQ-NCELDCMTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB13950</td>
      <td>WIN 55212-2</td>
      <td>HQVHOQAKMCMIIM-HXUWFJFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB15033</td>
      <td>Flortaucipir</td>
      <td>GETAAWDSFUCLBS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB01669</td>
      <td>Virginiamycin M1</td>
      <td>DAIKHDNSXMZDCU-FQTGFAPKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB04785</td>
      <td>Streptolydigin</td>
      <td>KVTPRMVXYZKLIG-NCAOFHFGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15177</td>
      <td>VX-659</td>
      <td>IGEOJNMYRZUKIK-IBGZPJMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB14660</td>
      <td>Trenbolone acetate</td>
      <td>CMRJPMODSSEAPL-FYQPLNBISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB14795</td>
      <td>AZD-3759</td>
      <td>MXDSJQHFFDGFDK-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB15407</td>
      <td>Acalisib</td>
      <td>DOCINCLJNAXZQF-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB15294</td>
      <td>SB-1578</td>
      <td>NNXDIGHYPZHXTR-ONEGZZNKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB12649</td>
      <td>Ibipinabant</td>
      <td>AXJQVVLKUYCICH-OAQYLSRUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15403</td>
      <td>Ziritaxestat</td>
      <td>REQQVBGILUTQNN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB14659</td>
      <td>Melengestrol acetate</td>
      <td>UDKABVSQKJNZBH-DWNQPYOZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15193</td>
      <td>BMS-955176</td>
      <td>XDMUFNNPLXHNKA-ZTESCHFWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB03397</td>
      <td>Uridine-Diphosphate-N-Acetylglucosamine</td>
      <td>LFTYTUAZOPRMMI-CFRASDGPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13772</td>
      <td>Rufloxacin</td>
      <td>NJCJBUHJQLFDSW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB12010</td>
      <td>Fostamatinib</td>
      <td>GKDRMWXFWHEQQT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15442</td>
      <td>Trilaciclib</td>
      <td>PDGKHKMBHVFCMG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB15003</td>
      <td>PF-06700841</td>
      <td>BUWBRTXGQRBBHG-MJBXVCDLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB01380</td>
      <td>Cortisone acetate</td>
      <td>ITRJWOMZKQRYTA-RFZYENFJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB03671</td>
      <td>4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>SHIBSTMRCDJXLN-KCZCNTNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB15011</td>
      <td>Avacopan</td>
      <td>PUKBOVABABRILL-YZNIXAGQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB04238</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid</td>
      <td>GNANSBQAIRJZPA-XZOQPEGZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13927</td>
      <td>anle138b</td>
      <td>RCQIIBJSUWYYFU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07812</td>
      <td>N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide</td>
      <td>TWYNGDRSMHRPSY-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB14810</td>
      <td>AZD-1656</td>
      <td>FJEJHJINOKKDCW-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB14795</td>
      <td>AZD-3759</td>
      <td>MXDSJQHFFDGFDK-CYBMUJFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB03461</td>
      <td>2'-Monophosphoadenosine 5'-Diphosphoribose</td>
      <td>XJLXINKUBYWONI-NNYOXOHSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB00421</td>
      <td>Spironolactone</td>
      <td>LXMSZDCAJNLERA-ZHYRCANASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13952</td>
      <td>Estradiol acetate</td>
      <td>FHXBMXJMKMWVRG-SLHNCBLASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15444</td>
      <td>Elexacaftor</td>
      <td>MVRHVFSOIWFBTE-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB11871</td>
      <td>PF-00610355</td>
      <td>YPHDIMUXXABSSO-YTTGMZPUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB14790</td>
      <td>BPN-14770</td>
      <td>KRRGWHSEDYQKDQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB01514</td>
      <td>Furazabol</td>
      <td>RGLLOUBXMOGLDQ-IVEVATEUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB12494</td>
      <td>SGI-1776</td>
      <td>MHXGEROHKGDZGO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB14879</td>
      <td>Cefiderocol</td>
      <td>DBPPRLRVDVJOCL-FQRUVTKNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6wiq</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6wiq</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB14218</td>
      <td>Telotristat</td>
      <td>NCLGDOBQAWBXRA-PGRDOPGGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB15126</td>
      <td>IMG-7289</td>
      <td>KQKBMHGOHXOHTD-KKUQBAQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB12806</td>
      <td>GSK-1004723</td>
      <td>YANGEESWIGIKOP-UUWRZZSWSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB14068</td>
      <td>Dexniguldipine</td>
      <td>SVJMLYUFVDMUHP-MGBGTMOVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13689</td>
      <td>Tacalcitol</td>
      <td>BJYLYJCXYAMOFT-RSFVBTMBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB15177</td>
      <td>VX-659</td>
      <td>IGEOJNMYRZUKIK-IBGZPJMESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB00673</td>
      <td>Aprepitant</td>
      <td>ATALOFNDEOCMKK-OITMNORJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB15132</td>
      <td>AZD-8165</td>
      <td>YUHNXUAATAMVKD-PZJWPPBQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB04216</td>
      <td>Quercetin</td>
      <td>REFJWTPEDVJJIY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB04107</td>
      <td>[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester</td>
      <td>RNOYCNIZOAIUSV-LSWMGQQCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB01329</td>
      <td>Cefoperazone</td>
      <td>GCFBRXLSHGKWDP-XCGNWRKASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB14914</td>
      <td>Flortaucipir F-18</td>
      <td>GETAAWDSFUCLBS-SJPDSGJFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13649</td>
      <td>Proquazone</td>
      <td>JTIGKVIOEQASGT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB14854</td>
      <td>TC-6987</td>
      <td>UAKZGMMGIMKFMV-RBUKOAKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB04030</td>
      <td>1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole</td>
      <td>ADXYEWMDAGIULV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13470</td>
      <td>Cefodizime</td>
      <td>XDZKBRJLTGRPSS-BGZQYGJUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB04759</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)</td>
      <td>GTBUZLPQANSGGE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15266</td>
      <td>TAK-580</td>
      <td>VWMJHAFYPMOMGF-ZCFIWIBFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12724</td>
      <td>AZD-7295</td>
      <td>MAQDQJWCSSCURR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB03903</td>
      <td>Tmr</td>
      <td>KGFLZYXDJDOIEE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB15273</td>
      <td>VS-4718</td>
      <td>IGUBBWJDMLCRIK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB03262</td>
      <td>Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]</td>
      <td>PZLYYZPXSSNGJS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB02152</td>
      <td>K-252a</td>
      <td>KOZFSFOOLUUIGY-SOLYNIJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB00808</td>
      <td>Indapamide</td>
      <td>NDDAHWYSQHTHNT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB11968</td>
      <td>MK-7145</td>
      <td>OCKGFTQIICXDQW-ZEQRLZLVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB04632</td>
      <td>4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE</td>
      <td>JHHBGNIRSUTQAS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB15245</td>
      <td>Olorofim</td>
      <td>SUFPWYYDCOKDLL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB14820</td>
      <td>Profoxydim</td>
      <td>KRQUFUKTQHISJB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB03925</td>
      <td>Freselestat</td>
      <td>HMPQTEPEMQZWQH-QZTJIDSGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13586</td>
      <td>Metandienone</td>
      <td>XWALNWXLMVGSFR-HLXURNFRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB03507</td>
      <td>6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One</td>
      <td>UXGUZFZBZPPZGL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07834</td>
      <td>N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide</td>
      <td>FOHZGCHKLPIBBX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB03476</td>
      <td>Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine</td>
      <td>NQRIWXVAIWPBEM-OALUTQOASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB07029</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE</td>
      <td>QQBNDYARFVOEGW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB14657</td>
      <td>Paramethasone acetate</td>
      <td>HYRKAAMZBDSJFJ-LFDBJOOHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB05983</td>
      <td>Bardoxolone methyl</td>
      <td>WPTTVJLTNAWYAO-KPOXMGGZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB00266</td>
      <td>Dicoumarol</td>
      <td>DOBMPNYZJYQDGZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB13788</td>
      <td>Chlorbenzoxamine</td>
      <td>VEVSKUJZSMGTMM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB13061</td>
      <td>MLN8054</td>
      <td>HHFBDROWDBDFBR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12505</td>
      <td>E-7820</td>
      <td>LWGUASZLXHYWIV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB07845</td>
      <td>2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide</td>
      <td>VGYXXQRDIVRILX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB02449</td>
      <td>3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid</td>
      <td>ULOTXPTWJAUGGE-MHZLTWQESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB13093</td>
      <td>TAK-593</td>
      <td>DZFZXPPHBWCXPQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB02668</td>
      <td>Je-2147, Ag1776, Kni-764</td>
      <td>CUFQBQOBLVLKRF-RZDMPUFOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB12207</td>
      <td>Verdinexor</td>
      <td>OPAKEJZFFCECPN-XQRVVYSFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08184</td>
      <td>2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE</td>
      <td>YOZKTHGEOJHIDP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB12306</td>
      <td>Cipargamin</td>
      <td>CKLPLPZSUQEDRT-WPCRTTGESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB12054</td>
      <td>BQ-123</td>
      <td>VYCMAAOURFJIHD-PJNXIOHISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB01690</td>
      <td>Bis(Adenosine)-5'-Triphosphate</td>
      <td>QCICUPZZLIQAPA-XPWFQUROSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB13078</td>
      <td>KOSN-1724</td>
      <td>JAYGOFBXDFAXBW-CYEKYUJNSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB09233</td>
      <td>Cronidipine</td>
      <td>CNIJVNPIIHWRRP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB04042</td>
      <td>2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol</td>
      <td>XLJNZONSWKENRP-VABIIVNOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB01092</td>
      <td>Ouabain</td>
      <td>LPMXVESGRSUGHW-HBYQJFLCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB13119</td>
      <td>GSK-364735</td>
      <td>QWLNINWUBHHOLU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08026</td>
      <td>2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide</td>
      <td>AJLILYAPRHIFAS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB06717</td>
      <td>Fosaprepitant</td>
      <td>BARDROPHSZEBKC-OITMNORJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB00287</td>
      <td>Travoprost</td>
      <td>MKPLKVHSHYCHOC-AHTXBMBWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB08865</td>
      <td>Crizotinib</td>
      <td>KTEIFNKAUNYNJU-GFCCVEGCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB13857</td>
      <td>Demegestone</td>
      <td>JWAHBTQSSMYISL-MHTWAQMVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB07817</td>
      <td>1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea</td>
      <td>NJPVZSIGDRLLTD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB03076</td>
      <td>AHA047</td>
      <td>CGBDAHCDSVOMCF-FYZVQMPESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08137</td>
      <td>(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide</td>
      <td>ZMWYSLJBNJUCRK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB04872</td>
      <td>Osanetant</td>
      <td>DZOJBGLFWINFBF-UMSFTDKQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB11487</td>
      <td>Dexamethasone isonicotinate</td>
      <td>BQTXJHAJMDGOFI-NJLPOHDGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB07405</td>
      <td>1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</td>
      <td>GIZYIOOBBUHOBS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB13451</td>
      <td>Tioclomarol</td>
      <td>WRGOVNKNTPWHLZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB08822</td>
      <td>Azilsartan medoxomil</td>
      <td>QJFSABGVXDWMIW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB08738</td>
      <td>1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one</td>
      <td>KWCKZIJGKMCYCI-QFIPXVFZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB06494</td>
      <td>Sufugolix</td>
      <td>UCQSBGOFELXYIN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB13675</td>
      <td>Metahexamide</td>
      <td>XXYTXQGCRQLRHA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB11814</td>
      <td>PF-03882845</td>
      <td>XNULRSOGWPFPBL-REWPJTCUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB00224</td>
      <td>Indinavir</td>
      <td>CBVCZFGXHXORBI-PXQQMZJSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08166</td>
      <td>(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile</td>
      <td>LPFQFJAOMCGYCP-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB03791</td>
      <td>(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid</td>
      <td>NAXSRXHZFIBFMI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08159</td>
      <td>4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE</td>
      <td>AHIJTWCJGCWHMT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB03907</td>
      <td>N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide</td>
      <td>UHHBFOLQOQSPLU-WGRQDFERSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB11942</td>
      <td>Selinexor</td>
      <td>DEVSOMFAQLZNKR-RJRFIUFISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08054</td>
      <td>1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>GEZALMMCQYDFML-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB06977</td>
      <td>(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine</td>
      <td>CAASENZOSQYNPX-HSTJUUNISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB04392</td>
      <td>Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]</td>
      <td>HIZKPJUTKKJDGA-BETUJISGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB13729</td>
      <td>Camostat</td>
      <td>XASIMHXSUQUHLV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB04408</td>
      <td>Ncs-Chromophore</td>
      <td>QZGIWPZCWHMVQL-UIYAJPBUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB13215</td>
      <td>Sulfobromophthalein</td>
      <td>OHTXTCNTQJFRIG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB01260</td>
      <td>Desonide</td>
      <td>WBGKWQHBNHJJPZ-LECWWXJVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15446</td>
      <td>Vidofludimus</td>
      <td>XPRDUGXOWVXZLL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07889</td>
      <td>(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol</td>
      <td>VCPXSBULBDYRLT-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB00773</td>
      <td>Etoposide</td>
      <td>VJJPUSNTGOMMGY-MRVIYFEKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB00620</td>
      <td>Triamcinolone</td>
      <td>GFNANZIMVAIWHM-OBYCQNJPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB14640</td>
      <td>Isoflupredone acetate</td>
      <td>ZOCUOMKMBMEYQV-GSLJADNHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB00528</td>
      <td>Lercanidipine</td>
      <td>ZDXUKAKRHYTAKV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15056</td>
      <td>Bifenthrin</td>
      <td>OMFRMAHOUUJSGP-IRHGGOMRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB12410</td>
      <td>Sabarubicin</td>
      <td>VQHRZZISQVWPLK-UIRGBLDSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08303</td>
      <td>(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide</td>
      <td>CUMKMTBOHBENJI-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB07025</td>
      <td>3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</td>
      <td>KBIHHEGEALBUMT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15092</td>
      <td>LY-2624803</td>
      <td>UEFWDVMEDFCHGW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07933</td>
      <td>Erteberel</td>
      <td>XIESSJVMWNJCGZ-VKJFTORMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15114</td>
      <td>Vamorolone</td>
      <td>ZYTXTXAMMDTYDQ-DGEXFFLYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB00319</td>
      <td>Piperacillin</td>
      <td>IVBHGBMCVLDMKU-GXNBUGAJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB00966</td>
      <td>Telmisartan</td>
      <td>RMMXLENWKUUMAY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB07270</td>
      <td>N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE</td>
      <td>GAYYMURZGLJDCT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB06817</td>
      <td>Raltegravir</td>
      <td>CZFFBEXEKNGXKS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB14875</td>
      <td>AZD-4017</td>
      <td>NCDZABJPWMBMIQ-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB14882</td>
      <td>CEP-9722</td>
      <td>CTLOSZHDGZLOQE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB01212</td>
      <td>Ceftriaxone</td>
      <td>VAAUVRVFOQPIGI-SPQHTLEESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB01184</td>
      <td>Domperidone</td>
      <td>FGXWKSZFVQUSTL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB11870</td>
      <td>RG-4733</td>
      <td>OJPLJFIFUQPSJR-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB01061</td>
      <td>Azlocillin</td>
      <td>JTWOMNBEOCYFNV-NFFDBFGFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB14944</td>
      <td>Tarloxotinib</td>
      <td>MUJMYVFVAWFUJL-SNAWJCMRSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08305</td>
      <td>(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>KQAGZLQCEURCKJ-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB04086</td>
      <td>2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside</td>
      <td>WFVCNOHOODVBQK-IUBYCILNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07934</td>
      <td>[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE</td>
      <td>KMUXFASJKPVMGU-HXUWFJFHSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15124</td>
      <td>PF-05241328</td>
      <td>RVTSXVZXEGFIPW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB15257</td>
      <td>Milademetan</td>
      <td>RYAYYVTWKAOAJF-QISPRATLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB14894</td>
      <td>Galicaftor</td>
      <td>QVDYQHXNAQHIKH-TZIWHRDSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB13016</td>
      <td>LY-2300559</td>
      <td>DWQVYDLTPMGYNE-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15391</td>
      <td>Elenbecestat</td>
      <td>AACUJFVOHGRMTR-DPXNYUHVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB13138</td>
      <td>Neladenoson bialanate</td>
      <td>WESNEIGKOAXSGX-VXKWHMMOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB14555</td>
      <td>Ursadiol</td>
      <td>RTLXJEJRLWILSU-GWNGJUQLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15437</td>
      <td>Rocacetrapib</td>
      <td>GBHPDJQHZADVAA-SOKVYYICSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB14055</td>
      <td>(S)-Warfarin</td>
      <td>PJVWKTKQMONHTI-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB04022</td>
      <td>Guanosine-5',3'-Tetraphosphate</td>
      <td>BUFLLCUFNHESEH-UUOKFMHZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB13640</td>
      <td>Acetoxolone</td>
      <td>FTQDJVZNPJRVPG-XWEVEMRCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07973</td>
      <td>N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE</td>
      <td>GIPCBGDQVGKMPO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB03632</td>
      <td>Argifin</td>
      <td>UHBHXSDKGLPPGO-HTDHLNIYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB00223</td>
      <td>Diflorasone</td>
      <td>WXURHACBFYSXBI-XHIJKXOTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15206</td>
      <td>Uprifosbuvir</td>
      <td>SFPFZQKYPOWCSI-KHFYHRBSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB13941</td>
      <td>Piperaquine</td>
      <td>UCRHFBCYFMIWHC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB12848</td>
      <td>PF-04217903</td>
      <td>PDMUGYOXRHVNMO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07941</td>
      <td>PH-797804</td>
      <td>KCAJXIDMCNPGHZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12972</td>
      <td>Sepranolone</td>
      <td>AURFZBICLPNKBZ-FZCSVUEKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB15295</td>
      <td>Tenalisib</td>
      <td>HDXDQPRPFRKGKZ-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m71</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB15269</td>
      <td>ALK-4290</td>
      <td>DWKNOLCXIFYNFV-HSZRJFAPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lxt</td>
      <td>DB15173</td>
      <td>JNJ-42165279</td>
      <td>YWGYNGCRVZLMCS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>7bv1</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13230</td>
      <td>Gestonorone</td>
      <td>GTFUITFQDGVJSK-XGXHKTLJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04685</td>
      <td>1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>GJNIPWYJQUGERM-BFLUCZKCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB05129</td>
      <td>Elsamitrucin</td>
      <td>MGQRRMONVLMKJL-KWJIQSIXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15151</td>
      <td>RO-6870810</td>
      <td>PKQXLRYFPSZKDU-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07460</td>
      <td>2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE</td>
      <td>UYJNQQDJUOUFQJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07468</td>
      <td>(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</td>
      <td>NJBBBRZNBVLTRZ-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07469</td>
      <td>(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</td>
      <td>KAJFGRLMKVNMLH-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15075</td>
      <td>4-demethyl-4-cholesteryloxycarbonylpenclomedine</td>
      <td>ZJUUIXYKTPSIOH-LEZJFEBPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07538</td>
      <td>4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE</td>
      <td>RGVVHQNJKUNSFQ-WDZFZDKYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB11867</td>
      <td>JNJ-39393406</td>
      <td>IURMHZBQEYNQOH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB11890</td>
      <td>Cilengitide</td>
      <td>AMLYAMJWYAIXIA-VWNVYAMZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06578</td>
      <td>Tonabersat</td>
      <td>XLIIRNOPGJTBJD-ROUUACIJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07557</td>
      <td>(5BETA)-PREGNANE-3,20-DIONE</td>
      <td>XMRPGKVKISIQBV-XWOJZHJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06494</td>
      <td>Sufugolix</td>
      <td>UCQSBGOFELXYIN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14993</td>
      <td>Pyrotinib</td>
      <td>SADXACCFNXBCFY-IYNHSRRRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02507</td>
      <td>4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One</td>
      <td>PJVWKTKQMONHTI-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07624</td>
      <td>1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide</td>
      <td>YJFULAYRAKPBCY-DYVFJYSZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02510</td>
      <td>'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine</td>
      <td>LKVJEMXWEODCAY-JVEUSOJLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07653</td>
      <td>N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE</td>
      <td>VXTCEUDVOCLEJG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14944</td>
      <td>Tarloxotinib</td>
      <td>MUJMYVFVAWFUJL-SNAWJCMRSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06454</td>
      <td>Sarizotan</td>
      <td>HKFMQJUJWSFOLY-OAQYLSRUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14932</td>
      <td>Coleneuramide</td>
      <td>CHMRTBYTCBDIRG-JQZMMWJVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07685</td>
      <td>4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>NMAZGYDYIYLSLJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15028</td>
      <td>MK-1064</td>
      <td>CKTWQGHVNRYNCM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14917</td>
      <td>Ceralasertib</td>
      <td>DTTJKLNXNZAVSM-JYCIKRDWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15157</td>
      <td>Voruciclib</td>
      <td>MRPGRAKIAJJGMM-OCCSQVGLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB11819</td>
      <td>ASP-4058</td>
      <td>NJNXCJPSMWKXHO-VIFPVBQESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB00457</td>
      <td>Prazosin</td>
      <td>IENZQIKPVFGBNW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB00310</td>
      <td>Chlorthalidone</td>
      <td>JIVPVXMEBJLZRO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07238</td>
      <td>Nesbuvir</td>
      <td>WTDWVLJJJOTABN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06786</td>
      <td>Halcinonide</td>
      <td>MUQNGPZZQDCDFT-JNQJZLCISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06746</td>
      <td>ginkgolide-J</td>
      <td>LMEHVEUFNRJAAV-UKWFQYJJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB00203</td>
      <td>Sildenafil</td>
      <td>BNRNXUUZRGQAQC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15450</td>
      <td>PF-05105679</td>
      <td>BXNMZRPTQFVRFA-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15435</td>
      <td>BMS-986158</td>
      <td>KGERZPVQIRYWRK-GDLZYMKVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15393</td>
      <td>Telatinib</td>
      <td>QFCXANHHBCGMAS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06589</td>
      <td>Pazopanib</td>
      <td>CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15391</td>
      <td>Elenbecestat</td>
      <td>AACUJFVOHGRMTR-DPXNYUHVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB11745</td>
      <td>Otenabant</td>
      <td>UNAZAADNBYXMIV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01496</td>
      <td>Barbituric acid derivative</td>
      <td>DNZPLHRZXUJATK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01493</td>
      <td>Ethylestrenol</td>
      <td>AOXRBFRFYPMWLR-XGXHKTLJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07337</td>
      <td>4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE</td>
      <td>SOKOHDQTKSROQZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07359</td>
      <td>3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide</td>
      <td>SJTQKYKXCYVFHX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB08191</td>
      <td>4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid</td>
      <td>KSFDVNIKNYXUIP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15254</td>
      <td>RO-5126766 free base</td>
      <td>LMMJFBMMJUMSJS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06626</td>
      <td>Axitinib</td>
      <td>RITAVMQDGBJQJZ-FMIVXFBMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01479</td>
      <td>BA-2664</td>
      <td>QGKQXZFZOIQFBI-XSWYFRFISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB15358</td>
      <td>JNJ-54175446</td>
      <td>CWFVVQFVGMFTBD-SECBINFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06916</td>
      <td>N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE</td>
      <td>LBCGUKCXRVUULK-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14889</td>
      <td>Derazantinib</td>
      <td>KPJDVVCDVBFRMU-AREMUKBSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14761</td>
      <td>Remdesivir</td>
      <td>RWWYLEGWBNMMLJ-YSOARWBDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB13040</td>
      <td>Gandotinib</td>
      <td>SQSZANZGUXWJEA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12562</td>
      <td>Setipiprant</td>
      <td>IHAXLPDVOWLUOS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08042</td>
      <td>N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>FLXGQDHYCWXTAI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12622</td>
      <td>Lupeol</td>
      <td>MQYXUWHLBZFQQO-QGTGJCAVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08068</td>
      <td>N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</td>
      <td>YQJVDUKATDECHF-ICSRJNTNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12885</td>
      <td>CF-102</td>
      <td>IPSYPUKKXMNCNQ-PFHKOEEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08011</td>
      <td>(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DXIHOIDYHQSQKJ-HMMYKYKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12658</td>
      <td>AFN-1252</td>
      <td>QXTWSUQCXCWEHF-JXMROGBWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08121</td>
      <td>(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid</td>
      <td>TZTPJJNNACUQQR-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08126</td>
      <td>3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE</td>
      <td>DMCRNUMVSATRTP-LCYFTJDESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12857</td>
      <td>NVP-LEQ-506</td>
      <td>POERAARDVFVDLO-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08137</td>
      <td>(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide</td>
      <td>ZMWYSLJBNJUCRK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB05263</td>
      <td>Caprospinol</td>
      <td>VMOZFSWFUBLCNN-AAPULDEBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12848</td>
      <td>PF-04217903</td>
      <td>PDMUGYOXRHVNMO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01393</td>
      <td>Bezafibrate</td>
      <td>IIBYAHWJQTYFKB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB05414</td>
      <td>Pipendoxifene</td>
      <td>JICOGKJOQXTAIP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14845</td>
      <td>Filgotinib</td>
      <td>RIJLVEAXPNLDTC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB13053</td>
      <td>CP-195543</td>
      <td>NZQDWKCNBOELAI-KSFYIVLOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06159</td>
      <td>Rubitecan</td>
      <td>VHXNKPBCCMUMSW-FQEVSTJZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14716</td>
      <td>Clonazolam</td>
      <td>XJRGLCAWBRZUFC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07756</td>
      <td>1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL</td>
      <td>GPBGHVRNVGXPNM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12134</td>
      <td>Gepotidacin</td>
      <td>PZFAZQUREQIODZ-LJQANCHMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02524</td>
      <td>2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)</td>
      <td>XFMMHXLUHKBKQE-UHEGPQQHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14649</td>
      <td>Dexamethasone acetate</td>
      <td>AKUJBENLRBOFTD-RPRRAYFGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06302</td>
      <td>Glesatinib</td>
      <td>YRCHYHRCBXNYNU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB14646</td>
      <td>Prednisone acetate</td>
      <td>MOVRKLZUVNCBIP-RFZYENFJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12180</td>
      <td>Apitolisib</td>
      <td>YOVVNQKCSKSHKT-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07812</td>
      <td>N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide</td>
      <td>TWYNGDRSMHRPSY-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07817</td>
      <td>1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea</td>
      <td>NJPVZSIGDRLLTD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07986</td>
      <td>[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID</td>
      <td>GNSLACGSDSJAIQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07831</td>
      <td>2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>SHSORWZDEKFFLP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB13766</td>
      <td>Lidoflazine</td>
      <td>ZBIAKUMOEKILTF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB13685</td>
      <td>Quingestanol</td>
      <td>PCJFRMOEZQQSAX-AIOSZGMZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB13631</td>
      <td>Methoserpidine</td>
      <td>ULBNWNUHGJLQHO-VKMIBBQISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB13591</td>
      <td>Metopimazine</td>
      <td>BQDBKDMTIJBJLA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07856</td>
      <td>6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE</td>
      <td>HPWBHQIUIBFTQC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12345</td>
      <td>MBX-2982</td>
      <td>NFTMKHWBOINJGM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08736</td>
      <td>S,R-Warfarin alcohol</td>
      <td>ZUJMMGHIYSAEOU-DOMZBBRYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB13347</td>
      <td>Diphenadione</td>
      <td>JYGLAHSAISAEAL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB13215</td>
      <td>Sulfobromophthalein</td>
      <td>OHTXTCNTQJFRIG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12260</td>
      <td>Radiprodil</td>
      <td>GKGRZLGAQZPEHO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12832</td>
      <td>Prednimustine</td>
      <td>HFVNWDWLWUCIHC-GUPDPFMOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07175</td>
      <td>N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide</td>
      <td>CXQRKICWSCAUGW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01540</td>
      <td>17alpha-methyl-4-hydroxynandrolone</td>
      <td>CLNUZOCYKSHICX-FAHHUNKHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB03523</td>
      <td>Brequinar</td>
      <td>PHEZJEYUWHETKO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07568</td>
      <td>(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE</td>
      <td>ADRNPUSZBRQDBG-KRWDZBQOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB03488</td>
      <td>Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose</td>
      <td>NGTCPFGWXMBZEP-NQQHDEILSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB05294</td>
      <td>Vandetanib</td>
      <td>UHTHHESEBZOYNR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB03383</td>
      <td>5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide</td>
      <td>YDCGVASFVACWKF-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB05414</td>
      <td>Pipendoxifene</td>
      <td>JICOGKJOQXTAIP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB05423</td>
      <td>ORG-34517</td>
      <td>DFELGYQKEOCHOA-BZAFBGKRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01858</td>
      <td>[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate</td>
      <td>QTPYRNAKLBXKNP-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB03262</td>
      <td>Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]</td>
      <td>PZLYYZPXSSNGJS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07982</td>
      <td>2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol</td>
      <td>PVTKDXZNSUHUMO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB03173</td>
      <td>CRA_10433</td>
      <td>CFSQPEBVGUSQII-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB02581</td>
      <td>5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</td>
      <td>VNZHOIDQBPFEJU-OAQYLSRUSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07435</td>
      <td>1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE</td>
      <td>GFANZDFKCCJYRF-NSISKUIASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB02929</td>
      <td>K201</td>
      <td>KCWGETCFOVJEPI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB02901</td>
      <td>Stanolone</td>
      <td>NVKAWKQGWWIWPM-ABEVXSGRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07405</td>
      <td>1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</td>
      <td>GIZYIOOBBUHOBS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB02830</td>
      <td>FR236913</td>
      <td>KCCUBLLGAMGDJL-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06157</td>
      <td>Istaroxime</td>
      <td>MPYLDWFDPHRTEG-PAAYLBSLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08976</td>
      <td>Floctafenine</td>
      <td>APQPGQGAWABJLN-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06228</td>
      <td>Rivaroxaban</td>
      <td>KGFYHTZWPPHNLQ-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08975</td>
      <td>Florantyrone</td>
      <td>QOBAOSCOLAGPKI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06257</td>
      <td>HE-2200</td>
      <td>OEVZKEVBDIDVOI-YSZCXEEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB03632</td>
      <td>Argifin</td>
      <td>UHBHXSDKGLPPGO-HTDHLNIYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB08539</td>
      <td>3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CCDIUVLNHCGSMH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04645</td>
      <td>5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID</td>
      <td>NJJIFGCFUDDBSP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07716</td>
      <td>(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL</td>
      <td>VDRIXSJOPKVWKM-HXGIDPQASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB09128</td>
      <td>Brexpiprazole</td>
      <td>ZKIAIYBUSXZPLP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04338</td>
      <td>SB220025</td>
      <td>VSPFURGQAYMVAN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB02545</td>
      <td>Fexaramine</td>
      <td>VLQTUNDJHLEFEQ-KGENOOAVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB08513</td>
      <td>[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID</td>
      <td>PAIQRYUOBBCBSE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB14770</td>
      <td>Lanraplenib</td>
      <td>XCIGZBVOUQVIPI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04839</td>
      <td>Cyproterone acetate</td>
      <td>UWFYSQMTEOIJJG-FDTZYFLXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04849</td>
      <td>Cediranib</td>
      <td>XXJWYDDUDKYVKI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07974</td>
      <td>1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE</td>
      <td>BDLMBQRBNPDCSS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB09168</td>
      <td>4-Phenylfentanyl</td>
      <td>BXCJXJLHYMWMQU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07845</td>
      <td>2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide</td>
      <td>VGYXXQRDIVRILX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04867</td>
      <td>Lintitript</td>
      <td>ILNRQFBVVQUOLP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04131</td>
      <td>10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione</td>
      <td>BLGDWFJQIHBUJY-NWJGULHDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04885</td>
      <td>Cilansetron</td>
      <td>NCNFDKWULDWJDS-OAHLLOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04891</td>
      <td>Becocalcidiol</td>
      <td>QSLUXQQUPXBIHH-YHSKWIAJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB04892</td>
      <td>Phenserine</td>
      <td>PBHFNBQPZCRWQP-QUCCMNQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB03916</td>
      <td>4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine</td>
      <td>RHOOHUMOHVIXEF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB03797</td>
      <td>3-Aminomethyl-Pyridinium-Adenine-Dinucleotide</td>
      <td>HMCRLFVYYFBZEZ-PLEFRAQWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB03751</td>
      <td>2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose</td>
      <td>YSYKRGRSMLTJNL-URARBOGNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB09050</td>
      <td>Ceftolozane</td>
      <td>JHFNIHVVXRKLEF-DCZLAGFPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06922</td>
      <td>2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>CZNPWASYMRBJCX-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB02698</td>
      <td>N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid</td>
      <td>NQOOJFXBGLOGTC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06274</td>
      <td>Alvimopan</td>
      <td>UPNUIXSCZBYVBB-JVFUWBCBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB11485</td>
      <td>Ceftiofur</td>
      <td>ZBHXIWJRIFEVQY-IHMPYVIRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB11487</td>
      <td>Dexamethasone isonicotinate</td>
      <td>BQTXJHAJMDGOFI-NJLPOHDGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06962</td>
      <td>(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone</td>
      <td>YKTUSHSSKIWDRY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB01224</td>
      <td>Quetiapine</td>
      <td>URKOMYMAXPYINW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB01208</td>
      <td>Sparfloxacin</td>
      <td>DZZWHBIBMUVIIW-DTORHVGOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB01148</td>
      <td>Flavoxate</td>
      <td>SPIUTQOUKAMGCX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB08883</td>
      <td>Perampanel</td>
      <td>PRMWGUBFXWROHD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02375</td>
      <td>Myricetin</td>
      <td>IKMDFBPHZNJCSN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02388</td>
      <td>Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</td>
      <td>UQFRSHRWRKYNDE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB09034</td>
      <td>Suvorexant</td>
      <td>JYTNQNCOQXFQPK-MRXNPFEDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06909</td>
      <td>1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide</td>
      <td>QZGJNFBMYYEFGM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB00878</td>
      <td>Chlorhexidine</td>
      <td>GHXZTYHSJHQHIJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07025</td>
      <td>3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</td>
      <td>KBIHHEGEALBUMT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07067</td>
      <td>(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE</td>
      <td>SQCDMTZMCHZYGO-FZMZJTMJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB09181</td>
      <td>Trefentanil</td>
      <td>RJSCINHYBGMIFT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08903</td>
      <td>Bedaquiline</td>
      <td>QUIJNHUBAXPXFS-XLJNKUFUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB06963</td>
      <td>3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide</td>
      <td>ZFGCLYUGFRNYFE-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB00728</td>
      <td>Rocuronium</td>
      <td>YXRDKMPIGHSVRX-OOJCLDBCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB07147</td>
      <td>methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate</td>
      <td>HJWMYFBKJRVWJY-YKSBVNFPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB00717</td>
      <td>Norethisterone</td>
      <td>VIKNJXKGJWUCNN-XGXHKTLJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB00670</td>
      <td>Pirenzepine</td>
      <td>RMHMFHUVIITRHF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB09095</td>
      <td>Difluocortolone</td>
      <td>OGPWIDANBSLJPC-RFPWEZLHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB08174</td>
      <td>5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE</td>
      <td>QCPYHSAHOYXXQK-DLBZAZTESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06908</td>
      <td>(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID</td>
      <td>PAWOPJKHTZCKMT-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06883</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea</td>
      <td>DHNYNLNKNQJSHF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB11263</td>
      <td>Polydatin</td>
      <td>HSTZMXCBWJGKHG-CUYWLFDKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB02197</td>
      <td>4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide</td>
      <td>NKORVPQBJCGYEC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB11371</td>
      <td>Alfaxalone</td>
      <td>DUHUCHOQIDJXAT-OLVMNOGESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06440</td>
      <td>Ravuconazole</td>
      <td>OPAHEYNNJWPQPX-RCDICMHDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06455</td>
      <td>Meclinertant</td>
      <td>DYLJVOXRWLXDIG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB08495</td>
      <td>4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>VXONTEUOQXFJJS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB11423</td>
      <td>Lasalocid</td>
      <td>BBMULGJBVDDDNI-OWKLGTHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06886</td>
      <td>N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL</td>
      <td>MACLRJNEKXUAJK-YDLSIGKMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB11431</td>
      <td>Moxidectin</td>
      <td>YZBLFMPOMVTDJY-LSGXYNIPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06710</td>
      <td>Methyltestosterone</td>
      <td>GCKMFJBGXUYNAG-HLXURNFRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB07142</td>
      <td>5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>ATFDKOLABYIYCC-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06809</td>
      <td>Plerixafor</td>
      <td>YIQPUIGJQJDJOS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB06831</td>
      <td>2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE</td>
      <td>UMMYTDJYDSTEMB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB01443</td>
      <td>19-Nor-5-androstenedione</td>
      <td>WELNRNVZXWUOGT-QXUSFIETSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB01434</td>
      <td>19-norandrostenedione</td>
      <td>JRIZOGLBRPZBLQ-QXUSFIETSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB08588</td>
      <td>2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE</td>
      <td>OYNURZXTLNNKAP-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB11457</td>
      <td>Rotenone</td>
      <td>JUVIOZPCNVVQFO-HBGVWJBISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB08607</td>
      <td>(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE</td>
      <td>GXPHKUHSUJUWKP-NTKDMRAZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB01530</td>
      <td>5alpha-androstane-3alpha,17beta-diol</td>
      <td>CBMYJHIOYJEBSB-KHOSGYARSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08240</td>
      <td>N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE</td>
      <td>RQAQWBFHPMSXKR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12724</td>
      <td>AZD-7295</td>
      <td>MAQDQJWCSSCURR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07974</td>
      <td>1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE</td>
      <td>BDLMBQRBNPDCSS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB15418</td>
      <td>AZD-9977</td>
      <td>MBKYLPOPYYLTNW-ZDUSSCGKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12322</td>
      <td>GW-870086</td>
      <td>WUBKGTSFJSEIEM-NSHBDUGJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12332</td>
      <td>Rucaparib</td>
      <td>HMABYWSNWIZPAG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07875</td>
      <td>5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide</td>
      <td>ARAVOODWJJJNBY-IRXDYDNUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07847</td>
      <td>6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE</td>
      <td>ICLOZQFWTRAYPX-LIRRHRJNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07792</td>
      <td>(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>VUKPNWLGSLOHIF-AWEZNQCLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07786</td>
      <td>1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>SMFRBBHLVBWHGB-DJJJIMSYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12303</td>
      <td>Motolimod</td>
      <td>QSPOQCXMGPDIHI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12279</td>
      <td>OBP-801</td>
      <td>XFLBOEMFLGLWFF-HDXRNPEWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07409</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>MPBUFKZCEBTBSK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07362</td>
      <td>1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>UOLCZAFAGDOUFX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07360</td>
      <td>1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>JJHXPDTVQKWKHA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12479</td>
      <td>Zabofloxacin</td>
      <td>ZNPOCLHDJCAZAH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07334</td>
      <td>N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</td>
      <td>HTIZPBXCJPQDEM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB01339</td>
      <td>Vecuronium</td>
      <td>BGSZAXLLHYERSY-XQIGCQGXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB01336</td>
      <td>Metocurine</td>
      <td>JFXBEKISTKFVAB-AJQTZOPKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01076</td>
      <td>Atorvastatin</td>
      <td>XUKUURHRXDUEBC-KAYWLYCHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12547</td>
      <td>LY-2886721</td>
      <td>NIDRNVHMMDAAIK-YPMLDQLKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12290</td>
      <td>Puerarin</td>
      <td>HKEAFJYKMMKDOR-VPRICQMDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12268</td>
      <td>Carmegliptin</td>
      <td>GUYMHFIHHOEFOA-ZCPGHIKRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08426</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</td>
      <td>PLXOQMHGHDZMSX-AWEZNQCLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB03081</td>
      <td>Crc200 (Chiron-Behring)</td>
      <td>ZOXOKTJHZSUHRJ-XZOQPEGZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12049</td>
      <td>Dasolampanel etibutil</td>
      <td>HPBRMCFZIGUGTK-ZMMAXQRCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12064</td>
      <td>BMS-777607</td>
      <td>VNBRGSXVFBYQNN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12066</td>
      <td>Orteronel</td>
      <td>OZPFIJIOIVJZMN-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12068</td>
      <td>T-900607</td>
      <td>FSXLOWIFSZNIMV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12073</td>
      <td>Albaconazole</td>
      <td>UHIXWHUVLCAJQL-MPBGBICISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB15075</td>
      <td>4-demethyl-4-cholesteryloxycarbonylpenclomedine</td>
      <td>ZJUUIXYKTPSIOH-LEZJFEBPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12269</td>
      <td>PF-06273340</td>
      <td>BPIWZDNVMQQBQX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12095</td>
      <td>Telotristat ethyl</td>
      <td>MDSQOJYHHZBZKA-GBXCKJPGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12116</td>
      <td>Epigallocatechin gallate</td>
      <td>WMBWREPUVVBILR-WIYYLYMNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08154</td>
      <td>3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>WHCLIFOVZDANCU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08124</td>
      <td>3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>FTQYGMLRLRXBPT-IDUWFGFVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08073</td>
      <td>(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>YWTBGJGMTBHQTM-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12218</td>
      <td>AZD-5363</td>
      <td>JDUBGYFRJFOXQC-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB09076</td>
      <td>Umeclidinium</td>
      <td>FVTWTVQXNAJTQP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08496</td>
      <td>(R)-warfarin</td>
      <td>PJVWKTKQMONHTI-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08057</td>
      <td>N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine</td>
      <td>VWJPPYCULHDHBB-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB11979</td>
      <td>Elagolix</td>
      <td>HEAUOKZIVMZVQL-VWLOTQADSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12113</td>
      <td>CE-224535</td>
      <td>FUCKCIVGBCBZNP-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12022</td>
      <td>Evatanepag</td>
      <td>WOHRHWDYFNWPNG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12325</td>
      <td>Idasanutlin</td>
      <td>TVTXCJFHQKSQQM-LJQIRTBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07215</td>
      <td>2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID</td>
      <td>ILUPZUOBHCUBKB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12863</td>
      <td>Sivelestat</td>
      <td>BTGNGJJLZOIYID-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB00984</td>
      <td>Nandrolone phenpropionate</td>
      <td>UBWXUGDQUBIEIZ-QNTYDACNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB06581</td>
      <td>Bevirimat</td>
      <td>YJEJKUQEXFSVCJ-WRFMNRASSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12890</td>
      <td>Dihydrexidine</td>
      <td>BGOQGUHWXBGXJW-YOEHRIQHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12924</td>
      <td>Ozenoxacin</td>
      <td>XPIJWUTXQAGSLK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12937</td>
      <td>Quercetin-3'-O-phosphate</td>
      <td>UWJBYNLLMAPJMM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12939</td>
      <td>Nikkomycin Z</td>
      <td>WWJFFVUVFNBJTN-VHDFTHOZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12941</td>
      <td>ODM-201</td>
      <td>BLIJXOOIHRSQRB-PXYINDEMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB03446</td>
      <td>N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide</td>
      <td>FSMWGHKWKYCPKE-QTVCLEQKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12985</td>
      <td>Quisinostat</td>
      <td>PAWIYAYFNXQGAP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB06629</td>
      <td>Zibotentan</td>
      <td>FJHHZXWJVIEFGJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12998</td>
      <td>PF-00217830</td>
      <td>QGNOXTFZOLDODX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB06144</td>
      <td>Sertindole</td>
      <td>GZKLJWGUPQBVJQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB05983</td>
      <td>Bardoxolone methyl</td>
      <td>WPTTVJLTNAWYAO-KPOXMGGZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB00894</td>
      <td>Testolactone</td>
      <td>BPEWUONYVDABNZ-DZBHQSCQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB05706</td>
      <td>13-deoxydoxorubicin</td>
      <td>RGVRUQHYQSORBY-JIGXQNLBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13089</td>
      <td>Enoxolone</td>
      <td>MPDGHEJMBKOTSU-YKLVYJNSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12479</td>
      <td>Zabofloxacin</td>
      <td>ZNPOCLHDJCAZAH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB05423</td>
      <td>ORG-34517</td>
      <td>DFELGYQKEOCHOA-BZAFBGKRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13164</td>
      <td>Olmutinib</td>
      <td>FDMQDKQUTRLUBU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB13016</td>
      <td>LY-2300559</td>
      <td>DWQVYDLTPMGYNE-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB01234</td>
      <td>Dexamethasone</td>
      <td>UREBDLICKHMUKA-CXSFZGCWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB06831</td>
      <td>2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE</td>
      <td>UMMYTDJYDSTEMB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB06837</td>
      <td>(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide</td>
      <td>VXDKQRWTOJFQKH-BJZITVGISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07175</td>
      <td>N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide</td>
      <td>CXQRKICWSCAUGW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07126</td>
      <td>O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE</td>
      <td>OWXORKPNCHJYOF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12345</td>
      <td>MBX-2982</td>
      <td>NFTMKHWBOINJGM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01030</td>
      <td>Topotecan</td>
      <td>UCFGDBYHRUNTLO-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB12180</td>
      <td>Apitolisib</td>
      <td>YOVVNQKCSKSHKT-HNNXBMFYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB01047</td>
      <td>Fluocinonide</td>
      <td>WJOHZNCJWYWUJD-IUGZLZTKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12375</td>
      <td>Oglemilast</td>
      <td>OKFDRAHPFKMAJH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB15033</td>
      <td>Flortaucipir</td>
      <td>GETAAWDSFUCLBS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12685</td>
      <td>K-134</td>
      <td>ULGNGSQNNMKROG-WOJBJXKFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07029</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE</td>
      <td>QQBNDYARFVOEGW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07026</td>
      <td>(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</td>
      <td>PPLDARNGJSQINK-OKZBNKHCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07024</td>
      <td>2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE</td>
      <td>CEXBEGBNDJVZPK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB07000</td>
      <td>N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide</td>
      <td>ILXJWLWSYAWJKZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB07530</td>
      <td>(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol</td>
      <td>PCHUQQNKOFNVDU-OSXMSNBXSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB00921</td>
      <td>Buprenorphine</td>
      <td>RMRJXGBAOAMLHD-IHFGGWKQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB06976</td>
      <td>1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA</td>
      <td>IWOOJEZSDPRYAZ-WFASDCNBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12796</td>
      <td>MRX-I</td>
      <td>SULYVXZZUMRQAX-NSHDSACASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB12808</td>
      <td>Trifarotene</td>
      <td>MFBCDACCJCDGBA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB06876</td>
      <td>N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE</td>
      <td>YJWJKKXGAPWLGT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB00973</td>
      <td>Ezetimibe</td>
      <td>OLNTVTPDXPETLC-XPWALMASSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB03005</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium</td>
      <td>ISUOMOOYAOQQPZ-UHFFFAOYSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB15011</td>
      <td>Avacopan</td>
      <td>PUKBOVABABRILL-YZNIXAGQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB04376</td>
      <td>13-Acetylphorbol</td>
      <td>SDSVJYOOAPRSDA-RPCQODIISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB13506</td>
      <td>Carfecillin</td>
      <td>NZDASSHFKWDBBU-KVMCETHSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB13528</td>
      <td>Chlormadinone</td>
      <td>VUHJZBBCZGVNDZ-TTYLFXKOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12054</td>
      <td>BQ-123</td>
      <td>VYCMAAOURFJIHD-PJNXIOHISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB04298</td>
      <td>3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One</td>
      <td>ZEBFKFGJWHOOST-LJAQVGFWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB02877</td>
      <td>Arotinoid acid</td>
      <td>FOIVPCKZDPCJJY-JQIJEIRASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB13556</td>
      <td>Sulfamazone</td>
      <td>BGLHAKAJGYLSOX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB11614</td>
      <td>Rupatadine</td>
      <td>WUZYKBABMWJHDL-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08556</td>
      <td>5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID</td>
      <td>CMHHNHDPPWDNAH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08881</td>
      <td>Vemurafenib</td>
      <td>GPXBXXGIAQBQNI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB13138</td>
      <td>Neladenoson bialanate</td>
      <td>WESNEIGKOAXSGX-VXKWHMMOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB11892</td>
      <td>Prulifloxacin</td>
      <td>PWNMXPDKBYZCOO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08956</td>
      <td>Hydroxydione</td>
      <td>USPYDUPOCUYHQL-VEVMSBRDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02789</td>
      <td>Pregnenolone</td>
      <td>ORNBQBCIOKFOEO-QGVNFLHTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB09034</td>
      <td>Suvorexant</td>
      <td>JYTNQNCOQXFQPK-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB09048</td>
      <td>Netupitant</td>
      <td>WAXQNWCZJDTGBU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB11853</td>
      <td>Relugolix</td>
      <td>AOMXMOCNKJTRQP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB09070</td>
      <td>Tibolone</td>
      <td>WZDGZWOAQTVYBX-XOINTXKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB11829</td>
      <td>Ruboxistaurin</td>
      <td>ZCBUQCWBWNUWSU-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB11805</td>
      <td>Saracatinib</td>
      <td>OUKYUETWWIPKQR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08912</td>
      <td>Dabrafenib</td>
      <td>BFSMGDJOXZAERB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB03696</td>
      <td>Lanosterol</td>
      <td>CAHGCLMLTWQZNJ-BQNIITSRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08591</td>
      <td>5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE</td>
      <td>IGXKSKWHHHYBFM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08639</td>
      <td>Dapivirine</td>
      <td>ILAYIAGXTHKHNT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08301</td>
      <td>N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE</td>
      <td>HDCXQTPVTAIPNZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12719</td>
      <td>Turofexorate isopropyl</td>
      <td>INASOKQDNHHMRE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02691</td>
      <td>Glycocholic acid</td>
      <td>RFDAIACWWDREDC-FRVQLJSFSA-M</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08444</td>
      <td>3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile</td>
      <td>YYGZQXRLQMFHDH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08460</td>
      <td>3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile</td>
      <td>KXDIHAQCVNNLIB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB11912</td>
      <td>Lanopepden</td>
      <td>SWHNZGMQMGFQGW-MSOLQXFVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08481</td>
      <td>4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE</td>
      <td>MXAPQGDBWFYKKX-ZROIWOOFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08487</td>
      <td>3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>PRMSFVUWLBPPLY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02698</td>
      <td>N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid</td>
      <td>NQOOJFXBGLOGTC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08614</td>
      <td>3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE</td>
      <td>MYFMPKCOIMRDDD-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12535</td>
      <td>AC-430</td>
      <td>DCRWIATZWHLIPN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB14914</td>
      <td>Flortaucipir F-18</td>
      <td>GETAAWDSFUCLBS-SJPDSGJFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12887</td>
      <td>Tazemetostat</td>
      <td>NSQSAUGJQHDYNO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12491</td>
      <td>Fasiglifam</td>
      <td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB04575</td>
      <td>Quinestrol</td>
      <td>PWZUUYSISTUNDW-VAFBSOEGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12426</td>
      <td>Bitopertin</td>
      <td>YUUGYIUSCYNSQR-LBPRGKRZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB11943</td>
      <td>Delafloxacin</td>
      <td>DYDCPNMLZGFQTM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB12339</td>
      <td>Radezolid</td>
      <td>BTTNOGHPGJANSW-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB08613</td>
      <td>2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL</td>
      <td>OFBFUNBBOQCNFX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB13003</td>
      <td>Cortivazol</td>
      <td>RKHQGWMMUURILY-UHRZLXHJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB04628</td>
      <td>Allosamidin</td>
      <td>MDWNFWDBQGOKNZ-XYUDZHFQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB13954</td>
      <td>Estradiol cypionate</td>
      <td>UOACKFBJUYNSLK-XRKIENNPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB14066</td>
      <td>Tetrandrine</td>
      <td>WVTKBKWTSCPRNU-KYJUHHDHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB11712</td>
      <td>Tezacaftor</td>
      <td>MJUVRTYWUMPBTR-MRXNPFEDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB14844</td>
      <td>ONC-201</td>
      <td>VLULRUCCHYVXOH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB11786</td>
      <td>Pefcalcitol</td>
      <td>SVCSMAZYWOQCBW-NVJMFHFGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB14856</td>
      <td>PF-05089771</td>
      <td>ZYSCOUXLBXGGIM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02915</td>
      <td>4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine</td>
      <td>MEZFDQUDLQCVNX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB11818</td>
      <td>Retosiban</td>
      <td>PLVGDGRBPMVYPB-FDUHJNRSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08881</td>
      <td>Vemurafenib</td>
      <td>GPXBXXGIAQBQNI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB02698</td>
      <td>N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid</td>
      <td>NQOOJFXBGLOGTC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB02917</td>
      <td>N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide</td>
      <td>LFGYSFPVLMPUPE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB11844</td>
      <td>Pritelivir</td>
      <td>IVZKZONQVYTCKC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08931</td>
      <td>Riociguat</td>
      <td>WXXSNCNJFUAIDG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB14862</td>
      <td>PF-06815345</td>
      <td>QTBYVAZRKWOIDU-FUHWJXTLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08703</td>
      <td>12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</td>
      <td>FGKKIHITEICGMN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB11885</td>
      <td>Anlotinib</td>
      <td>KSMZEXLVHXZPEF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB02432</td>
      <td>RU90395</td>
      <td>RLLAUERCSKPFGD-VMPREFPWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB11910</td>
      <td>MK-0249</td>
      <td>DDDZBLNULGDPGA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB14917</td>
      <td>Ceralasertib</td>
      <td>DTTJKLNXNZAVSM-JYCIKRDWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB02388</td>
      <td>Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</td>
      <td>UQFRSHRWRKYNDE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08656</td>
      <td>5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide</td>
      <td>UVERBUNNCOKGNZ-CQSZACIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB02354</td>
      <td>4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine</td>
      <td>IRKPNOLLMNHSOU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08500</td>
      <td>(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</td>
      <td>ZCJBDRSKHARECB-PYTCMNEWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12122</td>
      <td>Figopitant</td>
      <td>HUTHJVYJUPXHDF-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB11832</td>
      <td>Crenolanib</td>
      <td>DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB03020</td>
      <td>5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</td>
      <td>UINNILASBHZOTM-KMXXXSRASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB11742</td>
      <td>Ebastine</td>
      <td>MJJALKDDGIKVBE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB14822</td>
      <td>SB-649868</td>
      <td>ZJXIUGNEAIHSBI-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB11622</td>
      <td>Dehydrocholic acid</td>
      <td>OHXPGWPVLFPUSM-KLRNGDHRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB09231</td>
      <td>Benidipine</td>
      <td>QZVNQOLPLYWLHQ-ZEQKJWHPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB07831</td>
      <td>2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>SHSORWZDEKFFLP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB09233</td>
      <td>Cronidipine</td>
      <td>CNIJVNPIIHWRRP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB11725</td>
      <td>Latrepirdine</td>
      <td>JNODQFNWMXFMEV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB09371</td>
      <td>Norethynodrel</td>
      <td>ICTXHFFSOAJUMG-SLHNCBLASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB09383</td>
      <td>Meprednisone</td>
      <td>PIDANAQULIKBQS-RNUIGHNZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB11431</td>
      <td>Moxidectin</td>
      <td>YZBLFMPOMVTDJY-LSGXYNIPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB07817</td>
      <td>1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea</td>
      <td>NJPVZSIGDRLLTD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB07815</td>
      <td>GIBBERELLIN A4</td>
      <td>RSQSQJNRHICNNH-NFMPGMCNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB11745</td>
      <td>Otenabant</td>
      <td>UNAZAADNBYXMIV-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB09330</td>
      <td>Osimertinib</td>
      <td>DUYJMQONPNNFPI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB09295</td>
      <td>Talniflumate</td>
      <td>ANMLJLFWUCQGKZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB11562</td>
      <td>Bicuculline</td>
      <td>IYGYMKDQCDOMRE-ZWKOTPCHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB09272</td>
      <td>Eluxadoline</td>
      <td>QFNHIDANIVGXPE-FNZWTVRRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB03141</td>
      <td>3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril</td>
      <td>UYUWNNRWESUYOB-FIRIVFDPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB03126</td>
      <td>Mant-Adp</td>
      <td>QPKUEBLEGWBRHC-BFHYXJOUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB09223</td>
      <td>Blonanserin</td>
      <td>XVGOZDAJGBALKS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m3m</td>
      <td>DB11692</td>
      <td>Pavinetant</td>
      <td>QYTBBBAHNIWFOD-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9c</td>
      <td>DB14769</td>
      <td>Pamiparib</td>
      <td>DENYZIUJOTUUNY-MRXNPFEDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB12063</td>
      <td>CERC-301</td>
      <td>RECBFDWSXWAXHY-IAGOWNOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6m2n</td>
      <td>DB08997</td>
      <td>Dexetimide</td>
      <td>LQQIVYSCPWCSSD-HSZRJFAPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w9q</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB08878</td>
      <td>Aminopterin</td>
      <td>TVZGACDUOSZQKY-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB14761</td>
      <td>Remdesivir</td>
      <td>RWWYLEGWBNMMLJ-YSOARWBDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07729</td>
      <td>3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide</td>
      <td>GAKOBKPDJJGRIL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB00197</td>
      <td>Troglitazone</td>
      <td>GXPHKUHSUJUWKP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB07830</td>
      <td>(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE</td>
      <td>DIRIFWIKLRTNMB-DYVFJYSZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06370</td>
      <td>Indisulam</td>
      <td>SETFNECMODOHTO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB05983</td>
      <td>Bardoxolone methyl</td>
      <td>WPTTVJLTNAWYAO-KPOXMGGZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB12339</td>
      <td>Radezolid</td>
      <td>BTTNOGHPGJANSW-IBGZPJMESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB04750</td>
      <td>OREGON GREEN 488 CARBOXYLATE</td>
      <td>BRJCLSQFZSHLRL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB08351</td>
      <td>N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</td>
      <td>MNEXDVSJIUQQRH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB03186</td>
      <td>U-Pi-a-Pi</td>
      <td>JIAJERGOUFOENU-LNAOLWRRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB08339</td>
      <td>6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE</td>
      <td>ZIQFYVPVJZEOFS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB12282</td>
      <td>Defactinib</td>
      <td>FWLMVFUGMHIOAA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB15065</td>
      <td>PF-06291874</td>
      <td>IBDYYOQKQCCSDP-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07698</td>
      <td>3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine</td>
      <td>JDNMRPIWJIDDAY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB04609</td>
      <td>INHIBITOR Q8467 OF DUPONT MERCK</td>
      <td>HFLCERPZYCWLSZ-VKONIRKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB15075</td>
      <td>4-demethyl-4-cholesteryloxycarbonylpenclomedine</td>
      <td>ZJUUIXYKTPSIOH-LEZJFEBPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB04575</td>
      <td>Quinestrol</td>
      <td>PWZUUYSISTUNDW-VAFBSOEGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB06229</td>
      <td>Ocaperidone</td>
      <td>ZZQNEJILGNNOEP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07430</td>
      <td>(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one</td>
      <td>CMWRPDHVGMHLSZ-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB04177</td>
      <td>4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>XZTUSOXSLKTKJQ-CESUGQOBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB09534</td>
      <td>Ecamsule</td>
      <td>HEAHZSUCFKFERC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07489</td>
      <td>4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium</td>
      <td>WWGPTHOMFHDEEC-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB15448</td>
      <td>Acumapimod</td>
      <td>VGUSQKZDZHAAEE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4b</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07216</td>
      <td>(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE</td>
      <td>ZMGCFGGMTCMSDP-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB02259</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide</td>
      <td>VSYGXLAJQDAWCZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB08911</td>
      <td>Trametinib</td>
      <td>LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06927</td>
      <td>[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE</td>
      <td>ZKJVCUXZMYKTLT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06930</td>
      <td>N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide</td>
      <td>WVLDNAVUCUAGDP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB07396</td>
      <td>1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid</td>
      <td>KAJJGOCSAXKXBD-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB12627</td>
      <td>GSK-1292263</td>
      <td>AYJRTVVIBJSSKN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB07141</td>
      <td>5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>QVXYJVHNRPNRJL-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB00522</td>
      <td>Bentiromide</td>
      <td>SPPTWHFVYKCNNK-FQEVSTJZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB06827</td>
      <td>Viomycin</td>
      <td>GXFAIFRPOKBQRV-GHXCTMGLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB12929</td>
      <td>JNJ-39220675</td>
      <td>IQOWHZHNGJXGHG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07237</td>
      <td>{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone</td>
      <td>VUWFJUJWAWMRQN-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB03865</td>
      <td>6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine</td>
      <td>FEKRWNWZMOSVBX-UHFFFAOYSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06744</td>
      <td>ginkgolide-B</td>
      <td>SQOJOAFXDQDRGF-MMQTXUMRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB07630</td>
      <td>N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-IAGOWNOFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB06652</td>
      <td>Vicriviroc</td>
      <td>CNPVJJQCETWNEU-CYFREDJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB01690</td>
      <td>Bis(Adenosine)-5'-Triphosphate</td>
      <td>QCICUPZZLIQAPA-XPWFQUROSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB04238</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid</td>
      <td>GNANSBQAIRJZPA-XZOQPEGZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB07717</td>
      <td>(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE</td>
      <td>AJODXHGZHBERGJ-JLYQOUBASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB05611</td>
      <td>Apilimod</td>
      <td>HSKAZIJJKRAJAV-KOEQRZSOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07544</td>
      <td>N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE</td>
      <td>ZLQBZYKAQQWOTK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06999</td>
      <td>N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide</td>
      <td>YZDJQTHVDDOVHR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB00861</td>
      <td>Diflunisal</td>
      <td>HUPFGZXOMWLGNK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB01339</td>
      <td>Vecuronium</td>
      <td>BGSZAXLLHYERSY-XQIGCQGXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB12385</td>
      <td>10-hydroxycamptothecin</td>
      <td>HAWSQZCWOQZXHI-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB02703</td>
      <td>Fusidic acid</td>
      <td>IECPWNUMDGFDKC-MZJAQBGESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB11942</td>
      <td>Selinexor</td>
      <td>DEVSOMFAQLZNKR-RJRFIUFISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB03367</td>
      <td>PF-00356231</td>
      <td>VMTJQZUZINLEKC-JOCHJYFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB09233</td>
      <td>Cronidipine</td>
      <td>CNIJVNPIIHWRRP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB15273</td>
      <td>VS-4718</td>
      <td>IGUBBWJDMLCRIK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB04824</td>
      <td>Phenolphthalein</td>
      <td>KJFMBFZCATUALV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB01405</td>
      <td>Temafloxacin</td>
      <td>QKDHBVNJCZBTMR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB01338</td>
      <td>Pipecuronium</td>
      <td>OWWLUIWOFHMHOQ-XGHATYIMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB12375</td>
      <td>Oglemilast</td>
      <td>OKFDRAHPFKMAJH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB05294</td>
      <td>Vandetanib</td>
      <td>UHTHHESEBZOYNR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB05095</td>
      <td>Cimicoxib</td>
      <td>KYXDNECMRLFQMZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB04612</td>
      <td>N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE</td>
      <td>QKPXPZYQPBWDHS-MCJAPYMPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB11652</td>
      <td>Tucatinib</td>
      <td>SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB15227</td>
      <td>Tirabrutinib</td>
      <td>SEJLPXCPMNSRAM-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB01767</td>
      <td>Hemi-Babim</td>
      <td>KKJYVDXDZURHMA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB11971</td>
      <td>Vilaprisan</td>
      <td>JUFWQQVHQFDUOD-ANRPBIDPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06645</td>
      <td>Anamorelin</td>
      <td>VQPFSIRUEPQQPP-MXBOTTGLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB11910</td>
      <td>MK-0249</td>
      <td>DDDZBLNULGDPGA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB01261</td>
      <td>Sitagliptin</td>
      <td>MFFMDFFZMYYVKS-SECBINFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB03768</td>
      <td>N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3</td>
      <td>WRUVOSYKHXGAQN-GKRYNVPLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB05015</td>
      <td>Belinostat</td>
      <td>NCNRHFGMJRPRSK-MDZDMXLPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07268</td>
      <td>2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE</td>
      <td>QHPKKGUGRGRSGA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4b</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB12020</td>
      <td>Tecovirimat</td>
      <td>CSKDFZIMJXRJGH-VWLPUNTISA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB03596</td>
      <td>N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide</td>
      <td>FSRPBGBMEKDSIJ-CYBMUJFWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB03632</td>
      <td>Argifin</td>
      <td>UHBHXSDKGLPPGO-HTDHLNIYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07271</td>
      <td>4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one</td>
      <td>RMDAPSXWBVPVOG-IAPIXIRKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07396</td>
      <td>1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid</td>
      <td>KAJJGOCSAXKXBD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4b</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB03893</td>
      <td>Thionicotinamide-Adenine-Dinucleotide</td>
      <td>UQYPZLRUJKCREN-NNYOXOHSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB03222</td>
      <td>dATP</td>
      <td>SUYVUBYJARFZHO-RRKCRQDMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB15121</td>
      <td>AT-001</td>
      <td>YRGPAXAVTDMKDK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB08730</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</td>
      <td>CPFBZMFUCGHBAP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB08749</td>
      <td>3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</td>
      <td>KTRFBFMYAJOXLG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB11892</td>
      <td>Prulifloxacin</td>
      <td>PWNMXPDKBYZCOO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB11965</td>
      <td>SJG-136</td>
      <td>RWZVMMQNDHPRQD-SFTDATJTSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB03797</td>
      <td>3-Aminomethyl-Pyridinium-Adenine-Dinucleotide</td>
      <td>HMCRLFVYYFBZEZ-PLEFRAQWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB05465</td>
      <td>Tandutinib</td>
      <td>UXXQOJXBIDBUAC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07267</td>
      <td>2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine</td>
      <td>JONFDFIXMPXTRH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB04608</td>
      <td>9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</td>
      <td>IAUZTOZLTFSMIE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB06997</td>
      <td>2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</td>
      <td>BMPOCDJEXAXXEZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06897</td>
      <td>3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol</td>
      <td>MMGKIHLBFPJYJL-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB09079</td>
      <td>Nintedanib</td>
      <td>XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB07274</td>
      <td>N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide</td>
      <td>ZATGFXTWDKIEKC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB13528</td>
      <td>Chlormadinone</td>
      <td>VUHJZBBCZGVNDZ-TTYLFXKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB08833</td>
      <td>Taurochenodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-BJLOMENOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07211</td>
      <td>(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE</td>
      <td>YMJHMJLNQLVUAV-GHYUOPHCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4b</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB11176</td>
      <td>Zeaxanthin</td>
      <td>JKQXZKUSFCKOGQ-QAYBQHTQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB07544</td>
      <td>N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE</td>
      <td>ZLQBZYKAQQWOTK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB13061</td>
      <td>MLN8054</td>
      <td>HHFBDROWDBDFBR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB02152</td>
      <td>K-252a</td>
      <td>KOZFSFOOLUUIGY-SOLYNIJKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB15046</td>
      <td>LY-2881835</td>
      <td>FHRWHNJJQGSCQC-LJAQVGFWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB13814</td>
      <td>Talampicillin</td>
      <td>SOROUYSPFADXSN-SUWVAFIASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB04632</td>
      <td>4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE</td>
      <td>JHHBGNIRSUTQAS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06919</td>
      <td>D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide</td>
      <td>CJHLRGCXPGIPCB-MOPGFXCFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07128</td>
      <td>N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE</td>
      <td>ZTYBIJUAAWLJNU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB05552</td>
      <td>TG100-115</td>
      <td>UJIAQDJKSXQLIT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06266</td>
      <td>Lonidamine</td>
      <td>WDRYRZXSPDWGEB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07583</td>
      <td>(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE</td>
      <td>RLNNFNGBXLTQOB-RBUKOAKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB06959</td>
      <td>(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine</td>
      <td>BUCZDJYEOAQTHL-KEKNWZKVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB15435</td>
      <td>BMS-986158</td>
      <td>KGERZPVQIRYWRK-GDLZYMKVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB07156</td>
      <td>(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione</td>
      <td>JFEKAVPMVOLVTH-UNOMPAQXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB07257</td>
      <td>4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione</td>
      <td>WHMQZCPGFZBLBG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB08034</td>
      <td>(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</td>
      <td>TVOPERZEGKBKAY-RGVLZGJSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB07678</td>
      <td>(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL</td>
      <td>ANAMDWGJXBYJEB-OPWFCKQNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6lzg</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB06605</td>
      <td>Apixaban</td>
      <td>QNZCBYKSOIHPEH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB07642</td>
      <td>5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>GYKIQIOWVKCVBP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6cs2</td>
      <td>DB06178</td>
      <td>Talotrexin</td>
      <td>NYQPLPNEESYGNO-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB07072</td>
      <td>(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</td>
      <td>CNKRZILQBKJWDS-WMFXKJRFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB04378</td>
      <td>3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</td>
      <td>APJAEXGNDLFGPD-AWCRTANDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxx</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB04664</td>
      <td>Cyclohexyl-pentyl-maltoside</td>
      <td>RVTGFZGNOSKUDA-ZNGNCRBCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB06845</td>
      <td>(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide</td>
      <td>WXYKSWZWRHMJTE-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB04098</td>
      <td>Balanol</td>
      <td>XYUFCXJZFZPEJD-PGRDOPGGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6vxs</td>
      <td>DB04861</td>
      <td>Nebivolol</td>
      <td>KOHIRBRYDXPAMZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6w4h</td>
      <td>DB08237</td>
      <td>2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)</td>
      <td>COMPKRGNHXOXMN-GVDBMIGSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB05137</td>
      <td>Lobeline</td>
      <td>MXYUKLILVYORSK-HBMCJLEFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.2</td>
      <td>6crv</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB02152</td>
      <td>K-252a</td>
      <td>KOZFSFOOLUUIGY-SOLYNIJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12877</td>
      <td>Oxatomide</td>
      <td>BAINIUMDFURPJM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06930</td>
      <td>N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide</td>
      <td>WVLDNAVUCUAGDP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07072</td>
      <td>(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</td>
      <td>CNKRZILQBKJWDS-WMFXKJRFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07187</td>
      <td>6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE</td>
      <td>FXFPQPNUMWQRAO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08147</td>
      <td>4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid</td>
      <td>RMWVENXKUQXLPW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08043</td>
      <td>1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>DDDLGNOZDKDSEG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08142</td>
      <td>AT-7519</td>
      <td>OVPNQJVDAFNBDN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB02547</td>
      <td>Guanosine-5'-Diphosphate-Rhamnose</td>
      <td>LQEBEXMHBLQMDB-GDJBGNAASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB13029</td>
      <td>MK-0873</td>
      <td>JJWKQXNHYDJXKF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08125</td>
      <td>4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE</td>
      <td>BOMPRXSVSIPRDT-PTNGSMBKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB11968</td>
      <td>MK-7145</td>
      <td>OCKGFTQIICXDQW-ZEQRLZLVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB02545</td>
      <td>Fexaramine</td>
      <td>VLQTUNDJHLEFEQ-KGENOOAVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06932</td>
      <td>10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine</td>
      <td>NVINUNQBDNEMSY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB00607</td>
      <td>Nafcillin</td>
      <td>GPXLMGHLHQJAGZ-JTDSTZFVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB05038</td>
      <td>Anatibant</td>
      <td>XUHBBTKJWIBQMY-MHZLTWQESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB00836</td>
      <td>Loperamide</td>
      <td>RDOIQAHITMMDAJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB13104</td>
      <td>X-396</td>
      <td>ONPGOSVDVDPBCY-CQSZACIVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB02673</td>
      <td>(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium</td>
      <td>VLGAHTYYCHWLNI-BHRZLAGCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07141</td>
      <td>5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>QVXYJVHNRPNRJL-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08395</td>
      <td>2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE</td>
      <td>ZSOXFJURLPCSOO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08402</td>
      <td>2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID</td>
      <td>VNDRRWBKNSHALL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB11871</td>
      <td>PF-00610355</td>
      <td>YPHDIMUXXABSSO-YTTGMZPUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06771</td>
      <td>Besifloxacin</td>
      <td>QFFGVLORLPOAEC-SNVBAGLBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12558</td>
      <td>AEE-788</td>
      <td>OONFNUWBHFSNBT-HXUWFJFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB00682</td>
      <td>Warfarin</td>
      <td>PJVWKTKQMONHTI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB00635</td>
      <td>Prednisone</td>
      <td>XOFYZVNMUHMLCC-ZPOLXVRWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12904</td>
      <td>ZSTK-474</td>
      <td>HGVNLRPZOWWDKD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08424</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE</td>
      <td>IJDQETGUEUJVTB-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06737</td>
      <td>Zaltoprofen</td>
      <td>MUXFZBHBYYYLTH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08446</td>
      <td>3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile</td>
      <td>OHQMEDBYNUAVNE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB04724</td>
      <td>(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE</td>
      <td>COVPLULNDBDXTN-KYJUHHDHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB00547</td>
      <td>Desoximetasone</td>
      <td>VWVSBHGCDBMOOT-IIEHVVJPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB11819</td>
      <td>ASP-4058</td>
      <td>NJNXCJPSMWKXHO-VIFPVBQESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06730</td>
      <td>Gestodene</td>
      <td>SIGSPDASOTUPFS-XUDSTZEESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06741</td>
      <td>Gavestinel</td>
      <td>WZBNEZWCNKUOSM-VOTSOKGWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06833</td>
      <td>1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE</td>
      <td>MMIJMYOYKAKQPN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06869</td>
      <td>1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE</td>
      <td>BMHVHOJXEQTIEA-SIKLNZKXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB15156</td>
      <td>ABT-072</td>
      <td>XMZSTQYSBYEENY-RMKNXTFCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB11913</td>
      <td>LY-2090314</td>
      <td>HRJWTAWVFDCTGO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB05171</td>
      <td>E-2012</td>
      <td>PUOAETJYKQITMO-LANLRWRYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08292</td>
      <td>(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE</td>
      <td>AQKZYZQONWDDLS-IWQZZHSRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB05105</td>
      <td>Pleconaril</td>
      <td>KQOXLKOJHVFTRN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB11892</td>
      <td>Prulifloxacin</td>
      <td>PWNMXPDKBYZCOO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB13591</td>
      <td>Metopimazine</td>
      <td>BQDBKDMTIJBJLA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08699</td>
      <td>1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>FYCOTGCSHZKHPR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB04903</td>
      <td>Pagoclone</td>
      <td>HIUPRQPBWVEQJJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06897</td>
      <td>3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol</td>
      <td>MMGKIHLBFPJYJL-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB02573</td>
      <td>2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate</td>
      <td>LYWWDKIADIGKTH-IDMWBNCISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB13078</td>
      <td>KOSN-1724</td>
      <td>JAYGOFBXDFAXBW-CYEKYUJNSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB00663</td>
      <td>Flumethasone</td>
      <td>WXURHACBFYSXBI-GQKYHHCASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB13093</td>
      <td>TAK-593</td>
      <td>DZFZXPPHBWCXPQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02342</td>
      <td>2-Methoxyestradiol</td>
      <td>CQOQDQWUFQDJMK-SSTWWWIQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB01184</td>
      <td>Domperidone</td>
      <td>FGXWKSZFVQUSTL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07967</td>
      <td>9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE</td>
      <td>JJNKDTWKWYLERH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB04679</td>
      <td>H TYPE I TRISACCHARIDE</td>
      <td>MGSDFCKWGHNUSM-QVPNGJTFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07235</td>
      <td>N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE</td>
      <td>HHOVRZGUSBMKKU-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB14218</td>
      <td>Telotristat</td>
      <td>NCLGDOBQAWBXRA-PGRDOPGGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB01623</td>
      <td>Thiothixene</td>
      <td>GFBKORZTTCHDGY-UWVJOHFNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB06543</td>
      <td>Astaxanthin</td>
      <td>MQZIGYBFDRPAKN-UWFIBFSHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08164</td>
      <td>(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</td>
      <td>GOBIXGZJSMAOFV-QRWLVFNGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB14844</td>
      <td>ONC-201</td>
      <td>VLULRUCCHYVXOH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB02164</td>
      <td>N-Sulfo-Flavin Mononucleotide</td>
      <td>ZLPUGFBBLGQWBS-SCRDCRAPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08791</td>
      <td>1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE</td>
      <td>USLOIFPDNUDIEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB06518</td>
      <td>R-1487</td>
      <td>KKKRKRMVJRHDMG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07530</td>
      <td>(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol</td>
      <td>PCHUQQNKOFNVDU-OSXMSNBXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07536</td>
      <td>N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide</td>
      <td>FQYBTYFKOHPWQT-VGSWGCGISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB11818</td>
      <td>Retosiban</td>
      <td>PLVGDGRBPMVYPB-FDUHJNRSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12858</td>
      <td>LY-377604</td>
      <td>RBSGUQYXRDKPAE-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07133</td>
      <td>D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide</td>
      <td>CHKWABXWPATIIG-UXHICEINSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07567</td>
      <td>(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL</td>
      <td>XPVKGTWRXBSJKO-LHXLBICKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB04099</td>
      <td>Deamido-Nad+</td>
      <td>SENPVEZBRZQVST-HISDBWNOSA-O</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07245</td>
      <td>6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE</td>
      <td>AEVBKBAFFJKFJZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12550</td>
      <td>Taladegib</td>
      <td>SZBGQDXLNMELTB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12420</td>
      <td>Diazepinomicin</td>
      <td>SALVHVNECODMJP-GNUCVDFRSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02491</td>
      <td>4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine</td>
      <td>CJSSYVIHFXDFFC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07423</td>
      <td>(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide</td>
      <td>YVXVTLGIDOACBJ-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07257</td>
      <td>4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione</td>
      <td>WHMQZCPGFZBLBG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB06876</td>
      <td>N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE</td>
      <td>YJWJKKXGAPWLGT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB00590</td>
      <td>Doxazosin</td>
      <td>RUZYUOTYCVRMRZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12673</td>
      <td>ATX-914</td>
      <td>ALANRBCCCQEPFZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07321</td>
      <td>2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE</td>
      <td>KOKQLKWXOFRTHE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB01774</td>
      <td>Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester</td>
      <td>WFPZSXYXPSUOPY-ROYWQJLOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12659</td>
      <td>SJ-733</td>
      <td>VKCPFWKTFZAOTO-LEWJYISDSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07212</td>
      <td>N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE</td>
      <td>NNGZRCYXFBHMRM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB00568</td>
      <td>Cinnarizine</td>
      <td>DERZBLKQOCDDDZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB04908</td>
      <td>Flibanserin</td>
      <td>PPRRDFIXUUSXRA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB12644</td>
      <td>AZD-2066</td>
      <td>SXWHYTICXCLKDG-GFCCVEGCSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB06635</td>
      <td>Otamixaban</td>
      <td>PFGVNLZDWRZPJW-OPAMFIHVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02463</td>
      <td>2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine</td>
      <td>JPGNPKIYCTXJPG-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07415</td>
      <td>4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine</td>
      <td>RFLOFHKRBGKCOB-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB06605</td>
      <td>Apixaban</td>
      <td>QNZCBYKSOIHPEH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07426</td>
      <td>[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)</td>
      <td>NWIARQRYIRVYCM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07616</td>
      <td>4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid</td>
      <td>LKZZDHKJFDTYCH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB01501</td>
      <td>Difenoxin</td>
      <td>UFIVBRCCIRTJTN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12394</td>
      <td>Eleclazine</td>
      <td>YNUAEEJQYHYLMS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07936</td>
      <td>N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine</td>
      <td>BACSZMCLZIDTIO-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB02388</td>
      <td>Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</td>
      <td>UQFRSHRWRKYNDE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07027</td>
      <td>D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide</td>
      <td>JGZSVYZIJHGHMA-MOPGFXCFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07024</td>
      <td>2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE</td>
      <td>CEXBEGBNDJVZPK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB15105</td>
      <td>PF-06751979</td>
      <td>ZLZUHACSRMOLLV-RAALSFIWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07254</td>
      <td>N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</td>
      <td>KQGTYXRWSIBDOZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06590</td>
      <td>Ceftaroline fosamil</td>
      <td>ZCCUWMICIWSJIX-NQJJCJBVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB06090</td>
      <td>Bradanicline</td>
      <td>OXKRFEWMSWPKKV-GHTZIAJQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB08064</td>
      <td>N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA</td>
      <td>NTMADESEDXKNFZ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB01669</td>
      <td>Virginiamycin M1</td>
      <td>DAIKHDNSXMZDCU-FQTGFAPKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07011</td>
      <td>(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE</td>
      <td>HHOPJGKEAIIIDF-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06994</td>
      <td>(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine</td>
      <td>XCCSSVMRGIQMGF-LPHOPBHVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08034</td>
      <td>(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</td>
      <td>TVOPERZEGKBKAY-RGVLZGJSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB02466</td>
      <td>4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid</td>
      <td>ZXQHMEUGMCXKLO-KPKJPENVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07875</td>
      <td>5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide</td>
      <td>ARAVOODWJJJNBY-IRXDYDNUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB02360</td>
      <td>Bis-Napthyl Beta-Ketophosphonic Acid</td>
      <td>OFHMUASCSJJNNA-JOCHJYFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12812</td>
      <td>Palomid 529</td>
      <td>YEAHTLOYHVWAKW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB00637</td>
      <td>Astemizole</td>
      <td>GXDALQBWZGODGZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07638</td>
      <td>(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</td>
      <td>QJSMFUTULGSHNQ-ZOBUZTSGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07686</td>
      <td>4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>VPOGRVWIIVMWRI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB06409</td>
      <td>Morphine glucuronide</td>
      <td>GNJCUHZOSOYIEC-GAROZEBRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07064</td>
      <td>(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE</td>
      <td>HPVCRUIDFODATB-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07061</td>
      <td>1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL</td>
      <td>AXYFCRIRLKSCRR-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB01347</td>
      <td>Saprisartan</td>
      <td>DUEWVPTZCSAMNB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12345</td>
      <td>MBX-2982</td>
      <td>NFTMKHWBOINJGM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08305</td>
      <td>(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>KQAGZLQCEURCKJ-QGZVFWFLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07054</td>
      <td>(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL</td>
      <td>OSCWQKTUILTARV-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12590</td>
      <td>Indiplon</td>
      <td>CBIAWPMZSFFRGN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07768</td>
      <td>Epitestosterone</td>
      <td>MUMGGOZAMZWBJJ-KZYORJDKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12307</td>
      <td>Foretinib</td>
      <td>CXQHYVUVSFXTMY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07775</td>
      <td>3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE</td>
      <td>BRPKBUNFOZFULQ-SGAXSIHGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB12303</td>
      <td>Motolimod</td>
      <td>QSPOQCXMGPDIHI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB08366</td>
      <td>3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid</td>
      <td>XADCWKSMHQPTGH-OFBLZTNGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB00966</td>
      <td>Telmisartan</td>
      <td>RMMXLENWKUUMAY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07034</td>
      <td>2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID</td>
      <td>VOKATEXROYSXDW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB07049</td>
      <td>(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine</td>
      <td>SOFGQQQVQZQJFS-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB14555</td>
      <td>Ursadiol</td>
      <td>RTLXJEJRLWILSU-GWNGJUQLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB05608</td>
      <td>MKC-1</td>
      <td>OVSKGTONMLKNPZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08519</td>
      <td>N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>SQQAPOSROFWHIB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB00605</td>
      <td>Sulindac</td>
      <td>MLKXDPUZXIRXEP-MFOYZWKCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB00590</td>
      <td>Doxazosin</td>
      <td>RUZYUOTYCVRMRZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB02830</td>
      <td>FR236913</td>
      <td>KCCUBLLGAMGDJL-HXUWFJFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB13088</td>
      <td>AZD-0424</td>
      <td>MVWATCATLSSVBH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06274</td>
      <td>Alvimopan</td>
      <td>UPNUIXSCZBYVBB-JVFUWBCBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07458</td>
      <td>3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-KRWDZBQOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB00481</td>
      <td>Raloxifene</td>
      <td>GZUITABIAKMVPG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB07041</td>
      <td>N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide</td>
      <td>FDJWFDQRPKKBFA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB06134</td>
      <td>SNS-314</td>
      <td>FAYAUAZLLLJJGH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB13327</td>
      <td>Picotamide</td>
      <td>KYWCWBXGRWWINE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB07026</td>
      <td>(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</td>
      <td>PPLDARNGJSQINK-OKZBNKHCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB11611</td>
      <td>Lifitegrast</td>
      <td>JFOZKMSJYSPYLN-QHCPKHFHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07567</td>
      <td>(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL</td>
      <td>XPVKGTWRXBSJKO-LHXLBICKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB03476</td>
      <td>Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine</td>
      <td>NQRIWXVAIWPBEM-OALUTQOASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB00278</td>
      <td>Argatroban</td>
      <td>KXNPVXPOPUZYGB-IOVMHBDKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB06977</td>
      <td>(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine</td>
      <td>CAASENZOSQYNPX-HSTJUUNISA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB00620</td>
      <td>Triamcinolone</td>
      <td>GFNANZIMVAIWHM-OBYCQNJPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB03159</td>
      <td>CRA_8696</td>
      <td>GAVRMVQHHVMXFD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07570</td>
      <td>3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID</td>
      <td>ZKEZEXYKYHYIMQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13266</td>
      <td>Cefatrizine</td>
      <td>UOCJDOLVGGIYIQ-PBFPGSCMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12574</td>
      <td>LY-295501</td>
      <td>VAMFSFIPDOODFH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4b</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB01061</td>
      <td>Azlocillin</td>
      <td>JTWOMNBEOCYFNV-NFFDBFGFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB12198</td>
      <td>Fosdagrocorat</td>
      <td>BVXLAHSJXXSWFF-KEKPKEOLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13307</td>
      <td>Proscillaridin</td>
      <td>MYEJFUXQJGHEQK-ALRJYLEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB12128</td>
      <td>Ulimorelin</td>
      <td>WGYPAJVJMXQXTR-ABNZCKJZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB00972</td>
      <td>Azelastine</td>
      <td>MBUVEWMHONZEQD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB03336</td>
      <td>BIA</td>
      <td>KVIVJQWOYSWCCZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB13591</td>
      <td>Metopimazine</td>
      <td>BQDBKDMTIJBJLA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB03351</td>
      <td>Sri-9439</td>
      <td>KMSATRJZEXNGDP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB00932</td>
      <td>Tipranavir</td>
      <td>SUJUHGSWHZTSEU-FYBSXPHGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB12052</td>
      <td>Icariin</td>
      <td>TZJALUIVHRYQQB-XLRXWWTNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB05944</td>
      <td>Varlitinib</td>
      <td>UWXSAYUXVSFDBQ-CYBMUJFWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12850</td>
      <td>Etalocib</td>
      <td>YFIZRWPXUYFCSN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB07334</td>
      <td>N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</td>
      <td>HTIZPBXCJPQDEM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB03141</td>
      <td>3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril</td>
      <td>UYUWNNRWESUYOB-FIRIVFDPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB07296</td>
      <td>(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE</td>
      <td>PLGHLEBIWUQEPR-PDGQHHTCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08449</td>
      <td>2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid</td>
      <td>IEVFQDJUDLCOQY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12966</td>
      <td>Falnidamol</td>
      <td>FTFRZXFNZVCRSK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12764</td>
      <td>ABC-294640</td>
      <td>CAOTVXGYTWCKQE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08393</td>
      <td>2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL</td>
      <td>UQHINZSKNAAVOZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB13602</td>
      <td>Promegestone</td>
      <td>QFFCYTLOTYIJMR-XMGTWHOFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB13648</td>
      <td>Alcuronium</td>
      <td>MUQUYTSLDVKIOF-CHJKCJHBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB03638</td>
      <td>Cytidyl-2'-5'-Phospho-Guanosine</td>
      <td>QZDUXDLOEVJGDG-VMIOUTBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB14799</td>
      <td>PF-06821497</td>
      <td>RXCVUHMIWHRLDF-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB14854</td>
      <td>TC-6987</td>
      <td>UAKZGMMGIMKFMV-RBUKOAKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB14879</td>
      <td>Cefiderocol</td>
      <td>DBPPRLRVDVJOCL-FQRUVTKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB14937</td>
      <td>MK-8666</td>
      <td>CODQKEMYZZKQAE-QPVYNBJUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB13766</td>
      <td>Lidoflazine</td>
      <td>ZBIAKUMOEKILTF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08307</td>
      <td>2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE</td>
      <td>PMHVFNYNPNKNRO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13640</td>
      <td>Acetoxolone</td>
      <td>FTQDJVZNPJRVPG-XWEVEMRCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB14845</td>
      <td>Filgotinib</td>
      <td>RIJLVEAXPNLDTC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB03619</td>
      <td>Deoxycholic Acid</td>
      <td>KXGVEGMKQFWNSR-LLQZFEROSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB15028</td>
      <td>MK-1064</td>
      <td>CKTWQGHVNRYNCM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07267</td>
      <td>2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine</td>
      <td>JONFDFIXMPXTRH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4b</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB14766</td>
      <td>Etrasimod</td>
      <td>MVGWUTBTXDYMND-QGZVFWFLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB14729</td>
      <td>Rebeccamycin</td>
      <td>QEHOIJJIZXRMAN-QZQSLCQPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB09319</td>
      <td>Carindacillin</td>
      <td>JIRBAUWICKGBFE-MNRDOXJOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB14675</td>
      <td>Temsavir</td>
      <td>QRPZBKAMSFHVRW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB07144</td>
      <td>5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>XZXVRKHUCSXVBM-AWEZNQCLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13721</td>
      <td>Cypermethrin</td>
      <td>KAATUXNTWXVJKI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB13307</td>
      <td>Proscillaridin</td>
      <td>MYEJFUXQJGHEQK-ALRJYLEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12555</td>
      <td>Nelotanserin</td>
      <td>COSPVUFTLGQDQL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB06248</td>
      <td>Amelubant</td>
      <td>SBVYURPQULDJTI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13554</td>
      <td>Moperone</td>
      <td>AGAHNABIDCTLHW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07571</td>
      <td>N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE</td>
      <td>ZUWYQZGBCBSHFK-HSQYWUDLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB09048</td>
      <td>Netupitant</td>
      <td>WAXQNWCZJDTGBU-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4b</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB08973</td>
      <td>Fluclorolone acetonide</td>
      <td>NJNWEGFJCGYWQT-VSXGLTOVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB13729</td>
      <td>Camostat</td>
      <td>XASIMHXSUQUHLV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07578</td>
      <td>3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE</td>
      <td>WUOLYUKMMRCXGH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB13796</td>
      <td>Dibunate</td>
      <td>WBEBQCINXJDZCX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB00197</td>
      <td>Troglitazone</td>
      <td>GXPHKUHSUJUWKP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB15232</td>
      <td>Telaglenastat</td>
      <td>PRAAPINBUWJLGA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB13857</td>
      <td>Demegestone</td>
      <td>JWAHBTQSSMYISL-MHTWAQMVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB03507</td>
      <td>6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One</td>
      <td>UXGUZFZBZPPZGL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB06589</td>
      <td>Pazopanib</td>
      <td>CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB15367</td>
      <td>LY-2623091</td>
      <td>YPCLDHGBEKZGEB-RUDKWAFVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB14208</td>
      <td>Ramiprilat</td>
      <td>KEDYTOTWMPBSLG-HILJTLORSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB14209</td>
      <td>Trandolaprilat</td>
      <td>AHYHTSYNOHNUSH-HXFGRODQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB06494</td>
      <td>Sufugolix</td>
      <td>UCQSBGOFELXYIN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB14545</td>
      <td>Hydrocortisone succinate</td>
      <td>VWQWXZAWFPZJDA-CGVGKPPMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB08584</td>
      <td>6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB00455</td>
      <td>Loratadine</td>
      <td>JCCNYMKQOSZNPW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB03671</td>
      <td>4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>SHIBSTMRCDJXLN-KCZCNTNESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02812</td>
      <td>(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide</td>
      <td>VXDAVYUFYPFGDX-SNPRPXQTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB03642</td>
      <td>Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</td>
      <td>VBPPNJCVXGAZDD-PMACEKPBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12887</td>
      <td>Tazemetostat</td>
      <td>NSQSAUGJQHDYNO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07144</td>
      <td>5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>XZXVRKHUCSXVBM-AWEZNQCLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB11457</td>
      <td>Rotenone</td>
      <td>JUVIOZPCNVVQFO-HBGVWJBISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB11512</td>
      <td>Dihydrostreptomycin</td>
      <td>ASXBYYWOLISCLQ-HZYVHMACSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB03311</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</td>
      <td>SXKBTDJJEQQEGE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB03268</td>
      <td>RU82197</td>
      <td>WKTQBTSOHBKBRW-VMPREFPWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB03363</td>
      <td>3-Acetylpyridine Adenine Dinucleotide</td>
      <td>KPVQNXLUPNWQHM-RBEMOOQDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB11619</td>
      <td>Gestrinone</td>
      <td>BJJXHLWLUDYTGC-ANULTFPQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB03173</td>
      <td>CRA_10433</td>
      <td>CFSQPEBVGUSQII-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB03159</td>
      <td>CRA_8696</td>
      <td>GAVRMVQHHVMXFD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07375</td>
      <td>5-BETA-ANDROSTANE-3,17-DIONE</td>
      <td>RAJWOBJTTGJROA-QJISAEMRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB14982</td>
      <td>Miransertib</td>
      <td>HNFMVVHMKGFCMB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB03082</td>
      <td>6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide</td>
      <td>CSWQJKHBMACTGB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB14982</td>
      <td>Miransertib</td>
      <td>HNFMVVHMKGFCMB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB02812</td>
      <td>(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide</td>
      <td>VXDAVYUFYPFGDX-SNPRPXQTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07338</td>
      <td>Acifluorfen</td>
      <td>NUFNQYOELLVIPL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07334</td>
      <td>N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</td>
      <td>HTIZPBXCJPQDEM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB09200</td>
      <td>Rivoglitazone</td>
      <td>XMSXOLDPMGMWTH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07937</td>
      <td>2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine</td>
      <td>UGZWPZWADDDTRN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB00408</td>
      <td>Loxapine</td>
      <td>XJGVXQDUIWGIRW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08560</td>
      <td>3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE</td>
      <td>GULUFDCOGAXLEP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08608</td>
      <td>4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE</td>
      <td>IWFSHKKFDSWNLZ-BWACUDIHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08664</td>
      <td>({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER</td>
      <td>QUQQVMVIWCUYFV-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB04421</td>
      <td>Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct</td>
      <td>BZJFKYRGSZWSLT-YLIVDTKOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB03638</td>
      <td>Cytidyl-2'-5'-Phospho-Guanosine</td>
      <td>QZDUXDLOEVJGDG-VMIOUTBZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08794</td>
      <td>Ethyl biscoumacetate</td>
      <td>JCLHQFUTFHUXNN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB02873</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One</td>
      <td>YAWZIQKDHQIHOS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB14723</td>
      <td>Larotrectinib</td>
      <td>NYNZQNWKBKUAII-KBXCAEBGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12939</td>
      <td>Nikkomycin Z</td>
      <td>WWJFFVUVFNBJTN-VHDFTHOZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB08922</td>
      <td>Perospirone</td>
      <td>FBVFZWUMDDXLLG-HDICACEKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB04044</td>
      <td>4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>NAQUAVBNIYTIIS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB04006</td>
      <td>[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone</td>
      <td>WUGJIPFLBOATGL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02790</td>
      <td>Phenyl-Uridine-5'-Diphosphate</td>
      <td>ZHUWBKDWWGKIEN-FMKGYKFTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB00481</td>
      <td>Raloxifene</td>
      <td>GZUITABIAKMVPG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07856</td>
      <td>6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE</td>
      <td>HPWBHQIUIBFTQC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB09123</td>
      <td>Dienogest</td>
      <td>AZFLJNIPTRTECV-FUMNGEBKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB03744</td>
      <td>Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate</td>
      <td>RONLONYAIBUEKT-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB04040</td>
      <td>N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide</td>
      <td>MCMWCTMAKPQTPI-WGNYYXNJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB09178</td>
      <td>Phenaridine</td>
      <td>ODPKHHGQKIYCTJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB15245</td>
      <td>Olorofim</td>
      <td>SUFPWYYDCOKDLL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12941</td>
      <td>ODM-201</td>
      <td>BLIJXOOIHRSQRB-PXYINDEMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB11824</td>
      <td>Tofogliflozin</td>
      <td>VWVKUNOPTJGDOB-BDHVOXNPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB02587</td>
      <td>Colforsin</td>
      <td>OHCQJHSOBUTRHG-KGGHGJDLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB02519</td>
      <td>Indirubin-5-Sulphonate</td>
      <td>IHBOEHLUIBMBMY-YPKPFQOOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12203</td>
      <td>Tozadenant</td>
      <td>XNBRWUQWSKXMPW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB01764</td>
      <td>Dalfopristin</td>
      <td>SUYRLXYYZQTJHF-VMBLUXKRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB08005</td>
      <td>4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide</td>
      <td>ARMFMDYRYOKSOW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB01573</td>
      <td>Benzylmorphine</td>
      <td>RDJGWRFTDZZXSM-RNWLQCGYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12361</td>
      <td>Piclozotan</td>
      <td>URMTUEWUIGOJBW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12375</td>
      <td>Oglemilast</td>
      <td>OKFDRAHPFKMAJH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB03207</td>
      <td>2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid</td>
      <td>BNVMUDXGABBWGP-OAQYLSRUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06367</td>
      <td>Relacatib</td>
      <td>BWYBBMQLUKXECQ-GIVPXCGWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB05812</td>
      <td>Abiraterone</td>
      <td>GZOSMCIZMLWJML-VJLLXTKPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB01405</td>
      <td>Temafloxacin</td>
      <td>QKDHBVNJCZBTMR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB12434</td>
      <td>Steviolbioside</td>
      <td>OMHUCGDTACNQEX-OSHKXICASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12459</td>
      <td>Belotecan</td>
      <td>LNHWXBUNXOXMRL-VWLOTQADSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07490</td>
      <td>2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL</td>
      <td>MOZUMFSUQQHSCO-MRVPVSSYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13242</td>
      <td>Bucladesine</td>
      <td>CJGYSWNGNKCJSB-YVLZZHOMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB07181</td>
      <td>4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</td>
      <td>JYKFWUXBFJJDTP-HXUWFJFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12491</td>
      <td>Fasiglifam</td>
      <td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13252</td>
      <td>Tropatepine</td>
      <td>JOQKFRLFXDPXHX-HDICACEKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB07800</td>
      <td>N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE</td>
      <td>MIJGLXFQYBTIFY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12543</td>
      <td>Samidorphan</td>
      <td>RYIDHLJADOKWFM-MAODMQOUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12165</td>
      <td>Presatovir</td>
      <td>GOFXWTVKPWJNGD-UWJYYQICSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB11890</td>
      <td>Cilengitide</td>
      <td>AMLYAMJWYAIXIA-VWNVYAMZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB05408</td>
      <td>Emricasan</td>
      <td>SCVHJVCATBPIHN-SJCJKPOMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB08730</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</td>
      <td>CPFBZMFUCGHBAP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB13997</td>
      <td>Baloxavir marboxil</td>
      <td>RZVPBGBYGMDSBG-GGAORHGYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB11939</td>
      <td>Henagliflozin</td>
      <td>HYTPDMFFHVZBOR-VNXMGFANSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06460</td>
      <td>Enrasentan</td>
      <td>GLCKXJLCYIJMRB-UPRLRBBYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB13640</td>
      <td>Acetoxolone</td>
      <td>FTQDJVZNPJRVPG-XWEVEMRCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB13610</td>
      <td>Flumedroxone</td>
      <td>CDZJOBWKHSYNMO-SCUQKFFVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB02217</td>
      <td>Dpb-T</td>
      <td>WTZFKHNHHRPQOU-WSMBLCCSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB01831</td>
      <td>Tryptophanyl-5'amp</td>
      <td>IFQVDHDRFCKAAW-SQIXAUHQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB02177</td>
      <td>1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine</td>
      <td>GKGJFUXSTSUKPB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12048</td>
      <td>Savolitinib</td>
      <td>XYDNMOZJKOGZLS-NSHDSACASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB08164</td>
      <td>(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</td>
      <td>GOBIXGZJSMAOFV-QRWLVFNGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07680</td>
      <td>[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</td>
      <td>HUJXISJLAPAFBO-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13104</td>
      <td>X-396</td>
      <td>ONPGOSVDVDPBCY-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12101</td>
      <td>CC-220</td>
      <td>IXZOHGPZAQLIBH-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB06589</td>
      <td>Pazopanib</td>
      <td>CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB12127</td>
      <td>Sultamicillin</td>
      <td>OPYGFNJSCUDTBT-PMLPCWDUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07453</td>
      <td>2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE</td>
      <td>VFMMPHCGEFXGIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB13044</td>
      <td>Gossypol</td>
      <td>QBKSWRVVCFFDOT-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB08351</td>
      <td>N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</td>
      <td>MNEXDVSJIUQQRH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB05575</td>
      <td>Motesanib</td>
      <td>RAHBGWKEPAQNFF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02331</td>
      <td>(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>YBULOUKTPCHXAL-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB13256</td>
      <td>Clothiapine</td>
      <td>KAAZGXDPUNNEFN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12375</td>
      <td>Oglemilast</td>
      <td>OKFDRAHPFKMAJH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12341</td>
      <td>LY-2456302</td>
      <td>ZHPMYDSXGRRERG-DEOSSOPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB14581</td>
      <td>CPI-1205</td>
      <td>HPODOLXTMDHLLC-QGZVFWFLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB05511</td>
      <td>Piclidenoson</td>
      <td>HUJXGQILHAUCCV-MOROJQBDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12269</td>
      <td>PF-06273340</td>
      <td>BPIWZDNVMQQBQX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07835</td>
      <td>N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide</td>
      <td>BOPSUAHGQHFKGG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12020</td>
      <td>Tecovirimat</td>
      <td>CSKDFZIMJXRJGH-VWLPUNTISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB05482</td>
      <td>7-ethyl-10-hydroxycamptothecin</td>
      <td>FJHBVJOVLFPMQE-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB13252</td>
      <td>Tropatepine</td>
      <td>JOQKFRLFXDPXHX-HDICACEKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01431</td>
      <td>Allylestrenol</td>
      <td>ATXHVCQZZJYMCF-XUDSTZEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB14069</td>
      <td>ONT-093</td>
      <td>RSJCLODJSVZNQA-BQYQJAHWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12211</td>
      <td>PSI-697</td>
      <td>DIEPFYNZGUUVHD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB14152</td>
      <td>Ginsenosides</td>
      <td>NLHQJXWYMZLQJY-SWIZOJJJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB14541</td>
      <td>Hydrocortisone cypionate</td>
      <td>DLVOSEUFIRPIRM-KAQKJVHQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07811</td>
      <td>N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide</td>
      <td>UBVTVSINEVHYSY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06972</td>
      <td>7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile</td>
      <td>TZCXQSNBTXDAJG-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB14634</td>
      <td>Fluprednidene acetate</td>
      <td>DEFOZIFYUBUHHU-IYQKUMFPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12236</td>
      <td>Bexagliflozin</td>
      <td>BTCRKOKVYTVOLU-SJSRKZJXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB01831</td>
      <td>Tryptophanyl-5'amp</td>
      <td>IFQVDHDRFCKAAW-SQIXAUHQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07817</td>
      <td>1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea</td>
      <td>NJPVZSIGDRLLTD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB08973</td>
      <td>Fluclorolone acetonide</td>
      <td>NJNWEGFJCGYWQT-VSXGLTOVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB05812</td>
      <td>Abiraterone</td>
      <td>GZOSMCIZMLWJML-VJLLXTKPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07969</td>
      <td>3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol</td>
      <td>QNCYYRHIUFGGJX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12744</td>
      <td>CGI-1842</td>
      <td>ZXBFYBLSJMEBEP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12721</td>
      <td>RO-5028442</td>
      <td>QZXVLRCMAHJVIP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12781</td>
      <td>Balaglitazone</td>
      <td>IETKPTYAGKZLKY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12796</td>
      <td>MRX-I</td>
      <td>SULYVXZZUMRQAX-NSHDSACASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12673</td>
      <td>ATX-914</td>
      <td>ALANRBCCCQEPFZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB06833</td>
      <td>1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE</td>
      <td>MMIJMYOYKAKQPN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12659</td>
      <td>SJ-733</td>
      <td>VKCPFWKTFZAOTO-LEWJYISDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12877</td>
      <td>Oxatomide</td>
      <td>BAINIUMDFURPJM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12644</td>
      <td>AZD-2066</td>
      <td>SXWHYTICXCLKDG-GFCCVEGCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12910</td>
      <td>Emicerfont</td>
      <td>JFHJGXQFESYQGY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06746</td>
      <td>ginkgolide-J</td>
      <td>LMEHVEUFNRJAAV-UKWFQYJJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12183</td>
      <td>Sapitinib</td>
      <td>DFJSJLGUIXFDJP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06745</td>
      <td>ginkgolide-C</td>
      <td>AMOGMTLMADGEOQ-DTDWCABLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB15362</td>
      <td>LSZ-102</td>
      <td>SJXNPGGVGZXKKI-NYYWCZLTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08005</td>
      <td>4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide</td>
      <td>ARMFMDYRYOKSOW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06948</td>
      <td>2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE</td>
      <td>XWWRLKIBRPJQJX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12194</td>
      <td>Atamestane</td>
      <td>PEPMWUSGRKINHX-TXTPUJOMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB13078</td>
      <td>KOSN-1724</td>
      <td>JAYGOFBXDFAXBW-CYEKYUJNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06955</td>
      <td>3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid</td>
      <td>OAMCCJASDLMTOO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB08942</td>
      <td>Isoxicam</td>
      <td>YYUAYBYLJSNDCX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07973</td>
      <td>N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE</td>
      <td>GIPCBGDQVGKMPO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12385</td>
      <td>10-hydroxycamptothecin</td>
      <td>HAWSQZCWOQZXHI-FQEVSTJZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB13158</td>
      <td>Clobetasone</td>
      <td>XXIFVOHLGBURIG-OZCCCYNHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB14669</td>
      <td>Betamethasone phosphate</td>
      <td>VQODGRNSFPNSQE-DVTGEIKXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01450</td>
      <td>Dihydroetorphine</td>
      <td>BRTSNYPDACNMIP-FAWZKKEFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12238</td>
      <td>MK-0777</td>
      <td>QKIWQBLNTSQOLY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB15265</td>
      <td>USL-311</td>
      <td>XNUNVQKARNSSEO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB05016</td>
      <td>Ataluren</td>
      <td>OOUGLTULBSNHNF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB03678</td>
      <td>(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine</td>
      <td>WVGZKPGUHOZIJQ-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB15275</td>
      <td>GDC-0077</td>
      <td>SGEUNORSOZVTOL-CABZTGNLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07406</td>
      <td>(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE</td>
      <td>QWFFPYQWUWLDBV-NSHDSACASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB03638</td>
      <td>Cytidyl-2'-5'-Phospho-Guanosine</td>
      <td>QZDUXDLOEVJGDG-VMIOUTBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB11751</td>
      <td>Cabotegravir</td>
      <td>WCWSTNLSLKSJPK-LKFCYVNXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07395</td>
      <td>4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid</td>
      <td>NWQGDIBCFLDHDO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB05608</td>
      <td>MKC-1</td>
      <td>OVSKGTONMLKNPZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB11870</td>
      <td>RG-4733</td>
      <td>OJPLJFIFUQPSJR-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB00845</td>
      <td>Clofazimine</td>
      <td>WDQPAMHFFCXSNU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB11712</td>
      <td>Tezacaftor</td>
      <td>MJUVRTYWUMPBTR-MRXNPFEDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07359</td>
      <td>3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide</td>
      <td>SJTQKYKXCYVFHX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB09143</td>
      <td>Sonidegib</td>
      <td>VZZJRYRQSPEMTK-CALCHBBNSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB11886</td>
      <td>Infigratinib</td>
      <td>QADPYRIHXKWUSV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB11637</td>
      <td>Delamanid</td>
      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB03220</td>
      <td>FR233623</td>
      <td>OODDZQQDDOVCFD-SCLBCKFNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00146</td>
      <td>Calcifediol</td>
      <td>JWUBBDSIWDLEOM-DTOXIADCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00169</td>
      <td>Cholecalciferol</td>
      <td>QYSXJUFSXHHAJI-YRZJJWOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00180</td>
      <td>Flunisolide</td>
      <td>XSFJVAJPIHIPKU-XWCQMRHXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01526</td>
      <td>4-Androstenediol</td>
      <td>BTTWKVFKBPAFDK-LOVVWNRFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB11616</td>
      <td>Pirarubicin</td>
      <td>KMSKQZKKOZQFFG-YXRRJAAWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01061</td>
      <td>Azlocillin</td>
      <td>JTWOMNBEOCYFNV-NFFDBFGFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00319</td>
      <td>Piperacillin</td>
      <td>IVBHGBMCVLDMKU-GXNBUGAJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB15250</td>
      <td>Vercirnon</td>
      <td>JRWROCIMSDXGOZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB07029</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE</td>
      <td>QQBNDYARFVOEGW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12295</td>
      <td>Evodenoson</td>
      <td>SQJXTUJMBYVDBB-RQXXJAGISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9q</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07765</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>UKCFUFHREWUXJJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07717</td>
      <td>(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE</td>
      <td>AJODXHGZHBERGJ-JLYQOUBASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12096</td>
      <td>PF-05175157</td>
      <td>BDXXSFOJPYSYOC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB14844</td>
      <td>ONC-201</td>
      <td>VLULRUCCHYVXOH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB14899</td>
      <td>Tavapadon</td>
      <td>AKQXQLUNFKDZBN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06985</td>
      <td>2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid</td>
      <td>MEAQCLPMSVEOQF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07680</td>
      <td>[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</td>
      <td>HUJXISJLAPAFBO-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01469</td>
      <td>Acetorphine</td>
      <td>LFYBMMHFJIAKFE-PMEKXCSPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB11921</td>
      <td>Deflazacort</td>
      <td>FBHSPRKOSMHSIF-GRMWVWQJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9q</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB07215</td>
      <td>2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID</td>
      <td>ILUPZUOBHCUBKB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12253</td>
      <td>GDC-0810</td>
      <td>BURHGPHDEVGCEZ-KJGLQBJMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB11430</td>
      <td>Monensin</td>
      <td>GAOZTHIDHYLHMS-KEOBGNEYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07578</td>
      <td>3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE</td>
      <td>WUOLYUKMMRCXGH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB04131</td>
      <td>10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione</td>
      <td>BLGDWFJQIHBUJY-NWJGULHDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB15105</td>
      <td>PF-06751979</td>
      <td>ZLZUHACSRMOLLV-RAALSFIWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB15137</td>
      <td>VK-2809</td>
      <td>LGGPZDRLTDGYSQ-JADSYQMUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12275</td>
      <td>Seviteronel</td>
      <td>ZBRAJOQFSNYJMF-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB15183</td>
      <td>Fosmanogepix</td>
      <td>JQONJQKKVAHONF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB11804</td>
      <td>AZD-5672</td>
      <td>SCXSQUUTGCWHFU-WJOKGBTCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB11742</td>
      <td>Ebastine</td>
      <td>MJJALKDDGIKVBE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01082</td>
      <td>Streptomycin</td>
      <td>UCSJYZPVAKXKNQ-HZYVHMACSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB01289</td>
      <td>Glisoxepide</td>
      <td>ZKUDBRCEOBOWLF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07426</td>
      <td>[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)</td>
      <td>NWIARQRYIRVYCM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00351</td>
      <td>Megestrol acetate</td>
      <td>RQZAXGRLVPAYTJ-GQFGMJRRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB07026</td>
      <td>(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</td>
      <td>PPLDARNGJSQINK-OKZBNKHCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12776</td>
      <td>E-6005</td>
      <td>BBTFKAOFCSOZMB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07966</td>
      <td>[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile</td>
      <td>NVMCVWOODOWOLT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13991</td>
      <td>Pipequaline</td>
      <td>AMEWZCMTSIONOX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB11992</td>
      <td>Omarigliptin</td>
      <td>MKMPWKUAHLTIBJ-ISTRZQFTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB11800</td>
      <td>Tivozanib</td>
      <td>SPMVMDHWKHCIDT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13947</td>
      <td>Testosterone enantate benzilic acid hydrazone</td>
      <td>PTVXYACXDYZNID-JKXGKYMWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08546</td>
      <td>4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE</td>
      <td>CETLUACQMGBMFH-ZALSBGIRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB06922</td>
      <td>2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>CZNPWASYMRBJCX-GOSISDBHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB04898</td>
      <td>Ximelagatran</td>
      <td>ZXIBCJHYVWYIKI-PZJWPPBQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07685</td>
      <td>4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>NMAZGYDYIYLSLJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB08460</td>
      <td>3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile</td>
      <td>KXDIHAQCVNNLIB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07679</td>
      <td>(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid</td>
      <td>RRAAROKJUVKWAF-RDJZCZTQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB11864</td>
      <td>Preladenant</td>
      <td>DTYWJKSSUANMHD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB11652</td>
      <td>Tucatinib</td>
      <td>SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13865</td>
      <td>Dehydroemetine</td>
      <td>XXLZPUYGHQWHRN-RPBOFIJWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13843</td>
      <td>Cloprednol</td>
      <td>YTJIBEDMAQUYSZ-FDNPDPBUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13806</td>
      <td>Linopirdine</td>
      <td>YEJCDKJIEMIWRQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB11922</td>
      <td>Danirixin</td>
      <td>NGYNBSHYFOFVLS-LBPRGKRZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13764</td>
      <td>Monoxerutin</td>
      <td>MBHXKZDTQCSVPM-BDAFLREQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB11963</td>
      <td>Dacomitinib</td>
      <td>LVXJQMNHJWSHET-AATRIKPKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08459</td>
      <td>3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>SVMHTBVIPYVDIL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB06589</td>
      <td>Pazopanib</td>
      <td>CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB11969</td>
      <td>Uprosertib</td>
      <td>AXTAPYRUEKNRBA-JTQLQIEISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13919</td>
      <td>Candesartan</td>
      <td>HTQMVQVXFRQIKW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12100</td>
      <td>Abediterol</td>
      <td>SFYAXIFVXBKRPK-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB14581</td>
      <td>CPI-1205</td>
      <td>HPODOLXTMDHLLC-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12078</td>
      <td>Enobosarm</td>
      <td>JNGVJMBLXIUVRD-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06875</td>
      <td>3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE</td>
      <td>NSSOSHDCWCMNDM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB14802</td>
      <td>ONO-2952</td>
      <td>ZBQMTQGDBFZUBG-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB09050</td>
      <td>Ceftolozane</td>
      <td>JHFNIHVVXRKLEF-DCZLAGFPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB14790</td>
      <td>BPN-14770</td>
      <td>KRRGWHSEDYQKDQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB08400</td>
      <td>4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid</td>
      <td>KUEKMTNOUPAOBS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB11769</td>
      <td>Funapide</td>
      <td>NEBUOXBYNAHKFV-NRFANRHFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB14681</td>
      <td>Cortisone</td>
      <td>MFYSYFVPBJMHGN-ZPOLXVRWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12092</td>
      <td>Naftopidil</td>
      <td>HRRBJVNMSRJFHQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB14669</td>
      <td>Betamethasone phosphate</td>
      <td>VQODGRNSFPNSQE-DVTGEIKXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB08049</td>
      <td>7,8-dihydroxy-4-phenyl-2H-chromen-2-one</td>
      <td>JRVIIPJSVKTPBK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB08043</td>
      <td>1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>DDDLGNOZDKDSEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB14876</td>
      <td>TAS-116</td>
      <td>NVVPMZUGELHVMH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08755</td>
      <td>N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide</td>
      <td>MQWUTQCRGGBPBT-WIOPSUGQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB11426</td>
      <td>Marbofloxacin</td>
      <td>BPFYOAJNDMUVBL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB08439</td>
      <td>Parecoxib</td>
      <td>TZRHLKRLEZJVIJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08746</td>
      <td>1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE</td>
      <td>ZOSSOFIFNGGDKG-GIJQJNRQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB11485</td>
      <td>Ceftiofur</td>
      <td>ZBHXIWJRIFEVQY-IHMPYVIRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12021</td>
      <td>Dinaciclib</td>
      <td>PIMQWRZWLQKKBJ-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01184</td>
      <td>Domperidone</td>
      <td>FGXWKSZFVQUSTL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB14625</td>
      <td>Meprednisone acetate</td>
      <td>RZAMUHXEOMZXET-ABQXZQTJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB11971</td>
      <td>Vilaprisan</td>
      <td>JUFWQQVHQFDUOD-ANRPBIDPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08446</td>
      <td>3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile</td>
      <td>OHQMEDBYNUAVNE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12025</td>
      <td>Triptolide</td>
      <td>DFBIRQPKNDILPW-CIVMWXNOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12420</td>
      <td>Diazepinomicin</td>
      <td>SALVHVNECODMJP-GNUCVDFRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB15126</td>
      <td>IMG-7289</td>
      <td>KQKBMHGOHXOHTD-KKUQBAQOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07263</td>
      <td>[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid</td>
      <td>WDTMVBQZDFMOIK-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12447</td>
      <td>Nadifloxacin</td>
      <td>JYJTVFIEFKZWCJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12467</td>
      <td>TU-100</td>
      <td>KAYRGFYBCCETPE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08191</td>
      <td>4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid</td>
      <td>KSFDVNIKNYXUIP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12904</td>
      <td>ZSTK-474</td>
      <td>HGVNLRPZOWWDKD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB11925</td>
      <td>Vistusertib</td>
      <td>JUSFANSTBFGBAF-IRXDYDNUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12512</td>
      <td>Verucerfont</td>
      <td>VKHVAUKFLBBZFJ-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12522</td>
      <td>Toreforant</td>
      <td>FCRFVPZAXGJLPW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06800</td>
      <td>Methylnaltrexone</td>
      <td>JVLBPIPGETUEET-WIXLDOGYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01342</td>
      <td>Forasartan</td>
      <td>YONOBYIBNBCDSJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08138</td>
      <td>{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide</td>
      <td>BDRDBXXWQDFXEC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12553</td>
      <td>Fluocinolone</td>
      <td>UUOUOERPONYGOS-CLCRDYEYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12155</td>
      <td>Napabucasin</td>
      <td>DPHUWDIXHNQOSY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12562</td>
      <td>Setipiprant</td>
      <td>IHAXLPDVOWLUOS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07226</td>
      <td>N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE</td>
      <td>JWZVNUNTFNELHL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12591</td>
      <td>BMS-911543</td>
      <td>JCINBYQJBYJGDM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12598</td>
      <td>Nafamostat</td>
      <td>MQQNFDZXWVTQEH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07212</td>
      <td>N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE</td>
      <td>NNGZRCYXFBHMRM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12805</td>
      <td>Ataciguat</td>
      <td>PQHLRGARXNPFCF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB07021</td>
      <td>(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine</td>
      <td>SOSYXEPELJIJHZ-RNCFNFMXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB07025</td>
      <td>3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</td>
      <td>KBIHHEGEALBUMT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12658</td>
      <td>AFN-1252</td>
      <td>QXTWSUQCXCWEHF-JXMROGBWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12952</td>
      <td>Methylprednisone</td>
      <td>SVYCRJXQZUCUND-PQXSVQADSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07156</td>
      <td>(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione</td>
      <td>JFEKAVPMVOLVTH-UNOMPAQXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12973</td>
      <td>Serlopitant</td>
      <td>FLNYCRJBCNNHRH-OIYLJQICSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB15108</td>
      <td>Tipranavir C-14</td>
      <td>SUJUHGSWHZTSEU-MWQIXQBFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12052</td>
      <td>Icariin</td>
      <td>TZJALUIVHRYQQB-XLRXWWTNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08429</td>
      <td>N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide</td>
      <td>QRGBOABBMKYMLG-UXHICEINSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12114</td>
      <td>Poziotinib</td>
      <td>LPFWVDIFUFFKJU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB08520</td>
      <td>(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE</td>
      <td>VUCSBBBCFXBFFY-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12122</td>
      <td>Figopitant</td>
      <td>HUTHJVYJUPXHDF-DEOSSOPVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12135</td>
      <td>Elubrixin</td>
      <td>YQYFEGTYCUQBEI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13393</td>
      <td>Emetine</td>
      <td>AUVVAXYIELKVAI-CKBKHPSWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01264</td>
      <td>Darunavir</td>
      <td>CJBJHOAVZSMMDJ-HEXNFIEUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08389</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UPTQSRGSSJRBKJ-LJQANCHMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12203</td>
      <td>Tozadenant</td>
      <td>XNBRWUQWSKXMPW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01326</td>
      <td>Cefamandole</td>
      <td>OLVCFLKTBJRLHI-AXAPSJFSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12252</td>
      <td>PG-701</td>
      <td>OKRSVUYYCJPECG-LFGMFVMYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13215</td>
      <td>Sulfobromophthalein</td>
      <td>OHTXTCNTQJFRIG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08350</td>
      <td>5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE</td>
      <td>GYQRHHQPEMOLKH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12284</td>
      <td>LY-2608204</td>
      <td>QIIVJLHCZUTGSD-CUBQBAPOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB13126</td>
      <td>BMS-986115</td>
      <td>SRJNRAQUSAVENA-GSHUGGBRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12336</td>
      <td>GDC-0917</td>
      <td>HSHPBORBOJIXSQ-HARLFGEKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12341</td>
      <td>LY-2456302</td>
      <td>ZHPMYDSXGRRERG-DEOSSOPVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08242</td>
      <td>N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide</td>
      <td>OYTBZXSFNNAVKU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB08834</td>
      <td>Tauroursodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-LBSADWJPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB12986</td>
      <td>VS-5584</td>
      <td>QYBGBLQCOOISAR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12394</td>
      <td>Eleclazine</td>
      <td>YNUAEEJQYHYLMS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB12408</td>
      <td>PF-03635659</td>
      <td>WGOJWDWKHJHXSV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08353</td>
      <td>2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>NCVMTHVSAJMOPI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB11698</td>
      <td>Ipragliflozin</td>
      <td>AHFWIQIYAXSLBA-RQXATKFSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB09171</td>
      <td>??-Methylfentanyl</td>
      <td>UXIGUKSHASXDNI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB04232</td>
      <td>N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide</td>
      <td>DNGGPLKVDUPXFN-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB15356</td>
      <td>SLV-334</td>
      <td>LOFDNSDPZTVIIO-VPUSJEBWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB04716</td>
      <td>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</td>
      <td>VNDWQCSOSCCWIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB15294</td>
      <td>SB-1578</td>
      <td>NNXDIGHYPZHXTR-ONEGZZNKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB04608</td>
      <td>9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</td>
      <td>IAUZTOZLTFSMIE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB04378</td>
      <td>3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</td>
      <td>APJAEXGNDLFGPD-AWCRTANDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB12952</td>
      <td>Methylprednisone</td>
      <td>SVYCRJXQZUCUND-PQXSVQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12558</td>
      <td>AEE-788</td>
      <td>OONFNUWBHFSNBT-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07815</td>
      <td>GIBBERELLIN A4</td>
      <td>RSQSQJNRHICNNH-NFMPGMCNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB04698</td>
      <td>N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</td>
      <td>HJWYZPGYPZNDTN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB04471</td>
      <td>2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>FMWVCTJKLAVRPB-MUUNZHRXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12571</td>
      <td>Rimacalib</td>
      <td>MYTIJGWONQOOLC-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB15266</td>
      <td>TAK-580</td>
      <td>VWMJHAFYPMOMGF-ZCFIWIBFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB04596</td>
      <td>4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid</td>
      <td>GZJXZKGVHLWBOW-AISSFXTFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB09078</td>
      <td>Lenvatinib</td>
      <td>WOSKHXYHFSIKNG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12420</td>
      <td>Diazepinomicin</td>
      <td>SALVHVNECODMJP-GNUCVDFRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB04378</td>
      <td>3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</td>
      <td>APJAEXGNDLFGPD-AWCRTANDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB04644</td>
      <td>4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID</td>
      <td>FCEMCUPAYRPTLS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9q</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08536</td>
      <td>3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine</td>
      <td>IBUPHWYGVDAASU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB15268</td>
      <td>Afabicin</td>
      <td>HFYMDQMXVPJNTH-VQHVLOKHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB04689</td>
      <td>2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID</td>
      <td>ZXWVCCFKIRBLDP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01946</td>
      <td>3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione</td>
      <td>UQHKJRCFSLMWIA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03962</td>
      <td>Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate</td>
      <td>MDKMTCCUJSRQGW-NAJQWHGHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB08068</td>
      <td>N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</td>
      <td>YQJVDUKATDECHF-ICSRJNTNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9q</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB05263</td>
      <td>Caprospinol</td>
      <td>VMOZFSWFUBLCNN-AAPULDEBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB08057</td>
      <td>N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine</td>
      <td>VWJPPYCULHDHBB-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03161</td>
      <td>Thymidine-5'-Diphospho-Beta-D-Xylose</td>
      <td>AJUADKZRQSBUAK-KDGZBOQCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03221</td>
      <td>AL7099A</td>
      <td>RMOXCYSVWCHXII-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB09223</td>
      <td>Blonanserin</td>
      <td>XVGOZDAJGBALKS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03267</td>
      <td>1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine</td>
      <td>XFOWZKUTPKXWIE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB09219</td>
      <td>Bisoxatin</td>
      <td>BPKUDUSVDVLOPY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03351</td>
      <td>Sri-9439</td>
      <td>KMSATRJZEXNGDP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB07789</td>
      <td>1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea</td>
      <td>KNTGXMNWVXZIMW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03446</td>
      <td>N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide</td>
      <td>FSMWGHKWKYCPKE-QTVCLEQKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01876</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methanone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03696</td>
      <td>Lanosterol</td>
      <td>CAHGCLMLTWQZNJ-BQNIITSRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03714</td>
      <td>4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid</td>
      <td>OWWCIKSGGKYNHT-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03742</td>
      <td>Compound 4-D</td>
      <td>TWZNCTCQAGRUGQ-RRPNLBNLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12524</td>
      <td>BI-671800</td>
      <td>XEOSTBFUCNZKGS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07946</td>
      <td>N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>DZEJHPMTDNDECN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB04759</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)</td>
      <td>GTBUZLPQANSGGE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB03893</td>
      <td>Thionicotinamide-Adenine-Dinucleotide</td>
      <td>UQYPZLRUJKCREN-NNYOXOHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB04761</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]</td>
      <td>NHPBWKYFMTXWAA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB04689</td>
      <td>2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID</td>
      <td>ZXWVCCFKIRBLDP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB04693</td>
      <td>(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE</td>
      <td>CRDKSBHJIGNEOH-IMRIKWHGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07728</td>
      <td>2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>XJJYJNMNYDNXNO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB15173</td>
      <td>JNJ-42165279</td>
      <td>YWGYNGCRVZLMCS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB03207</td>
      <td>2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid</td>
      <td>BNVMUDXGABBWGP-OAQYLSRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06281</td>
      <td>Torcetrapib</td>
      <td>CMSGWTNRGKRWGS-NQIIRXRSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB13947</td>
      <td>Testosterone enantate benzilic acid hydrazone</td>
      <td>PTVXYACXDYZNID-JKXGKYMWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB00705</td>
      <td>Delavirdine</td>
      <td>WHBIGIKBNXZKFE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07311</td>
      <td>18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE</td>
      <td>JRSWWYITYIOHOP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06321</td>
      <td>R-348</td>
      <td>IGLNXKVGKIFNBQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07296</td>
      <td>(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE</td>
      <td>PLGHLEBIWUQEPR-PDGQHHTCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06346</td>
      <td>Fiboflapon</td>
      <td>DFQGDHBGRSTTHX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02224</td>
      <td>Taxifolin</td>
      <td>CXQWRCVTCMQVQX-LSDHHAIUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB03141</td>
      <td>3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril</td>
      <td>UYUWNNRWESUYOB-FIRIVFDPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9q</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB13520</td>
      <td>Metergoline</td>
      <td>WZHJKEUHNJHDLS-QTGUNEKASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06510</td>
      <td>Muraglitazar</td>
      <td>IRLWJILLXJGJTD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06532</td>
      <td>Pafuramidine</td>
      <td>UKOQVLAXCBRRGH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07216</td>
      <td>(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE</td>
      <td>ZMGCFGGMTCMSDP-QHCPKHFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12680</td>
      <td>Intepirdine</td>
      <td>JJZFWROHYSMCMU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08954</td>
      <td>Ifenprodil</td>
      <td>UYNVMODNBIQBMV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08360</td>
      <td>2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>BIFHJPUTQBOBGJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06635</td>
      <td>Otamixaban</td>
      <td>PFGVNLZDWRZPJW-OPAMFIHVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB12550</td>
      <td>Taladegib</td>
      <td>SZBGQDXLNMELTB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB07334</td>
      <td>N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</td>
      <td>HTIZPBXCJPQDEM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB05465</td>
      <td>Tandutinib</td>
      <td>UXXQOJXBIDBUAC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06213</td>
      <td>Regadenoson</td>
      <td>LZPZPHGJDAGEJZ-AKAIJSEGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB14675</td>
      <td>Temsavir</td>
      <td>QRPZBKAMSFHVRW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12585</td>
      <td>Ondelopran</td>
      <td>QWNDOCKIKKQJNN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB14768</td>
      <td>PF-06459988</td>
      <td>ODMXWZROLKITMS-RISCZKNCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB04793</td>
      <td>1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol</td>
      <td>DKBAWRNTUZFJKV-XMTFNYHQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02069</td>
      <td>N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide</td>
      <td>ULYMHSXFSKOHGH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB04797</td>
      <td>Triazolopyridine</td>
      <td>OVCXRBARSPBVMC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB04514</td>
      <td>Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester</td>
      <td>DFYLLEBFVZTKHD-VMIOUTBZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB04023</td>
      <td>Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester</td>
      <td>DNBSDUDYNPJVCN-ZXTXFPBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9q</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02081</td>
      <td>Bis-Benzamidine</td>
      <td>BXYGSMRTHHSAHZ-PMACEKPBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB13024</td>
      <td>MK-8245</td>
      <td>UJEAABFSXKCSGI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07140</td>
      <td>5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>JPENSYBRTSIYGO-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB03744</td>
      <td>Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate</td>
      <td>RONLONYAIBUEKT-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB05316</td>
      <td>Pimavanserin</td>
      <td>RKEWSXXUOLRFBX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB05327</td>
      <td>Ranirestat</td>
      <td>QCVNMNYRNIMDKV-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB14937</td>
      <td>MK-8666</td>
      <td>CODQKEMYZZKQAE-QPVYNBJUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB05422</td>
      <td>OPC-14523</td>
      <td>TZZGTNZBLPCBIS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB05424</td>
      <td>Canertinib</td>
      <td>OMZCMEYTWSXEPZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB02118</td>
      <td>CP-271485</td>
      <td>CIUMOGWIMXNXSQ-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08460</td>
      <td>3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile</td>
      <td>KXDIHAQCVNNLIB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB05590</td>
      <td>Bedoradrine</td>
      <td>OANCEOSLKSTLTA-REWPJTCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB13072</td>
      <td>GDC-0349</td>
      <td>RGJOJUGRHPQXGF-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12483</td>
      <td>Copanlisib</td>
      <td>PZBCKZWLPGJMAO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08997</td>
      <td>Dexetimide</td>
      <td>LQQIVYSCPWCSSD-HSZRJFAPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB06137</td>
      <td>KX-01</td>
      <td>HUNGUWOZPQBXGX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9q</td>
      <td>DB15029</td>
      <td>AZD-8186</td>
      <td>LMJFJIDLEAWOQJ-CQSZACIVSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02915</td>
      <td>4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine</td>
      <td>MEZFDQUDLQCVNX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02873</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One</td>
      <td>YAWZIQKDHQIHOS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB02354</td>
      <td>4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine</td>
      <td>IRKPNOLLMNHSOU-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB04797</td>
      <td>Triazolopyridine</td>
      <td>OVCXRBARSPBVMC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01589</td>
      <td>Quazepam</td>
      <td>IKMPWMZBZSAONZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB11992</td>
      <td>Omarigliptin</td>
      <td>MKMPWKUAHLTIBJ-ISTRZQFTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB05038</td>
      <td>Anatibant</td>
      <td>XUHBBTKJWIBQMY-MHZLTWQESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB06948</td>
      <td>2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE</td>
      <td>XWWRLKIBRPJQJX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01082</td>
      <td>Streptomycin</td>
      <td>UCSJYZPVAKXKNQ-HZYVHMACSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB06916</td>
      <td>N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE</td>
      <td>LBCGUKCXRVUULK-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB11491</td>
      <td>Sarafloxacin</td>
      <td>XBHBWNFJWIASRO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB11984</td>
      <td>Letaxaban</td>
      <td>GEHAEMCVKDPMKO-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01602</td>
      <td>Bacampicillin</td>
      <td>PFOLLRNADZZWEX-FFGRCDKISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB08833</td>
      <td>Taurochenodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-BJLOMENOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB01764</td>
      <td>Dalfopristin</td>
      <td>SUYRLXYYZQTJHF-VMBLUXKRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01261</td>
      <td>Sitagliptin</td>
      <td>MFFMDFFZMYYVKS-SECBINFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01668</td>
      <td>Nanaomycin D</td>
      <td>XUWPJKDMEZSVTP-UOSCCXBLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06654</td>
      <td>Safinamide</td>
      <td>NEMGRZFTLSKBAP-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB05100</td>
      <td>Prinomastat</td>
      <td>YKPYIPVDTNNYCN-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01338</td>
      <td>Pipecuronium</td>
      <td>OWWLUIWOFHMHOQ-XGHATYIMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07036</td>
      <td>(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol</td>
      <td>GPFRMIHXGMVMGF-BZSNNMDCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01705</td>
      <td>Bis(5-Amidino-Benzimidazolyl)Methane</td>
      <td>QZKOOEFIMWKZPK-UHFFFAOYSA-Q</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01420</td>
      <td>Testosterone propionate</td>
      <td>PDMMFKSKQVNJMI-BLQWBTBKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB06744</td>
      <td>ginkgolide-B</td>
      <td>SQOJOAFXDQDRGF-MMQTXUMRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB04792</td>
      <td>2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL</td>
      <td>CDEVHSIVANGYRI-XMTFNYHQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07006</td>
      <td>9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE</td>
      <td>AOGOZJCRIFBTTN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00923</td>
      <td>Ceforanide</td>
      <td>SLAYUXIURFNXPG-CRAIPNDOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB09048</td>
      <td>Netupitant</td>
      <td>WAXQNWCZJDTGBU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00421</td>
      <td>Spironolactone</td>
      <td>LXMSZDCAJNLERA-ZHYRCANASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07229</td>
      <td>3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE</td>
      <td>MINVOLKUPZPDNX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00450</td>
      <td>Droperidol</td>
      <td>RMEDXOLNCUSCGS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07226</td>
      <td>N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE</td>
      <td>JWZVNUNTFNELHL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07204</td>
      <td>(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</td>
      <td>DQIXTEDFNFZMCM-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00528</td>
      <td>Lercanidipine</td>
      <td>ZDXUKAKRHYTAKV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07186</td>
      <td>4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE</td>
      <td>TYYNSDQVFIOSFH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB11663</td>
      <td>Pictilisib</td>
      <td>LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB05412</td>
      <td>Talmapimod</td>
      <td>ZMELOYOKMZBMRB-DLBZAZTESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00603</td>
      <td>Medroxyprogesterone acetate</td>
      <td>PSGAAPLEWMOORI-PEINSRQWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB09272</td>
      <td>Eluxadoline</td>
      <td>QFNHIDANIVGXPE-FNZWTVRRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB02691</td>
      <td>Glycocholic acid</td>
      <td>RFDAIACWWDREDC-FRVQLJSFSA-M</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB11958</td>
      <td>Brivanib</td>
      <td>WCWUXEGQKLTGDX-LLVKDONJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00705</td>
      <td>Delavirdine</td>
      <td>WHBIGIKBNXZKFE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07081</td>
      <td>(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>FDEXEPZGMKFCTG-PSASIEDQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB07072</td>
      <td>(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</td>
      <td>CNKRZILQBKJWDS-WMFXKJRFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9q</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12180</td>
      <td>Apitolisib</td>
      <td>YOVVNQKCSKSHKT-HNNXBMFYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB04823</td>
      <td>Oxyphenisatin</td>
      <td>SJDACOMXKWHBOW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB00862</td>
      <td>Vardenafil</td>
      <td>SECKRCOLJRRGGV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB11577</td>
      <td>Indigotindisulfonic Acid</td>
      <td>CFZXDJWFRVEWSR-BUHFOSPRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01436</td>
      <td>Alfacalcidol</td>
      <td>OFHCOWSQAMBJIW-AVJTYSNKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB06743</td>
      <td>Ginkgolide A</td>
      <td>FPUXKXIZEIDQKW-VKMVSBOZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB12380</td>
      <td>GDC-0152</td>
      <td>WZRFLSDVFPIXOV-LRQRDZAKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02155</td>
      <td>Balanol Analog 8</td>
      <td>XVLMXAUKCDSMMW-YXLARRHKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02194</td>
      <td>8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>ULLMMKZQNNBLRN-SANMLTNESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB00921</td>
      <td>Buprenorphine</td>
      <td>RMRJXGBAOAMLHD-IHFGGWKQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB12441</td>
      <td>Tavilermide</td>
      <td>DVJXNXPFYJIACK-ULQDDVLXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB12419</td>
      <td>HSD-016</td>
      <td>ZWASRJHIEFYJGL-BFUOFWGJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB08353</td>
      <td>2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>NCVMTHVSAJMOPI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB06228</td>
      <td>Rivaroxaban</td>
      <td>KGFYHTZWPPHNLQ-AWEZNQCLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02341</td>
      <td>Mdl 101,146</td>
      <td>XQAMVCHQGHAELT-YPAWHYETSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB08305</td>
      <td>(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>KQAGZLQCEURCKJ-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02421</td>
      <td>Uridine-5'-Diphosphate-Mannose</td>
      <td>HSCJRCZFDFQWRP-NYYOCOOHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB08268</td>
      <td>6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</td>
      <td>SPVJRTJUEVXOMS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01774</td>
      <td>Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester</td>
      <td>WFPZSXYXPSUOPY-ROYWQJLOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02505</td>
      <td>N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)</td>
      <td>JJVQUUYZGJWBPW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02545</td>
      <td>Fexaramine</td>
      <td>VLQTUNDJHLEFEQ-KGENOOAVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB02449</td>
      <td>3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid</td>
      <td>ULOTXPTWJAUGGE-MHZLTWQESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB01780</td>
      <td>Fusicoccin</td>
      <td>KXTYBXCEQOANSX-WYKQKOHHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB06011</td>
      <td>AMG-222</td>
      <td>NVSWJKWHLUTHLP-CPJSRVTESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB12430</td>
      <td>BC-3781</td>
      <td>KPVIXBKIJXZQJX-IJUBVZAWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02639</td>
      <td>4-methylumbelliferyl ??-D-glucoside</td>
      <td>YUDPTGPSBJVHCN-JZYAIQKZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB09330</td>
      <td>Osimertinib</td>
      <td>DUYJMQONPNNFPI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB04764</td>
      <td>[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</td>
      <td>CCLHROFBSWWOQO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02716</td>
      <td>7-Methyl-Guanosine-5'-Triphosphate</td>
      <td>DKVRNHPCAOHRSI-KQYNXXCUSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxx</td>
      <td>DB00486</td>
      <td>Nabilone</td>
      <td>GECBBEABIDMGGL-RTBURBONSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB00858</td>
      <td>Drostanolone</td>
      <td>IKXILDNPCZPPRV-RFMGOVQKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB02152</td>
      <td>K-252a</td>
      <td>KOZFSFOOLUUIGY-SOLYNIJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB05552</td>
      <td>TG100-115</td>
      <td>UJIAQDJKSXQLIT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB04875</td>
      <td>Pralnacasan</td>
      <td>CXAGHAZMQSCAKJ-WAHHBDPQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01493</td>
      <td>Ethylestrenol</td>
      <td>AOXRBFRFYPMWLR-XGXHKTLJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01513</td>
      <td>17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane</td>
      <td>QGKQXZFZOIQFBI-UYEYMFBJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01524</td>
      <td>Androstenediol</td>
      <td>QADHLRWLCPCEKT-LOVVWNRFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01536</td>
      <td>Androstenedione</td>
      <td>AEMFNILZOJDQLW-QAGGRKNESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9c</td>
      <td>DB08549</td>
      <td>(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER</td>
      <td>MFDBNNQUDZFSES-KRWDZBQOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01586</td>
      <td>Ursodeoxycholic acid</td>
      <td>RUDATBOHQWOJDD-UZVSRGJWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01668</td>
      <td>Nanaomycin D</td>
      <td>XUWPJKDMEZSVTP-UOSCCXBLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06649</td>
      <td>Priralfinamide</td>
      <td>BHJIBOFHEFDSAU-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB04696</td>
      <td>4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN</td>
      <td>GFGZCXHXQCQRFP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB04698</td>
      <td>N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</td>
      <td>HJWYZPGYPZNDTN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01765</td>
      <td>(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid</td>
      <td>INSBKYCYLCEBOD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01768</td>
      <td>Methylumbelliferyl Sialic Acid</td>
      <td>KKDWIUJBUSOPGC-GKHMPSLRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01774</td>
      <td>Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester</td>
      <td>WFPZSXYXPSUOPY-ROYWQJLOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01793</td>
      <td>SB-409513</td>
      <td>ONVZFCHLOZUXRP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB14675</td>
      <td>Temsavir</td>
      <td>QRPZBKAMSFHVRW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB06494</td>
      <td>Sufugolix</td>
      <td>UCQSBGOFELXYIN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB00967</td>
      <td>Desloratadine</td>
      <td>JAUOIFJMECXRGI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12272</td>
      <td>Vidupiprant</td>
      <td>PFWVGKROPKKEDW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01940</td>
      <td>Balanol Analog 2</td>
      <td>SQLYTJZXRRDERK-ISKFKSNPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01944</td>
      <td>(S)-blebbistatin</td>
      <td>LZAXPYOBKSJSEX-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB01948</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One</td>
      <td>VXIYTVJEIXMAQF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB06409</td>
      <td>Morphine glucuronide</td>
      <td>GNJCUHZOSOYIEC-GAROZEBRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w9q</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6wiq</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m2n</td>
      <td>DB08942</td>
      <td>Isoxicam</td>
      <td>YYUAYBYLJSNDCX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14673</td>
      <td>Flurandrenolide acetate</td>
      <td>AUDPKCCPWYXNEV-XTLNBZDDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB11814</td>
      <td>PF-03882845</td>
      <td>XNULRSOGWPFPBL-REWPJTCUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB15403</td>
      <td>Ziritaxestat</td>
      <td>REQQVBGILUTQNN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB13095</td>
      <td>JTK-853</td>
      <td>JQLOVYLALGSISI-HXUWFJFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB11787</td>
      <td>Ralimetinib</td>
      <td>XPPBBJCBDOEXDN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB11853</td>
      <td>Relugolix</td>
      <td>AOMXMOCNKJTRQP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07179</td>
      <td>3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide</td>
      <td>DXUJQXZHHGJMFM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB15266</td>
      <td>TAK-580</td>
      <td>VWMJHAFYPMOMGF-ZCFIWIBFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB12128</td>
      <td>Ulimorelin</td>
      <td>WGYPAJVJMXQXTR-ABNZCKJZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB12843</td>
      <td>Oleandrin</td>
      <td>JLPDBLFIVFSOCC-XYXFTTADSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14678</td>
      <td>Norethindrone enanthate</td>
      <td>APTGJECXMIKIET-WOSSHHRXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB15221</td>
      <td>PF-06260414</td>
      <td>ZKAVFOXYJCREBQ-SNVBAGLBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB06314</td>
      <td>SGX-523</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lu7</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB15232</td>
      <td>Telaglenastat</td>
      <td>PRAAPINBUWJLGA-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB06922</td>
      <td>2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>CZNPWASYMRBJCX-GOSISDBHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13828</td>
      <td>Cyfluthrin</td>
      <td>QQODLKZGRKWIFG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB15449</td>
      <td>Citarinostat</td>
      <td>VLIUIBXPEDFJRF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB08911</td>
      <td>Trametinib</td>
      <td>LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07741</td>
      <td>4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE</td>
      <td>VPNYXOTTXAXSIH-SXYSDOLCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB15242</td>
      <td>MK-0533</td>
      <td>STWITCBWQHTJFJ-XMMPIXPASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB11431</td>
      <td>Moxidectin</td>
      <td>YZBLFMPOMVTDJY-LSGXYNIPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB11442</td>
      <td>Oleandomycin</td>
      <td>RZPAKFUAFGMUPI-QESOVKLGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB11611</td>
      <td>Lifitegrast</td>
      <td>JFOZKMSJYSPYLN-QHCPKHFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB06486</td>
      <td>Enzastaurin</td>
      <td>AXRCEOKUDYDWLF-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB04405</td>
      <td>2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid</td>
      <td>AQYSXARQCHHHLK-NRFANRHFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB13240</td>
      <td>Cymarin</td>
      <td>XQCGNURMLWFQJR-ZNDDOCHDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14654</td>
      <td>Bisoxatin acetate</td>
      <td>ZCBJDQBSLZREAA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB12282</td>
      <td>Defactinib</td>
      <td>FWLMVFUGMHIOAA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB06543</td>
      <td>Astaxanthin</td>
      <td>MQZIGYBFDRPAKN-UWFIBFSHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB03453</td>
      <td>(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester</td>
      <td>MRNGXYMKYHNMLV-PKTZIBPZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB15052</td>
      <td>Ansofaxine</td>
      <td>QKYBZJLEMOZFFU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07679</td>
      <td>(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid</td>
      <td>RRAAROKJUVKWAF-RDJZCZTQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB13610</td>
      <td>Flumedroxone</td>
      <td>CDZJOBWKHSYNMO-SCUQKFFVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB13953</td>
      <td>Estradiol benzoate</td>
      <td>UYIFTLBWAOGQBI-BZDYCCQFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB13997</td>
      <td>Baloxavir marboxil</td>
      <td>RZVPBGBYGMDSBG-GGAORHGYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB03311</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</td>
      <td>SXKBTDJJEQQEGE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07831</td>
      <td>2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>SHSORWZDEKFFLP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB04724</td>
      <td>(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE</td>
      <td>COVPLULNDBDXTN-KYJUHHDHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB06494</td>
      <td>Sufugolix</td>
      <td>UCQSBGOFELXYIN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB15362</td>
      <td>LSZ-102</td>
      <td>SJXNPGGVGZXKKI-NYYWCZLTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB06521</td>
      <td>Ertiprotafib</td>
      <td>FONCZICQWCUXEB-RUZDIDTESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07756</td>
      <td>1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL</td>
      <td>GPBGHVRNVGXPNM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14716</td>
      <td>Clonazolam</td>
      <td>XJRGLCAWBRZUFC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB15109</td>
      <td>Ingenol disoxate</td>
      <td>GLIUZQUNUNICGS-XUBYYPQFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13790</td>
      <td>Fipexide</td>
      <td>BFUJHVVEMMWLHC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB07764</td>
      <td>FLUORESCIN</td>
      <td>MURGITYSBWUQTI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB12345</td>
      <td>MBX-2982</td>
      <td>NFTMKHWBOINJGM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08008</td>
      <td>5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>LRHHXKBKRNNFRV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB12535</td>
      <td>AC-430</td>
      <td>DCRWIATZWHLIPN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB03311</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</td>
      <td>SXKBTDJJEQQEGE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB03921</td>
      <td>4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline</td>
      <td>IBCXZJCWDGCXQT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB05129</td>
      <td>Elsamitrucin</td>
      <td>MGQRRMONVLMKJL-KWJIQSIXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB06409</td>
      <td>Morphine glucuronide</td>
      <td>GNJCUHZOSOYIEC-GAROZEBRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB12973</td>
      <td>Serlopitant</td>
      <td>FLNYCRJBCNNHRH-OIYLJQICSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB15183</td>
      <td>Fosmanogepix</td>
      <td>JQONJQKKVAHONF-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06137</td>
      <td>KX-01</td>
      <td>HUNGUWOZPQBXGX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14097</td>
      <td>13-cis-12-(3'-Carboxyphenyl)retinoic acid</td>
      <td>XKKDQOHDTASHCE-PAZAWXFKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB08861</td>
      <td>DPDPE</td>
      <td>MCMMCRYPQBNCPH-WMIMKTLMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07066</td>
      <td>2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>LJAHIGGEXIWVJG-LLVKDONJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB09231</td>
      <td>Benidipine</td>
      <td>QZVNQOLPLYWLHQ-ZEQKJWHPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB03583</td>
      <td>(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</td>
      <td>AYOAIABDFUJDKQ-SQJPUDIVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB00246</td>
      <td>Ziprasidone</td>
      <td>MVWVFYHBGMAFLY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08152</td>
      <td>{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate</td>
      <td>ONXGIEJBNQLITK-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB09291</td>
      <td>Rolapitant</td>
      <td>FIVSJYGQAIEMOC-ZGNKEGEESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07084</td>
      <td>N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</td>
      <td>YHKGWOJTUMJPNW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08150</td>
      <td>4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium</td>
      <td>RZIDZIGAXXNODG-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB09298</td>
      <td>Silibinin</td>
      <td>SEBFKMXJBCUCAI-HKTJVKLFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB00319</td>
      <td>Piperacillin</td>
      <td>IVBHGBMCVLDMKU-GXNBUGAJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB04685</td>
      <td>1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>GJNIPWYJQUGERM-BFLUCZKCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB03141</td>
      <td>3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril</td>
      <td>UYUWNNRWESUYOB-FIRIVFDPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB07026</td>
      <td>(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</td>
      <td>PPLDARNGJSQINK-OKZBNKHCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB06117</td>
      <td>1alpha,24S-Dihydroxyvitamin D2</td>
      <td>ODZFJAXAEXQSKL-WRJREGAQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB00549</td>
      <td>Zafirlukast</td>
      <td>YEEZWCHGZNKEEK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB04158</td>
      <td>6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin</td>
      <td>ZKRKFZJAQKKHKL-SUGPNEFASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB02483</td>
      <td>Etheno-Nad</td>
      <td>JCDBQDNBEQHDHK-BSLNIGMPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB03984</td>
      <td>Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide</td>
      <td>MWTQNXVXPLTHJB-YADHBBJMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB13843</td>
      <td>Cloprednol</td>
      <td>YTJIBEDMAQUYSZ-FDNPDPBUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB05470</td>
      <td>VX-702</td>
      <td>FYSRKRZDBHOFAY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB12627</td>
      <td>GSK-1292263</td>
      <td>AYJRTVVIBJSSKN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lu7</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB06945</td>
      <td>N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide</td>
      <td>FOSWRYKPHVPIDJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB13060</td>
      <td>CEP-37440</td>
      <td>BCSHRERPHLTPEE-NRFANRHFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB00878</td>
      <td>Chlorhexidine</td>
      <td>GHXZTYHSJHQHIJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB00591</td>
      <td>Fluocinolone acetonide</td>
      <td>FEBLZLNTKCEFIT-VSXGLTOVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB12558</td>
      <td>AEE-788</td>
      <td>OONFNUWBHFSNBT-HXUWFJFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lu7</td>
      <td>DB12411</td>
      <td>R-428</td>
      <td>KXMZDGSRSGHMMK-VWLOTQADSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB13947</td>
      <td>Testosterone enantate benzilic acid hydrazone</td>
      <td>PTVXYACXDYZNID-JKXGKYMWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB06976</td>
      <td>1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA</td>
      <td>IWOOJEZSDPRYAZ-WFASDCNBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB01410</td>
      <td>Ciclesonide</td>
      <td>LUKZNWIVRBCLON-GXOBDPJESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB11742</td>
      <td>Ebastine</td>
      <td>MJJALKDDGIKVBE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB02524</td>
      <td>2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)</td>
      <td>XFMMHXLUHKBKQE-UHEGPQQHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB15385</td>
      <td>Acebilustat</td>
      <td>GERJIEKMNDGSCS-DQEYMECFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08230</td>
      <td>5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE</td>
      <td>ARSRJFRKVXALTF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08094</td>
      <td>(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE</td>
      <td>JRNJNYBQQYBCLE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB13019</td>
      <td>Henatinib</td>
      <td>MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB08087</td>
      <td>4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE</td>
      <td>NHBIWLQQJPSMNP-CABCVRRESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB04301</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate</td>
      <td>ZLAHDRAQCSQPOC-UHFFFAOYSA-P</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB06999</td>
      <td>N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide</td>
      <td>YZDJQTHVDDOVHR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB07253</td>
      <td>N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</td>
      <td>QTFCKBFCXDAZIU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14471</td>
      <td>2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate</td>
      <td>TWAOKHHZKFMFMD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB02498</td>
      <td>Carba-Nicotinamide-Adenine-Dinucleotide</td>
      <td>DGPLSUKWXXSBCU-VGXGLJSLSA-O</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB04875</td>
      <td>Pralnacasan</td>
      <td>CXAGHAZMQSCAKJ-WAHHBDPQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14944</td>
      <td>Tarloxotinib</td>
      <td>MUJMYVFVAWFUJL-SNAWJCMRSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lxt</td>
      <td>DB04131</td>
      <td>10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione</td>
      <td>BLGDWFJQIHBUJY-NWJGULHDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14899</td>
      <td>Tavapadon</td>
      <td>AKQXQLUNFKDZBN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6cs2</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB11901</td>
      <td>Apalutamide</td>
      <td>HJBWBFZLDZWPHF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6vxs</td>
      <td>DB00342</td>
      <td>Terfenadine</td>
      <td>GUGOEEXESWIERI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>7bv1</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6lzg</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14726</td>
      <td>Dabigatran</td>
      <td>YBSJFWOBGCMAKL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB14664</td>
      <td>Difluocortolone pivalate</td>
      <td>UWGRWFCLGQWKPR-GSTUPEFVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6crv</td>
      <td>DB14846</td>
      <td>Bimiralisib</td>
      <td>ADGGYDAFIHSYFI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB15212</td>
      <td>Pemafibrate</td>
      <td>ZHKNLJLMDFQVHJ-RUZDIDTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB15294</td>
      <td>SB-1578</td>
      <td>NNXDIGHYPZHXTR-ONEGZZNKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m3m</td>
      <td>DB15227</td>
      <td>Tirabrutinib</td>
      <td>SEJLPXCPMNSRAM-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6w4h</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.1</td>
      <td>6m71</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08710</td>
      <td>(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE</td>
      <td>BKZOQCGDCHOGOQ-MZLJFPOFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07015</td>
      <td>(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine</td>
      <td>XDSKICAQKGYYJF-OLZOCXBDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12706</td>
      <td>Seletalisib</td>
      <td>LNLJHGXOFYUARS-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06849</td>
      <td>1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine</td>
      <td>RQWYWHUKHYFIPB-VQHVLOKHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04704</td>
      <td>20-hydroxycholesterol</td>
      <td>MCKLJFJEQRYRQT-MGNSQDQZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB02732</td>
      <td>Nicotinamide Adenine Dinucleotide Acetone Adduct</td>
      <td>SGHBFOOIAAJJMI-YDKVLQLQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07124</td>
      <td>(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>CCIACUJJBPSOHE-KRWDZBQOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08905</td>
      <td>Formestane</td>
      <td>OSVMTWJCGUFAOD-KZQROQTASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07045</td>
      <td>(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol</td>
      <td>VBJKVZXRYLCYGQ-XNIJJKJLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06856</td>
      <td>6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE</td>
      <td>HUYQYLFFFNSAAX-BUXKBTBVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB13954</td>
      <td>Estradiol cypionate</td>
      <td>UOACKFBJUYNSLK-XRKIENNPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB01410</td>
      <td>Ciclesonide</td>
      <td>LUKZNWIVRBCLON-GXOBDPJESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB06997</td>
      <td>2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</td>
      <td>BMPOCDJEXAXXEZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07105</td>
      <td>2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE</td>
      <td>IEEYGOJDTRVYGR-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB06976</td>
      <td>1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA</td>
      <td>IWOOJEZSDPRYAZ-WFASDCNBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08080</td>
      <td>LATRUNCULIN B</td>
      <td>NSHPHXHGRHSMIK-JRIKCGFMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB07025</td>
      <td>3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</td>
      <td>KBIHHEGEALBUMT-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08003</td>
      <td>ISOTHIAZOLIDINONE ANALOG</td>
      <td>UILYPHAKDBTKQV-UFYCRDLUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06865</td>
      <td>6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID</td>
      <td>ZSRRBAKATXAISL-LMNJBCLMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12696</td>
      <td>BMS-582949</td>
      <td>GDTQLZHHDRRBEB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB02554</td>
      <td>Sulfoquinovose-Uridine-C1,5'-Diphosphate</td>
      <td>FQANCGQCBCUSMI-JZMIEXBBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06875</td>
      <td>3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE</td>
      <td>NSSOSHDCWCMNDM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07074</td>
      <td>6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER</td>
      <td>OUBRALHIKGRAMA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB14217</td>
      <td>Quinaprilat</td>
      <td>FLSLEGPOVLMJMN-YSSFQJQWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06954</td>
      <td>2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate</td>
      <td>BIASYWBGUYOWJR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB02519</td>
      <td>Indirubin-5-Sulphonate</td>
      <td>IHBOEHLUIBMBMY-YPKPFQOOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB13022</td>
      <td>LY-2874455</td>
      <td>GKJCVYLDJWTWQU-CXLRFSCWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07987</td>
      <td>[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER</td>
      <td>AWAKNMKLVLWIIQ-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08058</td>
      <td>4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one</td>
      <td>HGEPGGJUGUMFHT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB02505</td>
      <td>N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)</td>
      <td>JJVQUUYZGJWBPW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6wiq</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00663</td>
      <td>Flumethasone</td>
      <td>WXURHACBFYSXBI-GQKYHHCASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14902</td>
      <td>JHU-75528 C-11</td>
      <td>MCNQUWLLXZZZAC-BJUDXGSMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12579</td>
      <td>JNJ-37822681</td>
      <td>UVUYWJWYRLJHEN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07064</td>
      <td>(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE</td>
      <td>HPVCRUIDFODATB-LJQANCHMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB14822</td>
      <td>SB-649868</td>
      <td>ZJXIUGNEAIHSBI-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB11577</td>
      <td>Indigotindisulfonic Acid</td>
      <td>CFZXDJWFRVEWSR-BUHFOSPRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07198</td>
      <td>5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE</td>
      <td>GGEKOZPXKBYLNK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06999</td>
      <td>N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide</td>
      <td>YZDJQTHVDDOVHR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07127</td>
      <td>{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID</td>
      <td>SXDBFKLPNPUPRI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07204</td>
      <td>(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</td>
      <td>DQIXTEDFNFZMCM-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08097</td>
      <td>2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE</td>
      <td>OGWSGDLIXOEZJG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07323</td>
      <td>2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID</td>
      <td>CTZLIARLNXSXGL-ALCCZGGFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07325</td>
      <td>N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE</td>
      <td>VCOKUBHAJVTVNG-FMIVXFBMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB14856</td>
      <td>PF-05089771</td>
      <td>ZYSCOUXLBXGGIM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB13931</td>
      <td>Netarsudil</td>
      <td>OURRXQUGYQRVML-AREMUKBSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12658</td>
      <td>AFN-1252</td>
      <td>QXTWSUQCXCWEHF-JXMROGBWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB15186</td>
      <td>GDC-0084</td>
      <td>LGWACEZVCMBSKW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07360</td>
      <td>1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>JJHXPDTVQKWKHA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07406</td>
      <td>(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE</td>
      <td>QWFFPYQWUWLDBV-NSHDSACASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12096</td>
      <td>PF-05175157</td>
      <td>BDXXSFOJPYSYOC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12571</td>
      <td>Rimacalib</td>
      <td>MYTIJGWONQOOLC-HNNXBMFYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB11892</td>
      <td>Prulifloxacin</td>
      <td>PWNMXPDKBYZCOO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07479</td>
      <td>(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL</td>
      <td>WCUHTHVUZQCBTI-KBAYOESNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB06558</td>
      <td>Tezosentan</td>
      <td>TUYWTLTWNJOZNY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08304</td>
      <td>(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>QZBQVXXESPXFPZ-QGZVFWFLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB06519</td>
      <td>Edaglitazone</td>
      <td>HAAXAFNSRADSMK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB09534</td>
      <td>Ecamsule</td>
      <td>HEAHZSUCFKFERC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12690</td>
      <td>LY-2584702</td>
      <td>FYXRSVDHGLUMHB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08242</td>
      <td>N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide</td>
      <td>OYTBZXSFNNAVKU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07267</td>
      <td>2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine</td>
      <td>JONFDFIXMPXTRH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB06733</td>
      <td>Bafilomycin A1</td>
      <td>XDHNQDDQEHDUTM-JQWOJBOSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB02429</td>
      <td>4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide</td>
      <td>IXDVPACDZDRCTN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB06875</td>
      <td>3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE</td>
      <td>NSSOSHDCWCMNDM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07138</td>
      <td>Neflamapimod</td>
      <td>VEPKQEUBKLEPRA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB02449</td>
      <td>3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid</td>
      <td>ULOTXPTWJAUGGE-MHZLTWQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB13472</td>
      <td>Cyclofenil</td>
      <td>GVOUFPWUYJWQSK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB11457</td>
      <td>Rotenone</td>
      <td>JUVIOZPCNVVQFO-HBGVWJBISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08164</td>
      <td>(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</td>
      <td>GOBIXGZJSMAOFV-QRWLVFNGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07180</td>
      <td>5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide</td>
      <td>FIRPCWHHIWFKCD-GHXNOFRVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB03791</td>
      <td>(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid</td>
      <td>NAXSRXHZFIBFMI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB02197</td>
      <td>4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide</td>
      <td>NKORVPQBJCGYEC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB08241</td>
      <td>4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE</td>
      <td>RUUOIINPNMNPIU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07203</td>
      <td>6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE</td>
      <td>OUEGMEMDEAOAEG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12764</td>
      <td>ABC-294640</td>
      <td>CAOTVXGYTWCKQE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB02010</td>
      <td>Staurosporine</td>
      <td>HKSZLNNOFSGOKW-FYTWVXJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07237</td>
      <td>{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone</td>
      <td>VUWFJUJWAWMRQN-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08873</td>
      <td>Boceprevir</td>
      <td>LHHCSNFAOIFYRV-DOVBMPENSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07244</td>
      <td>5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE</td>
      <td>SRRWXMSVQYQCRX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB06856</td>
      <td>6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE</td>
      <td>HUYQYLFFFNSAAX-BUXKBTBVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07248</td>
      <td>7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE</td>
      <td>YENZSPIOXMNEFF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07249</td>
      <td>N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine</td>
      <td>QHIMVPIOWKYPSO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB02123</td>
      <td>Glycochenodeoxycholic Acid</td>
      <td>GHCZAUBVMUEKKP-GYPHWSFCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB13993</td>
      <td>MRK-409</td>
      <td>GOIFCXRIFSYPFG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB00773</td>
      <td>Etoposide</td>
      <td>VJJPUSNTGOMMGY-MRVIYFEKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB02341</td>
      <td>Mdl 101,146</td>
      <td>XQAMVCHQGHAELT-YPAWHYETSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB01219</td>
      <td>Dantrolene</td>
      <td>OZOMQRBLCMDCEG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB05154</td>
      <td>Pretomanid</td>
      <td>ZLHZLMOSPGACSZ-NSHDSACASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB11867</td>
      <td>JNJ-39393406</td>
      <td>IURMHZBQEYNQOH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB04408</td>
      <td>Ncs-Chromophore</td>
      <td>QZGIWPZCWHMVQL-UIYAJPBUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07716</td>
      <td>(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL</td>
      <td>VDRIXSJOPKVWKM-HXGIDPQASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB05608</td>
      <td>MKC-1</td>
      <td>OVSKGTONMLKNPZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB02166</td>
      <td>Propidium</td>
      <td>ZDWVWKDAWBGPDN-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB13060</td>
      <td>CEP-37440</td>
      <td>BCSHRERPHLTPEE-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03996</td>
      <td>3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol</td>
      <td>QBZAPFWYAPXRGQ-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB02115</td>
      <td>Daidzin</td>
      <td>KYQZWONCHDNPDP-QNDFHXLGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB05796</td>
      <td>Daglutril</td>
      <td>XMQODGUTLZXUGZ-RPBOFIJWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB03478</td>
      <td>2'-O-Acetyl Adenosine-5-Diphosphoribose</td>
      <td>BFNOPXRXIQJDHO-DLFWLGJNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB13074</td>
      <td>Macimorelin</td>
      <td>UJVDJAPJQWZRFR-DHIUTWEWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB13089</td>
      <td>Enoxolone</td>
      <td>MPDGHEJMBKOTSU-YKLVYJNSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB03367</td>
      <td>PF-00356231</td>
      <td>VMTJQZUZINLEKC-JOCHJYFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB05884</td>
      <td>HCV-086</td>
      <td>VBRUONUESYTIDA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14937</td>
      <td>MK-8666</td>
      <td>CODQKEMYZZKQAE-QPVYNBJUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB02466</td>
      <td>4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid</td>
      <td>ZXQHMEUGMCXKLO-KPKJPENVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07426</td>
      <td>[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)</td>
      <td>NWIARQRYIRVYCM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07410</td>
      <td>[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID</td>
      <td>BYVXAUZOTGITQZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB11763</td>
      <td>Momelotinib</td>
      <td>ZVHNDZWQTBEVRY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07450</td>
      <td>(R)-minalrestat</td>
      <td>BMHZAHGTGIZZCT-LJQANCHMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB14770</td>
      <td>Lanraplenib</td>
      <td>XCIGZBVOUQVIPI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08037</td>
      <td>(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide</td>
      <td>MYBGWENAVMIGMM-GIFXNVAJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08490</td>
      <td>CTS-1027</td>
      <td>ROSNVSQTEGHUKU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB11662</td>
      <td>Rabusertib</td>
      <td>SYYBDNPGDKKJDU-ZDUSSCGKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB13687</td>
      <td>Niaprazine</td>
      <td>RSKQGBFMNPDPLR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB15137</td>
      <td>VK-2809</td>
      <td>LGGPZDRLTDGYSQ-JADSYQMUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07688</td>
      <td>4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>RPJIMTALCNCQLV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB09053</td>
      <td>Ibrutinib</td>
      <td>XYFPWWZEPKGCCK-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07678</td>
      <td>(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL</td>
      <td>ANAMDWGJXBYJEB-OPWFCKQNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB04853</td>
      <td>Binodenoson</td>
      <td>XJFMHMFFBSOEPR-DNZQAUTHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB04863</td>
      <td>Lefradafiban</td>
      <td>PGCFXITVMNNKON-ROUUACIJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB14929</td>
      <td>Elsulfavirine</td>
      <td>ULTDEARCBRNRGR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB04903</td>
      <td>Pagoclone</td>
      <td>HIUPRQPBWVEQJJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB03944</td>
      <td>5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One</td>
      <td>IZLRMTJLQCLMKF-CYBMUJFWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB04946</td>
      <td>Iloperidone</td>
      <td>XMXHEBAFVSFQEX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB11912</td>
      <td>Lanopepden</td>
      <td>SWHNZGMQMGFQGW-MSOLQXFVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08547</td>
      <td>PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE</td>
      <td>JBBNFGYRYNBDIH-DBGGZKJISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07588</td>
      <td>3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID</td>
      <td>FZDVNXHYGMEEDT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB05107</td>
      <td>16-Bromoepiandrosterone</td>
      <td>CWVMWSZEMZOUPC-JUAXIXHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00719</td>
      <td>Azatadine</td>
      <td>SEBMTIQKRHYNIT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04706</td>
      <td>(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL</td>
      <td>OYXZMSRRJOYLLO-KGZHIOMZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB15057</td>
      <td>NUC-1031</td>
      <td>NHTKGYOMICWFQZ-KKQYNPQSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07396</td>
      <td>1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid</td>
      <td>KAJJGOCSAXKXBD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08584</td>
      <td>6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06533</td>
      <td>Ragaglitazar</td>
      <td>WMUIIGVAWPWQAW-XMMPIXPASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06590</td>
      <td>Ceftaroline fosamil</td>
      <td>ZCCUWMICIWSJIX-NQJJCJBVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12673</td>
      <td>ATX-914</td>
      <td>ALANRBCCCQEPFZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07702</td>
      <td>17alpha-Estriol</td>
      <td>PROQIPRRNZUXQM-PNVOZDDCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB04158</td>
      <td>6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin</td>
      <td>ZKRKFZJAQKKHKL-SUGPNEFASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB02830</td>
      <td>FR236913</td>
      <td>KCCUBLLGAMGDJL-HXUWFJFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06634</td>
      <td>Casopitant</td>
      <td>XGGTZCKQRWXCHW-WMTVXVAQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07181</td>
      <td>4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</td>
      <td>JYKFWUXBFJJDTP-HXUWFJFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08459</td>
      <td>3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>SVMHTBVIPYVDIL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12550</td>
      <td>Taladegib</td>
      <td>SZBGQDXLNMELTB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08950</td>
      <td>Indoramin</td>
      <td>JXZZEXZZKAWDSP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB13185</td>
      <td>Oxabolone cipionate</td>
      <td>KHKDIUPVDIEHAH-KXLSUQFWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06717</td>
      <td>Fosaprepitant</td>
      <td>BARDROPHSZEBKC-OITMNORJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12687</td>
      <td>Vesatolimod</td>
      <td>VFOKSTCIRGDTBR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00689</td>
      <td>Cephaloglycin</td>
      <td>FUBBGQLTSCSAON-PBFPGSCMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB13164</td>
      <td>Olmutinib</td>
      <td>FDMQDKQUTRLUBU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06733</td>
      <td>Bafilomycin A1</td>
      <td>XDHNQDDQEHDUTM-JQWOJBOSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06745</td>
      <td>ginkgolide-C</td>
      <td>AMOGMTLMADGEOQ-DTDWCABLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB03020</td>
      <td>5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</td>
      <td>UINNILASBHZOTM-KMXXXSRASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00694</td>
      <td>Daunorubicin</td>
      <td>STQGQHZAVUOBTE-VGBVRHCVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB07507</td>
      <td>2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</td>
      <td>ROMNEYAQUBNRLR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06519</td>
      <td>Edaglitazone</td>
      <td>HAAXAFNSRADSMK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB05197</td>
      <td>Sofalcone</td>
      <td>GFWRVVCDTLRWPK-KPKJPENVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07369</td>
      <td>N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide</td>
      <td>YMJLSOJLEXWATP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB15009</td>
      <td>PF-04937319</td>
      <td>MASKQITXHVYVFL-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB11751</td>
      <td>Cabotegravir</td>
      <td>WCWSTNLSLKSJPK-LKFCYVNXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB14569</td>
      <td>Tedizolid</td>
      <td>XFALPSLJIHVRKE-GFCCVEGCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06237</td>
      <td>Avanafil</td>
      <td>WEAJZXNPAWBCOA-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB06263</td>
      <td>Amrubicin</td>
      <td>VJZITPJGSQKZMX-XDPRQOKASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08974</td>
      <td>Flubendazole</td>
      <td>CPEUVMUXAHMANV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07706</td>
      <td>2-Hydroxyestradiol</td>
      <td>DILDHNKDVHLEQB-XSSYPUMDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB11745</td>
      <td>Otenabant</td>
      <td>UNAZAADNBYXMIV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB13950</td>
      <td>WIN 55212-2</td>
      <td>HQVHOQAKMCMIIM-HXUWFJFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08039</td>
      <td>(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE</td>
      <td>LOGJQOUIVKBFGH-YBEGLDIGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB01177</td>
      <td>Idarubicin</td>
      <td>XDXDZDZNSLXDNA-TZNDIEGXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12113</td>
      <td>CE-224535</td>
      <td>FUCKCIVGBCBZNP-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB03159</td>
      <td>CRA_8696</td>
      <td>GAVRMVQHHVMXFD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB13766</td>
      <td>Lidoflazine</td>
      <td>ZBIAKUMOEKILTF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB00549</td>
      <td>Zafirlukast</td>
      <td>YEEZWCHGZNKEEK-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14214</td>
      <td>Rose bengal lactone</td>
      <td>IICCLYANAQEHCI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14512</td>
      <td>Mometasone furoate</td>
      <td>WOFMFGQZHJDGCX-ZULDAHANSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07265</td>
      <td>3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID</td>
      <td>JDARUOOLJCFUOY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB03082</td>
      <td>6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide</td>
      <td>CSWQJKHBMACTGB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB03081</td>
      <td>Crc200 (Chiron-Behring)</td>
      <td>ZOXOKTJHZSUHRJ-XZOQPEGZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07167</td>
      <td>5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE</td>
      <td>NNPCFFIJVKYGHR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12693</td>
      <td>Ritanserin</td>
      <td>JUQLTPCYUFPYKE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB14774</td>
      <td>Balipodect</td>
      <td>KVHRYLNQDWXAGI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB06429</td>
      <td>Talnetant</td>
      <td>BIAVGWDGIJKWRM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07537</td>
      <td>N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide</td>
      <td>CLEGTVIMOPPIBR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07941</td>
      <td>PH-797804</td>
      <td>KCAJXIDMCNPGHZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08521</td>
      <td>4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>CDMGBJANTYXAIV-HHHXNRCGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08532</td>
      <td>6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine</td>
      <td>WCNPGRRMPFCHEO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB09295</td>
      <td>Talniflumate</td>
      <td>ANMLJLFWUCQGKZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08539</td>
      <td>3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CCDIUVLNHCGSMH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB11786</td>
      <td>Pefcalcitol</td>
      <td>SVCSMAZYWOQCBW-NVJMFHFGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08557</td>
      <td>2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide</td>
      <td>XQKFKSJUBJPOLY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB04099</td>
      <td>Deamido-Nad+</td>
      <td>SENPVEZBRZQVST-HISDBWNOSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB11742</td>
      <td>Ebastine</td>
      <td>MJJALKDDGIKVBE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB03476</td>
      <td>Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine</td>
      <td>NQRIWXVAIWPBEM-OALUTQOASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08590</td>
      <td>1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE</td>
      <td>CEAYRKIZESVQSN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB00443</td>
      <td>Betamethasone</td>
      <td>UREBDLICKHMUKA-DVTGEIKXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08391</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UBIIFKJMNRPNMT-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB00324</td>
      <td>Fluorometholone</td>
      <td>FAOZLTXFLGPHNG-KNAQIMQKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB03460</td>
      <td>Violaxanthin</td>
      <td>SZCBXWMUOPQSOX-WVJDLNGLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB00251</td>
      <td>Terconazole</td>
      <td>BLSQLHNBWJLIBQ-OZXSUGGESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08701</td>
      <td>2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE</td>
      <td>JZCUVYNOSDWORZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04432</td>
      <td>ZK-805623</td>
      <td>ZXIHYCYAQUQHSG-UHFFFAOYSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08707</td>
      <td>4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine</td>
      <td>AQVFETGXIRKVAQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB00267</td>
      <td>Cefmenoxime</td>
      <td>HJJDBAOLQAWBMH-YCRCPZNHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04378</td>
      <td>3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</td>
      <td>APJAEXGNDLFGPD-AWCRTANDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08737</td>
      <td>(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL</td>
      <td>FSYFYSFYUHBIHE-GLJUWKHASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04342</td>
      <td>7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid</td>
      <td>JWCSIUVGFCSJCK-LIUKBUMOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08745</td>
      <td>4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE</td>
      <td>QLHUDNKWOSQSMK-CXUHLZMHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB11703</td>
      <td>Acalabrutinib</td>
      <td>WDENQIQQYWYTPO-IBGZPJMESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07323</td>
      <td>2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID</td>
      <td>CTZLIARLNXSXGL-ALCCZGGFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04609</td>
      <td>INHIBITOR Q8467 OF DUPONT MERCK</td>
      <td>HFLCERPZYCWLSZ-VKONIRKNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08495</td>
      <td>4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>VXONTEUOQXFJJS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04841</td>
      <td>Flunarizine</td>
      <td>SMANXXCATUTDDT-QPJJXVBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB15173</td>
      <td>JNJ-42165279</td>
      <td>YWGYNGCRVZLMCS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB09095</td>
      <td>Difluocortolone</td>
      <td>OGPWIDANBSLJPC-RFPWEZLHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14770</td>
      <td>Lanraplenib</td>
      <td>XCIGZBVOUQVIPI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04793</td>
      <td>1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol</td>
      <td>DKBAWRNTUZFJKV-XMTFNYHQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB15183</td>
      <td>Fosmanogepix</td>
      <td>JQONJQKKVAHONF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB00596</td>
      <td>Ulobetasol</td>
      <td>LEHFPXVYPMWYQD-XHIJKXOTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04790</td>
      <td>2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol</td>
      <td>IBIUTOFGXGGVKQ-XMTFNYHQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04764</td>
      <td>[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</td>
      <td>CCLHROFBSWWOQO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04760</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)</td>
      <td>PYFRREJCFXFNRR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08490</td>
      <td>CTS-1027</td>
      <td>ROSNVSQTEGHUKU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08441</td>
      <td>6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE</td>
      <td>AWSQADBSXFTFKL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12910</td>
      <td>Emicerfont</td>
      <td>JFHJGXQFESYQGY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04750</td>
      <td>OREGON GREEN 488 CARBOXYLATE</td>
      <td>BRJCLSQFZSHLRL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12081</td>
      <td>Anecortave</td>
      <td>BCFCRXOJOFDUMZ-ONKRVSLGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB00522</td>
      <td>Bentiromide</td>
      <td>SPPTWHFVYKCNNK-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08486</td>
      <td>Efaproxiral</td>
      <td>BNFRJXLZYUTIII-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB00481</td>
      <td>Raloxifene</td>
      <td>GZUITABIAKMVPG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB04172</td>
      <td>[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine</td>
      <td>WATXEHGLYJKXOF-NDEPHWFRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08437</td>
      <td>Puromycin</td>
      <td>RXWNCPJZOCPEPQ-NVWDDTSBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB11618</td>
      <td>Zorubicin</td>
      <td>FBTUMDXHSRTGRV-BJISBDEGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB15238</td>
      <td>Olinciguat</td>
      <td>YWQFJNWMWZMXRW-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB15242</td>
      <td>MK-0533</td>
      <td>STWITCBWQHTJFJ-XMMPIXPASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08170</td>
      <td>(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE</td>
      <td>AYFCYVLVRYQGME-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08930</td>
      <td>Dolutegravir</td>
      <td>RHWKPHLQXYSBKR-BMIGLBTASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB03605</td>
      <td>(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>LAJJKGIZTCCOHY-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB14942</td>
      <td>BMS-986141</td>
      <td>KEEBLYWBELVGPQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12070</td>
      <td>Letermovir</td>
      <td>FWYSMLBETOMXAG-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB09209</td>
      <td>Pholcodine</td>
      <td>GPFAJKDEDBRFOS-FKQDBXSBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04578</td>
      <td>(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide</td>
      <td>OEVYDSSAPNIURZ-AEFFLSMTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB07817</td>
      <td>1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea</td>
      <td>NJPVZSIGDRLLTD-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11263</td>
      <td>Polydatin</td>
      <td>HSTZMXCBWJGKHG-CUYWLFDKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB04514</td>
      <td>Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester</td>
      <td>DFYLLEBFVZTKHD-VMIOUTBZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11372</td>
      <td>Altrenogest</td>
      <td>VWAUPFMBXBWEQY-ANULTFPQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB03276</td>
      <td>4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid</td>
      <td>RHYFMOCFCFUTNH-GZNVFMSSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11478</td>
      <td>Zeranol</td>
      <td>DWTTZBARDOXEAM-GXTWGEPZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08534</td>
      <td>5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>ZAIYYXVHGBMLEC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB03336</td>
      <td>BIA</td>
      <td>KVIVJQWOYSWCCZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08881</td>
      <td>Vemurafenib</td>
      <td>GPXBXXGIAQBQNI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12068</td>
      <td>T-900607</td>
      <td>FSXLOWIFSZNIMV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB04044</td>
      <td>4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>NAQUAVBNIYTIIS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04177</td>
      <td>4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>XZTUSOXSLKTKJQ-CESUGQOBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB15442</td>
      <td>Trilaciclib</td>
      <td>PDGKHKMBHVFCMG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB00197</td>
      <td>Troglitazone</td>
      <td>GXPHKUHSUJUWKP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB11577</td>
      <td>Indigotindisulfonic Acid</td>
      <td>CFZXDJWFRVEWSR-BUHFOSPRSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08846</td>
      <td>Ellagic Acid</td>
      <td>AFSDNFLWKVMVRB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB11562</td>
      <td>Bicuculline</td>
      <td>IYGYMKDQCDOMRE-ZWKOTPCHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB15250</td>
      <td>Vercirnon</td>
      <td>JRWROCIMSDXGOZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08878</td>
      <td>Aminopterin</td>
      <td>TVZGACDUOSZQKY-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12885</td>
      <td>CF-102</td>
      <td>IPSYPUKKXMNCNQ-PFHKOEEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07879</td>
      <td>N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide</td>
      <td>SMSIXMLQOONOQQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB15437</td>
      <td>Rocacetrapib</td>
      <td>GBHPDJQHZADVAA-SOKVYYICSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14795</td>
      <td>AZD-3759</td>
      <td>MXDSJQHFFDGFDK-CYBMUJFWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB01147</td>
      <td>Cloxacillin</td>
      <td>LQOLIRLGBULYKD-JKIFEVAISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB15414</td>
      <td>CM-4307</td>
      <td>MLDQJTXFUGDVEO-FIBGUPNXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB03962</td>
      <td>Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate</td>
      <td>MDKMTCCUJSRQGW-NAJQWHGHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB09050</td>
      <td>Ceftolozane</td>
      <td>JHFNIHVVXRKLEF-DCZLAGFPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB09078</td>
      <td>Lenvatinib</td>
      <td>WOSKHXYHFSIKNG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB13993</td>
      <td>MRK-409</td>
      <td>GOIFCXRIFSYPFG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB09169</td>
      <td>3-Allylfentanyl</td>
      <td>BZXKQFFMDLTPJL-LADGPHEKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08094</td>
      <td>(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE</td>
      <td>JRNJNYBQQYBCLE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB13991</td>
      <td>Pipequaline</td>
      <td>AMEWZCMTSIONOX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14840</td>
      <td>Ripretinib</td>
      <td>CEFJVGZHQAGLHS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB04842</td>
      <td>Fluspirilene</td>
      <td>QOYHHIBFXOOADH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB00430</td>
      <td>Cefpiramide</td>
      <td>PWAUCHMQEXVFJR-PMAPCBKXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12054</td>
      <td>BQ-123</td>
      <td>VYCMAAOURFJIHD-PJNXIOHISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08345</td>
      <td>4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>IWUUKHQIKFHWIW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB01336</td>
      <td>Metocurine</td>
      <td>JFXBEKISTKFVAB-AJQTZOPKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07769</td>
      <td>S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE</td>
      <td>KJMFOTCDISOHDX-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14662</td>
      <td>Flunisolide acetate</td>
      <td>WEGNFRKBIKYVLC-XTLNBZDDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07779</td>
      <td>N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE</td>
      <td>ANQHSFFUNMTTRS-MOPGFXCFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00502</td>
      <td>Haloperidol</td>
      <td>LNEPOXFFQSENCJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB03523</td>
      <td>Brequinar</td>
      <td>PHEZJEYUWHETKO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12272</td>
      <td>Vidupiprant</td>
      <td>PFWVGKROPKKEDW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07811</td>
      <td>N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide</td>
      <td>UBVTVSINEVHYSY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB01289</td>
      <td>Glisoxepide</td>
      <td>ZKUDBRCEOBOWLF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08743</td>
      <td>2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE</td>
      <td>XJNKUWDMCBZMTG-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07834</td>
      <td>N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide</td>
      <td>FOHZGCHKLPIBBX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07844</td>
      <td>6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE</td>
      <td>PHLKBODTBJLXRD-WFASDCNBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12158</td>
      <td>Filorexant</td>
      <td>NPFDWHQSDBWQLH-QZTJIDSGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07855</td>
      <td>(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE</td>
      <td>CWHMAWBXRCDOEB-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07260</td>
      <td>N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline</td>
      <td>HITMFLNAOQIZSN-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB06169</td>
      <td>Indibulin</td>
      <td>SOLIIYNRSAWTSQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07917</td>
      <td>4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE</td>
      <td>TZQGXAHOROZEKN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08737</td>
      <td>(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL</td>
      <td>FSYFYSFYUHBIHE-GLJUWKHASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB00354</td>
      <td>Buclizine</td>
      <td>MOYGZHXDRJNJEP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07707</td>
      <td>(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL</td>
      <td>LEOPSILMAOYZBO-IUTAEKPZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB06395</td>
      <td>Abafungin</td>
      <td>TYBHXIFFPVFXQW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12500</td>
      <td>Fedratinib</td>
      <td>JOOXLOJCABQBSG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6wiq</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB04790</td>
      <td>2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol</td>
      <td>IBIUTOFGXGGVKQ-XMTFNYHQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08763</td>
      <td>[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE</td>
      <td>FSNDLCSOLUMYRH-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB06497</td>
      <td>Aplaviroc</td>
      <td>GWNOTCOIYUNTQP-FQLXRVMXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07563</td>
      <td>1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine</td>
      <td>GCJSOJRPNOWSEH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07570</td>
      <td>3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID</td>
      <td>ZKEZEXYKYHYIMQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB06455</td>
      <td>Meclinertant</td>
      <td>DYLJVOXRWLXDIG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07583</td>
      <td>(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE</td>
      <td>RLNNFNGBXLTQOB-RBUKOAKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12776</td>
      <td>E-6005</td>
      <td>BBTFKAOFCSOZMB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07702</td>
      <td>17alpha-Estriol</td>
      <td>PROQIPRRNZUXQM-PNVOZDDCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08761</td>
      <td>(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione</td>
      <td>NGPCLOGFGKJCBP-HOTGVXAUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB15031</td>
      <td>Nemorexant</td>
      <td>NBGABHGMJVIVBW-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00542</td>
      <td>Benazepril</td>
      <td>XPCFTKFZXHTYIP-PMACEKPBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07612</td>
      <td>6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE</td>
      <td>XQKJVNGGVLHNLA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14661</td>
      <td>Loperamide oxide</td>
      <td>KXVSBTJVTUVNPM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04885</td>
      <td>Cilansetron</td>
      <td>NCNFDKWULDWJDS-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB08143</td>
      <td>5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE</td>
      <td>SXIYSYYSKHUTQQ-RDJZCZTQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB15033</td>
      <td>Flortaucipir</td>
      <td>GETAAWDSFUCLBS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07647</td>
      <td>(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL</td>
      <td>VBASHTSSQNDDAS-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB02732</td>
      <td>Nicotinamide Adenine Dinucleotide Acetone Adduct</td>
      <td>SGHBFOOIAAJJMI-YDKVLQLQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB02511</td>
      <td>2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine</td>
      <td>PZWMZAFFUAWVDN-CQXYXCHQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07596</td>
      <td>(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate</td>
      <td>NTSPHKOMJMBWOU-NNKXXINSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07968</td>
      <td>N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA</td>
      <td>RFOBTYLRURSVJE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12833</td>
      <td>Tandospirone</td>
      <td>CEIJFEGBUDEYSX-FZDBZEDMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB02581</td>
      <td>5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</td>
      <td>VNZHOIDQBPFEJU-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB09219</td>
      <td>Bisoxatin</td>
      <td>BPKUDUSVDVLOPY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12746</td>
      <td>AKN-028</td>
      <td>JLRIJKVMMZEKDF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08172</td>
      <td>(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide</td>
      <td>YUDQXOMZBLEWBH-KAMYIIQDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB11949</td>
      <td>Vestipitant</td>
      <td>SBBYBXSFWOLDDG-JLTOFOAXSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB00862</td>
      <td>Vardenafil</td>
      <td>SECKRCOLJRRGGV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08706</td>
      <td>(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID</td>
      <td>RNEACARJKXYVND-MZLJFPOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08204</td>
      <td>3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE</td>
      <td>FLWABCQDXUKNQY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08233</td>
      <td>6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE</td>
      <td>RFSDQDHHBKYQOD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12049</td>
      <td>Dasolampanel etibutil</td>
      <td>HPBRMCFZIGUGTK-ZMMAXQRCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12887</td>
      <td>Tazemetostat</td>
      <td>NSQSAUGJQHDYNO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB08022</td>
      <td>(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile</td>
      <td>RCYPVQCPYKNSTG-OAHLLOKOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB01166</td>
      <td>Cilostazol</td>
      <td>RRGUKTPIGVIEKM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08865</td>
      <td>Crizotinib</td>
      <td>KTEIFNKAUNYNJU-GFCCVEGCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB15163</td>
      <td>Selatogrel</td>
      <td>FYXHWMQPCJOJCH-GMAHTHKFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07287</td>
      <td>2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL</td>
      <td>AOVDSWPGWPRTSR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08250</td>
      <td>(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE</td>
      <td>OQMVLDZJPRSNOG-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB09199</td>
      <td>Netoglitazone</td>
      <td>PKWDZWYVIHVNKS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08293</td>
      <td>(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE</td>
      <td>AQKZYZQONWDDLS-HNQUOIGGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB05076</td>
      <td>Fenretinide</td>
      <td>AKJHMTWEGVYYSE-FXILSDISSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB00705</td>
      <td>Delavirdine</td>
      <td>WHBIGIKBNXZKFE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12848</td>
      <td>PF-04217903</td>
      <td>PDMUGYOXRHVNMO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB04785</td>
      <td>Streptolydigin</td>
      <td>KVTPRMVXYZKLIG-NCAOFHFGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB02102</td>
      <td>DMP450</td>
      <td>KYRSNWPSSXSNEP-ZRTHHSRSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08124</td>
      <td>3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>FTQYGMLRLRXBPT-IDUWFGFVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00482</td>
      <td>Celecoxib</td>
      <td>RZEKVGVHFLEQIL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08052</td>
      <td>1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>NVRXTLZYXZNATH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB07984</td>
      <td>2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide</td>
      <td>GKJWXEORYGBJFS-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB01067</td>
      <td>Glipizide</td>
      <td>ZJJXGWJIGJFDTL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB05667</td>
      <td>Levoketoconazole</td>
      <td>XMAYWYJOQHXEEK-ZEQKJWHPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB05653</td>
      <td>IRX-5183</td>
      <td>PNAWUIKCVQSLFG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08020</td>
      <td>(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</td>
      <td>RHQLNMNKTIOREN-AOIWGVFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB02698</td>
      <td>N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid</td>
      <td>NQOOJFXBGLOGTC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB14679</td>
      <td>Quingestanol acetate</td>
      <td>FLGJKPPXEKYCBY-AKCFYGDASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB14066</td>
      <td>Tetrandrine</td>
      <td>WVTKBKWTSCPRNU-KYJUHHDHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07054</td>
      <td>(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL</td>
      <td>OSCWQKTUILTARV-MRXNPFEDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB12001</td>
      <td>Abemaciclib</td>
      <td>UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08049</td>
      <td>7,8-dihydroxy-4-phenyl-2H-chromen-2-one</td>
      <td>JRVIIPJSVKTPBK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB03268</td>
      <td>RU82197</td>
      <td>WKTQBTSOHBKBRW-VMPREFPWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08055</td>
      <td>N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine</td>
      <td>NNBICZMPIJMWGC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08056</td>
      <td>N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine</td>
      <td>KKYYLKPGILUPOA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12863</td>
      <td>Sivelestat</td>
      <td>BTGNGJJLZOIYID-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB11765</td>
      <td>PF-04991532</td>
      <td>GKMLFBRLRVQVJO-ZDUSSCGKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB04862</td>
      <td>Merimepodib</td>
      <td>JBPUGFODGPKTDW-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08087</td>
      <td>4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE</td>
      <td>NHBIWLQQJPSMNP-CABCVRRESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB11984</td>
      <td>Letaxaban</td>
      <td>GEHAEMCVKDPMKO-HXUWFJFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB05470</td>
      <td>VX-702</td>
      <td>FYSRKRZDBHOFAY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07274</td>
      <td>N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide</td>
      <td>ZATGFXTWDKIEKC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB08346</td>
      <td>(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE</td>
      <td>YUZYDHRGGDTZLG-DUXPYHPUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08513</td>
      <td>[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID</td>
      <td>PAIQRYUOBBCBSE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB09075</td>
      <td>Edoxaban</td>
      <td>HGVDHZBSSITLCT-JLJPHGGASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08023</td>
      <td>N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine</td>
      <td>HYNNWLVWJXWXFO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07422</td>
      <td>(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide</td>
      <td>MMNRWNREMUMYQG-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB11800</td>
      <td>Tivozanib</td>
      <td>SPMVMDHWKHCIDT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07879</td>
      <td>N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide</td>
      <td>SMSIXMLQOONOQQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07006</td>
      <td>9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE</td>
      <td>AOGOZJCRIFBTTN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB15307</td>
      <td>Atabecestat</td>
      <td>VLLFGVHGKLDDLW-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07405</td>
      <td>1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</td>
      <td>GIZYIOOBBUHOBS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB11694</td>
      <td>Ilorasertib</td>
      <td>WPHKIQPVPYJNAX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB15408</td>
      <td>Silmitasertib</td>
      <td>MUOKSQABCJCOPU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB14942</td>
      <td>BMS-986141</td>
      <td>KEEBLYWBELVGPQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB15418</td>
      <td>AZD-9977</td>
      <td>MBKYLPOPYYLTNW-ZDUSSCGKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07011</td>
      <td>(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE</td>
      <td>HHOPJGKEAIIIDF-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB11638</td>
      <td>Artenimol</td>
      <td>BJDCWCLMFKKGEE-HVDUHBCDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11730</td>
      <td>Ribociclib</td>
      <td>RHXHGRAEPCAFML-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15151</td>
      <td>RO-6870810</td>
      <td>PKQXLRYFPSZKDU-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00136</td>
      <td>Calcitriol</td>
      <td>GMRQFYUYWCNGIN-NKMMMXOESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00206</td>
      <td>Reserpine</td>
      <td>QEVHRUUCFGRFIF-MDEJGZGSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB11925</td>
      <td>Vistusertib</td>
      <td>JUSFANSTBFGBAF-IRXDYDNUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB03251</td>
      <td>RWJ-51084</td>
      <td>NQABUEUFRXDDFI-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB03199</td>
      <td>4-Methoxy-E-Rhodomycin T</td>
      <td>XSSVYBYWQBNYOH-QJIXERIWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15123</td>
      <td>Dorzagliatin</td>
      <td>HMUMWSORCUWQJO-QAPCUYQASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12547</td>
      <td>LY-2886721</td>
      <td>NIDRNVHMMDAAIK-YPMLDQLKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB01095</td>
      <td>Fluvastatin</td>
      <td>FJLGEFLZQAZZCD-JUFISIKESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB06993</td>
      <td>(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine</td>
      <td>PTAHVQJZNFGPHN-WFWWEWPISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12693</td>
      <td>Ritanserin</td>
      <td>JUQLTPCYUFPYKE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB15048</td>
      <td>Licogliflozin</td>
      <td>XFJAMQQAAMJFGB-ZQGJOIPISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB06994</td>
      <td>(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine</td>
      <td>XCCSSVMRGIQMGF-LPHOPBHVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12270</td>
      <td>Losmapimod</td>
      <td>KKYABQBFGDZVNQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07770</td>
      <td>5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>DJPFUQBNQLKCAB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07220</td>
      <td>N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE</td>
      <td>ZXYIRNXOAJYLCU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB15078</td>
      <td>Rogaratinib</td>
      <td>HNLRRJSKGXOYNO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07874</td>
      <td>(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</td>
      <td>LQOCXPOKEPYGTJ-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB04125</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine</td>
      <td>ZUWBXGHMVKDMQO-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB15132</td>
      <td>AZD-8165</td>
      <td>YUHNXUAATAMVKD-PZJWPPBQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12998</td>
      <td>PF-00217830</td>
      <td>QGNOXTFZOLDODX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07530</td>
      <td>(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol</td>
      <td>PCHUQQNKOFNVDU-OSXMSNBXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB11464</td>
      <td>Sulfaquinoxaline</td>
      <td>NHZLNPMOSADWGC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB11828</td>
      <td>Neratinib</td>
      <td>JWNPDZNEKVCWMY-VQHVLOKHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12364</td>
      <td>Betrixaban</td>
      <td>XHOLNRLADUSQLD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB15187</td>
      <td>Dubermatinib</td>
      <td>YUAALFPUEOYPNX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB04064</td>
      <td>Nogalaviketone</td>
      <td>QHNJNOBWURJIEK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12289</td>
      <td>Darexaban</td>
      <td>IJNIQYINMSGIPS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12289</td>
      <td>Darexaban</td>
      <td>IJNIQYINMSGIPS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB11845</td>
      <td>Lucitanib</td>
      <td>CUDVHEFYRIWYQD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB14729</td>
      <td>Rebeccamycin</td>
      <td>QEHOIJJIZXRMAN-QZQSLCQPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00243</td>
      <td>Ranolazine</td>
      <td>XKLMZUWKNUAPSZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12302</td>
      <td>CP-724714</td>
      <td>LLVZBTWPGQVVLW-SNAWJCMRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07334</td>
      <td>N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</td>
      <td>HTIZPBXCJPQDEM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11656</td>
      <td>Rebamipide</td>
      <td>ALLWOAVDORUJLA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07159</td>
      <td>Tamatinib</td>
      <td>NHHQJBCNYHBUSI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB05408</td>
      <td>Emricasan</td>
      <td>SCVHJVCATBPIHN-SJCJKPOMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00673</td>
      <td>Aprepitant</td>
      <td>ATALOFNDEOCMKK-OITMNORJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00680</td>
      <td>Moricizine</td>
      <td>FUBVWMNBEHXPSU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB11951</td>
      <td>Lemborexant</td>
      <td>MUGXRYIUWFITCP-PGRDOPGGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11958</td>
      <td>Brivanib</td>
      <td>WCWUXEGQKLTGDX-LLVKDONJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07076</td>
      <td>6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</td>
      <td>FWTQOPWAMQXIMI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07395</td>
      <td>4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid</td>
      <td>NWQGDIBCFLDHDO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08391</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UBIIFKJMNRPNMT-CQSZACIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00736</td>
      <td>Esomeprazole</td>
      <td>SUBDBMMJDZJVOS-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12158</td>
      <td>Filorexant</td>
      <td>NPFDWHQSDBWQLH-QZTJIDSGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB02331</td>
      <td>(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>YBULOUKTPCHXAL-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB13471</td>
      <td>Nalfurafine</td>
      <td>XGZZHZMWIXFATA-UEZBDDGYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB11966</td>
      <td>BMS-986094</td>
      <td>YFXGICNMLCGLHJ-RSKRLRQZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11618</td>
      <td>Zorubicin</td>
      <td>FBTUMDXHSRTGRV-BJISBDEGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB09143</td>
      <td>Sonidegib</td>
      <td>VZZJRYRQSPEMTK-CALCHBBNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB02319</td>
      <td>5,6-Dihydroxy-Nadp</td>
      <td>LRAVAOPKUBJONV-IVCJQJMGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB09079</td>
      <td>Nintedanib</td>
      <td>XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11611</td>
      <td>Lifitegrast</td>
      <td>JFOZKMSJYSPYLN-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB15269</td>
      <td>ALK-4290</td>
      <td>DWKNOLCXIFYNFV-HSZRJFAPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00247</td>
      <td>Methysergide</td>
      <td>KPJZHOPZRAFDTN-NQUBZZJWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11666</td>
      <td>Buparlisib</td>
      <td>CWHUFRVAEUJCEF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB09048</td>
      <td>Netupitant</td>
      <td>WAXQNWCZJDTGBU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00266</td>
      <td>Dicoumarol</td>
      <td>DOBMPNYZJYQDGZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB14876</td>
      <td>TAS-116</td>
      <td>NVVPMZUGELHVMH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00275</td>
      <td>Olmesartan</td>
      <td>VTRAEEWXHOVJFV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08351</td>
      <td>N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</td>
      <td>MNEXDVSJIUQQRH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00338</td>
      <td>Omeprazole</td>
      <td>SUBDBMMJDZJVOS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB11511</td>
      <td>Difloxacin</td>
      <td>NOCJXYPHIIZEHN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00354</td>
      <td>Buclizine</td>
      <td>MOYGZHXDRJNJEP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08353</td>
      <td>2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>NCVMTHVSAJMOPI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB01873</td>
      <td>Epothilone D</td>
      <td>XOZIUKBZLSUILX-GIQCAXHBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15206</td>
      <td>Uprifosbuvir</td>
      <td>SFPFZQKYPOWCSI-KHFYHRBSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB09076</td>
      <td>Umeclidinium</td>
      <td>FVTWTVQXNAJTQP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00414</td>
      <td>Acetohexamide</td>
      <td>VGZSUPCWNCWDAN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12207</td>
      <td>Verdinexor</td>
      <td>OPAKEJZFFCECPN-XQRVVYSFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12134</td>
      <td>Gepotidacin</td>
      <td>PZFAZQUREQIODZ-LJQANCHMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12285</td>
      <td>Verubecestat</td>
      <td>YHYKUSGACIYRML-KRWDZBQOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11687</td>
      <td>E-6201</td>
      <td>MWUFVYLAWAXDHQ-HMNLTAHHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00481</td>
      <td>Raloxifene</td>
      <td>GZUITABIAKMVPG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11686</td>
      <td>Iferanserin</td>
      <td>UXIPFQUBOVWAQW-UEBLJOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB01047</td>
      <td>Fluocinonide</td>
      <td>WJOHZNCJWYWUJD-IUGZLZTKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00490</td>
      <td>Buspirone</td>
      <td>QWCRAEMEVRGPNT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12221</td>
      <td>Canrenone</td>
      <td>UJVLDDZCTMKXJK-WNHSNXHDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB01340</td>
      <td>Cilazapril</td>
      <td>HHHKFGXWKKUNCY-FHWLQOOXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15028</td>
      <td>MK-1064</td>
      <td>CKTWQGHVNRYNCM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB06733</td>
      <td>Bafilomycin A1</td>
      <td>XDHNQDDQEHDUTM-JQWOJBOSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08003</td>
      <td>ISOTHIAZOLIDINONE ANALOG</td>
      <td>UILYPHAKDBTKQV-UFYCRDLUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11859</td>
      <td>Brexanolone</td>
      <td>AURFZBICLPNKBZ-SYBPFIFISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04131</td>
      <td>10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione</td>
      <td>BLGDWFJQIHBUJY-NWJGULHDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB13345</td>
      <td>Dihydroergocristine</td>
      <td>DEQITUUQPICUMR-HJPBWRTMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB05983</td>
      <td>Bardoxolone methyl</td>
      <td>WPTTVJLTNAWYAO-KPOXMGGZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB05812</td>
      <td>Abiraterone</td>
      <td>GZOSMCIZMLWJML-VJLLXTKPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12885</td>
      <td>CF-102</td>
      <td>IPSYPUKKXMNCNQ-PFHKOEEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12001</td>
      <td>Abemaciclib</td>
      <td>UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB05653</td>
      <td>IRX-5183</td>
      <td>PNAWUIKCVQSLFG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07941</td>
      <td>PH-797804</td>
      <td>KCAJXIDMCNPGHZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07936</td>
      <td>N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine</td>
      <td>BACSZMCLZIDTIO-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08976</td>
      <td>Floctafenine</td>
      <td>APQPGQGAWABJLN-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12336</td>
      <td>GDC-0917</td>
      <td>HSHPBORBOJIXSQ-HARLFGEKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12325</td>
      <td>Idasanutlin</td>
      <td>TVTXCJFHQKSQQM-LJQIRTBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12219</td>
      <td>GSK-424887</td>
      <td>DRXBWLBZWAJIEF-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07848</td>
      <td>5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide</td>
      <td>BHNMMFGOJRIAEZ-LRDDRELGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB05835</td>
      <td>NS-3728</td>
      <td>OQRAKHDEGGGWQO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12303</td>
      <td>Motolimod</td>
      <td>QSPOQCXMGPDIHI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB05796</td>
      <td>Daglutril</td>
      <td>XMQODGUTLZXUGZ-RPBOFIJWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB14859</td>
      <td>Fosifloxuridine nafalbenamide</td>
      <td>BIOWRMNRHMERIO-ZVAHOJSLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07186</td>
      <td>4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE</td>
      <td>TYYNSDQVFIOSFH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12573</td>
      <td>LY-2452473</td>
      <td>IHIWYQYVBNODSV-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07229</td>
      <td>3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE</td>
      <td>MINVOLKUPZPDNX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12665</td>
      <td>Isoquercetin</td>
      <td>OVSQVDMCBVZWGM-QSOFNFLRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12673</td>
      <td>ATX-914</td>
      <td>ALANRBCCCQEPFZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07147</td>
      <td>methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate</td>
      <td>HJWMYFBKJRVWJY-YKSBVNFPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08080</td>
      <td>LATRUNCULIN B</td>
      <td>NSHPHXHGRHSMIK-JRIKCGFMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08068</td>
      <td>N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</td>
      <td>YQJVDUKATDECHF-ICSRJNTNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB14987</td>
      <td>Difamilast</td>
      <td>VFBILHPIHUPBPZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB06746</td>
      <td>ginkgolide-J</td>
      <td>LMEHVEUFNRJAAV-UKWFQYJJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07142</td>
      <td>5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>ATFDKOLABYIYCC-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07140</td>
      <td>5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>JPENSYBRTSIYGO-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB01342</td>
      <td>Forasartan</td>
      <td>YONOBYIBNBCDSJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07138</td>
      <td>Neflamapimod</td>
      <td>VEPKQEUBKLEPRA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12068</td>
      <td>T-900607</td>
      <td>FSXLOWIFSZNIMV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB13756</td>
      <td>Peruvoside</td>
      <td>PMTSPAGBAFCORP-HBUONDEYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08058</td>
      <td>4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one</td>
      <td>HGEPGGJUGUMFHT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07031</td>
      <td>3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid</td>
      <td>AANFHDFOMFRLLR-LJQANCHMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11921</td>
      <td>Deflazacort</td>
      <td>FBHSPRKOSMHSIF-GRMWVWQJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08899</td>
      <td>Enzalutamide</td>
      <td>WXCXUHSOUPDCQV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12848</td>
      <td>PF-04217903</td>
      <td>PDMUGYOXRHVNMO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB13667</td>
      <td>Cefozopran</td>
      <td>QDUIJCOKQCCXQY-WHJQOFBOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12290</td>
      <td>Puerarin</td>
      <td>HKEAFJYKMMKDOR-VPRICQMDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07756</td>
      <td>1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL</td>
      <td>GPBGHVRNVGXPNM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11786</td>
      <td>Pefcalcitol</td>
      <td>SVCSMAZYWOQCBW-NVJMFHFGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14766</td>
      <td>Etrasimod</td>
      <td>MVGWUTBTXDYMND-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12122</td>
      <td>Figopitant</td>
      <td>HUTHJVYJUPXHDF-DEOSSOPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14787</td>
      <td>BMS-830216</td>
      <td>YDTUJCNTIMWHPJ-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14795</td>
      <td>AZD-3759</td>
      <td>MXDSJQHFFDGFDK-CYBMUJFWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14821</td>
      <td>Macozinone</td>
      <td>BJDZBXGJNBMCAV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB15121</td>
      <td>AT-001</td>
      <td>YRGPAXAVTDMKDK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12252</td>
      <td>PG-701</td>
      <td>OKRSVUYYCJPECG-LFGMFVMYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12054</td>
      <td>BQ-123</td>
      <td>VYCMAAOURFJIHD-PJNXIOHISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12127</td>
      <td>Sultamicillin</td>
      <td>OPYGFNJSCUDTBT-PMLPCWDUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14856</td>
      <td>PF-05089771</td>
      <td>ZYSCOUXLBXGGIM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14866</td>
      <td>Amcasertib</td>
      <td>QDWKGEFGLQMDAM-ULJHMMPZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07689</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>NYNAFINLHQEHKU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14882</td>
      <td>CEP-9722</td>
      <td>CTLOSZHDGZLOQE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB04632</td>
      <td>4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE</td>
      <td>JHHBGNIRSUTQAS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12052</td>
      <td>Icariin</td>
      <td>TZJALUIVHRYQQB-XLRXWWTNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14929</td>
      <td>Elsulfavirine</td>
      <td>ULTDEARCBRNRGR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15102</td>
      <td>Pemigatinib</td>
      <td>HCDMJFOHIXMBOV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB04608</td>
      <td>9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</td>
      <td>IAUZTOZLTFSMIE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB05835</td>
      <td>NS-3728</td>
      <td>OQRAKHDEGGGWQO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB11900</td>
      <td>OC-459</td>
      <td>FATGTHLOZSXOBC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB05738</td>
      <td>Vapitadine</td>
      <td>VQWGYPVNVICKFC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB06977</td>
      <td>(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine</td>
      <td>CAASENZOSQYNPX-HSTJUUNISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14717</td>
      <td>Nitrazolam</td>
      <td>OYRPNABWTHDOFK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07265</td>
      <td>3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID</td>
      <td>JDARUOOLJCFUOY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12282</td>
      <td>Defactinib</td>
      <td>FWLMVFUGMHIOAA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB06755</td>
      <td>Beta carotene</td>
      <td>OENHQHLEOONYIE-JLTXGRSLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07834</td>
      <td>N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide</td>
      <td>FOHZGCHKLPIBBX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB15442</td>
      <td>Trilaciclib</td>
      <td>PDGKHKMBHVFCMG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12253</td>
      <td>GDC-0810</td>
      <td>BURHGPHDEVGCEZ-KJGLQBJMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB12252</td>
      <td>PG-701</td>
      <td>OKRSVUYYCJPECG-LFGMFVMYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12483</td>
      <td>Copanlisib</td>
      <td>PZBCKZWLPGJMAO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04863</td>
      <td>Lefradafiban</td>
      <td>PGCFXITVMNNKON-ROUUACIJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14037</td>
      <td>Madecassic acid</td>
      <td>PRAUVHZJPXOEIF-AOLYGAPISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15056</td>
      <td>Bifenthrin</td>
      <td>OMFRMAHOUUJSGP-IRHGGOMRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12225</td>
      <td>Beclabuvir</td>
      <td>ZTTKEBYSXUCBSE-QDFUAKMASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB14906</td>
      <td>Adafosbuvir</td>
      <td>NIJYGVDQZBBONK-SEUXLIJBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB05416</td>
      <td>Cardarine</td>
      <td>YDBLKRPLXZNVNB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14542</td>
      <td>Hydrocortisone phosphate</td>
      <td>BGSOJVFOEQLVMH-VWUMJDOOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14545</td>
      <td>Hydrocortisone succinate</td>
      <td>VWQWXZAWFPZJDA-CGVGKPPMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14569</td>
      <td>Tedizolid</td>
      <td>XFALPSLJIHVRKE-GFCCVEGCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB05412</td>
      <td>Talmapimod</td>
      <td>ZMELOYOKMZBMRB-DLBZAZTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB14640</td>
      <td>Isoflupredone acetate</td>
      <td>ZOCUOMKMBMEYQV-GSLJADNHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12465</td>
      <td>Ketanserin</td>
      <td>FPCCSQOGAWCVBH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB02194</td>
      <td>8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>ULLMMKZQNNBLRN-SANMLTNESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB13490</td>
      <td>Hidrosmin</td>
      <td>XYFLWVOTXWXNAM-WTNNCJBMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12877</td>
      <td>Oxatomide</td>
      <td>BAINIUMDFURPJM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08197</td>
      <td>(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime</td>
      <td>KYIXUSLGFINPTC-WVFAEZDRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB07049</td>
      <td>(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine</td>
      <td>SOFGQQQVQZQJFS-MRXNPFEDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07689</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>NYNAFINLHQEHKU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00845</td>
      <td>Clofazimine</td>
      <td>WDQPAMHFFCXSNU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12134</td>
      <td>Gepotidacin</td>
      <td>PZFAZQUREQIODZ-LJQANCHMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB12491</td>
      <td>Fasiglifam</td>
      <td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB03076</td>
      <td>AHA047</td>
      <td>CGBDAHCDSVOMCF-FYZVQMPESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11519</td>
      <td>Fluprostenol</td>
      <td>WWSWYXNVCBLWNZ-QIZQQNKQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB09235</td>
      <td>Efonidipine</td>
      <td>NSVFSAJIGAJDMR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07783</td>
      <td>1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>GUYYFMCFEPDDFL-OAQYLSRUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08058</td>
      <td>4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one</td>
      <td>HGEPGGJUGUMFHT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12345</td>
      <td>MBX-2982</td>
      <td>NFTMKHWBOINJGM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB00220</td>
      <td>Nelfinavir</td>
      <td>QAGYKUNXZHXKMR-HKWSIXNMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB03181</td>
      <td>2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione</td>
      <td>RXQAVKWRCZYGMV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB12500</td>
      <td>Fedratinib</td>
      <td>JOOXLOJCABQBSG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07988</td>
      <td>2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE</td>
      <td>HZAXNPDJVFUGDS-BYPYZUCNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07080</td>
      <td>N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE</td>
      <td>SGIWFELWJPNFDH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB12512</td>
      <td>Verucerfont</td>
      <td>VKHVAUKFLBBZFJ-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB07644</td>
      <td>5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine</td>
      <td>IDHINEMSCUFEIP-VIFPVBQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB05087</td>
      <td>Ganaxolone</td>
      <td>PGTVWKLGGCQMBR-FLBATMFCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB08901</td>
      <td>Ponatinib</td>
      <td>PHXJVRSECIGDHY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB08491</td>
      <td>N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE</td>
      <td>ARIRIZBKMKMEBD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08037</td>
      <td>(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide</td>
      <td>MYBGWENAVMIGMM-GIFXNVAJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB05039</td>
      <td>Indacaterol</td>
      <td>QZZUEBNBZAPZLX-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12500</td>
      <td>Fedratinib</td>
      <td>JOOXLOJCABQBSG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB00158</td>
      <td>Folic acid</td>
      <td>OVBPIULPVIDEAO-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB13766</td>
      <td>Lidoflazine</td>
      <td>ZBIAKUMOEKILTF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04740</td>
      <td>MOXALACTAM (HYDROLYZED)</td>
      <td>ZTOQXKUYWZBJLG-XNAIMREJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB05482</td>
      <td>7-ethyl-10-hydroxycamptothecin</td>
      <td>FJHBVJOVLFPMQE-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB08703</td>
      <td>12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</td>
      <td>FGKKIHITEICGMN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB08749</td>
      <td>3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</td>
      <td>KTRFBFMYAJOXLG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB12290</td>
      <td>Puerarin</td>
      <td>HKEAFJYKMMKDOR-VPRICQMDSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB01745</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester</td>
      <td>JJLGQWCKMHPBEB-DEOSSOPVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02510</td>
      <td>'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine</td>
      <td>LKVJEMXWEODCAY-JVEUSOJLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02511</td>
      <td>2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine</td>
      <td>PZWMZAFFUAWVDN-CQXYXCHQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02527</td>
      <td>Cyclic adenosine monophosphate</td>
      <td>IVOMOUWHDPKRLL-KQYNXXCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB00845</td>
      <td>Clofazimine</td>
      <td>WDQPAMHFFCXSNU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07685</td>
      <td>4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>NMAZGYDYIYLSLJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB01940</td>
      <td>Balanol Analog 2</td>
      <td>SQLYTJZXRRDERK-ISKFKSNPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02917</td>
      <td>N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide</td>
      <td>LFGYSFPVLMPUPE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB05913</td>
      <td>OSI-930</td>
      <td>FGTCROZDHDSNIO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08166</td>
      <td>(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile</td>
      <td>LPFQFJAOMCGYCP-GFCCVEGCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB01810</td>
      <td>[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester</td>
      <td>NOXVWFAAXREWMI-GURWAVDKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB04759</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)</td>
      <td>GTBUZLPQANSGGE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02732</td>
      <td>Nicotinamide Adenine Dinucleotide Acetone Adduct</td>
      <td>SGHBFOOIAAJJMI-YDKVLQLQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08126</td>
      <td>3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE</td>
      <td>DMCRNUMVSATRTP-LCYFTJDESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08124</td>
      <td>3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>FTQYGMLRLRXBPT-IDUWFGFVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12477</td>
      <td>Perfluoro tert-butylcyclohexane</td>
      <td>VLTXBOGHSBHSAC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08111</td>
      <td>4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol</td>
      <td>ZGJYGQLGSXWEMY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB15003</td>
      <td>PF-06700841</td>
      <td>BUWBRTXGQRBBHG-MJBXVCDLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB02354</td>
      <td>4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine</td>
      <td>IRKPNOLLMNHSOU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB12426</td>
      <td>Bitopertin</td>
      <td>YUUGYIUSCYNSQR-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB12523</td>
      <td>Mizolastine</td>
      <td>PVLJETXTTWAYEW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12557</td>
      <td>FK-614</td>
      <td>UYGZODVVDUIDDQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07814</td>
      <td>Gibberellic acid</td>
      <td>IXORZMNAPKEEDV-OBDJNFEBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB11922</td>
      <td>Danirixin</td>
      <td>NGYNBSHYFOFVLS-LBPRGKRZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB05992</td>
      <td>Plinabulin</td>
      <td>UNRCMCRRFYFGFX-TYPNBTCFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07793</td>
      <td>(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>ACSGSLPOHKRZCY-GXTWGEPZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB09079</td>
      <td>Nintedanib</td>
      <td>XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12419</td>
      <td>HSD-016</td>
      <td>ZWASRJHIEFYJGL-BFUOFWGJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB13927</td>
      <td>anle138b</td>
      <td>RCQIIBJSUWYYFU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB04626</td>
      <td>Apramycin</td>
      <td>XZNUGFQTQHRASN-XQENGBIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB04373</td>
      <td>4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</td>
      <td>WQUBEIMCFHCJCO-AWCRTANDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB00549</td>
      <td>Zafirlukast</td>
      <td>YEEZWCHGZNKEEK-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB15245</td>
      <td>Olorofim</td>
      <td>SUFPWYYDCOKDLL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB08538</td>
      <td>N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>HQPVGVSQPQVZLD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB04669</td>
      <td>TRIAZOLOPYRIMIDINE</td>
      <td>YWBFPKPWMSWWEA-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12573</td>
      <td>LY-2452473</td>
      <td>IHIWYQYVBNODSV-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB00590</td>
      <td>Doxazosin</td>
      <td>RUZYUOTYCVRMRZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB14037</td>
      <td>Madecassic acid</td>
      <td>PRAUVHZJPXOEIF-AOLYGAPISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB08497</td>
      <td>(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>NKBDSMREMMRFSI-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB08339</td>
      <td>6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE</td>
      <td>ZIQFYVPVJZEOFS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB09209</td>
      <td>Pholcodine</td>
      <td>GPFAJKDEDBRFOS-FKQDBXSBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB02115</td>
      <td>Daidzin</td>
      <td>KYQZWONCHDNPDP-QNDFHXLGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12548</td>
      <td>Sparsentan</td>
      <td>WRFHGDPIDHPWIQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB04862</td>
      <td>Merimepodib</td>
      <td>JBPUGFODGPKTDW-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB12138</td>
      <td>PF-03715455</td>
      <td>VGEXRDWWPSGZDH-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB09200</td>
      <td>Rivoglitazone</td>
      <td>XMSXOLDPMGMWTH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB03598</td>
      <td>Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]</td>
      <td>XSUAVPPTKHUTDX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB12535</td>
      <td>AC-430</td>
      <td>DCRWIATZWHLIPN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07811</td>
      <td>N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide</td>
      <td>UBVTVSINEVHYSY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB11901</td>
      <td>Apalutamide</td>
      <td>HJBWBFZLDZWPHF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB03701</td>
      <td>Vanoxerine</td>
      <td>NAUWTFJOPJWYOT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB15414</td>
      <td>CM-4307</td>
      <td>MLDQJTXFUGDVEO-FIBGUPNXSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB09166</td>
      <td>Etizolam</td>
      <td>VMZUTJCNQWMAGF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB03788</td>
      <td>GC-24</td>
      <td>JYHIGYLGYNCMGI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB03882</td>
      <td>5-Alpha-Androstane-3-Beta,17beta-Diol</td>
      <td>CBMYJHIOYJEBSB-YSZCXEEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB04771</td>
      <td>1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE</td>
      <td>FIZYZWLGMGGGBJ-OALUTQOASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB06933</td>
      <td>N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide</td>
      <td>GJTCKUKIFXWJKG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB06907</td>
      <td>2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID</td>
      <td>XVNRKPCHMYOPPL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB01941</td>
      <td>6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid</td>
      <td>SLXTWXQUEZSSTJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB04086</td>
      <td>2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside</td>
      <td>WFVCNOHOODVBQK-IUBYCILNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07105</td>
      <td>2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE</td>
      <td>IEEYGOJDTRVYGR-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB04137</td>
      <td>Guanosine-5'-Triphosphate</td>
      <td>XKMLYUALXHKNFT-UUOKFMHZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB04644</td>
      <td>4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID</td>
      <td>FCEMCUPAYRPTLS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB07945</td>
      <td>5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid</td>
      <td>GKBQRPKZHUFGOB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11971</td>
      <td>Vilaprisan</td>
      <td>JUFWQQVHQFDUOD-ANRPBIDPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB06959</td>
      <td>(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine</td>
      <td>BUCZDJYEOAQTHL-KEKNWZKVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15391</td>
      <td>Elenbecestat</td>
      <td>AACUJFVOHGRMTR-DPXNYUHVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB08912</td>
      <td>Dabrafenib</td>
      <td>BFSMGDJOXZAERB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB14944</td>
      <td>Tarloxotinib</td>
      <td>MUJMYVFVAWFUJL-SNAWJCMRSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB01765</td>
      <td>(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid</td>
      <td>INSBKYCYLCEBOD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12101</td>
      <td>CC-220</td>
      <td>IXZOHGPZAQLIBH-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12410</td>
      <td>Sabarubicin</td>
      <td>VQHRZZISQVWPLK-UIRGBLDSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01327</td>
      <td>Cefazolin</td>
      <td>MLYYVTUWGNIJIB-BXKDBHETSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08739</td>
      <td>2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione</td>
      <td>ZSXNPAWXICXNGZ-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07507</td>
      <td>2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</td>
      <td>ROMNEYAQUBNRLR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08698</td>
      <td>1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL</td>
      <td>BKSGACYTXOQQNI-OAQYLSRUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB11890</td>
      <td>Cilengitide</td>
      <td>AMLYAMJWYAIXIA-VWNVYAMZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB14675</td>
      <td>Temsavir</td>
      <td>QRPZBKAMSFHVRW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15275</td>
      <td>GDC-0077</td>
      <td>SGEUNORSOZVTOL-CABZTGNLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB06962</td>
      <td>(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone</td>
      <td>YKTUSHSSKIWDRY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01456</td>
      <td>5-androstenedione</td>
      <td>SQGZFRITSMYKRH-QAGGRKNESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15292</td>
      <td>Foliglurax</td>
      <td>ZTEDNASHAWNBKQ-NCELDCMTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB08865</td>
      <td>Crizotinib</td>
      <td>KTEIFNKAUNYNJU-GFCCVEGCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB06909</td>
      <td>1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide</td>
      <td>QZGJNFBMYYEFGM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01474</td>
      <td>17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene</td>
      <td>BNUOCVTVOYWNJC-DTMQFJJTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB08861</td>
      <td>DPDPE</td>
      <td>MCMMCRYPQBNCPH-WMIMKTLMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04298</td>
      <td>3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One</td>
      <td>ZEBFKFGJWHOOST-LJAQVGFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB11829</td>
      <td>Ruboxistaurin</td>
      <td>ZCBUQCWBWNUWSU-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01496</td>
      <td>Barbituric acid derivative</td>
      <td>DNZPLHRZXUJATK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01500</td>
      <td>Oxabolone</td>
      <td>GXHBCWCMYVTJOW-YGRHGMIBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01431</td>
      <td>Allylestrenol</td>
      <td>ATXHVCQZZJYMCF-XUDSTZEESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12084</td>
      <td>ADP-597</td>
      <td>WPDCHTSXOPUOII-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB01771</td>
      <td>CRA_10991</td>
      <td>QXAURVOBXQBPAP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12408</td>
      <td>PF-03635659</td>
      <td>WGOJWDWKHJHXSV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB04064</td>
      <td>Nogalaviketone</td>
      <td>QHNJNOBWURJIEK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB11969</td>
      <td>Uprosertib</td>
      <td>AXTAPYRUEKNRBA-JTQLQIEISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07406</td>
      <td>(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE</td>
      <td>QWFFPYQWUWLDBV-NSHDSACASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12198</td>
      <td>Fosdagrocorat</td>
      <td>BVXLAHSJXXSWFF-KEKPKEOLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00978</td>
      <td>Lomefloxacin</td>
      <td>ZEKZLJVOYLTDKK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB06879</td>
      <td>5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE</td>
      <td>QCFIRACCCDFXIP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB12036</td>
      <td>Naquotinib</td>
      <td>QKDCLUARMDUUKN-XMMPIXPASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01025</td>
      <td>Amlexanox</td>
      <td>SGRYPYWGNKJSDL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08922</td>
      <td>Perospirone</td>
      <td>FBVFZWUMDDXLLG-HDICACEKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB15242</td>
      <td>MK-0533</td>
      <td>STWITCBWQHTJFJ-XMMPIXPASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01081</td>
      <td>Diphenoxylate</td>
      <td>HYPPXZBJBPSRLK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB06972</td>
      <td>7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile</td>
      <td>TZCXQSNBTXDAJG-QFIPXVFZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB12808</td>
      <td>Trifarotene</td>
      <td>MFBCDACCJCDGBA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB06922</td>
      <td>2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>CZNPWASYMRBJCX-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB12006</td>
      <td>BMS-906024</td>
      <td>AYOUDDAETNMCBW-GSHUGGBRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB04669</td>
      <td>TRIAZOLOPYRIMIDINE</td>
      <td>YWBFPKPWMSWWEA-UHFFFAOYSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07453</td>
      <td>2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE</td>
      <td>VFMMPHCGEFXGIP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00997</td>
      <td>Doxorubicin</td>
      <td>AOJJSUZBOXZQNB-TZSSRYMLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01503</td>
      <td>1-Androstenediol</td>
      <td>RZFGPAMUAXASRE-YSZCXEEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01521</td>
      <td>Clostebol</td>
      <td>KCZCIYZKSLLNNH-FBPKJDBXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12055</td>
      <td>MK-0767</td>
      <td>ORZMUVMQJPGFOM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01861</td>
      <td>Uridine diphosphate glucose</td>
      <td>HSCJRCZFDFQWRP-JZMIEXBBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB13643</td>
      <td>Loprazolam</td>
      <td>UTEFBSAVJNEPTR-RGEXLXHISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08489</td>
      <td>N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE</td>
      <td>GCBPAPVOMPJQHK-NQIIRXRSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB12341</td>
      <td>LY-2456302</td>
      <td>ZHPMYDSXGRRERG-DEOSSOPVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB00705</td>
      <td>Delavirdine</td>
      <td>WHBIGIKBNXZKFE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB13664</td>
      <td>Formocortal</td>
      <td>QNXUUBBKHBYRFW-QWAPGEGQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxx</td>
      <td>DB01212</td>
      <td>Ceftriaxone</td>
      <td>VAAUVRVFOQPIGI-SPQHTLEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB14664</td>
      <td>Difluocortolone pivalate</td>
      <td>UWGRWFCLGQWKPR-GSTUPEFVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB06510</td>
      <td>Muraglitazar</td>
      <td>IRLWJILLXJGJTD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02059</td>
      <td>Adenosine-5-Diphosphoribose</td>
      <td>SRNWOUGRCWSEMX-ZQSHOCFMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB05116</td>
      <td>Thymectacin</td>
      <td>CFBLUORPOFELCE-BACVZHSASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02101</td>
      <td>(S,R)-fidarestat</td>
      <td>WAAPEIZFCHNLKK-QPUJVOFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02104</td>
      <td>2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine</td>
      <td>PEGMMEYCSOZKIT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB11968</td>
      <td>MK-7145</td>
      <td>OCKGFTQIICXDQW-ZEQRLZLVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB11562</td>
      <td>Bicuculline</td>
      <td>IYGYMKDQCDOMRE-ZWKOTPCHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08389</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UPTQSRGSSJRBKJ-LJQANCHMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB06314</td>
      <td>SGX-523</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02220</td>
      <td>AL7089A</td>
      <td>RMOXCYSVWCHXII-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB02224</td>
      <td>Taxifolin</td>
      <td>CXQWRCVTCMQVQX-LSDHHAIUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB11450</td>
      <td>Pimobendan</td>
      <td>GLBJJMFZWDBELO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB11786</td>
      <td>Pefcalcitol</td>
      <td>SVCSMAZYWOQCBW-NVJMFHFGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB11964</td>
      <td>Ilaprazole</td>
      <td>HRRXCXABAPSOCP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01764</td>
      <td>Dalfopristin</td>
      <td>SUYRLXYYZQTJHF-VMBLUXKRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01526</td>
      <td>4-Androstenediol</td>
      <td>BTTWKVFKBPAFDK-LOVVWNRFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01532</td>
      <td>??-Methylacetylfentanyl</td>
      <td>OKTLVZBUKMRPLL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01543</td>
      <td>18-methyl-19-nortestosterone</td>
      <td>FBYZQDCRLYHHHP-ZOFHRBRSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12050</td>
      <td>LY-3039478</td>
      <td>YCBAQKQAINQRFW-UGSOOPFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB12417</td>
      <td>Anagliptin</td>
      <td>LDXYBEHACFJIEL-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB15028</td>
      <td>MK-1064</td>
      <td>CKTWQGHVNRYNCM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB01184</td>
      <td>Domperidone</td>
      <td>FGXWKSZFVQUSTL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB08538</td>
      <td>N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>HQPVGVSQPQVZLD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB06588</td>
      <td>Triphendiol</td>
      <td>KQCJZAUNKSGEFM-UNMCSNQZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB12015</td>
      <td>Alpelisib</td>
      <td>STUWGJZDJHPWGZ-LBPRGKRZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB07608</td>
      <td>N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</td>
      <td>JDGOPNUGILVNJZ-IBGZPJMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9q</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB01162</td>
      <td>Terazosin</td>
      <td>VCKUSRYTPJJLNI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01705</td>
      <td>Bis(5-Amidino-Benzimidazolyl)Methane</td>
      <td>QZKOOEFIMWKZPK-UHFFFAOYSA-Q</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00969</td>
      <td>Alosetron</td>
      <td>JSWZEAMFRNKZNL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01713</td>
      <td>Udp-Alpha-D-Xylopyranose</td>
      <td>DQQDLYVHOTZLOR-OCIMBMBZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB01755</td>
      <td>N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone</td>
      <td>XVTRBLLRODNOJV-VBJYJYTRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m2n</td>
      <td>DB06519</td>
      <td>Edaglitazone</td>
      <td>HAAXAFNSRADSMK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB13591</td>
      <td>Metopimazine</td>
      <td>BQDBKDMTIJBJLA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB00860</td>
      <td>Prednisolone</td>
      <td>OIGNJSKKLXVSLS-VWUMJDOOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB13950</td>
      <td>WIN 55212-2</td>
      <td>HQVHOQAKMCMIIM-HXUWFJFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB06876</td>
      <td>N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE</td>
      <td>YJWJKKXGAPWLGT-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB14828</td>
      <td>ABX-464</td>
      <td>OZOGDCZJYVSUBR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15048</td>
      <td>Licogliflozin</td>
      <td>XFJAMQQAAMJFGB-ZQGJOIPISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB06199</td>
      <td>Atrasentan</td>
      <td>MOTJMGVDPWRKOC-QPVYNBJUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12129</td>
      <td>Tideglusib</td>
      <td>PMJIHLSCWIDGMD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB03962</td>
      <td>Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate</td>
      <td>MDKMTCCUJSRQGW-NAJQWHGHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08487</td>
      <td>3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>PRMSFVUWLBPPLY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB07193</td>
      <td>(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</td>
      <td>HJJAYSSCWGUPKO-ABAIWWIYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12512</td>
      <td>Verucerfont</td>
      <td>VKHVAUKFLBBZFJ-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB15310</td>
      <td>Vactosertib</td>
      <td>FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08355</td>
      <td>1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid</td>
      <td>ZOBRPBVIEUWYJR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03421</td>
      <td>2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione</td>
      <td>JSSVIGGKHIJEHO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11811</td>
      <td>Arhalofenate</td>
      <td>BJBCSGQLZQGGIQ-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12135</td>
      <td>Elubrixin</td>
      <td>YQYFEGTYCUQBEI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13638</td>
      <td>Cefbuperazone</td>
      <td>SMSRCGPDNDCXFR-CYWZMYCQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12696</td>
      <td>BMS-582949</td>
      <td>GDTQLZHHDRRBEB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00180</td>
      <td>Flunisolide</td>
      <td>XSFJVAJPIHIPKU-XWCQMRHXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB13053</td>
      <td>CP-195543</td>
      <td>NZQDWKCNBOELAI-KSFYIVLOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11833</td>
      <td>Basimglurant</td>
      <td>UPZWINBEAHDTLA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03751</td>
      <td>2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose</td>
      <td>YSYKRGRSMLTJNL-URARBOGNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03515</td>
      <td>Equilenin</td>
      <td>PDRGHUMCVRDZLQ-WMZOPIPTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB13060</td>
      <td>CEP-37440</td>
      <td>BCSHRERPHLTPEE-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB07362</td>
      <td>1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>UOLCZAFAGDOUFX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB07360</td>
      <td>1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>JJHXPDTVQKWKHA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB14066</td>
      <td>Tetrandrine</td>
      <td>WVTKBKWTSCPRNU-KYJUHHDHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08746</td>
      <td>1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE</td>
      <td>ZOSSOFIFNGGDKG-GIJQJNRQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB02611</td>
      <td>Balanol Analog 1</td>
      <td>FZJQHARRQUNVGZ-QZTJIDSGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB04244</td>
      <td>(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide</td>
      <td>YCDHZDINQZLSRR-DNQXCXABSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB09034</td>
      <td>Suvorexant</td>
      <td>JYTNQNCOQXFQPK-MRXNPFEDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB13080</td>
      <td>Roluperidone</td>
      <td>RNRYULFRLCBRQS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB06176</td>
      <td>Romidepsin</td>
      <td>OHRURASPPZQGQM-GCCNXGTGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03388</td>
      <td>3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid</td>
      <td>UKNZREOUDLFUFF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB13520</td>
      <td>Metergoline</td>
      <td>WZHJKEUHNJHDLS-QTGUNEKASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15381</td>
      <td>Menaquinone</td>
      <td>HYPYXGZDOYTYDR-HAJWAVTHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB13947</td>
      <td>Testosterone enantate benzilic acid hydrazone</td>
      <td>PTVXYACXDYZNID-JKXGKYMWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03488</td>
      <td>Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose</td>
      <td>NGTCPFGWXMBZEP-NQQHDEILSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00327</td>
      <td>Hydromorphone</td>
      <td>WVLOADHCBXTIJK-YNHQPCIGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB08912</td>
      <td>Dabrafenib</td>
      <td>BFSMGDJOXZAERB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12988</td>
      <td>LY-518674</td>
      <td>PNHFDVSKDSLUFH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08520</td>
      <td>(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE</td>
      <td>VUCSBBBCFXBFFY-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB00637</td>
      <td>Astemizole</td>
      <td>GXDALQBWZGODGZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB02917</td>
      <td>N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide</td>
      <td>LFGYSFPVLMPUPE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB08003</td>
      <td>ISOTHIAZOLIDINONE ANALOG</td>
      <td>UILYPHAKDBTKQV-UFYCRDLUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4b</td>
      <td>DB12886</td>
      <td>GSK-1521498</td>
      <td>WIEDUMBCZQRGSY-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB13534</td>
      <td>Gedocarnil</td>
      <td>SLYDYLLJUXFULK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB06163</td>
      <td>Plevitrexed</td>
      <td>IEJSCSAMMLUINT-NRFANRHFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB09298</td>
      <td>Silibinin</td>
      <td>SEBFKMXJBCUCAI-HKTJVKLFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07765</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>UKCFUFHREWUXJJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12194</td>
      <td>Atamestane</td>
      <td>PEPMWUSGRKINHX-TXTPUJOMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11741</td>
      <td>Famitinib</td>
      <td>GKEYKDOLBLYGRB-LGMDPLHJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4b</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12463</td>
      <td>Semagacestat</td>
      <td>PKXWXXPNHIWQHW-RCBQFDQVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB00136</td>
      <td>Calcitriol</td>
      <td>GMRQFYUYWCNGIN-NKMMMXOESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11775</td>
      <td>PF-03758309</td>
      <td>AYCPARAPKDAOEN-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB13605</td>
      <td>Phenoperidine</td>
      <td>IPOPQVVNCFQFRK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB13029</td>
      <td>MK-0873</td>
      <td>JJWKQXNHYDJXKF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12500</td>
      <td>Fedratinib</td>
      <td>JOOXLOJCABQBSG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12941</td>
      <td>ODM-201</td>
      <td>BLIJXOOIHRSQRB-PXYINDEMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08268</td>
      <td>6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</td>
      <td>SPVJRTJUEVXOMS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB07689</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>NYNAFINLHQEHKU-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08345</td>
      <td>4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>IWUUKHQIKFHWIW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15307</td>
      <td>Atabecestat</td>
      <td>VLLFGVHGKLDDLW-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12147</td>
      <td>Erdafitinib</td>
      <td>OLAHOMJCDNXHFI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08395</td>
      <td>2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE</td>
      <td>ZSOXFJURLPCSOO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15063</td>
      <td>Inarigivir soproxil</td>
      <td>CJCYTUJOSMYXLE-JDLSZIHUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07756</td>
      <td>1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL</td>
      <td>GPBGHVRNVGXPNM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03262</td>
      <td>Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]</td>
      <td>PZLYYZPXSSNGJS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB08220</td>
      <td>(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid</td>
      <td>RPNNXCYIESWDSC-JRZBRKEGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13571</td>
      <td>Pentamycin</td>
      <td>AGJUUQSLGVCRQA-SWOUQTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15229</td>
      <td>CNV-2197944</td>
      <td>BLFJGFDZMABYMY-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07168</td>
      <td>[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile</td>
      <td>MFMSRHREFZCFSN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13708</td>
      <td>Fenquizone</td>
      <td>DBDTUXMDTSTPQZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB00834</td>
      <td>Mifepristone</td>
      <td>VKHAHZOOUSRJNA-GCNJZUOMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12666</td>
      <td>Emapunil</td>
      <td>NBMBIEOUVBHEBM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11971</td>
      <td>Vilaprisan</td>
      <td>JUFWQQVHQFDUOD-ANRPBIDPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11969</td>
      <td>Uprosertib</td>
      <td>AXTAPYRUEKNRBA-JTQLQIEISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB15071</td>
      <td>Omidenepag isopropyl</td>
      <td>VIQCWEGEHRBLAC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13956</td>
      <td>Estradiol valerate</td>
      <td>RSEPBGGWRJCQGY-RBRWEJTLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08499</td>
      <td>N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide</td>
      <td>DQXBKUVWJSZHSI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB04609</td>
      <td>INHIBITOR Q8467 OF DUPONT MERCK</td>
      <td>HFLCERPZYCWLSZ-VKONIRKNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00319</td>
      <td>Piperacillin</td>
      <td>IVBHGBMCVLDMKU-GXNBUGAJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB13764</td>
      <td>Monoxerutin</td>
      <td>MBHXKZDTQCSVPM-BDAFLREQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12663</td>
      <td>Letrazuril</td>
      <td>XQKYUBTUOHHNDV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB00966</td>
      <td>Telmisartan</td>
      <td>RMMXLENWKUUMAY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB13764</td>
      <td>Monoxerutin</td>
      <td>MBHXKZDTQCSVPM-BDAFLREQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07359</td>
      <td>3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide</td>
      <td>SJTQKYKXCYVFHX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB02358</td>
      <td>LY374571</td>
      <td>SZHRIPFGZWWRKW-VIFPVBQESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB07457</td>
      <td>3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE</td>
      <td>APYXQTXFRIDSGE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB15414</td>
      <td>CM-4307</td>
      <td>MLDQJTXFUGDVEO-FIBGUPNXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13843</td>
      <td>Cloprednol</td>
      <td>YTJIBEDMAQUYSZ-FDNPDPBUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB04685</td>
      <td>1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>GJNIPWYJQUGERM-BFLUCZKCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13930</td>
      <td>Ulixertinib</td>
      <td>KSERXGMCDHOLSS-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB06169</td>
      <td>Indibulin</td>
      <td>SOLIIYNRSAWTSQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB06717</td>
      <td>Fosaprepitant</td>
      <td>BARDROPHSZEBKC-OITMNORJSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12704</td>
      <td>Spiradoline</td>
      <td>NYKCGQQJNVPOLU-ONTIZHBOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB02323</td>
      <td>EM-1745</td>
      <td>CKSDYJASHNGOOS-KTXOUVACSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12705</td>
      <td>Cenerimod</td>
      <td>KJKKMMMRWISKRF-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB13101</td>
      <td>4SC-202</td>
      <td>PRXXYMVLYKJITB-IZZDOVSWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB05608</td>
      <td>MKC-1</td>
      <td>OVSKGTONMLKNPZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB05667</td>
      <td>Levoketoconazole</td>
      <td>XMAYWYJOQHXEEK-ZEQKJWHPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB01029</td>
      <td>Irbesartan</td>
      <td>YOSHYTLCDANDAN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB08546</td>
      <td>4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE</td>
      <td>CETLUACQMGBMFH-ZALSBGIRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07537</td>
      <td>N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide</td>
      <td>CLEGTVIMOPPIBR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB00845</td>
      <td>Clofazimine</td>
      <td>WDQPAMHFFCXSNU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB01030</td>
      <td>Topotecan</td>
      <td>UCFGDBYHRUNTLO-QHCPKHFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB04703</td>
      <td>Hesperidin</td>
      <td>QUQPHWDTPGMPEX-QJBIFVCTSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12011</td>
      <td>Fevipiprant</td>
      <td>GFPPXZDRVCSVNR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB05713</td>
      <td>LY-517717</td>
      <td>VYNKVNDKAOGAAQ-RUZDIDTESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB06603</td>
      <td>Panobinostat</td>
      <td>FPOHNWQLNRZRFC-ZHACJKMWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB01082</td>
      <td>Streptomycin</td>
      <td>UCSJYZPVAKXKNQ-HZYVHMACSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB05653</td>
      <td>IRX-5183</td>
      <td>PNAWUIKCVQSLFG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4b</td>
      <td>DB05984</td>
      <td>RAF-265</td>
      <td>YABJJWZLRMPFSI-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11893</td>
      <td>Avagacestat</td>
      <td>XEAOPVUAMONVLA-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB08881</td>
      <td>Vemurafenib</td>
      <td>GPXBXXGIAQBQNI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB13643</td>
      <td>Loprazolam</td>
      <td>UTEFBSAVJNEPTR-RGEXLXHISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB08899</td>
      <td>Enzalutamide</td>
      <td>WXCXUHSOUPDCQV-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB06190</td>
      <td>Solabegron</td>
      <td>LLDXOPKUNJTIRF-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08341</td>
      <td>4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide</td>
      <td>CAUFYHKGKDJMQG-HZPDHXFCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03367</td>
      <td>PF-00356231</td>
      <td>VMTJQZUZINLEKC-JOCHJYFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4b</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB03336</td>
      <td>BIA</td>
      <td>KVIVJQWOYSWCCZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11883</td>
      <td>SB-705498</td>
      <td>JYILLRHXRVTRSH-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB13095</td>
      <td>JTK-853</td>
      <td>JQLOVYLALGSISI-HXUWFJFHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07638</td>
      <td>(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</td>
      <td>QJSMFUTULGSHNQ-ZOBUZTSGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12566</td>
      <td>Decernotinib</td>
      <td>ASUGUQWIHMTFJL-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12833</td>
      <td>Tandospirone</td>
      <td>CEIJFEGBUDEYSX-FZDBZEDMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB06519</td>
      <td>Edaglitazone</td>
      <td>HAAXAFNSRADSMK-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB13093</td>
      <td>TAK-593</td>
      <td>DZFZXPPHBWCXPQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB03020</td>
      <td>5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</td>
      <td>UINNILASBHZOTM-KMXXXSRASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12434</td>
      <td>Steviolbioside</td>
      <td>OMHUCGDTACNQEX-OSHKXICASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15011</td>
      <td>Avacopan</td>
      <td>PUKBOVABABRILL-YZNIXAGQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB14982</td>
      <td>Miransertib</td>
      <td>HNFMVVHMKGFCMB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB13874</td>
      <td>Enasidenib</td>
      <td>DYLUUSLLRIQKOE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03678</td>
      <td>(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine</td>
      <td>WVGZKPGUHOZIJQ-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB13939</td>
      <td>RAD-140</td>
      <td>XMBUPPIEVAFYHO-KPZWWZAWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07647</td>
      <td>(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL</td>
      <td>VBASHTSSQNDDAS-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12043</td>
      <td>Sepetaprost</td>
      <td>BKVUSNOUTQMSBE-XCMGCKIWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB02360</td>
      <td>Bis-Napthyl Beta-Ketophosphonic Acid</td>
      <td>OFHMUASCSJJNNA-JOCHJYFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12780</td>
      <td>Quinfamide</td>
      <td>SBJGFIXQRZOVTO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13991</td>
      <td>Pipequaline</td>
      <td>AMEWZCMTSIONOX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB07453</td>
      <td>2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE</td>
      <td>VFMMPHCGEFXGIP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB12985</td>
      <td>Quisinostat</td>
      <td>PAWIYAYFNXQGAP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB02259</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide</td>
      <td>VSYGXLAJQDAWCZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13997</td>
      <td>Baloxavir marboxil</td>
      <td>RZVPBGBYGMDSBG-GGAORHGYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB14054</td>
      <td>Asiatic acid</td>
      <td>JXSVIVRDWWRQRT-UYDOISQJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB01185</td>
      <td>Fluoxymesterone</td>
      <td>YLRFCQOZQXIBAB-RBZZARIASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08407</td>
      <td>PLATENSIMYCIN</td>
      <td>CSOMAHTTWTVBFL-OFBLZTNGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB15011</td>
      <td>Avacopan</td>
      <td>PUKBOVABABRILL-YZNIXAGQSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12242</td>
      <td>AZD-7762</td>
      <td>IAYGCINLNONXHY-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB04107</td>
      <td>[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester</td>
      <td>RNOYCNIZOAIUSV-LSWMGQQCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB07084</td>
      <td>N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</td>
      <td>YHKGWOJTUMJPNW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13411</td>
      <td>Lofepramine</td>
      <td>SAPNXPWPAUFAJU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB11562</td>
      <td>Bicuculline</td>
      <td>IYGYMKDQCDOMRE-ZWKOTPCHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13102</td>
      <td>AZD-8418</td>
      <td>MCPBSUCAISQZQK-JTQLQIEISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08731</td>
      <td>2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>GPOKTQCDBPECSS-MRXNPFEDSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB13052</td>
      <td>Upamostat</td>
      <td>HUASEDVYRABWCV-NDEPHWFRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13397</td>
      <td>Prenoxdiazine</td>
      <td>PXZDWASDNFWKSD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11687</td>
      <td>E-6201</td>
      <td>MWUFVYLAWAXDHQ-HMNLTAHHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15157</td>
      <td>Voruciclib</td>
      <td>MRPGRAKIAJJGMM-OCCSQVGLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB09053</td>
      <td>Ibrutinib</td>
      <td>XYFPWWZEPKGCCK-GOSISDBHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15145</td>
      <td>Ziresovir</td>
      <td>GAAICKUTDBZCMT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB06362</td>
      <td>Becatecarin</td>
      <td>JSKFWUPVIZYJMR-UDOAKELVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08703</td>
      <td>12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</td>
      <td>FGKKIHITEICGMN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07608</td>
      <td>N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</td>
      <td>JDGOPNUGILVNJZ-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB07969</td>
      <td>3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol</td>
      <td>QNCYYRHIUFGGJX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB04350</td>
      <td>Argadin</td>
      <td>FOZYKTUSOWWQGR-KNPYFFGGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m71</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13434</td>
      <td>Fenticonazole</td>
      <td>ZCJYUTQZBAIHBS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12238</td>
      <td>MK-0777</td>
      <td>QKIWQBLNTSQOLY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15123</td>
      <td>Dorzagliatin</td>
      <td>HMUMWSORCUWQJO-QAPCUYQASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07430</td>
      <td>(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one</td>
      <td>CMWRPDHVGMHLSZ-GFCCVEGCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00240</td>
      <td>Alclometasone</td>
      <td>FJXOGVLKCZQRDN-PHCHRAKRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB15408</td>
      <td>Silmitasertib</td>
      <td>MUOKSQABCJCOPU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB15137</td>
      <td>VK-2809</td>
      <td>LGGPZDRLTDGYSQ-JADSYQMUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB15450</td>
      <td>PF-05105679</td>
      <td>BXNMZRPTQFVRFA-QGZVFWFLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08346</td>
      <td>(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE</td>
      <td>YUZYDHRGGDTZLG-DUXPYHPUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13312</td>
      <td>Delapril</td>
      <td>WOUOLAUOZXOLJQ-MBSDFSHPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07456</td>
      <td>3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-QGZVFWFLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00158</td>
      <td>Folic acid</td>
      <td>OVBPIULPVIDEAO-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13215</td>
      <td>Sulfobromophthalein</td>
      <td>OHTXTCNTQJFRIG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB00443</td>
      <td>Betamethasone</td>
      <td>UREBDLICKHMUKA-DVTGEIKXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03598</td>
      <td>Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]</td>
      <td>XSUAVPPTKHUTDX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB01587</td>
      <td>Ketazolam</td>
      <td>PWAJCNITSBZRBL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB03186</td>
      <td>U-Pi-a-Pi</td>
      <td>JIAJERGOUFOENU-LNAOLWRRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB04238</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid</td>
      <td>GNANSBQAIRJZPA-XZOQPEGZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15191</td>
      <td>MAX-40279</td>
      <td>AVIOBQFPAGEICQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB03207</td>
      <td>2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid</td>
      <td>BNVMUDXGABBWGP-OAQYLSRUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB07982</td>
      <td>2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol</td>
      <td>PVTKDXZNSUHUMO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15208</td>
      <td>NOP-1A</td>
      <td>MZBCQWLYUQJXKA-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07237</td>
      <td>{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone</td>
      <td>VUWFJUJWAWMRQN-HXUWFJFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03777</td>
      <td>Rbt205 Inhibitor</td>
      <td>QMGUOJYZJKLOLH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12379</td>
      <td>Indirubin</td>
      <td>CRDNMYFJWFXOCH-BUHFOSPRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB00276</td>
      <td>Amsacrine</td>
      <td>XCPGHVQEEXUHNC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB11759</td>
      <td>Pevonedistat</td>
      <td>MPUQHZXIXSTTDU-QXGSTGNESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6cs2</td>
      <td>DB07783</td>
      <td>1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>GUYYFMCFEPDDFL-OAQYLSRUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03768</td>
      <td>N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3</td>
      <td>WRUVOSYKHXGAQN-GKRYNVPLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13208</td>
      <td>Prednylidene</td>
      <td>WSVOMANDJDYYEY-CWNVBEKCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB11650</td>
      <td>HT-0712</td>
      <td>ABEJDMOBAFLQNJ-NHCUHLMSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15169</td>
      <td>H3B-6527</td>
      <td>MBWRLLRCTIYXDW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12355</td>
      <td>Netazepide</td>
      <td>YDZYKNJZCVIKPP-VWLOTQADSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15170</td>
      <td>Evobrutinib</td>
      <td>QUIWHXQETADMGN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB13104</td>
      <td>X-396</td>
      <td>ONPGOSVDVDPBCY-CQSZACIVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12270</td>
      <td>Losmapimod</td>
      <td>KKYABQBFGDZVNQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13169</td>
      <td>Nandrolone</td>
      <td>NPAGDVCDWIYMMC-IZPLOLCNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4h</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB12000</td>
      <td>Apabetalone</td>
      <td>NETXMUIMUZJUTB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB14876</td>
      <td>TAS-116</td>
      <td>NVVPMZUGELHVMH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lxt</td>
      <td>DB06420</td>
      <td>Annamycin</td>
      <td>CIDNKDMVSINJCG-GKXONYSUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6lzg</td>
      <td>DB15028</td>
      <td>MK-1064</td>
      <td>CKTWQGHVNRYNCM-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB15294</td>
      <td>SB-1578</td>
      <td>NNXDIGHYPZHXTR-ONEGZZNKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB03622</td>
      <td>2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione</td>
      <td>IPBPOBHSNJFRFT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13532</td>
      <td>Cyclopenthiazide</td>
      <td>BKYKPTRYDKTTJY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6vxs</td>
      <td>DB04971</td>
      <td>Reglitazar</td>
      <td>QBQLYIISSRXYKL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13046</td>
      <td>Tocladesine</td>
      <td>CLLFEJLEDNXZNR-UUOKFMHZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w9c</td>
      <td>DB01763</td>
      <td>7-thionicotinamide-adenine-dinucleotide phosphate</td>
      <td>OJNFDOAQUXJWED-NNYOXOHSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB08224</td>
      <td>(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL</td>
      <td>WWSNTLOVYSRDEL-TVKPWXLESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6w4b</td>
      <td>DB12892</td>
      <td>MGB-BP-3</td>
      <td>OEKXCVYZBVOWBR-BQYQJAHWSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6crv</td>
      <td>DB07678</td>
      <td>(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL</td>
      <td>ANAMDWGJXBYJEB-OPWFCKQNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13044</td>
      <td>Gossypol</td>
      <td>QBKSWRVVCFFDOT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>7bv1</td>
      <td>DB07993</td>
      <td>N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>LPQUIIHPUGDHJK-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-9.0</td>
      <td>6m3m</td>
      <td>DB13024</td>
      <td>MK-8245</td>
      <td>UJEAABFSXKCSGI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06420</td>
      <td>Annamycin</td>
      <td>CIDNKDMVSINJCG-GKXONYSUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04882</td>
      <td>Edotecarin</td>
      <td>QMVPQBFHUJZJCS-NTKFZFFISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00678</td>
      <td>Losartan</td>
      <td>PSIFNNKUMBGKDQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB04612</td>
      <td>N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE</td>
      <td>QKPXPZYQPBWDHS-MCJAPYMPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09054</td>
      <td>Idelalisib</td>
      <td>IFSDAJWBUCMOAH-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB13022</td>
      <td>LY-2874455</td>
      <td>GKJCVYLDJWTWQU-CXLRFSCWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB00137</td>
      <td>Lutein</td>
      <td>KBPHJBAIARWVSC-RGZFRNHPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB13867</td>
      <td>Fluticasone</td>
      <td>MGNNYOODZCAHBA-GQKYHHCASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07679</td>
      <td>(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid</td>
      <td>RRAAROKJUVKWAF-RDJZCZTQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12597</td>
      <td>ABL-001</td>
      <td>VOVZXURTCKPRDQ-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB01392</td>
      <td>Yohimbine</td>
      <td>BLGXFZZNTVWLAY-SCYLSFHTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB11759</td>
      <td>Pevonedistat</td>
      <td>MPUQHZXIXSTTDU-QXGSTGNESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04841</td>
      <td>Flunarizine</td>
      <td>SMANXXCATUTDDT-QPJJXVBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB07786</td>
      <td>1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>SMFRBBHLVBWHGB-DJJJIMSYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07832</td>
      <td>4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde</td>
      <td>VKQPTVJDZIILPG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB13094</td>
      <td>Pruvanserin</td>
      <td>AQRLDDAFYYAIJP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14636</td>
      <td>Triciribine phosphate</td>
      <td>URLYINUFLXOMHP-HTVVRFAVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08024</td>
      <td>1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE</td>
      <td>MUUVLSCVDXKQQV-OALUTQOASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06335</td>
      <td>Saxagliptin</td>
      <td>QGJUIPDUBHWZPV-SGTAVMJGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08073</td>
      <td>(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>YWTBGJGMTBHQTM-IBGZPJMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB04238</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid</td>
      <td>GNANSBQAIRJZPA-XZOQPEGZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00741</td>
      <td>Hydrocortisone</td>
      <td>JYGXADMDTFJGBT-VWUMJDOOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12523</td>
      <td>Mizolastine</td>
      <td>PVLJETXTTWAYEW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12070</td>
      <td>Letermovir</td>
      <td>FWYSMLBETOMXAG-QHCPKHFHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB05667</td>
      <td>Levoketoconazole</td>
      <td>XMAYWYJOQHXEEK-ZEQKJWHPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07697</td>
      <td>1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine</td>
      <td>HMGDKYUJSFVHIY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB04841</td>
      <td>Flunarizine</td>
      <td>SMANXXCATUTDDT-QPJJXVBHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB11521</td>
      <td>Imidocarb</td>
      <td>SCEVFJUWLLRELN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB03802</td>
      <td>1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>ZGHFWBDHZZKWSI-LITSAYRRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB06268</td>
      <td>Sitaxentan</td>
      <td>PHWXUGHIIBDVKD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06347</td>
      <td>Cenisertib</td>
      <td>KSOVGRCOLZZTPF-QMKUDKLTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB12996</td>
      <td>Acteoside</td>
      <td>FBSKJMQYURKNSU-ZLSOWSIRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB13059</td>
      <td>PF-03814735</td>
      <td>RYYNGWLOYLRZLK-RBUKOAKNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB13078</td>
      <td>KOSN-1724</td>
      <td>JAYGOFBXDFAXBW-CYEKYUJNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB05048</td>
      <td>Cannabinor</td>
      <td>GSTZHANFXAKPSE-MXTREEOPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07607</td>
      <td>4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>RXDZANYWRNIAOR-HHHXNRCGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01459</td>
      <td>Bezitramide</td>
      <td>FLKWNFFCSSJANB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB14902</td>
      <td>JHU-75528 C-11</td>
      <td>MCNQUWLLXZZZAC-BJUDXGSMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB04040</td>
      <td>N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide</td>
      <td>MCMWCTMAKPQTPI-WGNYYXNJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB01147</td>
      <td>Cloxacillin</td>
      <td>LQOLIRLGBULYKD-JKIFEVAISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB01047</td>
      <td>Fluocinonide</td>
      <td>WJOHZNCJWYWUJD-IUGZLZTKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07140</td>
      <td>5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>JPENSYBRTSIYGO-AWEZNQCLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11765</td>
      <td>PF-04991532</td>
      <td>GKMLFBRLRVQVJO-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB03932</td>
      <td>LFA703</td>
      <td>WPVRNXUYVXQXPY-YFAYRSKXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07685</td>
      <td>4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>NMAZGYDYIYLSLJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB14896</td>
      <td>Selitrectinib</td>
      <td>OEBIHOVSAMBXIB-SJKOYZFVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06578</td>
      <td>Tonabersat</td>
      <td>XLIIRNOPGJTBJD-ROUUACIJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08042</td>
      <td>N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>FLXGQDHYCWXTAI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB08490</td>
      <td>CTS-1027</td>
      <td>ROSNVSQTEGHUKU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB13993</td>
      <td>MRK-409</td>
      <td>GOIFCXRIFSYPFG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB13061</td>
      <td>MLN8054</td>
      <td>HHFBDROWDBDFBR-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07252</td>
      <td>3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide</td>
      <td>TZHCXOMEOHEZDX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB14821</td>
      <td>Macozinone</td>
      <td>BJDZBXGJNBMCAV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08056</td>
      <td>N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine</td>
      <td>KKYYLKPGILUPOA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12269</td>
      <td>PF-06273340</td>
      <td>BPIWZDNVMQQBQX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB03460</td>
      <td>Violaxanthin</td>
      <td>SZCBXWMUOPQSOX-WVJDLNGLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07588</td>
      <td>3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID</td>
      <td>FZDVNXHYGMEEDT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB03207</td>
      <td>2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid</td>
      <td>BNVMUDXGABBWGP-OAQYLSRUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB12165</td>
      <td>Presatovir</td>
      <td>GOFXWTVKPWJNGD-UWJYYQICSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB02491</td>
      <td>4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine</td>
      <td>CJSSYVIHFXDFFC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08770</td>
      <td>4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol</td>
      <td>PWTBZOIUWZOPFT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB06940</td>
      <td>N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide</td>
      <td>ZZTMFGIGOADCFX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08520</td>
      <td>(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE</td>
      <td>VUCSBBBCFXBFFY-IBGZPJMESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12672</td>
      <td>Icaritin</td>
      <td>TUUXBSASAQJECY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06529</td>
      <td>Ocinaplon</td>
      <td>OQJFBUOFGHPMSR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12671</td>
      <td>Beloranib</td>
      <td>ZEZFKUBILQRZCK-MJSCXXSSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB11995</td>
      <td>Avatrombopag</td>
      <td>OFZJKCQENFPZBH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12434</td>
      <td>Steviolbioside</td>
      <td>OMHUCGDTACNQEX-OSHKXICASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB03596</td>
      <td>N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide</td>
      <td>FSRPBGBMEKDSIJ-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB15120</td>
      <td>GSK-239512</td>
      <td>YFRBKEVUUCQYOW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06993</td>
      <td>(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine</td>
      <td>PTAHVQJZNFGPHN-WFWWEWPISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12193</td>
      <td>Ajulemic acid</td>
      <td>YCHYFHOSGQABSW-RTBURBONSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB13606</td>
      <td>Phenazocine</td>
      <td>ZQHYKVKNPWDQSL-KNXBSLHKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB06263</td>
      <td>Amrubicin</td>
      <td>VJZITPJGSQKZMX-XDPRQOKASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04643</td>
      <td>4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID</td>
      <td>FYQVFMLCZJZZEM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lu7</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13936</td>
      <td>JNJ-28330835</td>
      <td>RYBKPGYFXRNMMU-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12273</td>
      <td>Ecopipam</td>
      <td>DMJWENQHWZZWDF-PKOBYXMFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07765</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>UKCFUFHREWUXJJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB01026</td>
      <td>Ketoconazole</td>
      <td>XMAYWYJOQHXEEK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB02917</td>
      <td>N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide</td>
      <td>LFGYSFPVLMPUPE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08020</td>
      <td>(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</td>
      <td>RHQLNMNKTIOREN-AOIWGVFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB02128</td>
      <td>[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester</td>
      <td>QCUBCTPTNWPFBC-ZEQRLZLVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06948</td>
      <td>2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE</td>
      <td>XWWRLKIBRPJQJX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08351</td>
      <td>N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</td>
      <td>MNEXDVSJIUQQRH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06986</td>
      <td>2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>LRHOLHTVXXSIMG-BXUZGUMPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07686</td>
      <td>4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>VPOGRVWIIVMWRI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB06995</td>
      <td>N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide</td>
      <td>USBSTVPJNQLYEM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB15414</td>
      <td>CM-4307</td>
      <td>MLDQJTXFUGDVEO-FIBGUPNXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB12185</td>
      <td>Exatecan</td>
      <td>ZVYVPGLRVWUPMP-FYSMJZIKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB07362</td>
      <td>1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>UOLCZAFAGDOUFX-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04792</td>
      <td>2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL</td>
      <td>CDEVHSIVANGYRI-XMTFNYHQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB08164</td>
      <td>(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE</td>
      <td>GOBIXGZJSMAOFV-QRWLVFNGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12391</td>
      <td>Sagopilone</td>
      <td>BFZKMNSQCNVFGM-UCEYFQQTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12234</td>
      <td>BMS-214662</td>
      <td>OLCWFLWEHWLBTO-HSZRJFAPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB12186</td>
      <td>SRT-2104</td>
      <td>LAMQVIQMVKWXOC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB15168</td>
      <td>Cilofexor</td>
      <td>KZSKGLFYQAYZCO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB04154</td>
      <td>N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</td>
      <td>ALBWBHNFOJJMCV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB06321</td>
      <td>R-348</td>
      <td>IGLNXKVGKIFNBQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07546</td>
      <td>[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid</td>
      <td>BBYRUZKRFAIQSR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB04244</td>
      <td>(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide</td>
      <td>YCDHZDINQZLSRR-DNQXCXABSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB13019</td>
      <td>Henatinib</td>
      <td>MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11878</td>
      <td>Filibuvir</td>
      <td>SLVAPEZTBDBAPI-GDLZYMKVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4b</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06944</td>
      <td>N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide</td>
      <td>RIGZCVNCFXYBEG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB06997</td>
      <td>2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</td>
      <td>BMPOCDJEXAXXEZ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB02059</td>
      <td>Adenosine-5-Diphosphoribose</td>
      <td>SRNWOUGRCWSEMX-ZQSHOCFMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11893</td>
      <td>Avagacestat</td>
      <td>XEAOPVUAMONVLA-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB04194</td>
      <td>Chitotriose</td>
      <td>WZZVUHWLNMNWLW-VFCSDQTKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00295</td>
      <td>Morphine</td>
      <td>BQJCRHHNABKAKU-KBQPJGBKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07458</td>
      <td>3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-KRWDZBQOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB07140</td>
      <td>5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>JPENSYBRTSIYGO-AWEZNQCLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB13451</td>
      <td>Tioclomarol</td>
      <td>WRGOVNKNTPWHLZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB05197</td>
      <td>Sofalcone</td>
      <td>GFWRVVCDTLRWPK-KPKJPENVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06140</td>
      <td>SUVN-502</td>
      <td>GWCYPEHWIZXYFZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12302</td>
      <td>CP-724714</td>
      <td>LLVZBTWPGQVVLW-SNAWJCMRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06292</td>
      <td>Dapagliflozin</td>
      <td>JVHXJTBJCFBINQ-ADAARDCZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB13682</td>
      <td>Cefpirome</td>
      <td>DKOQGJHPHLTOJR-WHRDSVKCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB14657</td>
      <td>Paramethasone acetate</td>
      <td>HYRKAAMZBDSJFJ-LFDBJOOHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB03572</td>
      <td>FR230513</td>
      <td>URGFTPMACWKJKU-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14125</td>
      <td>Benazeprilat</td>
      <td>MADRIHWFJGRSBP-ROUUACIJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB13950</td>
      <td>WIN 55212-2</td>
      <td>HQVHOQAKMCMIIM-HXUWFJFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06040</td>
      <td>Filanesib</td>
      <td>LLXISKGBWFTGEI-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12222</td>
      <td>Lurtotecan</td>
      <td>RVFGKBWWUQOIOU-NDEPHWFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07493</td>
      <td>(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE</td>
      <td>IEQQJQHHJMQETK-YPKPFQOOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB14662</td>
      <td>Flunisolide acetate</td>
      <td>WEGNFRKBIKYVLC-XTLNBZDDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB01328</td>
      <td>Cefonicid</td>
      <td>DYAIAHUQIPBDIP-AXAPSJFSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11824</td>
      <td>Tofogliflozin</td>
      <td>VWVKUNOPTJGDOB-BDHVOXNPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14093</td>
      <td>(1,2,6,7-3H)Testosterone</td>
      <td>MUMGGOZAMZWBJJ-JQSYSRDDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB05913</td>
      <td>OSI-930</td>
      <td>FGTCROZDHDSNIO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07856</td>
      <td>6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE</td>
      <td>HPWBHQIUIBFTQC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB12523</td>
      <td>Mizolastine</td>
      <td>PVLJETXTTWAYEW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB12325</td>
      <td>Idasanutlin</td>
      <td>TVTXCJFHQKSQQM-LJQIRTBHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB05944</td>
      <td>Varlitinib</td>
      <td>UWXSAYUXVSFDBQ-CYBMUJFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07456</td>
      <td>3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-QGZVFWFLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04705</td>
      <td>(3BETA)-CHOLEST-5-ENE-3,25-DIOL</td>
      <td>INBGSXNNRGWLJU-ZHHJOTBYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08063</td>
      <td>1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE</td>
      <td>HLZMYWLMBBLASX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07406</td>
      <td>(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE</td>
      <td>QWFFPYQWUWLDBV-NSHDSACASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB07186</td>
      <td>4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE</td>
      <td>TYYNSDQVFIOSFH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB03325</td>
      <td>Tyrosyladenylate</td>
      <td>MJZAZMKENKZBAJ-QTOWJTHWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB05295</td>
      <td>Eldecalcitol</td>
      <td>FZEXGDDBXLBRTD-AYIMTCTASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12235</td>
      <td>Estetrol</td>
      <td>AJIPIJNNOJSSQC-NYLIRDPKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB05552</td>
      <td>TG100-115</td>
      <td>UJIAQDJKSXQLIT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14575</td>
      <td>Eslicarbazepine</td>
      <td>BMPDWHIDQYTSHX-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14207</td>
      <td>Fosinoprilat</td>
      <td>WOIWWYDXDVSWAZ-RTWAWAEBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB14581</td>
      <td>CPI-1205</td>
      <td>HPODOLXTMDHLLC-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13739</td>
      <td>Penamecillin</td>
      <td>NLOOMWLTUVBWAW-HLLBOEOZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07193</td>
      <td>(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</td>
      <td>HJJAYSSCWGUPKO-ABAIWWIYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06620</td>
      <td>Aplindore</td>
      <td>DYJIKHYBKVODAC-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01436</td>
      <td>Alfacalcidol</td>
      <td>OFHCOWSQAMBJIW-AVJTYSNKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07333</td>
      <td>N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE</td>
      <td>KRGKAARWVPUWSY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB13044</td>
      <td>Gossypol</td>
      <td>QBKSWRVVCFFDOT-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08951</td>
      <td>Indoprofen</td>
      <td>RJMIEHBSYVWVIN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07809</td>
      <td>4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>MBJYEMUMDMGQQC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB14555</td>
      <td>Ursadiol</td>
      <td>RTLXJEJRLWILSU-GWNGJUQLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06246</td>
      <td>Exisulind</td>
      <td>MVGSNCBCUWPVDA-MFOYZWKCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB01092</td>
      <td>Ouabain</td>
      <td>LPMXVESGRSUGHW-HBYQJFLCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB07142</td>
      <td>5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>ATFDKOLABYIYCC-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14210</td>
      <td>Moexiprilat</td>
      <td>CMPAGYDKASJORH-YSSFQJQWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB13640</td>
      <td>Acetoxolone</td>
      <td>FTQDJVZNPJRVPG-XWEVEMRCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07159</td>
      <td>Tamatinib</td>
      <td>NHHQJBCNYHBUSI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07393</td>
      <td>2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE</td>
      <td>GSKNNHAAFLPYHG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB01573</td>
      <td>Benzylmorphine</td>
      <td>RDJGWRFTDZZXSM-RNWLQCGYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB11260</td>
      <td>Diacetyl benzoyl lathyrol</td>
      <td>JPYYWXPAHJBKJX-VWSFRBHVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06272</td>
      <td>Maxacalcitol</td>
      <td>DTXXSJZBSTYZKE-ZDQKKZTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB13029</td>
      <td>MK-0873</td>
      <td>JJWKQXNHYDJXKF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB02812</td>
      <td>(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide</td>
      <td>VXDAVYUFYPFGDX-SNPRPXQTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07793</td>
      <td>(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>ACSGSLPOHKRZCY-GXTWGEPZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07359</td>
      <td>3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide</td>
      <td>SJTQKYKXCYVFHX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07340</td>
      <td>N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine</td>
      <td>ZFLJHSQHILSNCM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB14569</td>
      <td>Tedizolid</td>
      <td>XFALPSLJIHVRKE-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08485</td>
      <td>(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID</td>
      <td>QMNMNSINKIFYBV-LMMKCTJWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB06985</td>
      <td>2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid</td>
      <td>MEAQCLPMSVEOQF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11827</td>
      <td>Ertugliflozin</td>
      <td>MCIACXAZCBVDEE-CUUWFGFTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07334</td>
      <td>N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</td>
      <td>HTIZPBXCJPQDEM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09008</td>
      <td>Cefaloridine</td>
      <td>CZTQZXZIADLWOZ-CRAIPNDOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB14810</td>
      <td>AZD-1656</td>
      <td>FJEJHJINOKKDCW-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB14627</td>
      <td>Oxyphenisatin acetate</td>
      <td>PHPUXYRXPHEJDF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB01406</td>
      <td>Danazol</td>
      <td>POZRVZJJTULAOH-LHZXLZLDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB03272</td>
      <td>4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol</td>
      <td>YNMHKERYELPEEF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08942</td>
      <td>Isoxicam</td>
      <td>YYUAYBYLJSNDCX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15121</td>
      <td>AT-001</td>
      <td>YRGPAXAVTDMKDK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14596</td>
      <td>Loteprednol etabonate</td>
      <td>DMKSVUSAATWOCU-HROMYWEYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12391</td>
      <td>Sagopilone</td>
      <td>BFZKMNSQCNVFGM-UCEYFQQTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB01573</td>
      <td>Benzylmorphine</td>
      <td>RDJGWRFTDZZXSM-RNWLQCGYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB00878</td>
      <td>Chlorhexidine</td>
      <td>GHXZTYHSJHQHIJ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07874</td>
      <td>(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</td>
      <td>LQOCXPOKEPYGTJ-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00275</td>
      <td>Olmesartan</td>
      <td>VTRAEEWXHOVJFV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB02300</td>
      <td>Calcipotriol</td>
      <td>LWQQLNNNIPYSNX-UROSTWAQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB06364</td>
      <td>XR5944</td>
      <td>SFOADSRLCHRTKT-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB15254</td>
      <td>RO-5126766 free base</td>
      <td>LMMJFBMMJUMSJS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB03701</td>
      <td>Vanoxerine</td>
      <td>NAUWTFJOPJWYOT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01455</td>
      <td>19-Nor-5-androstenediol</td>
      <td>VVUQRXPUVKXAIO-XFUVECHXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07144</td>
      <td>5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>XZXVRKHUCSXVBM-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09022</td>
      <td>Benfluorex</td>
      <td>CJAVTWRYCDNHSM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12221</td>
      <td>Canrenone</td>
      <td>UJVLDDZCTMKXJK-WNHSNXHDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12579</td>
      <td>JNJ-37822681</td>
      <td>UVUYWJWYRLJHEN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB05395</td>
      <td>Amibegron</td>
      <td>RDJQCOBTKKAQAH-FPOVZHCZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13212</td>
      <td>Phenolsulfonphthalein</td>
      <td>BELBBZDIHDAJOR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB11829</td>
      <td>Ruboxistaurin</td>
      <td>ZCBUQCWBWNUWSU-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12625</td>
      <td>Evogliptin</td>
      <td>LCDDAGSJHKEABN-MLGOLLRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB05552</td>
      <td>TG100-115</td>
      <td>UJIAQDJKSXQLIT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07142</td>
      <td>5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>ATFDKOLABYIYCC-INIZCTEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB05738</td>
      <td>Vapitadine</td>
      <td>VQWGYPVNVICKFC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12124</td>
      <td>Namitecan</td>
      <td>IBTISPLPBBHVSU-UVOOVGFISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12219</td>
      <td>GSK-424887</td>
      <td>DRXBWLBZWAJIEF-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12557</td>
      <td>FK-614</td>
      <td>UYGZODVVDUIDDQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB03495</td>
      <td>4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1-&gt;4)-Alpha-D-Threo-Hexopyranosyl-(1-&gt;6)-Alpha-L-Threo-Hexopyranose</td>
      <td>FZLCJZILHGFQLM-PISLJJGOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB13138</td>
      <td>Neladenoson bialanate</td>
      <td>WESNEIGKOAXSGX-VXKWHMMOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12322</td>
      <td>GW-870086</td>
      <td>WUBKGTSFJSEIEM-NSHBDUGJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB03480</td>
      <td>Brequinar Analog</td>
      <td>WYKKHJQZENLZID-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB13930</td>
      <td>Ulixertinib</td>
      <td>KSERXGMCDHOLSS-LJQANCHMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08046</td>
      <td>2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide</td>
      <td>JIVPVXMEBJLZRO-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB13088</td>
      <td>AZD-0424</td>
      <td>MVWATCATLSSVBH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12522</td>
      <td>Toreforant</td>
      <td>FCRFVPZAXGJLPW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB03161</td>
      <td>Thymidine-5'-Diphospho-Beta-D-Xylose</td>
      <td>AJUADKZRQSBUAK-KDGZBOQCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01452</td>
      <td>Diamorphine</td>
      <td>GVGLGOZIDCSQPN-PVHGPHFFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB05532</td>
      <td>BMS-488043</td>
      <td>DBPMWRYLTBNCCE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB13040</td>
      <td>Gandotinib</td>
      <td>SQSZANZGUXWJEA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08204</td>
      <td>3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE</td>
      <td>FLWABCQDXUKNQY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11784</td>
      <td>NRX-1074</td>
      <td>DVBUEXCIEIAXPM-PJUQSVSOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB07642</td>
      <td>5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>GYKIQIOWVKCVBP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB15268</td>
      <td>Afabicin</td>
      <td>HFYMDQMXVPJNTH-VQHVLOKHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB05616</td>
      <td>4'-Methylene-5,8,10-trideazaaminopterin</td>
      <td>NAWXUBYGYWOOIX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB14882</td>
      <td>CEP-9722</td>
      <td>CTLOSZHDGZLOQE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB14624</td>
      <td>Nandrolone hydrogen sulfate</td>
      <td>SKZMVWBZTQNCKW-IZPLOLCNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB14066</td>
      <td>Tetrandrine</td>
      <td>WVTKBKWTSCPRNU-KYJUHHDHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB13454</td>
      <td>Nicomorphine</td>
      <td>HNDXBGYRMHRUFN-CIVUWBIHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB06362</td>
      <td>Becatecarin</td>
      <td>JSKFWUPVIZYJMR-UDOAKELVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07362</td>
      <td>1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>UOLCZAFAGDOUFX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11614</td>
      <td>Rupatadine</td>
      <td>WUZYKBABMWJHDL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB08354</td>
      <td>2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>QCVULERVJOYHCP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB11964</td>
      <td>Ilaprazole</td>
      <td>HRRXCXABAPSOCP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB02673</td>
      <td>(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium</td>
      <td>VLGAHTYYCHWLNI-BHRZLAGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB06455</td>
      <td>Meclinertant</td>
      <td>DYLJVOXRWLXDIG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB02154</td>
      <td>2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid</td>
      <td>FFYBYVPVYLMLAR-KBPBESRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13008</td>
      <td>2,2-bis(4-hydroxy-3-tert-butylphenyl)propane</td>
      <td>ZDRSNHRWLQQICP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB00932</td>
      <td>Tipranavir</td>
      <td>SUJUHGSWHZTSEU-FYBSXPHGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00704</td>
      <td>Naltrexone</td>
      <td>DQCKKXVULJGBQN-XFWGSAIBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB09319</td>
      <td>Carindacillin</td>
      <td>JIRBAUWICKGBFE-MNRDOXJOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB09219</td>
      <td>Bisoxatin</td>
      <td>BPKUDUSVDVLOPY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06334</td>
      <td>Tucidinostat</td>
      <td>SZMJVTADHFNAIS-BJMVGYQFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB02195</td>
      <td>3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine</td>
      <td>ZSMYZLKEZDYVPI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB15377</td>
      <td>ATB-346</td>
      <td>YCNMAPLPQYQJFC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15273</td>
      <td>VS-4718</td>
      <td>IGUBBWJDMLCRIK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB15214</td>
      <td>BMS-986104</td>
      <td>BPMMYKAHRIEVDH-VOQZNFBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12432</td>
      <td>CC-401</td>
      <td>XDJCLCLBSGGNKS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00655</td>
      <td>Estrone</td>
      <td>DNXHEGUUPJUMQT-CBZIJGRNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00737</td>
      <td>Meclizine</td>
      <td>OCJYIGYOJCODJL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB02102</td>
      <td>DMP450</td>
      <td>KYRSNWPSSXSNEP-ZRTHHSRSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12364</td>
      <td>Betrixaban</td>
      <td>XHOLNRLADUSQLD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00843</td>
      <td>Donepezil</td>
      <td>ADEBPBSSDYVVLD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07426</td>
      <td>[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)</td>
      <td>NWIARQRYIRVYCM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00377</td>
      <td>Palonosetron</td>
      <td>CPZBLNMUGSZIPR-NVXWUHKLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB01254</td>
      <td>Dasatinib</td>
      <td>ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB12137</td>
      <td>GSK-256066</td>
      <td>JFHROPTYMMSOLG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06429</td>
      <td>Talnetant</td>
      <td>BIAVGWDGIJKWRM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB09124</td>
      <td>Medrogestone</td>
      <td>HCFSGRMEEXUOSS-JXEXPEPMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB00288</td>
      <td>Amcinonide</td>
      <td>ILKJAFIWWBXGDU-MOGDOJJUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13487</td>
      <td>Iodine (131I) norcholesterol</td>
      <td>QJHZPCLORSPENH-DRTKWHMQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06410</td>
      <td>Doxercalciferol</td>
      <td>HKXBNHCUPKIYDM-CGMHZMFXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00607</td>
      <td>Nafcillin</td>
      <td>GPXLMGHLHQJAGZ-JTDSTZFVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00783</td>
      <td>Estradiol</td>
      <td>VOXZDWNPVJITMN-ZBRFXRBCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07568</td>
      <td>(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE</td>
      <td>ADRNPUSZBRQDBG-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB02046</td>
      <td>N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid</td>
      <td>WHPKSASOSKNDPY-PKOBYXMFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB07193</td>
      <td>(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</td>
      <td>HJJAYSSCWGUPKO-ABAIWWIYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11648</td>
      <td>Afuresertib</td>
      <td>AFJRDFWMXUECEW-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB02716</td>
      <td>7-Methyl-Guanosine-5'-Triphosphate</td>
      <td>DKVRNHPCAOHRSI-KQYNXXCUSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11260</td>
      <td>Diacetyl benzoyl lathyrol</td>
      <td>JPYYWXPAHJBKJX-VWSFRBHVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08241</td>
      <td>4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE</td>
      <td>RUUOIINPNMNPIU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12483</td>
      <td>Copanlisib</td>
      <td>PZBCKZWLPGJMAO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00537</td>
      <td>Ciprofloxacin</td>
      <td>MYSWGUAQZAJSOK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB13307</td>
      <td>Proscillaridin</td>
      <td>MYEJFUXQJGHEQK-ALRJYLEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB15406</td>
      <td>GLPG-0974</td>
      <td>MPMKMQHJHDHPBE-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB09298</td>
      <td>Silibinin</td>
      <td>SEBFKMXJBCUCAI-HKTJVKLFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB00823</td>
      <td>Ethynodiol diacetate</td>
      <td>ONKUMRGIYFNPJW-KIEAKMPYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12307</td>
      <td>Foretinib</td>
      <td>CXQHYVUVSFXTMY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00504</td>
      <td>Levallorphan</td>
      <td>OZYUPQUCAUTOBP-QXAKKESOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB02615</td>
      <td>Compound 19</td>
      <td>UZOOIPXOYYJULJ-BLIZRMSTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08191</td>
      <td>4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid</td>
      <td>KSFDVNIKNYXUIP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB11921</td>
      <td>Deflazacort</td>
      <td>FBHSPRKOSMHSIF-GRMWVWQJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB09143</td>
      <td>Sonidegib</td>
      <td>VZZJRYRQSPEMTK-CALCHBBNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12929</td>
      <td>JNJ-39220675</td>
      <td>IQOWHZHNGJXGHG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB02738</td>
      <td>Adenosine-5'-Pentaphosphate</td>
      <td>WYJWVZZCMBUPSP-KQYNXXCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB02759</td>
      <td>4-Methylumbelliferyl Chitobiose</td>
      <td>UPSFMJHZUCSEHU-JYGUBCOQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00568</td>
      <td>Cinnarizine</td>
      <td>DERZBLKQOCDDDZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00596</td>
      <td>Ulobetasol</td>
      <td>LEHFPXVYPMWYQD-XHIJKXOTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB12428</td>
      <td>PAC-14028</td>
      <td>UKGJZDSUJSPAJL-YPUOHESYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08351</td>
      <td>N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</td>
      <td>MNEXDVSJIUQQRH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08350</td>
      <td>5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE</td>
      <td>GYQRHHQPEMOLKH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06237</td>
      <td>Avanafil</td>
      <td>WEAJZXNPAWBCOA-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00912</td>
      <td>Repaglinide</td>
      <td>FAEKWTJYAYMJKF-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB02358</td>
      <td>LY374571</td>
      <td>SZHRIPFGZWWRKW-VIFPVBQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11184</td>
      <td>Oftasceine</td>
      <td>DEGAKNSWVGKMLS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB09298</td>
      <td>Silibinin</td>
      <td>SEBFKMXJBCUCAI-HKTJVKLFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00670</td>
      <td>Pirenzepine</td>
      <td>RMHMFHUVIITRHF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12973</td>
      <td>Serlopitant</td>
      <td>FLNYCRJBCNNHRH-OIYLJQICSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11115</td>
      <td>Ensulizole</td>
      <td>UVCJGUGAGLDPAA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB02300</td>
      <td>Calcipotriol</td>
      <td>LWQQLNNNIPYSNX-UROSTWAQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04023</td>
      <td>Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester</td>
      <td>DNBSDUDYNPJVCN-ZXTXFPBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB06011</td>
      <td>AMG-222</td>
      <td>NVSWJKWHLUTHLP-CPJSRVTESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09534</td>
      <td>Ecamsule</td>
      <td>HEAHZSUCFKFERC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01561</td>
      <td>Androstanedione</td>
      <td>RAJWOBJTTGJROA-WZNAKSSCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08250</td>
      <td>(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE</td>
      <td>OQMVLDZJPRSNOG-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB09371</td>
      <td>Norethynodrel</td>
      <td>ICTXHFFSOAJUMG-SLHNCBLASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07162</td>
      <td>4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide</td>
      <td>KFJCXIOVAGJCKB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB02485</td>
      <td>Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid</td>
      <td>TXCIAUNLDRJGJZ-BILDWYJOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07531</td>
      <td>4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE</td>
      <td>JNPRTUHVCHGFHJ-GHXNOFRVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07061</td>
      <td>1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL</td>
      <td>AXYFCRIRLKSCRR-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01864</td>
      <td>5'-Guanosine-Diphosphate-Monothiophosphate</td>
      <td>XOFLBQFBSOEHOG-UUOKFMHZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB05105</td>
      <td>Pleconaril</td>
      <td>KQOXLKOJHVFTRN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06781</td>
      <td>Difluprednate</td>
      <td>WYQPLTPSGFELIB-JTQPXKBDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08613</td>
      <td>2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL</td>
      <td>OFBFUNBBOQCNFX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13347</td>
      <td>Diphenadione</td>
      <td>JYGLAHSAISAEAL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13806</td>
      <td>Linopirdine</td>
      <td>YEJCDKJIEMIWRQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04790</td>
      <td>2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol</td>
      <td>IBIUTOFGXGGVKQ-XMTFNYHQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13217</td>
      <td>Fentiazac</td>
      <td>JIEKMACRVQTPRC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13177</td>
      <td>4-methylumbelliferyl beta-D-glucoside</td>
      <td>YUDPTGPSBJVHCN-YMILTQATSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12214</td>
      <td>Luseogliflozin</td>
      <td>WHSOLWOTCHFFBK-ZQGJOIPISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01120</td>
      <td>Gliclazide</td>
      <td>BOVGTQGAOIONJV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13397</td>
      <td>Prenoxdiazine</td>
      <td>PXZDWASDNFWKSD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13174</td>
      <td>Rhein</td>
      <td>FCDLCPWAQCPTKC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01116</td>
      <td>Trimethaphan</td>
      <td>CHQOEHPMXSHGCL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04772</td>
      <td>1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE</td>
      <td>DSVCYWOHJLRGMK-PMACEKPBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07453</td>
      <td>2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE</td>
      <td>VFMMPHCGEFXGIP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01094</td>
      <td>Hesperetin</td>
      <td>AIONOLUJZLIMTK-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06945</td>
      <td>N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide</td>
      <td>FOSWRYKPHVPIDJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01708</td>
      <td>Prasterone</td>
      <td>FMGSKLZLMKYGDP-USOAJAOKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08709</td>
      <td>2,3-diphenyl-1H-indole-7-carboxylic acid</td>
      <td>OLUDUXWVPIEHDA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11478</td>
      <td>Zeranol</td>
      <td>DWTTZBARDOXEAM-GXTWGEPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01342</td>
      <td>Forasartan</td>
      <td>YONOBYIBNBCDSJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08437</td>
      <td>Puromycin</td>
      <td>RXWNCPJZOCPEPQ-NVWDDTSBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB08916</td>
      <td>Afatinib</td>
      <td>ULXXDDBFHOBEHA-CWDCEQMOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12225</td>
      <td>Beclabuvir</td>
      <td>ZTTKEBYSXUCBSE-QDFUAKMASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB13101</td>
      <td>4SC-202</td>
      <td>PRXXYMVLYKJITB-IZZDOVSWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB01774</td>
      <td>Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester</td>
      <td>WFPZSXYXPSUOPY-ROYWQJLOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04791</td>
      <td>2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL</td>
      <td>DKBAWRNTUZFJKV-BSDSXHPESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06886</td>
      <td>N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL</td>
      <td>MACLRJNEKXUAJK-YDLSIGKMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB15265</td>
      <td>USL-311</td>
      <td>XNUNVQKARNSSEO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07969</td>
      <td>3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol</td>
      <td>QNCYYRHIUFGGJX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08745</td>
      <td>4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE</td>
      <td>QLHUDNKWOSQSMK-CXUHLZMHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08834</td>
      <td>Tauroursodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-LBSADWJPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01326</td>
      <td>Cefamandole</td>
      <td>OLVCFLKTBJRLHI-AXAPSJFSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB11968</td>
      <td>MK-7145</td>
      <td>OCKGFTQIICXDQW-ZEQRLZLVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB11896</td>
      <td>Gedatolisib</td>
      <td>DWZAEMINVBZMHQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB07486</td>
      <td>3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline</td>
      <td>KLSZVPNVFKKIRD-FNORWQNLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01180</td>
      <td>Rescinnamine</td>
      <td>SZLZWPPUNLXJEA-LAFLMMDJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08731</td>
      <td>2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>GPOKTQCDBPECSS-MRXNPFEDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00430</td>
      <td>Cefpiramide</td>
      <td>PWAUCHMQEXVFJR-PMAPCBKXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15356</td>
      <td>SLV-334</td>
      <td>LOFDNSDPZTVIIO-VPUSJEBWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01089</td>
      <td>Deserpidine</td>
      <td>CVBMAZKKCSYWQR-WCGOZPBSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08441</td>
      <td>6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE</td>
      <td>AWSQADBSXFTFKL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13360</td>
      <td>Tolciclate</td>
      <td>CANCCLAKQQHLNK-LSDHHAIUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13418</td>
      <td>Moxestrol</td>
      <td>MTMZZIPTQITGCY-OLGWUGKESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08997</td>
      <td>Dexetimide</td>
      <td>LQQIVYSCPWCSSD-HSZRJFAPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01689</td>
      <td>Inhibitor Idd 384</td>
      <td>CJKKMQCZOLCXAM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08510</td>
      <td>5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE</td>
      <td>UVTGFMKBPVLATL-DSOJQRAMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB07124</td>
      <td>(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>CCIACUJJBPSOHE-KRWDZBQOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15047</td>
      <td>BMS-919373</td>
      <td>XGKULQQVQWCASY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07019</td>
      <td>N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE</td>
      <td>QWDOKZPZLWNULU-MZNJEOGPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06525</td>
      <td>Ganstigmine</td>
      <td>ZOBDWFRKFSPCRB-UNMCSNQZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01737</td>
      <td>Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester</td>
      <td>YAEIKQDHLCFGAA-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00897</td>
      <td>Triazolam</td>
      <td>JOFWLTCLBGQGBO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB02259</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide</td>
      <td>VSYGXLAJQDAWCZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01771</td>
      <td>CRA_10991</td>
      <td>QXAURVOBXQBPAP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB13552</td>
      <td>Trifluperidol</td>
      <td>GPMXUUPHFNMNDH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01792</td>
      <td>Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate</td>
      <td>FZCSEXOMUJFOHQ-KPKSGTNCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13451</td>
      <td>Tioclomarol</td>
      <td>WRGOVNKNTPWHLZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB11968</td>
      <td>MK-7145</td>
      <td>OCKGFTQIICXDQW-ZEQRLZLVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15056</td>
      <td>Bifenthrin</td>
      <td>OMFRMAHOUUJSGP-IRHGGOMRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12371</td>
      <td>Siponimod</td>
      <td>KIHYPELVXPAIDH-HNSNBQBZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB14675</td>
      <td>Temsavir</td>
      <td>QRPZBKAMSFHVRW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13386</td>
      <td>Epimestrol</td>
      <td>UHQGCIIQUZBJAE-RRQVMCLOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06993</td>
      <td>(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine</td>
      <td>PTAHVQJZNFGPHN-WFWWEWPISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB11614</td>
      <td>Rupatadine</td>
      <td>WUZYKBABMWJHDL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB11786</td>
      <td>Pefcalcitol</td>
      <td>SVCSMAZYWOQCBW-NVJMFHFGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13371</td>
      <td>Difenpiramide</td>
      <td>PWHROYKAGRUWDQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01058</td>
      <td>Praziquantel</td>
      <td>FSVJFNAIGNNGKK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06963</td>
      <td>3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide</td>
      <td>ZFGCLYUGFRNYFE-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01720</td>
      <td>(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid</td>
      <td>WLPJLQNKCJWAFL-RGEXLXHISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07949</td>
      <td>({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID</td>
      <td>BFQRPTKOSYMPOL-LALPNIDTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB07025</td>
      <td>3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</td>
      <td>KBIHHEGEALBUMT-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01557</td>
      <td>??-Methylfentanyl</td>
      <td>NGTVDHYUFBKWID-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13393</td>
      <td>Emetine</td>
      <td>AUVVAXYIELKVAI-CKBKHPSWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB05412</td>
      <td>Talmapimod</td>
      <td>ZMELOYOKMZBMRB-DLBZAZTESA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08962</td>
      <td>Glibornuride</td>
      <td>RMTYNAPTNBJHQI-LLDVTBCESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB01571</td>
      <td>3-Methylfentanyl</td>
      <td>MLQRZXNZHAOCHQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04771</td>
      <td>1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE</td>
      <td>FIZYZWLGMGGGBJ-OALUTQOASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB01347</td>
      <td>Saprisartan</td>
      <td>DUEWVPTZCSAMNB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07460</td>
      <td>2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE</td>
      <td>UYJNQQDJUOUFQJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB06605</td>
      <td>Apixaban</td>
      <td>QNZCBYKSOIHPEH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB02224</td>
      <td>Taxifolin</td>
      <td>CXQWRCVTCMQVQX-LSDHHAIUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB12389</td>
      <td>Zamicastat</td>
      <td>ZSSLCFLHEFXANG-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07544</td>
      <td>N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE</td>
      <td>ZLQBZYKAQQWOTK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08148</td>
      <td>1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine</td>
      <td>QOZMRRGNAZNWDN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00862</td>
      <td>Vardenafil</td>
      <td>SECKRCOLJRRGGV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB12432</td>
      <td>CC-401</td>
      <td>XDJCLCLBSGGNKS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04005</td>
      <td>Uridine 5'-triphosphate</td>
      <td>PGAVKCOVUIYSFO-XVFCMESISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13797</td>
      <td>Iodocholesterol (131I)</td>
      <td>FIOAEFCJGZJUPW-ODFYUTSGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07891</td>
      <td>4-{[(14beta,17alpha)-3-hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid</td>
      <td>YJPIDPAGJSWWBE-FNIAAEIWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB07845</td>
      <td>2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide</td>
      <td>VGYXXQRDIVRILX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07879</td>
      <td>N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide</td>
      <td>SMSIXMLQOONOQQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09173</td>
      <td>Butyrfentanyl</td>
      <td>QQOMYEQLWQJRKK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB03844</td>
      <td>N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide</td>
      <td>ZFNCKGXGCCDDFN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB05861</td>
      <td>Tasquinimod</td>
      <td>ONDYALNGTUAJDX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04040</td>
      <td>N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide</td>
      <td>MCMWCTMAKPQTPI-WGNYYXNJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04044</td>
      <td>4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>NAQUAVBNIYTIIS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB07254</td>
      <td>N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</td>
      <td>KQGTYXRWSIBDOZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01965</td>
      <td>2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate</td>
      <td>XZLLMTSKYYYJLH-SHYZEUOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04073</td>
      <td>N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide</td>
      <td>UEIGEWJJVQHIAX-DLBZZEGUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01485</td>
      <td>4-Hydroxytestosterone</td>
      <td>BQOIJSIMMIDHMO-FBPKJDBXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB15294</td>
      <td>SB-1578</td>
      <td>NNXDIGHYPZHXTR-ONEGZZNKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04098</td>
      <td>Balanol</td>
      <td>XYUFCXJZFZPEJD-PGRDOPGGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07520</td>
      <td>N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE</td>
      <td>BJIKKEHGGYGGIX-HOTGVXAUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07043</td>
      <td>7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide</td>
      <td>CKLCIJCZOIDJQU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04042</td>
      <td>2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol</td>
      <td>XLJNZONSWKENRP-VABIIVNOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09177</td>
      <td>p-Fluorofentanyl</td>
      <td>KXUBAVLIJFTASZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB11864</td>
      <td>Preladenant</td>
      <td>DTYWJKSSUANMHD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB05048</td>
      <td>Cannabinor</td>
      <td>GSTZHANFXAKPSE-MXTREEOPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB15138</td>
      <td>AZD-9496</td>
      <td>DFBDRVGWBHBJNR-BBNFHIFMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03725</td>
      <td>Phosphomethylphosphonic Acid-Guanylate Ester</td>
      <td>PHBDHXOBFUBCJD-KQYNXXCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04850</td>
      <td>Posizolid</td>
      <td>HBUJYEUPIIJJOS-PBHICJAKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03758</td>
      <td>Radicicol</td>
      <td>WYZWZEOGROVVHK-GTMNPGAYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB11778</td>
      <td>Danusertib</td>
      <td>XKFTZKGMDDZMJI-HSZRJFAPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13788</td>
      <td>Chlorbenzoxamine</td>
      <td>VEVSKUJZSMGTMM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12507</td>
      <td>Atecegatran metoxil</td>
      <td>XSNMGLZVFNDDPW-ZWKOTPCHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07102</td>
      <td>(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid</td>
      <td>BYSBXIPCDJNEBG-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11730</td>
      <td>Ribociclib</td>
      <td>RHXHGRAEPCAFML-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00813</td>
      <td>Fentanyl</td>
      <td>PJMPHNIQZUBGLI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13790</td>
      <td>Fipexide</td>
      <td>BFUJHVVEMMWLHC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB04764</td>
      <td>[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</td>
      <td>CCLHROFBSWWOQO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03926</td>
      <td>5-Alpha-Androstane-3-Beta,17-Alpha-Diol</td>
      <td>CBMYJHIOYJEBSB-MFXFBURESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07940</td>
      <td>9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE</td>
      <td>ZUCWQTWGZGIYPV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01938</td>
      <td>L-Histidine Beta Naphthylamide</td>
      <td>DKDILZBBFKZMRO-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB06581</td>
      <td>Bevirimat</td>
      <td>YJEJKUQEXFSVCJ-WRFMNRASSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB15281</td>
      <td>Ravoxertinib</td>
      <td>RZUOCXOYPYGSKL-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB12479</td>
      <td>Zabofloxacin</td>
      <td>ZNPOCLHDJCAZAH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12746</td>
      <td>AKN-028</td>
      <td>JLRIJKVMMZEKDF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB07435</td>
      <td>1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE</td>
      <td>GFANZDFKCCJYRF-NSISKUIASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB08572</td>
      <td>4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE</td>
      <td>YBKLJTXDSBEVRV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB11845</td>
      <td>Lucitanib</td>
      <td>CUDVHEFYRIWYQD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB03744</td>
      <td>Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate</td>
      <td>RONLONYAIBUEKT-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04424</td>
      <td>RPR128515</td>
      <td>XFKVLKLCLYJKNF-MZNJEOGPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06629</td>
      <td>Zibotentan</td>
      <td>FJHHZXWJVIEFGJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04432</td>
      <td>ZK-805623</td>
      <td>ZXIHYCYAQUQHSG-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB15333</td>
      <td>AZD-1386</td>
      <td>FPGNKXCEPARJDI-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB15273</td>
      <td>VS-4718</td>
      <td>IGUBBWJDMLCRIK-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04480</td>
      <td>3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole</td>
      <td>NBDZLUOYAAVYHF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB12116</td>
      <td>Epigallocatechin gallate</td>
      <td>WMBWREPUVVBILR-WIYYLYMNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB15173</td>
      <td>JNJ-42165279</td>
      <td>YWGYNGCRVZLMCS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12565</td>
      <td>Abexinostat</td>
      <td>MAUCONCHVWBMHK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07507</td>
      <td>2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</td>
      <td>ROMNEYAQUBNRLR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB11450</td>
      <td>Pimobendan</td>
      <td>GLBJJMFZWDBELO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB12644</td>
      <td>AZD-2066</td>
      <td>SXWHYTICXCLKDG-GFCCVEGCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04578</td>
      <td>(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide</td>
      <td>OEVYDSSAPNIURZ-AEFFLSMTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11749</td>
      <td>(R)-Praziquantel</td>
      <td>FSVJFNAIGNNGKK-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB07460</td>
      <td>2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE</td>
      <td>UYJNQQDJUOUFQJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB06816</td>
      <td>Pyrvinium</td>
      <td>QMHSXPLYMTVAMK-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB15208</td>
      <td>NOP-1A</td>
      <td>MZBCQWLYUQJXKA-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12290</td>
      <td>Puerarin</td>
      <td>HKEAFJYKMMKDOR-VPRICQMDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04140</td>
      <td>1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide</td>
      <td>SUSMVCKSLVPRCL-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB03882</td>
      <td>5-Alpha-Androstane-3-Beta,17beta-Diol</td>
      <td>CBMYJHIOYJEBSB-YSZCXEEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04190</td>
      <td>Inhibitor Bea425</td>
      <td>AHAVBKNGKPWROK-UMFPTGFGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01070</td>
      <td>Dihydrotachysterol</td>
      <td>ILYCWAKSDCYMBB-OPCMSESCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11786</td>
      <td>Pefcalcitol</td>
      <td>SVCSMAZYWOQCBW-NVJMFHFGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13816</td>
      <td>Aspoxicillin</td>
      <td>BHELIUBJHYAEDK-OAIUPTLZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08385</td>
      <td>4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid</td>
      <td>QUAGUFNCKDDJFZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11787</td>
      <td>Ralimetinib</td>
      <td>XPPBBJCBDOEXDN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04216</td>
      <td>Quercetin</td>
      <td>REFJWTPEDVJJIY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12547</td>
      <td>LY-2886721</td>
      <td>NIDRNVHMMDAAIK-YPMLDQLKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB03337</td>
      <td>1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea</td>
      <td>ZHCAYBOLUMAUQX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lu7</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB15241</td>
      <td>Methylsamidorphan</td>
      <td>ATCVVCBJNHXIEX-ZAHKBLQYSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07763</td>
      <td>(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE</td>
      <td>OZZFJGCAYWBVBI-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB04270</td>
      <td>(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid</td>
      <td>WUZIMDSVRIBNNI-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00137</td>
      <td>Lutein</td>
      <td>KBPHJBAIARWVSC-RGZFRNHPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00959</td>
      <td>Methylprednisolone</td>
      <td>VHRSUDSXCMQTMA-PJHHCJLFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB13991</td>
      <td>Pipequaline</td>
      <td>AMEWZCMTSIONOX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB15227</td>
      <td>Tirabrutinib</td>
      <td>SEJLPXCPMNSRAM-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB00799</td>
      <td>Tazarotene</td>
      <td>OGQICQVSFDPSEI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12290</td>
      <td>Puerarin</td>
      <td>HKEAFJYKMMKDOR-VPRICQMDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12550</td>
      <td>Taladegib</td>
      <td>SZBGQDXLNMELTB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB02715</td>
      <td>Compound 18</td>
      <td>UZOOIPXOYYJULJ-RHLLTPQKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07969</td>
      <td>3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol</td>
      <td>QNCYYRHIUFGGJX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07971</td>
      <td>5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE</td>
      <td>FQQVTDIBUYSVHM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09279</td>
      <td>Fimasartan</td>
      <td>AMEROGPZOLAFBN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB00637</td>
      <td>Astemizole</td>
      <td>GXDALQBWZGODGZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07917</td>
      <td>4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE</td>
      <td>TZQGXAHOROZEKN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03034</td>
      <td>D-Levofloxacin</td>
      <td>GSDSWSVVBLHKDQ-SNVBAGLBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB05424</td>
      <td>Canertinib</td>
      <td>OMZCMEYTWSXEPZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15065</td>
      <td>PF-06291874</td>
      <td>IBDYYOQKQCCSDP-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB05414</td>
      <td>Pipendoxifene</td>
      <td>JICOGKJOQXTAIP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12480</td>
      <td>Betulinic Acid</td>
      <td>QGJZLNKBHJESQX-FZFNOLFKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB01640</td>
      <td>(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One</td>
      <td>QNURTFDBHAQRSI-OAHLLOKOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07254</td>
      <td>N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</td>
      <td>KQGTYXRWSIBDOZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03046</td>
      <td>7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide</td>
      <td>KQUXAFOLFXHVQN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07263</td>
      <td>[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid</td>
      <td>WDTMVBQZDFMOIK-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11512</td>
      <td>Dihydrostreptomycin</td>
      <td>ASXBYYWOLISCLQ-HZYVHMACSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01058</td>
      <td>Praziquantel</td>
      <td>FSVJFNAIGNNGKK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07507</td>
      <td>2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione</td>
      <td>ROMNEYAQUBNRLR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB07296</td>
      <td>(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE</td>
      <td>PLGHLEBIWUQEPR-PDGQHHTCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11522</td>
      <td>Isoflupredone</td>
      <td>WAIJIHDWAKJCBX-BULBTXNYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11529</td>
      <td>Melengestrol</td>
      <td>OKHAOBQKCCIRLO-IBVJIVQJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB03126</td>
      <td>Mant-Adp</td>
      <td>QPKUEBLEGWBRHC-BFHYXJOUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12332</td>
      <td>Rucaparib</td>
      <td>HMABYWSNWIZPAG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00367</td>
      <td>Levonorgestrel</td>
      <td>WWYNJERNGUHSAO-XUDSTZEESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00699</td>
      <td>Nicergoline</td>
      <td>YSEXMKHXIOCEJA-FVFQAYNVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08138</td>
      <td>{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide</td>
      <td>BDRDBXXWQDFXEC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB00796</td>
      <td>Candesartan cilexetil</td>
      <td>GHOSNRCGJFBJIB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB11923</td>
      <td>Decoglurant</td>
      <td>DMJHZVARRXJSEG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00438</td>
      <td>Ceftazidime</td>
      <td>ORFOPKXBNMVMKC-DWVKKRMSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09304</td>
      <td>Setiptiline</td>
      <td>GVPIXRLYKVFFMK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13643</td>
      <td>Loprazolam</td>
      <td>UTEFBSAVJNEPTR-RGEXLXHISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB02834</td>
      <td>IDD552</td>
      <td>ZCAGEXZTORJQDZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11450</td>
      <td>Pimobendan</td>
      <td>GLBJJMFZWDBELO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07987</td>
      <td>[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER</td>
      <td>AWAKNMKLVLWIIQ-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB00470</td>
      <td>Dronabinol</td>
      <td>CYQFCXCEBYINGO-IAGOWNOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00394</td>
      <td>Beclomethasone dipropionate</td>
      <td>KUVIULQEHSCUHY-XYWKZLDCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB00450</td>
      <td>Droperidol</td>
      <td>RMEDXOLNCUSCGS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB05511</td>
      <td>Piclidenoson</td>
      <td>HUJXGQILHAUCCV-MOROJQBDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB00448</td>
      <td>Lansoprazole</td>
      <td>MJIHNNLFOKEZEW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB12483</td>
      <td>Copanlisib</td>
      <td>PZBCKZWLPGJMAO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00728</td>
      <td>Rocuronium</td>
      <td>YXRDKMPIGHSVRX-OOJCLDBCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB06497</td>
      <td>Aplaviroc</td>
      <td>GWNOTCOIYUNTQP-FQLXRVMXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB04716</td>
      <td>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</td>
      <td>VNDWQCSOSCCWIP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB02008</td>
      <td>1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine</td>
      <td>JHSHXKJSPVHPCJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB11971</td>
      <td>Vilaprisan</td>
      <td>JUFWQQVHQFDUOD-ANRPBIDPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03186</td>
      <td>U-Pi-a-Pi</td>
      <td>JIAJERGOUFOENU-LNAOLWRRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB03159</td>
      <td>CRA_8696</td>
      <td>GAVRMVQHHVMXFD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03447</td>
      <td>Uridylyl-2'-5'-Phospho-Adenosine</td>
      <td>QARCCHXXGAIRFS-KPKSGTNCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03453</td>
      <td>(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester</td>
      <td>MRNGXYMKYHNMLV-PKTZIBPZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB00950</td>
      <td>Fexofenadine</td>
      <td>RWTNPBWLLIMQHL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06163</td>
      <td>Plevitrexed</td>
      <td>IEJSCSAMMLUINT-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB15163</td>
      <td>Selatogrel</td>
      <td>FYXHWMQPCJOJCH-GMAHTHKFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00158</td>
      <td>Folic acid</td>
      <td>OVBPIULPVIDEAO-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07337</td>
      <td>4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE</td>
      <td>SOKOHDQTKSROQZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12512</td>
      <td>Verucerfont</td>
      <td>VKHVAUKFLBBZFJ-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB15460</td>
      <td>AGG-523</td>
      <td>JWQMTWCFNZSLNR-DEOSSOPVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01521</td>
      <td>Clostebol</td>
      <td>KCZCIYZKSLLNNH-FBPKJDBXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB15347</td>
      <td>Branebrutinib</td>
      <td>VJPPLCNBDLZIFG-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07993</td>
      <td>N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>LPQUIIHPUGDHJK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB15448</td>
      <td>Acumapimod</td>
      <td>VGUSQKZDZHAAEE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB04850</td>
      <td>Posizolid</td>
      <td>HBUJYEUPIIJJOS-PBHICJAKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB08867</td>
      <td>Ulipristal</td>
      <td>HKDLNTKNLJPAIY-WKWWZUSTSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07976</td>
      <td>3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>GIUMGVUBDBDTDX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB07410</td>
      <td>[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID</td>
      <td>BYVXAUZOTGITQZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB11682</td>
      <td>Daprodustat</td>
      <td>RUEYEZADQJCKGV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB01328</td>
      <td>Cefonicid</td>
      <td>DYAIAHUQIPBDIP-AXAPSJFSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB07830</td>
      <td>(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE</td>
      <td>DIRIFWIKLRTNMB-DYVFJYSZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB13728</td>
      <td>Halometasone</td>
      <td>GGXMRPUKBWXVHE-MIHLVHIWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12341</td>
      <td>LY-2456302</td>
      <td>ZHPMYDSXGRRERG-DEOSSOPVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08267</td>
      <td>6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>PBZAIUVFRISTSZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB05511</td>
      <td>Piclidenoson</td>
      <td>HUJXGQILHAUCCV-MOROJQBDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03220</td>
      <td>FR233623</td>
      <td>OODDZQQDDOVCFD-SCLBCKFNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB07294</td>
      <td>3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid</td>
      <td>AANFHDFOMFRLLR-IBGZPJMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB09226</td>
      <td>RP-5063</td>
      <td>PMKMNTBZJOXTJW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB00206</td>
      <td>Reserpine</td>
      <td>QEVHRUUCFGRFIF-MDEJGZGSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07323</td>
      <td>2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID</td>
      <td>CTZLIARLNXSXGL-ALCCZGGFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lu7</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9q</td>
      <td>DB11832</td>
      <td>Crenolanib</td>
      <td>DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB00240</td>
      <td>Alclometasone</td>
      <td>FJXOGVLKCZQRDN-PHCHRAKRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB00838</td>
      <td>Clocortolone</td>
      <td>YMTMADLUXIRMGX-RFPWEZLHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12355</td>
      <td>Netazepide</td>
      <td>YDZYKNJZCVIKPP-VWLOTQADSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB12010</td>
      <td>Fostamatinib</td>
      <td>GKDRMWXFWHEQQT-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB02449</td>
      <td>3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid</td>
      <td>ULOTXPTWJAUGGE-MHZLTWQESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB03358</td>
      <td>7n-Methyl-8-Hydroguanosine-5'-Triphosphate</td>
      <td>BUJQMJUTTBGELS-KQYNXXCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB05422</td>
      <td>OPC-14523</td>
      <td>TZZGTNZBLPCBIS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB08031</td>
      <td>N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</td>
      <td>LNQWELVSNCYKDU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01530</td>
      <td>5alpha-androstane-3alpha,17beta-diol</td>
      <td>CBMYJHIOYJEBSB-KHOSGYARSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB05864</td>
      <td>PPI-2458</td>
      <td>QBDVVYNLLXGUGN-XGTBZJOHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB07991</td>
      <td>N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE</td>
      <td>APLJSSOXDWUNGV-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB07140</td>
      <td>5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>JPENSYBRTSIYGO-AWEZNQCLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07005</td>
      <td>D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide</td>
      <td>VZFTWWJAUZOJDH-MOPGFXCFSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11886</td>
      <td>Infigratinib</td>
      <td>QADPYRIHXKWUSV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00700</td>
      <td>Eplerenone</td>
      <td>JUKPWJGBANNWMW-VWBFHTRKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB03336</td>
      <td>BIA</td>
      <td>KVIVJQWOYSWCCZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04573</td>
      <td>Estriol</td>
      <td>PROQIPRRNZUXQM-ZXXIGWHRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08308</td>
      <td>SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER</td>
      <td>IRQUJNVGEAJGSD-KIEDKLRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11867</td>
      <td>JNJ-39393406</td>
      <td>IURMHZBQEYNQOH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB03638</td>
      <td>Cytidyl-2'-5'-Phospho-Guanosine</td>
      <td>QZDUXDLOEVJGDG-VMIOUTBZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB08498</td>
      <td>(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>OVSAMUIBGQSLDC-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB03791</td>
      <td>(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid</td>
      <td>NAXSRXHZFIBFMI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB02545</td>
      <td>Fexaramine</td>
      <td>VLQTUNDJHLEFEQ-KGENOOAVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB02640</td>
      <td>Fumagillin</td>
      <td>NGGMYCMLYOUNGM-CSDLUJIJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07987</td>
      <td>[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER</td>
      <td>AWAKNMKLVLWIIQ-OAHLLOKOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB04886</td>
      <td>Calanolide A</td>
      <td>NIDRYBLTWYFCFV-FMTVUPSXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08352</td>
      <td>6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine</td>
      <td>FQYJTHIYAQQJAB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB02656</td>
      <td>LY-294002</td>
      <td>CZQHHVNHHHRRDU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08361</td>
      <td>2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide</td>
      <td>NZNTWOVDIXCHHS-LSDHHAIUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11885</td>
      <td>Anlotinib</td>
      <td>KSMZEXLVHXZPEF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB02483</td>
      <td>Etheno-Nad</td>
      <td>JCDBQDNBEQHDHK-BSLNIGMPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00434</td>
      <td>Cyproheptadine</td>
      <td>JJCFRYNCJDLXIK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB11891</td>
      <td>CUDC-907</td>
      <td>JOWXJLIFIIOYMS-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08366</td>
      <td>3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid</td>
      <td>XADCWKSMHQPTGH-OFBLZTNGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14993</td>
      <td>Pyrotinib</td>
      <td>SADXACCFNXBCFY-IYNHSRRRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01212</td>
      <td>Ceftriaxone</td>
      <td>VAAUVRVFOQPIGI-SPQHTLEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB05327</td>
      <td>Ranirestat</td>
      <td>QCVNMNYRNIMDKV-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB06605</td>
      <td>Apixaban</td>
      <td>QNZCBYKSOIHPEH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11950</td>
      <td>Teneligliptin</td>
      <td>WGRQANOPCQRCME-PMACEKPBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08463</td>
      <td>(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol</td>
      <td>HOCBJBNQIQQQGT-LJQANCHMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB03742</td>
      <td>Compound 4-D</td>
      <td>TWZNCTCQAGRUGQ-RRPNLBNLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04226</td>
      <td>Dihydro-Acarbose</td>
      <td>CUAQESWNTOXZJZ-RTNAABQMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB05171</td>
      <td>E-2012</td>
      <td>PUOAETJYKQITMO-LANLRWRYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11637</td>
      <td>Delamanid</td>
      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07795</td>
      <td>Fisetin</td>
      <td>XHEFDIBZLJXQHF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB14037</td>
      <td>Madecassic acid</td>
      <td>PRAUVHZJPXOEIF-AOLYGAPISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11902</td>
      <td>Gisadenafil</td>
      <td>YPFZMBHKIVDSNR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB02498</td>
      <td>Carba-Nicotinamide-Adenine-Dinucleotide</td>
      <td>DGPLSUKWXXSBCU-VGXGLJSLSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08707</td>
      <td>4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine</td>
      <td>AQVFETGXIRKVAQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11616</td>
      <td>Pirarubicin</td>
      <td>KMSKQZKKOZQFFG-YXRRJAAWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11987</td>
      <td>GSK-2018682</td>
      <td>NFIGDBFIDKDNIG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07783</td>
      <td>1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>GUYYFMCFEPDDFL-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB02659</td>
      <td>Cholic Acid</td>
      <td>BHQCQFFYRZLCQQ-OELDTZBJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00414</td>
      <td>Acetohexamide</td>
      <td>VGZSUPCWNCWDAN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB15191</td>
      <td>MAX-40279</td>
      <td>AVIOBQFPAGEICQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11829</td>
      <td>Ruboxistaurin</td>
      <td>ZCBUQCWBWNUWSU-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00496</td>
      <td>Darifenacin</td>
      <td>HXGBXQDTNZMWGS-RUZDIDTESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00485</td>
      <td>Dicloxacillin</td>
      <td>YFAGHNZHGGCZAX-JKIFEVAISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08656</td>
      <td>5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide</td>
      <td>UVERBUNNCOKGNZ-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00482</td>
      <td>Celecoxib</td>
      <td>RZEKVGVHFLEQIL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11827</td>
      <td>Ertugliflozin</td>
      <td>MCIACXAZCBVDEE-CUUWFGFTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08491</td>
      <td>N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE</td>
      <td>ARIRIZBKMKMEBD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB01977</td>
      <td>6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine</td>
      <td>AECPTICWHONWNW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08494</td>
      <td>S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate</td>
      <td>AWAKIULNKVOBKE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB11804</td>
      <td>AZD-5672</td>
      <td>SCXSQUUTGCWHFU-WJOKGBTCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11763</td>
      <td>Momelotinib</td>
      <td>ZVHNDZWQTBEVRY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12921</td>
      <td>Chlorsulfaquinoxaline</td>
      <td>CTSNHMQGVWXIEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB05087</td>
      <td>Ganaxolone</td>
      <td>PGTVWKLGGCQMBR-FLBATMFCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB03461</td>
      <td>2'-Monophosphoadenosine 5'-Diphosphoribose</td>
      <td>XJLXINKUBYWONI-NNYOXOHSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12796</td>
      <td>MRX-I</td>
      <td>SULYVXZZUMRQAX-NSHDSACASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11841</td>
      <td>Entinostat</td>
      <td>INVTYAOGFAGBOE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB00496</td>
      <td>Darifenacin</td>
      <td>HXGBXQDTNZMWGS-RUZDIDTESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB05498</td>
      <td>KW-7158</td>
      <td>NAFSYPCVPLWHFY-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08147</td>
      <td>4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid</td>
      <td>RMWVENXKUQXLPW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB08495</td>
      <td>4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>VXONTEUOQXFJJS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11864</td>
      <td>Preladenant</td>
      <td>DTYWJKSSUANMHD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11828</td>
      <td>Neratinib</td>
      <td>JWNPDZNEKVCWMY-VQHVLOKHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08393</td>
      <td>2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL</td>
      <td>UQHINZSKNAAVOZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB03311</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</td>
      <td>SXKBTDJJEQQEGE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07697</td>
      <td>1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine</td>
      <td>HMGDKYUJSFVHIY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08379</td>
      <td>6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one</td>
      <td>NOVPOXGMADEKPP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB03325</td>
      <td>Tyrosyladenylate</td>
      <td>MJZAZMKENKZBAJ-QTOWJTHWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB11855</td>
      <td>Revefenacin</td>
      <td>FYDWDCIFZSGNBU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07715</td>
      <td>Emodin</td>
      <td>RHMXXJGYXNZAPX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4b</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11871</td>
      <td>PF-00610355</td>
      <td>YPHDIMUXXABSSO-YTTGMZPUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11795</td>
      <td>GSK-2636771</td>
      <td>XTKLTGBKIDQGQL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13667</td>
      <td>Cefozopran</td>
      <td>QDUIJCOKQCCXQY-WHJQOFBOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08429</td>
      <td>N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide</td>
      <td>QRGBOABBMKYMLG-UXHICEINSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB06590</td>
      <td>Ceftaroline fosamil</td>
      <td>ZCCUWMICIWSJIX-NQJJCJBVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11950</td>
      <td>Teneligliptin</td>
      <td>WGRQANOPCQRCME-PMACEKPBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB14895</td>
      <td>Vibegron</td>
      <td>DJXRIQMCROIRCZ-XOEOCAAJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB01222</td>
      <td>Budesonide</td>
      <td>VOVIALXJUBGFJZ-KWVAZRHASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB06519</td>
      <td>Edaglitazone</td>
      <td>HAAXAFNSRADSMK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB13347</td>
      <td>Diphenadione</td>
      <td>JYGLAHSAISAEAL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08340</td>
      <td>N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE</td>
      <td>LLYYAUZAGCZEKV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB05835</td>
      <td>NS-3728</td>
      <td>OQRAKHDEGGGWQO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07889</td>
      <td>(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol</td>
      <td>VCPXSBULBDYRLT-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07563</td>
      <td>1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine</td>
      <td>GCJSOJRPNOWSEH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB02154</td>
      <td>2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid</td>
      <td>FFYBYVPVYLMLAR-KBPBESRZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4b</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB01198</td>
      <td>Zopiclone</td>
      <td>GBBSUAFBMRNDJC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07934</td>
      <td>[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE</td>
      <td>KMUXFASJKPVMGU-HXUWFJFHSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB03802</td>
      <td>1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>ZGHFWBDHZZKWSI-LITSAYRRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15168</td>
      <td>Cilofexor</td>
      <td>KZSKGLFYQAYZCO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15393</td>
      <td>Telatinib</td>
      <td>QFCXANHHBCGMAS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07940</td>
      <td>9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE</td>
      <td>ZUCWQTWGZGIYPV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB05616</td>
      <td>4'-Methylene-5,8,10-trideazaaminopterin</td>
      <td>NAWXUBYGYWOOIX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04263</td>
      <td>Geneticin</td>
      <td>BRZYSWJRSDMWLG-DJWUNRQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB15055</td>
      <td>ABT-639</td>
      <td>AGPIHNZOZNKRGT-CYBMUJFWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11921</td>
      <td>Deflazacort</td>
      <td>FBHSPRKOSMHSIF-GRMWVWQJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB00430</td>
      <td>Cefpiramide</td>
      <td>PWAUCHMQEXVFJR-PMAPCBKXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07787</td>
      <td>5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE</td>
      <td>PNPFDRCIGCUCMN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB15056</td>
      <td>Bifenthrin</td>
      <td>OMFRMAHOUUJSGP-IRHGGOMRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB06469</td>
      <td>Lestaurtinib</td>
      <td>UIARLYUEJFELEN-DMVVYWCZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07795</td>
      <td>Fisetin</td>
      <td>XHEFDIBZLJXQHF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07806</td>
      <td>(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID</td>
      <td>UDMBRVGTYILYDX-SVFBPWRDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07809</td>
      <td>4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>MBJYEMUMDMGQQC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06918</td>
      <td>2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE</td>
      <td>ZRYXDGAKQGRHFG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB00836</td>
      <td>Loperamide</td>
      <td>RDOIQAHITMMDAJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB12225</td>
      <td>Beclabuvir</td>
      <td>ZTTKEBYSXUCBSE-QDFUAKMASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12696</td>
      <td>BMS-582949</td>
      <td>GDTQLZHHDRRBEB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>1r42</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12808</td>
      <td>Trifarotene</td>
      <td>MFBCDACCJCDGBA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB14069</td>
      <td>ONT-093</td>
      <td>RSJCLODJSVZNQA-BQYQJAHWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB12186</td>
      <td>SRT-2104</td>
      <td>LAMQVIQMVKWXOC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB12185</td>
      <td>Exatecan</td>
      <td>ZVYVPGLRVWUPMP-FYSMJZIKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08360</td>
      <td>2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>BIFHJPUTQBOBGJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB00878</td>
      <td>Chlorhexidine</td>
      <td>GHXZTYHSJHQHIJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12260</td>
      <td>Radiprodil</td>
      <td>GKGRZLGAQZPEHO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB05129</td>
      <td>Elsamitrucin</td>
      <td>MGQRRMONVLMKJL-KWJIQSIXSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB08353</td>
      <td>2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>NCVMTHVSAJMOPI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11964</td>
      <td>Ilaprazole</td>
      <td>HRRXCXABAPSOCP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12021</td>
      <td>Dinaciclib</td>
      <td>PIMQWRZWLQKKBJ-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08052</td>
      <td>1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>NVRXTLZYXZNATH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14941</td>
      <td>BMS-817399</td>
      <td>GTDPZONCGOCXOD-JPYJTQIMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB02596</td>
      <td>Alpha,Beta-Methyleneadenosine-5'-Triphosphate</td>
      <td>CAWZRIXWFRFUQB-IOSLPCCCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08715</td>
      <td>2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL</td>
      <td>SLPKYEWAKMNCPT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11958</td>
      <td>Brivanib</td>
      <td>WCWUXEGQKLTGDX-LLVKDONJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB15013</td>
      <td>TAK-243</td>
      <td>KJDAGXLMHXUAGV-DGWLBADLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13070</td>
      <td>Surinabant</td>
      <td>HMXDWDSNPRNUKI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB08031</td>
      <td>N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</td>
      <td>LNQWELVSNCYKDU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00950</td>
      <td>Fexofenadine</td>
      <td>RWTNPBWLLIMQHL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07278</td>
      <td>2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE</td>
      <td>ACEFOQMQINFMRW-DYCFVMESSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08116</td>
      <td>(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine</td>
      <td>DEOZLEGRVHDNKC-UGKGYDQZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB15009</td>
      <td>PF-04937319</td>
      <td>MASKQITXHVYVFL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB02859</td>
      <td>Soraphen A</td>
      <td>WPMGNXPRKGXGBO-OFQQMTDKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB04960</td>
      <td>Tipifarnib</td>
      <td>PLHJCIYEEKOWNM-HHHXNRCGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00977</td>
      <td>Ethinylestradiol</td>
      <td>BFPYWIDHMRZLRN-SLHNCBLASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08444</td>
      <td>3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile</td>
      <td>YYGZQXRLQMFHDH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB03207</td>
      <td>2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid</td>
      <td>BNVMUDXGABBWGP-OAQYLSRUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08402</td>
      <td>2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID</td>
      <td>VNDRRWBKNSHALL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB00901</td>
      <td>Bitolterol</td>
      <td>FZGVEKPRDOIXJY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13752</td>
      <td>Tetramethrin</td>
      <td>CXBMCYHAMVGWJQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07973</td>
      <td>N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE</td>
      <td>GIPCBGDQVGKMPO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07570</td>
      <td>3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID</td>
      <td>ZKEZEXYKYHYIMQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07976</td>
      <td>3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>GIUMGVUBDBDTDX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14902</td>
      <td>JHU-75528 C-11</td>
      <td>MCNQUWLLXZZZAC-BJUDXGSMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12115</td>
      <td>AZD-9164</td>
      <td>FNYFFCOCVNTJCD-NNMXADRKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB11992</td>
      <td>Omarigliptin</td>
      <td>MKMPWKUAHLTIBJ-ISTRZQFTSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB15108</td>
      <td>Tipranavir C-14</td>
      <td>SUJUHGSWHZTSEU-MWQIXQBFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07584</td>
      <td>N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine</td>
      <td>OKGCSZUKOGMZAL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07993</td>
      <td>N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>LPQUIIHPUGDHJK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11962</td>
      <td>GSK-1059615</td>
      <td>QDITZBLZQQZVEE-YBEGLDIGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB06558</td>
      <td>Tezosentan</td>
      <td>TUYWTLTWNJOZNY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08022</td>
      <td>(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile</td>
      <td>RCYPVQCPYKNSTG-OAHLLOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB01640</td>
      <td>(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One</td>
      <td>QNURTFDBHAQRSI-OAHLLOKOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08026</td>
      <td>2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide</td>
      <td>AJLILYAPRHIFAS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12113</td>
      <td>CE-224535</td>
      <td>FUCKCIVGBCBZNP-MRXNPFEDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB15092</td>
      <td>LY-2624803</td>
      <td>UEFWDVMEDFCHGW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08513</td>
      <td>[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID</td>
      <td>PAIQRYUOBBCBSE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11764</td>
      <td>Spebrutinib</td>
      <td>KXBDTLQSDKGAEB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB06684</td>
      <td>Vilazodone</td>
      <td>SGEGOXDYSFKCPT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB03084</td>
      <td>Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</td>
      <td>XCTKFTOEAKJMII-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB09215</td>
      <td>Droxicam</td>
      <td>OEHFRZLKGRKFAS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12084</td>
      <td>ADP-597</td>
      <td>WPDCHTSXOPUOII-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB14895</td>
      <td>Vibegron</td>
      <td>DJXRIQMCROIRCZ-XOEOCAAJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13956</td>
      <td>Estradiol valerate</td>
      <td>RSEPBGGWRJCQGY-RBRWEJTLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB04030</td>
      <td>1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole</td>
      <td>ADXYEWMDAGIULV-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB03638</td>
      <td>Cytidyl-2'-5'-Phospho-Guanosine</td>
      <td>QZDUXDLOEVJGDG-VMIOUTBZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB09238</td>
      <td>Manidipine</td>
      <td>ANEBWFXPVPTEET-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01150</td>
      <td>Cefprozil</td>
      <td>WDLWHQDACQUCJR-PBFPGSCMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11665</td>
      <td>BMS-690514</td>
      <td>CSGQVNMSRKWUSH-IAGOWNOFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15257</td>
      <td>Milademetan</td>
      <td>RYAYYVTWKAOAJF-QISPRATLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB04042</td>
      <td>2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol</td>
      <td>XLJNZONSWKENRP-VABIIVNOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08828</td>
      <td>Vismodegib</td>
      <td>BPQMGSKTAYIVFO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB14664</td>
      <td>Difluocortolone pivalate</td>
      <td>UWGRWFCLGQWKPR-GSTUPEFVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB11637</td>
      <td>Delamanid</td>
      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB09008</td>
      <td>Cefaloridine</td>
      <td>CZTQZXZIADLWOZ-CRAIPNDOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB09015</td>
      <td>Canrenoic acid</td>
      <td>PBKZPPIHUVSDNM-WNHSNXHDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB14634</td>
      <td>Fluprednidene acetate</td>
      <td>DEFOZIFYUBUHHU-IYQKUMFPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB02009</td>
      <td>L-756,423</td>
      <td>AOMZDQMIOCTPQP-QHQMVRJISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4b</td>
      <td>DB14850</td>
      <td>Deleobuvir</td>
      <td>BMAIGAHXAJEULY-UKTHLTGXSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB03916</td>
      <td>4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine</td>
      <td>RHOOHUMOHVIXEF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB03907</td>
      <td>N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide</td>
      <td>UHHBFOLQOQSPLU-WGRQDFERSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08538</td>
      <td>N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>HQPVGVSQPQVZLD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB14654</td>
      <td>Bisoxatin acetate</td>
      <td>ZCBJDQBSLZREAA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB14657</td>
      <td>Paramethasone acetate</td>
      <td>HYRKAAMZBDSJFJ-LFDBJOOHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08301</td>
      <td>N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE</td>
      <td>HDCXQTPVTAIPNZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB03768</td>
      <td>N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3</td>
      <td>WRUVOSYKHXGAQN-GKRYNVPLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB09166</td>
      <td>Etizolam</td>
      <td>VMZUTJCNQWMAGF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB15047</td>
      <td>BMS-919373</td>
      <td>XGKULQQVQWCASY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB09171</td>
      <td>??-Methylfentanyl</td>
      <td>UXIGUKSHASXDNI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15282</td>
      <td>Fluorofuranylnorprogesterone F-18</td>
      <td>VJKRBRUNEOHPBS-JQKUZGBFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11829</td>
      <td>Ruboxistaurin</td>
      <td>ZCBUQCWBWNUWSU-SFHVURJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08752</td>
      <td>N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide</td>
      <td>IRSOCWQJNYLTDD-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB03020</td>
      <td>5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</td>
      <td>UINNILASBHZOTM-KMXXXSRASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11423</td>
      <td>Lasalocid</td>
      <td>BBMULGJBVDDDNI-OWKLGTHSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11638</td>
      <td>Artenimol</td>
      <td>BJDCWCLMFKKGEE-HVDUHBCDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15047</td>
      <td>BMS-919373</td>
      <td>XGKULQQVQWCASY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11431</td>
      <td>Moxidectin</td>
      <td>YZBLFMPOMVTDJY-LSGXYNIPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15028</td>
      <td>MK-1064</td>
      <td>CKTWQGHVNRYNCM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13952</td>
      <td>Estradiol acetate</td>
      <td>FHXBMXJMKMWVRG-SLHNCBLASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB00246</td>
      <td>Ziprasidone</td>
      <td>MVWVFYHBGMAFLY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB13407</td>
      <td>Nifenazone</td>
      <td>BRZANEXCSZCZCI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB03351</td>
      <td>Sri-9439</td>
      <td>KMSATRJZEXNGDP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB14845</td>
      <td>Filgotinib</td>
      <td>RIJLVEAXPNLDTC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11551</td>
      <td>Trenbolone</td>
      <td>MEHHPFQKXOUFFV-OWSLCNJRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB13947</td>
      <td>Testosterone enantate benzilic acid hydrazone</td>
      <td>PTVXYACXDYZNID-JKXGKYMWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB04154</td>
      <td>N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</td>
      <td>ALBWBHNFOJJMCV-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11800</td>
      <td>Tivozanib</td>
      <td>SPMVMDHWKHCIDT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11591</td>
      <td>Bilastine</td>
      <td>ACCMWZWAEFYUGZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB08097</td>
      <td>2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE</td>
      <td>OGWSGDLIXOEZJG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB09047</td>
      <td>Finafloxacin</td>
      <td>FYMHQCNFKNMJAV-HOTGVXAUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB14034</td>
      <td>Darglitazone</td>
      <td>QQKNSPHAFATFNQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11393</td>
      <td>Danofloxacin</td>
      <td>QMLVECGLEOSESV-RYUDHWBXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB07019</td>
      <td>N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE</td>
      <td>QWDOKZPZLWNULU-MZNJEOGPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB03351</td>
      <td>Sri-9439</td>
      <td>KMSATRJZEXNGDP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15177</td>
      <td>VX-659</td>
      <td>IGEOJNMYRZUKIK-IBGZPJMESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08745</td>
      <td>4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE</td>
      <td>QLHUDNKWOSQSMK-CXUHLZMHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB05316</td>
      <td>Pimavanserin</td>
      <td>RKEWSXXUOLRFBX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB08057</td>
      <td>N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine</td>
      <td>VWJPPYCULHDHBB-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08746</td>
      <td>1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE</td>
      <td>ZOSSOFIFNGGDKG-GIJQJNRQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB03496</td>
      <td>Alvocidib</td>
      <td>BIIVYFLTOXDAOV-YVEFUNNKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB09078</td>
      <td>Lenvatinib</td>
      <td>WOSKHXYHFSIKNG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11259</td>
      <td>Diosmetin</td>
      <td>MBNGWHIJMBWFHU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB14942</td>
      <td>BMS-986141</td>
      <td>KEEBLYWBELVGPQ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB14775</td>
      <td>Cavosonstat</td>
      <td>BXSZILNGNMDGSL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB11867</td>
      <td>JNJ-39393406</td>
      <td>IURMHZBQEYNQOH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB08063</td>
      <td>1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE</td>
      <td>HLZMYWLMBBLASX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB11786</td>
      <td>Pefcalcitol</td>
      <td>SVCSMAZYWOQCBW-NVJMFHFGSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB03461</td>
      <td>2'-Monophosphoadenosine 5'-Diphosphoribose</td>
      <td>XJLXINKUBYWONI-NNYOXOHSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13023</td>
      <td>IPI-493</td>
      <td>XYFFWTYOFPSZRM-TWNAANEASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11366</td>
      <td>Roquinimex</td>
      <td>SGOOQMRIPALTEL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB01940</td>
      <td>Balanol Analog 2</td>
      <td>SQLYTJZXRRDERK-ISKFKSNPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08532</td>
      <td>6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine</td>
      <td>WCNPGRRMPFCHEO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07785</td>
      <td>1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE</td>
      <td>UYAJDVNLQJVRHD-SCLBCKFNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08976</td>
      <td>Floctafenine</td>
      <td>APQPGQGAWABJLN-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB07226</td>
      <td>N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE</td>
      <td>JWZVNUNTFNELHL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB11704</td>
      <td>Adomeglivant</td>
      <td>FASLTMSUPQDLIB-MHZLTWQESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB02859</td>
      <td>Soraphen A</td>
      <td>WPMGNXPRKGXGBO-OFQQMTDKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB14218</td>
      <td>Telotristat</td>
      <td>NCLGDOBQAWBXRA-PGRDOPGGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB15065</td>
      <td>PF-06291874</td>
      <td>IBDYYOQKQCCSDP-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB15207</td>
      <td>Esaxerenone</td>
      <td>NOSNHVJANRODGR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00303</td>
      <td>Ertapenem</td>
      <td>JUZNIMUFDBIJCM-ANEDZVCMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB08446</td>
      <td>3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile</td>
      <td>OHQMEDBYNUAVNE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00301</td>
      <td>Flucloxacillin</td>
      <td>UIOFUWFRIANQPC-JKIFEVAISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08597</td>
      <td>6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine</td>
      <td>XHBVYDAKJHETMP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12010</td>
      <td>Fostamatinib</td>
      <td>GKDRMWXFWHEQQT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08590</td>
      <td>1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE</td>
      <td>CEAYRKIZESVQSN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11784</td>
      <td>NRX-1074</td>
      <td>DVBUEXCIEIAXPM-PJUQSVSOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07788</td>
      <td>(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE</td>
      <td>NEQZWEXWOFPKOT-QHSZRYGNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08705</td>
      <td>6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE</td>
      <td>SVSYJTYGPLVUOZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00275</td>
      <td>Olmesartan</td>
      <td>VTRAEEWXHOVJFV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB14793</td>
      <td>RO-5045337</td>
      <td>QBGKPEROWUKSBK-QPPIDDCLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB04392</td>
      <td>Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]</td>
      <td>HIZKPJUTKKJDGA-BETUJISGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB04373</td>
      <td>4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</td>
      <td>WQUBEIMCFHCJCO-AWCRTANDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11698</td>
      <td>Ipragliflozin</td>
      <td>AHFWIQIYAXSLBA-RQXATKFSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11853</td>
      <td>Relugolix</td>
      <td>AOMXMOCNKJTRQP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB08463</td>
      <td>(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol</td>
      <td>HOCBJBNQIQQQGT-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06581</td>
      <td>Bevirimat</td>
      <td>YJEJKUQEXFSVCJ-WRFMNRASSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08531</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CVYWYUAQFJMLEO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07792</td>
      <td>(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>VUKPNWLGSLOHIF-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08534</td>
      <td>5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>ZAIYYXVHGBMLEC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB03583</td>
      <td>(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One</td>
      <td>AYOAIABDFUJDKQ-SQJPUDIVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11741</td>
      <td>Famitinib</td>
      <td>GKEYKDOLBLYGRB-LGMDPLHJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB03161</td>
      <td>Thymidine-5'-Diphospho-Beta-D-Xylose</td>
      <td>AJUADKZRQSBUAK-KDGZBOQCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08543</td>
      <td>1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE</td>
      <td>BZJHCQBNFUNZPJ-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12011</td>
      <td>Fevipiprant</td>
      <td>GFPPXZDRVCSVNR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00402</td>
      <td>Eszopiclone</td>
      <td>GBBSUAFBMRNDJC-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07971</td>
      <td>5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE</td>
      <td>FQQVTDIBUYSVHM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB02715</td>
      <td>Compound 18</td>
      <td>UZOOIPXOYYJULJ-RHLLTPQKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08614</td>
      <td>3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE</td>
      <td>MYFMPKCOIMRDDD-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08577</td>
      <td>3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE</td>
      <td>JNDVEAXZWJIOKB-JYRVWZFOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB15057</td>
      <td>NUC-1031</td>
      <td>NHTKGYOMICWFQZ-KKQYNPQSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB06888</td>
      <td>(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</td>
      <td>KBLPHMRCKHFBJB-OLZOCXBDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08591</td>
      <td>5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE</td>
      <td>IGXKSKWHHHYBFM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00354</td>
      <td>Buclizine</td>
      <td>MOYGZHXDRJNJEP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00404</td>
      <td>Alprazolam</td>
      <td>VREFGVBLTWBCJP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15403</td>
      <td>Ziritaxestat</td>
      <td>REQQVBGILUTQNN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12933</td>
      <td>RO-4987655</td>
      <td>FIMYFEGKMOCQKT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB02880</td>
      <td>N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide</td>
      <td>KFTNEILVDDUXGR-SECBINFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB11424</td>
      <td>Lufenuron</td>
      <td>PWPJGUXAGUPAHP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB15096</td>
      <td>18-methoxycoronaridine</td>
      <td>DTJQBBHYRQYDEG-SVBQBFEESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB03461</td>
      <td>2'-Monophosphoadenosine 5'-Diphosphoribose</td>
      <td>XJLXINKUBYWONI-NNYOXOHSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11450</td>
      <td>Pimobendan</td>
      <td>GLBJJMFZWDBELO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07769</td>
      <td>S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE</td>
      <td>KJMFOTCDISOHDX-INIZCTEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15435</td>
      <td>BMS-986158</td>
      <td>KGERZPVQIRYWRK-GDLZYMKVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB14802</td>
      <td>ONO-2952</td>
      <td>ZBQMTQGDBFZUBG-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12887</td>
      <td>Tazemetostat</td>
      <td>NSQSAUGJQHDYNO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08927</td>
      <td>Amperozide</td>
      <td>NNAIYOXJNVGUOM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08619</td>
      <td>Testosterone succinate</td>
      <td>CJQNBXFUHQZFOE-VYAQIDIUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB12857</td>
      <td>NVP-LEQ-506</td>
      <td>POERAARDVFVDLO-QGZVFWFLSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08950</td>
      <td>Indoramin</td>
      <td>JXZZEXZZKAWDSP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12022</td>
      <td>Evatanepag</td>
      <td>WOHRHWDYFNWPNG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB11263</td>
      <td>Polydatin</td>
      <td>HSTZMXCBWJGKHG-CUYWLFDKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB02698</td>
      <td>N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid</td>
      <td>NQOOJFXBGLOGTC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB15106</td>
      <td>Surufatinib</td>
      <td>TTZSNFLLYPYKIL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04596</td>
      <td>4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid</td>
      <td>GZJXZKGVHLWBOW-AISSFXTFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB04107</td>
      <td>[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester</td>
      <td>RNOYCNIZOAIUSV-LSWMGQQCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB08005</td>
      <td>4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide</td>
      <td>ARMFMDYRYOKSOW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB15091</td>
      <td>Upadacitinib</td>
      <td>WYQFJHHDOKWSHR-MNOVXSKESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB08747</td>
      <td>(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one</td>
      <td>JJTPPGUNMJMPLY-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07982</td>
      <td>2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol</td>
      <td>PVTKDXZNSUHUMO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08568</td>
      <td>(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE</td>
      <td>BPNUQXPIQBZCMR-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB14899</td>
      <td>Tavapadon</td>
      <td>AKQXQLUNFKDZBN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06155</td>
      <td>Rimonabant</td>
      <td>JZCPYUJPEARBJL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB14859</td>
      <td>Fosifloxuridine nafalbenamide</td>
      <td>BIOWRMNRHMERIO-ZVAHOJSLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB14840</td>
      <td>Ripretinib</td>
      <td>CEFJVGZHQAGLHS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08557</td>
      <td>2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide</td>
      <td>XQKFKSJUBJPOLY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB11749</td>
      <td>(R)-Praziquantel</td>
      <td>FSVJFNAIGNNGKK-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB02716</td>
      <td>7-Methyl-Guanosine-5'-Triphosphate</td>
      <td>DKVRNHPCAOHRSI-KQYNXXCUSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB15078</td>
      <td>Rogaratinib</td>
      <td>HNLRRJSKGXOYNO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08607</td>
      <td>(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE</td>
      <td>GXPHKUHSUJUWKP-NTKDMRAZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00180</td>
      <td>Flunisolide</td>
      <td>XSFJVAJPIHIPKU-XWCQMRHXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB00278</td>
      <td>Argatroban</td>
      <td>KXNPVXPOPUZYGB-IOVMHBDKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB11522</td>
      <td>Isoflupredone</td>
      <td>WAIJIHDWAKJCBX-BULBTXNYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB15254</td>
      <td>RO-5126766 free base</td>
      <td>LMMJFBMMJUMSJS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB00203</td>
      <td>Sildenafil</td>
      <td>BNRNXUUZRGQAQC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08220</td>
      <td>(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid</td>
      <td>RPNNXCYIESWDSC-JRZBRKEGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB14862</td>
      <td>PF-06815345</td>
      <td>QTBYVAZRKWOIDU-FUHWJXTLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB11652</td>
      <td>Tucatinib</td>
      <td>SDEAXTCZPQIFQM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13865</td>
      <td>Dehydroemetine</td>
      <td>XXLZPUYGHQWHRN-RPBOFIJWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4b</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07548</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE</td>
      <td>JXHWVKOKYDAROD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06809</td>
      <td>Plerixafor</td>
      <td>YIQPUIGJQJDJOS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB13640</td>
      <td>Acetoxolone</td>
      <td>FTQDJVZNPJRVPG-XWEVEMRCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB14035</td>
      <td>Englitazone</td>
      <td>MVDXXGIBARMXSA-PYUWXLGESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB06747</td>
      <td>ginkgolide-M</td>
      <td>KDKROYXEHCYLJQ-FJFAJXJPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB13061</td>
      <td>MLN8054</td>
      <td>HHFBDROWDBDFBR-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB06786</td>
      <td>Halcinonide</td>
      <td>MUQNGPZZQDCDFT-JNQJZLCISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB13643</td>
      <td>Loprazolam</td>
      <td>UTEFBSAVJNEPTR-RGEXLXHISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB07041</td>
      <td>N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide</td>
      <td>FDJWFDQRPKKBFA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB06786</td>
      <td>Halcinonide</td>
      <td>MUQNGPZZQDCDFT-JNQJZLCISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08770</td>
      <td>4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol</td>
      <td>PWTBZOIUWZOPFT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12436</td>
      <td>Vofopitant</td>
      <td>XILNRORTJVDYRH-HKUYNNGSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB07297</td>
      <td>5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE</td>
      <td>PTILEOLOGGMFCS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB02106</td>
      <td>[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid</td>
      <td>KIRQJXNQGZAKGR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12234</td>
      <td>BMS-214662</td>
      <td>OLCWFLWEHWLBTO-HSZRJFAPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07519</td>
      <td>(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</td>
      <td>VDFBMQAUECXNKR-OAQYLSRUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07190</td>
      <td>3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide</td>
      <td>JGFCNVHEEMBVJG-MOPGFXCFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08174</td>
      <td>5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE</td>
      <td>QCPYHSAHOYXXQK-DLBZAZTESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12494</td>
      <td>SGI-1776</td>
      <td>MHXGEROHKGDZGO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12500</td>
      <td>Fedratinib</td>
      <td>JOOXLOJCABQBSG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB08794</td>
      <td>Ethyl biscoumacetate</td>
      <td>JCLHQFUTFHUXNN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12515</td>
      <td>9-aminocamptothecin</td>
      <td>FUXVKZWTXQUGMW-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00620</td>
      <td>Triamcinolone</td>
      <td>GFNANZIMVAIWHM-OBYCQNJPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07165</td>
      <td>N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE</td>
      <td>SOBGXPPOYFFGTK-UGKGYDQZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12774</td>
      <td>AZD-8055</td>
      <td>KVLFRAWTRWDEDF-IRXDYDNUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08080</td>
      <td>LATRUNCULIN B</td>
      <td>NSHPHXHGRHSMIK-JRIKCGFMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB06469</td>
      <td>Lestaurtinib</td>
      <td>UIARLYUEJFELEN-DMVVYWCZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07642</td>
      <td>5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>GYKIQIOWVKCVBP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12058</td>
      <td>Recoflavone</td>
      <td>BCPQOBQIVJZOFL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07628</td>
      <td>6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one</td>
      <td>IEWYEWDDQWYJLU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07089</td>
      <td>N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide</td>
      <td>VZSMTBLDWPKVRW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB08143</td>
      <td>5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE</td>
      <td>SXIYSYYSKHUTQQ-RDJZCZTQSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB14726</td>
      <td>Dabigatran</td>
      <td>YBSJFWOBGCMAKL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB11875</td>
      <td>3,3'-diindolylmethane</td>
      <td>VFTRKSBEFQDZKX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB06817</td>
      <td>Raltegravir</td>
      <td>CZFFBEXEKNGXKS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB04875</td>
      <td>Pralnacasan</td>
      <td>CXAGHAZMQSCAKJ-WAHHBDPQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12096</td>
      <td>PF-05175157</td>
      <td>BDXXSFOJPYSYOC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07113</td>
      <td>(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE</td>
      <td>KHZQOXQOUCGGGA-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB12887</td>
      <td>Tazemetostat</td>
      <td>NSQSAUGJQHDYNO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB06977</td>
      <td>(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine</td>
      <td>CAASENZOSQYNPX-HSTJUUNISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB15021</td>
      <td>Leriglitazone</td>
      <td>OXVFDZYQLGRLCD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11978</td>
      <td>Glasdegib</td>
      <td>SFNSLLSYNZWZQG-VQIMIIECSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08745</td>
      <td>4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE</td>
      <td>QLHUDNKWOSQSMK-CXUHLZMHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14845</td>
      <td>Filgotinib</td>
      <td>RIJLVEAXPNLDTC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB08121</td>
      <td>(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid</td>
      <td>TZTPJJNNACUQQR-FQEVSTJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07439</td>
      <td>1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>CAWXCABXSPTFRN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB02217</td>
      <td>Dpb-T</td>
      <td>WTZFKHNHHRPQOU-WSMBLCCSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07584</td>
      <td>N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine</td>
      <td>OKGCSZUKOGMZAL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06414</td>
      <td>Etravirine</td>
      <td>PYGWGZALEOIKDF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB02033</td>
      <td>N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide</td>
      <td>GDRNWAKVNIROCG-DEOSSOPVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07568</td>
      <td>(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE</td>
      <td>ADRNPUSZBRQDBG-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB13040</td>
      <td>Gandotinib</td>
      <td>SQSZANZGUXWJEA-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12888</td>
      <td>Ezutromid</td>
      <td>KSGCNXAZROJSNW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB08237</td>
      <td>2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)</td>
      <td>COMPKRGNHXOXMN-GVDBMIGSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01388</td>
      <td>Mibefradil</td>
      <td>HBNPJJILLOYFJU-VMPREFPWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07382</td>
      <td>N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine</td>
      <td>WJNBSTLIALIIEW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB12649</td>
      <td>Ibipinabant</td>
      <td>AXJQVVLKUYCICH-OAQYLSRUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07373</td>
      <td>ANDROSTA-1,4-DIENE-3,17-DIONE</td>
      <td>LUJVUUWNAPIQQI-QAGGRKNESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08749</td>
      <td>3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</td>
      <td>KTRFBFMYAJOXLG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB01933</td>
      <td>7-Hydroxystaurosporine</td>
      <td>PBCZSGKMGDDXIJ-HQCWYSJUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB14066</td>
      <td>Tetrandrine</td>
      <td>WVTKBKWTSCPRNU-KYJUHHDHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB06229</td>
      <td>Ocaperidone</td>
      <td>ZZQNEJILGNNOEP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB15047</td>
      <td>BMS-919373</td>
      <td>XGKULQQVQWCASY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00604</td>
      <td>Cisapride</td>
      <td>DCSUBABJRXZOMT-IRLDBZIGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB01763</td>
      <td>7-thionicotinamide-adenine-dinucleotide phosphate</td>
      <td>OJNFDOAQUXJWED-NNYOXOHSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08094</td>
      <td>(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE</td>
      <td>JRNJNYBQQYBCLE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07343</td>
      <td>4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE</td>
      <td>NFNNMVVXXITVGD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB02102</td>
      <td>DMP450</td>
      <td>KYRSNWPSSXSNEP-ZRTHHSRSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB01893</td>
      <td>N6-Benzyl Adenosine-5'-Diphosphate</td>
      <td>MRHGMAGSDAQUFH-LSCFUAHRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB11263</td>
      <td>Polydatin</td>
      <td>HSTZMXCBWJGKHG-CUYWLFDKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB14125</td>
      <td>Benazeprilat</td>
      <td>MADRIHWFJGRSBP-ROUUACIJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07457</td>
      <td>3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE</td>
      <td>APYXQTXFRIDSGE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06608</td>
      <td>Tafenoquine</td>
      <td>LBHLFPGPEGDCJG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB14152</td>
      <td>Ginsenosides</td>
      <td>NLHQJXWYMZLQJY-SWIZOJJJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12165</td>
      <td>Presatovir</td>
      <td>GOFXWTVKPWJNGD-UWJYYQICSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12680</td>
      <td>Intepirdine</td>
      <td>JJZFWROHYSMCMU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14769</td>
      <td>Pamiparib</td>
      <td>DENYZIUJOTUUNY-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12193</td>
      <td>Ajulemic acid</td>
      <td>YCHYFHOSGQABSW-RTBURBONSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07175</td>
      <td>N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide</td>
      <td>CXQRKICWSCAUGW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB12725</td>
      <td>TD-8954</td>
      <td>MZOITCJKGUIQEI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB15046</td>
      <td>LY-2881835</td>
      <td>FHRWHNJJQGSCQC-LJAQVGFWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB06634</td>
      <td>Casopitant</td>
      <td>XGGTZCKQRWXCHW-WMTVXVAQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14802</td>
      <td>ONO-2952</td>
      <td>ZBQMTQGDBFZUBG-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB03157</td>
      <td>N,O-Didansyl-L-Tyrosine</td>
      <td>LUBOPDUYHWABFG-NDEPHWFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07245</td>
      <td>6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE</td>
      <td>AEVBKBAFFJKFJZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12745</td>
      <td>GSK-690693</td>
      <td>KGPGFQWBCSZGEL-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB06212</td>
      <td>Tolvaptan</td>
      <td>GYHCTFXIZSNGJT-XMMPIXPASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB06879</td>
      <td>5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE</td>
      <td>QCFIRACCCDFXIP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07222</td>
      <td>(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE</td>
      <td>RJWMDETWDDESBP-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08064</td>
      <td>N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA</td>
      <td>NTMADESEDXKNFZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12720</td>
      <td>Nivocasan</td>
      <td>VYFGDLGHHBUDTQ-ZLGUVYLKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12744</td>
      <td>CGI-1842</td>
      <td>ZXBFYBLSJMEBEP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08747</td>
      <td>(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one</td>
      <td>JJTPPGUNMJMPLY-QFIPXVFZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB06581</td>
      <td>Bevirimat</td>
      <td>YJEJKUQEXFSVCJ-WRFMNRASSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB01732</td>
      <td>(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One</td>
      <td>SQBOSZXDOHQFAA-ZRTHHSRSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07245</td>
      <td>6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE</td>
      <td>AEVBKBAFFJKFJZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07447</td>
      <td>5beta-dihydrotestosterone</td>
      <td>NVKAWKQGWWIWPM-MISPCMORSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07676</td>
      <td>3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one</td>
      <td>CKLAPOFDFZKCPB-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11949</td>
      <td>Vestipitant</td>
      <td>SBBYBXSFWOLDDG-JLTOFOAXSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14717</td>
      <td>Nitrazolam</td>
      <td>OYRPNABWTHDOFK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01137</td>
      <td>Levofloxacin</td>
      <td>GSDSWSVVBLHKDQ-JTQLQIEISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB14723</td>
      <td>Larotrectinib</td>
      <td>NYNZQNWKBKUAII-KBXCAEBGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB08882</td>
      <td>Linagliptin</td>
      <td>LTXREWYXXSTFRX-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07250</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>HMKLUOPMOJOUDZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB06777</td>
      <td>Chenodeoxycholic acid</td>
      <td>RUDATBOHQWOJDD-BSWAIDMHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06932</td>
      <td>10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine</td>
      <td>NVINUNQBDNEMSY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w9c</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB13596</td>
      <td>Oxycinchophen</td>
      <td>XAPRFLSJBSXESP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lzg</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB02917</td>
      <td>N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide</td>
      <td>LFGYSFPVLMPUPE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07226</td>
      <td>N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE</td>
      <td>JWZVNUNTFNELHL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB08207</td>
      <td>2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE</td>
      <td>BIHLSRJPJFOESJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07706</td>
      <td>2-Hydroxyestradiol</td>
      <td>DILDHNKDVHLEQB-XSSYPUMDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB15183</td>
      <td>Fosmanogepix</td>
      <td>JQONJQKKVAHONF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07538</td>
      <td>4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE</td>
      <td>RGVVHQNJKUNSFQ-WDZFZDKYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04867</td>
      <td>Lintitript</td>
      <td>ILNRQFBVVQUOLP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB02519</td>
      <td>Indirubin-5-Sulphonate</td>
      <td>IHBOEHLUIBMBMY-YPKPFQOOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB14086</td>
      <td>Cianidanol</td>
      <td>PFTAWBLQPZVEMU-DZGCQCFKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12073</td>
      <td>Albaconazole</td>
      <td>UHIXWHUVLCAJQL-MPBGBICISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB13138</td>
      <td>Neladenoson bialanate</td>
      <td>WESNEIGKOAXSGX-VXKWHMMOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07724</td>
      <td>Indeglitazar</td>
      <td>YMPALHOKRBVHOJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06410</td>
      <td>Doxercalciferol</td>
      <td>HKXBNHCUPKIYDM-CGMHZMFXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07655</td>
      <td>3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE</td>
      <td>MPJYGQHMIFDQIN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00307</td>
      <td>Bexarotene</td>
      <td>NAVMQTYZDKMPEU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07022</td>
      <td>3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate</td>
      <td>PXERBGNIBOFZOW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB06743</td>
      <td>Ginkgolide A</td>
      <td>FPUXKXIZEIDQKW-VKMVSBOZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxx</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4b</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12345</td>
      <td>MBX-2982</td>
      <td>NFTMKHWBOINJGM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB12101</td>
      <td>CC-220</td>
      <td>IXZOHGPZAQLIBH-NRFANRHFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB06977</td>
      <td>(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine</td>
      <td>CAASENZOSQYNPX-HSTJUUNISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB12973</td>
      <td>Serlopitant</td>
      <td>FLNYCRJBCNNHRH-OIYLJQICSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB14802</td>
      <td>ONO-2952</td>
      <td>ZBQMTQGDBFZUBG-NRFANRHFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08340</td>
      <td>N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE</td>
      <td>LLYYAUZAGCZEKV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB15170</td>
      <td>Evobrutinib</td>
      <td>QUIWHXQETADMGN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB11176</td>
      <td>Zeaxanthin</td>
      <td>JKQXZKUSFCKOGQ-QAYBQHTQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB14937</td>
      <td>MK-8666</td>
      <td>CODQKEMYZZKQAE-QPVYNBJUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>7bv1</td>
      <td>DB06732</td>
      <td>beta-Naphthoflavone</td>
      <td>OUGIDAPQYNCXRA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12141</td>
      <td>Gilteritinib</td>
      <td>GYQYAJJFPNQOOW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12952</td>
      <td>Methylprednisone</td>
      <td>SVYCRJXQZUCUND-PQXSVQADSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB03895</td>
      <td>Malachite Green</td>
      <td>VFCNQNZNPKRXIT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB04669</td>
      <td>TRIAZOLOPYRIMIDINE</td>
      <td>YWBFPKPWMSWWEA-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB14083</td>
      <td>Bisphenol A diglycidyl ether</td>
      <td>LCFVJGUPQDGYKZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06921</td>
      <td>(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID</td>
      <td>FNZHLCNFXRRIIC-RBUKOAKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB12708</td>
      <td>Sulprostone</td>
      <td>UQZVCDCIMBLVNR-TWYODKAFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB09143</td>
      <td>Sonidegib</td>
      <td>VZZJRYRQSPEMTK-CALCHBBNSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6vxs</td>
      <td>DB12941</td>
      <td>ODM-201</td>
      <td>BLIJXOOIHRSQRB-PXYINDEMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12385</td>
      <td>10-hydroxycamptothecin</td>
      <td>HAWSQZCWOQZXHI-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08126</td>
      <td>3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE</td>
      <td>DMCRNUMVSATRTP-LCYFTJDESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB08354</td>
      <td>2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>QCVULERVJOYHCP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB00655</td>
      <td>Estrone</td>
      <td>DNXHEGUUPJUMQT-CBZIJGRNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB07460</td>
      <td>2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE</td>
      <td>UYJNQQDJUOUFQJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07729</td>
      <td>3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide</td>
      <td>GAKOBKPDJJGRIL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6lxt</td>
      <td>DB02524</td>
      <td>2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)</td>
      <td>XFMMHXLUHKBKQE-UHEGPQQHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB12301</td>
      <td>Doravirine</td>
      <td>ZIAOVIPSKUPPQW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB04154</td>
      <td>N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</td>
      <td>ALBWBHNFOJJMCV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4b</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6wiq</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m71</td>
      <td>DB07076</td>
      <td>6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</td>
      <td>FWTQOPWAMQXIMI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08026</td>
      <td>2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide</td>
      <td>AJLILYAPRHIFAS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6w4h</td>
      <td>DB03893</td>
      <td>Thionicotinamide-Adenine-Dinucleotide</td>
      <td>UQYPZLRUJKCREN-NNYOXOHSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6cs2</td>
      <td>DB04020</td>
      <td>4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol</td>
      <td>AIBKIFHSQQYXLG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB06597</td>
      <td>Estradiol sulfamate</td>
      <td>YXYXCSOJKUAPJI-ZBRFXRBCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6crv</td>
      <td>DB01406</td>
      <td>Danazol</td>
      <td>POZRVZJJTULAOH-LHZXLZLDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m2n</td>
      <td>DB08303</td>
      <td>(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide</td>
      <td>CUMKMTBOHBENJI-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB12295</td>
      <td>Evodenoson</td>
      <td>SQJXTUJMBYVDBB-RQXXJAGISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.9</td>
      <td>6m3m</td>
      <td>DB07741</td>
      <td>4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE</td>
      <td>VPNYXOTTXAXSIH-SXYSDOLCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01562</td>
      <td>1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine</td>
      <td>BVURVTVDNWSNFN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB04432</td>
      <td>ZK-805623</td>
      <td>ZXIHYCYAQUQHSG-UHFFFAOYSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07148</td>
      <td>(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one</td>
      <td>HPAFVLDARQIHPU-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB11712</td>
      <td>Tezacaftor</td>
      <td>MJUVRTYWUMPBTR-MRXNPFEDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB08930</td>
      <td>Dolutegravir</td>
      <td>RHWKPHLQXYSBKR-BMIGLBTASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB11577</td>
      <td>Indigotindisulfonic Acid</td>
      <td>CFZXDJWFRVEWSR-BUHFOSPRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11511</td>
      <td>Difloxacin</td>
      <td>NOCJXYPHIIZEHN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB12009</td>
      <td>GW-406381</td>
      <td>NXMZBNYLCVTRGB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB06865</td>
      <td>6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID</td>
      <td>ZSRRBAKATXAISL-LMNJBCLMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06908</td>
      <td>(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID</td>
      <td>PAWOPJKHTZCKMT-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14889</td>
      <td>Derazantinib</td>
      <td>KPJDVVCDVBFRMU-AREMUKBSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03181</td>
      <td>2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione</td>
      <td>RXQAVKWRCZYGMV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB02684</td>
      <td>5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine</td>
      <td>FTSDEWPMACCNGN-YTMOPEAISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB13215</td>
      <td>Sulfobromophthalein</td>
      <td>OHTXTCNTQJFRIG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB14678</td>
      <td>Norethindrone enanthate</td>
      <td>APTGJECXMIKIET-WOSSHHRXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB11791</td>
      <td>Capmatinib</td>
      <td>LIOLIMKSCNQPLV-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07254</td>
      <td>N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</td>
      <td>KQGTYXRWSIBDOZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB05913</td>
      <td>OSI-930</td>
      <td>FGTCROZDHDSNIO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11864</td>
      <td>Preladenant</td>
      <td>DTYWJKSSUANMHD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB05936</td>
      <td>CVT-6883</td>
      <td>KOYXXLLNCXWUNF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB15106</td>
      <td>Surufatinib</td>
      <td>TTZSNFLLYPYKIL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08861</td>
      <td>DPDPE</td>
      <td>MCMMCRYPQBNCPH-WMIMKTLMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12399</td>
      <td>Polmacoxib</td>
      <td>IJWPAFMIFNSIGD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB01933</td>
      <td>7-Hydroxystaurosporine</td>
      <td>PBCZSGKMGDDXIJ-HQCWYSJUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07369</td>
      <td>N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide</td>
      <td>YMJLSOJLEXWATP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB06741</td>
      <td>Gavestinel</td>
      <td>WZBNEZWCNKUOSM-VOTSOKGWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00656</td>
      <td>Trazodone</td>
      <td>PHLBKPHSAVXXEF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB09268</td>
      <td>Picosulfuric acid</td>
      <td>UJIDKYTZIQTXPM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11656</td>
      <td>Rebamipide</td>
      <td>ALLWOAVDORUJLA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06849</td>
      <td>1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine</td>
      <td>RQWYWHUKHYFIPB-VQHVLOKHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07753</td>
      <td>3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID</td>
      <td>VCEFNMHMLWBFNV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08095</td>
      <td>3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA</td>
      <td>ZWYFTKPEHRQCCW-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07179</td>
      <td>3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide</td>
      <td>DXUJQXZHHGJMFM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07180</td>
      <td>5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide</td>
      <td>FIRPCWHHIWFKCD-GHXNOFRVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13919</td>
      <td>Candesartan</td>
      <td>HTQMVQVXFRQIKW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07181</td>
      <td>4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</td>
      <td>JYKFWUXBFJJDTP-HXUWFJFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB01254</td>
      <td>Dasatinib</td>
      <td>ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12167</td>
      <td>LY-3023414</td>
      <td>ACCFLVVUVBJNGT-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00554</td>
      <td>Piroxicam</td>
      <td>QYSPLQLAKJAUJT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04865</td>
      <td>Omacetaxine mepesuccinate</td>
      <td>HYFHYPWGAURHIV-JFIAXGOJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB14769</td>
      <td>Pamiparib</td>
      <td>DENYZIUJOTUUNY-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13930</td>
      <td>Ulixertinib</td>
      <td>KSERXGMCDHOLSS-LJQANCHMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB12064</td>
      <td>BMS-777607</td>
      <td>VNBRGSXVFBYQNN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13024</td>
      <td>MK-8245</td>
      <td>UJEAABFSXKCSGI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03788</td>
      <td>GC-24</td>
      <td>JYHIGYLGYNCMGI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB15431</td>
      <td>M-2698</td>
      <td>HXAUJHZZPCBFPN-QGZVFWFLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB06747</td>
      <td>ginkgolide-M</td>
      <td>KDKROYXEHCYLJQ-FJFAJXJPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07193</td>
      <td>(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</td>
      <td>HJJAYSSCWGUPKO-ABAIWWIYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13939</td>
      <td>RAD-140</td>
      <td>XMBUPPIEVAFYHO-KPZWWZAWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11893</td>
      <td>Avagacestat</td>
      <td>XEAOPVUAMONVLA-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11263</td>
      <td>Polydatin</td>
      <td>HSTZMXCBWJGKHG-CUYWLFDKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07203</td>
      <td>6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE</td>
      <td>OUEGMEMDEAOAEG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08971</td>
      <td>Fluocortolone</td>
      <td>GAKMQHDJQHZUTJ-ULHLPKEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11732</td>
      <td>Lasmiditan</td>
      <td>XEDHVZKDSYZQBF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01196</td>
      <td>Estramustine</td>
      <td>FRPJXPJMRWBBIH-RBRWEJTLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01120</td>
      <td>Gliclazide</td>
      <td>BOVGTQGAOIONJV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB09383</td>
      <td>Meprednisone</td>
      <td>PIDANAQULIKBQS-RNUIGHNZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14914</td>
      <td>Flortaucipir F-18</td>
      <td>GETAAWDSFUCLBS-SJPDSGJFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08092</td>
      <td>3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide</td>
      <td>VMLSXFMXUNVCSK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07154</td>
      <td>(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE</td>
      <td>SWKGZJAAGSVROJ-MWLCHTKSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB07326</td>
      <td>6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</td>
      <td>FEGRQUWSKADGSP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB08389</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UPTQSRGSSJRBKJ-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00611</td>
      <td>Butorphanol</td>
      <td>IFKLAQQSCNILHL-PWRODBHTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01041</td>
      <td>Thalidomide</td>
      <td>UEJJHQNACJXSKW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14569</td>
      <td>Tedizolid</td>
      <td>XFALPSLJIHVRKE-GFCCVEGCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00605</td>
      <td>Sulindac</td>
      <td>MLKXDPUZXIRXEP-MFOYZWKCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06771</td>
      <td>Besifloxacin</td>
      <td>QFFGVLORLPOAEC-SNVBAGLBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00604</td>
      <td>Cisapride</td>
      <td>DCSUBABJRXZOMT-IRLDBZIGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB14844</td>
      <td>ONC-201</td>
      <td>VLULRUCCHYVXOH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13778</td>
      <td>Cefazedone</td>
      <td>VTLCNEGVSVJLDN-MLGOLLRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14545</td>
      <td>Hydrocortisone succinate</td>
      <td>VWQWXZAWFPZJDA-CGVGKPPMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB13927</td>
      <td>anle138b</td>
      <td>RCQIIBJSUWYYFU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13806</td>
      <td>Linopirdine</td>
      <td>YEJCDKJIEMIWRQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11507</td>
      <td>Cloprostenol</td>
      <td>VJGGHXVGBSZVMZ-QIZQQNKQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB11971</td>
      <td>Vilaprisan</td>
      <td>JUFWQQVHQFDUOD-ANRPBIDPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14854</td>
      <td>TC-6987</td>
      <td>UAKZGMMGIMKFMV-RBUKOAKNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14821</td>
      <td>Macozinone</td>
      <td>BJDZBXGJNBMCAV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12745</td>
      <td>GSK-690693</td>
      <td>KGPGFQWBCSZGEL-ZDUSSCGKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB06755</td>
      <td>Beta carotene</td>
      <td>OENHQHLEOONYIE-JLTXGRSLSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB08058</td>
      <td>4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one</td>
      <td>HGEPGGJUGUMFHT-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08927</td>
      <td>Amperozide</td>
      <td>NNAIYOXJNVGUOM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12149</td>
      <td>S-3304</td>
      <td>YWCLDDLVLSQGSZ-JOCHJYFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12066</td>
      <td>Orteronel</td>
      <td>OZPFIJIOIVJZMN-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00589</td>
      <td>Lisuride</td>
      <td>BKRGVLQUQGGVSM-KBXCAEBGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB13490</td>
      <td>Hidrosmin</td>
      <td>XYFLWVOTXWXNAM-WTNNCJBMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB14726</td>
      <td>Dabigatran</td>
      <td>YBSJFWOBGCMAKL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08022</td>
      <td>(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile</td>
      <td>RCYPVQCPYKNSTG-OAHLLOKOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00408</td>
      <td>Loxapine</td>
      <td>XJGVXQDUIWGIRW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB06744</td>
      <td>ginkgolide-B</td>
      <td>SQOJOAFXDQDRGF-MMQTXUMRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07325</td>
      <td>N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE</td>
      <td>VCOKUBHAJVTVNG-FMIVXFBMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12379</td>
      <td>Indirubin</td>
      <td>CRDNMYFJWFXOCH-BUHFOSPRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08822</td>
      <td>Azilsartan medoxomil</td>
      <td>QJFSABGVXDWMIW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08903</td>
      <td>Bedaquiline</td>
      <td>QUIJNHUBAXPXFS-XLJNKUFUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB11529</td>
      <td>Melengestrol</td>
      <td>OKHAOBQKCCIRLO-IBVJIVQJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB11759</td>
      <td>Pevonedistat</td>
      <td>MPUQHZXIXSTTDU-QXGSTGNESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12180</td>
      <td>Apitolisib</td>
      <td>YOVVNQKCSKSHKT-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB15219</td>
      <td>Tomivosertib</td>
      <td>HKTBYUWLRDZAJK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08950</td>
      <td>Indoramin</td>
      <td>JXZZEXZZKAWDSP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB06306</td>
      <td>Onalespib</td>
      <td>IFRGXKKQHBVPCQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08975</td>
      <td>Florantyrone</td>
      <td>QOBAOSCOLAGPKI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB07022</td>
      <td>3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate</td>
      <td>PXERBGNIBOFZOW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB09047</td>
      <td>Finafloxacin</td>
      <td>FYMHQCNFKNMJAV-HOTGVXAUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB06721</td>
      <td>Gimatecan</td>
      <td>UIVFUQKYVFCEKJ-OPTOVBNMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07882</td>
      <td>4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID</td>
      <td>VFIZFTGABDUGCF-UPVHCHBVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB08042</td>
      <td>N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>FLXGQDHYCWXTAI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12185</td>
      <td>Exatecan</td>
      <td>ZVYVPGLRVWUPMP-FYSMJZIKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12339</td>
      <td>Radezolid</td>
      <td>BTTNOGHPGJANSW-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13135</td>
      <td>AGN-201904</td>
      <td>PPCGSVWOZKNPCX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14652</td>
      <td>Clocortolone acetate</td>
      <td>ARPLCFGLEYFDCN-CDACMRRYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB08124</td>
      <td>3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>FTQYGMLRLRXBPT-IDUWFGFVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04875</td>
      <td>Pralnacasan</td>
      <td>CXAGHAZMQSCAKJ-WAHHBDPQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB06717</td>
      <td>Fosaprepitant</td>
      <td>BARDROPHSZEBKC-OITMNORJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06959</td>
      <td>(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine</td>
      <td>BUCZDJYEOAQTHL-KEKNWZKVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11519</td>
      <td>Fluprostenol</td>
      <td>WWSWYXNVCBLWNZ-QIZQQNKQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12939</td>
      <td>Nikkomycin Z</td>
      <td>WWJFFVUVFNBJTN-VHDFTHOZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08867</td>
      <td>Ulipristal</td>
      <td>HKDLNTKNLJPAIY-WKWWZUSTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08927</td>
      <td>Amperozide</td>
      <td>NNAIYOXJNVGUOM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12371</td>
      <td>Siponimod</td>
      <td>KIHYPELVXPAIDH-HNSNBQBZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13308</td>
      <td>Oxametacin</td>
      <td>AJRNYCDWNITGHF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08970</td>
      <td>Fluprednidene</td>
      <td>YVHXHNGGPURVOS-SBTDHBFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB11775</td>
      <td>PF-03758309</td>
      <td>AYCPARAPKDAOEN-LJQANCHMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13223</td>
      <td>Fluocortin</td>
      <td>PUWHHWCHAVXSIG-NCLPIGKXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07140</td>
      <td>5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>JPENSYBRTSIYGO-AWEZNQCLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13708</td>
      <td>Fenquizone</td>
      <td>DBDTUXMDTSTPQZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06985</td>
      <td>2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid</td>
      <td>MEAQCLPMSVEOQF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB00598</td>
      <td>Labetalol</td>
      <td>SGUAFYQXFOLMHL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14766</td>
      <td>Etrasimod</td>
      <td>MVGWUTBTXDYMND-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07142</td>
      <td>5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>ATFDKOLABYIYCC-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB13403</td>
      <td>Oxypertine</td>
      <td>XCWPUUGSGHNIDZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01588</td>
      <td>Prazepam</td>
      <td>MWQCHHACWWAQLJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB02220</td>
      <td>AL7089A</td>
      <td>RMOXCYSVWCHXII-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB14770</td>
      <td>Lanraplenib</td>
      <td>XCIGZBVOUQVIPI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12937</td>
      <td>Quercetin-3'-O-phosphate</td>
      <td>UWJBYNLLMAPJMM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB01946</td>
      <td>3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione</td>
      <td>UQHKJRCFSLMWIA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB15424</td>
      <td>Bfpet F-18</td>
      <td>QWPLCHDPESWJRN-FNNGWQQSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12204</td>
      <td>Terbogrel</td>
      <td>XUTLOCQNGLJNSA-RGVLZGJSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12949</td>
      <td>PF-03382792</td>
      <td>AGMOFKKOVMRGAK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00956</td>
      <td>Hydrocodone</td>
      <td>LLPOLZWFYMWNKH-CMKMFDCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07008</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE</td>
      <td>XPXGYINSBORUMM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB15393</td>
      <td>Telatinib</td>
      <td>QFCXANHHBCGMAS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB04971</td>
      <td>Reglitazar</td>
      <td>QBQLYIISSRXYKL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB06745</td>
      <td>ginkgolide-C</td>
      <td>AMOGMTLMADGEOQ-DTDWCABLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06741</td>
      <td>Gavestinel</td>
      <td>WZBNEZWCNKUOSM-VOTSOKGWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB09168</td>
      <td>4-Phenylfentanyl</td>
      <td>BXCJXJLHYMWMQU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB07253</td>
      <td>N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</td>
      <td>QTFCKBFCXDAZIU-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB12127</td>
      <td>Sultamicillin</td>
      <td>OPYGFNJSCUDTBT-PMLPCWDUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07838</td>
      <td>(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE</td>
      <td>ZTWBCEZQPRYIGY-ZROIWOOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08042</td>
      <td>N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>FLXGQDHYCWXTAI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00301</td>
      <td>Flucloxacillin</td>
      <td>UIOFUWFRIANQPC-JKIFEVAISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12218</td>
      <td>AZD-5363</td>
      <td>JDUBGYFRJFOXQC-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07063</td>
      <td>{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID</td>
      <td>KYHVTMFADJNSGS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB12185</td>
      <td>Exatecan</td>
      <td>ZVYVPGLRVWUPMP-FYSMJZIKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>1r42</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB06346</td>
      <td>Fiboflapon</td>
      <td>DFQGDHBGRSTTHX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB02155</td>
      <td>Balanol Analog 8</td>
      <td>XVLMXAUKCDSMMW-YXLARRHKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB06847</td>
      <td>5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>YYCPXVRHQUEVAW-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12404</td>
      <td>Remimazolam</td>
      <td>CYHWMBVXXDIZNZ-KRWDZBQOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06983</td>
      <td>(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol</td>
      <td>RBLKWWBHDUBPFN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06959</td>
      <td>(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine</td>
      <td>BUCZDJYEOAQTHL-KEKNWZKVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB13533</td>
      <td>Methylestrenolone</td>
      <td>ZXSWTMLNIIZPET-ZOFHRBRSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB12186</td>
      <td>SRT-2104</td>
      <td>LAMQVIQMVKWXOC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12812</td>
      <td>Palomid 529</td>
      <td>YEAHTLOYHVWAKW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12426</td>
      <td>Bitopertin</td>
      <td>YUUGYIUSCYNSQR-LBPRGKRZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06933</td>
      <td>N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide</td>
      <td>GJTCKUKIFXWJKG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB15291</td>
      <td>BMS-986142</td>
      <td>ZRYMMWAJAFUANM-INIZCTEOSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14649</td>
      <td>Dexamethasone acetate</td>
      <td>AKUJBENLRBOFTD-RPRRAYFGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB01177</td>
      <td>Idarubicin</td>
      <td>XDXDZDZNSLXDNA-TZNDIEGXSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00875</td>
      <td>Flupentixol</td>
      <td>NJMYODHXAKYRHW-DVZOWYKESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08281</td>
      <td>O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate</td>
      <td>BDVAWAILQCYMQE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB09050</td>
      <td>Ceftolozane</td>
      <td>JHFNIHVVXRKLEF-DCZLAGFPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12888</td>
      <td>Ezutromid</td>
      <td>KSGCNXAZROJSNW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB09371</td>
      <td>Norethynodrel</td>
      <td>ICTXHFFSOAJUMG-SLHNCBLASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB09073</td>
      <td>Palbociclib</td>
      <td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01098</td>
      <td>Rosuvastatin</td>
      <td>BPRHUIZQVSMCRT-VEUZHWNKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04942</td>
      <td>Tamibarotene</td>
      <td>MUTNCGKQJGXKEM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB13129</td>
      <td>Trimegestone</td>
      <td>JUNDJWOLDSCTFK-MTZCLOFQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB11742</td>
      <td>Ebastine</td>
      <td>MJJALKDDGIKVBE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07043</td>
      <td>7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide</td>
      <td>CKLCIJCZOIDJQU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08011</td>
      <td>(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DXIHOIDYHQSQKJ-HMMYKYKNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04764</td>
      <td>[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</td>
      <td>CCLHROFBSWWOQO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00844</td>
      <td>Nalbuphine</td>
      <td>NETZHAKZCGBWSS-CEDHKZHLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB06334</td>
      <td>Tucidinostat</td>
      <td>SZMJVTADHFNAIS-BJMVGYQFSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12597</td>
      <td>ABL-001</td>
      <td>VOVZXURTCKPRDQ-CQSZACIVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11853</td>
      <td>Relugolix</td>
      <td>AOMXMOCNKJTRQP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07872</td>
      <td>5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide</td>
      <td>IYGIXVNAMZPBDK-CQSZACIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB15222</td>
      <td>GS-6620</td>
      <td>YAAQYJCOIFNMKX-RSTNYOGXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB06844</td>
      <td>4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE</td>
      <td>MBXKBJLIESPLIK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB07216</td>
      <td>(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE</td>
      <td>ZMGCFGGMTCMSDP-QHCPKHFHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08749</td>
      <td>3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</td>
      <td>KTRFBFMYAJOXLG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB06409</td>
      <td>Morphine glucuronide</td>
      <td>GNJCUHZOSOYIEC-GAROZEBRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB07845</td>
      <td>2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide</td>
      <td>VGYXXQRDIVRILX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB11971</td>
      <td>Vilaprisan</td>
      <td>JUFWQQVHQFDUOD-ANRPBIDPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11619</td>
      <td>Gestrinone</td>
      <td>BJJXHLWLUDYTGC-ANULTFPQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03325</td>
      <td>Tyrosyladenylate</td>
      <td>MJZAZMKENKZBAJ-QTOWJTHWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11263</td>
      <td>Polydatin</td>
      <td>HSTZMXCBWJGKHG-CUYWLFDKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB12756</td>
      <td>TAK-901</td>
      <td>WKDACQVEJIVHMZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB09053</td>
      <td>Ibrutinib</td>
      <td>XYFPWWZEPKGCCK-GOSISDBHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB15013</td>
      <td>TAK-243</td>
      <td>KJDAGXLMHXUAGV-DGWLBADLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08239</td>
      <td>(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE</td>
      <td>NKLVBHMAIMEVEH-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB15224</td>
      <td>Lisavanbulin</td>
      <td>NIPZLALJRAHABJ-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07294</td>
      <td>3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid</td>
      <td>AANFHDFOMFRLLR-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12046</td>
      <td>Atopaxar</td>
      <td>QWKAUGRRIXBIPO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01339</td>
      <td>Vecuronium</td>
      <td>BGSZAXLLHYERSY-XQIGCQGXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01234</td>
      <td>Dexamethasone</td>
      <td>UREBDLICKHMUKA-CXSFZGCWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07253</td>
      <td>N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</td>
      <td>QTFCKBFCXDAZIU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12041</td>
      <td>Mapracorat</td>
      <td>VJGFOYBQOIPQFY-XMMPIXPASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07215</td>
      <td>2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID</td>
      <td>ILUPZUOBHCUBKB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB15242</td>
      <td>MK-0533</td>
      <td>STWITCBWQHTJFJ-XMMPIXPASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB13828</td>
      <td>Cyfluthrin</td>
      <td>QQODLKZGRKWIFG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12022</td>
      <td>Evatanepag</td>
      <td>WOHRHWDYFNWPNG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB00203</td>
      <td>Sildenafil</td>
      <td>BNRNXUUZRGQAQC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13653</td>
      <td>Lorcainide</td>
      <td>XHOJAWVAWFHGHL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12417</td>
      <td>Anagliptin</td>
      <td>LDXYBEHACFJIEL-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03268</td>
      <td>RU82197</td>
      <td>WKTQBTSOHBKBRW-VMPREFPWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01453</td>
      <td>Beta-hydroxyfentanyl</td>
      <td>JEFVHLMGRUJLET-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB02732</td>
      <td>Nicotinamide Adenine Dinucleotide Acetone Adduct</td>
      <td>SGHBFOOIAAJJMI-YDKVLQLQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07486</td>
      <td>3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline</td>
      <td>KLSZVPNVFKKIRD-FNORWQNLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB13371</td>
      <td>Difenpiramide</td>
      <td>PWHROYKAGRUWDQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB14914</td>
      <td>Flortaucipir F-18</td>
      <td>GETAAWDSFUCLBS-SJPDSGJFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07467</td>
      <td>4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide</td>
      <td>NDDAHWYSQHTHNT-JTQLQIEISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB14917</td>
      <td>Ceralasertib</td>
      <td>DTTJKLNXNZAVSM-JYCIKRDWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12082</td>
      <td>Vesnarinone</td>
      <td>ZVNYJIZDIRKMBF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB12571</td>
      <td>Rimacalib</td>
      <td>MYTIJGWONQOOLC-HNNXBMFYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB13552</td>
      <td>Trifluperidol</td>
      <td>GPMXUUPHFNMNDH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB03719</td>
      <td>N-Ethyl-5'-Carboxamido Adenosine</td>
      <td>JADDQZYHOWSFJD-BMYQGPEFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11794</td>
      <td>Berzosertib</td>
      <td>JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB12558</td>
      <td>AEE-788</td>
      <td>OONFNUWBHFSNBT-HXUWFJFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB15033</td>
      <td>Flortaucipir</td>
      <td>GETAAWDSFUCLBS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12114</td>
      <td>Poziotinib</td>
      <td>LPFWVDIFUFFKJU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07616</td>
      <td>4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid</td>
      <td>LKZZDHKJFDTYCH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB12799</td>
      <td>Laniquidar</td>
      <td>TULGGJGJQXESOO-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB04690</td>
      <td>Camptothecin</td>
      <td>VSJKWCGYPAHWDS-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB01830</td>
      <td>{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid</td>
      <td>SPSGYTWOIGAABK-DQEYMECFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07815</td>
      <td>GIBBERELLIN A4</td>
      <td>RSQSQJNRHICNNH-NFMPGMCNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB02009</td>
      <td>L-756,423</td>
      <td>AOMZDQMIOCTPQP-QHQMVRJISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB13520</td>
      <td>Metergoline</td>
      <td>WZHJKEUHNJHDLS-QTGUNEKASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB12020</td>
      <td>Tecovirimat</td>
      <td>CSKDFZIMJXRJGH-VWLPUNTISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12434</td>
      <td>Steviolbioside</td>
      <td>OMHUCGDTACNQEX-OSHKXICASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB07430</td>
      <td>(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one</td>
      <td>CMWRPDHVGMHLSZ-GFCCVEGCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13767</td>
      <td>Vorozole</td>
      <td>XLMPPFTZALNBFS-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB01328</td>
      <td>Cefonicid</td>
      <td>DYAIAHUQIPBDIP-AXAPSJFSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB01337</td>
      <td>Pancuronium</td>
      <td>GVEAYVLWDAFXET-XGHATYIMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB13710</td>
      <td>Metenolone</td>
      <td>ANJQEDFWRSLVBR-VHUDCFPWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB11965</td>
      <td>SJG-136</td>
      <td>RWZVMMQNDHPRQD-SFTDATJTSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11778</td>
      <td>Danusertib</td>
      <td>XKFTZKGMDDZMJI-HSZRJFAPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB14768</td>
      <td>PF-06459988</td>
      <td>ODMXWZROLKITMS-RISCZKNCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11990</td>
      <td>MK-0812</td>
      <td>UNVWTBOGMHPKJM-CWKRKGSWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07878</td>
      <td>N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE</td>
      <td>OEHUTYXPQSSKAK-RVLLMHTFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11778</td>
      <td>Danusertib</td>
      <td>XKFTZKGMDDZMJI-HSZRJFAPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12115</td>
      <td>AZD-9164</td>
      <td>FNYFFCOCVNTJCD-NNMXADRKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB08731</td>
      <td>2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>GPOKTQCDBPECSS-MRXNPFEDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB12480</td>
      <td>Betulinic Acid</td>
      <td>QGJZLNKBHJESQX-FZFNOLFKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11963</td>
      <td>Dacomitinib</td>
      <td>LVXJQMNHJWSHET-AATRIKPKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04429</td>
      <td>4'-Hydroxyflavanone</td>
      <td>ZLHVIYHWWQYJID-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12116</td>
      <td>Epigallocatechin gallate</td>
      <td>WMBWREPUVVBILR-WIYYLYMNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB13606</td>
      <td>Phenazocine</td>
      <td>ZQHYKVKNPWDQSL-KNXBSLHKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB06673</td>
      <td>Almorexant</td>
      <td>DKMACHNQISHMDN-RPLLCQBOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB06237</td>
      <td>Avanafil</td>
      <td>WEAJZXNPAWBCOA-INIZCTEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB03672</td>
      <td>9-N-Phenylmethylamino-Tacrine</td>
      <td>JYJAEHAURXXPSD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB07629</td>
      <td>N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-DLBZAZTESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11992</td>
      <td>Omarigliptin</td>
      <td>MKMPWKUAHLTIBJ-ISTRZQFTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08309</td>
      <td>3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL</td>
      <td>AMFGILNPFBVREA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13506</td>
      <td>Carfecillin</td>
      <td>NZDASSHFKWDBBU-KVMCETHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB13491</td>
      <td>Fluperolone</td>
      <td>SLVCCRYLKTYUQP-DVTGEIKXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07578</td>
      <td>3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE</td>
      <td>WUOLYUKMMRCXGH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB04542</td>
      <td>3'-Azido-3'-Deoxythymidine-5'-Diphosphate</td>
      <td>QOYVAFWJURKBJG-XLPZGREQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07193</td>
      <td>(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</td>
      <td>HJJAYSSCWGUPKO-ABAIWWIYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB14906</td>
      <td>Adafosbuvir</td>
      <td>NIJYGVDQZBBONK-SEUXLIJBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB06497</td>
      <td>Aplaviroc</td>
      <td>GWNOTCOIYUNTQP-FQLXRVMXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08355</td>
      <td>1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid</td>
      <td>ZOBRPBVIEUWYJR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07651</td>
      <td>N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE</td>
      <td>KPMMESISHWWXNM-ROUUACIJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13631</td>
      <td>Methoserpidine</td>
      <td>ULBNWNUHGJLQHO-VKMIBBQISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB15092</td>
      <td>LY-2624803</td>
      <td>UEFWDVMEDFCHGW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB08820</td>
      <td>Ivacaftor</td>
      <td>PURKAOJPTOLRMP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08361</td>
      <td>2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide</td>
      <td>NZNTWOVDIXCHHS-LSDHHAIUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB08448</td>
      <td>(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol</td>
      <td>PCBWLKUEKANDCL-INIZCTEOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB06976</td>
      <td>1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA</td>
      <td>IWOOJEZSDPRYAZ-WFASDCNBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08339</td>
      <td>6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE</td>
      <td>ZIQFYVPVJZEOFS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB04574</td>
      <td>Estrone sulfate</td>
      <td>JKKFKPJIXZFSSB-CBZIJGRNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12055</td>
      <td>MK-0767</td>
      <td>ORZMUVMQJPGFOM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB13212</td>
      <td>Phenolsulfonphthalein</td>
      <td>BELBBZDIHDAJOR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB08389</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UPTQSRGSSJRBKJ-LJQANCHMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12290</td>
      <td>Puerarin</td>
      <td>HKEAFJYKMMKDOR-VPRICQMDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB13158</td>
      <td>Clobetasone</td>
      <td>XXIFVOHLGBURIG-OZCCCYNHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11922</td>
      <td>Danirixin</td>
      <td>NGYNBSHYFOFVLS-LBPRGKRZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03446</td>
      <td>N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide</td>
      <td>FSMWGHKWKYCPKE-QTVCLEQKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11939</td>
      <td>Henagliflozin</td>
      <td>HYTPDMFFHVZBOR-VNXMGFANSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB12743</td>
      <td>Z-160</td>
      <td>VCPMZDWBEWTGNW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07811</td>
      <td>N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide</td>
      <td>UBVTVSINEVHYSY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07289</td>
      <td>5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>XEQPGVUGYAUMSA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB12015</td>
      <td>Alpelisib</td>
      <td>STUWGJZDJHPWGZ-LBPRGKRZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12135</td>
      <td>Elubrixin</td>
      <td>YQYFEGTYCUQBEI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB04578</td>
      <td>(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide</td>
      <td>OEVYDSSAPNIURZ-AEFFLSMTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB04610</td>
      <td>7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin</td>
      <td>XMFJTCGUDFSWSW-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01327</td>
      <td>Cefazolin</td>
      <td>MLYYVTUWGNIJIB-BXKDBHETSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB15099</td>
      <td>GW-468816</td>
      <td>XDKRVNKVAKCFGW-WXWBBQJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12270</td>
      <td>Losmapimod</td>
      <td>KKYABQBFGDZVNQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07360</td>
      <td>1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>JJHXPDTVQKWKHA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12379</td>
      <td>Indirubin</td>
      <td>CRDNMYFJWFXOCH-BUHFOSPRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB15048</td>
      <td>Licogliflozin</td>
      <td>XFJAMQQAAMJFGB-ZQGJOIPISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07559</td>
      <td>(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide</td>
      <td>DDSLONVJHZPSBB-UVTDQMKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB15106</td>
      <td>Surufatinib</td>
      <td>TTZSNFLLYPYKIL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11832</td>
      <td>Crenolanib</td>
      <td>DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08382</td>
      <td>Gosogliptin</td>
      <td>QWEWGXUTRTXFRF-KBPBESRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03672</td>
      <td>9-N-Phenylmethylamino-Tacrine</td>
      <td>JYJAEHAURXXPSD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11766</td>
      <td>AZD-1305</td>
      <td>BLLNYXOLLAVTRF-HDICACEKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01252</td>
      <td>Mitiglinide</td>
      <td>WPGGHFDDFPHPOB-BBWFWOEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB15261</td>
      <td>Butafenacil</td>
      <td>JEDYYFXHPAIBGR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB06817</td>
      <td>Raltegravir</td>
      <td>CZFFBEXEKNGXKS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB00932</td>
      <td>Tipranavir</td>
      <td>SUJUHGSWHZTSEU-FYBSXPHGSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB15156</td>
      <td>ABT-072</td>
      <td>XMZSTQYSBYEENY-RMKNXTFCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB14025</td>
      <td>Clinafloxacin</td>
      <td>QGPKADBNRMWEQR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB04086</td>
      <td>2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside</td>
      <td>WFVCNOHOODVBQK-IUBYCILNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12128</td>
      <td>Ulimorelin</td>
      <td>WGYPAJVJMXQXTR-ABNZCKJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11743</td>
      <td>Ipatasertib</td>
      <td>GRZXWCHAXNAUHY-NSISKUIASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12149</td>
      <td>S-3304</td>
      <td>YWCLDDLVLSQGSZ-JOCHJYFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB15003</td>
      <td>PF-06700841</td>
      <td>BUWBRTXGQRBBHG-MJBXVCDLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07537</td>
      <td>N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide</td>
      <td>CLEGTVIMOPPIBR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB12002</td>
      <td>AZD-4818</td>
      <td>HVTUHSABWJPWNK-SFHVURJKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04463</td>
      <td>3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol</td>
      <td>CPLGZXQPPYRNRC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07688</td>
      <td>4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>RPJIMTALCNCQLV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB13252</td>
      <td>Tropatepine</td>
      <td>JOQKFRLFXDPXHX-HDICACEKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01319</td>
      <td>Fosamprenavir</td>
      <td>MLBVMOWEQCZNCC-OEMFJLHTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB13308</td>
      <td>Oxametacin</td>
      <td>AJRNYCDWNITGHF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB15393</td>
      <td>Telatinib</td>
      <td>QFCXANHHBCGMAS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12064</td>
      <td>BMS-777607</td>
      <td>VNBRGSXVFBYQNN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11855</td>
      <td>Revefenacin</td>
      <td>FYDWDCIFZSGNBU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07568</td>
      <td>(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE</td>
      <td>ADRNPUSZBRQDBG-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07563</td>
      <td>1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine</td>
      <td>GCJSOJRPNOWSEH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB15099</td>
      <td>GW-468816</td>
      <td>XDKRVNKVAKCFGW-WXWBBQJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12066</td>
      <td>Orteronel</td>
      <td>OZPFIJIOIVJZMN-SFHVURJKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12082</td>
      <td>Vesnarinone</td>
      <td>ZVNYJIZDIRKMBF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08123</td>
      <td>N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE</td>
      <td>GEWPSTLKJDIUHW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB15346</td>
      <td>GLPG-1205</td>
      <td>IRBAWVGZNJIROV-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11732</td>
      <td>Lasmiditan</td>
      <td>XEDHVZKDSYZQBF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01348</td>
      <td>Spirapril</td>
      <td>HRWCVUIFMSZDJS-SZMVWBNQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03823</td>
      <td>Epigallocatechin</td>
      <td>XMOCLSLCDHWDHP-IUODEOHRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14944</td>
      <td>Tarloxotinib</td>
      <td>MUJMYVFVAWFUJL-SNAWJCMRSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12574</td>
      <td>LY-295501</td>
      <td>VAMFSFIPDOODFH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01195</td>
      <td>Flecainide</td>
      <td>DJBNUMBKLMJRSA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB15346</td>
      <td>GLPG-1205</td>
      <td>IRBAWVGZNJIROV-SFHVURJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB11870</td>
      <td>RG-4733</td>
      <td>OJPLJFIFUQPSJR-INIZCTEOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB15047</td>
      <td>BMS-919373</td>
      <td>XGKULQQVQWCASY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12128</td>
      <td>Ulimorelin</td>
      <td>WGYPAJVJMXQXTR-ABNZCKJZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12206</td>
      <td>N-6022</td>
      <td>YVPGZQLRPAGKLA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB14718</td>
      <td>Pyrazolam</td>
      <td>BGRWSFIQQPVEML-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB14538</td>
      <td>Hydrocortisone aceponate</td>
      <td>MFBMYAOAMQLLPK-FZNHGJLXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11909</td>
      <td>Varespladib</td>
      <td>BHLXTPHDSZUFHR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12567</td>
      <td>Camicinal</td>
      <td>RZKDEGZIFSJVNA-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01532</td>
      <td>??-Methylacetylfentanyl</td>
      <td>OKTLVZBUKMRPLL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07267</td>
      <td>2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine</td>
      <td>JONFDFIXMPXTRH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB05327</td>
      <td>Ranirestat</td>
      <td>QCVNMNYRNIMDKV-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB01026</td>
      <td>Ketoconazole</td>
      <td>XMAYWYJOQHXEEK-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB15446</td>
      <td>Vidofludimus</td>
      <td>XPRDUGXOWVXZLL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB01459</td>
      <td>Bezitramide</td>
      <td>FLKWNFFCSSJANB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB04378</td>
      <td>3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide</td>
      <td>APJAEXGNDLFGPD-AWCRTANDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07296</td>
      <td>(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE</td>
      <td>PLGHLEBIWUQEPR-PDGQHHTCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11816</td>
      <td>Omecamtiv Mecarbil</td>
      <td>RFUBTTPMWSKEIW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB11901</td>
      <td>Apalutamide</td>
      <td>HJBWBFZLDZWPHF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB15229</td>
      <td>CNV-2197944</td>
      <td>BLFJGFDZMABYMY-ZDUSSCGKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07704</td>
      <td>6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</td>
      <td>UKRVQKUVWNDGMN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB11950</td>
      <td>Teneligliptin</td>
      <td>WGRQANOPCQRCME-PMACEKPBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07268</td>
      <td>2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE</td>
      <td>QHPKKGUGRGRSGA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB14790</td>
      <td>BPN-14770</td>
      <td>KRRGWHSEDYQKDQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB15197</td>
      <td>RSV-604</td>
      <td>MTPVBMVUENFFLL-HXUWFJFHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00377</td>
      <td>Palonosetron</td>
      <td>CPZBLNMUGSZIPR-NVXWUHKLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07008</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE</td>
      <td>XPXGYINSBORUMM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB14054</td>
      <td>Asiatic acid</td>
      <td>JXSVIVRDWWRQRT-UYDOISQJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB12055</td>
      <td>MK-0767</td>
      <td>ORZMUVMQJPGFOM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00445</td>
      <td>Epirubicin</td>
      <td>AOJJSUZBOXZQNB-VTZDEGQISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB09070</td>
      <td>Tibolone</td>
      <td>WZDGZWOAQTVYBX-XOINTXKNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07969</td>
      <td>3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol</td>
      <td>QNCYYRHIUFGGJX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB14541</td>
      <td>Hydrocortisone cypionate</td>
      <td>DLVOSEUFIRPIRM-KAQKJVHQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB13616</td>
      <td>Melagatran</td>
      <td>DKWNMCUOEDMMIN-PKOBYXMFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11371</td>
      <td>Alfaxalone</td>
      <td>DUHUCHOQIDJXAT-OLVMNOGESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06257</td>
      <td>HE-2200</td>
      <td>OEVZKEVBDIDVOI-YSZCXEEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11736</td>
      <td>PF-00489791</td>
      <td>ZUHZNKJIJDAJFD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01426</td>
      <td>Ajmaline</td>
      <td>CJDRUOGAGYHKKD-HEFSZTOGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB14761</td>
      <td>Remdesivir</td>
      <td>RWWYLEGWBNMMLJ-YSOARWBDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01554</td>
      <td>Bolandiol</td>
      <td>CMXKUJNZWYTFJN-XFUVECHXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08572</td>
      <td>4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE</td>
      <td>YBKLJTXDSBEVRV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB14770</td>
      <td>Lanraplenib</td>
      <td>XCIGZBVOUQVIPI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12806</td>
      <td>GSK-1004723</td>
      <td>YANGEESWIGIKOP-UUWRZZSWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB06745</td>
      <td>ginkgolide-C</td>
      <td>AMOGMTLMADGEOQ-DTDWCABLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08597</td>
      <td>6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine</td>
      <td>XHBVYDAKJHETMP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB12808</td>
      <td>Trifarotene</td>
      <td>MFBCDACCJCDGBA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB09075</td>
      <td>Edoxaban</td>
      <td>HGVDHZBSSITLCT-JLJPHGGASA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB02790</td>
      <td>Phenyl-Uridine-5'-Diphosphate</td>
      <td>ZHUWBKDWWGKIEN-FMKGYKFTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01053</td>
      <td>Benzylpenicillin</td>
      <td>JGSARLDLIJGVTE-MBNYWOFBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11478</td>
      <td>Zeranol</td>
      <td>DWTTZBARDOXEAM-GXTWGEPZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB11457</td>
      <td>Rotenone</td>
      <td>JUVIOZPCNVVQFO-HBGVWJBISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11759</td>
      <td>Pevonedistat</td>
      <td>MPUQHZXIXSTTDU-QXGSTGNESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB01289</td>
      <td>Glisoxepide</td>
      <td>ZKUDBRCEOBOWLF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB14929</td>
      <td>Elsulfavirine</td>
      <td>ULTDEARCBRNRGR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07405</td>
      <td>1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</td>
      <td>GIZYIOOBBUHOBS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04842</td>
      <td>Fluspirilene</td>
      <td>QOYHHIBFXOOADH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00247</td>
      <td>Methysergide</td>
      <td>KPJZHOPZRAFDTN-NQUBZZJWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01536</td>
      <td>Androstenedione</td>
      <td>AEMFNILZOJDQLW-QAGGRKNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB14221</td>
      <td>Beclomethasone 17-monopropionate</td>
      <td>OHYGPBKGZGRQKT-XGQKBEPLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB06879</td>
      <td>5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE</td>
      <td>QCFIRACCCDFXIP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07311</td>
      <td>18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE</td>
      <td>JRSWWYITYIOHOP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07686</td>
      <td>4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>VPOGRVWIIVMWRI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB06888</td>
      <td>(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</td>
      <td>KBLPHMRCKHFBJB-OLZOCXBDSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12477</td>
      <td>Perfluoro tert-butylcyclohexane</td>
      <td>VLTXBOGHSBHSAC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03572</td>
      <td>FR230513</td>
      <td>URGFTPMACWKJKU-OAHLLOKOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB07778</td>
      <td>FAMOXADONE</td>
      <td>PCCSBWNGDMYFCW-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08498</td>
      <td>(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>OVSAMUIBGQSLDC-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB08861</td>
      <td>DPDPE</td>
      <td>MCMMCRYPQBNCPH-WMIMKTLMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB15424</td>
      <td>Bfpet F-18</td>
      <td>QWPLCHDPESWJRN-FNNGWQQSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB15431</td>
      <td>M-2698</td>
      <td>HXAUJHZZPCBFPN-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08499</td>
      <td>N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide</td>
      <td>DQXBKUVWJSZHSI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08500</td>
      <td>(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</td>
      <td>ZCJBDRSKHARECB-PYTCMNEWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11893</td>
      <td>Avagacestat</td>
      <td>XEAOPVUAMONVLA-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB15141</td>
      <td>Deutivacaftor</td>
      <td>PURKAOJPTOLRMP-ASMGOKTBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07015</td>
      <td>(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine</td>
      <td>XDSKICAQKGYYJF-OLZOCXBDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB13764</td>
      <td>Monoxerutin</td>
      <td>MBHXKZDTQCSVPM-BDAFLREQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07665</td>
      <td>N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>STHCHQXQLDMISY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB11903</td>
      <td>GW842166</td>
      <td>TWQYWUXBZHPIIV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB14673</td>
      <td>Flurandrenolide acetate</td>
      <td>AUDPKCCPWYXNEV-XTLNBZDDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB06137</td>
      <td>KX-01</td>
      <td>HUNGUWOZPQBXGX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07268</td>
      <td>2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE</td>
      <td>QHPKKGUGRGRSGA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01497</td>
      <td>Etorphine</td>
      <td>CAHCBJPUTCKATP-HBDRVVKHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB03593</td>
      <td>N7-Methyl-Guanosine-5'-Monophosphate</td>
      <td>AOKQNZVJJXPUQA-KQYNXXCUSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07649</td>
      <td>(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol</td>
      <td>DIGGNILBPCEZIV-CVEARBPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07624</td>
      <td>1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide</td>
      <td>YJFULAYRAKPBCY-DYVFJYSZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07761</td>
      <td>(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol</td>
      <td>ZVSBKYYVBCKDBO-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB12461</td>
      <td>GLPG-0492</td>
      <td>VAJGULUVTFDTAS-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB13919</td>
      <td>Candesartan</td>
      <td>HTQMVQVXFRQIKW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07649</td>
      <td>(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol</td>
      <td>DIGGNILBPCEZIV-CVEARBPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB14859</td>
      <td>Fosifloxuridine nafalbenamide</td>
      <td>BIOWRMNRHMERIO-ZVAHOJSLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB08499</td>
      <td>N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide</td>
      <td>DQXBKUVWJSZHSI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08495</td>
      <td>4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>VXONTEUOQXFJJS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB14679</td>
      <td>Quingestanol acetate</td>
      <td>FLGJKPPXEKYCBY-AKCFYGDASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01503</td>
      <td>1-Androstenediol</td>
      <td>RZFGPAMUAXASRE-YSZCXEEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04186</td>
      <td>N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea</td>
      <td>KLVYMYQTRZCMLE-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB11818</td>
      <td>Retosiban</td>
      <td>PLVGDGRBPMVYPB-FDUHJNRSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB01763</td>
      <td>7-thionicotinamide-adenine-dinucleotide phosphate</td>
      <td>OJNFDOAQUXJWED-NNYOXOHSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07181</td>
      <td>4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide</td>
      <td>JYKFWUXBFJJDTP-HXUWFJFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01531</td>
      <td>Desomorphine</td>
      <td>LNNWVNGFPYWNQE-GMIGKAJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11721</td>
      <td>Mitoglitazone</td>
      <td>IRNJSRAGRIZIHD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB11853</td>
      <td>Relugolix</td>
      <td>AOMXMOCNKJTRQP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB15241</td>
      <td>Methylsamidorphan</td>
      <td>ATCVVCBJNHXIEX-ZAHKBLQYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04859</td>
      <td>Zanapezil</td>
      <td>PMBLXLOXUGVTGB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB06410</td>
      <td>Doxercalciferol</td>
      <td>HKXBNHCUPKIYDM-CGMHZMFXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00231</td>
      <td>Temazepam</td>
      <td>SEQDDYPDSLOBDC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB14569</td>
      <td>Tedizolid</td>
      <td>XFALPSLJIHVRKE-GFCCVEGCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07265</td>
      <td>3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID</td>
      <td>JDARUOOLJCFUOY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07396</td>
      <td>1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid</td>
      <td>KAJJGOCSAXKXBD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB14801</td>
      <td>Lanifibranor</td>
      <td>OQDQIFQRNZIEEJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08519</td>
      <td>N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>SQQAPOSROFWHIB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11793</td>
      <td>Niraparib</td>
      <td>PCHKPVIQAHNQLW-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB06995</td>
      <td>N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide</td>
      <td>USBSTVPJNQLYEM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB07675</td>
      <td>(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID</td>
      <td>WMUIIGVAWPWQAW-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB00137</td>
      <td>Lutein</td>
      <td>KBPHJBAIARWVSC-RGZFRNHPSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB15033</td>
      <td>Flortaucipir</td>
      <td>GETAAWDSFUCLBS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB13857</td>
      <td>Demegestone</td>
      <td>JWAHBTQSSMYISL-MHTWAQMVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13651</td>
      <td>Lorajmine</td>
      <td>LAHDERDHXJFFJU-ZWNKPRIXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB15028</td>
      <td>MK-1064</td>
      <td>CKTWQGHVNRYNCM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB05263</td>
      <td>Caprospinol</td>
      <td>VMOZFSWFUBLCNN-AAPULDEBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB13490</td>
      <td>Hidrosmin</td>
      <td>XYFLWVOTXWXNAM-WTNNCJBMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB11890</td>
      <td>Cilengitide</td>
      <td>AMLYAMJWYAIXIA-VWNVYAMZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB08504</td>
      <td>6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM</td>
      <td>ZNHVIJAGMFQGMS-IHPCNDPISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04850</td>
      <td>Posizolid</td>
      <td>HBUJYEUPIIJJOS-PBHICJAKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB08351</td>
      <td>N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</td>
      <td>MNEXDVSJIUQQRH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07891</td>
      <td>4-{[(14beta,17alpha)-3-hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid</td>
      <td>YJPIDPAGJSWWBE-FNIAAEIWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB00186</td>
      <td>Lorazepam</td>
      <td>DIWRORZWFLOCLC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07274</td>
      <td>N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide</td>
      <td>ZATGFXTWDKIEKC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB14581</td>
      <td>CPI-1205</td>
      <td>HPODOLXTMDHLLC-QGZVFWFLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB03207</td>
      <td>2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid</td>
      <td>BNVMUDXGABBWGP-OAQYLSRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB13050</td>
      <td>Tirilazad</td>
      <td>RBKASMJPSJDQKY-RBFSKHHSSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB15418</td>
      <td>AZD-9977</td>
      <td>MBKYLPOPYYLTNW-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12665</td>
      <td>Isoquercetin</td>
      <td>OVSQVDMCBVZWGM-QSOFNFLRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12812</td>
      <td>Palomid 529</td>
      <td>YEAHTLOYHVWAKW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB01691</td>
      <td>Indole Naphthyridinone</td>
      <td>VAZMNDXVXVUKFY-JXMROGBWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB07326</td>
      <td>6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</td>
      <td>FEGRQUWSKADGSP-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13016</td>
      <td>LY-2300559</td>
      <td>DWQVYDLTPMGYNE-DEOSSOPVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB02115</td>
      <td>Daidzin</td>
      <td>KYQZWONCHDNPDP-QNDFHXLGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07192</td>
      <td>(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE</td>
      <td>MVPIURCUINFSAB-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13939</td>
      <td>RAD-140</td>
      <td>XMBUPPIEVAFYHO-KPZWWZAWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB02046</td>
      <td>N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid</td>
      <td>WHPKSASOSKNDPY-PKOBYXMFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB04044</td>
      <td>4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>NAQUAVBNIYTIIS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB07189</td>
      <td>(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid</td>
      <td>BFZXMIUWGSTUAL-ZSOKXDGFSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB14054</td>
      <td>Asiatic acid</td>
      <td>JXSVIVRDWWRQRT-UYDOISQJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07242</td>
      <td>(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile</td>
      <td>XGUIMGJMQKZRGM-LLVKDONJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB14066</td>
      <td>Tetrandrine</td>
      <td>WVTKBKWTSCPRNU-KYJUHHDHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04098</td>
      <td>Balanol</td>
      <td>XYUFCXJZFZPEJD-PGRDOPGGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB01765</td>
      <td>(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid</td>
      <td>INSBKYCYLCEBOD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06755</td>
      <td>Beta carotene</td>
      <td>OENHQHLEOONYIE-JLTXGRSLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB01200</td>
      <td>Bromocriptine</td>
      <td>OZVBMTJYIDMWIL-AYFBDAFISA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB14069</td>
      <td>ONT-093</td>
      <td>RSJCLODJSVZNQA-BQYQJAHWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06732</td>
      <td>beta-Naphthoflavone</td>
      <td>OUGIDAPQYNCXRA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07268</td>
      <td>2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE</td>
      <td>QHPKKGUGRGRSGA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB01876</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methanone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB02177</td>
      <td>1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine</td>
      <td>GKGJFUXSTSUKPB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08865</td>
      <td>Crizotinib</td>
      <td>KTEIFNKAUNYNJU-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07206</td>
      <td>6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE</td>
      <td>OSHSZKRWKLQZBV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6wiq</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13941</td>
      <td>Piperaquine</td>
      <td>UCRHFBCYFMIWHC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB15023</td>
      <td>BMS-791826</td>
      <td>DZBKAUMYTFPJIS-QHCPKHFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07005</td>
      <td>D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide</td>
      <td>VZFTWWJAUZOJDH-MOPGFXCFSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07008</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE</td>
      <td>XPXGYINSBORUMM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB01690</td>
      <td>Bis(Adenosine)-5'-Triphosphate</td>
      <td>QCICUPZZLIQAPA-XPWFQUROSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07065</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>AHPKUZJCNHGFQA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB02673</td>
      <td>(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium</td>
      <td>VLGAHTYYCHWLNI-BHRZLAGCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07070</td>
      <td>(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid</td>
      <td>BDLLIPYDNFENMY-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07000</td>
      <td>N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide</td>
      <td>ILXJWLWSYAWJKZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07074</td>
      <td>6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER</td>
      <td>OUBRALHIKGRAMA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB06985</td>
      <td>2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid</td>
      <td>MEAQCLPMSVEOQF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00643</td>
      <td>Mebendazole</td>
      <td>OPXLLQIJSORQAM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6wiq</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB00699</td>
      <td>Nicergoline</td>
      <td>YSEXMKHXIOCEJA-FVFQAYNVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06985</td>
      <td>2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid</td>
      <td>MEAQCLPMSVEOQF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07125</td>
      <td>4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid</td>
      <td>KKZYGUVAFJCULH-CYBMUJFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13022</td>
      <td>LY-2874455</td>
      <td>GKJCVYLDJWTWQU-CXLRFSCWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12897</td>
      <td>MK-7622</td>
      <td>JUVQLZBJFOGEEO-GOTSBHOMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB13991</td>
      <td>Pipequaline</td>
      <td>AMEWZCMTSIONOX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06972</td>
      <td>7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile</td>
      <td>TZCXQSNBTXDAJG-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08491</td>
      <td>N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE</td>
      <td>ARIRIZBKMKMEBD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06953</td>
      <td>2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE</td>
      <td>JVWHVGIRXILXMU-XMMPIXPASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08248</td>
      <td>3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE</td>
      <td>BKDUVKJYBJDZQW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07039</td>
      <td>(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide</td>
      <td>RXSZCFAPSDTELY-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08836</td>
      <td>Temocapril</td>
      <td>FIQOFIRCTOWDOW-BJLQDIEVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07300</td>
      <td>2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine</td>
      <td>QSSGYSRUMIOURP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07511</td>
      <td>4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile</td>
      <td>MVYDBJXCIFMINH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12122</td>
      <td>Figopitant</td>
      <td>HUTHJVYJUPXHDF-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12658</td>
      <td>AFN-1252</td>
      <td>QXTWSUQCXCWEHF-JXMROGBWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB12659</td>
      <td>SJ-733</td>
      <td>VKCPFWKTFZAOTO-LEWJYISDSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12093</td>
      <td>Tetrahydropalmatine</td>
      <td>AEQDJSLRWYMAQI-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00543</td>
      <td>Amoxapine</td>
      <td>QWGDMFLQWFTERH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB03962</td>
      <td>Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate</td>
      <td>MDKMTCCUJSRQGW-NAJQWHGHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB02152</td>
      <td>K-252a</td>
      <td>KOZFSFOOLUUIGY-SOLYNIJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB02338</td>
      <td>Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate</td>
      <td>ACFIXJIJDZMPPO-NNYOXOHSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB01471</td>
      <td>Bolasterone</td>
      <td>IVFYLRMMHVYGJH-VLOLGRDOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07249</td>
      <td>N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine</td>
      <td>QHIMVPIOWKYPSO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB15177</td>
      <td>VX-659</td>
      <td>IGEOJNMYRZUKIK-IBGZPJMESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07643</td>
      <td>5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>XVLUVRFYGVJKGJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07126</td>
      <td>O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE</td>
      <td>OWXORKPNCHJYOF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07649</td>
      <td>(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol</td>
      <td>DIGGNILBPCEZIV-CVEARBPZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07651</td>
      <td>N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE</td>
      <td>KPMMESISHWWXNM-ROUUACIJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07665</td>
      <td>N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>STHCHQXQLDMISY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07676</td>
      <td>3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one</td>
      <td>CKLAPOFDFZKCPB-LBPRGKRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06440</td>
      <td>Ravuconazole</td>
      <td>OPAHEYNNJWPQPX-RCDICMHDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12796</td>
      <td>MRX-I</td>
      <td>SULYVXZZUMRQAX-NSHDSACASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03124</td>
      <td>5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid</td>
      <td>LBAHOXPDTNUYCX-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB00637</td>
      <td>Astemizole</td>
      <td>GXDALQBWZGODGZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12131</td>
      <td>Vinpocetine</td>
      <td>DDNCQMVWWZOMLN-IRLDBZIGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB14097</td>
      <td>13-cis-12-(3'-Carboxyphenyl)retinoic acid</td>
      <td>XKKDQOHDTASHCE-PAZAWXFKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07311</td>
      <td>18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE</td>
      <td>JRSWWYITYIOHOP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6wiq</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB03970</td>
      <td>(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid</td>
      <td>CHNMLWCTGYMVFH-GFCCVEGCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB14127</td>
      <td>Sacubitrilat</td>
      <td>DOBNVUFHFMVMDB-BEFAXECRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04044</td>
      <td>4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>NAQUAVBNIYTIIS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06660</td>
      <td>Saredutant</td>
      <td>PGKXDIMONUAMFR-AREMUKBSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB02194</td>
      <td>8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>ULLMMKZQNNBLRN-SANMLTNESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB13019</td>
      <td>Henatinib</td>
      <td>MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12158</td>
      <td>Filorexant</td>
      <td>NPFDWHQSDBWQLH-QZTJIDSGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04645</td>
      <td>5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID</td>
      <td>NJJIFGCFUDDBSP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13114</td>
      <td>Amitriptylinoxide</td>
      <td>ZPMKQFOGINQDAM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00567</td>
      <td>Cephalexin</td>
      <td>ZAIPMKNFIOOWCQ-UEKVPHQBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12148</td>
      <td>Menatetrenone</td>
      <td>DKHGMERMDICWDU-GHDNBGIDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06624</td>
      <td>Taranabant</td>
      <td>QLYKJCMUNUWAGO-GAJHUEQPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12598</td>
      <td>Nafamostat</td>
      <td>MQQNFDZXWVTQEH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00564</td>
      <td>Carbamazepine</td>
      <td>FFGPTBGBLSHEPO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06590</td>
      <td>Ceftaroline fosamil</td>
      <td>ZCCUWMICIWSJIX-NQJJCJBVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04348</td>
      <td>Taurocholic Acid</td>
      <td>WBWWGRHZICKQGZ-HZAMXZRMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB14209</td>
      <td>Trandolaprilat</td>
      <td>AHYHTSYNOHNUSH-HXFGRODQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB14859</td>
      <td>Fosifloxuridine nafalbenamide</td>
      <td>BIOWRMNRHMERIO-ZVAHOJSLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB14214</td>
      <td>Rose bengal lactone</td>
      <td>IICCLYANAQEHCI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB06581</td>
      <td>Bevirimat</td>
      <td>YJEJKUQEXFSVCJ-WRFMNRASSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB14512</td>
      <td>Mometasone furoate</td>
      <td>WOFMFGQZHJDGCX-ZULDAHANSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06605</td>
      <td>Apixaban</td>
      <td>QNZCBYKSOIHPEH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6wiq</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB02319</td>
      <td>5,6-Dihydroxy-Nadp</td>
      <td>LRAVAOPKUBJONV-IVCJQJMGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB07039</td>
      <td>(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide</td>
      <td>RXSZCFAPSDTELY-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB14210</td>
      <td>Moexiprilat</td>
      <td>CMPAGYDKASJORH-YSSFQJQWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB01572</td>
      <td>Methyl-1-testosterone</td>
      <td>JRNSSSJKIGAFCT-YDSAWKJFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08979</td>
      <td>Fenspiride</td>
      <td>FVNFBBAOMBJTST-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07154</td>
      <td>(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE</td>
      <td>SWKGZJAAGSVROJ-MWLCHTKSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB06209</td>
      <td>Prasugrel</td>
      <td>DTGLZDAWLRGWQN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB13471</td>
      <td>Nalfurafine</td>
      <td>XGZZHZMWIXFATA-UEZBDDGYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12512</td>
      <td>Verucerfont</td>
      <td>VKHVAUKFLBBZFJ-SFHVURJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12382</td>
      <td>R-306465</td>
      <td>MUTBJZVSRNUIHA-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB14218</td>
      <td>Telotristat</td>
      <td>NCLGDOBQAWBXRA-PGRDOPGGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB08861</td>
      <td>DPDPE</td>
      <td>MCMMCRYPQBNCPH-WMIMKTLMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB08037</td>
      <td>(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide</td>
      <td>MYBGWENAVMIGMM-GIFXNVAJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13856</td>
      <td>Fluclorolone</td>
      <td>VTWKPILBIUBMDS-OTJLYDAYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08055</td>
      <td>N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine</td>
      <td>NNBICZMPIJMWGC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00704</td>
      <td>Naltrexone</td>
      <td>DQCKKXVULJGBQN-XFWGSAIBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07778</td>
      <td>FAMOXADONE</td>
      <td>PCCSBWNGDMYFCW-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04154</td>
      <td>N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</td>
      <td>ALBWBHNFOJJMCV-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07274</td>
      <td>N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide</td>
      <td>ZATGFXTWDKIEKC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB01357</td>
      <td>Mestranol</td>
      <td>IMSSROKUHAOUJS-MJCUULBUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB02255</td>
      <td>GM6001</td>
      <td>NITYDPDXAAFEIT-DYVFJYSZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07263</td>
      <td>[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid</td>
      <td>WDTMVBQZDFMOIK-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB03084</td>
      <td>Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</td>
      <td>XCTKFTOEAKJMII-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB13556</td>
      <td>Sulfamazone</td>
      <td>BGLHAKAJGYLSOX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB06460</td>
      <td>Enrasentan</td>
      <td>GLCKXJLCYIJMRB-UPRLRBBYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB14661</td>
      <td>Loperamide oxide</td>
      <td>KXVSBTJVTUVNPM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13490</td>
      <td>Hidrosmin</td>
      <td>XYFLWVOTXWXNAM-WTNNCJBMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07382</td>
      <td>N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine</td>
      <td>WJNBSTLIALIIEW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12507</td>
      <td>Atecegatran metoxil</td>
      <td>XSNMGLZVFNDDPW-ZWKOTPCHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB03696</td>
      <td>Lanosterol</td>
      <td>CAHGCLMLTWQZNJ-BQNIITSRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB05416</td>
      <td>Cardarine</td>
      <td>YDBLKRPLXZNVNB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12622</td>
      <td>Lupeol</td>
      <td>MQYXUWHLBZFQQO-QGTGJCAVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07471</td>
      <td>5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE</td>
      <td>UHCHLTQBLNUYRT-GFCCVEGCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB14773</td>
      <td>Lifirafenib</td>
      <td>NGFFVZQXSRKHBM-FKBYEOEOSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB01212</td>
      <td>Ceftriaxone</td>
      <td>VAAUVRVFOQPIGI-SPQHTLEESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB01047</td>
      <td>Fluocinonide</td>
      <td>WJOHZNCJWYWUJD-IUGZLZTKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB05611</td>
      <td>Apilimod</td>
      <td>HSKAZIJJKRAJAV-KOEQRZSOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB05454</td>
      <td>Paliroden</td>
      <td>CNEWKIDCGDXBDE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07468</td>
      <td>(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</td>
      <td>NJBBBRZNBVLTRZ-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB03496</td>
      <td>Alvocidib</td>
      <td>BIIVYFLTOXDAOV-YVEFUNNKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB14866</td>
      <td>Amcasertib</td>
      <td>QDWKGEFGLQMDAM-ULJHMMPZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07643</td>
      <td>5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>XVLUVRFYGVJKGJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08444</td>
      <td>3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile</td>
      <td>YYGZQXRLQMFHDH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB14790</td>
      <td>BPN-14770</td>
      <td>KRRGWHSEDYQKDQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB14774</td>
      <td>Balipodect</td>
      <td>KVHRYLNQDWXAGI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB03351</td>
      <td>Sri-9439</td>
      <td>KMSATRJZEXNGDP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB05423</td>
      <td>ORG-34517</td>
      <td>DFELGYQKEOCHOA-BZAFBGKRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12654</td>
      <td>GSK-376501</td>
      <td>OIDYMQICWGYEDR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB06134</td>
      <td>SNS-314</td>
      <td>FAYAUAZLLLJJGH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB01089</td>
      <td>Deserpidine</td>
      <td>CVBMAZKKCSYWQR-WCGOZPBSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB13042</td>
      <td>Fenoverine</td>
      <td>UBAJTZKNDCEGKL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00712</td>
      <td>Flurbiprofen</td>
      <td>SYTBZMRGLBWNTM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB03069</td>
      <td>Cytidine-5'-Diphospho-Beta-D-Xylose</td>
      <td>NWSKPSPTJOAICE-OCIMBMBZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB03041</td>
      <td>UDP-alpha-D-glucuronic acid</td>
      <td>HDYANYHVCAPMJV-LXQIFKJMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB06472</td>
      <td>Fradafiban</td>
      <td>IKZACQMAVUIGPY-HOTGVXAUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07113</td>
      <td>(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE</td>
      <td>KHZQOXQOUCGGGA-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07076</td>
      <td>6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</td>
      <td>FWTQOPWAMQXIMI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12720</td>
      <td>Nivocasan</td>
      <td>VYFGDLGHHBUDTQ-ZLGUVYLKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00670</td>
      <td>Pirenzepine</td>
      <td>RMHMFHUVIITRHF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB07193</td>
      <td>(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine</td>
      <td>HJJAYSSCWGUPKO-ABAIWWIYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB15197</td>
      <td>RSV-604</td>
      <td>MTPVBMVUENFFLL-HXUWFJFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB02573</td>
      <td>2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate</td>
      <td>LYWWDKIADIGKTH-IDMWBNCISA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB15197</td>
      <td>RSV-604</td>
      <td>MTPVBMVUENFFLL-HXUWFJFHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03213</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-P</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13155</td>
      <td>Esculin</td>
      <td>XHCADAYNFIFUHF-TVKJYDDYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB02510</td>
      <td>'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine</td>
      <td>LKVJEMXWEODCAY-JVEUSOJLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB01501</td>
      <td>Difenoxin</td>
      <td>UFIVBRCCIRTJTN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03202</td>
      <td>2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide</td>
      <td>JWSWTHSJMGVOKE-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB11775</td>
      <td>PF-03758309</td>
      <td>AYCPARAPKDAOEN-LJQANCHMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08916</td>
      <td>Afatinib</td>
      <td>ULXXDDBFHOBEHA-CWDCEQMOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13138</td>
      <td>Neladenoson bialanate</td>
      <td>WESNEIGKOAXSGX-VXKWHMMOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12301</td>
      <td>Doravirine</td>
      <td>ZIAOVIPSKUPPQW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB01661</td>
      <td>1-(5-phospho-D-ribosyl)-ATP</td>
      <td>RKNHJBVBFHDXGR-MRUDJCSFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12985</td>
      <td>Quisinostat</td>
      <td>PAWIYAYFNXQGAP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08489</td>
      <td>N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE</td>
      <td>GCBPAPVOMPJQHK-NQIIRXRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00656</td>
      <td>Trazodone</td>
      <td>PHLBKPHSAVXXEF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03181</td>
      <td>2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione</td>
      <td>RXQAVKWRCZYGMV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12949</td>
      <td>PF-03382792</td>
      <td>AGMOFKKOVMRGAK-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB07072</td>
      <td>(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</td>
      <td>CNKRZILQBKJWDS-WMFXKJRFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB13094</td>
      <td>Pruvanserin</td>
      <td>AQRLDDAFYYAIJP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06397</td>
      <td>Nicaraven</td>
      <td>KTXBOOWDLPUROC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB01669</td>
      <td>Virginiamycin M1</td>
      <td>DAIKHDNSXMZDCU-FQTGFAPKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB06858</td>
      <td>N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide</td>
      <td>MMLOIDMSBRJZAE-FQEVSTJZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07703</td>
      <td>(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE</td>
      <td>NZUJVBSYQXETNF-PQWITYJESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB11793</td>
      <td>Niraparib</td>
      <td>PCHKPVIQAHNQLW-CQSZACIVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07229</td>
      <td>3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE</td>
      <td>MINVOLKUPZPDNX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12672</td>
      <td>Icaritin</td>
      <td>TUUXBSASAQJECY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12673</td>
      <td>ATX-914</td>
      <td>ALANRBCCCQEPFZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB06579</td>
      <td>Adipiplon</td>
      <td>UAMAIHOEGLEXSV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB02873</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One</td>
      <td>YAWZIQKDHQIHOS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB02834</td>
      <td>IDD552</td>
      <td>ZCAGEXZTORJQDZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03235</td>
      <td>N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide</td>
      <td>UEIGEWJJVQHIAX-MKQKURRLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB02827</td>
      <td>7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</td>
      <td>MDYIGSPVMWSFEZ-JTQLQIEISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB06629</td>
      <td>Zibotentan</td>
      <td>FJHHZXWJVIEFGJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB07430</td>
      <td>(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one</td>
      <td>CMWRPDHVGMHLSZ-GFCCVEGCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12371</td>
      <td>Siponimod</td>
      <td>KIHYPELVXPAIDH-HNSNBQBZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB02804</td>
      <td>A-98881</td>
      <td>PMBZSBGCSQGJAQ-GRKNLSHJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB01501</td>
      <td>Difenoxin</td>
      <td>UFIVBRCCIRTJTN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07607</td>
      <td>4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>RXDZANYWRNIAOR-HHHXNRCGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB06746</td>
      <td>ginkgolide-J</td>
      <td>LMEHVEUFNRJAAV-UKWFQYJJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08339</td>
      <td>6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE</td>
      <td>ZIQFYVPVJZEOFS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12649</td>
      <td>Ibipinabant</td>
      <td>AXJQVVLKUYCICH-OAQYLSRUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00683</td>
      <td>Midazolam</td>
      <td>DDLIGBOFAVUZHB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB06448</td>
      <td>Lonafarnib</td>
      <td>DHMTURDWPRKSOA-RUZDIDTESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB14512</td>
      <td>Mometasone furoate</td>
      <td>WOFMFGQZHJDGCX-ZULDAHANSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06622</td>
      <td>7-beta-Hydroxyepiandrosterone</td>
      <td>VFPMCLQMAUVEHD-UCPSWNCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB07608</td>
      <td>N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</td>
      <td>JDGOPNUGILVNJZ-IBGZPJMESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB01337</td>
      <td>Pancuronium</td>
      <td>GVEAYVLWDAFXET-XGHATYIMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12368</td>
      <td>AZD-3839</td>
      <td>MRXBCEQZNKUUIP-DEOSSOPVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06414</td>
      <td>Etravirine</td>
      <td>PYGWGZALEOIKDF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06412</td>
      <td>Oxymetholone</td>
      <td>ICMWWNHDUZJFDW-DHODBPELSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08656</td>
      <td>5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide</td>
      <td>UVERBUNNCOKGNZ-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB11701</td>
      <td>Amenamevir</td>
      <td>MNHNIVNAFBSLLX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08659</td>
      <td>2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide</td>
      <td>PPDLAUCFAOODER-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB04098</td>
      <td>Balanol</td>
      <td>XYUFCXJZFZPEJD-PGRDOPGGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB04461</td>
      <td>Coproporphyrinogen III</td>
      <td>NIUVHXTXUXOFEB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB02698</td>
      <td>N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid</td>
      <td>NQOOJFXBGLOGTC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB02877</td>
      <td>Arotinoid acid</td>
      <td>FOIVPCKZDPCJJY-JQIJEIRASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB04042</td>
      <td>2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol</td>
      <td>XLJNZONSWKENRP-VABIIVNOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB08498</td>
      <td>(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>OVSAMUIBGQSLDC-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB04348</td>
      <td>Taurocholic Acid</td>
      <td>WBWWGRHZICKQGZ-HZAMXZRMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08151</td>
      <td>(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol</td>
      <td>YLTDNVVQKRHCJP-RKQHYHRCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB15232</td>
      <td>Telaglenastat</td>
      <td>PRAAPINBUWJLGA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08569</td>
      <td>3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE</td>
      <td>VLPMRZSKJUTRBQ-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB05289</td>
      <td>Tarenflurbil</td>
      <td>SYTBZMRGLBWNTM-SNVBAGLBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08791</td>
      <td>1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE</td>
      <td>USLOIFPDNUDIEG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB08597</td>
      <td>6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine</td>
      <td>XHBVYDAKJHETMP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB02738</td>
      <td>Adenosine-5'-Pentaphosphate</td>
      <td>WYJWVZZCMBUPSP-KQYNXXCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07324</td>
      <td>3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE</td>
      <td>ZUJWSOPIDUWELP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB04140</td>
      <td>1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide</td>
      <td>SUSMVCKSLVPRCL-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08861</td>
      <td>DPDPE</td>
      <td>MCMMCRYPQBNCPH-WMIMKTLMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13029</td>
      <td>MK-0873</td>
      <td>JJWKQXNHYDJXKF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB06367</td>
      <td>Relacatib</td>
      <td>BWYBBMQLUKXECQ-GIVPXCGWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12938</td>
      <td>Isoxaflutole</td>
      <td>OYIKARCXOQLFHF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB15444</td>
      <td>Elexacaftor</td>
      <td>MVRHVFSOIWFBTE-INIZCTEOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08609</td>
      <td>(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide</td>
      <td>SHEIQJGQDUYUBE-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB03081</td>
      <td>Crc200 (Chiron-Behring)</td>
      <td>ZOXOKTJHZSUHRJ-XZOQPEGZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB05016</td>
      <td>Ataluren</td>
      <td>OOUGLTULBSNHNF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11853</td>
      <td>Relugolix</td>
      <td>AOMXMOCNKJTRQP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB05552</td>
      <td>TG100-115</td>
      <td>UJIAQDJKSXQLIT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08149</td>
      <td>1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine</td>
      <td>KCWPSUKJCKZEAO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13052</td>
      <td>Upamostat</td>
      <td>HUASEDVYRABWCV-NDEPHWFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06472</td>
      <td>Fradafiban</td>
      <td>IKZACQMAVUIGPY-HOTGVXAUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB14716</td>
      <td>Clonazolam</td>
      <td>XJRGLCAWBRZUFC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08463</td>
      <td>(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol</td>
      <td>HOCBJBNQIQQQGT-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11828</td>
      <td>Neratinib</td>
      <td>JWNPDZNEKVCWMY-VQHVLOKHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12805</td>
      <td>Ataciguat</td>
      <td>PQHLRGARXNPFCF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB00457</td>
      <td>Prazosin</td>
      <td>IENZQIKPVFGBNW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB11800</td>
      <td>Tivozanib</td>
      <td>SPMVMDHWKHCIDT-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12808</td>
      <td>Trifarotene</td>
      <td>MFBCDACCJCDGBA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB03126</td>
      <td>Mant-Adp</td>
      <td>QPKUEBLEGWBRHC-BFHYXJOUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08517</td>
      <td>(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one</td>
      <td>DJOJDHGQRNZXQQ-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB03397</td>
      <td>Uridine-Diphosphate-N-Acetylglucosamine</td>
      <td>LFTYTUAZOPRMMI-CFRASDGPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB14770</td>
      <td>Lanraplenib</td>
      <td>XCIGZBVOUQVIPI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12817</td>
      <td>Zoliflodacin</td>
      <td>ZSWMIFNWDQEXDT-ZESJGQACSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08549</td>
      <td>(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER</td>
      <td>MFDBNNQUDZFSES-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB08546</td>
      <td>4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE</td>
      <td>CETLUACQMGBMFH-ZALSBGIRSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB03802</td>
      <td>1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>ZGHFWBDHZZKWSI-LITSAYRRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12858</td>
      <td>LY-377604</td>
      <td>RBSGUQYXRDKPAE-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB15191</td>
      <td>MAX-40279</td>
      <td>AVIOBQFPAGEICQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB09226</td>
      <td>RP-5063</td>
      <td>PMKMNTBZJOXTJW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11681</td>
      <td>Tofimilast</td>
      <td>DHCOPPHTVOXDKU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11675</td>
      <td>Mosapride</td>
      <td>YPELFRMCRYSPKZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB03325</td>
      <td>Tyrosyladenylate</td>
      <td>MJZAZMKENKZBAJ-QTOWJTHWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB03311</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide</td>
      <td>SXKBTDJJEQQEGE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB09330</td>
      <td>Osimertinib</td>
      <td>DUYJMQONPNNFPI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB14902</td>
      <td>JHU-75528 C-11</td>
      <td>MCNQUWLLXZZZAC-BJUDXGSMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB15157</td>
      <td>Voruciclib</td>
      <td>MRPGRAKIAJJGMM-OCCSQVGLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07360</td>
      <td>1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>JJHXPDTVQKWKHA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00353</td>
      <td>Methylergometrine</td>
      <td>UNBRKDKAWYKMIV-QWQRMKEZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04575</td>
      <td>Quinestrol</td>
      <td>PWZUUYSISTUNDW-VAFBSOEGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11385</td>
      <td>Cefalonium</td>
      <td>FMZXNVLFJHCSAF-DNVCBOLYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13004</td>
      <td>Mavoglurant</td>
      <td>ZFPZEYHRWGMJCV-ZHALLVOQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB08822</td>
      <td>Azilsartan medoxomil</td>
      <td>QJFSABGVXDWMIW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11430</td>
      <td>Monensin</td>
      <td>GAOZTHIDHYLHMS-KEOBGNEYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12910</td>
      <td>Emicerfont</td>
      <td>JFHJGXQFESYQGY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11485</td>
      <td>Ceftiofur</td>
      <td>ZBHXIWJRIFEVQY-IHMPYVIRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB03367</td>
      <td>PF-00356231</td>
      <td>VMTJQZUZINLEKC-JOCHJYFZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB04623</td>
      <td>2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>CGBRFCVAMLJVEA-ZGURCIGKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11521</td>
      <td>Imidocarb</td>
      <td>SCEVFJUWLLRELN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB03325</td>
      <td>Tyrosyladenylate</td>
      <td>MJZAZMKENKZBAJ-QTOWJTHWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB08772</td>
      <td>3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID</td>
      <td>BCSVCWVQNOXFGL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB02834</td>
      <td>IDD552</td>
      <td>ZCAGEXZTORJQDZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12885</td>
      <td>CF-102</td>
      <td>IPSYPUKKXMNCNQ-PFHKOEEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB14946</td>
      <td>PCO-371</td>
      <td>LDZJFVOUPUFOHX-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06519</td>
      <td>Edaglitazone</td>
      <td>HAAXAFNSRADSMK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB04023</td>
      <td>Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester</td>
      <td>DNBSDUDYNPJVCN-ZXTXFPBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB02766</td>
      <td>(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium</td>
      <td>VLIGBVLLNSWVMI-MRXNPFEDSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08975</td>
      <td>Florantyrone</td>
      <td>QOBAOSCOLAGPKI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB03944</td>
      <td>5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One</td>
      <td>IZLRMTJLQCLMKF-CYBMUJFWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB03453</td>
      <td>(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester</td>
      <td>MRNGXYMKYHNMLV-PKTZIBPZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB03921</td>
      <td>4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline</td>
      <td>IBCXZJCWDGCXQT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12962</td>
      <td>CP-547632</td>
      <td>HXHAJRMTJXHJJZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB03802</td>
      <td>1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>ZGHFWBDHZZKWSI-LITSAYRRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06529</td>
      <td>Ocinaplon</td>
      <td>OQJFBUOFGHPMSR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB14882</td>
      <td>CEP-9722</td>
      <td>CTLOSZHDGZLOQE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB03632</td>
      <td>Argifin</td>
      <td>UHBHXSDKGLPPGO-HTDHLNIYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB03865</td>
      <td>6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine</td>
      <td>FEKRWNWZMOSVBX-UHFFFAOYSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB09076</td>
      <td>Umeclidinium</td>
      <td>FVTWTVQXNAJTQP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11704</td>
      <td>Adomeglivant</td>
      <td>FASLTMSUPQDLIB-MHZLTWQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB02799</td>
      <td>N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide</td>
      <td>OJBZDUMTXGGVSP-KTKRTIGZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB00984</td>
      <td>Nandrolone phenpropionate</td>
      <td>UBWXUGDQUBIEIZ-QNTYDACNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB09172</td>
      <td>Brifentanil</td>
      <td>KKMGCTVJCQYQPV-WBVHZDCISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB03723</td>
      <td>2'-Deoxy-Thymidine-Beta-L-Rhamnose</td>
      <td>ZOSQFDVXNQFKBY-CGAXJHMRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08545</td>
      <td>(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE</td>
      <td>YPTMOJMDCPUCJT-ZDUSSCGKSA-M</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00328</td>
      <td>Indometacin</td>
      <td>CGIGDMFJXJATDK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08169</td>
      <td>(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide</td>
      <td>CAGGGMPTWTUYHZ-ZCXUNETKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB09075</td>
      <td>Edoxaban</td>
      <td>HGVDHZBSSITLCT-JLJPHGGASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB05265</td>
      <td>Ecabet</td>
      <td>IWCWQNVIUXZOMJ-MISYRCLQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB04824</td>
      <td>Phenolphthalein</td>
      <td>KJFMBFZCATUALV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB05038</td>
      <td>Anatibant</td>
      <td>XUHBBTKJWIBQMY-MHZLTWQESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06202</td>
      <td>Lasofoxifene</td>
      <td>GXESHMAMLJKROZ-IAPPQJPRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB07697</td>
      <td>1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine</td>
      <td>HMGDKYUJSFVHIY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07874</td>
      <td>(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</td>
      <td>LQOCXPOKEPYGTJ-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08116</td>
      <td>(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine</td>
      <td>DEOZLEGRVHDNKC-UGKGYDQZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB04690</td>
      <td>Camptothecin</td>
      <td>VSJKWCGYPAHWDS-FQEVSTJZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06166</td>
      <td>Fosdevirine</td>
      <td>CGBYTKOSZYQOPV-CCEZBSFNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07909</td>
      <td>(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL</td>
      <td>OBWILOKKNDYPLX-HBMCJLEFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04628</td>
      <td>Allosamidin</td>
      <td>MDWNFWDBQGOKNZ-XYUDZHFQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06160</td>
      <td>Garenoxacin</td>
      <td>NJDRXTDGYFKORP-LLVKDONJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB04190</td>
      <td>Inhibitor Bea425</td>
      <td>AHAVBKNGKPWROK-UMFPTGFGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB01148</td>
      <td>Flavoxate</td>
      <td>SPIUTQOUKAMGCX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB15168</td>
      <td>Cilofexor</td>
      <td>KZSKGLFYQAYZCO-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB02197</td>
      <td>4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide</td>
      <td>NKORVPQBJCGYEC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB01108</td>
      <td>Trilostane</td>
      <td>KVJXBPDAXMEYOA-CXANFOAXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03926</td>
      <td>5-Alpha-Androstane-3-Beta,17-Alpha-Diol</td>
      <td>CBMYJHIOYJEBSB-MFXFBURESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07982</td>
      <td>2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol</td>
      <td>PVTKDXZNSUHUMO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB08192</td>
      <td>2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE</td>
      <td>HCUGCUQZFBURHR-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13083</td>
      <td>Talarozole</td>
      <td>SNFYYXUGUBUECJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07987</td>
      <td>[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER</td>
      <td>AWAKNMKLVLWIIQ-OAHLLOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12078</td>
      <td>Enobosarm</td>
      <td>JNGVJMBLXIUVRD-SFHVURJKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB15163</td>
      <td>Selatogrel</td>
      <td>FYXHWMQPCJOJCH-GMAHTHKFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03069</td>
      <td>Cytidine-5'-Diphospho-Beta-D-Xylose</td>
      <td>NWSKPSPTJOAICE-OCIMBMBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB05706</td>
      <td>13-deoxydoxorubicin</td>
      <td>RGVRUQHYQSORBY-JIGXQNLBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07839</td>
      <td>N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE</td>
      <td>VFNWTXUFNNOQHD-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00486</td>
      <td>Nabilone</td>
      <td>GECBBEABIDMGGL-RTBURBONSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13097</td>
      <td>1alpha-Hydroxyvitamin D5</td>
      <td>NWFOBODUYTUMNC-VPSCEVSQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07701</td>
      <td>1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE</td>
      <td>ADEBPBSSDYVVLD-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00525</td>
      <td>Tolnaftate</td>
      <td>FUSNMLFNXJSCDI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB01342</td>
      <td>Forasartan</td>
      <td>YONOBYIBNBCDSJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB15048</td>
      <td>Licogliflozin</td>
      <td>XFJAMQQAAMJFGB-ZQGJOIPISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12802</td>
      <td>Picropodophyllin</td>
      <td>YJGVMLPVUAXIQN-HAEOHBJNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00136</td>
      <td>Calcitriol</td>
      <td>GMRQFYUYWCNGIN-NKMMMXOESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB07743</td>
      <td>S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE</td>
      <td>VNGWUVBXUIDQTK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB01328</td>
      <td>Cefonicid</td>
      <td>DYAIAHUQIPBDIP-AXAPSJFSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06334</td>
      <td>Tucidinostat</td>
      <td>SZMJVTADHFNAIS-BJMVGYQFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB13252</td>
      <td>Tropatepine</td>
      <td>JOQKFRLFXDPXHX-HDICACEKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB13307</td>
      <td>Proscillaridin</td>
      <td>MYEJFUXQJGHEQK-ALRJYLEOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB04698</td>
      <td>N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</td>
      <td>HJWYZPGYPZNDTN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB06420</td>
      <td>Annamycin</td>
      <td>CIDNKDMVSINJCG-GKXONYSUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB01319</td>
      <td>Fosamprenavir</td>
      <td>MLBVMOWEQCZNCC-OEMFJLHTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12260</td>
      <td>Radiprodil</td>
      <td>GKGRZLGAQZPEHO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12021</td>
      <td>Dinaciclib</td>
      <td>PIMQWRZWLQKKBJ-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB06237</td>
      <td>Avanafil</td>
      <td>WEAJZXNPAWBCOA-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB01264</td>
      <td>Darunavir</td>
      <td>CJBJHOAVZSMMDJ-HEXNFIEUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB02081</td>
      <td>Bis-Benzamidine</td>
      <td>BXYGSMRTHHSAHZ-PMACEKPBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08095</td>
      <td>3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA</td>
      <td>ZWYFTKPEHRQCCW-HNNXBMFYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08001</td>
      <td>5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID</td>
      <td>DQSRCEFDWMQCCV-GQCTYLIASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB01177</td>
      <td>Idarubicin</td>
      <td>XDXDZDZNSLXDNA-TZNDIEGXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB11592</td>
      <td>Nitrocefin</td>
      <td>LHNIIDJCEODSHA-OQRUQETBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB05134</td>
      <td>Tanespimycin</td>
      <td>AYUNIORJHRXIBJ-TXHRRWQRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB04708</td>
      <td>(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>SYNSHNDQFWMLJW-YZGRCXSVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB03758</td>
      <td>Radicicol</td>
      <td>WYZWZEOGROVVHK-GTMNPGAYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08230</td>
      <td>5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE</td>
      <td>ARSRJFRKVXALTF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03037</td>
      <td>Oxidized Acetyl Dithranol</td>
      <td>IKFRFGXQHSBCQM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06140</td>
      <td>SUVN-502</td>
      <td>GWCYPEHWIZXYFZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13941</td>
      <td>Piperaquine</td>
      <td>UCRHFBCYFMIWHC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB02547</td>
      <td>Guanosine-5'-Diphosphate-Rhamnose</td>
      <td>LQEBEXMHBLQMDB-GDJBGNAASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB00713</td>
      <td>Oxacillin</td>
      <td>UWYHMGVUTGAWSP-JKIFEVAISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08268</td>
      <td>6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</td>
      <td>SPVJRTJUEVXOMS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08270</td>
      <td>N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE</td>
      <td>QPXXBNKMAHUXBB-PMACEKPBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08300</td>
      <td>1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>UOKGZPYGRJDACN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB04982</td>
      <td>Talampanel</td>
      <td>JACAAXNEHGBPOQ-LLVKDONJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB00687</td>
      <td>Fludrocortisone</td>
      <td>AAXVEMMRQDVLJB-BULBTXNYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB00680</td>
      <td>Moricizine</td>
      <td>FUBVWMNBEHXPSU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07288</td>
      <td>N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide</td>
      <td>GGPZCOONYBPZEW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB02547</td>
      <td>Guanosine-5'-Diphosphate-Rhamnose</td>
      <td>LQEBEXMHBLQMDB-GDJBGNAASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB04879</td>
      <td>Vatalanib</td>
      <td>YCOYDOIWSSHVCK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB00673</td>
      <td>Aprepitant</td>
      <td>ATALOFNDEOCMKK-OITMNORJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB00671</td>
      <td>Cefixime</td>
      <td>OKBVVJOGVLARMR-QSWIMTSFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB04623</td>
      <td>2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE</td>
      <td>CGBRFCVAMLJVEA-ZGURCIGKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB02573</td>
      <td>2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate</td>
      <td>LYWWDKIADIGKTH-IDMWBNCISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08382</td>
      <td>Gosogliptin</td>
      <td>QWEWGXUTRTXFRF-KBPBESRZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB08423</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE</td>
      <td>QKZZJXRGCHXIAI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB04834</td>
      <td>Rapacuronium</td>
      <td>HTIKWNNIPGXLGM-YLINKJIISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11865</td>
      <td>Brivanib alaninate</td>
      <td>LTEJRLHKIYCEOX-OCCSQVGLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB00834</td>
      <td>Mifepristone</td>
      <td>VKHAHZOOUSRJNA-GCNJZUOMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11978</td>
      <td>Glasdegib</td>
      <td>SFNSLLSYNZWZQG-VQIMIIECSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB14068</td>
      <td>Dexniguldipine</td>
      <td>SVJMLYUFVDMUHP-MGBGTMOVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB01289</td>
      <td>Glisoxepide</td>
      <td>ZKUDBRCEOBOWLF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB13643</td>
      <td>Loprazolam</td>
      <td>UTEFBSAVJNEPTR-RGEXLXHISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11967</td>
      <td>Binimetinib</td>
      <td>ACWZRVQXLIRSDF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB05552</td>
      <td>TG100-115</td>
      <td>UJIAQDJKSXQLIT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08051</td>
      <td>(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>XXRHRPGYYNOBHO-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB04875</td>
      <td>Pralnacasan</td>
      <td>CXAGHAZMQSCAKJ-WAHHBDPQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11963</td>
      <td>Dacomitinib</td>
      <td>LVXJQMNHJWSHET-AATRIKPKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB01678</td>
      <td>RU84687</td>
      <td>SAFPHFWYRLLBFO-NSOVKSMOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB05511</td>
      <td>Piclidenoson</td>
      <td>HUJXGQILHAUCCV-MOROJQBDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB11992</td>
      <td>Omarigliptin</td>
      <td>MKMPWKUAHLTIBJ-ISTRZQFTSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB04823</td>
      <td>Oxyphenisatin</td>
      <td>SJDACOMXKWHBOW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB05498</td>
      <td>KW-7158</td>
      <td>NAFSYPCVPLWHFY-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08073</td>
      <td>(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>YWTBGJGMTBHQTM-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB00246</td>
      <td>Ziprasidone</td>
      <td>MVWVFYHBGMAFLY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB08448</td>
      <td>(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol</td>
      <td>PCBWLKUEKANDCL-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB00923</td>
      <td>Ceforanide</td>
      <td>SLAYUXIURFNXPG-CRAIPNDOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB05412</td>
      <td>Talmapimod</td>
      <td>ZMELOYOKMZBMRB-DLBZAZTESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB04797</td>
      <td>Triazolopyridine</td>
      <td>OVCXRBARSPBVMC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB05416</td>
      <td>Cardarine</td>
      <td>YDBLKRPLXZNVNB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08138</td>
      <td>{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide</td>
      <td>BDRDBXXWQDFXEC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB08148</td>
      <td>1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine</td>
      <td>QOZMRRGNAZNWDN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB04724</td>
      <td>(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE</td>
      <td>COVPLULNDBDXTN-KYJUHHDHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04540</td>
      <td>Cholesterol</td>
      <td>HVYWMOMLDIMFJA-DPAQBDIFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB11960</td>
      <td>Carboxyamidotriazole</td>
      <td>WNRZHQBJSXRYJK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07550</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE</td>
      <td>ZIGSBBKEPNQXRG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB03213</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-P</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07578</td>
      <td>3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE</td>
      <td>WUOLYUKMMRCXGH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03572</td>
      <td>FR230513</td>
      <td>URGFTPMACWKJKU-OAHLLOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04853</td>
      <td>Binodenoson</td>
      <td>XJFMHMFFBSOEPR-DNZQAUTHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00858</td>
      <td>Drostanolone</td>
      <td>IKXILDNPCZPPRV-RFMGOVQKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB08772</td>
      <td>3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID</td>
      <td>BCSVCWVQNOXFGL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12805</td>
      <td>Ataciguat</td>
      <td>PQHLRGARXNPFCF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06280</td>
      <td>Senicapoc</td>
      <td>SCTZUZTYRMOMKT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06515</td>
      <td>Resiniferatoxin</td>
      <td>DSDNAKHZNJAGHN-MXTYGGKSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08497</td>
      <td>(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>NKBDSMREMMRFSI-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04841</td>
      <td>Flunarizine</td>
      <td>SMANXXCATUTDDT-QPJJXVBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08498</td>
      <td>(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>OVSAMUIBGQSLDC-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04839</td>
      <td>Cyproterone acetate</td>
      <td>UWFYSQMTEOIJJG-FDTZYFLXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB01289</td>
      <td>Glisoxepide</td>
      <td>ZKUDBRCEOBOWLF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB11753</td>
      <td>Rifamycin</td>
      <td>HJYYPODYNSCCOU-ODRIEIDWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04824</td>
      <td>Phenolphthalein</td>
      <td>KJFMBFZCATUALV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01767</td>
      <td>Hemi-Babim</td>
      <td>KKJYVDXDZURHMA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB00180</td>
      <td>Flunisolide</td>
      <td>XSFJVAJPIHIPKU-XWCQMRHXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB12904</td>
      <td>ZSTK-474</td>
      <td>HGVNLRPZOWWDKD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13335</td>
      <td>Pinazepam</td>
      <td>MFZOSKPPVCIFMT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB00224</td>
      <td>Indinavir</td>
      <td>CBVCZFGXHXORBI-PXQQMZJSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04867</td>
      <td>Lintitript</td>
      <td>ILNRQFBVVQUOLP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07616</td>
      <td>4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid</td>
      <td>LKZZDHKJFDTYCH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08039</td>
      <td>(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE</td>
      <td>LOGJQOUIVKBFGH-YBEGLDIGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03325</td>
      <td>Tyrosyladenylate</td>
      <td>MJZAZMKENKZBAJ-QTOWJTHWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01964</td>
      <td>AL5424</td>
      <td>ZWTSOJQGEWPWGO-NSHDSACASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03368</td>
      <td>5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione</td>
      <td>RTBMLCLTYAPKIF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB15456</td>
      <td>Vericiguat</td>
      <td>QZFHIXARHDBPBY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04942</td>
      <td>Tamibarotene</td>
      <td>MUTNCGKQJGXKEM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB02033</td>
      <td>N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide</td>
      <td>GDRNWAKVNIROCG-DEOSSOPVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03451</td>
      <td>1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3</td>
      <td>KLZOTDOJMRMLDX-YBBVPDDNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB11971</td>
      <td>Vilaprisan</td>
      <td>JUFWQQVHQFDUOD-ANRPBIDPSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08003</td>
      <td>ISOTHIAZOLIDINONE ANALOG</td>
      <td>UILYPHAKDBTKQV-UFYCRDLUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07794</td>
      <td>5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</td>
      <td>XVECMUKVOMUNLE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03490</td>
      <td>3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole</td>
      <td>NHOACLCXCKJMAK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB13048</td>
      <td>PAC-1</td>
      <td>YQNRVGJCPCNMKT-LFVJCYFKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03515</td>
      <td>Equilenin</td>
      <td>PDRGHUMCVRDZLQ-WMZOPIPTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06395</td>
      <td>Abafungin</td>
      <td>TYBHXIFFPVFXQW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00580</td>
      <td>Valdecoxib</td>
      <td>LNPDTQAFDNKSHK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB08730</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</td>
      <td>CPFBZMFUCGHBAP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04107</td>
      <td>[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester</td>
      <td>RNOYCNIZOAIUSV-LSWMGQQCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04142</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide</td>
      <td>FEYGJZKVMASWJB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB00301</td>
      <td>Flucloxacillin</td>
      <td>UIOFUWFRIANQPC-JKIFEVAISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04177</td>
      <td>4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One</td>
      <td>XZTUSOXSLKTKJQ-CESUGQOBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB02827</td>
      <td>7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</td>
      <td>MDYIGSPVMWSFEZ-JTQLQIEISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB12424</td>
      <td>MK-3207</td>
      <td>AZAANWYREOQRFB-SETSBSEESA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04201</td>
      <td>Histidyl-Adenosine Monophosphate</td>
      <td>XTFBSLZFYLGYAT-OPYVMVOTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01644</td>
      <td>3,6-dihydroxy-xanthene-9-propionic acid</td>
      <td>PFQGLFBMMPZYEU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04205</td>
      <td>Thymidine-3',5'-Diphosphate</td>
      <td>CSNCBOPUCJOHLS-XLPZGREQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08597</td>
      <td>6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine</td>
      <td>XHBVYDAKJHETMP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13104</td>
      <td>X-396</td>
      <td>ONPGOSVDVDPBCY-CQSZACIVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01976</td>
      <td>Aminoanthracene</td>
      <td>YUENFNPLGJCNRB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07855</td>
      <td>(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE</td>
      <td>CWHMAWBXRCDOEB-HNNXBMFYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB15343</td>
      <td>HM-43239</td>
      <td>FZLSDZZNPXXBBB-KDURUIRLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB15319</td>
      <td>VM4-037</td>
      <td>QGYZPMXIVNIGKA-GMAHTHKFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11409</td>
      <td>Febantel</td>
      <td>HMCCXLBXIJMERM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12732</td>
      <td>Firategrast</td>
      <td>YLFZHHDVRSYTKT-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07123</td>
      <td>N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE</td>
      <td>DVOLWKZEIDCCES-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB08520</td>
      <td>(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE</td>
      <td>VUCSBBBCFXBFFY-IBGZPJMESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB00288</td>
      <td>Amcinonide</td>
      <td>ILKJAFIWWBXGDU-MOGDOJJUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04725</td>
      <td>Licofelone</td>
      <td>UAWXGRJVZSAUSZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08816</td>
      <td>Ticagrelor</td>
      <td>OEKWJQXRCDYSHL-FNOIDJSQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB08710</td>
      <td>(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE</td>
      <td>BKZOQCGDCHOGOQ-MZLJFPOFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB12910</td>
      <td>Emicerfont</td>
      <td>JFHJGXQFESYQGY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB05835</td>
      <td>NS-3728</td>
      <td>OQRAKHDEGGGWQO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB11845</td>
      <td>Lucitanib</td>
      <td>CUDVHEFYRIWYQD-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03823</td>
      <td>Epigallocatechin</td>
      <td>XMOCLSLCDHWDHP-IUODEOHRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03830</td>
      <td>Phosphorylated Dihydropteroate</td>
      <td>DNKVHXNVVYQUDC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB04785</td>
      <td>Streptolydigin</td>
      <td>KVTPRMVXYZKLIG-NCAOFHFGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12388</td>
      <td>Evocalcet</td>
      <td>RZNUIYPHQFXBAN-XLIONFOSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03869</td>
      <td>5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine</td>
      <td>HQXFJGONGJPTLZ-YTMOPEAISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07045</td>
      <td>(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol</td>
      <td>VBJKVZXRYLCYGQ-XNIJJKJLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07422</td>
      <td>(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide</td>
      <td>MMNRWNREMUMYQG-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03903</td>
      <td>Tmr</td>
      <td>KGFLZYXDJDOIEE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07941</td>
      <td>PH-797804</td>
      <td>KCAJXIDMCNPGHZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12096</td>
      <td>PF-05175157</td>
      <td>BDXXSFOJPYSYOC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01712</td>
      <td>(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester</td>
      <td>NDDSSAGSYFVBTG-SFTDATJTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB05812</td>
      <td>Abiraterone</td>
      <td>GZOSMCIZMLWJML-VJLLXTKPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07430</td>
      <td>(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one</td>
      <td>CMWRPDHVGMHLSZ-GFCCVEGCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04750</td>
      <td>OREGON GREEN 488 CARBOXYLATE</td>
      <td>BRJCLSQFZSHLRL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03996</td>
      <td>3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol</td>
      <td>QBZAPFWYAPXRGQ-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB15232</td>
      <td>Telaglenastat</td>
      <td>PRAAPINBUWJLGA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB11651</td>
      <td>Dactolisib</td>
      <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08459</td>
      <td>3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>SVMHTBVIPYVDIL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03239</td>
      <td>3',5'-Dinitro-N-Acetyl-L-Thyronine</td>
      <td>VZSQTOXQXPKQJX-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00680</td>
      <td>Moricizine</td>
      <td>FUBVWMNBEHXPSU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02255</td>
      <td>GM6001</td>
      <td>NITYDPDXAAFEIT-DYVFJYSZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB09183</td>
      <td>Dasabuvir</td>
      <td>NBRBXGKOEOGLOI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB04859</td>
      <td>Zanapezil</td>
      <td>PMBLXLOXUGVTGB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07986</td>
      <td>[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID</td>
      <td>GNSLACGSDSJAIQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02669</td>
      <td>RB106</td>
      <td>ZWDQTNWLXALTOV-QYZOEREBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB05796</td>
      <td>Daglutril</td>
      <td>XMQODGUTLZXUGZ-RPBOFIJWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00875</td>
      <td>Flupentixol</td>
      <td>NJMYODHXAKYRHW-DVZOWYKESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07056</td>
      <td>2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide</td>
      <td>JNWQLOFSMUGRNY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB13088</td>
      <td>AZD-0424</td>
      <td>MVWATCATLSSVBH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02706</td>
      <td>Mercaptocarboxylate Inhibitor</td>
      <td>DUKDFMPUZRDWLT-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00913</td>
      <td>Anileridine</td>
      <td>LKYQLAWMNBFNJT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB12465</td>
      <td>Ketanserin</td>
      <td>FPCCSQOGAWCVBH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03447</td>
      <td>Uridylyl-2'-5'-Phospho-Adenosine</td>
      <td>QARCCHXXGAIRFS-KPKSGTNCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06302</td>
      <td>Glesatinib</td>
      <td>YRCHYHRCBXNYNU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00687</td>
      <td>Fludrocortisone</td>
      <td>AAXVEMMRQDVLJB-BULBTXNYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02621</td>
      <td>Latrunculin A</td>
      <td>DDVBPZROPPMBLW-IZGXTMSKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02616</td>
      <td>FR117016</td>
      <td>CKJGKHXCUDWFDC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08731</td>
      <td>2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>GPOKTQCDBPECSS-MRXNPFEDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02479</td>
      <td>(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide</td>
      <td>ZFWHOUCRVSOZJE-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12962</td>
      <td>CP-547632</td>
      <td>HXHAJRMTJXHJJZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12960</td>
      <td>INCB-9471</td>
      <td>ZMCJFJZOSKEMOM-DNKZPPIMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02431</td>
      <td>Cytidine-5'-Triphosphate</td>
      <td>PCDQPRRSZKQHHS-XVFCMESISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12974</td>
      <td>Roniciclib</td>
      <td>UELYDGOOJPRWGF-SRQXXRKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12949</td>
      <td>PF-03382792</td>
      <td>AGMOFKKOVMRGAK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB05134</td>
      <td>Tanespimycin</td>
      <td>AYUNIORJHRXIBJ-TXHRRWQRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08739</td>
      <td>2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione</td>
      <td>ZSXNPAWXICXNGZ-HNNXBMFYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00906</td>
      <td>Tiagabine</td>
      <td>PBJUNZJWGZTSKL-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB04715</td>
      <td>IMIDAZOPYRIDAZIN 1</td>
      <td>IVUBNTNWKIPCPS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB00846</td>
      <td>Flurandrenolide</td>
      <td>POPFMWWJOGLOIF-XWCQMRHXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08303</td>
      <td>(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide</td>
      <td>CUMKMTBOHBENJI-SFHVURJKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13126</td>
      <td>BMS-986115</td>
      <td>SRJNRAQUSAVENA-GSHUGGBRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02375</td>
      <td>Myricetin</td>
      <td>IKMDFBPHZNJCSN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB07534</td>
      <td>4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE</td>
      <td>BKUMVXIXUVYKDQ-GHXNOFRVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02316</td>
      <td>1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid</td>
      <td>JTGPYFFQVOIJKR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06090</td>
      <td>Bradanicline</td>
      <td>OXKRFEWMSWPKKV-GHTZIAJQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11259</td>
      <td>Diosmetin</td>
      <td>MBNGWHIJMBWFHU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02292</td>
      <td>Irosustat</td>
      <td>DSLPMJSGSBLWRE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02610</td>
      <td>N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide</td>
      <td>LRKSHOLYETXPGY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB05992</td>
      <td>Plinabulin</td>
      <td>UNRCMCRRFYFGFX-TYPNBTCFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB11925</td>
      <td>Vistusertib</td>
      <td>JUSFANSTBFGBAF-IRXDYDNUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB03397</td>
      <td>Uridine-Diphosphate-N-Acetylglucosamine</td>
      <td>LFTYTUAZOPRMMI-CFRASDGPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08097</td>
      <td>2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE</td>
      <td>OGWSGDLIXOEZJG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB09143</td>
      <td>Sonidegib</td>
      <td>VZZJRYRQSPEMTK-CALCHBBNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02164</td>
      <td>N-Sulfo-Flavin Mononucleotide</td>
      <td>ZLPUGFBBLGQWBS-SCRDCRAPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00764</td>
      <td>Mometasone</td>
      <td>QLIIKPVHVRXHRI-CXSFZGCWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07326</td>
      <td>6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide</td>
      <td>FEGRQUWSKADGSP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB04703</td>
      <td>Hesperidin</td>
      <td>QUQPHWDTPGMPEX-QJBIFVCTSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03141</td>
      <td>3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril</td>
      <td>UYUWNNRWESUYOB-FIRIVFDPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02140</td>
      <td>N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide</td>
      <td>ZPFPZRVOBBMZMP-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02132</td>
      <td>Zenarestat</td>
      <td>SXONDGSPUVNZLO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>1r42</td>
      <td>DB00320</td>
      <td>Dihydroergotamine</td>
      <td>LUZRJRNZXALNLM-JGRZULCMSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB11952</td>
      <td>Duvelisib</td>
      <td>SJVQHLPISAIATJ-ZDUSSCGKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03154</td>
      <td>{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid</td>
      <td>VHKBLEYUHBIBNR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB09003</td>
      <td>Clocapramine</td>
      <td>QAZKXHSIKKNOHH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB05212</td>
      <td>HE3286</td>
      <td>JJKOQZHWYLMASZ-FJWDNACWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03205</td>
      <td>Pyrroloquinoline Quinone</td>
      <td>MMXZSJMASHPLLR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB06212</td>
      <td>Tolvaptan</td>
      <td>GYHCTFXIZSNGJT-XMMPIXPASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08423</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE</td>
      <td>QKZZJXRGCHXIAI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07204</td>
      <td>(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</td>
      <td>DQIXTEDFNFZMCM-SFHVURJKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00823</td>
      <td>Ethynodiol diacetate</td>
      <td>ONKUMRGIYFNPJW-KIEAKMPYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00923</td>
      <td>Ceforanide</td>
      <td>SLAYUXIURFNXPG-CRAIPNDOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB05107</td>
      <td>16-Bromoepiandrosterone</td>
      <td>CWVMWSZEMZOUPC-JUAXIXHSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07765</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>UKCFUFHREWUXJJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB12388</td>
      <td>Evocalcet</td>
      <td>RZNUIYPHQFXBAN-XLIONFOSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02170</td>
      <td>1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One</td>
      <td>ZOHCDJRFYXKEQW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06321</td>
      <td>R-348</td>
      <td>IGLNXKVGKIFNBQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB09079</td>
      <td>Nintedanib</td>
      <td>XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02854</td>
      <td>Aetiocholanolone</td>
      <td>QGXBDMJGAMFCBF-BNSUEQOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB11934</td>
      <td>Epelsiban</td>
      <td>UWHCWRQFNKUYCG-QUZACWSFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB05532</td>
      <td>BMS-488043</td>
      <td>DBPMWRYLTBNCCE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB12480</td>
      <td>Betulinic Acid</td>
      <td>QGJZLNKBHJESQX-FZFNOLFKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB02466</td>
      <td>4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid</td>
      <td>ZXQHMEUGMCXKLO-KPKJPENVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB06292</td>
      <td>Dapagliflozin</td>
      <td>JVHXJTBJCFBINQ-ADAARDCZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00635</td>
      <td>Prednisone</td>
      <td>XOFYZVNMUHMLCC-ZPOLXVRWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03701</td>
      <td>Vanoxerine</td>
      <td>NAUWTFJOPJWYOT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00739</td>
      <td>Hetacillin</td>
      <td>DXVUYOAEDJXBPY-NFFDBFGFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB00434</td>
      <td>Cyproheptadine</td>
      <td>JJCFRYNCJDLXIK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02187</td>
      <td>Equilin</td>
      <td>WKRLQDKEXYKHJB-HFTRVMKXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB11732</td>
      <td>Lasmiditan</td>
      <td>XEDHVZKDSYZQBF-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03037</td>
      <td>Oxidized Acetyl Dithranol</td>
      <td>IKFRFGXQHSBCQM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00839</td>
      <td>Tolazamide</td>
      <td>OUDSBRTVNLOZBN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB02181</td>
      <td>2'-Deoxyguanosine-5'-Triphosphate</td>
      <td>HAAZLUGHYHWQIW-KVQBGUIXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB12285</td>
      <td>Verubecestat</td>
      <td>YHYKUSGACIYRML-KRWDZBQOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB03069</td>
      <td>Cytidine-5'-Diphospho-Beta-D-Xylose</td>
      <td>NWSKPSPTJOAICE-OCIMBMBZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04626</td>
      <td>Apramycin</td>
      <td>XZNUGFQTQHRASN-XQENGBIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB12282</td>
      <td>Defactinib</td>
      <td>FWLMVFUGMHIOAA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB00776</td>
      <td>Oxcarbazepine</td>
      <td>CTRLABGOLIVAIY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB12410</td>
      <td>Sabarubicin</td>
      <td>VQHRZZISQVWPLK-UIRGBLDSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB01089</td>
      <td>Deserpidine</td>
      <td>CVBMAZKKCSYWQR-WCGOZPBSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB08931</td>
      <td>Riociguat</td>
      <td>WXXSNCNJFUAIDG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB01674</td>
      <td>[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid</td>
      <td>AYMRQIHECFEMIQ-AYVTZFPOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04301</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate</td>
      <td>ZLAHDRAQCSQPOC-UHFFFAOYSA-P</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB11775</td>
      <td>PF-03758309</td>
      <td>AYCPARAPKDAOEN-LJQANCHMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06684</td>
      <td>Vilazodone</td>
      <td>SGEGOXDYSFKCPT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04348</td>
      <td>Taurocholic Acid</td>
      <td>WBWWGRHZICKQGZ-HZAMXZRMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB11986</td>
      <td>Entrectinib</td>
      <td>HAYYBYPASCDWEQ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB08930</td>
      <td>Dolutegravir</td>
      <td>RHWKPHLQXYSBKR-BMIGLBTASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07778</td>
      <td>FAMOXADONE</td>
      <td>PCCSBWNGDMYFCW-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB15299</td>
      <td>AMG-232</td>
      <td>DRLCSJFKKILATL-YWCVFVGNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB11730</td>
      <td>Ribociclib</td>
      <td>RHXHGRAEPCAFML-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB05416</td>
      <td>Cardarine</td>
      <td>YDBLKRPLXZNVNB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08560</td>
      <td>3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE</td>
      <td>GULUFDCOGAXLEP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04624</td>
      <td>DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME)</td>
      <td>SIHNJMGWRHPFAZ-XHDPSFHLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00977</td>
      <td>Ethinylestradiol</td>
      <td>BFPYWIDHMRZLRN-SLHNCBLASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB11443</td>
      <td>Orbifloxacin</td>
      <td>QIPQASLPWJVQMH-DTORHVGOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB08366</td>
      <td>3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid</td>
      <td>XADCWKSMHQPTGH-OFBLZTNGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB12364</td>
      <td>Betrixaban</td>
      <td>XHOLNRLADUSQLD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07786</td>
      <td>1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>SMFRBBHLVBWHGB-DJJJIMSYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB12222</td>
      <td>Lurtotecan</td>
      <td>RVFGKBWWUQOIOU-NDEPHWFRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB00496</td>
      <td>Darifenacin</td>
      <td>HXGBXQDTNZMWGS-RUZDIDTESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04957</td>
      <td>Azimilide</td>
      <td>MREBEPTUUMTTIA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB01138</td>
      <td>Sulfinpyrazone</td>
      <td>MBGGBVCUIVRRBF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB13093</td>
      <td>TAK-593</td>
      <td>DZFZXPPHBWCXPQ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB13119</td>
      <td>GSK-364735</td>
      <td>QWLNINWUBHHOLU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01264</td>
      <td>Darunavir</td>
      <td>CJBJHOAVZSMMDJ-HEXNFIEUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB08521</td>
      <td>4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>CDMGBJANTYXAIV-HHHXNRCGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB15254</td>
      <td>RO-5126766 free base</td>
      <td>LMMJFBMMJUMSJS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12621</td>
      <td>ST-101</td>
      <td>QZWYXEBIQWJXAR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB06346</td>
      <td>Fiboflapon</td>
      <td>DFQGDHBGRSTTHX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>7bv1</td>
      <td>DB12420</td>
      <td>Diazepinomicin</td>
      <td>SALVHVNECODMJP-GNUCVDFRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04754</td>
      <td>GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE</td>
      <td>HYAPEMYRVFIHDJ-QWEIRQIHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB09073</td>
      <td>Palbociclib</td>
      <td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07692</td>
      <td>1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine</td>
      <td>SHWNKRPMUBFWKE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04726</td>
      <td>7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE</td>
      <td>KPDQZGKJTJRBGU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04716</td>
      <td>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</td>
      <td>VNDWQCSOSCCWIP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4b</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01452</td>
      <td>Diamorphine</td>
      <td>GVGLGOZIDCSQPN-PVHGPHFFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08657</td>
      <td>2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID</td>
      <td>SSXCWVOQWRUMGN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04715</td>
      <td>IMIDAZOPYRIDAZIN 1</td>
      <td>IVUBNTNWKIPCPS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB06732</td>
      <td>beta-Naphthoflavone</td>
      <td>OUGIDAPQYNCXRA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08707</td>
      <td>4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine</td>
      <td>AQVFETGXIRKVAQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07680</td>
      <td>[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</td>
      <td>HUJXISJLAPAFBO-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04834</td>
      <td>Rapacuronium</td>
      <td>HTIKWNNIPGXLGM-YLINKJIISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04872</td>
      <td>Osanetant</td>
      <td>DZOJBGLFWINFBF-UMSFTDKQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB00705</td>
      <td>Delavirdine</td>
      <td>WHBIGIKBNXZKFE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07665</td>
      <td>N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>STHCHQXQLDMISY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04014</td>
      <td>Alsterpaullone</td>
      <td>OLUKILHGKRVDCT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lzg</td>
      <td>DB00826</td>
      <td>Natamycin</td>
      <td>NCXMLFZGDNKEPB-FFPOYIOWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04873</td>
      <td>Piboserod</td>
      <td>KVCSJPATKXABRQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6lxt</td>
      <td>DB00700</td>
      <td>Eplerenone</td>
      <td>JUKPWJGBANNWMW-VWBFHTRKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04696</td>
      <td>4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN</td>
      <td>GFGZCXHXQCQRFP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB08715</td>
      <td>2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL</td>
      <td>SLPKYEWAKMNCPT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07679</td>
      <td>(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid</td>
      <td>RRAAROKJUVKWAF-RDJZCZTQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03678</td>
      <td>(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine</td>
      <td>WVGZKPGUHOZIJQ-HNNXBMFYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9q</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07729</td>
      <td>3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide</td>
      <td>GAKOBKPDJJGRIL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04845</td>
      <td>Ixabepilone</td>
      <td>FABUFPQFXZVHFB-PVYNADRNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB07993</td>
      <td>N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>LPQUIIHPUGDHJK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04761</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]</td>
      <td>NHPBWKYFMTXWAA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB09034</td>
      <td>Suvorexant</td>
      <td>JYTNQNCOQXFQPK-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB03768</td>
      <td>N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3</td>
      <td>WRUVOSYKHXGAQN-GKRYNVPLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04362</td>
      <td>Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid</td>
      <td>VGXBGQACJQRWLV-LKGUXBDMSA-K</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01554</td>
      <td>Bolandiol</td>
      <td>CMXKUJNZWYTFJN-XFUVECHXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB05076</td>
      <td>Fenretinide</td>
      <td>AKJHMTWEGVYYSE-FXILSDISSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w4h</td>
      <td>DB13093</td>
      <td>TAK-593</td>
      <td>DZFZXPPHBWCXPQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB03173</td>
      <td>CRA_10433</td>
      <td>CFSQPEBVGUSQII-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04461</td>
      <td>Coproporphyrinogen III</td>
      <td>NIUVHXTXUXOFEB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04371</td>
      <td>AL6528</td>
      <td>FBBLOSCXOZYUSS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB12566</td>
      <td>Decernotinib</td>
      <td>ASUGUQWIHMTFJL-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04405</td>
      <td>2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid</td>
      <td>AQYSXARQCHHHLK-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00485</td>
      <td>Dicloxacillin</td>
      <td>YFAGHNZHGGCZAX-JKIFEVAISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m2n</td>
      <td>DB04575</td>
      <td>Quinestrol</td>
      <td>PWZUUYSISTUNDW-VAFBSOEGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB13046</td>
      <td>Tocladesine</td>
      <td>CLLFEJLEDNXZNR-UUOKFMHZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB11925</td>
      <td>Vistusertib</td>
      <td>JUSFANSTBFGBAF-IRXDYDNUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07817</td>
      <td>1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea</td>
      <td>NJPVZSIGDRLLTD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6cs2</td>
      <td>DB13685</td>
      <td>Quingestanol</td>
      <td>PCJFRMOEZQQSAX-AIOSZGMZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB00967</td>
      <td>Desloratadine</td>
      <td>JAUOIFJMECXRGI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01570</td>
      <td>Ohmefentanyl</td>
      <td>FRPRNNRJTCONEC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01254</td>
      <td>Dasatinib</td>
      <td>ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04434</td>
      <td>Naphthyridine Inhibitor</td>
      <td>YRBHUKMLAGQYHS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxx</td>
      <td>DB12949</td>
      <td>PF-03382792</td>
      <td>AGMOFKKOVMRGAK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB13393</td>
      <td>Emetine</td>
      <td>AUVVAXYIELKVAI-CKBKHPSWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6crv</td>
      <td>DB05990</td>
      <td>Obeticholic acid</td>
      <td>ZXERDUOLZKYMJM-ZWECCWDJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04582</td>
      <td>IMAZAQUIN</td>
      <td>CABMTIJINOIHOD-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB12725</td>
      <td>TD-8954</td>
      <td>MZOITCJKGUIQEI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m71</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB04421</td>
      <td>Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct</td>
      <td>BZJFKYRGSZWSLT-YLIVDTKOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6vxs</td>
      <td>DB07078</td>
      <td>(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>AYSXURJZVXBSRV-WJDWOHSUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01569</td>
      <td>Formebolone</td>
      <td>AMVODTGMYSRMNP-GNIMZFFESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01624</td>
      <td>Zuclopenthixol</td>
      <td>WFPIAZLQTJBIFN-DVZOWYKESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB04350</td>
      <td>Argadin</td>
      <td>FOZYKTUSOWWQGR-KNPYFFGGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6w9c</td>
      <td>DB07584</td>
      <td>N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine</td>
      <td>OKGCSZUKOGMZAL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.8</td>
      <td>6m3m</td>
      <td>DB01605</td>
      <td>Pivmecillinam</td>
      <td>NPGNOVNWUSPMDP-HLLBOEOZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB15169</td>
      <td>H3B-6527</td>
      <td>MBWRLLRCTIYXDW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB15120</td>
      <td>GSK-239512</td>
      <td>YFRBKEVUUCQYOW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB04908</td>
      <td>Flibanserin</td>
      <td>PPRRDFIXUUSXRA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12401</td>
      <td>Bromperidol</td>
      <td>RKLNONIVDFXQRX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB14993</td>
      <td>Pyrotinib</td>
      <td>SADXACCFNXBCFY-IYNHSRRRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB15151</td>
      <td>RO-6870810</td>
      <td>PKQXLRYFPSZKDU-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB00158</td>
      <td>Folic acid</td>
      <td>OVBPIULPVIDEAO-LBPRGKRZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00769</td>
      <td>Hydrocortamate</td>
      <td>FWFVLWGEFDIZMJ-FOMYWIRZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12448</td>
      <td>Lifibrol</td>
      <td>LNXBEIZREVRNTF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12221</td>
      <td>Canrenone</td>
      <td>UJVLDDZCTMKXJK-WNHSNXHDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06733</td>
      <td>Bafilomycin A1</td>
      <td>XDHNQDDQEHDUTM-JQWOJBOSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB05575</td>
      <td>Motesanib</td>
      <td>RAHBGWKEPAQNFF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB01067</td>
      <td>Glipizide</td>
      <td>ZJJXGWJIGJFDTL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08934</td>
      <td>Sofosbuvir</td>
      <td>TTZHDVOVKQGIBA-IQWMDFIBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB12225</td>
      <td>Beclabuvir</td>
      <td>ZTTKEBYSXUCBSE-QDFUAKMASA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB11962</td>
      <td>GSK-1059615</td>
      <td>QDITZBLZQQZVEE-YBEGLDIGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12890</td>
      <td>Dihydrexidine</td>
      <td>BGOQGUHWXBGXJW-YOEHRIQHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06746</td>
      <td>ginkgolide-J</td>
      <td>LMEHVEUFNRJAAV-UKWFQYJJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06747</td>
      <td>ginkgolide-M</td>
      <td>KDKROYXEHCYLJQ-FJFAJXJPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB02629</td>
      <td>Inhibitor Bea403</td>
      <td>LYHLPPXMBKMSSZ-JQFCFGFHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12888</td>
      <td>Ezutromid</td>
      <td>KSGCNXAZROJSNW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB06721</td>
      <td>Gimatecan</td>
      <td>UIVFUQKYVFCEKJ-OPTOVBNMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB15308</td>
      <td>Ridinilazole</td>
      <td>UHQFBTAJFNVZIV-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08497</td>
      <td>(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>NKBDSMREMMRFSI-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00990</td>
      <td>Exemestane</td>
      <td>BFYIZQONLCFLEV-DAELLWKTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB04861</td>
      <td>Nebivolol</td>
      <td>KOHIRBRYDXPAMZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00894</td>
      <td>Testolactone</td>
      <td>BPEWUONYVDABNZ-DZBHQSCQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06874</td>
      <td>(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL</td>
      <td>LSIZSSASMKSUIU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB04946</td>
      <td>Iloperidone</td>
      <td>XMXHEBAFVSFQEX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB03005</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium</td>
      <td>ISUOMOOYAOQQPZ-UHFFFAOYSA-O</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00910</td>
      <td>Paricalcitol</td>
      <td>BPKAHTKRCLCHEA-UBFJEZKGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB11816</td>
      <td>Omecamtiv Mecarbil</td>
      <td>RFUBTTPMWSKEIW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01039</td>
      <td>Fenofibrate</td>
      <td>YMTINGFKWWXKFG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB12355</td>
      <td>Netazepide</td>
      <td>YDZYKNJZCVIKPP-VWLOTQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07147</td>
      <td>methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate</td>
      <td>HJWMYFBKJRVWJY-YKSBVNFPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06267</td>
      <td>Udenafil</td>
      <td>IYFNEFQTYQPVOC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11701</td>
      <td>Amenamevir</td>
      <td>MNHNIVNAFBSLLX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB03802</td>
      <td>1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>ZGHFWBDHZZKWSI-LITSAYRRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB02804</td>
      <td>A-98881</td>
      <td>PMBZSBGCSQGJAQ-GRKNLSHJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB06744</td>
      <td>ginkgolide-B</td>
      <td>SQOJOAFXDQDRGF-MMQTXUMRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07450</td>
      <td>(R)-minalrestat</td>
      <td>BMHZAHGTGIZZCT-LJQANCHMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB13685</td>
      <td>Quingestanol</td>
      <td>PCJFRMOEZQQSAX-AIOSZGMZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07146</td>
      <td>2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE</td>
      <td>QUIQCYFSBGOBKE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06848</td>
      <td>1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine</td>
      <td>VCUDZTCDUDDJGG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00342</td>
      <td>Terfenadine</td>
      <td>GUGOEEXESWIERI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB15126</td>
      <td>IMG-7289</td>
      <td>KQKBMHGOHXOHTD-KKUQBAQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14768</td>
      <td>PF-06459988</td>
      <td>ODMXWZROLKITMS-RISCZKNCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07124</td>
      <td>(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>CCIACUJJBPSOHE-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06160</td>
      <td>Garenoxacin</td>
      <td>NJDRXTDGYFKORP-LLVKDONJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07458</td>
      <td>3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-KRWDZBQOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB01261</td>
      <td>Sitagliptin</td>
      <td>MFFMDFFZMYYVKS-SECBINFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00470</td>
      <td>Dronabinol</td>
      <td>CYQFCXCEBYINGO-IAGOWNOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07127</td>
      <td>{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID</td>
      <td>SXDBFKLPNPUPRI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB09209</td>
      <td>Pholcodine</td>
      <td>GPFAJKDEDBRFOS-FKQDBXSBSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06213</td>
      <td>Regadenoson</td>
      <td>LZPZPHGJDAGEJZ-AKAIJSEGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00846</td>
      <td>Flurandrenolide</td>
      <td>POPFMWWJOGLOIF-XWCQMRHXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07456</td>
      <td>3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-QGZVFWFLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08916</td>
      <td>Afatinib</td>
      <td>ULXXDDBFHOBEHA-CWDCEQMOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB03020</td>
      <td>5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</td>
      <td>UINNILASBHZOTM-KMXXXSRASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13327</td>
      <td>Picotamide</td>
      <td>KYWCWBXGRWWINE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00875</td>
      <td>Flupentixol</td>
      <td>NJMYODHXAKYRHW-DVZOWYKESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB15092</td>
      <td>LY-2624803</td>
      <td>UEFWDVMEDFCHGW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00344</td>
      <td>Protriptyline</td>
      <td>BWPIARFWQZKAIA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB06985</td>
      <td>2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid</td>
      <td>MEAQCLPMSVEOQF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB01573</td>
      <td>Benzylmorphine</td>
      <td>RDJGWRFTDZZXSM-RNWLQCGYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06853</td>
      <td>N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide</td>
      <td>BYTJPDBCLWUEBU-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB12002</td>
      <td>AZD-4818</td>
      <td>HVTUHSABWJPWNK-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB00973</td>
      <td>Ezetimibe</td>
      <td>OLNTVTPDXPETLC-XPWALMASSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07334</td>
      <td>N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</td>
      <td>HTIZPBXCJPQDEM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08657</td>
      <td>2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID</td>
      <td>SSXCWVOQWRUMGN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB07545</td>
      <td>N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE</td>
      <td>RDTDWGQDFJPTPD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB06962</td>
      <td>(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone</td>
      <td>YKTUSHSSKIWDRY-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06969</td>
      <td>2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide</td>
      <td>WJUNQSYQHHIVFX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13994</td>
      <td>AZD-7325</td>
      <td>KYDURMHFWXCKMW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14828</td>
      <td>ABX-464</td>
      <td>OZOGDCZJYVSUBR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14840</td>
      <td>Ripretinib</td>
      <td>CEFJVGZHQAGLHS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB00197</td>
      <td>Troglitazone</td>
      <td>GXPHKUHSUJUWKP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12924</td>
      <td>Ozenoxacin</td>
      <td>XPIJWUTXQAGSLK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08613</td>
      <td>2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL</td>
      <td>OFBFUNBBOQCNFX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB12812</td>
      <td>Palomid 529</td>
      <td>YEAHTLOYHVWAKW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB12207</td>
      <td>Verdinexor</td>
      <td>OPAKEJZFFCECPN-XQRVVYSFSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00396</td>
      <td>Progesterone</td>
      <td>RJKFOVLPORLFTN-LEKSSAKUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08437</td>
      <td>Puromycin</td>
      <td>RXWNCPJZOCPEPQ-NVWDDTSBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB12042</td>
      <td>Ibodutant</td>
      <td>YQYSVMKCMIUCHY-WJOKGBTCSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14841</td>
      <td>Centanafadine</td>
      <td>HKHCSWPSUSWGLI-CABCVRRESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB15268</td>
      <td>Afabicin</td>
      <td>HFYMDQMXVPJNTH-VQHVLOKHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06680</td>
      <td>Asoprisnil</td>
      <td>GJMNAFGEUJBOCE-MEQIQULJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08791</td>
      <td>1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE</td>
      <td>USLOIFPDNUDIEG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB14766</td>
      <td>Etrasimod</td>
      <td>MVGWUTBTXDYMND-QGZVFWFLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13395</td>
      <td>Eprozinol</td>
      <td>QSRHLIUOSXVKTG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00438</td>
      <td>Ceftazidime</td>
      <td>ORFOPKXBNMVMKC-DWVKKRMSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB15327</td>
      <td>Abivertinib</td>
      <td>UOFYSRZSLXWIQB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB07570</td>
      <td>3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID</td>
      <td>ZKEZEXYKYHYIMQ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06660</td>
      <td>Saredutant</td>
      <td>PGKXDIMONUAMFR-AREMUKBSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB11978</td>
      <td>Glasdegib</td>
      <td>SFNSLLSYNZWZQG-VQIMIIECSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB15408</td>
      <td>Silmitasertib</td>
      <td>MUOKSQABCJCOPU-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB04942</td>
      <td>Tamibarotene</td>
      <td>MUTNCGKQJGXKEM-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14898</td>
      <td>Retagliptin</td>
      <td>WIIAMRXFUJLYEF-SNVBAGLBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06992</td>
      <td>(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone</td>
      <td>SIDDLTBLAQYZIZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12253</td>
      <td>GDC-0810</td>
      <td>BURHGPHDEVGCEZ-KJGLQBJMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06994</td>
      <td>(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine</td>
      <td>XCCSSVMRGIQMGF-LPHOPBHVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14885</td>
      <td>PF-05180999</td>
      <td>CLGCHUKGBICQTE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14014</td>
      <td>SR-9011</td>
      <td>PPUYOYQTTWJTIU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11804</td>
      <td>AZD-5672</td>
      <td>SCXSQUUTGCWHFU-WJOKGBTCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00246</td>
      <td>Ziprasidone</td>
      <td>MVWVFYHBGMAFLY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08742</td>
      <td>1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)</td>
      <td>CEEUUHVULXTFGS-BQXVGYHGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB14795</td>
      <td>AZD-3759</td>
      <td>MXDSJQHFFDGFDK-CYBMUJFWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB15229</td>
      <td>CNV-2197944</td>
      <td>BLFJGFDZMABYMY-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB12345</td>
      <td>MBX-2982</td>
      <td>NFTMKHWBOINJGM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06616</td>
      <td>Bosutinib</td>
      <td>UBPYILGKFZZVDX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB01767</td>
      <td>Hemi-Babim</td>
      <td>KKJYVDXDZURHMA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00278</td>
      <td>Argatroban</td>
      <td>KXNPVXPOPUZYGB-IOVMHBDKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB04942</td>
      <td>Tamibarotene</td>
      <td>MUTNCGKQJGXKEM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB05586</td>
      <td>Facinicline</td>
      <td>TXCYUSKWBHUVEP-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13374</td>
      <td>Vincamine</td>
      <td>RXPRRQLKFXBCSJ-GIVPXCGWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB06263</td>
      <td>Amrubicin</td>
      <td>VJZITPJGSQKZMX-XDPRQOKASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB15209</td>
      <td>MK-0736</td>
      <td>ORQZQBUNAMJFCY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12929</td>
      <td>JNJ-39220675</td>
      <td>IQOWHZHNGJXGHG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB06922</td>
      <td>2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>CZNPWASYMRBJCX-GOSISDBHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB03723</td>
      <td>2'-Deoxy-Thymidine-Beta-L-Rhamnose</td>
      <td>ZOSQFDVXNQFKBY-CGAXJHMRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06635</td>
      <td>Otamixaban</td>
      <td>PFGVNLZDWRZPJW-OPAMFIHVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB07025</td>
      <td>3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE</td>
      <td>KBIHHEGEALBUMT-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12392</td>
      <td>Resminostat</td>
      <td>FECGNJPYVFEKOD-VMPITWQZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01140</td>
      <td>Cefadroxil</td>
      <td>BOEGTKLJZSQCCD-UEKVPHQBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14037</td>
      <td>Madecassic acid</td>
      <td>PRAUVHZJPXOEIF-AOLYGAPISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB15254</td>
      <td>RO-5126766 free base</td>
      <td>LMMJFBMMJUMSJS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB06229</td>
      <td>Ocaperidone</td>
      <td>ZZQNEJILGNNOEP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13308</td>
      <td>Oxametacin</td>
      <td>AJRNYCDWNITGHF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14737</td>
      <td>Cannabinol</td>
      <td>VBGLYOIFKLUMQG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13360</td>
      <td>Tolciclate</td>
      <td>CANCCLAKQQHLNK-LSDHHAIUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08416</td>
      <td>(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE</td>
      <td>AQSNIXKAKUZPSI-SSTWWWIQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12282</td>
      <td>Defactinib</td>
      <td>FWLMVFUGMHIOAA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00670</td>
      <td>Pirenzepine</td>
      <td>RMHMFHUVIITRHF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00946</td>
      <td>Phenprocoumon</td>
      <td>DQDAYGNAKTZFIW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07065</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>AHPKUZJCNHGFQA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06362</td>
      <td>Becatecarin</td>
      <td>JSKFWUPVIZYJMR-UDOAKELVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11890</td>
      <td>Cilengitide</td>
      <td>AMLYAMJWYAIXIA-VWNVYAMZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08510</td>
      <td>5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE</td>
      <td>UVTGFMKBPVLATL-DSOJQRAMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06159</td>
      <td>Rubitecan</td>
      <td>VHXNKPBCCMUMSW-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB05265</td>
      <td>Ecabet</td>
      <td>IWCWQNVIUXZOMJ-MISYRCLQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08860</td>
      <td>Pitavastatin</td>
      <td>VGYFMXBACGZSIL-MCBHFWOFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14059</td>
      <td>SC-236</td>
      <td>NSQNZEUFHPTJME-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB02573</td>
      <td>2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate</td>
      <td>LYWWDKIADIGKTH-IDMWBNCISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00699</td>
      <td>Nicergoline</td>
      <td>YSEXMKHXIOCEJA-FVFQAYNVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13687</td>
      <td>Niaprazine</td>
      <td>RSKQGBFMNPDPLR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13943</td>
      <td>Testosterone cypionate</td>
      <td>HPFVBGJFAYZEBE-ZLQWOROUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB14568</td>
      <td>Ivosidenib</td>
      <td>WIJZXSAJMHAVGX-DHLKQENFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB11878</td>
      <td>Filibuvir</td>
      <td>SLVAPEZTBDBAPI-GDLZYMKVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08534</td>
      <td>5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>ZAIYYXVHGBMLEC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08538</td>
      <td>N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>HQPVGVSQPQVZLD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB12379</td>
      <td>Indirubin</td>
      <td>CRDNMYFJWFXOCH-BUHFOSPRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13397</td>
      <td>Prenoxdiazine</td>
      <td>PXZDWASDNFWKSD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14775</td>
      <td>Cavosonstat</td>
      <td>BXSZILNGNMDGSL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07045</td>
      <td>(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol</td>
      <td>VBJKVZXRYLCYGQ-XNIJJKJLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB15333</td>
      <td>AZD-1386</td>
      <td>FPGNKXCEPARJDI-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB15310</td>
      <td>Vactosertib</td>
      <td>FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB12412</td>
      <td>Gemigliptin</td>
      <td>ZWPRRQZNBDYKLH-VIFPVBQESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06148</td>
      <td>Mianserin</td>
      <td>UEQUQVLFIPOEMF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08820</td>
      <td>Ivacaftor</td>
      <td>PURKAOJPTOLRMP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB15294</td>
      <td>SB-1578</td>
      <td>NNXDIGHYPZHXTR-ONEGZZNKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11769</td>
      <td>Funapide</td>
      <td>NEBUOXBYNAHKFV-NRFANRHFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06446</td>
      <td>Dotarizine</td>
      <td>LRMJAFKKJLRDLE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13797</td>
      <td>Iodocholesterol (131I)</td>
      <td>FIOAEFCJGZJUPW-ODFYUTSGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB04038</td>
      <td>Ergosterol</td>
      <td>DNVPQKQSNYMLRS-APGDWVJJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01013</td>
      <td>Clobetasol propionate</td>
      <td>CBGUOGMQLZIXBE-XGQKBEPLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB05263</td>
      <td>Caprospinol</td>
      <td>VMOZFSWFUBLCNN-AAPULDEBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12275</td>
      <td>Seviteronel</td>
      <td>ZBRAJOQFSNYJMF-SFHVURJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB00591</td>
      <td>Fluocinolone acetonide</td>
      <td>FEBLZLNTKCEFIT-VSXGLTOVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB15235</td>
      <td>Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone</td>
      <td>GNLZNQJBZNOUBM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB14885</td>
      <td>PF-05180999</td>
      <td>CLGCHUKGBICQTE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB03903</td>
      <td>Tmr</td>
      <td>KGFLZYXDJDOIEE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00948</td>
      <td>Mezlocillin</td>
      <td>YPBATNHYBCGSSN-VWPFQQQWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB15186</td>
      <td>GDC-0084</td>
      <td>LGWACEZVCMBSKW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB15346</td>
      <td>GLPG-1205</td>
      <td>IRBAWVGZNJIROV-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11616</td>
      <td>Pirarubicin</td>
      <td>KMSKQZKKOZQFFG-YXRRJAAWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06521</td>
      <td>Ertiprotafib</td>
      <td>FONCZICQWCUXEB-RUZDIDTESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB06844</td>
      <td>4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE</td>
      <td>MBXKBJLIESPLIK-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB15109</td>
      <td>Ingenol disoxate</td>
      <td>GLIUZQUNUNICGS-XUBYYPQFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB00485</td>
      <td>Dicloxacillin</td>
      <td>YFAGHNZHGGCZAX-JKIFEVAISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB06334</td>
      <td>Tucidinostat</td>
      <td>SZMJVTADHFNAIS-BJMVGYQFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB00445</td>
      <td>Epirubicin</td>
      <td>AOJJSUZBOXZQNB-VTZDEGQISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB02675</td>
      <td>(4-Hydroxymaltosephenyl)Glycine</td>
      <td>PHPOPZGUOBMSPZ-QHJSCRBTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB12974</td>
      <td>Roniciclib</td>
      <td>UELYDGOOJPRWGF-SRQXXRKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB11833</td>
      <td>Basimglurant</td>
      <td>UPZWINBEAHDTLA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08003</td>
      <td>ISOTHIAZOLIDINONE ANALOG</td>
      <td>UILYPHAKDBTKQV-UFYCRDLUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13182</td>
      <td>Daidzein</td>
      <td>ZQSIJRDFPHDXIC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07965</td>
      <td>6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile</td>
      <td>OGODDSLNRULSMM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00783</td>
      <td>Estradiol</td>
      <td>VOXZDWNPVJITMN-ZBRFXRBCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12693</td>
      <td>Ritanserin</td>
      <td>JUQLTPCYUFPYKE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB13991</td>
      <td>Pipequaline</td>
      <td>AMEWZCMTSIONOX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB02611</td>
      <td>Balanol Analog 1</td>
      <td>FZJQHARRQUNVGZ-QZTJIDSGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06737</td>
      <td>Zaltoprofen</td>
      <td>MUXFZBHBYYYLTH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB04872</td>
      <td>Osanetant</td>
      <td>DZOJBGLFWINFBF-UMSFTDKQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14649</td>
      <td>Dexamethasone acetate</td>
      <td>AKUJBENLRBOFTD-RPRRAYFGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12622</td>
      <td>Lupeol</td>
      <td>MQYXUWHLBZFQQO-QGTGJCAVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB00705</td>
      <td>Delavirdine</td>
      <td>WHBIGIKBNXZKFE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07550</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE</td>
      <td>ZIGSBBKEPNQXRG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13312</td>
      <td>Delapril</td>
      <td>WOUOLAUOZXOLJQ-MBSDFSHPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB08738</td>
      <td>1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one</td>
      <td>KWCKZIJGKMCYCI-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB15435</td>
      <td>BMS-986158</td>
      <td>KGERZPVQIRYWRK-GDLZYMKVSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB06314</td>
      <td>SGX-523</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB04376</td>
      <td>13-Acetylphorbol</td>
      <td>SDSVJYOOAPRSDA-RPCQODIISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB11457</td>
      <td>Rotenone</td>
      <td>JUVIOZPCNVVQFO-HBGVWJBISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13060</td>
      <td>CEP-37440</td>
      <td>BCSHRERPHLTPEE-NRFANRHFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>1r42</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB04424</td>
      <td>RPR128515</td>
      <td>XFKVLKLCLYJKNF-MZNJEOGPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14555</td>
      <td>Ursadiol</td>
      <td>RTLXJEJRLWILSU-GWNGJUQLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13055</td>
      <td>Oteseconazole</td>
      <td>IDUYJRXRDSPPRC-NRFANRHFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB13579</td>
      <td>Mepixanox</td>
      <td>PYSOHOOUXFWCFF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12562</td>
      <td>Setipiprant</td>
      <td>IHAXLPDVOWLUOS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB02717</td>
      <td>Cellotetraose</td>
      <td>LUEWUZLMQUOBSB-HGDSAIHNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB13580</td>
      <td>Succinylsulfathiazole</td>
      <td>SKVLYVHULOWXTD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB11778</td>
      <td>Danusertib</td>
      <td>XKFTZKGMDDZMJI-HSZRJFAPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB02567</td>
      <td>PD173955</td>
      <td>VAARYSWULJUGST-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12545</td>
      <td>Indobufen</td>
      <td>AYDXAULLCROVIT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08703</td>
      <td>12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</td>
      <td>FGKKIHITEICGMN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB04690</td>
      <td>Camptothecin</td>
      <td>VSJKWCGYPAHWDS-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14208</td>
      <td>Ramiprilat</td>
      <td>KEDYTOTWMPBSLG-HILJTLORSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB13616</td>
      <td>Melagatran</td>
      <td>DKWNMCUOEDMMIN-PKOBYXMFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13993</td>
      <td>MRK-409</td>
      <td>GOIFCXRIFSYPFG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB12933</td>
      <td>RO-4987655</td>
      <td>FIMYFEGKMOCQKT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB14034</td>
      <td>Darglitazone</td>
      <td>QQKNSPHAFATFNQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB12927</td>
      <td>Theodrenaline</td>
      <td>WMCMJIGLYZDKRN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6wiq</td>
      <td>DB04289</td>
      <td>Genz-10850</td>
      <td>YYMZSGIXLQPFAC-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB00276</td>
      <td>Amsacrine</td>
      <td>XCPGHVQEEXUHNC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB12926</td>
      <td>Cafedrine</td>
      <td>UJSKUDDDPKGBJY-WFASDCNBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB12318</td>
      <td>BMS-599626</td>
      <td>LUJZZYWHBDHDQX-QFIPXVFZSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08749</td>
      <td>3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</td>
      <td>KTRFBFMYAJOXLG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB04651</td>
      <td>BIOTINOL-5-AMP</td>
      <td>KBOGUFFJCBPJEH-SQGSUPJISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08915</td>
      <td>Aleglitazar</td>
      <td>DAYKLWSKQJBGCS-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB15408</td>
      <td>Silmitasertib</td>
      <td>MUOKSQABCJCOPU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07987</td>
      <td>[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER</td>
      <td>AWAKNMKLVLWIIQ-OAHLLOKOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6wiq</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6wiq</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13169</td>
      <td>Nandrolone</td>
      <td>NPAGDVCDWIYMMC-IZPLOLCNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB06747</td>
      <td>ginkgolide-M</td>
      <td>KDKROYXEHCYLJQ-FJFAJXJPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08931</td>
      <td>Riociguat</td>
      <td>WXXSNCNJFUAIDG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB02882</td>
      <td>Cyanocinnoline</td>
      <td>CUWRVIIPSSUUDJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12843</td>
      <td>Oleandrin</td>
      <td>JLPDBLFIVFSOCC-XYXFTTADSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB12580</td>
      <td>Tradipitant</td>
      <td>CAVRKWRKTNINFF-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB03082</td>
      <td>6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide</td>
      <td>CSWQJKHBMACTGB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07945</td>
      <td>5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid</td>
      <td>GKBQRPKZHUFGOB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08927</td>
      <td>Amperozide</td>
      <td>NNAIYOXJNVGUOM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00805</td>
      <td>Minaprine</td>
      <td>LDMWSLGGVTVJPG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00298</td>
      <td>Dapiprazole</td>
      <td>RFWZESUMWJKKRN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08057</td>
      <td>N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine</td>
      <td>VWJPPYCULHDHBB-HNNXBMFYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB11442</td>
      <td>Oleandomycin</td>
      <td>RZPAKFUAFGMUPI-QESOVKLGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB03984</td>
      <td>Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide</td>
      <td>MWTQNXVXPLTHJB-YADHBBJMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB03453</td>
      <td>(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester</td>
      <td>MRNGXYMKYHNMLV-PKTZIBPZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB13451</td>
      <td>Tioclomarol</td>
      <td>WRGOVNKNTPWHLZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12500</td>
      <td>Fedratinib</td>
      <td>JOOXLOJCABQBSG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13078</td>
      <td>KOSN-1724</td>
      <td>JAYGOFBXDFAXBW-CYEKYUJNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB01436</td>
      <td>Alfacalcidol</td>
      <td>OFHCOWSQAMBJIW-AVJTYSNKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12336</td>
      <td>GDC-0917</td>
      <td>HSHPBORBOJIXSQ-HARLFGEKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB03996</td>
      <td>3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol</td>
      <td>QBZAPFWYAPXRGQ-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB11263</td>
      <td>Polydatin</td>
      <td>HSTZMXCBWJGKHG-CUYWLFDKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00177</td>
      <td>Valsartan</td>
      <td>ACWBQPMHZXGDFX-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB12511</td>
      <td>Imiglitazar</td>
      <td>ULVDFHLHKNJICZ-QCWLDUFUSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB08450</td>
      <td>N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine</td>
      <td>HNHRWNUXTCATSG-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07761</td>
      <td>(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol</td>
      <td>ZVSBKYYVBCKDBO-OAHLLOKOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB04392</td>
      <td>Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]</td>
      <td>HIZKPJUTKKJDGA-BETUJISGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB03916</td>
      <td>4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine</td>
      <td>RHOOHUMOHVIXEF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB13991</td>
      <td>Pipequaline</td>
      <td>AMEWZCMTSIONOX-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06188</td>
      <td>Ispinesib</td>
      <td>QJZRFPJCWMNVAV-HHHXNRCGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB11819</td>
      <td>ASP-4058</td>
      <td>NJNXCJPSMWKXHO-VIFPVBQESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06625</td>
      <td>Vipadenant</td>
      <td>HQSBCDPYXDGTCL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12269</td>
      <td>PF-06273340</td>
      <td>BPIWZDNVMQQBQX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06040</td>
      <td>Filanesib</td>
      <td>LLXISKGBWFTGEI-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB13814</td>
      <td>Talampicillin</td>
      <td>SOROUYSPFADXSN-SUWVAFIASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07728</td>
      <td>2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>XJJYJNMNYDNXNO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB06718</td>
      <td>Stanozolol</td>
      <td>LKAJKIOFIWVMDJ-IYRCEVNGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB00834</td>
      <td>Mifepristone</td>
      <td>VKHAHZOOUSRJNA-GCNJZUOMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07741</td>
      <td>4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE</td>
      <td>VPNYXOTTXAXSIH-SXYSDOLCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB11804</td>
      <td>AZD-5672</td>
      <td>SCXSQUUTGCWHFU-WJOKGBTCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00247</td>
      <td>Methysergide</td>
      <td>KPJZHOPZRAFDTN-NQUBZZJWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08351</td>
      <td>N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide</td>
      <td>MNEXDVSJIUQQRH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12623</td>
      <td>Taprenepag</td>
      <td>MFFBXYNKZHTCEY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12910</td>
      <td>Emicerfont</td>
      <td>JFHJGXQFESYQGY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01116</td>
      <td>Trimethaphan</td>
      <td>CHQOEHPMXSHGCL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12511</td>
      <td>Imiglitazar</td>
      <td>ULVDFHLHKNJICZ-QCWLDUFUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12022</td>
      <td>Evatanepag</td>
      <td>WOHRHWDYFNWPNG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB12887</td>
      <td>Tazemetostat</td>
      <td>NSQSAUGJQHDYNO-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13533</td>
      <td>Methylestrenolone</td>
      <td>ZXSWTMLNIIZPET-ZOFHRBRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB03076</td>
      <td>AHA047</td>
      <td>CGBDAHCDSVOMCF-FYZVQMPESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB12998</td>
      <td>PF-00217830</td>
      <td>QGNOXTFZOLDODX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB01659</td>
      <td>3-(1,10-Phenanthrol-2-Yl)-L-Alanine</td>
      <td>LODBCIBKOKOGNL-LBPRGKRZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01094</td>
      <td>Hesperetin</td>
      <td>AIONOLUJZLIMTK-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB13532</td>
      <td>Cyclopenthiazide</td>
      <td>BKYKPTRYDKTTJY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06623</td>
      <td>Flupirtine</td>
      <td>JUUFBMODXQKSTD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13308</td>
      <td>Oxametacin</td>
      <td>AJRNYCDWNITGHF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07844</td>
      <td>6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE</td>
      <td>PHLKBODTBJLXRD-WFASDCNBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07830</td>
      <td>(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE</td>
      <td>DIRIFWIKLRTNMB-DYVFJYSZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB05830</td>
      <td>Trestolone</td>
      <td>YSGQGNQWBLYHPE-CFUSNLFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13531</td>
      <td>Nicofetamide</td>
      <td>DWODOIKZDGJOPQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12420</td>
      <td>Diazepinomicin</td>
      <td>SALVHVNECODMJP-GNUCVDFRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07665</td>
      <td>N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>STHCHQXQLDMISY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07664</td>
      <td>5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE</td>
      <td>ARIOBGGRZJITQX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13954</td>
      <td>Estradiol cypionate</td>
      <td>UOACKFBJUYNSLK-XRKIENNPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12591</td>
      <td>BMS-911543</td>
      <td>JCINBYQJBYJGDM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB00773</td>
      <td>Etoposide</td>
      <td>VJJPUSNTGOMMGY-MRVIYFEKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB01147</td>
      <td>Cloxacillin</td>
      <td>LQOLIRLGBULYKD-JKIFEVAISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12590</td>
      <td>Indiplon</td>
      <td>CBIAWPMZSFFRGN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07795</td>
      <td>Fisetin</td>
      <td>XHEFDIBZLJXQHF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB04097</td>
      <td>Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose</td>
      <td>OAPPZHVTNHJVAL-JZMIEXBBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB04301</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate</td>
      <td>ZLAHDRAQCSQPOC-UHFFFAOYSA-P</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB13002</td>
      <td>HKI-357</td>
      <td>NERXPXBELDBEPZ-RMKNXTFCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB13397</td>
      <td>Prenoxdiazine</td>
      <td>PXZDWASDNFWKSD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB13874</td>
      <td>Enasidenib</td>
      <td>DYLUUSLLRIQKOE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB03173</td>
      <td>CRA_10433</td>
      <td>CFSQPEBVGUSQII-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB03157</td>
      <td>N,O-Didansyl-L-Tyrosine</td>
      <td>LUBOPDUYHWABFG-NDEPHWFRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB07183</td>
      <td>N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide</td>
      <td>CPVRYQAOUPSUDO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12715</td>
      <td>MSX-122</td>
      <td>PXZXYRKDDXKDTK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB15346</td>
      <td>GLPG-1205</td>
      <td>IRBAWVGZNJIROV-SFHVURJKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07382</td>
      <td>N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine</td>
      <td>WJNBSTLIALIIEW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lu7</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08309</td>
      <td>3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL</td>
      <td>AMFGILNPFBVREA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00317</td>
      <td>Gefitinib</td>
      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB12134</td>
      <td>Gepotidacin</td>
      <td>PZFAZQUREQIODZ-LJQANCHMSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08341</td>
      <td>4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide</td>
      <td>CAUFYHKGKDJMQG-HZPDHXFCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB05608</td>
      <td>MKC-1</td>
      <td>OVSKGTONMLKNPZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB05611</td>
      <td>Apilimod</td>
      <td>HSKAZIJJKRAJAV-KOEQRZSOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14075</td>
      <td>Imidurea</td>
      <td>ZCTXEAQXZGPWFG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB06849</td>
      <td>1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine</td>
      <td>RQWYWHUKHYFIPB-VQHVLOKHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13425</td>
      <td>Flutrimazole</td>
      <td>QHMWCHQXCUNUAK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB00694</td>
      <td>Daunorubicin</td>
      <td>STQGQHZAVUOBTE-VGBVRHCVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB11912</td>
      <td>Lanopepden</td>
      <td>SWHNZGMQMGFQGW-MSOLQXFVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB14982</td>
      <td>Miransertib</td>
      <td>HNFMVVHMKGFCMB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14093</td>
      <td>(1,2,6,7-3H)Testosterone</td>
      <td>MUMGGOZAMZWBJJ-JQSYSRDDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB13072</td>
      <td>GDC-0349</td>
      <td>RGJOJUGRHPQXGF-INIZCTEOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12770</td>
      <td>Lafutidine</td>
      <td>KMZQAVXSMUKBPD-DJWKRKHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11950</td>
      <td>Teneligliptin</td>
      <td>WGRQANOPCQRCME-PMACEKPBSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB06638</td>
      <td>Quarfloxin</td>
      <td>WOQIDNWTQOYDLF-CGAIIQECSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13919</td>
      <td>Candesartan</td>
      <td>HTQMVQVXFRQIKW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB05294</td>
      <td>Vandetanib</td>
      <td>UHTHHESEBZOYNR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB09073</td>
      <td>Palbociclib</td>
      <td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12150</td>
      <td>Pelubiprofen</td>
      <td>AUZUGWXLBGZUPP-GXDHUFHOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB15425</td>
      <td>CYC-065</td>
      <td>DLPIYBKBHMZCJI-WBVHZDCISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB15109</td>
      <td>Ingenol disoxate</td>
      <td>GLIUZQUNUNICGS-XUBYYPQFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB01774</td>
      <td>Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester</td>
      <td>WFPZSXYXPSUOPY-ROYWQJLOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB05408</td>
      <td>Emricasan</td>
      <td>SCVHJVCATBPIHN-SJCJKPOMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01415</td>
      <td>Ceftibuten</td>
      <td>UNJFKXSSGBWRBZ-BJCIPQKHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB03916</td>
      <td>4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine</td>
      <td>RHOOHUMOHVIXEF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01406</td>
      <td>Danazol</td>
      <td>POZRVZJJTULAOH-LHZXLZLDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08233</td>
      <td>6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE</td>
      <td>RFSDQDHHBKYQOD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01261</td>
      <td>Sitagliptin</td>
      <td>MFFMDFFZMYYVKS-SECBINFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB15057</td>
      <td>NUC-1031</td>
      <td>NHTKGYOMICWFQZ-KKQYNPQSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01147</td>
      <td>Cloxacillin</td>
      <td>LQOLIRLGBULYKD-JKIFEVAISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14679</td>
      <td>Quingestanol acetate</td>
      <td>FLGJKPPXEKYCBY-AKCFYGDASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12719</td>
      <td>Turofexorate isopropyl</td>
      <td>INASOKQDNHHMRE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12147</td>
      <td>Erdafitinib</td>
      <td>OLAHOMJCDNXHFI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB07539</td>
      <td>4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID</td>
      <td>JLRKRQCTYQGDKJ-GHXNOFRVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01092</td>
      <td>Ouabain</td>
      <td>LPMXVESGRSUGHW-HBYQJFLCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>1r42</td>
      <td>DB02555</td>
      <td>SP4160</td>
      <td>VCXMTWSYQSVWRK-AREMUKBSSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB05465</td>
      <td>Tandutinib</td>
      <td>UXXQOJXBIDBUAC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01070</td>
      <td>Dihydrotachysterol</td>
      <td>ILYCWAKSDCYMBB-OPCMSESCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB15209</td>
      <td>MK-0736</td>
      <td>ORQZQBUNAMJFCY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06833</td>
      <td>1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE</td>
      <td>MMIJMYOYKAKQPN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB13571</td>
      <td>Pentamycin</td>
      <td>AGJUUQSLGVCRQA-SWOUQTJZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB06140</td>
      <td>SUVN-502</td>
      <td>GWCYPEHWIZXYFZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08423</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE</td>
      <td>QKZZJXRGCHXIAI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07187</td>
      <td>6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE</td>
      <td>FXFPQPNUMWQRAO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08400</td>
      <td>4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid</td>
      <td>KUEKMTNOUPAOBS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB12323</td>
      <td>Radotinib</td>
      <td>DUPWHXBITIZIKZ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB12432</td>
      <td>CC-401</td>
      <td>XDJCLCLBSGGNKS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB02358</td>
      <td>LY374571</td>
      <td>SZHRIPFGZWWRKW-VIFPVBQESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB15063</td>
      <td>Inarigivir soproxil</td>
      <td>CJCYTUJOSMYXLE-JDLSZIHUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07216</td>
      <td>(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE</td>
      <td>ZMGCFGGMTCMSDP-QHCPKHFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07210</td>
      <td>3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>JECHSYMSTXETFI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB02621</td>
      <td>Latrunculin A</td>
      <td>DDVBPZROPPMBLW-IZGXTMSKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01254</td>
      <td>Dasatinib</td>
      <td>ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB15205</td>
      <td>Capromorelin</td>
      <td>KVLLHLWBPNCVNR-SKCUWOTOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14879</td>
      <td>Cefiderocol</td>
      <td>DBPPRLRVDVJOCL-FQRUVTKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB05511</td>
      <td>Piclidenoson</td>
      <td>HUJXGQILHAUCCV-MOROJQBDSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12306</td>
      <td>Cipargamin</td>
      <td>CKLPLPZSUQEDRT-WPCRTTGESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08395</td>
      <td>2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE</td>
      <td>ZSOXFJURLPCSOO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB00897</td>
      <td>Triazolam</td>
      <td>JOFWLTCLBGQGBO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08795</td>
      <td>Azidocillin</td>
      <td>ODFHGIPNGIAMDK-NJBDSQKTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08514</td>
      <td>6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>IQKMJWDYMFWZRF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13927</td>
      <td>anle138b</td>
      <td>RCQIIBJSUWYYFU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB12260</td>
      <td>Radiprodil</td>
      <td>GKGRZLGAQZPEHO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13587</td>
      <td>Mesterolone</td>
      <td>UXYRZJKIQKRJCF-TZPFWLJSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB00948</td>
      <td>Mezlocillin</td>
      <td>YPBATNHYBCGSSN-VWPFQQQWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB01340</td>
      <td>Cilazapril</td>
      <td>HHHKFGXWKKUNCY-FHWLQOOXSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04942</td>
      <td>Tamibarotene</td>
      <td>MUTNCGKQJGXKEM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07794</td>
      <td>5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</td>
      <td>XVECMUKVOMUNLE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12627</td>
      <td>GSK-1292263</td>
      <td>AYJRTVVIBJSSKN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6wiq</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB14714</td>
      <td>Tenivastatin</td>
      <td>XWLXKKNPFMNSFA-HGQWONQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB11732</td>
      <td>Lasmiditan</td>
      <td>XEDHVZKDSYZQBF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08111</td>
      <td>4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol</td>
      <td>ZGJYGQLGSXWEMY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01859</td>
      <td>4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate</td>
      <td>HTJXTKBIUVFUAR-XHIBXCGHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB13002</td>
      <td>HKI-357</td>
      <td>NERXPXBELDBEPZ-RMKNXTFCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06235</td>
      <td>Vadimezan</td>
      <td>XGOYIMQSIKSOBS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07770</td>
      <td>5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>DJPFUQBNQLKCAB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB14069</td>
      <td>ONT-093</td>
      <td>RSJCLODJSVZNQA-BQYQJAHWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6wiq</td>
      <td>DB07833</td>
      <td>N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide</td>
      <td>PMMLSQFPBFKLHH-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4b</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06710</td>
      <td>Methyltestosterone</td>
      <td>GCKMFJBGXUYNAG-HLXURNFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB13471</td>
      <td>Nalfurafine</td>
      <td>XGZZHZMWIXFATA-UEZBDDGYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB13994</td>
      <td>AZD-7325</td>
      <td>KYDURMHFWXCKMW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB12385</td>
      <td>10-hydroxycamptothecin</td>
      <td>HAWSQZCWOQZXHI-FQEVSTJZSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08043</td>
      <td>1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>DDDLGNOZDKDSEG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08052</td>
      <td>1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>NVRXTLZYXZNATH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB01948</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One</td>
      <td>VXIYTVJEIXMAQF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB08770</td>
      <td>4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol</td>
      <td>PWTBZOIUWZOPFT-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB12973</td>
      <td>Serlopitant</td>
      <td>FLNYCRJBCNNHRH-OIYLJQICSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB14035</td>
      <td>Englitazone</td>
      <td>MVDXXGIBARMXSA-PYUWXLGESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01990</td>
      <td>Cholesterol sulfate</td>
      <td>BHYOQNUELFTYRT-DPAQBDIFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6wiq</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB11966</td>
      <td>BMS-986094</td>
      <td>YFXGICNMLCGLHJ-RSKRLRQZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB07274</td>
      <td>N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide</td>
      <td>ZATGFXTWDKIEKC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB03067</td>
      <td>4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>VFYAZSTYKPFSFL-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12732</td>
      <td>Firategrast</td>
      <td>YLFZHHDVRSYTKT-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08153</td>
      <td>(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE</td>
      <td>VZTAZMSAAIUZJV-HWKANZROSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08907</td>
      <td>Canagliflozin</td>
      <td>XTNGUQKDFGDXSJ-ZXGKGEBGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB08911</td>
      <td>Trametinib</td>
      <td>LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01640</td>
      <td>(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One</td>
      <td>QNURTFDBHAQRSI-OAHLLOKOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB01761</td>
      <td>4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine</td>
      <td>QICPQLFMWYQJGX-SFHVURJKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12746</td>
      <td>AKN-028</td>
      <td>JLRIJKVMMZEKDF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB14899</td>
      <td>Tavapadon</td>
      <td>AKQXQLUNFKDZBN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6wiq</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11979</td>
      <td>Elagolix</td>
      <td>HEAUOKZIVMZVQL-VWLOTQADSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08159</td>
      <td>4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE</td>
      <td>AHIJTWCJGCWHMT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13616</td>
      <td>Melagatran</td>
      <td>DKWNMCUOEDMMIN-PKOBYXMFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB12121</td>
      <td>Entospletinib</td>
      <td>XSMSNFMDVXXHGJ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB05408</td>
      <td>Emricasan</td>
      <td>SCVHJVCATBPIHN-SJCJKPOMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01713</td>
      <td>Udp-Alpha-D-Xylopyranose</td>
      <td>DQQDLYVHOTZLOR-OCIMBMBZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB05076</td>
      <td>Fenretinide</td>
      <td>AKJHMTWEGVYYSE-FXILSDISSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB06625</td>
      <td>Vipadenant</td>
      <td>HQSBCDPYXDGTCL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08125</td>
      <td>4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE</td>
      <td>BOMPRXSVSIPRDT-PTNGSMBKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB04892</td>
      <td>Phenserine</td>
      <td>PBHFNBQPZCRWQP-QUCCMNQESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB08350</td>
      <td>5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE</td>
      <td>GYQRHHQPEMOLKH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08126</td>
      <td>3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE</td>
      <td>DMCRNUMVSATRTP-LCYFTJDESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB04908</td>
      <td>Flibanserin</td>
      <td>PPRRDFIXUUSXRA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12163</td>
      <td>Sarpogrelate</td>
      <td>FFYNAVGJSYHHFO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB02196</td>
      <td>Uridine-Diphosphate-N-Acetylgalactosamine</td>
      <td>LFTYTUAZOPRMMI-NESSUJCYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>7bv1</td>
      <td>DB06652</td>
      <td>Vicriviroc</td>
      <td>CNPVJJQCETWNEU-CYFREDJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12644</td>
      <td>AZD-2066</td>
      <td>SXWHYTICXCLKDG-GFCCVEGCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB12645</td>
      <td>Givinostat</td>
      <td>YALNUENQHAQXEA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9q</td>
      <td>DB11855</td>
      <td>Revefenacin</td>
      <td>FYDWDCIFZSGNBU-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB01732</td>
      <td>(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One</td>
      <td>SQBOSZXDOHQFAA-ZRTHHSRSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB13458</td>
      <td>Thebacon</td>
      <td>RRJQTGHQFYTZOW-ILWKUFEGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB07680</td>
      <td>[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</td>
      <td>HUJXISJLAPAFBO-IBGZPJMESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11995</td>
      <td>Avatrombopag</td>
      <td>OFZJKCQENFPZBH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB04957</td>
      <td>Azimilide</td>
      <td>MREBEPTUUMTTIA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lxt</td>
      <td>DB11637</td>
      <td>Delamanid</td>
      <td>XDAOLTSRNUSPPH-XMMPIXPASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB00197</td>
      <td>Troglitazone</td>
      <td>GXPHKUHSUJUWKP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB08962</td>
      <td>Glibornuride</td>
      <td>RMTYNAPTNBJHQI-LLDVTBCESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB07360</td>
      <td>1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>JJHXPDTVQKWKHA-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB15075</td>
      <td>4-demethyl-4-cholesteryloxycarbonylpenclomedine</td>
      <td>ZJUUIXYKTPSIOH-LEZJFEBPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04609</td>
      <td>INHIBITOR Q8467 OF DUPONT MERCK</td>
      <td>HFLCERPZYCWLSZ-VKONIRKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04576</td>
      <td>Fleroxacin</td>
      <td>XBJBPGROQZJDOJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB15358</td>
      <td>JNJ-54175446</td>
      <td>CWFVVQFVGMFTBD-SECBINFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB14055</td>
      <td>(S)-Warfarin</td>
      <td>PJVWKTKQMONHTI-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB15407</td>
      <td>Acalisib</td>
      <td>DOCINCLJNAXZQF-LBPRGKRZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07966</td>
      <td>[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile</td>
      <td>NVMCVWOODOWOLT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07811</td>
      <td>N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide</td>
      <td>UBVTVSINEVHYSY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB14069</td>
      <td>ONT-093</td>
      <td>RSJCLODJSVZNQA-BQYQJAHWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08562</td>
      <td>4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID</td>
      <td>FTXJWRRYLLRFMG-MDZDMXLPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB14086</td>
      <td>Cianidanol</td>
      <td>PFTAWBLQPZVEMU-DZGCQCFKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02001</td>
      <td>5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine</td>
      <td>CZLWCJRHDBTCGQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08569</td>
      <td>3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE</td>
      <td>VLPMRZSKJUTRBQ-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04514</td>
      <td>Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester</td>
      <td>DFYLLEBFVZTKHD-VMIOUTBZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04615</td>
      <td>(S)-tacrine(10)-hupyridone</td>
      <td>ROTFGKJJMRTWBD-MHZLTWQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04616</td>
      <td>TACRINE(8)-4-AMINOQUINOLINE</td>
      <td>UNVOAAWEEGAXTN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04630</td>
      <td>Aldosterone</td>
      <td>PQSUYGKTWSAVDQ-ZVIOFETBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04778</td>
      <td>SC45647</td>
      <td>LPSXGZAUAOMRNU-FZKQIMNGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB13778</td>
      <td>Cefazedone</td>
      <td>VTLCNEGVSVJLDN-MLGOLLRUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB13783</td>
      <td>Acemetacin</td>
      <td>FSQKKOOTNAMONP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00203</td>
      <td>Sildenafil</td>
      <td>BNRNXUUZRGQAQC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04757</td>
      <td>GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE</td>
      <td>GKAPYWCOOQBBHV-KXSYMAMXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04725</td>
      <td>Licofelone</td>
      <td>UAWXGRJVZSAUSZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06844</td>
      <td>4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE</td>
      <td>MBXKBJLIESPLIK-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB15456</td>
      <td>Vericiguat</td>
      <td>QZFHIXARHDBPBY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15241</td>
      <td>Methylsamidorphan</td>
      <td>ATCVVCBJNHXIEX-ZAHKBLQYSA-O</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04664</td>
      <td>Cyclohexyl-pentyl-maltoside</td>
      <td>RVTGFZGNOSKUDA-ZNGNCRBCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB01092</td>
      <td>Ouabain</td>
      <td>LPMXVESGRSUGHW-HBYQJFLCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04651</td>
      <td>BIOTINOL-5-AMP</td>
      <td>KBOGUFFJCBPJEH-SQGSUPJISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15247</td>
      <td>Vorolanib</td>
      <td>KMIOJWCYOHBUJS-HAKPAVFJSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07589</td>
      <td>N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE</td>
      <td>DWWVPKCSDHDILN-OALUTQOASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15282</td>
      <td>Fluorofuranylnorprogesterone F-18</td>
      <td>VJKRBRUNEOHPBS-JQKUZGBFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04791</td>
      <td>2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL</td>
      <td>DKBAWRNTUZFJKV-BSDSXHPESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04409</td>
      <td>Naphthalene Trisulfonate</td>
      <td>ZPBSAMLXSQCSOX-UHFFFAOYSA-K</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01990</td>
      <td>Cholesterol sulfate</td>
      <td>BHYOQNUELFTYRT-DPAQBDIFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06228</td>
      <td>Rivaroxaban</td>
      <td>KGFYHTZWPPHNLQ-AWEZNQCLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03802</td>
      <td>1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>ZGHFWBDHZZKWSI-LITSAYRRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB15145</td>
      <td>Ziresovir</td>
      <td>GAAICKUTDBZCMT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03744</td>
      <td>Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate</td>
      <td>RONLONYAIBUEKT-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07967</td>
      <td>9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE</td>
      <td>JJNKDTWKWYLERH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB09073</td>
      <td>Palbociclib</td>
      <td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06190</td>
      <td>Solabegron</td>
      <td>LLDXOPKUNJTIRF-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03585</td>
      <td>Oxyphenbutazone</td>
      <td>HFHZKZSRXITVMK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15450</td>
      <td>PF-05105679</td>
      <td>BXNMZRPTQFVRFA-QGZVFWFLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03509</td>
      <td>2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide</td>
      <td>FLYGLPYJEQPCFY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07999</td>
      <td>{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID</td>
      <td>IXLBOIRSEDMRPI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03496</td>
      <td>Alvocidib</td>
      <td>BIIVYFLTOXDAOV-YVEFUNNKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03495</td>
      <td>4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1-&gt;4)-Alpha-D-Threo-Hexopyranosyl-(1-&gt;6)-Alpha-L-Threo-Hexopyranose</td>
      <td>FZLCJZILHGFQLM-PISLJJGOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB14765</td>
      <td>Rivoceranib</td>
      <td>WPEWQEMJFLWMLV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04434</td>
      <td>Naphthyridine Inhibitor</td>
      <td>YRBHUKMLAGQYHS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06302</td>
      <td>Glesatinib</td>
      <td>YRCHYHRCBXNYNU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03909</td>
      <td>Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate</td>
      <td>UFZTZBNSLXELAL-IOSLPCCCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06469</td>
      <td>Lestaurtinib</td>
      <td>UIARLYUEJFELEN-DMVVYWCZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04298</td>
      <td>3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One</td>
      <td>ZEBFKFGJWHOOST-LJAQVGFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB04764</td>
      <td>[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</td>
      <td>CCLHROFBSWWOQO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08352</td>
      <td>6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine</td>
      <td>FQYJTHIYAQQJAB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04200</td>
      <td>Matairesinol</td>
      <td>MATGKVZWFZHCLI-LSDHHAIUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07608</td>
      <td>N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</td>
      <td>JDGOPNUGILVNJZ-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07612</td>
      <td>6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE</td>
      <td>XQKJVNGGVLHNLA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07848</td>
      <td>5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide</td>
      <td>BHNMMFGOJRIAEZ-LRDDRELGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04725</td>
      <td>Licofelone</td>
      <td>UAWXGRJVZSAUSZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01967</td>
      <td>N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide</td>
      <td>LICJTIDRHJECTD-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB15269</td>
      <td>ALK-4290</td>
      <td>DWKNOLCXIFYNFV-HSZRJFAPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04092</td>
      <td>Apstatin</td>
      <td>YVUUZAPYLPWFHE-HXFGRODQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07917</td>
      <td>4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE</td>
      <td>TZQGXAHOROZEKN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06311</td>
      <td>Darapladib</td>
      <td>WDPFJWLDPVQCAJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB09178</td>
      <td>Phenaridine</td>
      <td>ODPKHHGQKIYCTJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15297</td>
      <td>Petesicatib</td>
      <td>KXAAIORSMACJSI-AEFFLSMTSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03478</td>
      <td>2'-O-Acetyl Adenosine-5-Diphosphoribose</td>
      <td>BFNOPXRXIQJDHO-DLFWLGJNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06908</td>
      <td>(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID</td>
      <td>PAWOPJKHTZCKMT-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB13718</td>
      <td>Hydroquinine</td>
      <td>LJOQGZACKSYWCH-WZBLMQSHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06280</td>
      <td>Senicapoc</td>
      <td>SCTZUZTYRMOMKT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00482</td>
      <td>Celecoxib</td>
      <td>RZEKVGVHFLEQIL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB13954</td>
      <td>Estradiol cypionate</td>
      <td>UOACKFBJUYNSLK-XRKIENNPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06249</td>
      <td>Arzoxifene</td>
      <td>MCGDSOGUHLTADD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB14568</td>
      <td>Ivosidenib</td>
      <td>WIJZXSAJMHAVGX-DHLKQENFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08426</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</td>
      <td>PLXOQMHGHDZMSX-AWEZNQCLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB13941</td>
      <td>Piperaquine</td>
      <td>UCRHFBCYFMIWHC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06176</td>
      <td>Romidepsin</td>
      <td>OHRURASPPZQGQM-GCCNXGTGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07395</td>
      <td>4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid</td>
      <td>NWQGDIBCFLDHDO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06090</td>
      <td>Bradanicline</td>
      <td>OXKRFEWMSWPKKV-GHTZIAJQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08437</td>
      <td>Puromycin</td>
      <td>RXWNCPJZOCPEPQ-NVWDDTSBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB05903</td>
      <td>KOS-1584</td>
      <td>XAYAKDZVINDZGB-BMVMHAJPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB14664</td>
      <td>Difluocortolone pivalate</td>
      <td>UWGRWFCLGQWKPR-GSTUPEFVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07323</td>
      <td>2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID</td>
      <td>CTZLIARLNXSXGL-ALCCZGGFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB13936</td>
      <td>JNJ-28330835</td>
      <td>RYBKPGYFXRNMMU-LBPRGKRZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB14801</td>
      <td>Lanifibranor</td>
      <td>OQDQIFQRNZIEEJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00611</td>
      <td>Butorphanol</td>
      <td>IFKLAQQSCNILHL-PWRODBHTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06604</td>
      <td>Ilepatril</td>
      <td>FXKFFTMLFPWYFH-RDGPPVDQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB13032</td>
      <td>Enecadin</td>
      <td>SZSHJTJCJOWMHM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB13552</td>
      <td>Trifluperidol</td>
      <td>GPMXUUPHFNMNDH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00547</td>
      <td>Desoximetasone</td>
      <td>VWVSBHGCDBMOOT-IIEHVVJPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07081</td>
      <td>(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>FDEXEPZGMKFCTG-PSASIEDQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB14802</td>
      <td>ONO-2952</td>
      <td>ZBQMTQGDBFZUBG-NRFANRHFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07253</td>
      <td>N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</td>
      <td>QTFCKBFCXDAZIU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06457</td>
      <td>Tecastemizole</td>
      <td>SFOVDSLXFUGAIV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB02616</td>
      <td>FR117016</td>
      <td>CKJGKHXCUDWFDC-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06403</td>
      <td>Ambrisentan</td>
      <td>OUJTZYPIHDYQMC-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06370</td>
      <td>Indisulam</td>
      <td>SETFNECMODOHTO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06345</td>
      <td>AR-9281</td>
      <td>HUDQLWBKJOMXSZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB13266</td>
      <td>Cefatrizine</td>
      <td>UOCJDOLVGGIYIQ-PBFPGSCMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04807</td>
      <td>4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE</td>
      <td>HQYVHBCTLFPWRQ-ZMFOIVQCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07432</td>
      <td>[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate</td>
      <td>ITVRELFVFCOUMV-ZVZWZHPPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07147</td>
      <td>methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate</td>
      <td>HJWMYFBKJRVWJY-YKSBVNFPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB09003</td>
      <td>Clocapramine</td>
      <td>QAZKXHSIKKNOHH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02106</td>
      <td>[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid</td>
      <td>KIRQJXNQGZAKGR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB13651</td>
      <td>Lorajmine</td>
      <td>LAHDERDHXJFFJU-ZWNKPRIXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07616</td>
      <td>4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid</td>
      <td>LKZZDHKJFDTYCH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08493</td>
      <td>5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID</td>
      <td>AKWKBACKRMYPRV-NQIIRXRSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00253</td>
      <td>Medrysone</td>
      <td>GZENKSODFLBBHQ-ILSZZQPISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04883</td>
      <td>Darusentan</td>
      <td>FEJVSJIALLTFRP-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06922</td>
      <td>2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>CZNPWASYMRBJCX-GOSISDBHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15108</td>
      <td>Tipranavir C-14</td>
      <td>SUJUHGSWHZTSEU-MWQIXQBFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15120</td>
      <td>GSK-239512</td>
      <td>YFRBKEVUUCQYOW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06920</td>
      <td>Eribaxaban</td>
      <td>QQBKAVAGLMGMHI-WIYYLYMNSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB15124</td>
      <td>PF-05241328</td>
      <td>RVTSXVZXEGFIPW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB04886</td>
      <td>Calanolide A</td>
      <td>NIDRYBLTWYFCFV-FMTVUPSXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB03480</td>
      <td>Brequinar Analog</td>
      <td>WYKKHJQZENLZID-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB05116</td>
      <td>Thymectacin</td>
      <td>CFBLUORPOFELCE-BACVZHSASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>1r42</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08422</td>
      <td>[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE</td>
      <td>GEIDRYBJURDUSW-MOPGFXCFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB13407</td>
      <td>Nifenazone</td>
      <td>BRZANEXCSZCZCI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07453</td>
      <td>2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE</td>
      <td>VFMMPHCGEFXGIP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB05767</td>
      <td>Andrographolide</td>
      <td>BOJKULTULYSRAS-OTESTREVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02187</td>
      <td>Equilin</td>
      <td>WKRLQDKEXYKHJB-HFTRVMKXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07460</td>
      <td>2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE</td>
      <td>UYJNQQDJUOUFQJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB14889</td>
      <td>Derazantinib</td>
      <td>KPJDVVCDVBFRMU-AREMUKBSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB05524</td>
      <td>Pelitinib</td>
      <td>WVUNYSQLFKLYNI-AATRIKPKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB05498</td>
      <td>KW-7158</td>
      <td>NAFSYPCVPLWHFY-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00328</td>
      <td>Indometacin</td>
      <td>CGIGDMFJXJATDK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07546</td>
      <td>[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid</td>
      <td>BBYRUZKRFAIQSR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08399</td>
      <td>PICEATANNOL</td>
      <td>CDRPUGZCRXZLFL-OWOJBTEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00276</td>
      <td>Amsacrine</td>
      <td>XCPGHVQEEXUHNC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08397</td>
      <td>6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID</td>
      <td>NKGNOWNPXBURRW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06963</td>
      <td>3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide</td>
      <td>ZFGCLYUGFRNYFE-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB05861</td>
      <td>Tasquinimod</td>
      <td>ONDYALNGTUAJDX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06608</td>
      <td>Tafenoquine</td>
      <td>LBHLFPGPEGDCJG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03476</td>
      <td>Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine</td>
      <td>NQRIWXVAIWPBEM-OALUTQOASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03435</td>
      <td>Uridine-5'-Diphosphate</td>
      <td>XCCTYIAWTASOJW-XVFCMESISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01852</td>
      <td>Kaempherol</td>
      <td>IYRMWMYZSQPJKC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB13215</td>
      <td>Sulfobromophthalein</td>
      <td>OHTXTCNTQJFRIG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01838</td>
      <td>6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone</td>
      <td>GKDYOXMZSXVKPP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01748</td>
      <td>N-Benzyl-4-Sulfamoyl-Benzamide</td>
      <td>CZKNSZUJCJHTTM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08282</td>
      <td>O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate</td>
      <td>BWRRXOIACQYNEK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01873</td>
      <td>Epothilone D</td>
      <td>XOZIUKBZLSUILX-GIQCAXHBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB15460</td>
      <td>AGG-523</td>
      <td>JWQMTWCFNZSLNR-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01661</td>
      <td>1-(5-phospho-D-ribosyl)-ATP</td>
      <td>RKNHJBVBFHDXGR-MRUDJCSFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01633</td>
      <td>Deoxy-2-fluoro-beta-D-cellotrioside</td>
      <td>BZNXZJAUEMJQJB-QSCMNUSVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB15110</td>
      <td>Onvansertib</td>
      <td>QHLVBNKYJGBCQJ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01594</td>
      <td>Cinolazepam</td>
      <td>XAXMYHMKTCNRRZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08539</td>
      <td>3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CCDIUVLNHCGSMH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB04424</td>
      <td>RPR128515</td>
      <td>XFKVLKLCLYJKNF-MZNJEOGPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB13422</td>
      <td>Nicofuranose</td>
      <td>FUWFSXZKBMCSKF-ZASNTINBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB04685</td>
      <td>1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>GJNIPWYJQUGERM-BFLUCZKCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07630</td>
      <td>N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-IAGOWNOFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07203</td>
      <td>6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE</td>
      <td>OUEGMEMDEAOAEG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02058</td>
      <td>SU4984</td>
      <td>AZGZGRJOCKSSHA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08429</td>
      <td>N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide</td>
      <td>QRGBOABBMKYMLG-UXHICEINSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02023</td>
      <td>8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate</td>
      <td>AQIVLFLYHYFRKU-VPENINKCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB15319</td>
      <td>VM4-037</td>
      <td>QGYZPMXIVNIGKA-GMAHTHKFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11366</td>
      <td>Roquinimex</td>
      <td>SGOOQMRIPALTEL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01755</td>
      <td>N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone</td>
      <td>XVTRBLLRODNOJV-VBJYJYTRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB01219</td>
      <td>Dantrolene</td>
      <td>OZOMQRBLCMDCEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06281</td>
      <td>Torcetrapib</td>
      <td>CMSGWTNRGKRWGS-NQIIRXRSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB04690</td>
      <td>Camptothecin</td>
      <td>VSJKWCGYPAHWDS-FQEVSTJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB04689</td>
      <td>2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID</td>
      <td>ZXWVCCFKIRBLDP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB15106</td>
      <td>Surufatinib</td>
      <td>TTZSNFLLYPYKIL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08485</td>
      <td>(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID</td>
      <td>QMNMNSINKIFYBV-LMMKCTJWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB00444</td>
      <td>Teniposide</td>
      <td>NRUKOCRGYNPUPR-QBPJDGROSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08772</td>
      <td>3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID</td>
      <td>BCSVCWVQNOXFGL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB00559</td>
      <td>Bosentan</td>
      <td>GJPICJJJRGTNOD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB00734</td>
      <td>Risperidone</td>
      <td>RAPZEAPATHNIPO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB01640</td>
      <td>(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One</td>
      <td>QNURTFDBHAQRSI-OAHLLOKOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08911</td>
      <td>Trametinib</td>
      <td>LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01219</td>
      <td>Dantrolene</td>
      <td>OZOMQRBLCMDCEG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB01812</td>
      <td>Adenosine-3'-5'-Diphosphate</td>
      <td>WHTCPDAXWFLDIH-KQYNXXCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB01792</td>
      <td>Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate</td>
      <td>FZCSEXOMUJFOHQ-KPKSGTNCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01640</td>
      <td>(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One</td>
      <td>QNURTFDBHAQRSI-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07435</td>
      <td>1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE</td>
      <td>GFANZDFKCCJYRF-NSISKUIASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11512</td>
      <td>Dihydrostreptomycin</td>
      <td>ASXBYYWOLISCLQ-HZYVHMACSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07131</td>
      <td>(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide</td>
      <td>DOTBZTLJSXFKCP-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04794</td>
      <td>Bifonazole</td>
      <td>OCAPBUJLXMYKEJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01138</td>
      <td>Sulfinpyrazone</td>
      <td>MBGGBVCUIVRRBF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB02010</td>
      <td>Staurosporine</td>
      <td>HKSZLNNOFSGOKW-FYTWVXJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB01852</td>
      <td>Kaempherol</td>
      <td>IYRMWMYZSQPJKC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01157</td>
      <td>Trimetrexate</td>
      <td>NOYPYLRCIDNJJB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01319</td>
      <td>Fosamprenavir</td>
      <td>MLBVMOWEQCZNCC-OEMFJLHTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01320</td>
      <td>Fosphenytoin</td>
      <td>XWLUWCNOOVRFPX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB01329</td>
      <td>Cefoperazone</td>
      <td>GCFBRXLSHGKWDP-XCGNWRKASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01548</td>
      <td>Diprenorphine</td>
      <td>OIJXLIIMXHRJJH-KNLIIKEYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08244</td>
      <td>(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE</td>
      <td>VCOUEHUEFUDZIS-PMACEKPBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB01406</td>
      <td>Danazol</td>
      <td>POZRVZJJTULAOH-LHZXLZLDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08236</td>
      <td>(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one</td>
      <td>KEGQNJITMFBVAC-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB01180</td>
      <td>Rescinnamine</td>
      <td>SZLZWPPUNLXJEA-LAFLMMDJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01455</td>
      <td>19-Nor-5-androstenediol</td>
      <td>VVUQRXPUVKXAIO-XFUVECHXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01453</td>
      <td>Beta-hydroxyfentanyl</td>
      <td>JEFVHLMGRUJLET-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11455</td>
      <td>Robenacoxib</td>
      <td>ZEXGDYFACFXQPF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB01261</td>
      <td>Sitagliptin</td>
      <td>MFFMDFFZMYYVKS-SECBINFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11464</td>
      <td>Sulfaquinoxaline</td>
      <td>NHZLNPMOSADWGC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB01720</td>
      <td>(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid</td>
      <td>WLPJLQNKCJWAFL-RGEXLXHISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08710</td>
      <td>(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE</td>
      <td>BKZOQCGDCHOGOQ-MZLJFPOFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB01327</td>
      <td>Cefazolin</td>
      <td>MLYYVTUWGNIJIB-BXKDBHETSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB01732</td>
      <td>(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One</td>
      <td>SQBOSZXDOHQFAA-ZRTHHSRSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01568</td>
      <td>Codeine-N-oxide</td>
      <td>BDLSDHWCOJPHIE-KFUGMXNISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB06159</td>
      <td>Rubitecan</td>
      <td>VHXNKPBCCMUMSW-FQEVSTJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB13689</td>
      <td>Tacalcitol</td>
      <td>BJYLYJCXYAMOFT-RSFVBTMBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB04849</td>
      <td>Cediranib</td>
      <td>XXJWYDDUDKYVKI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08063</td>
      <td>1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE</td>
      <td>HLZMYWLMBBLASX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08073</td>
      <td>(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>YWTBGJGMTBHQTM-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11398</td>
      <td>Diclazuril</td>
      <td>ZSZFUDFOPOMEET-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07729</td>
      <td>3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide</td>
      <td>GAKOBKPDJJGRIL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08697</td>
      <td>4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide</td>
      <td>JDYIYIRPQKMWMM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB00436</td>
      <td>Bendroflumethiazide</td>
      <td>HDWIHXWEUNVBIY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB09268</td>
      <td>Picosulfuric acid</td>
      <td>UJIDKYTZIQTXPM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08092</td>
      <td>3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide</td>
      <td>VMLSXFMXUNVCSK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB15062</td>
      <td>Inarigivir</td>
      <td>LYMICVBGNUEHGE-FUQPUAIBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07728</td>
      <td>2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>XJJYJNMNYDNXNO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07700</td>
      <td>3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN</td>
      <td>YVAJWBACBRSVPR-NDUHRLLKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02861</td>
      <td>4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide</td>
      <td>DEHMSTGBNAXEGX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB14717</td>
      <td>Nitrazolam</td>
      <td>OYRPNABWTHDOFK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02932</td>
      <td>(R)-Bicalutamide</td>
      <td>LKJPYSCBVHEWIU-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03126</td>
      <td>Mant-Adp</td>
      <td>QPKUEBLEGWBRHC-BFHYXJOUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB05553</td>
      <td>Regrelor</td>
      <td>NXHAXEBZOXCDKD-XIXRRVGJSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB00354</td>
      <td>Buclizine</td>
      <td>MOYGZHXDRJNJEP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06229</td>
      <td>Ocaperidone</td>
      <td>ZZQNEJILGNNOEP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08011</td>
      <td>(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DXIHOIDYHQSQKJ-HMMYKYKNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB14867</td>
      <td>Parsaclisib</td>
      <td>ZQPDJCIXJHUERQ-QWRGUYRKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08657</td>
      <td>2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID</td>
      <td>SSXCWVOQWRUMGN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB15013</td>
      <td>TAK-243</td>
      <td>KJDAGXLMHXUAGV-DGWLBADLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03361</td>
      <td>2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate</td>
      <td>UQFVHIGKDHNMJT-XPTSAGLGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08034</td>
      <td>(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</td>
      <td>TVOPERZEGKBKAY-RGVLZGJSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07287</td>
      <td>2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL</td>
      <td>AOVDSWPGWPRTSR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB02483</td>
      <td>Etheno-Nad</td>
      <td>JCDBQDNBEQHDHK-BSLNIGMPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08043</td>
      <td>1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>DDDLGNOZDKDSEG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03234</td>
      <td>(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone</td>
      <td>YATCZCSDJCQNAL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB14896</td>
      <td>Selitrectinib</td>
      <td>OEBIHOVSAMBXIB-SJKOYZFVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB09230</td>
      <td>Azelnidipine</td>
      <td>ZKFQEACEUNWPMT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07648</td>
      <td>(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL</td>
      <td>TWEONIHFGKSPLC-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB03199</td>
      <td>4-Methoxy-E-Rhodomycin T</td>
      <td>XSSVYBYWQBNYOH-QJIXERIWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02804</td>
      <td>A-98881</td>
      <td>PMBZSBGCSQGJAQ-GRKNLSHJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB15109</td>
      <td>Ingenol disoxate</td>
      <td>GLIUZQUNUNICGS-XUBYYPQFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02491</td>
      <td>4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine</td>
      <td>CJSSYVIHFXDFFC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08248</td>
      <td>3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE</td>
      <td>BKDUVKJYBJDZQW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB15221</td>
      <td>PF-06260414</td>
      <td>ZKAVFOXYJCREBQ-SNVBAGLBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB15232</td>
      <td>Telaglenastat</td>
      <td>PRAAPINBUWJLGA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02398</td>
      <td>6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>NLBDETRVUYOIHQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08304</td>
      <td>(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>QZBQVXXESPXFPZ-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB04862</td>
      <td>Merimepodib</td>
      <td>JBPUGFODGPKTDW-SFHVURJKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08322</td>
      <td>2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID</td>
      <td>VJLMRHSHSNLOGC-NOPZTHQXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB15242</td>
      <td>MK-0533</td>
      <td>STWITCBWQHTJFJ-XMMPIXPASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06267</td>
      <td>Udenafil</td>
      <td>IYFNEFQTYQPVOC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB00878</td>
      <td>Chlorhexidine</td>
      <td>GHXZTYHSJHQHIJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB02432</td>
      <td>RU90395</td>
      <td>RLLAUERCSKPFGD-VMPREFPWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01765</td>
      <td>(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid</td>
      <td>INSBKYCYLCEBOD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08360</td>
      <td>2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>BIFHJPUTQBOBGJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02342</td>
      <td>2-Methoxyestradiol</td>
      <td>CQOQDQWUFQDJMK-SSTWWWIQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02507</td>
      <td>4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One</td>
      <td>PJVWKTKQMONHTI-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08242</td>
      <td>N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide</td>
      <td>OYTBZXSFNNAVKU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB04863</td>
      <td>Lefradafiban</td>
      <td>PGCFXITVMNNKON-ROUUACIJSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07059</td>
      <td>N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE</td>
      <td>GBXSOZDYCSBLQX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02694</td>
      <td>Pantoyl Adenylate</td>
      <td>GDPVENOGSVMRJL-FSRKKXLISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB14569</td>
      <td>Tedizolid</td>
      <td>XFALPSLJIHVRKE-GFCCVEGCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08159</td>
      <td>4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE</td>
      <td>AHIJTWCJGCWHMT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB14152</td>
      <td>Ginsenosides</td>
      <td>NLHQJXWYMZLQJY-SWIZOJJJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02656</td>
      <td>LY-294002</td>
      <td>CZQHHVNHHHRRDU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB00808</td>
      <td>Indapamide</td>
      <td>NDDAHWYSQHTHNT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02636</td>
      <td>9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid</td>
      <td>UCLGCTLOEZZSLA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02628</td>
      <td>1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide</td>
      <td>JUJIMRZGUBTJRV-NASSWSRMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB15149</td>
      <td>Futibatinib</td>
      <td>KEIPNCCJPRMIAX-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07689</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>NYNAFINLHQEHKU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB02602</td>
      <td>AL7182</td>
      <td>ICIXQGGQPKFQRL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB09488</td>
      <td>Acrivastine</td>
      <td>PWACSDKDOHSSQD-IUTFFREVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06625</td>
      <td>Vipadenant</td>
      <td>HQSBCDPYXDGTCL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02319</td>
      <td>5,6-Dihydroxy-Nadp</td>
      <td>LRAVAOPKUBJONV-IVCJQJMGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB11870</td>
      <td>RG-4733</td>
      <td>OJPLJFIFUQPSJR-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02673</td>
      <td>(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium</td>
      <td>VLGAHTYYCHWLNI-BHRZLAGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08390</td>
      <td>(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE</td>
      <td>AKNIHFDXRAOPAI-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07289</td>
      <td>5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>XEQPGVUGYAUMSA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB02827</td>
      <td>7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</td>
      <td>MDYIGSPVMWSFEZ-JTQLQIEISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04861</td>
      <td>Nebivolol</td>
      <td>KOHIRBRYDXPAMZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07692</td>
      <td>1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine</td>
      <td>SHWNKRPMUBFWKE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04942</td>
      <td>Tamibarotene</td>
      <td>MUTNCGKQJGXKEM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB02049</td>
      <td>2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide</td>
      <td>QOPFTBAEAJQKSY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04971</td>
      <td>Reglitazar</td>
      <td>QBQLYIISSRXYKL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08315</td>
      <td>2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE</td>
      <td>KIJXWOGFYAWTNC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02639</td>
      <td>4-methylumbelliferyl ??-D-glucoside</td>
      <td>YUDPTGPSBJVHCN-JZYAIQKZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02659</td>
      <td>Cholic Acid</td>
      <td>BHQCQFFYRZLCQQ-OELDTZBJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04792</td>
      <td>2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL</td>
      <td>CDEVHSIVANGYRI-XMTFNYHQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB02833</td>
      <td>[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine</td>
      <td>DYTKVFHLKPDNRW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08460</td>
      <td>3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile</td>
      <td>KXDIHAQCVNNLIB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04669</td>
      <td>TRIAZOLOPYRIMIDINE</td>
      <td>YWBFPKPWMSWWEA-UHFFFAOYSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07423</td>
      <td>(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide</td>
      <td>YVXVTLGIDOACBJ-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08459</td>
      <td>3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>SVMHTBVIPYVDIL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB02259</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide</td>
      <td>VSYGXLAJQDAWCZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB02164</td>
      <td>N-Sulfo-Flavin Mononucleotide</td>
      <td>ZLPUGFBBLGQWBS-SCRDCRAPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04716</td>
      <td>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</td>
      <td>VNDWQCSOSCCWIP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04759</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)</td>
      <td>GTBUZLPQANSGGE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08439</td>
      <td>Parecoxib</td>
      <td>TZRHLKRLEZJVIJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07965</td>
      <td>6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile</td>
      <td>OGODDSLNRULSMM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB07966</td>
      <td>[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile</td>
      <td>NVMCVWOODOWOLT-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04791</td>
      <td>2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL</td>
      <td>DKBAWRNTUZFJKV-BSDSXHPESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12005</td>
      <td>Nirogacestat</td>
      <td>VFCRKLWBYMDAED-REWPJTCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08701</td>
      <td>2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE</td>
      <td>JZCUVYNOSDWORZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08488</td>
      <td>4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE</td>
      <td>PLWVUIRWJVKSSD-XBXARRHUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07689</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>NYNAFINLHQEHKU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB03082</td>
      <td>6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide</td>
      <td>CSWQJKHBMACTGB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08141</td>
      <td>4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide</td>
      <td>KOMNQBZWMCFDTQ-VIFPVBQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB11966</td>
      <td>BMS-986094</td>
      <td>YFXGICNMLCGLHJ-RSKRLRQZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08133</td>
      <td>N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide</td>
      <td>MNHPHKFLWAPNOV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB03020</td>
      <td>5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide</td>
      <td>UINNILASBHZOTM-KMXXXSRASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB11971</td>
      <td>Vilaprisan</td>
      <td>JUFWQQVHQFDUOD-ANRPBIDPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01944</td>
      <td>(S)-blebbistatin</td>
      <td>LZAXPYOBKSJSEX-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01977</td>
      <td>6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine</td>
      <td>AECPTICWHONWNW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08099</td>
      <td>6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine</td>
      <td>UOYVKYJWAXJTTE-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02610</td>
      <td>N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide</td>
      <td>LRKSHOLYETXPGY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07664</td>
      <td>5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE</td>
      <td>ARIOBGGRZJITQX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08064</td>
      <td>N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA</td>
      <td>NTMADESEDXKNFZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01876</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methanone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01830</td>
      <td>{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid</td>
      <td>SPSGYTWOIGAABK-DQEYMECFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12024</td>
      <td>PF-04418948</td>
      <td>LWJGMYMNSNVCEM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB05424</td>
      <td>Canertinib</td>
      <td>OMZCMEYTWSXEPZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB05399</td>
      <td>Succinobucol</td>
      <td>RKSMVPNZHBRNNS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08150</td>
      <td>4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium</td>
      <td>RZIDZIGAXXNODG-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB02008</td>
      <td>1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine</td>
      <td>JHSHXKJSPVHPCJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB14899</td>
      <td>Tavapadon</td>
      <td>AKQXQLUNFKDZBN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB03084</td>
      <td>Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</td>
      <td>XCTKFTOEAKJMII-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02628</td>
      <td>1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide</td>
      <td>JUJIMRZGUBTJRV-NASSWSRMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07685</td>
      <td>4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>NMAZGYDYIYLSLJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08229</td>
      <td>[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID</td>
      <td>JGMMFVVACJREFE-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB05212</td>
      <td>HE3286</td>
      <td>JJKOQZHWYLMASZ-FJWDNACWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08169</td>
      <td>(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide</td>
      <td>CAGGGMPTWTUYHZ-ZCXUNETKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12054</td>
      <td>BQ-123</td>
      <td>VYCMAAOURFJIHD-PJNXIOHISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB14898</td>
      <td>Retagliptin</td>
      <td>WIIAMRXFUJLYEF-SNVBAGLBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08195</td>
      <td>(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE</td>
      <td>YKWHKILAGONYKL-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08143</td>
      <td>5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE</td>
      <td>SXIYSYYSKHUTQQ-RDJZCZTQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB15009</td>
      <td>PF-04937319</td>
      <td>MASKQITXHVYVFL-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12084</td>
      <td>ADP-597</td>
      <td>WPDCHTSXOPUOII-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08173</td>
      <td>5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE</td>
      <td>UCKHUNHXYMAFQM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08724</td>
      <td>5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole</td>
      <td>UXIYKMARWUSIKU-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08490</td>
      <td>CTS-1027</td>
      <td>ROSNVSQTEGHUKU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB02323</td>
      <td>EM-1745</td>
      <td>CKSDYJASHNGOOS-KTXOUVACSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02854</td>
      <td>Aetiocholanolone</td>
      <td>QGXBDMJGAMFCBF-BNSUEQOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB09101</td>
      <td>Elvitegravir</td>
      <td>JUZYLCPPVHEVSV-LJQANCHMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07786</td>
      <td>1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>SMFRBBHLVBWHGB-DJJJIMSYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB09199</td>
      <td>Netoglitazone</td>
      <td>PKWDZWYVIHVNKS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB09091</td>
      <td>Tixocortol</td>
      <td>YWDBSCORAARPPF-VWUMJDOOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08531</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CVYWYUAQFJMLEO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB09168</td>
      <td>4-Phenylfentanyl</td>
      <td>BXCJXJLHYMWMQU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB09080</td>
      <td>Olodaterol</td>
      <td>COUYJEVMBVSIHV-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB09215</td>
      <td>Droxicam</td>
      <td>OEHFRZLKGRKFAS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11689</td>
      <td>Selumetinib</td>
      <td>CYOHGALHFOKKQC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11701</td>
      <td>Amenamevir</td>
      <td>MNHNIVNAFBSLLX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08703</td>
      <td>12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</td>
      <td>FGKKIHITEICGMN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11725</td>
      <td>Latrepirdine</td>
      <td>JNODQFNWMXFMEV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB03837</td>
      <td>Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide</td>
      <td>YUMYYTORLYHUFW-ZUDLOMHPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB03213</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-P</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB03262</td>
      <td>Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]</td>
      <td>PZLYYZPXSSNGJS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB09183</td>
      <td>Dasabuvir</td>
      <td>NBRBXGKOEOGLOI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB03453</td>
      <td>(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester</td>
      <td>MRNGXYMKYHNMLV-PKTZIBPZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB03446</td>
      <td>N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide</td>
      <td>FSMWGHKWKYCPKE-QTVCLEQKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11362</td>
      <td>Selexipag</td>
      <td>QXWZQTURMXZVHJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08590</td>
      <td>1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE</td>
      <td>CEAYRKIZESVQSN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08584</td>
      <td>6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB03476</td>
      <td>Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine</td>
      <td>NQRIWXVAIWPBEM-OALUTQOASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB03480</td>
      <td>Brequinar Analog</td>
      <td>WYKKHJQZENLZID-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11426</td>
      <td>Marbofloxacin</td>
      <td>BPFYOAJNDMUVBL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB02915</td>
      <td>4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine</td>
      <td>MEZFDQUDLQCVNX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB03523</td>
      <td>Brequinar</td>
      <td>PHEZJEYUWHETKO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08539</td>
      <td>3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CCDIUVLNHCGSMH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB09239</td>
      <td>Niguldipine</td>
      <td>SVJMLYUFVDMUHP-XIFFEERXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB09206</td>
      <td>Trimazosin</td>
      <td>YNZXWQJZEDLQEG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07373</td>
      <td>ANDROSTA-1,4-DIENE-3,17-DIONE</td>
      <td>LUJVUUWNAPIQQI-QAGGRKNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08974</td>
      <td>Flubendazole</td>
      <td>CPEUVMUXAHMANV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08496</td>
      <td>(R)-warfarin</td>
      <td>PJVWKTKQMONHTI-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB03041</td>
      <td>UDP-alpha-D-glucuronic acid</td>
      <td>HDYANYHVCAPMJV-LXQIFKJMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08942</td>
      <td>Isoxicam</td>
      <td>YYUAYBYLJSNDCX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02976</td>
      <td>Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester</td>
      <td>NGTCPFGWXMBZEP-KBQKSTHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04471</td>
      <td>2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>FMWVCTJKLAVRPB-MUUNZHRXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB02455</td>
      <td>Fluoresceinylthioureido</td>
      <td>VHJFQSRUDVDTEO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11900</td>
      <td>OC-459</td>
      <td>FATGTHLOZSXOBC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04540</td>
      <td>Cholesterol</td>
      <td>HVYWMOMLDIMFJA-DPAQBDIFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08706</td>
      <td>(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID</td>
      <td>RNEACARJKXYVND-MZLJFPOFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB05575</td>
      <td>Motesanib</td>
      <td>RAHBGWKEPAQNFF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07717</td>
      <td>(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE</td>
      <td>AJODXHGZHBERGJ-JLYQOUBASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07415</td>
      <td>4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine</td>
      <td>RFLOFHKRBGKCOB-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08494</td>
      <td>S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate</td>
      <td>AWAKIULNKVOBKE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11952</td>
      <td>Duvelisib</td>
      <td>SJVQHLPISAIATJ-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08503</td>
      <td>(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</td>
      <td>HRCKGDOSPBFICB-MZHQWRCYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04612</td>
      <td>N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE</td>
      <td>QKPXPZYQPBWDHS-MCJAPYMPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB11769</td>
      <td>Funapide</td>
      <td>NEBUOXBYNAHKFV-NRFANRHFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11836</td>
      <td>Sapanisertib</td>
      <td>GYLDXIAOMVERTK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07401</td>
      <td>METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE</td>
      <td>WFDXOXNFNRHQEC-GHRIWEEISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08916</td>
      <td>Afatinib</td>
      <td>ULXXDDBFHOBEHA-CWDCEQMOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08521</td>
      <td>4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>CDMGBJANTYXAIV-HHHXNRCGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04099</td>
      <td>Deamido-Nad+</td>
      <td>SENPVEZBRZQVST-HISDBWNOSA-O</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08519</td>
      <td>N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>SQQAPOSROFWHIB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08588</td>
      <td>2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE</td>
      <td>OYNURZXTLNNKAP-QGZVFWFLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08553</td>
      <td>(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime</td>
      <td>KWEFZSZCLBHIEQ-YYADALCUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04600</td>
      <td>4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE</td>
      <td>GHDKYBCUDPSXGJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB02827</td>
      <td>7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</td>
      <td>MDYIGSPVMWSFEZ-JTQLQIEISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08513</td>
      <td>[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID</td>
      <td>PAIQRYUOBBCBSE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08705</td>
      <td>6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE</td>
      <td>SVSYJTYGPLVUOZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08708</td>
      <td>N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine</td>
      <td>XYYDXQCAYXOGQT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11806</td>
      <td>VTP-194204</td>
      <td>BOOOLEGQBVUTKC-NVQSDHBMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08770</td>
      <td>4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol</td>
      <td>PWTBZOIUWZOPFT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB11816</td>
      <td>Omecamtiv Mecarbil</td>
      <td>RFUBTTPMWSKEIW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB04301</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate</td>
      <td>ZLAHDRAQCSQPOC-UHFFFAOYSA-P</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08954</td>
      <td>Ifenprodil</td>
      <td>UYNVMODNBIQBMV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB08023</td>
      <td>N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine</td>
      <td>HYNNWLVWJXWXFO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08037</td>
      <td>(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide</td>
      <td>MYBGWENAVMIGMM-GIFXNVAJSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08730</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE</td>
      <td>CPFBZMFUCGHBAP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12670</td>
      <td>Rolofylline</td>
      <td>PJBFVWGQFLYWCB-QUYAXPHCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB05913</td>
      <td>OSI-930</td>
      <td>FGTCROZDHDSNIO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07090</td>
      <td>(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE</td>
      <td>NJNMAZNXKKBTPS-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06994</td>
      <td>(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine</td>
      <td>XCCSSVMRGIQMGF-LPHOPBHVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06995</td>
      <td>N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide</td>
      <td>USBSTVPJNQLYEM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB07549</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE</td>
      <td>WOYBPRBUPLYTPY-UHFFFAOYSA-P</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01016</td>
      <td>Glyburide</td>
      <td>ZNNLBTZKUZBEKO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07011</td>
      <td>(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE</td>
      <td>HHOPJGKEAIIIDF-FQEVSTJZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB05936</td>
      <td>CVT-6883</td>
      <td>KOYXXLLNCXWUNF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07014</td>
      <td>2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole</td>
      <td>TUTZKAQTSPMEBI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08882</td>
      <td>Linagliptin</td>
      <td>LTXREWYXXSTFRX-QGZVFWFLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07426</td>
      <td>[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)</td>
      <td>NWIARQRYIRVYCM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07021</td>
      <td>(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine</td>
      <td>SOSYXEPELJIJHZ-RNCFNFMXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07059</td>
      <td>N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE</td>
      <td>GBXSOZDYCSBLQX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07143</td>
      <td>D-phenylalanyl-N-benzyl-L-prolinamide</td>
      <td>MEPJWLFTTFHOQO-MOPGFXCFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07549</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE</td>
      <td>WOYBPRBUPLYTPY-UHFFFAOYSA-P</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12657</td>
      <td>JNJ-42396302</td>
      <td>BPLVDYJDAVYLRQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06730</td>
      <td>Gestodene</td>
      <td>SIGSPDASOTUPFS-XUDSTZEESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07608</td>
      <td>N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</td>
      <td>JDGOPNUGILVNJZ-IBGZPJMESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08220</td>
      <td>(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid</td>
      <td>RPNNXCYIESWDSC-JRZBRKEGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07235</td>
      <td>N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE</td>
      <td>HHOVRZGUSBMKKU-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06875</td>
      <td>3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE</td>
      <td>NSSOSHDCWCMNDM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12591</td>
      <td>BMS-911543</td>
      <td>JCINBYQJBYJGDM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07217</td>
      <td>N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide</td>
      <td>YVYPYORTKAIUGJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01180</td>
      <td>Rescinnamine</td>
      <td>SZLZWPPUNLXJEA-LAFLMMDJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01134</td>
      <td>Desoxycorticosterone pivalate</td>
      <td>VVOIQBFMTVCINR-WWMZEODYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12781</td>
      <td>Balaglitazone</td>
      <td>IETKPTYAGKZLKY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06897</td>
      <td>3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol</td>
      <td>MMGKIHLBFPJYJL-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01108</td>
      <td>Trilostane</td>
      <td>KVJXBPDAXMEYOA-CXANFOAXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07182</td>
      <td>(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID</td>
      <td>HFRHWTYCVGKGIE-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB04881</td>
      <td>Elacridar</td>
      <td>OSFCMRGOZNQUSW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07026</td>
      <td>(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</td>
      <td>PPLDARNGJSQINK-OKZBNKHCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12706</td>
      <td>Seletalisib</td>
      <td>LNLJHGXOFYUARS-OAQYLSRUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07029</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE</td>
      <td>QQBNDYARFVOEGW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02358</td>
      <td>LY374571</td>
      <td>SZHRIPFGZWWRKW-VIFPVBQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07126</td>
      <td>O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE</td>
      <td>OWXORKPNCHJYOF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07382</td>
      <td>N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine</td>
      <td>WJNBSTLIALIIEW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06829</td>
      <td>4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>RXDVFLTWXCTCEX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07131</td>
      <td>(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide</td>
      <td>DOTBZTLJSXFKCP-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06800</td>
      <td>Methylnaltrexone</td>
      <td>JVLBPIPGETUEET-WIXLDOGYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08934</td>
      <td>Sofosbuvir</td>
      <td>TTZHDVOVKQGIBA-IQWMDFIBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08345</td>
      <td>4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>IWUUKHQIKFHWIW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12867</td>
      <td>Benperidol</td>
      <td>FEBOTPHFXYHVPL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07333</td>
      <td>N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE</td>
      <td>KRGKAARWVPUWSY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07146</td>
      <td>2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE</td>
      <td>QUIQCYFSBGOBKE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00717</td>
      <td>Norethisterone</td>
      <td>VIKNJXKGJWUCNN-XGXHKTLJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00713</td>
      <td>Oxacillin</td>
      <td>UWYHMGVUTGAWSP-JKIFEVAISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02329</td>
      <td>Carbenoxolone</td>
      <td>OBZHEBDUNPOCJG-WBXJDKIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06743</td>
      <td>Ginkgolide A</td>
      <td>FPUXKXIZEIDQKW-VKMVSBOZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08931</td>
      <td>Riociguat</td>
      <td>WXXSNCNJFUAIDG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00844</td>
      <td>Nalbuphine</td>
      <td>NETZHAKZCGBWSS-CEDHKZHLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07081</td>
      <td>(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>FDEXEPZGMKFCTG-PSASIEDQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07419</td>
      <td>S-23</td>
      <td>SSFVOEAXHZGTRJ-KRWDZBQOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08111</td>
      <td>4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol</td>
      <td>ZGJYGQLGSXWEMY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07065</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>AHPKUZJCNHGFQA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB08304</td>
      <td>(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>QZBQVXXESPXFPZ-QGZVFWFLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12787</td>
      <td>Norethandrolone</td>
      <td>ZDHCJEIGTNNEMY-XGXHKTLJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07066</td>
      <td>2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>LJAHIGGEXIWVJG-LLVKDONJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06955</td>
      <td>3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid</td>
      <td>OAMCCJASDLMTOO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB00862</td>
      <td>Vardenafil</td>
      <td>SECKRCOLJRRGGV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06940</td>
      <td>N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide</td>
      <td>ZZTMFGIGOADCFX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06933</td>
      <td>N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide</td>
      <td>GJTCKUKIFXWJKG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB13055</td>
      <td>Oteseconazole</td>
      <td>IDUYJRXRDSPPRC-NRFANRHFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB04859</td>
      <td>Zanapezil</td>
      <td>PMBLXLOXUGVTGB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07524</td>
      <td>N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine</td>
      <td>CQFGXDQUQWRXLE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06907</td>
      <td>2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID</td>
      <td>XVNRKPCHMYOPPL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB06891</td>
      <td>5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE</td>
      <td>HOLJYLOVIHBQHO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB07041</td>
      <td>N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide</td>
      <td>FDJWFDQRPKKBFA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01260</td>
      <td>Desonide</td>
      <td>WBGKWQHBNHJJPZ-LECWWXJVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07315</td>
      <td>5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide</td>
      <td>SHCHFGSUYJUEBR-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06228</td>
      <td>Rivaroxaban</td>
      <td>KGFYHTZWPPHNLQ-AWEZNQCLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07835</td>
      <td>N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide</td>
      <td>BOPSUAHGQHFKGG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07469</td>
      <td>(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</td>
      <td>KAJFGRLMKVNMLH-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB02554</td>
      <td>Sulfoquinovose-Uridine-C1,5'-Diphosphate</td>
      <td>FQANCGQCBCUSMI-JZMIEXBBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12222</td>
      <td>Lurtotecan</td>
      <td>RVFGKBWWUQOIOU-NDEPHWFRSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12183</td>
      <td>Sapitinib</td>
      <td>DFJSJLGUIXFDJP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB05015</td>
      <td>Belinostat</td>
      <td>NCNRHFGMJRPRSK-MDZDMXLPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07618</td>
      <td>2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE</td>
      <td>AITZHKQVQNLKHI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12367</td>
      <td>Selurampanel</td>
      <td>MCECSFFXUPEPDB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07763</td>
      <td>(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE</td>
      <td>OZZFJGCAYWBVBI-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07889</td>
      <td>(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol</td>
      <td>VCPXSBULBDYRLT-SFHVURJKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06347</td>
      <td>Cenisertib</td>
      <td>KSOVGRCOLZZTPF-QMKUDKLTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07855</td>
      <td>(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE</td>
      <td>CWHMAWBXRCDOEB-HNNXBMFYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB05039</td>
      <td>Indacaterol</td>
      <td>QZZUEBNBZAPZLX-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12306</td>
      <td>Cipargamin</td>
      <td>CKLPLPZSUQEDRT-WPCRTTGESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07459</td>
      <td>4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE</td>
      <td>HVLSCZSVTCNAQX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07999</td>
      <td>{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID</td>
      <td>IXLBOIRSEDMRPI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01705</td>
      <td>Bis(5-Amidino-Benzimidazolyl)Methane</td>
      <td>QZKOOEFIMWKZPK-UHFFFAOYSA-Q</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12095</td>
      <td>Telotristat ethyl</td>
      <td>MDSQOJYHHZBZKA-GBXCKJPGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12229</td>
      <td>Cerlapirdine</td>
      <td>NXQGEDVQXVTCDA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06117</td>
      <td>1alpha,24S-Dihydroxyvitamin D2</td>
      <td>ODZFJAXAEXQSKL-WRJREGAQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08031</td>
      <td>N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</td>
      <td>LNQWELVSNCYKDU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07971</td>
      <td>5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE</td>
      <td>FQQVTDIBUYSVHM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB15013</td>
      <td>TAK-243</td>
      <td>KJDAGXLMHXUAGV-DGWLBADLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB08073</td>
      <td>(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>YWTBGJGMTBHQTM-IBGZPJMESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08750</td>
      <td>1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE</td>
      <td>SFPCNWQWKOUNRT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB08006</td>
      <td>N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>OXYDLVAOXASTMW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07946</td>
      <td>N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>DZEJHPMTDNDECN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07944</td>
      <td>N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE</td>
      <td>MPTWCWHNLVMCRW-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07458</td>
      <td>3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07933</td>
      <td>Erteberel</td>
      <td>XIESSJVMWNJCGZ-VKJFTORMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12355</td>
      <td>Netazepide</td>
      <td>YDZYKNJZCVIKPP-VWLOTQADSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07470</td>
      <td>(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</td>
      <td>DOMYOVZXZIZTRD-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07683</td>
      <td>N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine</td>
      <td>RZWYSEXQXOXWKA-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07679</td>
      <td>(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid</td>
      <td>RRAAROKJUVKWAF-RDJZCZTQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12515</td>
      <td>9-aminocamptothecin</td>
      <td>FUXVKZWTXQUGMW-FQEVSTJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07467</td>
      <td>4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide</td>
      <td>NDDAHWYSQHTHNT-JTQLQIEISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07227</td>
      <td>4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE</td>
      <td>JNUGFGAVPBYSHF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08820</td>
      <td>Ivacaftor</td>
      <td>PURKAOJPTOLRMP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12579</td>
      <td>JNJ-37822681</td>
      <td>UVUYWJWYRLJHEN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08303</td>
      <td>(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide</td>
      <td>CUMKMTBOHBENJI-SFHVURJKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07396</td>
      <td>1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid</td>
      <td>KAJJGOCSAXKXBD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06629</td>
      <td>Zibotentan</td>
      <td>FJHHZXWJVIEFGJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06645</td>
      <td>Anamorelin</td>
      <td>VQPFSIRUEPQQPP-MXBOTTGLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB01338</td>
      <td>Pipecuronium</td>
      <td>OWWLUIWOFHMHOQ-XGHATYIMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB06652</td>
      <td>Vicriviroc</td>
      <td>CNPVJJQCETWNEU-CYFREDJKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07324</td>
      <td>3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE</td>
      <td>ZUJWSOPIDUWELP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07316</td>
      <td>N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide</td>
      <td>FAVXIEFZKPJZRT-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07531</td>
      <td>4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE</td>
      <td>JNPRTUHVCHGFHJ-GHXNOFRVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12491</td>
      <td>Fasiglifam</td>
      <td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12393</td>
      <td>Fanapanel</td>
      <td>WZMQMKNCWDCCMT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07250</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>HMKLUOPMOJOUDZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12401</td>
      <td>Bromperidol</td>
      <td>RKLNONIVDFXQRX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07648</td>
      <td>(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL</td>
      <td>TWEONIHFGKSPLC-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12405</td>
      <td>Triciribine</td>
      <td>HOGVTUZUJGHKPL-HTVVRFAVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12408</td>
      <td>PF-03635659</td>
      <td>WGOJWDWKHJHXSV-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07479</td>
      <td>(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL</td>
      <td>WCUHTHVUZQCBTI-KBAYOESNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12412</td>
      <td>Gemigliptin</td>
      <td>ZWPRRQZNBDYKLH-VIFPVBQESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04644</td>
      <td>4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID</td>
      <td>FCEMCUPAYRPTLS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB12416</td>
      <td>VTP-27999</td>
      <td>NXWASIVXQMMPLM-ZXMXYHOLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB07595</td>
      <td>(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE</td>
      <td>WSIQKQLAGWVKSL-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB08305</td>
      <td>(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>KQAGZLQCEURCKJ-QGZVFWFLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB07787</td>
      <td>5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE</td>
      <td>PNPFDRCIGCUCMN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB04942</td>
      <td>Tamibarotene</td>
      <td>MUTNCGKQJGXKEM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB02432</td>
      <td>RU90395</td>
      <td>RLLAUERCSKPFGD-VMPREFPWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07263</td>
      <td>[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid</td>
      <td>WDTMVBQZDFMOIK-GOSISDBHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07809</td>
      <td>4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>MBJYEMUMDMGQQC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06969</td>
      <td>2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide</td>
      <td>WJUNQSYQHHIVFX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07707</td>
      <td>(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL</td>
      <td>LEOPSILMAOYZBO-IUTAEKPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08052</td>
      <td>1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>NVRXTLZYXZNATH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB04172</td>
      <td>[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine</td>
      <td>WATXEHGLYJKXOF-NDEPHWFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13266</td>
      <td>Cefatrizine</td>
      <td>UOCJDOLVGGIYIQ-PBFPGSCMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB04154</td>
      <td>N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide</td>
      <td>ALBWBHNFOJJMCV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12167</td>
      <td>LY-3023414</td>
      <td>ACCFLVVUVBJNGT-AWEZNQCLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11957</td>
      <td>Idalopirdine</td>
      <td>YBAWYTYNMZWMMJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12147</td>
      <td>Erdafitinib</td>
      <td>OLAHOMJCDNXHFI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12230</td>
      <td>Bunazosin</td>
      <td>RHLJLALHBZGAFM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB15091</td>
      <td>Upadacitinib</td>
      <td>WYQFJHHDOKWSHR-MNOVXSKESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB02524</td>
      <td>2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)</td>
      <td>XFMMHXLUHKBKQE-UHEGPQQHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB15096</td>
      <td>18-methoxycoronaridine</td>
      <td>DTJQBBHYRQYDEG-SVBQBFEESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13451</td>
      <td>Tioclomarol</td>
      <td>WRGOVNKNTPWHLZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB04609</td>
      <td>INHIBITOR Q8467 OF DUPONT MERCK</td>
      <td>HFLCERPZYCWLSZ-VKONIRKNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB06543</td>
      <td>Astaxanthin</td>
      <td>MQZIGYBFDRPAKN-UWFIBFSHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB15106</td>
      <td>Surufatinib</td>
      <td>TTZSNFLLYPYKIL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12120</td>
      <td>Avoralstat</td>
      <td>TUWMKPVJGGWGNL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB15292</td>
      <td>Foliglurax</td>
      <td>ZTEDNASHAWNBKQ-NCELDCMTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12211</td>
      <td>PSI-697</td>
      <td>DIEPFYNZGUUVHD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12649</td>
      <td>Ibipinabant</td>
      <td>AXJQVVLKUYCICH-OAQYLSRUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12776</td>
      <td>E-6005</td>
      <td>BBTFKAOFCSOZMB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04010</td>
      <td>2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide</td>
      <td>NVVWVYYHTKCIAE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12598</td>
      <td>Nafamostat</td>
      <td>MQQNFDZXWVTQEH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB04693</td>
      <td>(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE</td>
      <td>CRDKSBHJIGNEOH-IMRIKWHGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB09268</td>
      <td>Picosulfuric acid</td>
      <td>UJIDKYTZIQTXPM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12101</td>
      <td>CC-220</td>
      <td>IXZOHGPZAQLIBH-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB01410</td>
      <td>Ciclesonide</td>
      <td>LUKZNWIVRBCLON-GXOBDPJESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB11769</td>
      <td>Funapide</td>
      <td>NEBUOXBYNAHKFV-NRFANRHFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08029</td>
      <td>N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide</td>
      <td>QQDWEVONJRXVDB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB14846</td>
      <td>Bimiralisib</td>
      <td>ADGGYDAFIHSYFI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB14867</td>
      <td>Parsaclisib</td>
      <td>ZQPDJCIXJHUERQ-QWRGUYRKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01456</td>
      <td>5-androstenedione</td>
      <td>SQGZFRITSMYKRH-QAGGRKNESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12203</td>
      <td>Tozadenant</td>
      <td>XNBRWUQWSKXMPW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06983</td>
      <td>(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol</td>
      <td>RBLKWWBHDUBPFN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12627</td>
      <td>GSK-1292263</td>
      <td>AYJRTVVIBJSSKN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB11943</td>
      <td>Delafloxacin</td>
      <td>DYDCPNMLZGFQTM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB14934</td>
      <td>GDC-0927</td>
      <td>KJAAPZIFCQQQKX-NDEPHWFRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12649</td>
      <td>Ibipinabant</td>
      <td>AXJQVVLKUYCICH-OAQYLSRUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB02338</td>
      <td>Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate</td>
      <td>ACFIXJIJDZMPPO-NNYOXOHSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08039</td>
      <td>(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE</td>
      <td>LOGJQOUIVKBFGH-YBEGLDIGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB02226</td>
      <td>3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium</td>
      <td>NAARZDJZGYBXKL-UHFFFAOYSA-O</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB01199</td>
      <td>Tubocurarine</td>
      <td>JFJZZMVDLULRGK-URLMMPGGSA-O</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13246</td>
      <td>Quinupramine</td>
      <td>JCBQCKFFSPGEDY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12219</td>
      <td>GSK-424887</td>
      <td>DRXBWLBZWAJIEF-IBGZPJMESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB08043</td>
      <td>1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>DDDLGNOZDKDSEG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB02319</td>
      <td>5,6-Dihydroxy-Nadp</td>
      <td>LRAVAOPKUBJONV-IVCJQJMGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13520</td>
      <td>Metergoline</td>
      <td>WZHJKEUHNJHDLS-QTGUNEKASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB15141</td>
      <td>Deutivacaftor</td>
      <td>PURKAOJPTOLRMP-ASMGOKTBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13816</td>
      <td>Aspoxicillin</td>
      <td>BHELIUBJHYAEDK-OAIUPTLZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB13104</td>
      <td>X-396</td>
      <td>ONPGOSVDVDPBCY-CQSZACIVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB13138</td>
      <td>Neladenoson bialanate</td>
      <td>WESNEIGKOAXSGX-VXKWHMMOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11985</td>
      <td>Dapaconazole</td>
      <td>FUAHXHWSMYFWGE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB11656</td>
      <td>Rebamipide</td>
      <td>ALLWOAVDORUJLA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB06896</td>
      <td>1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide</td>
      <td>OBSFXHDOLBYWRJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13939</td>
      <td>RAD-140</td>
      <td>XMBUPPIEVAFYHO-KPZWWZAWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07015</td>
      <td>(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine</td>
      <td>XDSKICAQKGYYJF-OLZOCXBDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB06844</td>
      <td>4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE</td>
      <td>MBXKBJLIESPLIK-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB11656</td>
      <td>Rebamipide</td>
      <td>ALLWOAVDORUJLA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB11824</td>
      <td>Tofogliflozin</td>
      <td>VWVKUNOPTJGDOB-BDHVOXNPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB06817</td>
      <td>Raltegravir</td>
      <td>CZFFBEXEKNGXKS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13943</td>
      <td>Testosterone cypionate</td>
      <td>HPFVBGJFAYZEBE-ZLQWOROUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB11732</td>
      <td>Lasmiditan</td>
      <td>XEDHVZKDSYZQBF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01524</td>
      <td>Androstenediol</td>
      <td>QADHLRWLCPCEKT-LOVVWNRFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00178</td>
      <td>Ramipril</td>
      <td>HDACQVRGBOVJII-JBDAPHQKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11725</td>
      <td>Latrepirdine</td>
      <td>JNODQFNWMXFMEV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12740</td>
      <td>CC-115</td>
      <td>GMYLVKUGJMYTFB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB01070</td>
      <td>Dihydrotachysterol</td>
      <td>ILYCWAKSDCYMBB-OPCMSESCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00248</td>
      <td>Cabergoline</td>
      <td>KORNTPPJEAJQIU-KJXAQDMKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB03181</td>
      <td>2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione</td>
      <td>RXQAVKWRCZYGMV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB15319</td>
      <td>VM4-037</td>
      <td>QGYZPMXIVNIGKA-GMAHTHKFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB15317</td>
      <td>Posiphen</td>
      <td>PBHFNBQPZCRWQP-AZUAARDMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB11900</td>
      <td>OC-459</td>
      <td>FATGTHLOZSXOBC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB04097</td>
      <td>Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose</td>
      <td>OAPPZHVTNHJVAL-JZMIEXBBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12798</td>
      <td>Relenopride</td>
      <td>KGMMSPVVHZGPHL-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB07608</td>
      <td>N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide</td>
      <td>JDGOPNUGILVNJZ-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB11805</td>
      <td>Saracatinib</td>
      <td>OUKYUETWWIPKQR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB03970</td>
      <td>(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid</td>
      <td>CHNMLWCTGYMVFH-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13631</td>
      <td>Methoserpidine</td>
      <td>ULBNWNUHGJLQHO-VKMIBBQISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB02014</td>
      <td>5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid</td>
      <td>QKHWJUMLYAYZFS-ONEGZZNKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06446</td>
      <td>Dotarizine</td>
      <td>LRMJAFKKJLRDLE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB15206</td>
      <td>Uprifosbuvir</td>
      <td>SFPFZQKYPOWCSI-KHFYHRBSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11961</td>
      <td>AZD-1236</td>
      <td>SFJFBTPHDHUUPU-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB11979</td>
      <td>Elagolix</td>
      <td>HEAUOKZIVMZVQL-VWLOTQADSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB15193</td>
      <td>BMS-955176</td>
      <td>XDMUFNNPLXHNKA-ZTESCHFWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB15229</td>
      <td>CNV-2197944</td>
      <td>BLFJGFDZMABYMY-ZDUSSCGKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07252</td>
      <td>3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide</td>
      <td>TZHCXOMEOHEZDX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB07026</td>
      <td>(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</td>
      <td>PPLDARNGJSQINK-OKZBNKHCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB07020</td>
      <td>N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide</td>
      <td>LMDMJDCLPIVGQD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01215</td>
      <td>Estazolam</td>
      <td>CDCHDCWJMGXXRH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13685</td>
      <td>Quingestanol</td>
      <td>PCJFRMOEZQQSAX-AIOSZGMZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01482</td>
      <td>Fenethylline</td>
      <td>NMCHYWGKBADVMK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB13061</td>
      <td>MLN8054</td>
      <td>HHFBDROWDBDFBR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB11912</td>
      <td>Lanopepden</td>
      <td>SWHNZGMQMGFQGW-MSOLQXFVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB07638</td>
      <td>(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</td>
      <td>QJSMFUTULGSHNQ-ZOBUZTSGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB08303</td>
      <td>(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide</td>
      <td>CUMKMTBOHBENJI-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB15265</td>
      <td>USL-311</td>
      <td>XNUNVQKARNSSEO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB06645</td>
      <td>Anamorelin</td>
      <td>VQPFSIRUEPQQPP-MXBOTTGLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06953</td>
      <td>2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE</td>
      <td>JVWHVGIRXILXMU-XMMPIXPASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06954</td>
      <td>2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate</td>
      <td>BIASYWBGUYOWJR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB05944</td>
      <td>Varlitinib</td>
      <td>UWXSAYUXVSFDBQ-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13094</td>
      <td>Pruvanserin</td>
      <td>AQRLDDAFYYAIJP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB05838</td>
      <td>OPC-51803</td>
      <td>INGXCNVWWKKWOO-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11645</td>
      <td>PF-4191834</td>
      <td>DVNQWYLVSNPCJZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB00862</td>
      <td>Vardenafil</td>
      <td>SECKRCOLJRRGGV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11618</td>
      <td>Zorubicin</td>
      <td>FBTUMDXHSRTGRV-BJISBDEGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13185</td>
      <td>Oxabolone cipionate</td>
      <td>KHKDIUPVDIEHAH-KXLSUQFWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11616</td>
      <td>Pirarubicin</td>
      <td>KMSKQZKKOZQFFG-YXRRJAAWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB07187</td>
      <td>6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE</td>
      <td>FXFPQPNUMWQRAO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11577</td>
      <td>Indigotindisulfonic Acid</td>
      <td>CFZXDJWFRVEWSR-BUHFOSPRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13242</td>
      <td>Bucladesine</td>
      <td>CJGYSWNGNKCJSB-YVLZZHOMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12355</td>
      <td>Netazepide</td>
      <td>YDZYKNJZCVIKPP-VWLOTQADSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04037</td>
      <td>N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine</td>
      <td>UOUXILZUBDIWQU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07965</td>
      <td>6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile</td>
      <td>OGODDSLNRULSMM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12623</td>
      <td>Taprenepag</td>
      <td>MFFBXYNKZHTCEY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12812</td>
      <td>Palomid 529</td>
      <td>YEAHTLOYHVWAKW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB07237</td>
      <td>{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone</td>
      <td>VUWFJUJWAWMRQN-HXUWFJFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB07238</td>
      <td>Nesbuvir</td>
      <td>WTDWVLJJJOTABN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12427</td>
      <td>Orvepitant</td>
      <td>XWNBGDJPEXZSQM-VZOBGQTKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11694</td>
      <td>Ilorasertib</td>
      <td>WPHKIQPVPYJNAX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04040</td>
      <td>N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide</td>
      <td>MCMWCTMAKPQTPI-WGNYYXNJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11861</td>
      <td>Litronesib</td>
      <td>YVAFBXLHPINSIK-QHCPKHFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12833</td>
      <td>Tandospirone</td>
      <td>CEIJFEGBUDEYSX-FZDBZEDMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12705</td>
      <td>Cenerimod</td>
      <td>KJKKMMMRWISKRF-FQEVSTJZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB15257</td>
      <td>Milademetan</td>
      <td>RYAYYVTWKAOAJF-QISPRATLSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12665</td>
      <td>Isoquercetin</td>
      <td>OVSQVDMCBVZWGM-QSOFNFLRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB11273</td>
      <td>Dihydroergocornine</td>
      <td>SEALOBQTUQIVGU-QNIJNHAOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12721</td>
      <td>RO-5028442</td>
      <td>QZXVLRCMAHJVIP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11772</td>
      <td>Pilaralisib</td>
      <td>QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12643</td>
      <td>Nelivaptan</td>
      <td>NJXZWIIMWNEOGJ-WEWKHQNJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12419</td>
      <td>HSD-016</td>
      <td>ZWASRJHIEFYJGL-BFUOFWGJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11836</td>
      <td>Sapanisertib</td>
      <td>GYLDXIAOMVERTK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11877</td>
      <td>Basmisanil</td>
      <td>VCGRFBXVSFAGGA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11878</td>
      <td>Filibuvir</td>
      <td>SLVAPEZTBDBAPI-GDLZYMKVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12627</td>
      <td>GSK-1292263</td>
      <td>AYJRTVVIBJSSKN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12988</td>
      <td>LY-518674</td>
      <td>PNHFDVSKDSLUFH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12998</td>
      <td>PF-00217830</td>
      <td>QGNOXTFZOLDODX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07751</td>
      <td>(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol</td>
      <td>ZVSBKYYVBCKDBO-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11737</td>
      <td>Icotinib</td>
      <td>QQLKULDARVNMAL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07976</td>
      <td>3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>GIUMGVUBDBDTDX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12591</td>
      <td>BMS-911543</td>
      <td>JCINBYQJBYJGDM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11704</td>
      <td>Adomeglivant</td>
      <td>FASLTMSUPQDLIB-MHZLTWQESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07076</td>
      <td>6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</td>
      <td>FWTQOPWAMQXIMI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07084</td>
      <td>N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</td>
      <td>YHKGWOJTUMJPNW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12941</td>
      <td>ODM-201</td>
      <td>BLIJXOOIHRSQRB-PXYINDEMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB11424</td>
      <td>Lufenuron</td>
      <td>PWPJGUXAGUPAHP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12001</td>
      <td>Abemaciclib</td>
      <td>UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13470</td>
      <td>Cefodizime</td>
      <td>XDZKBRJLTGRPSS-BGZQYGJUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13981</td>
      <td>Nomegestrol acetate</td>
      <td>IIVBFTNIGYRNQY-YQLZSBIMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12505</td>
      <td>E-7820</td>
      <td>LWGUASZLXHYWIV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB07271</td>
      <td>4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one</td>
      <td>RMDAPSXWBVPVOG-IAPIXIRKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12522</td>
      <td>Toreforant</td>
      <td>FCRFVPZAXGJLPW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB14544</td>
      <td>Hydrocortisone valerate</td>
      <td>FZCHYNWYXKICIO-FZNHGJLXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12375</td>
      <td>Oglemilast</td>
      <td>OKFDRAHPFKMAJH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB11795</td>
      <td>GSK-2636771</td>
      <td>XTKLTGBKIDQGQL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06519</td>
      <td>Edaglitazone</td>
      <td>HAAXAFNSRADSMK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB07536</td>
      <td>N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide</td>
      <td>FQYBTYFKOHPWQT-VGSWGCGISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB14631</td>
      <td>Prednisolone phosphate</td>
      <td>JDOZJEUDSLGTLU-VWUMJDOOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12269</td>
      <td>PF-06273340</td>
      <td>BPIWZDNVMQQBQX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12399</td>
      <td>Polmacoxib</td>
      <td>IJWPAFMIFNSIGD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB05351</td>
      <td>Dexlansoprazole</td>
      <td>MJIHNNLFOKEZEW-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB15362</td>
      <td>LSZ-102</td>
      <td>SJXNPGGVGZXKKI-NYYWCZLTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12289</td>
      <td>Darexaban</td>
      <td>IJNIQYINMSGIPS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB14637</td>
      <td>Fluprednisolone acetate</td>
      <td>CYMBAKFTWRNHPS-APRQOCPKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB08407</td>
      <td>PLATENSIMYCIN</td>
      <td>CSOMAHTTWTVBFL-OFBLZTNGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB14644</td>
      <td>Methylprednisolone hemisuccinate</td>
      <td>IMBXEJJVJRTNOW-XYMSELFBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB05316</td>
      <td>Pimavanserin</td>
      <td>RKEWSXXUOLRFBX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB14652</td>
      <td>Clocortolone acetate</td>
      <td>ARPLCFGLEYFDCN-CDACMRRYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB05265</td>
      <td>Ecabet</td>
      <td>IWCWQNVIUXZOMJ-MISYRCLQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12309</td>
      <td>GI-181771X</td>
      <td>CABBMMXFOOZVMS-PMERELPUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB01455</td>
      <td>19-Nor-5-androstenediol</td>
      <td>VVUQRXPUVKXAIO-XFUVECHXSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12141</td>
      <td>Gilteritinib</td>
      <td>GYQYAJJFPNQOOW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01329</td>
      <td>Cefoperazone</td>
      <td>GCFBRXLSHGKWDP-XCGNWRKASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00267</td>
      <td>Cefmenoxime</td>
      <td>HJJDBAOLQAWBMH-YCRCPZNHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12234</td>
      <td>BMS-214662</td>
      <td>OLCWFLWEHWLBTO-HSZRJFAPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12929</td>
      <td>JNJ-39220675</td>
      <td>IQOWHZHNGJXGHG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13471</td>
      <td>Nalfurafine</td>
      <td>XGZZHZMWIXFATA-UEZBDDGYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12857</td>
      <td>NVP-LEQ-506</td>
      <td>POERAARDVFVDLO-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13499</td>
      <td>Cefsulodin</td>
      <td>SYLKGLMBLAAGSC-QLVMHMETSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12085</td>
      <td>LCL-161</td>
      <td>UFPFGVNKHCLJJO-SSKFGXFMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12138</td>
      <td>PF-03715455</td>
      <td>VGEXRDWWPSGZDH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06515</td>
      <td>Resiniferatoxin</td>
      <td>DSDNAKHZNJAGHN-MXTYGGKSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB12505</td>
      <td>E-7820</td>
      <td>LWGUASZLXHYWIV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB09488</td>
      <td>Acrivastine</td>
      <td>PWACSDKDOHSSQD-IUTFFREVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12910</td>
      <td>Emicerfont</td>
      <td>JFHJGXQFESYQGY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07937</td>
      <td>2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine</td>
      <td>UGZWPZWADDDTRN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13606</td>
      <td>Phenazocine</td>
      <td>ZQHYKVKNPWDQSL-KNXBSLHKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13651</td>
      <td>Lorajmine</td>
      <td>LAHDERDHXJFFJU-ZWNKPRIXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13664</td>
      <td>Formocortal</td>
      <td>QNXUUBBKHBYRFW-QWAPGEGQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB12198</td>
      <td>Fosdagrocorat</td>
      <td>BVXLAHSJXXSWFF-KEKPKEOLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12494</td>
      <td>SGI-1776</td>
      <td>MHXGEROHKGDZGO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB12924</td>
      <td>Ozenoxacin</td>
      <td>XPIJWUTXQAGSLK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13816</td>
      <td>Aspoxicillin</td>
      <td>BHELIUBJHYAEDK-OAIUPTLZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB13856</td>
      <td>Fluclorolone</td>
      <td>VTWKPILBIUBMDS-OTJLYDAYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07159</td>
      <td>Tamatinib</td>
      <td>NHHQJBCNYHBUSI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB05465</td>
      <td>Tandutinib</td>
      <td>UXXQOJXBIDBUAC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08001</td>
      <td>5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID</td>
      <td>DQSRCEFDWMQCCV-GQCTYLIASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00276</td>
      <td>Amsacrine</td>
      <td>XCPGHVQEEXUHNC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01476</td>
      <td>Haloxazolam</td>
      <td>XDKCGKQHVBOOHC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB00932</td>
      <td>Tipranavir</td>
      <td>SUJUHGSWHZTSEU-FYBSXPHGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08064</td>
      <td>N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA</td>
      <td>NTMADESEDXKNFZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07058</td>
      <td>5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione</td>
      <td>QBVJMUOTMRYUKR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB15345</td>
      <td>GSK-945237</td>
      <td>SRICOHRDRMZREQ-MRXNPFEDSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB06879</td>
      <td>5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE</td>
      <td>QCFIRACCCDFXIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB11666</td>
      <td>Buparlisib</td>
      <td>CWHUFRVAEUJCEF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14570</td>
      <td>Hydroxyprogesterone</td>
      <td>DBPWSSGDRRHUNT-CEGNMAFCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB09198</td>
      <td>Lobeglitazone</td>
      <td>CHHXEZSCHQVSRE-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB11911</td>
      <td>Galunisertib</td>
      <td>IVRXNBXKWIJUQB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB03325</td>
      <td>Tyrosyladenylate</td>
      <td>MJZAZMKENKZBAJ-QTOWJTHWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB03331</td>
      <td>N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>OARVXDFNTLYMCJ-JVUUKAHWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00561</td>
      <td>Doxapram</td>
      <td>XFDJYSQDBULQSI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07107</td>
      <td>(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE</td>
      <td>SGHXFHRRWFLILP-XJDXJNMNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14801</td>
      <td>Lanifibranor</td>
      <td>OQDQIFQRNZIEEJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB09038</td>
      <td>Empagliflozin</td>
      <td>OBWASQILIWPZMG-QZMOQZSNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB03367</td>
      <td>PF-00356231</td>
      <td>VMTJQZUZINLEKC-JOCHJYFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB06178</td>
      <td>Talotrexin</td>
      <td>NYQPLPNEESYGNO-IBGZPJMESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08993</td>
      <td>Enviomycin</td>
      <td>HPWIIERXAFODPP-GHBBWTPBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB11618</td>
      <td>Zorubicin</td>
      <td>FBTUMDXHSRTGRV-BJISBDEGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB15310</td>
      <td>Vactosertib</td>
      <td>FJCDSQATIJKQKA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB11819</td>
      <td>ASP-4058</td>
      <td>NJNXCJPSMWKXHO-VIFPVBQESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00904</td>
      <td>Ondansetron</td>
      <td>FELGMEQIXOGIFQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01545</td>
      <td>Ethyl loflazepate</td>
      <td>CUCHJCMWNFEYOM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14542</td>
      <td>Hydrocortisone phosphate</td>
      <td>BGSOJVFOEQLVMH-VWUMJDOOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00487</td>
      <td>Pefloxacin</td>
      <td>FHFYDNQZQSQIAI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08122</td>
      <td>N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE</td>
      <td>IKASAFLVQIJQOK-UVTDQMKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00502</td>
      <td>Haloperidol</td>
      <td>LNEPOXFFQSENCJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB05263</td>
      <td>Caprospinol</td>
      <td>VMOZFSWFUBLCNN-AAPULDEBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB09050</td>
      <td>Ceftolozane</td>
      <td>JHFNIHVVXRKLEF-DCZLAGFPSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB14766</td>
      <td>Etrasimod</td>
      <td>MVGWUTBTXDYMND-QGZVFWFLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12903</td>
      <td>DEBIO-1347</td>
      <td>BEMNJULZEQTDJY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08056</td>
      <td>N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine</td>
      <td>KKYYLKPGILUPOA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14624</td>
      <td>Nandrolone hydrogen sulfate</td>
      <td>SKZMVWBZTQNCKW-IZPLOLCNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB09209</td>
      <td>Pholcodine</td>
      <td>GPFAJKDEDBRFOS-FKQDBXSBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB06856</td>
      <td>6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE</td>
      <td>HUYQYLFFFNSAAX-BUXKBTBVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14627</td>
      <td>Oxyphenisatin acetate</td>
      <td>PHPUXYRXPHEJDF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00278</td>
      <td>Argatroban</td>
      <td>KXNPVXPOPUZYGB-IOVMHBDKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14631</td>
      <td>Prednisolone phosphate</td>
      <td>JDOZJEUDSLGTLU-VWUMJDOOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB07396</td>
      <td>1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid</td>
      <td>KAJJGOCSAXKXBD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB04158</td>
      <td>6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin</td>
      <td>ZKRKFZJAQKKHKL-SUGPNEFASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14640</td>
      <td>Isoflupredone acetate</td>
      <td>ZOCUOMKMBMEYQV-GSLJADNHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB12039</td>
      <td>Epicatechin</td>
      <td>PFTAWBLQPZVEMU-UKRRQHHQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08039</td>
      <td>(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE</td>
      <td>LOGJQOUIVKBFGH-YBEGLDIGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB03962</td>
      <td>Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate</td>
      <td>MDKMTCCUJSRQGW-NAJQWHGHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB04006</td>
      <td>[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone</td>
      <td>WUGJIPFLBOATGL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB04044</td>
      <td>4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>NAQUAVBNIYTIIS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB09183</td>
      <td>Dasabuvir</td>
      <td>NBRBXGKOEOGLOI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB06274</td>
      <td>Alvimopan</td>
      <td>UPNUIXSCZBYVBB-JVFUWBCBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB03480</td>
      <td>Brequinar Analog</td>
      <td>WYKKHJQZENLZID-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB15333</td>
      <td>AZD-1386</td>
      <td>FPGNKXCEPARJDI-ZDUSSCGKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB11718</td>
      <td>Encorafenib</td>
      <td>CMJCXYNUCSMDBY-ZDUSSCGKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01571</td>
      <td>3-Methylfentanyl</td>
      <td>MLQRZXNZHAOCHQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06603</td>
      <td>Panobinostat</td>
      <td>FPOHNWQLNRZRFC-ZHACJKMWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB03383</td>
      <td>5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide</td>
      <td>YDCGVASFVACWKF-NRFANRHFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14716</td>
      <td>Clonazolam</td>
      <td>XJRGLCAWBRZUFC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB04690</td>
      <td>Camptothecin</td>
      <td>VSJKWCGYPAHWDS-FQEVSTJZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB03791</td>
      <td>(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid</td>
      <td>NAXSRXHZFIBFMI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11650</td>
      <td>HT-0712</td>
      <td>ABEJDMOBAFLQNJ-NHCUHLMSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07791</td>
      <td>4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE</td>
      <td>MZWCVBFANHIPTJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB11582</td>
      <td>Thiocolchicoside</td>
      <td>LEQAKWQJCITZNK-AXHKHJLKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB08146</td>
      <td>7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine</td>
      <td>QFWNOFXQNCLFBC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00799</td>
      <td>Tazarotene</td>
      <td>OGQICQVSFDPSEI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14673</td>
      <td>Flurandrenolide acetate</td>
      <td>AUDPKCCPWYXNEV-XTLNBZDDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB03351</td>
      <td>Sri-9439</td>
      <td>KMSATRJZEXNGDP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB09238</td>
      <td>Manidipine</td>
      <td>ANEBWFXPVPTEET-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB11701</td>
      <td>Amenamevir</td>
      <td>MNHNIVNAFBSLLX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB11656</td>
      <td>Rebamipide</td>
      <td>ALLWOAVDORUJLA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07801</td>
      <td>N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide</td>
      <td>WOYITRCGMUXUDE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6lzg</td>
      <td>DB11804</td>
      <td>AZD-5672</td>
      <td>SCXSQUUTGCWHFU-WJOKGBTCSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB03154</td>
      <td>{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid</td>
      <td>VHKBLEYUHBIBNR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14038</td>
      <td>beta-Sitosterol</td>
      <td>KZJWDPNRJALLNS-VJSFXXLFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14097</td>
      <td>13-cis-12-(3'-Carboxyphenyl)retinoic acid</td>
      <td>XKKDQOHDTASHCE-PAZAWXFKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00317</td>
      <td>Gefitinib</td>
      <td>XGALLCVXEZPNRQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06608</td>
      <td>Tafenoquine</td>
      <td>LBHLFPGPEGDCJG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11522</td>
      <td>Isoflupredone</td>
      <td>WAIJIHDWAKJCBX-BULBTXNYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08931</td>
      <td>Riociguat</td>
      <td>WXXSNCNJFUAIDG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB14034</td>
      <td>Darglitazone</td>
      <td>QQKNSPHAFATFNQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11551</td>
      <td>Trenbolone</td>
      <td>MEHHPFQKXOUFFV-OWSLCNJRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB11521</td>
      <td>Imidocarb</td>
      <td>SCEVFJUWLLRELN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06605</td>
      <td>Apixaban</td>
      <td>QNZCBYKSOIHPEH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB13874</td>
      <td>Enasidenib</td>
      <td>DYLUUSLLRIQKOE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB06624</td>
      <td>Taranabant</td>
      <td>QLYKJCMUNUWAGO-GAJHUEQPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB01060</td>
      <td>Amoxicillin</td>
      <td>LSQZJLSUYDQPKJ-NJBDSQKTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB02932</td>
      <td>(R)-Bicalutamide</td>
      <td>LKJPYSCBVHEWIU-KRWDZBQOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB08916</td>
      <td>Afatinib</td>
      <td>ULXXDDBFHOBEHA-CWDCEQMOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11718</td>
      <td>Encorafenib</td>
      <td>CMJCXYNUCSMDBY-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB06605</td>
      <td>Apixaban</td>
      <td>QNZCBYKSOIHPEH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB02181</td>
      <td>2'-Deoxyguanosine-5'-Triphosphate</td>
      <td>HAAZLUGHYHWQIW-KVQBGUIXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00358</td>
      <td>Mefloquine</td>
      <td>XEEQGYMUWCZPDN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB11704</td>
      <td>Adomeglivant</td>
      <td>FASLTMSUPQDLIB-MHZLTWQESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB04796</td>
      <td>Inecalcitol</td>
      <td>HHGRMHMXKPQNGF-WNSNRMDMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m2n</td>
      <td>DB11784</td>
      <td>NRX-1074</td>
      <td>DVBUEXCIEIAXPM-PJUQSVSOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB14669</td>
      <td>Betamethasone phosphate</td>
      <td>VQODGRNSFPNSQE-DVTGEIKXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11994</td>
      <td>Diacerein</td>
      <td>TYNLGDBUJLVSMA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00287</td>
      <td>Travoprost</td>
      <td>MKPLKVHSHYCHOC-AHTXBMBWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00327</td>
      <td>Hydromorphone</td>
      <td>WVLOADHCBXTIJK-YNHQPCIGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB11793</td>
      <td>Niraparib</td>
      <td>PCHKPVIQAHNQLW-CQSZACIVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m3m</td>
      <td>DB00404</td>
      <td>Alprazolam</td>
      <td>VREFGVBLTWBCJP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w9c</td>
      <td>DB13993</td>
      <td>MRK-409</td>
      <td>GOIFCXRIFSYPFG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12052</td>
      <td>Icariin</td>
      <td>TZJALUIVHRYQQB-XLRXWWTNSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB11694</td>
      <td>Ilorasertib</td>
      <td>WPHKIQPVPYJNAX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB07769</td>
      <td>S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE</td>
      <td>KJMFOTCDISOHDX-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB11890</td>
      <td>Cilengitide</td>
      <td>AMLYAMJWYAIXIA-VWNVYAMZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01192</td>
      <td>Oxymorphone</td>
      <td>UQCNKQCJZOAFTQ-ISWURRPUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6m71</td>
      <td>DB06626</td>
      <td>Axitinib</td>
      <td>RITAVMQDGBJQJZ-FMIVXFBMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6w4h</td>
      <td>DB12756</td>
      <td>TAK-901</td>
      <td>WKDACQVEJIVHMZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6cs2</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB08087</td>
      <td>4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE</td>
      <td>NHBIWLQQJPSMNP-CABCVRRESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6crv</td>
      <td>DB01586</td>
      <td>Ursodeoxycholic acid</td>
      <td>RUDATBOHQWOJDD-UZVSRGJWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxx</td>
      <td>DB03148</td>
      <td>Phosphomethylphosphonic Acid Adenosyl Ester</td>
      <td>OLCWZBFDIYXLAA-IOSLPCCCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.7</td>
      <td>6vxs</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13237</td>
      <td>Clofoctol</td>
      <td>HQVZOORKDNCGCK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12221</td>
      <td>Canrenone</td>
      <td>UJVLDDZCTMKXJK-WNHSNXHDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB07162</td>
      <td>4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide</td>
      <td>KFJCXIOVAGJCKB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01179</td>
      <td>Podofilox</td>
      <td>YJGVMLPVUAXIQN-XVVDYKMHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07595</td>
      <td>(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE</td>
      <td>WSIQKQLAGWVKSL-UHFFFAOYSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB04903</td>
      <td>Pagoclone</td>
      <td>HIUPRQPBWVEQJJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12467</td>
      <td>TU-100</td>
      <td>KAYRGFYBCCETPE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07938</td>
      <td>5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine</td>
      <td>HWJPWWYTGBZDEG-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB04739</td>
      <td>4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE</td>
      <td>JHMBUEWQJDGKGS-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12480</td>
      <td>Betulinic Acid</td>
      <td>QGJZLNKBHJESQX-FZFNOLFKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00257</td>
      <td>Clotrimazole</td>
      <td>VNFPBHJOKIVQEB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB15403</td>
      <td>Ziritaxestat</td>
      <td>REQQVBGILUTQNN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12645</td>
      <td>Givinostat</td>
      <td>YALNUENQHAQXEA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB05511</td>
      <td>Piclidenoson</td>
      <td>HUJXGQILHAUCCV-MOROJQBDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12580</td>
      <td>Tradipitant</td>
      <td>CAVRKWRKTNINFF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13208</td>
      <td>Prednylidene</td>
      <td>WSVOMANDJDYYEY-CWNVBEKCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB02932</td>
      <td>(R)-Bicalutamide</td>
      <td>LKJPYSCBVHEWIU-KRWDZBQOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01067</td>
      <td>Glipizide</td>
      <td>ZJJXGWJIGJFDTL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03222</td>
      <td>dATP</td>
      <td>SUYVUBYJARFZHO-RRKCRQDMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12548</td>
      <td>Sparsentan</td>
      <td>WRFHGDPIDHPWIQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11745</td>
      <td>Otenabant</td>
      <td>UNAZAADNBYXMIV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB05676</td>
      <td>Apremilast</td>
      <td>IMOZEMNVLZVGJZ-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB01831</td>
      <td>Tryptophanyl-5'amp</td>
      <td>IFQVDHDRFCKAAW-SQIXAUHQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12535</td>
      <td>AC-430</td>
      <td>DCRWIATZWHLIPN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01426</td>
      <td>Ajmaline</td>
      <td>CJDRUOGAGYHKKD-HEFSZTOGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12515</td>
      <td>9-aminocamptothecin</td>
      <td>FUXVKZWTXQUGMW-FQEVSTJZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15208</td>
      <td>NOP-1A</td>
      <td>MZBCQWLYUQJXKA-KRWDZBQOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07809</td>
      <td>4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>MBJYEMUMDMGQQC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11736</td>
      <td>PF-00489791</td>
      <td>ZUHZNKJIJDAJFD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12494</td>
      <td>SGI-1776</td>
      <td>MHXGEROHKGDZGO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB15168</td>
      <td>Cilofexor</td>
      <td>KZSKGLFYQAYZCO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB15029</td>
      <td>AZD-8186</td>
      <td>LMJFJIDLEAWOQJ-CQSZACIVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04070</td>
      <td>6-Deoxyerythronolide B</td>
      <td>HQZOLNNEQAKEHT-IBBGRPSASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04509</td>
      <td>N-Methylnaloxonium</td>
      <td>PCSQOABIHJXZMR-YNUHATHGSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB15206</td>
      <td>Uprifosbuvir</td>
      <td>SFPFZQKYPOWCSI-KHFYHRBSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12221</td>
      <td>Canrenone</td>
      <td>UJVLDDZCTMKXJK-WNHSNXHDSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB00158</td>
      <td>Folic acid</td>
      <td>OVBPIULPVIDEAO-LBPRGKRZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04069</td>
      <td>5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine</td>
      <td>QKVREUJWFZJEJK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB11855</td>
      <td>Revefenacin</td>
      <td>FYDWDCIFZSGNBU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB01940</td>
      <td>Balanol Analog 2</td>
      <td>SQLYTJZXRRDERK-ISKFKSNPSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00252</td>
      <td>Phenytoin</td>
      <td>CXOFVDLJLONNDW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB11942</td>
      <td>Selinexor</td>
      <td>DEVSOMFAQLZNKR-RJRFIUFISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12594</td>
      <td>AZD-9056</td>
      <td>HSQAARMBHJCUOK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07792</td>
      <td>(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>VUKPNWLGSLOHIF-AWEZNQCLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12524</td>
      <td>BI-671800</td>
      <td>XEOSTBFUCNZKGS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12532</td>
      <td>Oxetacaine</td>
      <td>FTLDJPRFCGDUFH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB03251</td>
      <td>RWJ-51084</td>
      <td>NQABUEUFRXDDFI-AWEZNQCLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13275</td>
      <td>Clorindione</td>
      <td>NJDUWAXIURWWLN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11560</td>
      <td>Lesinurad</td>
      <td>FGQFOYHRJSUHMR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07675</td>
      <td>(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID</td>
      <td>WMUIIGVAWPWQAW-DEOSSOPVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB03367</td>
      <td>PF-00356231</td>
      <td>VMTJQZUZINLEKC-JOCHJYFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB01763</td>
      <td>7-thionicotinamide-adenine-dinucleotide phosphate</td>
      <td>OJNFDOAQUXJWED-NNYOXOHSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB02668</td>
      <td>Je-2147, Ag1776, Kni-764</td>
      <td>CUFQBQOBLVLKRF-RZDMPUFOSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01254</td>
      <td>Dasatinib</td>
      <td>ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB15006</td>
      <td>Flufenoxuron</td>
      <td>RYLHNOVXKPXDIP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14787</td>
      <td>BMS-830216</td>
      <td>YDTUJCNTIMWHPJ-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB03355</td>
      <td>5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine</td>
      <td>UPVAPSGKXAAHBG-CKTDUXNWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01216</td>
      <td>Finasteride</td>
      <td>DBEPLOCGEIEOCV-WSBQPABSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07568</td>
      <td>(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE</td>
      <td>ADRNPUSZBRQDBG-KRWDZBQOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11511</td>
      <td>Difloxacin</td>
      <td>NOCJXYPHIIZEHN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB15013</td>
      <td>TAK-243</td>
      <td>KJDAGXLMHXUAGV-DGWLBADLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB05590</td>
      <td>Bedoradrine</td>
      <td>OANCEOSLKSTLTA-REWPJTCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB00715</td>
      <td>Paroxetine</td>
      <td>AHOUBRCZNHFOSL-YOEHRIQHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12388</td>
      <td>Evocalcet</td>
      <td>RZNUIYPHQFXBAN-XLIONFOSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11463</td>
      <td>Sulfanitran</td>
      <td>GWBPFRGXNGPPMF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06629</td>
      <td>Zibotentan</td>
      <td>FJHHZXWJVIEFGJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11455</td>
      <td>Robenacoxib</td>
      <td>ZEXGDYFACFXQPF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB04578</td>
      <td>(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide</td>
      <td>OEVYDSSAPNIURZ-AEFFLSMTSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12573</td>
      <td>LY-2452473</td>
      <td>IHIWYQYVBNODSV-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06358</td>
      <td>Iclaprim</td>
      <td>HWJPWWYTGBZDEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01380</td>
      <td>Cortisone acetate</td>
      <td>ITRJWOMZKQRYTA-RFZYENFJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11686</td>
      <td>Iferanserin</td>
      <td>UXIPFQUBOVWAQW-UEBLJOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08530</td>
      <td>7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE</td>
      <td>QFSMMXJBEBXTJP-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB14899</td>
      <td>Tavapadon</td>
      <td>AKQXQLUNFKDZBN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01347</td>
      <td>Saprisartan</td>
      <td>DUEWVPTZCSAMNB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07741</td>
      <td>4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE</td>
      <td>VPNYXOTTXAXSIH-SXYSDOLCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB03397</td>
      <td>Uridine-Diphosphate-N-Acetylglucosamine</td>
      <td>LFTYTUAZOPRMMI-CFRASDGPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12391</td>
      <td>Sagopilone</td>
      <td>BFZKMNSQCNVFGM-UCEYFQQTSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15241</td>
      <td>Methylsamidorphan</td>
      <td>ATCVVCBJNHXIEX-ZAHKBLQYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13276</td>
      <td>Idanpramine</td>
      <td>HVYGXNYMNHSBGD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB15048</td>
      <td>Licogliflozin</td>
      <td>XFJAMQQAAMJFGB-ZQGJOIPISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12253</td>
      <td>GDC-0810</td>
      <td>BURHGPHDEVGCEZ-KJGLQBJMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB15275</td>
      <td>GDC-0077</td>
      <td>SGEUNORSOZVTOL-CABZTGNLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07716</td>
      <td>(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL</td>
      <td>VDRIXSJOPKVWKM-HXGIDPQASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11644</td>
      <td>Tafamidis</td>
      <td>TXEIIPDJKFWEEC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12499</td>
      <td>Clascoterone</td>
      <td>GPNHMOZDMYNCPO-PDUMRIMRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07584</td>
      <td>N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine</td>
      <td>OKGCSZUKOGMZAL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB02197</td>
      <td>4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide</td>
      <td>NKORVPQBJCGYEC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB00354</td>
      <td>Buclizine</td>
      <td>MOYGZHXDRJNJEP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12379</td>
      <td>Indirubin</td>
      <td>CRDNMYFJWFXOCH-BUHFOSPRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06869</td>
      <td>1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE</td>
      <td>BMHVHOJXEQTIEA-SIKLNZKXSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB12823</td>
      <td>Tecarfarin</td>
      <td>QFLNTQDOVCLQKW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04480</td>
      <td>3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole</td>
      <td>NBDZLUOYAAVYHF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02836</td>
      <td>Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate</td>
      <td>NGYWTCOGOZELRS-UUOKFMHZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB14944</td>
      <td>Tarloxotinib</td>
      <td>MUJMYVFVAWFUJL-SNAWJCMRSA-O</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB01215</td>
      <td>Estazolam</td>
      <td>CDCHDCWJMGXXRH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12483</td>
      <td>Copanlisib</td>
      <td>PZBCKZWLPGJMAO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB14068</td>
      <td>Dexniguldipine</td>
      <td>SVJMLYUFVDMUHP-MGBGTMOVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07932</td>
      <td>dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate</td>
      <td>CRLQCBACIMUGDZ-BGYRXZFFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07826</td>
      <td>2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide</td>
      <td>DTGVSZSMDOMAEB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB13042</td>
      <td>Fenoverine</td>
      <td>UBAJTZKNDCEGKL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01946</td>
      <td>3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione</td>
      <td>UQHKJRCFSLMWIA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11962</td>
      <td>GSK-1059615</td>
      <td>QDITZBLZQQZVEE-YBEGLDIGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07444</td>
      <td>6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE</td>
      <td>PKPNSCZPIWCHMW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07859</td>
      <td>4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE</td>
      <td>LZMOSYUFVYJEPY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB02331</td>
      <td>(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>YBULOUKTPCHXAL-DEOSSOPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15065</td>
      <td>PF-06291874</td>
      <td>IBDYYOQKQCCSDP-QFIPXVFZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12186</td>
      <td>SRT-2104</td>
      <td>LAMQVIQMVKWXOC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01990</td>
      <td>Cholesterol sulfate</td>
      <td>BHYOQNUELFTYRT-DPAQBDIFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB14662</td>
      <td>Flunisolide acetate</td>
      <td>WEGNFRKBIKYVLC-XTLNBZDDSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12998</td>
      <td>PF-00217830</td>
      <td>QGNOXTFZOLDODX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12180</td>
      <td>Apitolisib</td>
      <td>YOVVNQKCSKSHKT-HNNXBMFYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB14653</td>
      <td>Clocortolone caproate</td>
      <td>MMTRTBFDFNRBQO-ANHDKODLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB13029</td>
      <td>MK-0873</td>
      <td>JJWKQXNHYDJXKF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB00224</td>
      <td>Indinavir</td>
      <td>CBVCZFGXHXORBI-PXQQMZJSSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06465</td>
      <td>FK-960</td>
      <td>XTOKQKWTUYYVAO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12960</td>
      <td>INCB-9471</td>
      <td>ZMCJFJZOSKEMOM-DNKZPPIMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB06673</td>
      <td>Almorexant</td>
      <td>DKMACHNQISHMDN-RPLLCQBOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03154</td>
      <td>{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid</td>
      <td>VHKBLEYUHBIBNR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01720</td>
      <td>(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid</td>
      <td>WLPJLQNKCJWAFL-RGEXLXHISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08731</td>
      <td>2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid</td>
      <td>GPOKTQCDBPECSS-MRXNPFEDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08387</td>
      <td>2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>AZEXWHKOMMASPA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB13756</td>
      <td>Peruvoside</td>
      <td>PMTSPAGBAFCORP-HBUONDEYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13115</td>
      <td>Saroglitazar</td>
      <td>MRWFZSLZNUJVQW-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08382</td>
      <td>Gosogliptin</td>
      <td>QWEWGXUTRTXFRF-KBPBESRZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08051</td>
      <td>(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>XXRHRPGYYNOBHO-QGZVFWFLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01792</td>
      <td>Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate</td>
      <td>FZCSEXOMUJFOHQ-KPKSGTNCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12843</td>
      <td>Oleandrin</td>
      <td>JLPDBLFIVFSOCC-XYXFTTADSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01873</td>
      <td>Epothilone D</td>
      <td>XOZIUKBZLSUILX-GIQCAXHBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12183</td>
      <td>Sapitinib</td>
      <td>DFJSJLGUIXFDJP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13078</td>
      <td>KOSN-1724</td>
      <td>JAYGOFBXDFAXBW-CYEKYUJNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB06578</td>
      <td>Tonabersat</td>
      <td>XLIIRNOPGJTBJD-ROUUACIJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB05767</td>
      <td>Andrographolide</td>
      <td>BOJKULTULYSRAS-OTESTREVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07851</td>
      <td>(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE</td>
      <td>DQJXBZGPJVSWFI-ROUUACIJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB05470</td>
      <td>VX-702</td>
      <td>FYSRKRZDBHOFAY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB13563</td>
      <td>Norgestrienone</td>
      <td>GVDMJXQHPUYPHP-FYQPLNBISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB01030</td>
      <td>Topotecan</td>
      <td>UCFGDBYHRUNTLO-QHCPKHFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB13607</td>
      <td>Picloxydine</td>
      <td>YNCLPFSAZFGQCD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06732</td>
      <td>beta-Naphthoflavone</td>
      <td>OUGIDAPQYNCXRA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14938</td>
      <td>Flurbiprofen axetil</td>
      <td>ALIVXCSEERJYHU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB03010</td>
      <td>Patupilone</td>
      <td>QXRSDHAAWVKZLJ-PVYNADRNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08239</td>
      <td>(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE</td>
      <td>NKLVBHMAIMEVEH-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB13856</td>
      <td>Fluclorolone</td>
      <td>VTWKPILBIUBMDS-OTJLYDAYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04142</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide</td>
      <td>FEYGJZKVMASWJB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB13471</td>
      <td>Nalfurafine</td>
      <td>XGZZHZMWIXFATA-UEZBDDGYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB13778</td>
      <td>Cefazedone</td>
      <td>VTLCNEGVSVJLDN-MLGOLLRUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12082</td>
      <td>Vesnarinone</td>
      <td>ZVNYJIZDIRKMBF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB13682</td>
      <td>Cefpirome</td>
      <td>DKOQGJHPHLTOJR-WHRDSVKCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06731</td>
      <td>Seproxetine</td>
      <td>WIQRCHMSJFFONW-HNNXBMFYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>1r42</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>1r42</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB06510</td>
      <td>Muraglitazar</td>
      <td>IRLWJILLXJGJTD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB14649</td>
      <td>Dexamethasone acetate</td>
      <td>AKUJBENLRBOFTD-RPRRAYFGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14934</td>
      <td>GDC-0927</td>
      <td>KJAAPZIFCQQQKX-NDEPHWFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12059</td>
      <td>JNJ-40411813</td>
      <td>HYOGJHCDLQSAHX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11982</td>
      <td>GDC-0623</td>
      <td>RFWVETIZUQEJEF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB13104</td>
      <td>X-396</td>
      <td>ONPGOSVDVDPBCY-CQSZACIVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB13607</td>
      <td>Picloxydine</td>
      <td>YNCLPFSAZFGQCD-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB13135</td>
      <td>AGN-201904</td>
      <td>PPCGSVWOZKNPCX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB01128</td>
      <td>Bicalutamide</td>
      <td>LKJPYSCBVHEWIU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB13055</td>
      <td>Oteseconazole</td>
      <td>IDUYJRXRDSPPRC-NRFANRHFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15038</td>
      <td>Litoxetine</td>
      <td>MJJDYOLPMGIWND-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12046</td>
      <td>Atopaxar</td>
      <td>QWKAUGRRIXBIPO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB12985</td>
      <td>Quisinostat</td>
      <td>PAWIYAYFNXQGAP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB13089</td>
      <td>Enoxolone</td>
      <td>MPDGHEJMBKOTSU-YKLVYJNSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03086</td>
      <td>N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide</td>
      <td>IQMLIGOOOFEBAH-CVEARBPZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB01149</td>
      <td>Nefazodone</td>
      <td>VRBKIVRKKCLPHA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11985</td>
      <td>Dapaconazole</td>
      <td>FUAHXHWSMYFWGE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08174</td>
      <td>5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE</td>
      <td>QCPYHSAHOYXXQK-DLBZAZTESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB15163</td>
      <td>Selatogrel</td>
      <td>FYXHWMQPCJOJCH-GMAHTHKFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB14795</td>
      <td>AZD-3759</td>
      <td>MXDSJQHFFDGFDK-CYBMUJFWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB14821</td>
      <td>Macozinone</td>
      <td>BJDZBXGJNBMCAV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08572</td>
      <td>4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE</td>
      <td>YBKLJTXDSBEVRV-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB11836</td>
      <td>Sapanisertib</td>
      <td>GYLDXIAOMVERTK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB01721</td>
      <td>Analogue of Indinavir Drug</td>
      <td>MJIRDPUZGGHJMX-OIVSQUILSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08772</td>
      <td>3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID</td>
      <td>BCSVCWVQNOXFGL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14875</td>
      <td>AZD-4017</td>
      <td>NCDZABJPWMBMIQ-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12719</td>
      <td>Turofexorate isopropyl</td>
      <td>INASOKQDNHHMRE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB07124</td>
      <td>(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>CCIACUJJBPSOHE-KRWDZBQOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12341</td>
      <td>LY-2456302</td>
      <td>ZHPMYDSXGRRERG-DEOSSOPVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12339</td>
      <td>Radezolid</td>
      <td>BTTNOGHPGJANSW-IBGZPJMESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB12939</td>
      <td>Nikkomycin Z</td>
      <td>WWJFFVUVFNBJTN-VHDFTHOZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12380</td>
      <td>GDC-0152</td>
      <td>WZRFLSDVFPIXOV-LRQRDZAKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13174</td>
      <td>Rhein</td>
      <td>FCDLCPWAQCPTKC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB01329</td>
      <td>Cefoperazone</td>
      <td>GCFBRXLSHGKWDP-XCGNWRKASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13166</td>
      <td>Zofenopril</td>
      <td>IAIDUHCBNLFXEF-MNEFBYGVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07966</td>
      <td>[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile</td>
      <td>NVMCVWOODOWOLT-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB14896</td>
      <td>Selitrectinib</td>
      <td>OEBIHOVSAMBXIB-SJKOYZFVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06589</td>
      <td>Pazopanib</td>
      <td>CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB04946</td>
      <td>Iloperidone</td>
      <td>XMXHEBAFVSFQEX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB02889</td>
      <td>4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose</td>
      <td>SNMISNLUIRCRQE-SFSRYZOZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07612</td>
      <td>6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE</td>
      <td>XQKJVNGGVLHNLA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB11772</td>
      <td>Pilaralisib</td>
      <td>QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07613</td>
      <td>3-phenyl-5-(1H-pyrazol-3-yl)isoxazole</td>
      <td>SRSSTOPJERVMRZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB04983</td>
      <td>Denufosol</td>
      <td>FPNPSEMJLALQSA-MIYUEGBISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12325</td>
      <td>Idasanutlin</td>
      <td>TVTXCJFHQKSQQM-LJQIRTBHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03221</td>
      <td>AL7099A</td>
      <td>RMOXCYSVWCHXII-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB12874</td>
      <td>Quizartinib</td>
      <td>CVWXJKQAOSCOAB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12937</td>
      <td>Quercetin-3'-O-phosphate</td>
      <td>UWJBYNLLMAPJMM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07920</td>
      <td>N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide</td>
      <td>OGRPZMQLAVBWPV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01469</td>
      <td>Acetorphine</td>
      <td>LFYBMMHFJIAKFE-PMEKXCSPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB07133</td>
      <td>D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide</td>
      <td>CHKWABXWPATIIG-UXHICEINSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB05884</td>
      <td>HCV-086</td>
      <td>VBRUONUESYTIDA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07872</td>
      <td>5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide</td>
      <td>IYGIXVNAMZPBDK-CQSZACIVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01452</td>
      <td>Diamorphine</td>
      <td>GVGLGOZIDCSQPN-PVHGPHFFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB13607</td>
      <td>Picloxydine</td>
      <td>YNCLPFSAZFGQCD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12391</td>
      <td>Sagopilone</td>
      <td>BFZKMNSQCNVFGM-UCEYFQQTSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04073</td>
      <td>N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide</td>
      <td>UEIGEWJJVQHIAX-DLBZZEGUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12262</td>
      <td>CRS-3123</td>
      <td>NNTYBKTXMKBRFA-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12719</td>
      <td>Turofexorate isopropyl</td>
      <td>INASOKQDNHHMRE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB14870</td>
      <td>PF-5190457</td>
      <td>ZIUDADZJCKGWKR-AREMUKBSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08429</td>
      <td>N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide</td>
      <td>QRGBOABBMKYMLG-UXHICEINSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00323</td>
      <td>Tolcapone</td>
      <td>MIQPIUSUKVNLNT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08426</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</td>
      <td>PLXOQMHGHDZMSX-AWEZNQCLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08424</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE</td>
      <td>IJDQETGUEUJVTB-HNNXBMFYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12264</td>
      <td>Atevirdine</td>
      <td>UCPOMLWZWRTIAA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB14581</td>
      <td>CPI-1205</td>
      <td>HPODOLXTMDHLLC-QGZVFWFLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB13019</td>
      <td>Henatinib</td>
      <td>MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB00878</td>
      <td>Chlorhexidine</td>
      <td>GHXZTYHSJHQHIJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB02510</td>
      <td>'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine</td>
      <td>LKVJEMXWEODCAY-JVEUSOJLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB02466</td>
      <td>4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid</td>
      <td>ZXQHMEUGMCXKLO-KPKJPENVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB13019</td>
      <td>Henatinib</td>
      <td>MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13125</td>
      <td>Lusutrombopag</td>
      <td>NOZIJMHMKORZBA-KJCUYJGMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01668</td>
      <td>Nanaomycin D</td>
      <td>XUWPJKDMEZSVTP-UOSCCXBLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB01254</td>
      <td>Dasatinib</td>
      <td>ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15117</td>
      <td>Transfluthrin</td>
      <td>DDVNRFNDOPPVQJ-HQJQHLMTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01476</td>
      <td>Haloxazolam</td>
      <td>XDKCGKQHVBOOHC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12302</td>
      <td>CP-724714</td>
      <td>LLVZBTWPGQVVLW-SNAWJCMRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12781</td>
      <td>Balaglitazone</td>
      <td>IETKPTYAGKZLKY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB07072</td>
      <td>(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</td>
      <td>CNKRZILQBKJWDS-WMFXKJRFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB01289</td>
      <td>Glisoxepide</td>
      <td>ZKUDBRCEOBOWLF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12325</td>
      <td>Idasanutlin</td>
      <td>TVTXCJFHQKSQQM-LJQIRTBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB14717</td>
      <td>Nitrazolam</td>
      <td>OYRPNABWTHDOFK-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01591</td>
      <td>Solifenacin</td>
      <td>FBOUYBDGKBSUES-VXKWHMMOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01540</td>
      <td>17alpha-methyl-4-hydroxynandrolone</td>
      <td>CLNUZOCYKSHICX-FAHHUNKHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01564</td>
      <td>Calusterone</td>
      <td>IVFYLRMMHVYGJH-PVPPCFLZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB01259</td>
      <td>Lapatinib</td>
      <td>BCFGMOOMADDAQU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08710</td>
      <td>(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE</td>
      <td>BKZOQCGDCHOGOQ-MZLJFPOFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07776</td>
      <td>Flavone</td>
      <td>VHBFFQKBGNRLFZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB03300</td>
      <td>Pterin Cytosine Dinucleotide</td>
      <td>WKSPNQYEWZEMMI-FEFZDOOUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12285</td>
      <td>Verubecestat</td>
      <td>YHYKUSGACIYRML-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01586</td>
      <td>Ursodeoxycholic acid</td>
      <td>RUDATBOHQWOJDD-UZVSRGJWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15124</td>
      <td>PF-05241328</td>
      <td>RVTSXVZXEGFIPW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07753</td>
      <td>3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID</td>
      <td>VCEFNMHMLWBFNV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB15132</td>
      <td>AZD-8165</td>
      <td>YUHNXUAATAMVKD-PZJWPPBQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06876</td>
      <td>N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE</td>
      <td>YJWJKKXGAPWLGT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB14555</td>
      <td>Ursadiol</td>
      <td>RTLXJEJRLWILSU-GWNGJUQLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06347</td>
      <td>Cenisertib</td>
      <td>KSOVGRCOLZZTPF-QMKUDKLTSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07141</td>
      <td>5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>QVXYJVHNRPNRJL-HNNXBMFYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB02331</td>
      <td>(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>YBULOUKTPCHXAL-DEOSSOPVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB00457</td>
      <td>Prazosin</td>
      <td>IENZQIKPVFGBNW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07244</td>
      <td>5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE</td>
      <td>SRRWXMSVQYQCRX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03753</td>
      <td>Flurbiprofen Methyl Ester</td>
      <td>CPJBKHZROFMSQM-NSHDSACASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB02323</td>
      <td>EM-1745</td>
      <td>CKSDYJASHNGOOS-KTXOUVACSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06257</td>
      <td>HE-2200</td>
      <td>OEVZKEVBDIDVOI-YSZCXEEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14122</td>
      <td>Dihydroxymethoxychalcone</td>
      <td>NYSZJNUIVUBQMM-BQYQJAHWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB14716</td>
      <td>Clonazolam</td>
      <td>XJRGLCAWBRZUFC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07252</td>
      <td>3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide</td>
      <td>TZHCXOMEOHEZDX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08302</td>
      <td>3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid</td>
      <td>IRHZCQDCMUWUKV-RAXLEYEMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB08354</td>
      <td>2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>QCVULERVJOYHCP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07297</td>
      <td>5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE</td>
      <td>PTILEOLOGGMFCS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07256</td>
      <td>3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE</td>
      <td>ZVQZIVCQLFGXFZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB02877</td>
      <td>Arotinoid acid</td>
      <td>FOIVPCKZDPCJJY-JQIJEIRASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB05129</td>
      <td>Elsamitrucin</td>
      <td>MGQRRMONVLMKJL-KWJIQSIXSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06652</td>
      <td>Vicriviroc</td>
      <td>CNPVJJQCETWNEU-CYFREDJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06311</td>
      <td>Darapladib</td>
      <td>WDPFJWLDPVQCAJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06743</td>
      <td>Ginkgolide A</td>
      <td>FPUXKXIZEIDQKW-VKMVSBOZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB15143</td>
      <td>PF-06650833</td>
      <td>JKDGKIBAOAFRPJ-ZBINZKHDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07029</td>
      <td>4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE</td>
      <td>QQBNDYARFVOEGW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB15265</td>
      <td>USL-311</td>
      <td>XNUNVQKARNSSEO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB04764</td>
      <td>[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</td>
      <td>CCLHROFBSWWOQO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB07215</td>
      <td>2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID</td>
      <td>ILUPZUOBHCUBKB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07216</td>
      <td>(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE</td>
      <td>ZMGCFGGMTCMSDP-QHCPKHFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB02873</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One</td>
      <td>YAWZIQKDHQIHOS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB03300</td>
      <td>Pterin Cytosine Dinucleotide</td>
      <td>WKSPNQYEWZEMMI-FEFZDOOUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB02827</td>
      <td>7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</td>
      <td>MDYIGSPVMWSFEZ-JTQLQIEISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB13943</td>
      <td>Testosterone cypionate</td>
      <td>HPFVBGJFAYZEBE-ZLQWOROUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB02759</td>
      <td>4-Methylumbelliferyl Chitobiose</td>
      <td>UPSFMJHZUCSEHU-JYGUBCOQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB04983</td>
      <td>Denufosol</td>
      <td>FPNPSEMJLALQSA-MIYUEGBISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB11694</td>
      <td>Ilorasertib</td>
      <td>WPHKIQPVPYJNAX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06202</td>
      <td>Lasofoxifene</td>
      <td>GXESHMAMLJKROZ-IAPPQJPRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB09319</td>
      <td>Carindacillin</td>
      <td>JIRBAUWICKGBFE-MNRDOXJOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB04872</td>
      <td>Osanetant</td>
      <td>DZOJBGLFWINFBF-UMSFTDKQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03785</td>
      <td>(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid</td>
      <td>QLJODMDSTUBWDW-BXMDZJJMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB14066</td>
      <td>Tetrandrine</td>
      <td>WVTKBKWTSCPRNU-KYJUHHDHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB15163</td>
      <td>Selatogrel</td>
      <td>FYXHWMQPCJOJCH-GMAHTHKFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06163</td>
      <td>Plevitrexed</td>
      <td>IEJSCSAMMLUINT-NRFANRHFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06744</td>
      <td>ginkgolide-B</td>
      <td>SQOJOAFXDQDRGF-MMQTXUMRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB05263</td>
      <td>Caprospinol</td>
      <td>VMOZFSWFUBLCNN-AAPULDEBSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB11734</td>
      <td>Fedovapagon</td>
      <td>RUOLFWZIFNQQGH-DEOSSOPVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>2fxp</td>
      <td>DB04016</td>
      <td>2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid</td>
      <td>XUJQPDQURBZEGJ-KXQOOQHDSA-N</td>
      <td>HR2</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB14774</td>
      <td>Balipodect</td>
      <td>KVHRYLNQDWXAGI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07716</td>
      <td>(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL</td>
      <td>VDRIXSJOPKVWKM-HXGIDPQASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06955</td>
      <td>3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid</td>
      <td>OAMCCJASDLMTOO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03647</td>
      <td>3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid</td>
      <td>LRHXIDOGMBZJFN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07741</td>
      <td>4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE</td>
      <td>VPNYXOTTXAXSIH-SXYSDOLCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07765</td>
      <td>METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE</td>
      <td>UKCFUFHREWUXJJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB07307</td>
      <td>N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide</td>
      <td>GQXMJOSCBRZMKE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15062</td>
      <td>Inarigivir</td>
      <td>LYMICVBGNUEHGE-FUQPUAIBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB02738</td>
      <td>Adenosine-5'-Pentaphosphate</td>
      <td>WYJWVZZCMBUPSP-KQYNXXCUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15092</td>
      <td>LY-2624803</td>
      <td>UEFWDVMEDFCHGW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08092</td>
      <td>3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide</td>
      <td>VMLSXFMXUNVCSK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06207</td>
      <td>Silodosin</td>
      <td>PNCPYILNMDWPEY-QGZVFWFLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13586</td>
      <td>Metandienone</td>
      <td>XWALNWXLMVGSFR-HLXURNFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15168</td>
      <td>Cilofexor</td>
      <td>KZSKGLFYQAYZCO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07031</td>
      <td>3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid</td>
      <td>AANFHDFOMFRLLR-LJQANCHMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07156</td>
      <td>(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione</td>
      <td>JFEKAVPMVOLVTH-UNOMPAQXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB01573</td>
      <td>Benzylmorphine</td>
      <td>RDJGWRFTDZZXSM-RNWLQCGYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15238</td>
      <td>Olinciguat</td>
      <td>YWQFJNWMWZMXRW-HXUWFJFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00214</td>
      <td>Torasemide</td>
      <td>NGBFQHCMQULJNZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB14775</td>
      <td>Cavosonstat</td>
      <td>BXSZILNGNMDGSL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06169</td>
      <td>Indibulin</td>
      <td>SOLIIYNRSAWTSQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB13055</td>
      <td>Oteseconazole</td>
      <td>IDUYJRXRDSPPRC-NRFANRHFSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12706</td>
      <td>Seletalisib</td>
      <td>LNLJHGXOFYUARS-OAQYLSRUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06246</td>
      <td>Exisulind</td>
      <td>MVGSNCBCUWPVDA-MFOYZWKCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB09233</td>
      <td>Cronidipine</td>
      <td>CNIJVNPIIHWRRP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB14840</td>
      <td>Ripretinib</td>
      <td>CEFJVGZHQAGLHS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB13109</td>
      <td>PKI-179</td>
      <td>WXUUCRLKXQMWRY-OYRHEFFESA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB14879</td>
      <td>Cefiderocol</td>
      <td>DBPPRLRVDVJOCL-FQRUVTKNSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07435</td>
      <td>1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE</td>
      <td>GFANZDFKCCJYRF-NSISKUIASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB14882</td>
      <td>CEP-9722</td>
      <td>CTLOSZHDGZLOQE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06747</td>
      <td>ginkgolide-M</td>
      <td>KDKROYXEHCYLJQ-FJFAJXJPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB05653</td>
      <td>IRX-5183</td>
      <td>PNAWUIKCVQSLFG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB14934</td>
      <td>GDC-0927</td>
      <td>KJAAPZIFCQQQKX-NDEPHWFRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12843</td>
      <td>Oleandrin</td>
      <td>JLPDBLFIVFSOCC-XYXFTTADSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB05812</td>
      <td>Abiraterone</td>
      <td>GZOSMCIZMLWJML-VJLLXTKPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB05913</td>
      <td>OSI-930</td>
      <td>FGTCROZDHDSNIO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07014</td>
      <td>2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole</td>
      <td>TUTZKAQTSPMEBI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12720</td>
      <td>Nivocasan</td>
      <td>VYFGDLGHHBUDTQ-ZLGUVYLKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB13767</td>
      <td>Vorozole</td>
      <td>XLMPPFTZALNBFS-INIZCTEOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07629</td>
      <td>N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-DLBZAZTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB01893</td>
      <td>N6-Benzyl Adenosine-5'-Diphosphate</td>
      <td>MRHGMAGSDAQUFH-LSCFUAHRSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07296</td>
      <td>(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE</td>
      <td>PLGHLEBIWUQEPR-PDGQHHTCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15035</td>
      <td>Zanubrutinib</td>
      <td>RNOAOAWBMHREKO-QFIPXVFZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB06897</td>
      <td>3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol</td>
      <td>MMGKIHLBFPJYJL-HNNXBMFYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB00693</td>
      <td>Fluorescein</td>
      <td>GNBHRKFJIUUOQI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB07519</td>
      <td>(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</td>
      <td>VDFBMQAUECXNKR-OAQYLSRUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB13814</td>
      <td>Talampicillin</td>
      <td>SOROUYSPFADXSN-SUWVAFIASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB13764</td>
      <td>Monoxerutin</td>
      <td>MBHXKZDTQCSVPM-BDAFLREQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB13728</td>
      <td>Halometasone</td>
      <td>GGXMRPUKBWXVHE-MIHLVHIWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB03802</td>
      <td>1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol</td>
      <td>ZGHFWBDHZZKWSI-LITSAYRRSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB01216</td>
      <td>Finasteride</td>
      <td>DBEPLOCGEIEOCV-WSBQPABSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB04194</td>
      <td>Chitotriose</td>
      <td>WZZVUHWLNMNWLW-VFCSDQTKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB08459</td>
      <td>3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>SVMHTBVIPYVDIL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB05327</td>
      <td>Ranirestat</td>
      <td>QCVNMNYRNIMDKV-QGZVFWFLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB05408</td>
      <td>Emricasan</td>
      <td>SCVHJVCATBPIHN-SJCJKPOMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB06334</td>
      <td>Tucidinostat</td>
      <td>SZMJVTADHFNAIS-BJMVGYQFSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB03268</td>
      <td>RU82197</td>
      <td>WKTQBTSOHBKBRW-VMPREFPWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB04099</td>
      <td>Deamido-Nad+</td>
      <td>SENPVEZBRZQVST-HISDBWNOSA-O</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB04098</td>
      <td>Balanol</td>
      <td>XYUFCXJZFZPEJD-PGRDOPGGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB03300</td>
      <td>Pterin Cytosine Dinucleotide</td>
      <td>WKSPNQYEWZEMMI-FEFZDOOUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB04270</td>
      <td>(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid</td>
      <td>WUZIMDSVRIBNNI-DEOSSOPVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB04044</td>
      <td>4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid</td>
      <td>NAQUAVBNIYTIIS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08240</td>
      <td>N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE</td>
      <td>RQAQWBFHPMSXKR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB04038</td>
      <td>Ergosterol</td>
      <td>DNVPQKQSNYMLRS-APGDWVJJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB00834</td>
      <td>Mifepristone</td>
      <td>VKHAHZOOUSRJNA-GCNJZUOMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB00728</td>
      <td>Rocuronium</td>
      <td>YXRDKMPIGHSVRX-OOJCLDBCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB05944</td>
      <td>Varlitinib</td>
      <td>UWXSAYUXVSFDBQ-CYBMUJFWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB08878</td>
      <td>Aminopterin</td>
      <td>TVZGACDUOSZQKY-LBPRGKRZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB04348</td>
      <td>Taurocholic Acid</td>
      <td>WBWWGRHZICKQGZ-HZAMXZRMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB11614</td>
      <td>Rupatadine</td>
      <td>WUZYKBABMWJHDL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB04628</td>
      <td>Allosamidin</td>
      <td>MDWNFWDBQGOKNZ-XYUDZHFQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12910</td>
      <td>Emicerfont</td>
      <td>JFHJGXQFESYQGY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12978</td>
      <td>Pexidartinib</td>
      <td>JGWRKYUXBBNENE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12996</td>
      <td>Acteoside</td>
      <td>FBSKJMQYURKNSU-ZLSOWSIRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB04724</td>
      <td>(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE</td>
      <td>COVPLULNDBDXTN-KYJUHHDHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB01940</td>
      <td>Balanol Analog 2</td>
      <td>SQLYTJZXRRDERK-ISKFKSNPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB02545</td>
      <td>Fexaramine</td>
      <td>VLQTUNDJHLEFEQ-KGENOOAVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB04750</td>
      <td>OREGON GREEN 488 CARBOXYLATE</td>
      <td>BRJCLSQFZSHLRL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB00717</td>
      <td>Norethisterone</td>
      <td>VIKNJXKGJWUCNN-XGXHKTLJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB02581</td>
      <td>5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</td>
      <td>VNZHOIDQBPFEJU-OAQYLSRUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB01831</td>
      <td>Tryptophanyl-5'amp</td>
      <td>IFQVDHDRFCKAAW-SQIXAUHQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB04006</td>
      <td>[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone</td>
      <td>WUGJIPFLBOATGL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB00146</td>
      <td>Calcifediol</td>
      <td>JWUBBDSIWDLEOM-DTOXIADCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB03957</td>
      <td>SP2456</td>
      <td>SSSXBBASYYVGCI-HSZRJFAPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB02691</td>
      <td>Glycocholic acid</td>
      <td>RFDAIACWWDREDC-FRVQLJSFSA-M</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB02827</td>
      <td>7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid</td>
      <td>MDYIGSPVMWSFEZ-JTQLQIEISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB02976</td>
      <td>Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester</td>
      <td>NGTCPFGWXMBZEP-KBQKSTHMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB13040</td>
      <td>Gandotinib</td>
      <td>SQSZANZGUXWJEA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB04882</td>
      <td>Edotecarin</td>
      <td>QMVPQBFHUJZJCS-NTKFZFFISA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB01933</td>
      <td>7-Hydroxystaurosporine</td>
      <td>PBCZSGKMGDDXIJ-HQCWYSJUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15245</td>
      <td>Olorofim</td>
      <td>SUFPWYYDCOKDLL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB03460</td>
      <td>Violaxanthin</td>
      <td>SZCBXWMUOPQSOX-WVJDLNGLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB03480</td>
      <td>Brequinar Analog</td>
      <td>WYKKHJQZENLZID-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB13347</td>
      <td>Diphenadione</td>
      <td>JYGLAHSAISAEAL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB06605</td>
      <td>Apixaban</td>
      <td>QNZCBYKSOIHPEH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB03383</td>
      <td>5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide</td>
      <td>YDCGVASFVACWKF-NRFANRHFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07081</td>
      <td>(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>FDEXEPZGMKFCTG-PSASIEDQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14054</td>
      <td>Asiatic acid</td>
      <td>JXSVIVRDWWRQRT-UYDOISQJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB02621</td>
      <td>Latrunculin A</td>
      <td>DDVBPZROPPMBLW-IZGXTMSKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB03453</td>
      <td>(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester</td>
      <td>MRNGXYMKYHNMLV-PKTZIBPZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB08400</td>
      <td>4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid</td>
      <td>KUEKMTNOUPAOBS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB07204</td>
      <td>(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</td>
      <td>DQIXTEDFNFZMCM-SFHVURJKSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB06732</td>
      <td>beta-Naphthoflavone</td>
      <td>OUGIDAPQYNCXRA-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14065</td>
      <td>Lomerizine</td>
      <td>JQSAYKKFZOSZGJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB06733</td>
      <td>Bafilomycin A1</td>
      <td>XDHNQDDQEHDUTM-JQWOJBOSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00206</td>
      <td>Reserpine</td>
      <td>QEVHRUUCFGRFIF-MDEJGZGSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB15297</td>
      <td>Petesicatib</td>
      <td>KXAAIORSMACJSI-AEFFLSMTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB07065</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>AHPKUZJCNHGFQA-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB06589</td>
      <td>Pazopanib</td>
      <td>CUIHSIWYWATEQL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB04071</td>
      <td>Cpad</td>
      <td>LFERELMXERXKKQ-KMXXXSRASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB08423</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE</td>
      <td>QKZZJXRGCHXIAI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB15108</td>
      <td>Tipranavir C-14</td>
      <td>SUJUHGSWHZTSEU-MWQIXQBFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB06169</td>
      <td>Indibulin</td>
      <td>SOLIIYNRSAWTSQ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB11430</td>
      <td>Monensin</td>
      <td>GAOZTHIDHYLHMS-KEOBGNEYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB15403</td>
      <td>Ziritaxestat</td>
      <td>REQQVBGILUTQNN-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB00137</td>
      <td>Lutein</td>
      <td>KBPHJBAIARWVSC-RGZFRNHPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB13094</td>
      <td>Pruvanserin</td>
      <td>AQRLDDAFYYAIJP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB03638</td>
      <td>Cytidyl-2'-5'-Phospho-Guanosine</td>
      <td>QZDUXDLOEVJGDG-VMIOUTBZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB03788</td>
      <td>GC-24</td>
      <td>JYHIGYLGYNCMGI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13816</td>
      <td>Aspoxicillin</td>
      <td>BHELIUBJHYAEDK-OAIUPTLZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB04514</td>
      <td>Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester</td>
      <td>DFYLLEBFVZTKHD-VMIOUTBZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB03878</td>
      <td>N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide</td>
      <td>YWQVBESSYLICRX-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB06302</td>
      <td>Glesatinib</td>
      <td>YRCHYHRCBXNYNU-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB03638</td>
      <td>Cytidyl-2'-5'-Phospho-Guanosine</td>
      <td>QZDUXDLOEVJGDG-VMIOUTBZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB00655</td>
      <td>Estrone</td>
      <td>DNXHEGUUPJUMQT-CBZIJGRNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB13451</td>
      <td>Tioclomarol</td>
      <td>WRGOVNKNTPWHLZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB15377</td>
      <td>ATB-346</td>
      <td>YCNMAPLPQYQJFC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13793</td>
      <td>Vinburnine</td>
      <td>WYJAPUKIYAZSEM-MOPGFXCFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03880</td>
      <td>Batimastat</td>
      <td>XFILPEOLDIKJHX-QYZOEREBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07254</td>
      <td>N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</td>
      <td>KQGTYXRWSIBDOZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07265</td>
      <td>3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID</td>
      <td>JDARUOOLJCFUOY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15257</td>
      <td>Milademetan</td>
      <td>RYAYYVTWKAOAJF-QISPRATLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13115</td>
      <td>Saroglitazar</td>
      <td>MRWFZSLZNUJVQW-DEOSSOPVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08861</td>
      <td>DPDPE</td>
      <td>MCMMCRYPQBNCPH-WMIMKTLMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15446</td>
      <td>Vidofludimus</td>
      <td>XPRDUGXOWVXZLL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB13164</td>
      <td>Olmutinib</td>
      <td>FDMQDKQUTRLUBU-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB11890</td>
      <td>Cilengitide</td>
      <td>AMLYAMJWYAIXIA-VWNVYAMZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07076</td>
      <td>6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</td>
      <td>FWTQOPWAMQXIMI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12491</td>
      <td>Fasiglifam</td>
      <td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB11796</td>
      <td>Fostemsavir</td>
      <td>SWMDAPWAQQTBOG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB13158</td>
      <td>Clobetasone</td>
      <td>XXIFVOHLGBURIG-OZCCCYNHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03460</td>
      <td>Violaxanthin</td>
      <td>SZCBXWMUOPQSOX-WVJDLNGLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06908</td>
      <td>(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID</td>
      <td>PAWOPJKHTZCKMT-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB01029</td>
      <td>Irbesartan</td>
      <td>YOSHYTLCDANDAN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00543</td>
      <td>Amoxapine</td>
      <td>QWGDMFLQWFTERH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB15133</td>
      <td>Tepotinib</td>
      <td>AHYMHWXQRWRBKT-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13090</td>
      <td>Zidebactam</td>
      <td>YCZPXRQPDCXTIO-BBBLOLIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07138</td>
      <td>Neflamapimod</td>
      <td>VEPKQEUBKLEPRA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB15245</td>
      <td>Olorofim</td>
      <td>SUFPWYYDCOKDLL-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00554</td>
      <td>Piroxicam</td>
      <td>QYSPLQLAKJAUJT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13122</td>
      <td>Trabodenoson</td>
      <td>AQLVRTWKJDTWQQ-SDBHATRESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13135</td>
      <td>AGN-201904</td>
      <td>PPCGSVWOZKNPCX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB11773</td>
      <td>BMS-903452</td>
      <td>OGIAVRWXUPYGGC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07054</td>
      <td>(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL</td>
      <td>OSCWQKTUILTARV-MRXNPFEDSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13374</td>
      <td>Vincamine</td>
      <td>RXPRRQLKFXBCSJ-GIVPXCGWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13369</td>
      <td>Benzilone</td>
      <td>ZKCWITXZGWUJAV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13355</td>
      <td>Visnadine</td>
      <td>GVBNSPFBYXGREE-CXWAGAITSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB07967</td>
      <td>9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE</td>
      <td>JJNKDTWKWYLERH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08011</td>
      <td>(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DXIHOIDYHQSQKJ-HMMYKYKNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00434</td>
      <td>Cyproheptadine</td>
      <td>JJCFRYNCJDLXIK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB11645</td>
      <td>PF-4191834</td>
      <td>DVNQWYLVSNPCJZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB12012</td>
      <td>PF-04457845</td>
      <td>BATCTBJIJJEPHM-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB11663</td>
      <td>Pictilisib</td>
      <td>LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08513</td>
      <td>[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID</td>
      <td>PAIQRYUOBBCBSE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00568</td>
      <td>Cinnarizine</td>
      <td>DERZBLKQOCDDDZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13248</td>
      <td>Phthalylsulfathiazole</td>
      <td>PBMSWVPMRUJMPE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12511</td>
      <td>Imiglitazar</td>
      <td>ULVDFHLHKNJICZ-QCWLDUFUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08703</td>
      <td>12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one</td>
      <td>FGKKIHITEICGMN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13242</td>
      <td>Bucladesine</td>
      <td>CJGYSWNGNKCJSB-YVLZZHOMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06137</td>
      <td>KX-01</td>
      <td>HUNGUWOZPQBXGX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13237</td>
      <td>Clofoctol</td>
      <td>HQVZOORKDNCGCK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13212</td>
      <td>Phenolsulfonphthalein</td>
      <td>BELBBZDIHDAJOR-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08749</td>
      <td>3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</td>
      <td>KTRFBFMYAJOXLG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13175</td>
      <td>Rheinanthrone</td>
      <td>OZFQHULMMDWMIV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07053</td>
      <td>2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID</td>
      <td>TWVYNPULGKGJOS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08445</td>
      <td>(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>IFKWHPAWYJARQJ-DYVFJYSZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07144</td>
      <td>5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>XZXVRKHUCSXVBM-AWEZNQCLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13039</td>
      <td>Aminaphthone</td>
      <td>YLMPBJUYFTWHKJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB09280</td>
      <td>Lumacaftor</td>
      <td>UFSKUSARDNFIRC-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00897</td>
      <td>Triazolam</td>
      <td>JOFWLTCLBGQGBO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06321</td>
      <td>R-348</td>
      <td>IGLNXKVGKIFNBQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB13552</td>
      <td>Trifluperidol</td>
      <td>GPMXUUPHFNMNDH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB11763</td>
      <td>Momelotinib</td>
      <td>ZVHNDZWQTBEVRY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15325</td>
      <td>ONO-8539</td>
      <td>ALLLQQUASFFEKP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB01128</td>
      <td>Bicalutamide</td>
      <td>LKJPYSCBVHEWIU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15323</td>
      <td>Trelagliptin</td>
      <td>IWYJYHUNXVAVAA-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00933</td>
      <td>Mesoridazine</td>
      <td>SLVMESMUVMCQIY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB13104</td>
      <td>X-396</td>
      <td>ONPGOSVDVDPBCY-CQSZACIVSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01013</td>
      <td>Clobetasol propionate</td>
      <td>CBGUOGMQLZIXBE-XGQKBEPLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB06494</td>
      <td>Sufugolix</td>
      <td>UCQSBGOFELXYIN-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB01180</td>
      <td>Rescinnamine</td>
      <td>SZLZWPPUNLXJEA-LAFLMMDJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07479</td>
      <td>(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL</td>
      <td>WCUHTHVUZQCBTI-KBAYOESNSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12137</td>
      <td>GSK-256066</td>
      <td>JFHROPTYMMSOLG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB01025</td>
      <td>Amlexanox</td>
      <td>SGRYPYWGNKJSDL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB11793</td>
      <td>Niraparib</td>
      <td>PCHKPVIQAHNQLW-CQSZACIVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07512</td>
      <td>7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE</td>
      <td>ZOCADHRNWNJARU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB11819</td>
      <td>ASP-4058</td>
      <td>NJNXCJPSMWKXHO-VIFPVBQESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15305</td>
      <td>Risdiplam</td>
      <td>ASKZRYGFUPSJPN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12036</td>
      <td>Naquotinib</td>
      <td>QKDCLUARMDUUKN-XMMPIXPASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB11663</td>
      <td>Pictilisib</td>
      <td>LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00860</td>
      <td>Prednisolone</td>
      <td>OIGNJSKKLXVSLS-VWUMJDOOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12832</td>
      <td>Prednimustine</td>
      <td>HFVNWDWLWUCIHC-GUPDPFMOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13022</td>
      <td>LY-2874455</td>
      <td>GKJCVYLDJWTWQU-CXLRFSCWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB09319</td>
      <td>Carindacillin</td>
      <td>JIRBAUWICKGBFE-MNRDOXJOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00621</td>
      <td>Oxandrolone</td>
      <td>QSLJIVKCVHQPLV-PEMPUTJUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07254</td>
      <td>N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</td>
      <td>KQGTYXRWSIBDOZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12467</td>
      <td>TU-100</td>
      <td>KAYRGFYBCCETPE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB11907</td>
      <td>Rociletinib</td>
      <td>HUFOZJXAKZVRNJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00678</td>
      <td>Losartan</td>
      <td>PSIFNNKUMBGKDQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00683</td>
      <td>Midazolam</td>
      <td>DDLIGBOFAVUZHB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB15039</td>
      <td>ITI-214</td>
      <td>BBIPVJCGIASXJB-PKTZIBPZSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03449</td>
      <td>N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine</td>
      <td>ZZVGLDBDDYESAB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lu7</td>
      <td>DB12983</td>
      <td>Phthalocyanine</td>
      <td>IEQIEDJGQAUEQZ-UHFFFAOYSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00719</td>
      <td>Azatadine</td>
      <td>SEBMTIQKRHYNIT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB11949</td>
      <td>Vestipitant</td>
      <td>SBBYBXSFWOLDDG-JLTOFOAXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00808</td>
      <td>Indapamide</td>
      <td>NDDAHWYSQHTHNT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB12869</td>
      <td>Eliprodil</td>
      <td>GGUSQTSTQSHJAH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB02833</td>
      <td>[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine</td>
      <td>DYTKVFHLKPDNRW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB07337</td>
      <td>4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE</td>
      <td>SOKOHDQTKSROQZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00831</td>
      <td>Trifluoperazine</td>
      <td>ZEWQUBUPAILYHI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB12001</td>
      <td>Abemaciclib</td>
      <td>UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lu7</td>
      <td>DB04868</td>
      <td>Nilotinib</td>
      <td>HHZIURLSWUIHRB-UHFFFAOYSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB12443</td>
      <td>Sonedenoson</td>
      <td>WUCQGGOGHZRELS-LSCFUAHRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB07550</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE</td>
      <td>ZIGSBBKEPNQXRG-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB15224</td>
      <td>Lisavanbulin</td>
      <td>NIPZLALJRAHABJ-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13435</td>
      <td>Endralazine</td>
      <td>ALAXZYHFVBSJKZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB01254</td>
      <td>Dasatinib</td>
      <td>ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08354</td>
      <td>2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>QCVULERVJOYHCP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07630</td>
      <td>N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-IAGOWNOFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06533</td>
      <td>Ragaglitazar</td>
      <td>WMUIIGVAWPWQAW-XMMPIXPASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08362</td>
      <td>N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE</td>
      <td>QVKXQLGRDOMAGC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06555</td>
      <td>Siramesine</td>
      <td>XWAONOGAGZNUSF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB14013</td>
      <td>SR-9009</td>
      <td>MMJJNHOIVCGAAP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lu7</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07666</td>
      <td>(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE</td>
      <td>OAWGQHXWGXOUKV-BEFAXECRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB08034</td>
      <td>(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</td>
      <td>TVOPERZEGKBKAY-RGVLZGJSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13957</td>
      <td>J147</td>
      <td>HYMZAYGFKNNHDN-SSDVNMTOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07680</td>
      <td>[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</td>
      <td>HUJXISJLAPAFBO-IBGZPJMESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15416</td>
      <td>PX-102</td>
      <td>XBUXXJUEBFDQHD-NHCUHLMSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06967</td>
      <td>6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE</td>
      <td>MLSVRCGEBXIIQO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13487</td>
      <td>Iodine (131I) norcholesterol</td>
      <td>QJHZPCLORSPENH-DRTKWHMQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB06962</td>
      <td>(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone</td>
      <td>YKTUSHSSKIWDRY-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13944</td>
      <td>Testosterone enanthate</td>
      <td>VOCBWIIFXDYGNZ-IXKNJLPQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14626</td>
      <td>Pregnenolone acetate</td>
      <td>CRRKVZVYZQXICQ-RJJCNJEVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB01260</td>
      <td>Desonide</td>
      <td>WBGKWQHBNHJJPZ-LECWWXJVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB05431</td>
      <td>MLN-977</td>
      <td>YANONWCPCKIWEC-CABCVRRESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08248</td>
      <td>3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE</td>
      <td>BKDUVKJYBJDZQW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07297</td>
      <td>5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE</td>
      <td>PTILEOLOGGMFCS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06334</td>
      <td>Tucidinostat</td>
      <td>SZMJVTADHFNAIS-BJMVGYQFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15273</td>
      <td>VS-4718</td>
      <td>IGUBBWJDMLCRIK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07405</td>
      <td>1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</td>
      <td>GIZYIOOBBUHOBS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB01338</td>
      <td>Pipecuronium</td>
      <td>OWWLUIWOFHMHOQ-XGHATYIMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15281</td>
      <td>Ravoxertinib</td>
      <td>RZUOCXOYPYGSKL-GOSISDBHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB07422</td>
      <td>(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide</td>
      <td>MMNRWNREMUMYQG-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08068</td>
      <td>N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</td>
      <td>YQJVDUKATDECHF-ICSRJNTNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06983</td>
      <td>(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol</td>
      <td>RBLKWWBHDUBPFN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03501</td>
      <td>Galactose-uridine-5'-diphosphate</td>
      <td>HSCJRCZFDFQWRP-ABVWGUQPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08079</td>
      <td>AMG-208</td>
      <td>HEAIZQNMNCHNFD-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB01328</td>
      <td>Cefonicid</td>
      <td>DYAIAHUQIPBDIP-AXAPSJFSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB01320</td>
      <td>Fosphenytoin</td>
      <td>XWLUWCNOOVRFPX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08096</td>
      <td>8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM</td>
      <td>ZWKOUFZHPNIQSH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08097</td>
      <td>2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE</td>
      <td>OGWSGDLIXOEZJG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15292</td>
      <td>Foliglurax</td>
      <td>ZTEDNASHAWNBKQ-NCELDCMTSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB15294</td>
      <td>SB-1578</td>
      <td>NNXDIGHYPZHXTR-ONEGZZNKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB15085</td>
      <td>Fulacimstat</td>
      <td>JDARDSVOVYVQST-MRXNPFEDSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06497</td>
      <td>Aplaviroc</td>
      <td>GWNOTCOIYUNTQP-FQLXRVMXSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07340</td>
      <td>N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine</td>
      <td>ZFLJHSQHILSNCM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB01329</td>
      <td>Cefoperazone</td>
      <td>GCFBRXLSHGKWDP-XCGNWRKASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13432</td>
      <td>Lonazolac</td>
      <td>XVUQHFRQHBLHQD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB07382</td>
      <td>N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine</td>
      <td>WJNBSTLIALIIEW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB12381</td>
      <td>Merestinib</td>
      <td>QHADVLVFMKEIIP-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB06944</td>
      <td>N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide</td>
      <td>RIGZCVNCFXYBEG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00248</td>
      <td>Cabergoline</td>
      <td>KORNTPPJEAJQIU-KJXAQDMKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB09079</td>
      <td>Nintedanib</td>
      <td>XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB13788</td>
      <td>Chlorbenzoxamine</td>
      <td>VEVSKUJZSMGTMM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06976</td>
      <td>1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA</td>
      <td>IWOOJEZSDPRYAZ-WFASDCNBSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08349</td>
      <td>N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide</td>
      <td>WMEYCLAVMZKZCS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13552</td>
      <td>Trifluperidol</td>
      <td>GPMXUUPHFNMNDH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB09371</td>
      <td>Norethynodrel</td>
      <td>ICTXHFFSOAJUMG-SLHNCBLASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB02205</td>
      <td>6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One</td>
      <td>JCDLLLXYAICSQV-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06267</td>
      <td>Udenafil</td>
      <td>IYFNEFQTYQPVOC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13551</td>
      <td>Cinchophen</td>
      <td>YTRMTPPVNRALON-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13534</td>
      <td>Gedocarnil</td>
      <td>SLYDYLLJUXFULK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00294</td>
      <td>Etonogestrel</td>
      <td>GCKFUYQCUCGESZ-BPIQYHPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07564</td>
      <td>6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>JUHXOBNFTFUPKQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB13411</td>
      <td>Lofepramine</td>
      <td>SAPNXPWPAUFAJU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB12044</td>
      <td>MK-0893</td>
      <td>DNTVJEMGHBIUMW-IBGZPJMESA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07563</td>
      <td>1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine</td>
      <td>GCJSOJRPNOWSEH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB11450</td>
      <td>Pimobendan</td>
      <td>GLBJJMFZWDBELO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB00694</td>
      <td>Daunorubicin</td>
      <td>STQGQHZAVUOBTE-VGBVRHCVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08154</td>
      <td>3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>WHCLIFOVZDANCU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08124</td>
      <td>3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>FTQYGMLRLRXBPT-IDUWFGFVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08034</td>
      <td>(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</td>
      <td>TVOPERZEGKBKAY-RGVLZGJSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB12669</td>
      <td>4SC-203</td>
      <td>MAFACRSJGNJHCF-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB15444</td>
      <td>Elexacaftor</td>
      <td>MVRHVFSOIWFBTE-INIZCTEOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB03490</td>
      <td>3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole</td>
      <td>NHOACLCXCKJMAK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB14636</td>
      <td>Triciribine phosphate</td>
      <td>URLYINUFLXOMHP-HTVVRFAVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB08815</td>
      <td>Lurasidone</td>
      <td>PQXKDMSYBGKCJA-CVTJIBDQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08034</td>
      <td>(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</td>
      <td>TVOPERZEGKBKAY-RGVLZGJSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06897</td>
      <td>3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol</td>
      <td>MMGKIHLBFPJYJL-HNNXBMFYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00220</td>
      <td>Nelfinavir</td>
      <td>QAGYKUNXZHXKMR-HKWSIXNMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06858</td>
      <td>N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide</td>
      <td>MMLOIDMSBRJZAE-FQEVSTJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08388</td>
      <td>5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE</td>
      <td>XRSYNYGEEYTXJV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00224</td>
      <td>Indinavir</td>
      <td>CBVCZFGXHXORBI-PXQQMZJSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB08068</td>
      <td>N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</td>
      <td>YQJVDUKATDECHF-ICSRJNTNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13692</td>
      <td>Tretoquinol</td>
      <td>RGVPOXRFEPSFGH-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00240</td>
      <td>Alclometasone</td>
      <td>FJXOGVLKCZQRDN-PHCHRAKRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB01029</td>
      <td>Irbesartan</td>
      <td>YOSHYTLCDANDAN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB06933</td>
      <td>N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide</td>
      <td>GJTCKUKIFXWJKG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB00246</td>
      <td>Ziprasidone</td>
      <td>MVWVFYHBGMAFLY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB09038</td>
      <td>Empagliflozin</td>
      <td>OBWASQILIWPZMG-QZMOQZSNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB13739</td>
      <td>Penamecillin</td>
      <td>NLOOMWLTUVBWAW-HLLBOEOZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m71</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08727</td>
      <td>3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole</td>
      <td>NEAZMARKCJKUMF-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00967</td>
      <td>Desloratadine</td>
      <td>JAUOIFJMECXRGI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07409</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>MPBUFKZCEBTBSK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB05039</td>
      <td>Indacaterol</td>
      <td>QZZUEBNBZAPZLX-QFIPXVFZSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08976</td>
      <td>Floctafenine</td>
      <td>APQPGQGAWABJLN-GFCCVEGCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00947</td>
      <td>Fulvestrant</td>
      <td>VWUXBMIQPBEWFH-WCCTWKNTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07011</td>
      <td>(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE</td>
      <td>HHOPJGKEAIIIDF-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00919</td>
      <td>Spectinomycin</td>
      <td>UNFWWIHTNXNPBV-WXKVUWSESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00912</td>
      <td>Repaglinide</td>
      <td>FAEKWTJYAYMJKF-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07022</td>
      <td>3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate</td>
      <td>PXERBGNIBOFZOW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB05171</td>
      <td>E-2012</td>
      <td>PUOAETJYKQITMO-LANLRWRYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08974</td>
      <td>Flubendazole</td>
      <td>CPEUVMUXAHMANV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB05087</td>
      <td>Ganaxolone</td>
      <td>PGTVWKLGGCQMBR-FLBATMFCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00890</td>
      <td>Dienestrol</td>
      <td>NFDFQCUYFHCNBW-SCGPFSFSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00885</td>
      <td>Pemirolast</td>
      <td>HIANJWSAHKJQTH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00876</td>
      <td>Eprosartan</td>
      <td>OROAFUQRIXKEMV-LDADJPATSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB09053</td>
      <td>Ibrutinib</td>
      <td>XYFPWWZEPKGCCK-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB02266</td>
      <td>Flufenamic Acid</td>
      <td>LPEPZBJOKDYZAD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00846</td>
      <td>Flurandrenolide</td>
      <td>POPFMWWJOGLOIF-XWCQMRHXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07054</td>
      <td>(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL</td>
      <td>OSCWQKTUILTARV-MRXNPFEDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00813</td>
      <td>Fentanyl</td>
      <td>PJMPHNIQZUBGLI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11629</td>
      <td>Laropiprant</td>
      <td>NXFFJDQHYLNEJK-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB02623</td>
      <td>Aminophosphonic Acid-Guanylate Ester</td>
      <td>ZGPDMUBRWRJAQQ-UUOKFMHZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00751</td>
      <td>Epinastine</td>
      <td>WHWZLSFABNNENI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07067</td>
      <td>(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE</td>
      <td>SQCDMTZMCHZYGO-FZMZJTMJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB02639</td>
      <td>4-methylumbelliferyl ??-D-glucoside</td>
      <td>YUDPTGPSBJVHCN-JZYAIQKZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00719</td>
      <td>Azatadine</td>
      <td>SEBMTIQKRHYNIT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00716</td>
      <td>Nedocromil</td>
      <td>RQTOOFIXOKYGAN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB02197</td>
      <td>4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide</td>
      <td>NKORVPQBJCGYEC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB05263</td>
      <td>Caprospinol</td>
      <td>VMOZFSWFUBLCNN-AAPULDEBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06673</td>
      <td>Almorexant</td>
      <td>DKMACHNQISHMDN-RPLLCQBOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01066</td>
      <td>Cefditoren</td>
      <td>KMIPKYQIOVAHOP-YLGJWRNMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB01691</td>
      <td>Indole Naphthyridinone</td>
      <td>VAZMNDXVXVUKFY-JXMROGBWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07519</td>
      <td>(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</td>
      <td>VDFBMQAUECXNKR-OAQYLSRUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB06875</td>
      <td>3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE</td>
      <td>NSSOSHDCWCMNDM-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07508</td>
      <td>4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE</td>
      <td>MEUAVGJWGDPTLF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB06666</td>
      <td>Lixivaptan</td>
      <td>PPHTXRNHTVLQED-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07460</td>
      <td>2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE</td>
      <td>UYJNQQDJUOUFQJ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06858</td>
      <td>N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide</td>
      <td>MMLOIDMSBRJZAE-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08743</td>
      <td>2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE</td>
      <td>XJNKUWDMCBZMTG-OAHLLOKOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01641</td>
      <td>(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One</td>
      <td>JUWJATLABHTRDF-JURWUIOISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06875</td>
      <td>3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE</td>
      <td>NSSOSHDCWCMNDM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08816</td>
      <td>Ticagrelor</td>
      <td>OEKWJQXRCDYSHL-FNOIDJSQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11490</td>
      <td>Nalorphine</td>
      <td>UIQMVEYFGZJHCZ-SSTWWWIQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01172</td>
      <td>Kanamycin</td>
      <td>SBUJHOSQTJFQJX-NOAMYHISSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01166</td>
      <td>Cilostazol</td>
      <td>RRGUKTPIGVIEKM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB06521</td>
      <td>Ertiprotafib</td>
      <td>FONCZICQWCUXEB-RUZDIDTESA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06909</td>
      <td>1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide</td>
      <td>QZGJNFBMYYEFGM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01149</td>
      <td>Nefazodone</td>
      <td>VRBKIVRKKCLPHA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01136</td>
      <td>Carvedilol</td>
      <td>OGHNVEJMJSYVRP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06930</td>
      <td>N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide</td>
      <td>WVLDNAVUCUAGDP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08881</td>
      <td>Vemurafenib</td>
      <td>GPXBXXGIAQBQNI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01132</td>
      <td>Pioglitazone</td>
      <td>HYAFETHFCAUJAY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08882</td>
      <td>Linagliptin</td>
      <td>LTXREWYXXSTFRX-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08899</td>
      <td>Enzalutamide</td>
      <td>WXCXUHSOUPDCQV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01068</td>
      <td>Clonazepam</td>
      <td>DGBIGWXXNGSACT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB06248</td>
      <td>Amelubant</td>
      <td>SBVYURPQULDJTI-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08906</td>
      <td>Fluticasone furoate</td>
      <td>XTULMSXFIHGYFS-VLSRWLAYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB02177</td>
      <td>1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine</td>
      <td>GKGJFUXSTSUKPB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00714</td>
      <td>Apomorphine</td>
      <td>VMWNQDUVQKEIOC-CYBMUJFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB09199</td>
      <td>Netoglitazone</td>
      <td>PKWDZWYVIHVNKS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11633</td>
      <td>Isavuconazole</td>
      <td>DDFOUSQFMYRUQK-RCDICMHDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00468</td>
      <td>Quinine</td>
      <td>LOUPRKONTZGTKE-WZBLMQSHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00448</td>
      <td>Lansoprazole</td>
      <td>MJIHNNLFOKEZEW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11424</td>
      <td>Lufenuron</td>
      <td>PWPJGUXAGUPAHP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11442</td>
      <td>Oleandomycin</td>
      <td>RZPAKFUAFGMUPI-QESOVKLGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00434</td>
      <td>Cyproheptadine</td>
      <td>JJCFRYNCJDLXIK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07244</td>
      <td>5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE</td>
      <td>SRRWXMSVQYQCRX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07249</td>
      <td>N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine</td>
      <td>QHIMVPIOWKYPSO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07325</td>
      <td>N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE</td>
      <td>VCOKUBHAJVTVNG-FMIVXFBMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00370</td>
      <td>Mirtazapine</td>
      <td>RONZAEMNMFQXRA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00365</td>
      <td>Grepafloxacin</td>
      <td>AIJTTZAVMXIJGM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB12128</td>
      <td>Ulimorelin</td>
      <td>WGYPAJVJMXQXTR-ABNZCKJZSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB11903</td>
      <td>GW842166</td>
      <td>TWQYWUXBZHPIIV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00353</td>
      <td>Methylergometrine</td>
      <td>UNBRKDKAWYKMIV-QWQRMKEZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11704</td>
      <td>Adomeglivant</td>
      <td>FASLTMSUPQDLIB-MHZLTWQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12322</td>
      <td>GW-870086</td>
      <td>WUBKGTSFJSEIEM-NSHBDUGJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12122</td>
      <td>Figopitant</td>
      <td>HUTHJVYJUPXHDF-DEOSSOPVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11551</td>
      <td>Trenbolone</td>
      <td>MEHHPFQKXOUFFV-OWSLCNJRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB11900</td>
      <td>OC-459</td>
      <td>FATGTHLOZSXOBC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11629</td>
      <td>Laropiprant</td>
      <td>NXFFJDQHYLNEJK-CYBMUJFWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01068</td>
      <td>Clonazepam</td>
      <td>DGBIGWXXNGSACT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11671</td>
      <td>AZD-4877</td>
      <td>SMFXSYMLJDHGIE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06696</td>
      <td>Arbekacin</td>
      <td>MKKYBZZTJQGVCD-XTCKQBCOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11701</td>
      <td>Amenamevir</td>
      <td>MNHNIVNAFBSLLX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB05575</td>
      <td>Motesanib</td>
      <td>RAHBGWKEPAQNFF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB03608</td>
      <td>Diminazene</td>
      <td>XNYZHCFCZNMTFY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01548</td>
      <td>Diprenorphine</td>
      <td>OIJXLIIMXHRJJH-KNLIIKEYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00497</td>
      <td>Oxycodone</td>
      <td>BRUQQQPBMZOVGD-XFKAJCMBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07212</td>
      <td>N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE</td>
      <td>NNGZRCYXFBHMRM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB05416</td>
      <td>Cardarine</td>
      <td>YDBLKRPLXZNVNB-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB02331</td>
      <td>(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>YBULOUKTPCHXAL-DEOSSOPVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00691</td>
      <td>Moexipril</td>
      <td>UWWDHYUMIORJTA-HSQYWUDLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11636</td>
      <td>Nomegestrol</td>
      <td>KZUIYQJTUIACIG-YBZCJVABSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB09231</td>
      <td>Benidipine</td>
      <td>QZVNQOLPLYWLHQ-ZEQKJWHPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00683</td>
      <td>Midazolam</td>
      <td>DDLIGBOFAVUZHB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07140</td>
      <td>5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>JPENSYBRTSIYGO-AWEZNQCLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07141</td>
      <td>5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>QVXYJVHNRPNRJL-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00682</td>
      <td>Warfarin</td>
      <td>PJVWKTKQMONHTI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07144</td>
      <td>5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>XZXVRKHUCSXVBM-AWEZNQCLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04825</td>
      <td>Prenylamine</td>
      <td>IFFPICMESYHZPQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04838</td>
      <td>Cyclandelate</td>
      <td>WZHCOOQXZCIUNC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB02717</td>
      <td>Cellotetraose</td>
      <td>LUEWUZLMQUOBSB-HGDSAIHNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB09279</td>
      <td>Fimasartan</td>
      <td>AMEROGPZOLAFBN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04785</td>
      <td>Streptolydigin</td>
      <td>KVTPRMVXYZKLIG-NCAOFHFGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00607</td>
      <td>Nafcillin</td>
      <td>GPXLMGHLHQJAGZ-JTDSTZFVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB09295</td>
      <td>Talniflumate</td>
      <td>ANMLJLFWUCQGKZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB09378</td>
      <td>Fluprednisolone</td>
      <td>MYYIMZRZXIQBGI-HVIRSNARSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07359</td>
      <td>3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide</td>
      <td>SJTQKYKXCYVFHX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07340</td>
      <td>N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine</td>
      <td>ZFLJHSQHILSNCM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB09488</td>
      <td>Acrivastine</td>
      <td>PWACSDKDOHSSQD-IUTFFREVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01557</td>
      <td>??-Methylfentanyl</td>
      <td>NGTVDHYUFBKWID-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11184</td>
      <td>Oftasceine</td>
      <td>DEGAKNSWVGKMLS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB00524</td>
      <td>Metolazone</td>
      <td>AQCHWTWZEMGIFD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11675</td>
      <td>Mosapride</td>
      <td>YPELFRMCRYSPKZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11679</td>
      <td>Fruquintinib</td>
      <td>BALLNEJQLSTPIO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB09048</td>
      <td>Netupitant</td>
      <td>WAXQNWCZJDTGBU-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07156</td>
      <td>(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione</td>
      <td>JFEKAVPMVOLVTH-UNOMPAQXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15333</td>
      <td>AZD-1386</td>
      <td>FPGNKXCEPARJDI-ZDUSSCGKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01469</td>
      <td>Acetorphine</td>
      <td>LFYBMMHFJIAKFE-PMEKXCSPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01538</td>
      <td>Acetyldihydrocodeine</td>
      <td>LGGDXXJAGWBUSL-BKRJIHRRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12494</td>
      <td>SGI-1776</td>
      <td>MHXGEROHKGDZGO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB02925</td>
      <td>Piretanide</td>
      <td>UJEWTUDSLQGTOA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB02919</td>
      <td>2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine</td>
      <td>PUOZHLHNKHRTOW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB05498</td>
      <td>KW-7158</td>
      <td>NAFSYPCVPLWHFY-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB09290</td>
      <td>Ramosetron</td>
      <td>NTHPAPBPFQJABD-LLVKDONJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07716</td>
      <td>(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL</td>
      <td>VDRIXSJOPKVWKM-HXGIDPQASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB08708</td>
      <td>N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine</td>
      <td>XYYDXQCAYXOGQT-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB05575</td>
      <td>Motesanib</td>
      <td>RAHBGWKEPAQNFF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07698</td>
      <td>3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine</td>
      <td>JDNMRPIWJIDDAY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB14716</td>
      <td>Clonazolam</td>
      <td>XJRGLCAWBRZUFC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07067</td>
      <td>(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE</td>
      <td>SQCDMTZMCHZYGO-FZMZJTMJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB09143</td>
      <td>Sonidegib</td>
      <td>VZZJRYRQSPEMTK-CALCHBBNSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08142</td>
      <td>AT-7519</td>
      <td>OVPNQJVDAFNBDN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12459</td>
      <td>Belotecan</td>
      <td>LNHWXBUNXOXMRL-VWLOTQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08143</td>
      <td>5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE</td>
      <td>SXIYSYYSKHUTQQ-RDJZCZTQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB02684</td>
      <td>5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine</td>
      <td>FTSDEWPMACCNGN-YTMOPEAISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB05772</td>
      <td>Rabeximod</td>
      <td>PDNNUMNEXITLCZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB05812</td>
      <td>Abiraterone</td>
      <td>GZOSMCIZMLWJML-VJLLXTKPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB15078</td>
      <td>Rogaratinib</td>
      <td>HNLRRJSKGXOYNO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB02623</td>
      <td>Aminophosphonic Acid-Guanylate Ester</td>
      <td>ZGPDMUBRWRJAQQ-UUOKFMHZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12459</td>
      <td>Belotecan</td>
      <td>LNHWXBUNXOXMRL-VWLOTQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB12307</td>
      <td>Foretinib</td>
      <td>CXQHYVUVSFXTMY-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06077</td>
      <td>Lumateperone</td>
      <td>HOIIHACBCFLJET-SFTDATJTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB00836</td>
      <td>Loperamide</td>
      <td>RDOIQAHITMMDAJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB05416</td>
      <td>Cardarine</td>
      <td>YDBLKRPLXZNVNB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB00844</td>
      <td>Nalbuphine</td>
      <td>NETZHAKZCGBWSS-CEDHKZHLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08087</td>
      <td>4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE</td>
      <td>NHBIWLQQJPSMNP-CABCVRRESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB05399</td>
      <td>Succinobucol</td>
      <td>RKSMVPNZHBRNNS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03687</td>
      <td>4-Diphosphocytidyl-2-C-Methyl-D-Erythritol</td>
      <td>YFAUKWZNPVBCFF-XHIBXCGHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00823</td>
      <td>Ethynodiol diacetate</td>
      <td>ONKUMRGIYFNPJW-KIEAKMPYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07089</td>
      <td>N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide</td>
      <td>VZSMTBLDWPKVRW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08639</td>
      <td>Dapivirine</td>
      <td>ILAYIAGXTHKHNT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB12228</td>
      <td>Telcagepant</td>
      <td>CGDZXLJGHVKVIE-DNVCBOLYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03596</td>
      <td>N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide</td>
      <td>FSRPBGBMEKDSIJ-CYBMUJFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07991</td>
      <td>N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE</td>
      <td>APLJSSOXDWUNGV-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03534</td>
      <td>3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide</td>
      <td>AWTBJNJPBKTHEV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB12101</td>
      <td>CC-220</td>
      <td>IXZOHGPZAQLIBH-NRFANRHFSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12524</td>
      <td>BI-671800</td>
      <td>XEOSTBFUCNZKGS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB09201</td>
      <td>Ciglitazone</td>
      <td>YZFWTZACSRHJQD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12522</td>
      <td>Toreforant</td>
      <td>FCRFVPZAXGJLPW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03421</td>
      <td>2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione</td>
      <td>JSSVIGGKHIJEHO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04946</td>
      <td>Iloperidone</td>
      <td>XMXHEBAFVSFQEX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03349</td>
      <td>8-Bromo-Adenosine-5'-Monophosphate</td>
      <td>DNPIJKNXFSPNNY-UUOKFMHZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB05016</td>
      <td>Ataluren</td>
      <td>OOUGLTULBSNHNF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03348</td>
      <td>Huperzine B</td>
      <td>YYWGABLTRMRUIT-HWWQOWPSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB00171</td>
      <td>ATP</td>
      <td>ZKHQWZAMYRWXGA-KQYNXXCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12515</td>
      <td>9-aminocamptothecin</td>
      <td>FUXVKZWTXQUGMW-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB00180</td>
      <td>Flunisolide</td>
      <td>XSFJVAJPIHIPKU-XWCQMRHXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08051</td>
      <td>(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>XXRHRPGYYNOBHO-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12511</td>
      <td>Imiglitazar</td>
      <td>ULVDFHLHKNJICZ-QCWLDUFUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB03696</td>
      <td>Lanosterol</td>
      <td>CAHGCLMLTWQZNJ-BQNIITSRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB00421</td>
      <td>Spironolactone</td>
      <td>LXMSZDCAJNLERA-ZHYRCANASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06137</td>
      <td>KX-01</td>
      <td>HUNGUWOZPQBXGX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB02524</td>
      <td>2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)</td>
      <td>XFMMHXLUHKBKQE-UHEGPQQHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06157</td>
      <td>Istaroxime</td>
      <td>MPYLDWFDPHRTEG-PAAYLBSLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00956</td>
      <td>Hydrocodone</td>
      <td>LLPOLZWFYMWNKH-CMKMFDCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB01264</td>
      <td>Darunavir</td>
      <td>CJBJHOAVZSMMDJ-HEXNFIEUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08503</td>
      <td>(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</td>
      <td>HRCKGDOSPBFICB-MZHQWRCYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08504</td>
      <td>6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM</td>
      <td>ZNHVIJAGMFQGMS-IHPCNDPISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01698</td>
      <td>Rutin</td>
      <td>IKGXIBQEEMLURG-NVPNHPEKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01697</td>
      <td>beta-cellotriose</td>
      <td>FYGDTMLNYKFZSV-CSHPIKHBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01685</td>
      <td>Topiroxostat</td>
      <td>UBVZQGOVTLIHLH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06578</td>
      <td>Tonabersat</td>
      <td>XLIIRNOPGJTBJD-ROUUACIJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08521</td>
      <td>4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>CDMGBJANTYXAIV-HHHXNRCGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08531</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CVYWYUAQFJMLEO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07607</td>
      <td>4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>RXDZANYWRNIAOR-HHHXNRCGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01621</td>
      <td>Pipotiazine</td>
      <td>JOMHSQGEWSNUKU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06597</td>
      <td>Estradiol sulfamate</td>
      <td>YXYXCSOJKUAPJI-ZBRFXRBCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01604</td>
      <td>Pivampicillin</td>
      <td>ZEMIJUDPLILVNQ-ZXFNITATSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00990</td>
      <td>Exemestane</td>
      <td>BFYIZQONLCFLEV-DAELLWKTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06626</td>
      <td>Axitinib</td>
      <td>RITAVMQDGBJQJZ-FMIVXFBMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11430</td>
      <td>Monensin</td>
      <td>GAOZTHIDHYLHMS-KEOBGNEYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB04882</td>
      <td>Edotecarin</td>
      <td>QMVPQBFHUJZJCS-NTKFZFFISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB07078</td>
      <td>(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>AYSXURJZVXBSRV-WJDWOHSUSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB07026</td>
      <td>(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE</td>
      <td>PPLDARNGJSQINK-OKZBNKHCSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08547</td>
      <td>PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE</td>
      <td>JBBNFGYRYNBDIH-DBGGZKJISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB01357</td>
      <td>Mestranol</td>
      <td>IMSSROKUHAOUJS-MJCUULBUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01009</td>
      <td>Ketoprofen</td>
      <td>DKYWVDODHFEZIM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB01380</td>
      <td>Cortisone acetate</td>
      <td>ITRJWOMZKQRYTA-RFZYENFJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB01260</td>
      <td>Desonide</td>
      <td>WBGKWQHBNHJJPZ-LECWWXJVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08493</td>
      <td>5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID</td>
      <td>AKWKBACKRMYPRV-NQIIRXRSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01895</td>
      <td>Aspartyl-Adenosine-5'-Monophosphate</td>
      <td>QPBSGQWTJLPZNF-VWJPMABRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01771</td>
      <td>CRA_10991</td>
      <td>QXAURVOBXQBPAP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06169</td>
      <td>Indibulin</td>
      <td>SOLIIYNRSAWTSQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB02400</td>
      <td>5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione</td>
      <td>IBLWSLZYYZHSRG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08341</td>
      <td>4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide</td>
      <td>CAUFYHKGKDJMQG-HZPDHXFCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12417</td>
      <td>Anagliptin</td>
      <td>LDXYBEHACFJIEL-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08365</td>
      <td>8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide</td>
      <td>XUAHLMVOYLUYSB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB02237</td>
      <td>Maltotetraose</td>
      <td>UYQJCPNSAVWAFU-KVXMBEGHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB08221</td>
      <td>N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE</td>
      <td>NESXBRNDMQUVNG-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB06306</td>
      <td>Onalespib</td>
      <td>IFRGXKKQHBVPCQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB01392</td>
      <td>Yohimbine</td>
      <td>BLGXFZZNTVWLAY-SCYLSFHTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07665</td>
      <td>N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide</td>
      <td>STHCHQXQLDMISY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08400</td>
      <td>4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid</td>
      <td>KUEKMTNOUPAOBS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB02128</td>
      <td>[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester</td>
      <td>QCUBCTPTNWPFBC-ZEQRLZLVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08426</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</td>
      <td>PLXOQMHGHDZMSX-AWEZNQCLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB02049</td>
      <td>2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide</td>
      <td>QOPFTBAEAJQKSY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01977</td>
      <td>6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine</td>
      <td>AECPTICWHONWNW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12408</td>
      <td>PF-03635659</td>
      <td>WGOJWDWKHJHXSV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01967</td>
      <td>N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide</td>
      <td>LICJTIDRHJECTD-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB01965</td>
      <td>2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate</td>
      <td>XZLLMTSKYYYJLH-SHYZEUOFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08460</td>
      <td>3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile</td>
      <td>KXDIHAQCVNNLIB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08487</td>
      <td>3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>PRMSFVUWLBPPLY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB07969</td>
      <td>3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol</td>
      <td>QNCYYRHIUFGGJX-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08770</td>
      <td>4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol</td>
      <td>PWTBZOIUWZOPFT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11741</td>
      <td>Famitinib</td>
      <td>GKEYKDOLBLYGRB-LGMDPLHJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB03619</td>
      <td>Deoxycholic Acid</td>
      <td>KXGVEGMKQFWNSR-LLQZFEROSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11750</td>
      <td>Clobetasol</td>
      <td>FCSHDIVRCWTZOX-DVTGEIKXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08365</td>
      <td>8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide</td>
      <td>XUAHLMVOYLUYSB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15062</td>
      <td>Inarigivir</td>
      <td>LYMICVBGNUEHGE-FUQPUAIBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12235</td>
      <td>Estetrol</td>
      <td>AJIPIJNNOJSSQC-NYLIRDPKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13240</td>
      <td>Cymarin</td>
      <td>XQCGNURMLWFQJR-ZNDDOCHDSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12129</td>
      <td>Tideglusib</td>
      <td>PMJIHLSCWIDGMD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB08816</td>
      <td>Ticagrelor</td>
      <td>OEKWJQXRCDYSHL-FNOIDJSQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13312</td>
      <td>Delapril</td>
      <td>WOUOLAUOZXOLJQ-MBSDFSHPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12183</td>
      <td>Sapitinib</td>
      <td>DFJSJLGUIXFDJP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13425</td>
      <td>Flutrimazole</td>
      <td>QHMWCHQXCUNUAK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12129</td>
      <td>Tideglusib</td>
      <td>PMJIHLSCWIDGMD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06963</td>
      <td>3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide</td>
      <td>ZFGCLYUGFRNYFE-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08416</td>
      <td>(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE</td>
      <td>AQSNIXKAKUZPSI-SSTWWWIQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12072</td>
      <td>Orantinib</td>
      <td>NHFDRBXTEDBWCZ-ZROIWOOFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07607</td>
      <td>4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>RXDZANYWRNIAOR-HHHXNRCGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12048</td>
      <td>Savolitinib</td>
      <td>XYDNMOZJKOGZLS-NSHDSACASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08439</td>
      <td>Parecoxib</td>
      <td>TZRHLKRLEZJVIJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01228</td>
      <td>Encainide</td>
      <td>PJWPNDMDCLXCOM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13602</td>
      <td>Promegestone</td>
      <td>QFFCYTLOTYIJMR-XMGTWHOFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15024</td>
      <td>Apararenone</td>
      <td>AZNHWXAFPBYFGH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08449</td>
      <td>2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid</td>
      <td>IEVFQDJUDLCOQY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB02009</td>
      <td>L-756,423</td>
      <td>AOMZDQMIOCTPQP-QHQMVRJISA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB02008</td>
      <td>1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine</td>
      <td>JHSHXKJSPVHPCJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11943</td>
      <td>Delafloxacin</td>
      <td>DYDCPNMLZGFQTM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07643</td>
      <td>5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>XVLUVRFYGVJKGJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08490</td>
      <td>CTS-1027</td>
      <td>ROSNVSQTEGHUKU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07653</td>
      <td>N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE</td>
      <td>VXTCEUDVOCLEJG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15065</td>
      <td>PF-06291874</td>
      <td>IBDYYOQKQCCSDP-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07663</td>
      <td>2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID</td>
      <td>QISJEFYTLZTWIQ-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12238</td>
      <td>MK-0777</td>
      <td>QKIWQBLNTSQOLY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13230</td>
      <td>Gestonorone</td>
      <td>GTFUITFQDGVJSK-XGXHKTLJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06992</td>
      <td>(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone</td>
      <td>SIDDLTBLAQYZIZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12428</td>
      <td>PAC-14028</td>
      <td>UKGJZDSUJSPAJL-YPUOHESYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08213</td>
      <td>1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE</td>
      <td>PFAYCUAUBOGVDX-AWEZNQCLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15114</td>
      <td>Vamorolone</td>
      <td>ZYTXTXAMMDTYDQ-DGEXFFLYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07267</td>
      <td>2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine</td>
      <td>JONFDFIXMPXTRH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12949</td>
      <td>PF-03382792</td>
      <td>AGMOFKKOVMRGAK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12972</td>
      <td>Sepranolone</td>
      <td>AURFZBICLPNKBZ-FZCSVUEKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12391</td>
      <td>Sagopilone</td>
      <td>BFZKMNSQCNVFGM-UCEYFQQTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB00875</td>
      <td>Flupentixol</td>
      <td>NJMYODHXAKYRHW-DVZOWYKESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08246</td>
      <td>(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE</td>
      <td>WFFMEXQHWXEKBV-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01337</td>
      <td>Pancuronium</td>
      <td>GVEAYVLWDAFXET-XGHATYIMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12350</td>
      <td>Rostafuroxin</td>
      <td>AEAPORIZZWBIEX-DTBDINHYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08304</td>
      <td>(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide</td>
      <td>QZBQVXXESPXFPZ-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06829</td>
      <td>4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>RXDVFLTWXCTCEX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12322</td>
      <td>GW-870086</td>
      <td>WUBKGTSFJSEIEM-NSHBDUGJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12321</td>
      <td>Ifetroban</td>
      <td>BBPRUNPUJIUXSE-DXKRWKNPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13132</td>
      <td>Artemisinin</td>
      <td>BLUAFEHZUWYNDE-NNWCWBAJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13135</td>
      <td>AGN-201904</td>
      <td>PPCGSVWOZKNPCX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15102</td>
      <td>Pemigatinib</td>
      <td>HCDMJFOHIXMBOV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07548</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE</td>
      <td>JXHWVKOKYDAROD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06455</td>
      <td>Meclinertant</td>
      <td>DYLJVOXRWLXDIG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB11464</td>
      <td>Sulfaquinoxaline</td>
      <td>NHZLNPMOSADWGC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12285</td>
      <td>Verubecestat</td>
      <td>YHYKUSGACIYRML-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13185</td>
      <td>Oxabolone cipionate</td>
      <td>KHKDIUPVDIEHAH-KXLSUQFWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12275</td>
      <td>Seviteronel</td>
      <td>ZBRAJOQFSNYJMF-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12254</td>
      <td>ABT-751</td>
      <td>URCVCIZFVQDVPM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13223</td>
      <td>Fluocortin</td>
      <td>PUWHHWCHAVXSIG-NCLPIGKXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12242</td>
      <td>AZD-7762</td>
      <td>IAYGCINLNONXHY-LBPRGKRZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06944</td>
      <td>N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide</td>
      <td>RIGZCVNCFXYBEG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11883</td>
      <td>SB-705498</td>
      <td>JYILLRHXRVTRSH-GFCCVEGCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13867</td>
      <td>Fluticasone</td>
      <td>MGNNYOODZCAHBA-GQKYHHCASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11511</td>
      <td>Difloxacin</td>
      <td>NOCJXYPHIIZEHN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06858</td>
      <td>N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide</td>
      <td>MMLOIDMSBRJZAE-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11443</td>
      <td>Orbifloxacin</td>
      <td>QIPQASLPWJVQMH-DTORHVGOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12029</td>
      <td>Chlorogenic Acid</td>
      <td>CWVRJTMFETXNAD-JUHZACGLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06865</td>
      <td>6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID</td>
      <td>ZSRRBAKATXAISL-LMNJBCLMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11371</td>
      <td>Alfaxalone</td>
      <td>DUHUCHOQIDJXAT-OLVMNOGESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08770</td>
      <td>4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol</td>
      <td>PWTBZOIUWZOPFT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06837</td>
      <td>(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide</td>
      <td>VXDKQRWTOJFQKH-BJZITVGISA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB14641</td>
      <td>Estriol tripropionate</td>
      <td>ONMZMZJEZHMWQL-REUUDLSRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB09378</td>
      <td>Fluprednisolone</td>
      <td>MYYIMZRZXIQBGI-HVIRSNARSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06866</td>
      <td>6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID</td>
      <td>NMOUMGFCBOWPAB-RZUBCFFCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB09371</td>
      <td>Norethynodrel</td>
      <td>ICTXHFFSOAJUMG-SLHNCBLASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB09279</td>
      <td>Fimasartan</td>
      <td>AMEROGPZOLAFBN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06869</td>
      <td>1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE</td>
      <td>BMHVHOJXEQTIEA-SIKLNZKXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB14677</td>
      <td>Gestonorone caproate</td>
      <td>XURCMZMFZXXQDJ-UKNJCJGYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB08055</td>
      <td>N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine</td>
      <td>NNBICZMPIJMWGC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06870</td>
      <td>17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE</td>
      <td>OXHNQTSIKGHVBH-ANULTFPQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB09123</td>
      <td>Dienogest</td>
      <td>AZFLJNIPTRTECV-FUMNGEBKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB11818</td>
      <td>Retosiban</td>
      <td>PLVGDGRBPMVYPB-FDUHJNRSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB11794</td>
      <td>Berzosertib</td>
      <td>JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB09006</td>
      <td>Clinofibrate</td>
      <td>BMOVQUBVGICXQN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08993</td>
      <td>Enviomycin</td>
      <td>HPWIIERXAFODPP-GHBBWTPBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06755</td>
      <td>Beta carotene</td>
      <td>OENHQHLEOONYIE-JLTXGRSLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08976</td>
      <td>Floctafenine</td>
      <td>APQPGQGAWABJLN-GFCCVEGCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB08096</td>
      <td>8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM</td>
      <td>ZWKOUFZHPNIQSH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08922</td>
      <td>Perospirone</td>
      <td>FBVFZWUMDDXLLG-HDICACEKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08973</td>
      <td>Fluclorolone acetonide</td>
      <td>NJNWEGFJCGYWQT-VSXGLTOVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07988</td>
      <td>2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE</td>
      <td>HZAXNPDJVFUGDS-BYPYZUCNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11592</td>
      <td>Nitrocefin</td>
      <td>LHNIIDJCEODSHA-OQRUQETBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB14583</td>
      <td>Segesterone acetate</td>
      <td>CKFBRGLGTWAVLG-GOMYTPFNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11645</td>
      <td>PF-4191834</td>
      <td>DVNQWYLVSNPCJZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07680</td>
      <td>[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID</td>
      <td>HUJXISJLAPAFBO-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13931</td>
      <td>Netarsudil</td>
      <td>OURRXQUGYQRVML-AREMUKBSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB13941</td>
      <td>Piperaquine</td>
      <td>UCRHFBCYFMIWHC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08535</td>
      <td>3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>SMIZFGZXFDGISG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11811</td>
      <td>Arhalofenate</td>
      <td>BJBCSGQLZQGGIQ-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07717</td>
      <td>(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE</td>
      <td>AJODXHGZHBERGJ-JLYQOUBASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08549</td>
      <td>(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER</td>
      <td>MFDBNNQUDZFSES-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB04477</td>
      <td>N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine</td>
      <td>FDZQGEIYGFPMOB-ZUURFMEUSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB14029</td>
      <td>Furafylline</td>
      <td>HMZQULPVMKITSP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06626</td>
      <td>Axitinib</td>
      <td>RITAVMQDGBJQJZ-FMIVXFBMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB11681</td>
      <td>Tofimilast</td>
      <td>DHCOPPHTVOXDKU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB08487</td>
      <td>3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>PRMSFVUWLBPPLY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11765</td>
      <td>PF-04991532</td>
      <td>GKMLFBRLRVQVJO-ZDUSSCGKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12480</td>
      <td>Betulinic Acid</td>
      <td>QGJZLNKBHJESQX-FZFNOLFKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB11863</td>
      <td>Alvelestat</td>
      <td>QNQZWEGMKJBHEM-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07973</td>
      <td>N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE</td>
      <td>GIPCBGDQVGKMPO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB11694</td>
      <td>Ilorasertib</td>
      <td>WPHKIQPVPYJNAX-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11725</td>
      <td>Latrepirdine</td>
      <td>JNODQFNWMXFMEV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB14128</td>
      <td>Nadide</td>
      <td>BAWFJGJZGIEFAR-NNYOXOHSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11692</td>
      <td>Pavinetant</td>
      <td>QYTBBBAHNIWFOD-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06634</td>
      <td>Casopitant</td>
      <td>XGGTZCKQRWXCHW-WMTVXVAQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11687</td>
      <td>E-6201</td>
      <td>MWUFVYLAWAXDHQ-HMNLTAHHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11679</td>
      <td>Fruquintinib</td>
      <td>BALLNEJQLSTPIO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB14906</td>
      <td>Adafosbuvir</td>
      <td>NIJYGVDQZBBONK-SEUXLIJBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB11703</td>
      <td>Acalabrutinib</td>
      <td>WDENQIQQYWYTPO-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08701</td>
      <td>2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE</td>
      <td>JZCUVYNOSDWORZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB11670</td>
      <td>SP-8203</td>
      <td>SJZBPVOSFYUHFV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06630</td>
      <td>Anacetrapib</td>
      <td>MZZLGJHLQGUVPN-HAWMADMCSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15317</td>
      <td>Posiphen</td>
      <td>PBHFNBQPZCRWQP-AZUAARDMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12542</td>
      <td>GSK-356278</td>
      <td>AWDJJMXJUOHGLC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15319</td>
      <td>VM4-037</td>
      <td>QGYZPMXIVNIGKA-GMAHTHKFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07620</td>
      <td>2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE</td>
      <td>INAZPZCJNPPHGV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07624</td>
      <td>1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide</td>
      <td>YJFULAYRAKPBCY-DYVFJYSZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11892</td>
      <td>Prulifloxacin</td>
      <td>PWNMXPDKBYZCOO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB00696</td>
      <td>Ergotamine</td>
      <td>XCGSFFUVFURLIX-VFGNJEKYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12064</td>
      <td>BMS-777607</td>
      <td>VNBRGSXVFBYQNN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11894</td>
      <td>Efatutazone</td>
      <td>JCYNMRJCUYVDBC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11755</td>
      <td>Tetrahydrocannabivarin</td>
      <td>ZROLHBHDLIHEMS-HUUCEWRRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11901</td>
      <td>Apalutamide</td>
      <td>HJBWBFZLDZWPHF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07678</td>
      <td>(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL</td>
      <td>ANAMDWGJXBYJEB-OPWFCKQNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB14898</td>
      <td>Retagliptin</td>
      <td>WIIAMRXFUJLYEF-SNVBAGLBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07686</td>
      <td>4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>VPOGRVWIIVMWRI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB04644</td>
      <td>4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID</td>
      <td>FCEMCUPAYRPTLS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB00210</td>
      <td>Adapalene</td>
      <td>LZCDAPDGXCYOEH-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12055</td>
      <td>MK-0767</td>
      <td>ORZMUVMQJPGFOM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB04669</td>
      <td>TRIAZOLOPYRIMIDINE</td>
      <td>YWBFPKPWMSWWEA-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB14840</td>
      <td>Ripretinib</td>
      <td>CEFJVGZHQAGLHS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB04685</td>
      <td>1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>GJNIPWYJQUGERM-BFLUCZKCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12242</td>
      <td>AZD-7762</td>
      <td>IAYGCINLNONXHY-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07743</td>
      <td>S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE</td>
      <td>VNGWUVBXUIDQTK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB14718</td>
      <td>Pyrazolam</td>
      <td>BGRWSFIQQPVEML-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12241</td>
      <td>TAK-733</td>
      <td>RCLQNICOARASSR-SECBINFHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15460</td>
      <td>AGG-523</td>
      <td>JWQMTWCFNZSLNR-DEOSSOPVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07779</td>
      <td>N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE</td>
      <td>ANQHSFFUNMTTRS-MOPGFXCFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11792</td>
      <td>Mirodenafil</td>
      <td>MIJFNYMSCFYZNY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06295</td>
      <td>Pramiconazole</td>
      <td>AEKNYBWUEYNWMJ-QWOOXDRHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06302</td>
      <td>Glesatinib</td>
      <td>YRCHYHRCBXNYNU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06213</td>
      <td>Regadenoson</td>
      <td>LZPZPHGJDAGEJZ-AKAIJSEGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB01419</td>
      <td>Antrafenine</td>
      <td>NWGGKKGAFZIVBJ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15055</td>
      <td>ABT-639</td>
      <td>AGPIHNZOZNKRGT-CYBMUJFWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB04607</td>
      <td>PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE</td>
      <td>UQAWGIKJINAKIZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12299</td>
      <td>Bavisant</td>
      <td>BGBVSGSIXIIREO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15282</td>
      <td>Fluorofuranylnorprogesterone F-18</td>
      <td>VJKRBRUNEOHPBS-JQKUZGBFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11773</td>
      <td>BMS-903452</td>
      <td>OGIAVRWXUPYGGC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB03685</td>
      <td>Uridine monophosphate</td>
      <td>DJJCXFVJDGTHFX-XVFCMESISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB03687</td>
      <td>4-Diphosphocytidyl-2-C-Methyl-D-Erythritol</td>
      <td>YFAUKWZNPVBCFF-XHIBXCGHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11789</td>
      <td>Hyodeoxycholic Acid</td>
      <td>DGABKXLVXPYZII-SIBKNCMHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01481</td>
      <td>1-Testosterone</td>
      <td>OKJCFMUGMSVJBG-ABEVXSGRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15219</td>
      <td>Tomivosertib</td>
      <td>HKTBYUWLRDZAJK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06137</td>
      <td>KX-01</td>
      <td>HUNGUWOZPQBXGX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15209</td>
      <td>MK-0736</td>
      <td>ORQZQBUNAMJFCY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15207</td>
      <td>Esaxerenone</td>
      <td>NOSNHVJANRODGR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB03725</td>
      <td>Phosphomethylphosphonic Acid-Guanylate Ester</td>
      <td>PHBDHXOBFUBCJD-KQYNXXCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB04616</td>
      <td>TACRINE(8)-4-AMINOQUINOLINE</td>
      <td>UNVOAAWEEGAXTN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB14636</td>
      <td>Triciribine phosphate</td>
      <td>URLYINUFLXOMHP-HTVVRFAVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15192</td>
      <td>ABT-288</td>
      <td>GNIRITULTPTAQW-KNQAVFIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB11841</td>
      <td>Entinostat</td>
      <td>INVTYAOGFAGBOE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11816</td>
      <td>Omecamtiv Mecarbil</td>
      <td>RFUBTTPMWSKEIW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01092</td>
      <td>Ouabain</td>
      <td>LPMXVESGRSUGHW-HBYQJFLCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB02241</td>
      <td>8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>HOSWCJDTHOAORT-SANMLTNESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB11841</td>
      <td>Entinostat</td>
      <td>INVTYAOGFAGBOE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15124</td>
      <td>PF-05241328</td>
      <td>RVTSXVZXEGFIPW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15123</td>
      <td>Dorzagliatin</td>
      <td>HMUMWSORCUWQJO-QAPCUYQASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07226</td>
      <td>N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE</td>
      <td>JWZVNUNTFNELHL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07548</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE</td>
      <td>JXHWVKOKYDAROD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15092</td>
      <td>LY-2624803</td>
      <td>UEFWDVMEDFCHGW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06997</td>
      <td>2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</td>
      <td>BMPOCDJEXAXXEZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB15065</td>
      <td>PF-06291874</td>
      <td>IBDYYOQKQCCSDP-QFIPXVFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08631</td>
      <td>N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE</td>
      <td>UVSIFVBCHJEYJP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB05408</td>
      <td>Emricasan</td>
      <td>SCVHJVCATBPIHN-SJCJKPOMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12210</td>
      <td>AZD-6280</td>
      <td>NVWCZRPXYVDQEE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12929</td>
      <td>JNJ-39220675</td>
      <td>IQOWHZHNGJXGHG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08034</td>
      <td>(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE</td>
      <td>TVOPERZEGKBKAY-RGVLZGJSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB06347</td>
      <td>Cenisertib</td>
      <td>KSOVGRCOLZZTPF-QMKUDKLTSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12637</td>
      <td>Onapristone</td>
      <td>IEXUMDBQLIVNHZ-YOUGDJEHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12174</td>
      <td>CUDC-101</td>
      <td>PLIVFNIUGLLCEK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08051</td>
      <td>(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE</td>
      <td>XXRHRPGYYNOBHO-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB06837</td>
      <td>(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide</td>
      <td>VXDKQRWTOJFQKH-BJZITVGISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12696</td>
      <td>BMS-582949</td>
      <td>GDTQLZHHDRRBEB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB06777</td>
      <td>Chenodeoxycholic acid</td>
      <td>RUDATBOHQWOJDD-BSWAIDMHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08063</td>
      <td>1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE</td>
      <td>HLZMYWLMBBLASX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12732</td>
      <td>Firategrast</td>
      <td>YLFZHHDVRSYTKT-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12731</td>
      <td>Daporinad</td>
      <td>KPBNHDGDUADAGP-VAWYXSNFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12740</td>
      <td>CC-115</td>
      <td>GMYLVKUGJMYTFB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15325</td>
      <td>ONO-8539</td>
      <td>ALLLQQUASFFEKP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07148</td>
      <td>(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one</td>
      <td>HPAFVLDARQIHPU-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12744</td>
      <td>CGI-1842</td>
      <td>ZXBFYBLSJMEBEP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12696</td>
      <td>BMS-582949</td>
      <td>GDTQLZHHDRRBEB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12746</td>
      <td>AKN-028</td>
      <td>JLRIJKVMMZEKDF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08097</td>
      <td>2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE</td>
      <td>OGWSGDLIXOEZJG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12686</td>
      <td>PHA-793887</td>
      <td>HUXYBQXJVXOMKX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12675</td>
      <td>PF-04995274</td>
      <td>WLLOFQROROXOMO-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB11957</td>
      <td>Idalopirdine</td>
      <td>YBAWYTYNMZWMMJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07183</td>
      <td>N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide</td>
      <td>CPVRYQAOUPSUDO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB07242</td>
      <td>(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile</td>
      <td>XGUIMGJMQKZRGM-LLVKDONJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11922</td>
      <td>Danirixin</td>
      <td>NGYNBSHYFOFVLS-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB08142</td>
      <td>AT-7519</td>
      <td>OVPNQJVDAFNBDN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12547</td>
      <td>LY-2886721</td>
      <td>NIDRNVHMMDAAIK-YPMLDQLKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB12966</td>
      <td>Falnidamol</td>
      <td>FTFRZXFNZVCRSK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12623</td>
      <td>Taprenepag</td>
      <td>MFFBXYNKZHTCEY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB15391</td>
      <td>Elenbecestat</td>
      <td>AACUJFVOHGRMTR-DPXNYUHVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12574</td>
      <td>LY-295501</td>
      <td>VAMFSFIPDOODFH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB13991</td>
      <td>Pipequaline</td>
      <td>AMEWZCMTSIONOX-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11811</td>
      <td>Arhalofenate</td>
      <td>BJBCSGQLZQGGIQ-QGZVFWFLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07831</td>
      <td>2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>SHSORWZDEKFFLP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB13865</td>
      <td>Dehydroemetine</td>
      <td>XXLZPUYGHQWHRN-RPBOFIJWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12272</td>
      <td>Vidupiprant</td>
      <td>PFWVGKROPKKEDW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07843</td>
      <td>5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE</td>
      <td>LTJNKFUIOOJXNJ-WFASDCNBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12015</td>
      <td>Alpelisib</td>
      <td>STUWGJZDJHPWGZ-LBPRGKRZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB13788</td>
      <td>Chlorbenzoxamine</td>
      <td>VEVSKUJZSMGTMM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB01836</td>
      <td>[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone</td>
      <td>ZLAKCKVFSRSENR-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12295</td>
      <td>Evodenoson</td>
      <td>SQJXTUJMBYVDBB-RQXXJAGISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12320</td>
      <td>Palovarotene</td>
      <td>YTFHCXIPDIHOIA-DHZHZOJOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07861</td>
      <td>(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide</td>
      <td>MMOUXLMPQFMDRD-JOCHJYFZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB13534</td>
      <td>Gedocarnil</td>
      <td>SLYDYLLJUXFULK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB11115</td>
      <td>Ensulizole</td>
      <td>UVCJGUGAGLDPAA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07147</td>
      <td>methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate</td>
      <td>HJWMYFBKJRVWJY-YKSBVNFPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB05626</td>
      <td>Retaspimycin</td>
      <td>OAKGNIRUXAZDQF-TXHRRWQRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12350</td>
      <td>Rostafuroxin</td>
      <td>AEAPORIZZWBIEX-DTBDINHYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07945</td>
      <td>5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid</td>
      <td>GKBQRPKZHUFGOB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11845</td>
      <td>Lucitanib</td>
      <td>CUDVHEFYRIWYQD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB11847</td>
      <td>Cadazolid</td>
      <td>XWFCFMXQTBGXQW-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB08970</td>
      <td>Fluprednidene</td>
      <td>YVHXHNGGPURVOS-SBTDHBFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12379</td>
      <td>Indirubin</td>
      <td>CRDNMYFJWFXOCH-BUHFOSPRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB13132</td>
      <td>Artemisinin</td>
      <td>BLUAFEHZUWYNDE-NNWCWBAJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB13122</td>
      <td>Trabodenoson</td>
      <td>AQLVRTWKJDTWQQ-SDBHATRESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12394</td>
      <td>Eleclazine</td>
      <td>YNUAEEJQYHYLMS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB13051</td>
      <td>CH-5132799</td>
      <td>JEGHXKRHKHPBJD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB07889</td>
      <td>(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol</td>
      <td>VCPXSBULBDYRLT-SFHVURJKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07966</td>
      <td>[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile</td>
      <td>NVMCVWOODOWOLT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12443</td>
      <td>Sonedenoson</td>
      <td>WUCQGGOGHZRELS-LSCFUAHRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04793</td>
      <td>1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol</td>
      <td>DKBAWRNTUZFJKV-XMTFNYHQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06230</td>
      <td>Nalmefene</td>
      <td>WJBLNOPPDWQMCH-MBPVOVBZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB14879</td>
      <td>Cefiderocol</td>
      <td>DBPPRLRVDVJOCL-FQRUVTKNSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB00693</td>
      <td>Fluorescein</td>
      <td>GNBHRKFJIUUOQI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07791</td>
      <td>4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE</td>
      <td>MZWCVBFANHIPTJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06306</td>
      <td>Onalespib</td>
      <td>IFRGXKKQHBVPCQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02545</td>
      <td>Fexaramine</td>
      <td>VLQTUNDJHLEFEQ-KGENOOAVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12805</td>
      <td>Ataciguat</td>
      <td>PQHLRGARXNPFCF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB08111</td>
      <td>4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol</td>
      <td>ZGJYGQLGSXWEMY-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB15055</td>
      <td>ABT-639</td>
      <td>AGPIHNZOZNKRGT-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07747</td>
      <td>(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE</td>
      <td>YTBGBMPLINFTBQ-OAHLLOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07713</td>
      <td>(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid</td>
      <td>BZVYQWLRCHLAGK-KRWDZBQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08754</td>
      <td>(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE</td>
      <td>VSHUQLRHTJOKTA-XBXARRHUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12682</td>
      <td>Mubritinib</td>
      <td>ZTFBIUXIQYRUNT-MDWZMJQESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08125</td>
      <td>4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE</td>
      <td>BOMPRXSVSIPRDT-PTNGSMBKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12369</td>
      <td>Sotrastaurin</td>
      <td>OAVGBZOFDPFGPJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00535</td>
      <td>Cefdinir</td>
      <td>RTXOFQZKPXMALH-GHXIOONMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB01392</td>
      <td>Yohimbine</td>
      <td>BLGXFZZNTVWLAY-SCYLSFHTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12385</td>
      <td>10-hydroxycamptothecin</td>
      <td>HAWSQZCWOQZXHI-FQEVSTJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB03921</td>
      <td>4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline</td>
      <td>IBCXZJCWDGCXQT-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB01413</td>
      <td>Cefepime</td>
      <td>HVFLCNVBZFFHBT-ZKDACBOMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6wiq</td>
      <td>DB14785</td>
      <td>Fenebrutinib</td>
      <td>WNEODWDFDXWOLU-QHCPKHFHSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07644</td>
      <td>5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine</td>
      <td>IDHINEMSCUFEIP-VIFPVBQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB04204</td>
      <td>[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid</td>
      <td>SRHSAABKYJDBDV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07629</td>
      <td>N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-DLBZAZTESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB03642</td>
      <td>Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</td>
      <td>VBPPNJCVXGAZDD-PMACEKPBSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07620</td>
      <td>2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE</td>
      <td>INAZPZCJNPPHGV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12666</td>
      <td>Emapunil</td>
      <td>NBMBIEOUVBHEBM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07257</td>
      <td>4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione</td>
      <td>WHMQZCPGFZBLBG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07246</td>
      <td>(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE</td>
      <td>MKRPIBSCGZAUCH-OAHLLOKOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07838</td>
      <td>(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE</td>
      <td>ZTWBCEZQPRYIGY-ZROIWOOFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07851</td>
      <td>(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE</td>
      <td>DQJXBZGPJVSWFI-ROUUACIJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08052</td>
      <td>1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>NVRXTLZYXZNATH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB11805</td>
      <td>Saracatinib</td>
      <td>OUKYUETWWIPKQR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB05616</td>
      <td>4'-Methylene-5,8,10-trideazaaminopterin</td>
      <td>NAWXUBYGYWOOIX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12048</td>
      <td>Savolitinib</td>
      <td>XYDNMOZJKOGZLS-NSHDSACASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB01030</td>
      <td>Topotecan</td>
      <td>UCFGDBYHRUNTLO-QHCPKHFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB05676</td>
      <td>Apremilast</td>
      <td>IMOZEMNVLZVGJZ-QGZVFWFLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08732</td>
      <td>NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE</td>
      <td>UUOOAGBWJUGBMV-APWZRJJASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB13874</td>
      <td>Enasidenib</td>
      <td>DYLUUSLLRIQKOE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB05075</td>
      <td>TG-100801</td>
      <td>JMGXJHWTVBGOKG-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06137</td>
      <td>KX-01</td>
      <td>HUNGUWOZPQBXGX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06144</td>
      <td>Sertindole</td>
      <td>GZKLJWGUPQBVJQ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07974</td>
      <td>1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE</td>
      <td>BDLMBQRBNPDCSS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04624</td>
      <td>DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME)</td>
      <td>SIHNJMGWRHPFAZ-XHDPSFHLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12832</td>
      <td>Prednimustine</td>
      <td>HFVNWDWLWUCIHC-GUPDPFMOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12096</td>
      <td>PF-05175157</td>
      <td>BDXXSFOJPYSYOC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12101</td>
      <td>CC-220</td>
      <td>IXZOHGPZAQLIBH-NRFANRHFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07263</td>
      <td>[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid</td>
      <td>WDTMVBQZDFMOIK-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB01179</td>
      <td>Podofilox</td>
      <td>YJGVMLPVUAXIQN-XVVDYKMHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12127</td>
      <td>Sultamicillin</td>
      <td>OPYGFNJSCUDTBT-PMLPCWDUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07935</td>
      <td>5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile</td>
      <td>JYAHFMKZJRVTDT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB01185</td>
      <td>Fluoxymesterone</td>
      <td>YLRFCQOZQXIBAB-RBZZARIASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08389</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UPTQSRGSSJRBKJ-LJQANCHMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB00773</td>
      <td>Etoposide</td>
      <td>VJJPUSNTGOMMGY-MRVIYFEKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12137</td>
      <td>GSK-256066</td>
      <td>JFHROPTYMMSOLG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06194</td>
      <td>Elocalcitol</td>
      <td>LRLWXBHFPGSUOX-GJQYOBCGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB01219</td>
      <td>Dantrolene</td>
      <td>OZOMQRBLCMDCEG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08092</td>
      <td>3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide</td>
      <td>VMLSXFMXUNVCSK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08154</td>
      <td>3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>WHCLIFOVZDANCU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB01586</td>
      <td>Ursodeoxycholic acid</td>
      <td>RUDATBOHQWOJDD-UZVSRGJWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06510</td>
      <td>Muraglitazar</td>
      <td>IRLWJILLXJGJTD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB02128</td>
      <td>[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester</td>
      <td>QCUBCTPTNWPFBC-ZEQRLZLVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06908</td>
      <td>(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID</td>
      <td>PAWOPJKHTZCKMT-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04659</td>
      <td>(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE</td>
      <td>LZDZCEOFJWRJIA-GGASBGQWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12598</td>
      <td>Nafamostat</td>
      <td>MQQNFDZXWVTQEH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07136</td>
      <td>(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID</td>
      <td>WFFOOKSVFDUPDH-FCHUYYIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07131</td>
      <td>(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide</td>
      <td>DOTBZTLJSXFKCP-IBGZPJMESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07091</td>
      <td>(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide</td>
      <td>IWPMQJKXKKKSEY-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02421</td>
      <td>Uridine-5'-Diphosphate-Mannose</td>
      <td>HSCJRCZFDFQWRP-NYYOCOOHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07085</td>
      <td>2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID</td>
      <td>LBMZLHCAPBBOFS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00652</td>
      <td>Pentazocine</td>
      <td>VOKSWYLNZZRQPF-GDIGMMSISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB14840</td>
      <td>Ripretinib</td>
      <td>CEFJVGZHQAGLHS-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00654</td>
      <td>Latanoprost</td>
      <td>GGXICVAJURFBLW-CEYXHVGTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6wiq</td>
      <td>DB02741</td>
      <td>CD564</td>
      <td>RWYREGSYPCNZTL-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB02358</td>
      <td>LY374571</td>
      <td>SZHRIPFGZWWRKW-VIFPVBQESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07030</td>
      <td>(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID</td>
      <td>VABIMMIJVWNHFI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02363</td>
      <td>2'-Monophosphoadenosine-5'-Diphosphate</td>
      <td>YPTPYQSAVGGMFN-KQYNXXCUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB01640</td>
      <td>(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One</td>
      <td>QNURTFDBHAQRSI-OAHLLOKOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08303</td>
      <td>(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide</td>
      <td>CUMKMTBOHBENJI-SFHVURJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB13602</td>
      <td>Promegestone</td>
      <td>QFFCYTLOTYIJMR-XMGTWHOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB13019</td>
      <td>Henatinib</td>
      <td>MCTXSDCWFQAGFS-UEXNTNOUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06970</td>
      <td>2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE</td>
      <td>MZCDQILVXXIMEV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6wiq</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB13053</td>
      <td>CP-195543</td>
      <td>NZQDWKCNBOELAI-KSFYIVLOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB13060</td>
      <td>CEP-37440</td>
      <td>BCSHRERPHLTPEE-NRFANRHFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB12571</td>
      <td>Rimacalib</td>
      <td>MYTIJGWONQOOLC-HNNXBMFYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07078</td>
      <td>(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE</td>
      <td>AYSXURJZVXBSRV-WJDWOHSUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07187</td>
      <td>6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE</td>
      <td>FXFPQPNUMWQRAO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6wiq</td>
      <td>DB06435</td>
      <td>Tarazepide</td>
      <td>CZPILLBHPRAPCB-AREMUKBSSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06886</td>
      <td>N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL</td>
      <td>MACLRJNEKXUAJK-YDLSIGKMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12776</td>
      <td>E-6005</td>
      <td>BBTFKAOFCSOZMB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07540</td>
      <td>4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE</td>
      <td>AKFVRSQELXTCFW-JYRVWZFOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12511</td>
      <td>Imiglitazar</td>
      <td>ULVDFHLHKNJICZ-QCWLDUFUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12512</td>
      <td>Verucerfont</td>
      <td>VKHVAUKFLBBZFJ-SFHVURJKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07485</td>
      <td>4,4'-cyclohexane-1,1-diyldiphenol</td>
      <td>SDDLEVPIDBLVHC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07470</td>
      <td>(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</td>
      <td>DOMYOVZXZIZTRD-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6wiq</td>
      <td>DB12457</td>
      <td>Rimegepant</td>
      <td>KRNAOFGYEFKHPB-ANJVHQHFSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12522</td>
      <td>Toreforant</td>
      <td>FCRFVPZAXGJLPW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12574</td>
      <td>LY-295501</td>
      <td>VAMFSFIPDOODFH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07418</td>
      <td>bis(4-nitrophenyl) hydrogen phosphate</td>
      <td>MHSVUSZEHNVFKW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07352</td>
      <td>Apigenin</td>
      <td>KZNIFHPLKGYRTM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB01767</td>
      <td>Hemi-Babim</td>
      <td>KKJYVDXDZURHMA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07338</td>
      <td>Acifluorfen</td>
      <td>NUFNQYOELLVIPL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06680</td>
      <td>Asoprisnil</td>
      <td>GJMNAFGEUJBOCE-MEQIQULJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12731</td>
      <td>Daporinad</td>
      <td>KPBNHDGDUADAGP-VAWYXSNFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07090</td>
      <td>(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE</td>
      <td>NJNMAZNXKKBTPS-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00580</td>
      <td>Valdecoxib</td>
      <td>LNPDTQAFDNKSHK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07277</td>
      <td>2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE</td>
      <td>IAUZEBLXCOCAFL-JSGCOSHPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12705</td>
      <td>Cenerimod</td>
      <td>KJKKMMMRWISKRF-FQEVSTJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07271</td>
      <td>4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one</td>
      <td>RMDAPSXWBVPVOG-IAPIXIRKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12719</td>
      <td>Turofexorate isopropyl</td>
      <td>INASOKQDNHHMRE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07246</td>
      <td>(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE</td>
      <td>MKRPIBSCGZAUCH-OAHLLOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12622</td>
      <td>Lupeol</td>
      <td>MQYXUWHLBZFQQO-QGTGJCAVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB12743</td>
      <td>Z-160</td>
      <td>VCPMZDWBEWTGNW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08241</td>
      <td>4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE</td>
      <td>RUUOIINPNMNPIU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08233</td>
      <td>6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE</td>
      <td>RFSDQDHHBKYQOD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6wiq</td>
      <td>DB06925</td>
      <td>3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>YEIASMOUYNOXGA-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB06684</td>
      <td>Vilazodone</td>
      <td>SGEGOXDYSFKCPT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB02587</td>
      <td>Colforsin</td>
      <td>OHCQJHSOBUTRHG-KGGHGJDLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB01013</td>
      <td>Clobetasol propionate</td>
      <td>CBGUOGMQLZIXBE-XGQKBEPLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00972</td>
      <td>Azelastine</td>
      <td>MBUVEWMHONZEQD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB09235</td>
      <td>Efonidipine</td>
      <td>NSVFSAJIGAJDMR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09038</td>
      <td>Empagliflozin</td>
      <td>OBWASQILIWPZMG-QZMOQZSNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB15385</td>
      <td>Acebilustat</td>
      <td>GERJIEKMNDGSCS-DQEYMECFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04590</td>
      <td>(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID</td>
      <td>PGYOHIAQCFZQDK-AUUYWEPGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09020</td>
      <td>Bisacodyl</td>
      <td>KHOITXIGCFIULA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09017</td>
      <td>Brotizolam</td>
      <td>UMSGKTJDUHERQW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08962</td>
      <td>Glibornuride</td>
      <td>RMTYNAPTNBJHQI-LLDVTBCESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02759</td>
      <td>4-Methylumbelliferyl Chitobiose</td>
      <td>UPSFMJHZUCSEHU-JYGUBCOQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12857</td>
      <td>NVP-LEQ-506</td>
      <td>POERAARDVFVDLO-QGZVFWFLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08934</td>
      <td>Sofosbuvir</td>
      <td>TTZHDVOVKQGIBA-IQWMDFIBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08915</td>
      <td>Aleglitazar</td>
      <td>DAYKLWSKQJBGCS-NRFANRHFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07328</td>
      <td>METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE</td>
      <td>USDCNOQKDUFKRD-IKGGRYGDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB04092</td>
      <td>Apstatin</td>
      <td>YVUUZAPYLPWFHE-HXFGRODQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02755</td>
      <td>1-3 Sugar Ring of Pentamannosyl 6-Phosphate</td>
      <td>HDQMHAJOIVYOIP-NAVBLJQLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB11450</td>
      <td>Pimobendan</td>
      <td>GLBJJMFZWDBELO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00370</td>
      <td>Mirtazapine</td>
      <td>RONZAEMNMFQXRA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00146</td>
      <td>Calcifediol</td>
      <td>JWUBBDSIWDLEOM-DTOXIADCSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB04121</td>
      <td>Guanosine-3'-Monophosphate-5'-Diphosphate</td>
      <td>HEYSFDAMRDTCJM-UUOKFMHZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB11521</td>
      <td>Imidocarb</td>
      <td>SCEVFJUWLLRELN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB04144</td>
      <td>Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone</td>
      <td>ZXIPEZDMQNYFOO-WUFINQPMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB14934</td>
      <td>GDC-0927</td>
      <td>KJAAPZIFCQQQKX-NDEPHWFRSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08810</td>
      <td>Cinitapride</td>
      <td>ZDLBNXXKDMLZMF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12935</td>
      <td>Remogliflozin etabonate</td>
      <td>UAOCLDQAQNNEAX-ABMICEGHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08762</td>
      <td>O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID</td>
      <td>UPJNMOBJDSFRTI-FCEWJHQRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07322</td>
      <td>2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID</td>
      <td>RRXVUYHFDBLTEL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08580</td>
      <td>4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline</td>
      <td>JEGGWFHNKPRKTO-CQSZACIVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB04362</td>
      <td>Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid</td>
      <td>VGXBGQACJQRWLV-LKGUXBDMSA-K</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08497</td>
      <td>(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate</td>
      <td>NKBDSMREMMRFSI-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09054</td>
      <td>Idelalisib</td>
      <td>IFSDAJWBUCMOAH-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB15333</td>
      <td>AZD-1386</td>
      <td>FPGNKXCEPARJDI-ZDUSSCGKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB04495</td>
      <td>RU81843</td>
      <td>GGPXNASQNUOIPB-NSOVKSMOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB02009</td>
      <td>L-756,423</td>
      <td>AOMZDQMIOCTPQP-QHQMVRJISA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12895</td>
      <td>TD-139</td>
      <td>YGIDGBAHDZEYMT-MQFIMZJJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB01897</td>
      <td>2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride</td>
      <td>BEIGFKLRGRRJJA-JLHYYAGUSA-O</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB03490</td>
      <td>3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole</td>
      <td>NHOACLCXCKJMAK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09279</td>
      <td>Fimasartan</td>
      <td>AMEROGPZOLAFBN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB03619</td>
      <td>Deoxycholic Acid</td>
      <td>KXGVEGMKQFWNSR-LLQZFEROSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00358</td>
      <td>Mefloquine</td>
      <td>XEEQGYMUWCZPDN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB04092</td>
      <td>Apstatin</td>
      <td>YVUUZAPYLPWFHE-HXFGRODQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB09070</td>
      <td>Tibolone</td>
      <td>WZDGZWOAQTVYBX-XOINTXKNSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lxt</td>
      <td>DB15192</td>
      <td>ABT-288</td>
      <td>GNIRITULTPTAQW-KNQAVFIVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB03701</td>
      <td>Vanoxerine</td>
      <td>NAUWTFJOPJWYOT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12988</td>
      <td>LY-518674</td>
      <td>PNHFDVSKDSLUFH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09198</td>
      <td>Lobeglitazone</td>
      <td>CHHXEZSCHQVSRE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09182</td>
      <td>Benzylfentanyl</td>
      <td>POQDXIFVWVZVML-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09181</td>
      <td>Trefentanil</td>
      <td>RJSCINHYBGMIFT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB09198</td>
      <td>Lobeglitazone</td>
      <td>CHHXEZSCHQVSRE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09177</td>
      <td>p-Fluorofentanyl</td>
      <td>KXUBAVLIJFTASZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09174</td>
      <td>Lofentanil</td>
      <td>IMYHGORQCPYVBZ-NLFFAJNJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB07848</td>
      <td>5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide</td>
      <td>BHNMMFGOJRIAEZ-LRDDRELGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB03751</td>
      <td>2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose</td>
      <td>YSYKRGRSMLTJNL-URARBOGNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12877</td>
      <td>Oxatomide</td>
      <td>BAINIUMDFURPJM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB09097</td>
      <td>Quinagolide</td>
      <td>GDFGTRDCCWFXTG-ZIFCJYIRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB05416</td>
      <td>Cardarine</td>
      <td>YDBLKRPLXZNVNB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB05414</td>
      <td>Pipendoxifene</td>
      <td>JICOGKJOQXTAIP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4b</td>
      <td>DB00984</td>
      <td>Nandrolone phenpropionate</td>
      <td>UBWXUGDQUBIEIZ-QNTYDACNSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00266</td>
      <td>Dicoumarol</td>
      <td>DOBMPNYZJYQDGZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB04405</td>
      <td>2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid</td>
      <td>AQYSXARQCHHHLK-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00276</td>
      <td>Amsacrine</td>
      <td>XCPGHVQEEXUHNC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB05039</td>
      <td>Indacaterol</td>
      <td>QZZUEBNBZAPZLX-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08702</td>
      <td>2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID</td>
      <td>QPKYPOMZPFDBEZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB05087</td>
      <td>Ganaxolone</td>
      <td>PGTVWKLGGCQMBR-FLBATMFCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08003</td>
      <td>ISOTHIAZOLIDINONE ANALOG</td>
      <td>UILYPHAKDBTKQV-UFYCRDLUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00737</td>
      <td>Meclizine</td>
      <td>OCJYIGYOJCODJL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08005</td>
      <td>4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide</td>
      <td>ARMFMDYRYOKSOW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08239</td>
      <td>(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE</td>
      <td>NKLVBHMAIMEVEH-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08224</td>
      <td>(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL</td>
      <td>WWSNTLOVYSRDEL-TVKPWXLESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB15138</td>
      <td>AZD-9496</td>
      <td>DFBDRVGWBHBJNR-BBNFHIFMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB15132</td>
      <td>AZD-8165</td>
      <td>YUHNXUAATAMVKD-PZJWPPBQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00814</td>
      <td>Meloxicam</td>
      <td>ZRVUJXDFFKFLMG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08213</td>
      <td>1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE</td>
      <td>PFAYCUAUBOGVDX-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00831</td>
      <td>Trifluoperazine</td>
      <td>ZEWQUBUPAILYHI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB11922</td>
      <td>Danirixin</td>
      <td>NGYNBSHYFOFVLS-LBPRGKRZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB15124</td>
      <td>PF-05241328</td>
      <td>RVTSXVZXEGFIPW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00445</td>
      <td>Epirubicin</td>
      <td>AOJJSUZBOXZQNB-VTZDEGQISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB11934</td>
      <td>Epelsiban</td>
      <td>UWHCWRQFNKUYCG-QUZACWSFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB11942</td>
      <td>Selinexor</td>
      <td>DEVSOMFAQLZNKR-RJRFIUFISA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07283</td>
      <td>9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid</td>
      <td>VDOXYKGIKBUISK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08159</td>
      <td>4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE</td>
      <td>AHIJTWCJGCWHMT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB02155</td>
      <td>Balanol Analog 8</td>
      <td>XVLMXAUKCDSMMW-YXLARRHKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB05408</td>
      <td>Emricasan</td>
      <td>SCVHJVCATBPIHN-SJCJKPOMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00920</td>
      <td>Ketotifen</td>
      <td>ZCVMWBYGMWKGHF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00921</td>
      <td>Buprenorphine</td>
      <td>RMRJXGBAOAMLHD-IHFGGWKQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08122</td>
      <td>N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE</td>
      <td>IKASAFLVQIJQOK-UVTDQMKNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>7bv1</td>
      <td>DB02059</td>
      <td>Adenosine-5-Diphosphoribose</td>
      <td>SRNWOUGRCWSEMX-ZQSHOCFMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08080</td>
      <td>LATRUNCULIN B</td>
      <td>NSHPHXHGRHSMIK-JRIKCGFMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08340</td>
      <td>N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE</td>
      <td>LLYYAUZAGCZEKV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB04853</td>
      <td>Binodenoson</td>
      <td>XJFMHMFFBSOEPR-DNZQAUTHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12781</td>
      <td>Balaglitazone</td>
      <td>IETKPTYAGKZLKY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00611</td>
      <td>Butorphanol</td>
      <td>IFKLAQQSCNILHL-PWRODBHTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08697</td>
      <td>4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide</td>
      <td>JDYIYIRPQKMWMM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12931</td>
      <td>Fenobam</td>
      <td>DWPQODZAOSWNHB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08686</td>
      <td>5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE</td>
      <td>UXCLJNSXDNCIIT-HNNXBMFYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00307</td>
      <td>Bexarotene</td>
      <td>NAVMQTYZDKMPEU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08665</td>
      <td>6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE</td>
      <td>YCFJZPGDTZVVSM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08613</td>
      <td>2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL</td>
      <td>OFBFUNBBOQCNFX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB11712</td>
      <td>Tezacaftor</td>
      <td>MJUVRTYWUMPBTR-MRXNPFEDSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08596</td>
      <td>5'-deoxy-5'-piperidin-1-ylthymidine</td>
      <td>GMOUOGHZJCSNOZ-YNEHKIRRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB11763</td>
      <td>Momelotinib</td>
      <td>ZVHNDZWQTBEVRY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB11772</td>
      <td>Pilaralisib</td>
      <td>QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB04578</td>
      <td>(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide</td>
      <td>OEVYDSSAPNIURZ-AEFFLSMTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00408</td>
      <td>Loxapine</td>
      <td>XJGVXQDUIWGIRW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08542</td>
      <td>3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione</td>
      <td>YUHVBHDSVLKFNI-NJSLBKSFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02595</td>
      <td>Bulgecin A</td>
      <td>RPNZWZDLNYCCIG-HMMVDTEZSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB07312</td>
      <td>2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE</td>
      <td>JCXZHFCBNFFHRC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00434</td>
      <td>Cyproheptadine</td>
      <td>JJCFRYNCJDLXIK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00436</td>
      <td>Bendroflumethiazide</td>
      <td>HDWIHXWEUNVBIY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08493</td>
      <td>5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID</td>
      <td>AKWKBACKRMYPRV-NQIIRXRSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB04632</td>
      <td>4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE</td>
      <td>JHHBGNIRSUTQAS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08471</td>
      <td>1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine</td>
      <td>SJEVDMFUHCVNPM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08659</td>
      <td>2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide</td>
      <td>PPDLAUCFAOODER-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB00543</td>
      <td>Amoxapine</td>
      <td>QWGDMFLQWFTERH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB11841</td>
      <td>Entinostat</td>
      <td>INVTYAOGFAGBOE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB08672</td>
      <td>4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE</td>
      <td>OIWWNWQZJJKBTR-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08422</td>
      <td>[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE</td>
      <td>GEIDRYBJURDUSW-MOPGFXCFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB05220</td>
      <td>Alisertib</td>
      <td>ZLHFILGSQDJULK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB08537</td>
      <td>3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine</td>
      <td>LZLKFNBMXXLTLX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6wiq</td>
      <td>DB00619</td>
      <td>Imatinib</td>
      <td>KTUFNOKKBVMGRW-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB07312</td>
      <td>2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE</td>
      <td>JCXZHFCBNFFHRC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06794</td>
      <td>Lodoxamide</td>
      <td>RVGLGHVJXCETIO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB03777</td>
      <td>Rbt205 Inhibitor</td>
      <td>QMGUOJYZJKLOLH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07583</td>
      <td>(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE</td>
      <td>RLNNFNGBXLTQOB-RBUKOAKNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB05105</td>
      <td>Pleconaril</td>
      <td>KQOXLKOJHVFTRN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB13791</td>
      <td>Penfluridol</td>
      <td>MDLAAYDRRZXJIF-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB05100</td>
      <td>Prinomastat</td>
      <td>YKPYIPVDTNNYCN-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12465</td>
      <td>Ketanserin</td>
      <td>FPCCSQOGAWCVBH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB07982</td>
      <td>2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol</td>
      <td>PVTKDXZNSUHUMO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB03921</td>
      <td>4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline</td>
      <td>IBCXZJCWDGCXQT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB01678</td>
      <td>RU84687</td>
      <td>SAFPHFWYRLLBFO-NSOVKSMOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12459</td>
      <td>Belotecan</td>
      <td>LNHWXBUNXOXMRL-VWLOTQADSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB13023</td>
      <td>IPI-493</td>
      <td>XYFFWTYOFPSZRM-TWNAANEASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04876</td>
      <td>Vildagliptin</td>
      <td>SYOKIDBDQMKNDQ-XWTIBIIYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00751</td>
      <td>Epinastine</td>
      <td>WHWZLSFABNNENI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB04792</td>
      <td>2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL</td>
      <td>CDEVHSIVANGYRI-XMTFNYHQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04816</td>
      <td>Dantron</td>
      <td>QBPFLULOKWLNNW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04812</td>
      <td>Benoxaprofen</td>
      <td>MITFXPHMIHQXPI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04806</td>
      <td>(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE</td>
      <td>OPIFSICVWOWJMJ-HAAGFXOZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04794</td>
      <td>Bifonazole</td>
      <td>OCAPBUJLXMYKEJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04092</td>
      <td>Apstatin</td>
      <td>YVUUZAPYLPWFHE-HXFGRODQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07688</td>
      <td>4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE</td>
      <td>RPJIMTALCNCQLV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB13042</td>
      <td>Fenoverine</td>
      <td>UBAJTZKNDCEGKL-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04137</td>
      <td>Guanosine-5'-Triphosphate</td>
      <td>XKMLYUALXHKNFT-UUOKFMHZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB04790</td>
      <td>2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol</td>
      <td>IBIUTOFGXGGVKQ-XMTFNYHQSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB05137</td>
      <td>Lobeline</td>
      <td>MXYUKLILVYORSK-HBMCJLEFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB15170</td>
      <td>Evobrutinib</td>
      <td>QUIWHXQETADMGN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB05187</td>
      <td>Elafibranor</td>
      <td>AFLFKFHDSCQHOL-IZZDOVSWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB03725</td>
      <td>Phosphomethylphosphonic Acid-Guanylate Ester</td>
      <td>PHBDHXOBFUBCJD-KQYNXXCUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07394</td>
      <td>AUROVERTIN B</td>
      <td>QXCOFYWOWZJFEA-YJMRODJJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB12507</td>
      <td>Atecegatran metoxil</td>
      <td>XSNMGLZVFNDDPW-ZWKOTPCHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06148</td>
      <td>Mianserin</td>
      <td>UEQUQVLFIPOEMF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB03355</td>
      <td>5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine</td>
      <td>UPVAPSGKXAAHBG-CKTDUXNWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB05864</td>
      <td>PPI-2458</td>
      <td>QBDVVYNLLXGUGN-XGTBZJOHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB08446</td>
      <td>3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile</td>
      <td>OHQMEDBYNUAVNE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB13080</td>
      <td>Roluperidone</td>
      <td>RNRYULFRLCBRQS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB14916</td>
      <td>Selonsertib</td>
      <td>YIDDLAAKOYYGJG-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07441</td>
      <td>3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID</td>
      <td>FRBAOMHMZCGBOJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB03476</td>
      <td>Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine</td>
      <td>NQRIWXVAIWPBEM-OALUTQOASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB14844</td>
      <td>ONC-201</td>
      <td>VLULRUCCHYVXOH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB14859</td>
      <td>Fosifloxuridine nafalbenamide</td>
      <td>BIOWRMNRHMERIO-ZVAHOJSLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08015</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime</td>
      <td>SZYREAUDQRVVLV-DAFNUICNSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB04244</td>
      <td>(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide</td>
      <td>YCDHZDINQZLSRR-DNQXCXABSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08459</td>
      <td>3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile</td>
      <td>SVMHTBVIPYVDIL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07493</td>
      <td>(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE</td>
      <td>IEQQJQHHJMQETK-YPKPFQOOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB08011</td>
      <td>(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DXIHOIDYHQSQKJ-HMMYKYKNSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB14896</td>
      <td>Selitrectinib</td>
      <td>OEBIHOVSAMBXIB-SJKOYZFVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB14584</td>
      <td>Segesterone</td>
      <td>SFLXYFZGKSGFKA-XUDSTZEESA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB08470</td>
      <td>3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole</td>
      <td>KMGPJKOKSYGMJD-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB03678</td>
      <td>(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine</td>
      <td>WVGZKPGUHOZIJQ-HNNXBMFYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB04849</td>
      <td>Cediranib</td>
      <td>XXJWYDDUDKYVKI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07563</td>
      <td>1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine</td>
      <td>GCJSOJRPNOWSEH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12621</td>
      <td>ST-101</td>
      <td>QZWYXEBIQWJXAR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB15036</td>
      <td>Sitravatinib</td>
      <td>WLAVZAAODLTUSW-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB01685</td>
      <td>Topiroxostat</td>
      <td>UBVZQGOVTLIHLH-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07698</td>
      <td>3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine</td>
      <td>JDNMRPIWJIDDAY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB09119</td>
      <td>Eslicarbazepine acetate</td>
      <td>QIALRBLEEWJACW-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB09124</td>
      <td>Medrogestone</td>
      <td>HCFSGRMEEXUOSS-JXEXPEPMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04590</td>
      <td>(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID</td>
      <td>PGYOHIAQCFZQDK-AUUYWEPGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB15292</td>
      <td>Foliglurax</td>
      <td>ZTEDNASHAWNBKQ-NCELDCMTSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04609</td>
      <td>INHIBITOR Q8467 OF DUPONT MERCK</td>
      <td>HFLCERPZYCWLSZ-VKONIRKNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB15295</td>
      <td>Tenalisib</td>
      <td>HDXDQPRPFRKGKZ-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04715</td>
      <td>IMIDAZOPYRIDAZIN 1</td>
      <td>IVUBNTNWKIPCPS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12939</td>
      <td>Nikkomycin Z</td>
      <td>WWJFFVUVFNBJTN-VHDFTHOZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04226</td>
      <td>Dihydro-Acarbose</td>
      <td>CUAQESWNTOXZJZ-RTNAABQMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04196</td>
      <td>Pteroic Acid</td>
      <td>JOAQINSXLLMRCV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04186</td>
      <td>N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea</td>
      <td>KLVYMYQTRZCMLE-CYBMUJFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04696</td>
      <td>4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN</td>
      <td>GFGZCXHXQCQRFP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07847</td>
      <td>6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE</td>
      <td>ICLOZQFWTRAYPX-LIRRHRJNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB15385</td>
      <td>Acebilustat</td>
      <td>GERJIEKMNDGSCS-DQEYMECFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxs</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB01958</td>
      <td>5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine</td>
      <td>MNYDVPDMLAJJPB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03970</td>
      <td>(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid</td>
      <td>CHNMLWCTGYMVFH-GFCCVEGCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03921</td>
      <td>4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline</td>
      <td>IBCXZJCWDGCXQT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03880</td>
      <td>Batimastat</td>
      <td>XFILPEOLDIKJHX-QYZOEREBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04790</td>
      <td>2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol</td>
      <td>IBIUTOFGXGGVKQ-XMTFNYHQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07943</td>
      <td>2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol</td>
      <td>CATQHDWESBRRQA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB03860</td>
      <td>N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide</td>
      <td>BVVFOLSZMQVDKV-KXQIQQEYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB00799</td>
      <td>Tazarotene</td>
      <td>OGQICQVSFDPSEI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB13005</td>
      <td>Rebastinib</td>
      <td>WVXNSAVVKYZVOE-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB09080</td>
      <td>Olodaterol</td>
      <td>COUYJEVMBVSIHV-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04226</td>
      <td>Dihydro-Acarbose</td>
      <td>CUAQESWNTOXZJZ-RTNAABQMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB04712</td>
      <td>ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE</td>
      <td>ADKWVGPRAQKVKB-YIYPIFLZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07756</td>
      <td>1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL</td>
      <td>GPBGHVRNVGXPNM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07764</td>
      <td>FLUORESCIN</td>
      <td>MURGITYSBWUQTI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04678</td>
      <td>H TYPE II TRISACCHARIDE</td>
      <td>PHTAQVMXYWFMHF-QVPNGJTFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB12875</td>
      <td>Mavatrep</td>
      <td>ORDHXXHTBUZRCN-NTEUORMPSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04338</td>
      <td>SB220025</td>
      <td>VSPFURGQAYMVAN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04649</td>
      <td>TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S</td>
      <td>MVFPGTZTOAHVBP-HXYLPHSESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04362</td>
      <td>Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid</td>
      <td>VGXBGQACJQRWLV-LKGUXBDMSA-K</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04642</td>
      <td>7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID</td>
      <td>XQTOWNDCHQJXOQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04395</td>
      <td>Phosphoaminophosphonic Acid-Adenylate Ester</td>
      <td>PVKSNHVPLWYQGJ-FCIPNVEPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04610</td>
      <td>7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin</td>
      <td>XMFJTCGUDFSWSW-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB12985</td>
      <td>Quisinostat</td>
      <td>PAWIYAYFNXQGAP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02010</td>
      <td>Staurosporine</td>
      <td>HKSZLNNOFSGOKW-FYTWVXJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB04432</td>
      <td>ZK-805623</td>
      <td>ZXIHYCYAQUQHSG-UHFFFAOYSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB00796</td>
      <td>Candesartan cilexetil</td>
      <td>GHOSNRCGJFBJIB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB04632</td>
      <td>4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE</td>
      <td>JHHBGNIRSUTQAS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07804</td>
      <td>5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE</td>
      <td>FKCQUVAGEOSYRU-QWRGUYRKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02004</td>
      <td>5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine</td>
      <td>RCJFINNFYUNFGH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04554</td>
      <td>8-Bromoadenosine-5'-Diphosphate</td>
      <td>KVVVTFSHHQCHNZ-UUOKFMHZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB04509</td>
      <td>N-Methylnaloxonium</td>
      <td>PCSQOABIHJXZMR-YNUHATHGSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB04644</td>
      <td>4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID</td>
      <td>FCEMCUPAYRPTLS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB12414</td>
      <td>Usistapide</td>
      <td>WSYALRNYQFNNGP-WJOKGBTCSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB08426</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</td>
      <td>PLXOQMHGHDZMSX-AWEZNQCLSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07549</td>
      <td>2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE</td>
      <td>WOYBPRBUPLYTPY-UHFFFAOYSA-P</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08423</td>
      <td>[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE</td>
      <td>QKZZJXRGCHXIAI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB03205</td>
      <td>Pyrroloquinoline Quinone</td>
      <td>MMXZSJMASHPLLR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08402</td>
      <td>2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID</td>
      <td>VNDRRWBKNSHALL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06395</td>
      <td>Abafungin</td>
      <td>TYBHXIFFPVFXQW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB04285</td>
      <td>{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid</td>
      <td>GBLDYRVJENYQNH-AGLOJYHOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07254</td>
      <td>N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE</td>
      <td>KQGTYXRWSIBDOZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08383</td>
      <td>4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole</td>
      <td>XBMULXNXJLWLLD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB03038</td>
      <td>LY341770</td>
      <td>MXAFDBCLWLMXSI-ZDUSSCGKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07252</td>
      <td>3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide</td>
      <td>TZHCXOMEOHEZDX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w4h</td>
      <td>DB04186</td>
      <td>N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea</td>
      <td>KLVYMYQTRZCMLE-CYBMUJFWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB03010</td>
      <td>Patupilone</td>
      <td>QXRSDHAAWVKZLJ-PVYNADRNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07215</td>
      <td>2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID</td>
      <td>ILUPZUOBHCUBKB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07212</td>
      <td>N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE</td>
      <td>NNGZRCYXFBHMRM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB12679</td>
      <td>WP 1066</td>
      <td>VFUAJMPDXIRPKO-LQELWAHVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07203</td>
      <td>6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE</td>
      <td>OUEGMEMDEAOAEG-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06609</td>
      <td>Odiparcil</td>
      <td>JRHNIQQUVJOPQC-AQNFWKISSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07199</td>
      <td>(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID</td>
      <td>SWYJAQWTBADJTB-RHGYRFJNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6crv</td>
      <td>DB02307</td>
      <td>N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine</td>
      <td>FOJUHLDAXGNCIP-FHWLQOOXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB08361</td>
      <td>2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide</td>
      <td>NZNTWOVDIXCHHS-LSDHHAIUSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB08358</td>
      <td>2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>OWFLADWRSCINST-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB02799</td>
      <td>N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide</td>
      <td>OJBZDUMTXGGVSP-KTKRTIGZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB02790</td>
      <td>Phenyl-Uridine-5'-Diphosphate</td>
      <td>ZHUWBKDWWGKIEN-FMKGYKFTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06673</td>
      <td>Almorexant</td>
      <td>DKMACHNQISHMDN-RPLLCQBOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06684</td>
      <td>Vilazodone</td>
      <td>SGEGOXDYSFKCPT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08350</td>
      <td>5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE</td>
      <td>GYQRHHQPEMOLKH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06729</td>
      <td>Sulfaphenazole</td>
      <td>QWCJHSGMANYXCW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9q</td>
      <td>DB15399</td>
      <td>BMS-754807</td>
      <td>LQVXSNNAFNGRAH-QHCPKHFHSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06747</td>
      <td>ginkgolide-M</td>
      <td>KDKROYXEHCYLJQ-FJFAJXJPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08340</td>
      <td>N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE</td>
      <td>LLYYAUZAGCZEKV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6lzg</td>
      <td>DB13947</td>
      <td>Testosterone enantate benzilic acid hydrazone</td>
      <td>PTVXYACXDYZNID-JKXGKYMWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6vxx</td>
      <td>DB13499</td>
      <td>Cefsulodin</td>
      <td>SYLKGLMBLAAGSC-QLVMHMETSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m3m</td>
      <td>DB06235</td>
      <td>Vadimezan</td>
      <td>XGOYIMQSIKSOBS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6m2n</td>
      <td>DB02929</td>
      <td>K201</td>
      <td>KCWGETCFOVJEPI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB08750</td>
      <td>1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE</td>
      <td>SFPCNWQWKOUNRT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6cs2</td>
      <td>DB08418</td>
      <td>(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate</td>
      <td>LSJKARAMQNGZDF-YOEKFXIASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.6</td>
      <td>6w9c</td>
      <td>DB07337</td>
      <td>4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE</td>
      <td>SOKOHDQTKSROQZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07595</td>
      <td>(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE</td>
      <td>WSIQKQLAGWVKSL-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02455</td>
      <td>Fluoresceinylthioureido</td>
      <td>VHJFQSRUDVDTEO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB13756</td>
      <td>Peruvoside</td>
      <td>PMTSPAGBAFCORP-HBUONDEYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02450</td>
      <td>2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid</td>
      <td>ASEJDWRSZYAIOT-GJZGRUSLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08104</td>
      <td>N-(3,5-dibromo-4-hydroxyphenyl)benzamide</td>
      <td>HKODPZBPODONGO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07316</td>
      <td>N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide</td>
      <td>FAVXIEFZKPJZRT-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02019</td>
      <td>Acetyl Dithranol</td>
      <td>IXLRLZOYKJERRA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07539</td>
      <td>4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID</td>
      <td>JLRKRQCTYQGDKJ-GHXNOFRVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15169</td>
      <td>H3B-6527</td>
      <td>MBWRLLRCTIYXDW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04807</td>
      <td>4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE</td>
      <td>HQYVHBCTLFPWRQ-ZMFOIVQCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB09292</td>
      <td>Sacubitril</td>
      <td>PYNXFZCZUAOOQC-UTKZUKDTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01208</td>
      <td>Sparfloxacin</td>
      <td>DZZWHBIBMUVIIW-DTORHVGOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07662</td>
      <td>N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE</td>
      <td>HTUBKQUPEREOGA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06213</td>
      <td>Regadenoson</td>
      <td>LZPZPHGJDAGEJZ-AKAIJSEGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12779</td>
      <td>Higenamine</td>
      <td>WZRCQWQRFZITDX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>1r42</td>
      <td>DB00872</td>
      <td>Conivaptan</td>
      <td>IKENVDNFQMCRTR-UHFFFAOYSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08560</td>
      <td>3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE</td>
      <td>GULUFDCOGAXLEP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB14152</td>
      <td>Ginsenosides</td>
      <td>NLHQJXWYMZLQJY-SWIZOJJJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02901</td>
      <td>Stanolone</td>
      <td>NVKAWKQGWWIWPM-ABEVXSGRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13351</td>
      <td>Piperidolate</td>
      <td>KTHVBAZBLKXIHZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11990</td>
      <td>MK-0812</td>
      <td>UNVWTBOGMHPKJM-CWKRKGSWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00624</td>
      <td>Testosterone</td>
      <td>MUMGGOZAMZWBJJ-DYKIIFRCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00243</td>
      <td>Ranolazine</td>
      <td>XKLMZUWKNUAPSZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01198</td>
      <td>Zopiclone</td>
      <td>GBBSUAFBMRNDJC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11753</td>
      <td>Rifamycin</td>
      <td>HJYYPODYNSCCOU-ODRIEIDWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08981</td>
      <td>Fenbufen</td>
      <td>ZPAKPRAICRBAOD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00764</td>
      <td>Mometasone</td>
      <td>QLIIKPVHVRXHRI-CXSFZGCWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06678</td>
      <td>Esmirtazapine</td>
      <td>RONZAEMNMFQXRA-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07510</td>
      <td>3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid</td>
      <td>CPZFGNOKCMJZFO-BTHQEHEQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15177</td>
      <td>VX-659</td>
      <td>IGEOJNMYRZUKIK-IBGZPJMESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08177</td>
      <td>(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID</td>
      <td>YZLFZFALAZYTCI-NTEUORMPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB01100</td>
      <td>Pimozide</td>
      <td>YVUQSNJEYSNKRX-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08880</td>
      <td>Teriflunomide</td>
      <td>UTNUDOFZCWSZMS-YFHOEESVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15209</td>
      <td>MK-0736</td>
      <td>ORQZQBUNAMJFCY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB01070</td>
      <td>Dihydrotachysterol</td>
      <td>ILYCWAKSDCYMBB-OPCMSESCSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01535</td>
      <td>Carfentanil</td>
      <td>YDSDEBIZUNNPOB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02703</td>
      <td>Fusidic acid</td>
      <td>IECPWNUMDGFDKC-MZJAQBGESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB05838</td>
      <td>OPC-51803</td>
      <td>INGXCNVWWKKWOO-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04518</td>
      <td>3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol</td>
      <td>JJDRRZFRTKZLFT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00412</td>
      <td>Rosiglitazone</td>
      <td>YASAKCUCGLMORW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00216</td>
      <td>Eletriptan</td>
      <td>PWVXXGRKLHYWKM-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07870</td>
      <td>(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID</td>
      <td>GOCUAJYOYBLQRH-MRVPVSSYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07311</td>
      <td>18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE</td>
      <td>JRSWWYITYIOHOP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13717</td>
      <td>Phenothrin</td>
      <td>SBNFWQZLDJGRLK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07421</td>
      <td>4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile</td>
      <td>INVUBEGZQHQAMY-SJORKVTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12131</td>
      <td>Vinpocetine</td>
      <td>DDNCQMVWWZOMLN-IRLDBZIGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12130</td>
      <td>Lorlatinib</td>
      <td>IIXWYSCJSQVBQM-LLVKDONJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13355</td>
      <td>Visnadine</td>
      <td>GVBNSPFBYXGREE-CXWAGAITSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB09421</td>
      <td>Protirelin</td>
      <td>XNSAINXGIQZQOO-SRVKXCTJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13710</td>
      <td>Metenolone</td>
      <td>ANJQEDFWRSLVBR-VHUDCFPWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01139</td>
      <td>Cefapirin</td>
      <td>UQLLWWBDSUHNEB-CZUORRHYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08379</td>
      <td>6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one</td>
      <td>NOVPOXGMADEKPP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08099</td>
      <td>6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine</td>
      <td>UOYVKYJWAXJTTE-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB13676</td>
      <td>Mosapramine</td>
      <td>PXUIZULXJVRBPC-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB03950</td>
      <td>(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide</td>
      <td>ZFWHOUCRVSOZJE-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13399</td>
      <td>Terguride</td>
      <td>JOAHPSVPXZTVEP-YXJHDRRASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08123</td>
      <td>N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE</td>
      <td>GEWPSTLKJDIUHW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13656</td>
      <td>Eberconazole</td>
      <td>MPTJIDOGFUQSQH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06272</td>
      <td>Maxacalcitol</td>
      <td>DTXXSJZBSTYZKE-ZDQKKZTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13988</td>
      <td>SB-269970</td>
      <td>HWKROQUZSKPIKQ-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>1r42</td>
      <td>DB02483</td>
      <td>Etheno-Nad</td>
      <td>JCDBQDNBEQHDHK-BSLNIGMPSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>1r42</td>
      <td>DB02449</td>
      <td>3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid</td>
      <td>ULOTXPTWJAUGGE-MHZLTWQESA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01097</td>
      <td>Leflunomide</td>
      <td>VHOGYURTWQBHIL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12689</td>
      <td>Azeliragon</td>
      <td>KJNNWYBAOPXVJY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12792</td>
      <td>Boscalid</td>
      <td>WYEMLYFITZORAB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04430</td>
      <td>3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile</td>
      <td>FLPLCJJGNZGOAW-QXMHVHEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06884</td>
      <td>4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE</td>
      <td>MFDXHRPPSJRQFX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07616</td>
      <td>4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid</td>
      <td>LKZZDHKJFDTYCH-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13012</td>
      <td>AQX-1125</td>
      <td>MDEJTPWQNNMAQF-BVMLLJBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB09174</td>
      <td>Lofentanil</td>
      <td>IMYHGORQCPYVBZ-NLFFAJNJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06153</td>
      <td>Pizotifen</td>
      <td>FIADGNVRKBPQEU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01153</td>
      <td>Sertaconazole</td>
      <td>JLGKQTAYUIMGRK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01889</td>
      <td>16,17-Androstene-3-Ol</td>
      <td>KRVXMNNRSSQZJP-PHFHYRSDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04357</td>
      <td>Pteric Acid</td>
      <td>JOAQINSXLLMRCV-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12059</td>
      <td>JNJ-40411813</td>
      <td>HYOGJHCDLQSAHX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00831</td>
      <td>Trifluoperazine</td>
      <td>ZEWQUBUPAILYHI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB14734</td>
      <td>Cannabigerol</td>
      <td>QXACEHWTBCFNSA-SFQUDFHCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12079</td>
      <td>Gefarnate</td>
      <td>ZPACYDRSPFRDHO-ROBAGEODSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08148</td>
      <td>1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine</td>
      <td>QOZMRRGNAZNWDN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01565</td>
      <td>Dihydromorphine</td>
      <td>IJVCSMSMFSCRME-KBQPJGBKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07352</td>
      <td>Apigenin</td>
      <td>KZNIFHPLKGYRTM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07530</td>
      <td>(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol</td>
      <td>PCHUQQNKOFNVDU-OSXMSNBXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB09183</td>
      <td>Dasabuvir</td>
      <td>NBRBXGKOEOGLOI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01621</td>
      <td>Pipotiazine</td>
      <td>JOMHSQGEWSNUKU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13591</td>
      <td>Metopimazine</td>
      <td>BQDBKDMTIJBJLA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13396</td>
      <td>Neocitrullamon</td>
      <td>PAJBBDCZSMDSFL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04254</td>
      <td>8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine</td>
      <td>ARWHTQLGMWHTAZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06873</td>
      <td>1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>CSXNPJKDZKLDET-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06876</td>
      <td>N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE</td>
      <td>YJWJKKXGAPWLGT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11946</td>
      <td>AZD-1981</td>
      <td>JWYIGNODXSRKGP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01865</td>
      <td>3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide</td>
      <td>AKFPMLBVLWZSQX-CSKARUKUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13540</td>
      <td>Isepamicin</td>
      <td>UDIIBEDMEYAVNG-ZKFPOVNWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04756</td>
      <td>2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid</td>
      <td>SNAMTVTZDPUVRA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11999</td>
      <td>Vosaroxin</td>
      <td>XZAFZXJXZHRNAQ-STQMWFEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07513</td>
      <td>7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE</td>
      <td>JMGUSOLCNQVZCT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11622</td>
      <td>Dehydrocholic acid</td>
      <td>OHXPGWPVLFPUSM-KLRNGDHRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07607</td>
      <td>4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>RXDZANYWRNIAOR-HHHXNRCGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11665</td>
      <td>BMS-690514</td>
      <td>CSGQVNMSRKWUSH-IAGOWNOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04270</td>
      <td>(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid</td>
      <td>WUZIMDSVRIBNNI-DEOSSOPVSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13638</td>
      <td>Cefbuperazone</td>
      <td>SMSRCGPDNDCXFR-CYWZMYCQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07179</td>
      <td>3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide</td>
      <td>DXUJQXZHHGJMFM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07330</td>
      <td>trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium</td>
      <td>KXSIHXHEHABEJX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01838</td>
      <td>6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone</td>
      <td>GKDYOXMZSXVKPP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01852</td>
      <td>Kaempherol</td>
      <td>IYRMWMYZSQPJKC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01104</td>
      <td>Sertraline</td>
      <td>VGKDLMBJGBXTGI-SJCJKPOMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB05252</td>
      <td>Fenoxaprop-ethyl</td>
      <td>PQKBPHSEKWERTG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01098</td>
      <td>Rosuvastatin</td>
      <td>BPRHUIZQVSMCRT-VEUZHWNKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13635</td>
      <td>Tiracizine</td>
      <td>KJAMZCVTJDTESW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13317</td>
      <td>Flunoxaprofen</td>
      <td>ARPYQKTVRGFPIS-VIFPVBQESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08322</td>
      <td>2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID</td>
      <td>VJLMRHSHSNLOGC-NOPZTHQXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01977</td>
      <td>6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine</td>
      <td>AECPTICWHONWNW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07775</td>
      <td>3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE</td>
      <td>BRPKBUNFOZFULQ-SGAXSIHGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB14725</td>
      <td>Cefamandole nafate</td>
      <td>RRJHESVQVSRQEX-SUYBPPKGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB14067</td>
      <td>Dofequidar</td>
      <td>KLWUUPVJTLHYIM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB09172</td>
      <td>Brifentanil</td>
      <td>KKMGCTVJCQYQPV-WBVHZDCISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15367</td>
      <td>LY-2623091</td>
      <td>YPCLDHGBEKZGEB-RUDKWAFVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12504</td>
      <td>JNJ-40346527</td>
      <td>BNVPFDRNGHMRJS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13617</td>
      <td>Clorexolone</td>
      <td>VPMWFZKOWULPGT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01861</td>
      <td>Uridine diphosphate glucose</td>
      <td>HSCJRCZFDFQWRP-JZMIEXBBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02333</td>
      <td>Deoxyuridine-5'-Triphosphate</td>
      <td>AHCYMLUZIRLXAA-SHYZEUOFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00540</td>
      <td>Nortriptyline</td>
      <td>PHVGLTMQBUFIQQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08753</td>
      <td>4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE</td>
      <td>GARHCDOTUULBOQ-PKNBQFBNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15219</td>
      <td>Tomivosertib</td>
      <td>HKTBYUWLRDZAJK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12376</td>
      <td>Ricolinostat</td>
      <td>QGZYDVAGYRLSKP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB01215</td>
      <td>Estazolam</td>
      <td>CDCHDCWJMGXXRH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB03205</td>
      <td>Pyrroloquinoline Quinone</td>
      <td>MMXZSJMASHPLLR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07468</td>
      <td>(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</td>
      <td>NJBBBRZNBVLTRZ-GOSISDBHSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB05959</td>
      <td>ENMD-1198</td>
      <td>YQJWOUQGXATDAE-ACNBBOPNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12645</td>
      <td>Givinostat</td>
      <td>YALNUENQHAQXEA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB03467</td>
      <td>Naringenin</td>
      <td>FTVWIRXFELQLPI-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06967</td>
      <td>6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE</td>
      <td>MLSVRCGEBXIIQO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13821</td>
      <td>Ceftezole</td>
      <td>DZMVCVMFETWNIU-LDYMZIIASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01089</td>
      <td>Deserpidine</td>
      <td>CVBMAZKKCSYWQR-WCGOZPBSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB01218</td>
      <td>Halofantrine</td>
      <td>FOHHNHSLJDZUGQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13136</td>
      <td>Fluindione</td>
      <td>NASXCEITKQITLD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12210</td>
      <td>AZD-6280</td>
      <td>NVWCZRPXYVDQEE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01418</td>
      <td>Acenocoumarol</td>
      <td>VABCILAOYCMVPS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08059</td>
      <td>Wortmannin</td>
      <td>QDLHCMPXEPAAMD-QAIWCSMKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08068</td>
      <td>N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</td>
      <td>YQJVDUKATDECHF-ICSRJNTNSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06718</td>
      <td>Stanozolol</td>
      <td>LKAJKIOFIWVMDJ-IYRCEVNGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11518</td>
      <td>Flunixin</td>
      <td>NOOCSNJCXJYGPE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lu7</td>
      <td>DB11904</td>
      <td>Flumatinib</td>
      <td>BJCJYEYYYGBROF-UHFFFAOYSA-N</td>
      <td>active site</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00714</td>
      <td>Apomorphine</td>
      <td>VMWNQDUVQKEIOC-CYBMUJFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07230</td>
      <td>3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE</td>
      <td>DHPCBFMFERFZLR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00718</td>
      <td>Adefovir dipivoxil</td>
      <td>WOZSCQDILHKSGG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00546</td>
      <td>Adinazolam</td>
      <td>GJSLOMWRLALDCT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15193</td>
      <td>BMS-955176</td>
      <td>XDMUFNNPLXHNKA-ZTESCHFWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07165</td>
      <td>N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE</td>
      <td>SOBGXPPOYFFGTK-UGKGYDQZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07217</td>
      <td>N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide</td>
      <td>YVYPYORTKAIUGJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB14641</td>
      <td>Estriol tripropionate</td>
      <td>ONMZMZJEZHMWQL-REUUDLSRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02587</td>
      <td>Colforsin</td>
      <td>OHCQJHSOBUTRHG-KGGHGJDLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11395</td>
      <td>Deracoxib</td>
      <td>WAZQAZKAZLXFMK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01110</td>
      <td>Miconazole</td>
      <td>BYBLEWFAAKGYCD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08833</td>
      <td>Taurochenodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-BJLOMENOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13185</td>
      <td>Oxabolone cipionate</td>
      <td>KHKDIUPVDIEHAH-KXLSUQFWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08000</td>
      <td>2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE</td>
      <td>ZTJGXDGAXGWOGR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01712</td>
      <td>(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester</td>
      <td>NDDSSAGSYFVBTG-SFTDATJTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13177</td>
      <td>4-methylumbelliferyl beta-D-glucoside</td>
      <td>YUDPTGPSBJVHCN-YMILTQATSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07148</td>
      <td>(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one</td>
      <td>HPAFVLDARQIHPU-HNNXBMFYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12239</td>
      <td>Balicatib</td>
      <td>LLCRBOWRJOUJAE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00497</td>
      <td>Oxycodone</td>
      <td>BRUQQQPBMZOVGD-XFKAJCMBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04953</td>
      <td>Ezogabine</td>
      <td>PCOBBVZJEWWZFR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01451</td>
      <td>1-Androstenedione</td>
      <td>WJIQCDPCDVWDDE-WZNAKSSCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08014</td>
      <td>(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE</td>
      <td>AQILFLLHLFBLLG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01713</td>
      <td>Udp-Alpha-D-Xylopyranose</td>
      <td>DQQDLYVHOTZLOR-OCIMBMBZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11446</td>
      <td>Oxfendazole</td>
      <td>BEZZFPOZAYTVHN-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13842</td>
      <td>Etofylline nicotinate</td>
      <td>ZWIAODBBEZGVPY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13835</td>
      <td>Caroverine</td>
      <td>MSPRUJDUTKRMLM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01599</td>
      <td>Probucol</td>
      <td>FYPMFJGVHOHGLL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07999</td>
      <td>{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID</td>
      <td>IXLBOIRSEDMRPI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB14626</td>
      <td>Pregnenolone acetate</td>
      <td>CRRKVZVYZQXICQ-RJJCNJEVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01443</td>
      <td>19-Nor-5-androstenedione</td>
      <td>WELNRNVZXWUOGT-QXUSFIETSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08796</td>
      <td>Pipazethate</td>
      <td>DTVJXCOMJLLMAK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15229</td>
      <td>CNV-2197944</td>
      <td>BLFJGFDZMABYMY-ZDUSSCGKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB14653</td>
      <td>Clocortolone caproate</td>
      <td>MMTRTBFDFNRBQO-ANHDKODLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11800</td>
      <td>Tivozanib</td>
      <td>SPMVMDHWKHCIDT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06970</td>
      <td>2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE</td>
      <td>MZCDQILVXXIMEV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07717</td>
      <td>(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE</td>
      <td>AJODXHGZHBERGJ-JLYQOUBASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06403</td>
      <td>Ambrisentan</td>
      <td>OUJTZYPIHDYQMC-LJQANCHMSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08246</td>
      <td>(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE</td>
      <td>WFFMEXQHWXEKBV-SFHVURJKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06969</td>
      <td>2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide</td>
      <td>WJUNQSYQHHIVFX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15028</td>
      <td>MK-1064</td>
      <td>CKTWQGHVNRYNCM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13175</td>
      <td>Rheinanthrone</td>
      <td>OZFQHULMMDWMIV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12721</td>
      <td>RO-5028442</td>
      <td>QZXVLRCMAHJVIP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06944</td>
      <td>N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide</td>
      <td>RIGZCVNCFXYBEG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13248</td>
      <td>Phthalylsulfathiazole</td>
      <td>PBMSWVPMRUJMPE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12428</td>
      <td>PAC-14028</td>
      <td>UKGJZDSUJSPAJL-YPUOHESYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12430</td>
      <td>BC-3781</td>
      <td>KPVIXBKIJXZQJX-IJUBVZAWSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07134</td>
      <td>5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE</td>
      <td>LCPRWBWCEGWNKF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04474</td>
      <td>1-Anilino-8-Naphthalene Sulfonate</td>
      <td>FWEOQOXTVHGIFQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13783</td>
      <td>Acemetacin</td>
      <td>FSQKKOOTNAMONP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB14129</td>
      <td>Macelignan</td>
      <td>QDDILOVMGWUNGD-UONOGXRCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02071</td>
      <td>WAY-151693</td>
      <td>AINJYWXKBKRQSX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07131</td>
      <td>(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide</td>
      <td>DOTBZTLJSXFKCP-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15456</td>
      <td>Vericiguat</td>
      <td>QZFHIXARHDBPBY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01025</td>
      <td>Amlexanox</td>
      <td>SGRYPYWGNKJSDL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02266</td>
      <td>Flufenamic Acid</td>
      <td>LPEPZBJOKDYZAD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06455</td>
      <td>Meclinertant</td>
      <td>DYLJVOXRWLXDIG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB01254</td>
      <td>Dasatinib</td>
      <td>ZBNZXTGUTAYRHI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB13710</td>
      <td>Metenolone</td>
      <td>ANJQEDFWRSLVBR-VHUDCFPWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04643</td>
      <td>4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID</td>
      <td>FYQVFMLCZJZZEM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13759</td>
      <td>Fenpiverinium</td>
      <td>QDIYJDPBMZUZEH-UHFFFAOYSA-O</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07169</td>
      <td>5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE</td>
      <td>GAOOBYJHWAKZKU-LLVKDONJSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07055</td>
      <td>2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione</td>
      <td>DEOJDUHRJBKATO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13463</td>
      <td>Oxetorone</td>
      <td>VZVRZTZPHOHSCK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06588</td>
      <td>Triphendiol</td>
      <td>KQCJZAUNKSGEFM-UNMCSNQZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07755</td>
      <td>(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol</td>
      <td>GNLAGGCSJGJECE-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15187</td>
      <td>Dubermatinib</td>
      <td>YUAALFPUEOYPNX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB15281</td>
      <td>Ravoxertinib</td>
      <td>RZUOCXOYPYGSKL-GOSISDBHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB09063</td>
      <td>Ceritinib</td>
      <td>VERWOWGGCGHDQE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08179</td>
      <td>methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate</td>
      <td>BLXSEOJIXHWXQJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07017</td>
      <td>(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one</td>
      <td>HYVZYASDRIAOPU-BJOHPYRUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02292</td>
      <td>Irosustat</td>
      <td>DSLPMJSGSBLWRE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04371</td>
      <td>AL6528</td>
      <td>FBBLOSCXOZYUSS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08704</td>
      <td>[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate</td>
      <td>NUNQIQQEEPOGDJ-JDOAOKHLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12840</td>
      <td>Pirnabine</td>
      <td>AADNQNOXNWEYHS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB14637</td>
      <td>Fluprednisolone acetate</td>
      <td>CYMBAKFTWRNHPS-APRQOCPKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02104</td>
      <td>2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine</td>
      <td>PEGMMEYCSOZKIT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00179</td>
      <td>Masoprocol</td>
      <td>HCZKYJDFEPMADG-TXEJJXNPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12612</td>
      <td>Ozanimod</td>
      <td>XRVDGNKRPOAQTN-FQEVSTJZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00701</td>
      <td>Amprenavir</td>
      <td>YMARZQAQMVYCKC-OEMFJLHTSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB13855</td>
      <td>Nifuroxazide</td>
      <td>YCWSUKQGVSGXJO-NTUHNPAUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06940</td>
      <td>N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide</td>
      <td>ZZTMFGIGOADCFX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04873</td>
      <td>Piboserod</td>
      <td>KVCSJPATKXABRQ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB03121</td>
      <td>(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid</td>
      <td>ZEKCBTQHDTUHRJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01128</td>
      <td>Bicalutamide</td>
      <td>LKJPYSCBVHEWIU-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00955</td>
      <td>Netilmicin</td>
      <td>CIDUJQMULVCIBT-MQDUPKMGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB12740</td>
      <td>CC-115</td>
      <td>GMYLVKUGJMYTFB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06936</td>
      <td>N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide</td>
      <td>AEKJCSNKYXWOAQ-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08392</td>
      <td>2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL</td>
      <td>ARBUGBBNEFAECO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00950</td>
      <td>Fexofenadine</td>
      <td>RWTNPBWLLIMQHL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB06923</td>
      <td>2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE</td>
      <td>KJUSXMYSVXZFDJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB14196</td>
      <td>N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine</td>
      <td>ZRMMVODKVLXCBB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07750</td>
      <td>(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol</td>
      <td>GNLAGGCSJGJECE-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11736</td>
      <td>PF-00489791</td>
      <td>ZUHZNKJIJDAJFD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00735</td>
      <td>Naftifine</td>
      <td>OZGNYLLQHRPOBR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB04639</td>
      <td>Biphenylalanine</td>
      <td>JCZLABDVDPYLRZ-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02189</td>
      <td>2',3'-Dideoxyadenosine-5'-Triphosphate</td>
      <td>OAKPWEUQDVLTCN-NKWVEPMBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08442</td>
      <td>4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol</td>
      <td>TWODFUZHWYZBHZ-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB05585</td>
      <td>Verubulin</td>
      <td>SNHCRNMVYDHVDT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB00447</td>
      <td>Loracarbef</td>
      <td>JAPHQRWPEGVNBT-UTUOFQBUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08292</td>
      <td>(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE</td>
      <td>AQKZYZQONWDDLS-IWQZZHSRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB11560</td>
      <td>Lesinurad</td>
      <td>FGQFOYHRJSUHMR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB05395</td>
      <td>Amibegron</td>
      <td>RDJQCOBTKKAQAH-FPOVZHCZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB07441</td>
      <td>3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID</td>
      <td>FRBAOMHMZCGBOJ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB08846</td>
      <td>Ellagic Acid</td>
      <td>AFSDNFLWKVMVRB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB02602</td>
      <td>AL7182</td>
      <td>ICIXQGGQPKFQRL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB01470</td>
      <td>??-methylthiofentanyl</td>
      <td>YPOXDUYRRSUFFG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08401</td>
      <td>(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID</td>
      <td>LDNKNKRRFZRLIG-HWQJWEFDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB13014</td>
      <td>Hypericin</td>
      <td>BTXNYTINYBABQR-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08130</td>
      <td>N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine</td>
      <td>FPDWDLAITHFTTP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08077</td>
      <td>2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID</td>
      <td>OYJPTSMWFKGZJM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08054</td>
      <td>1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>GEZALMMCQYDFML-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12640</td>
      <td>CP-609754</td>
      <td>JAHDAIPFBPPQHQ-GDLZYMKVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08046</td>
      <td>2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide</td>
      <td>JIVPVXMEBJLZRO-AWEZNQCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08035</td>
      <td>1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE</td>
      <td>QUPXEJURIFFVSX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>1r42</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>ACE2 area with important AAs</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08146</td>
      <td>7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine</td>
      <td>QFWNOFXQNCLFBC-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06962</td>
      <td>(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone</td>
      <td>YKTUSHSSKIWDRY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06993</td>
      <td>(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine</td>
      <td>PTAHVQJZNFGPHN-WFWWEWPISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07027</td>
      <td>D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide</td>
      <td>JGZSVYZIJHGHMA-MOPGFXCFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07937</td>
      <td>2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine</td>
      <td>UGZWPZWADDDTRN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07036</td>
      <td>(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol</td>
      <td>GPFRMIHXGMVMGF-BZSNNMDCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07920</td>
      <td>N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide</td>
      <td>OGRPZMQLAVBWPV-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07045</td>
      <td>(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol</td>
      <td>VBJKVZXRYLCYGQ-XNIJJKJLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08100</td>
      <td>2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol</td>
      <td>PAHKYLUYTGBFNW-CMDGGOBGSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07788</td>
      <td>(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE</td>
      <td>NEQZWEXWOFPKOT-QHSZRYGNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08111</td>
      <td>4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol</td>
      <td>ZGJYGQLGSXWEMY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08061</td>
      <td>4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE</td>
      <td>GELALLNTKKLQLM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07063</td>
      <td>{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID</td>
      <td>KYHVTMFADJNSGS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12612</td>
      <td>Ozanimod</td>
      <td>XRVDGNKRPOAQTN-FQEVSTJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06932</td>
      <td>10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine</td>
      <td>NVINUNQBDNEMSY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08660</td>
      <td>1,2,5,8-tetrahydroxyanthracene-9,10-dione</td>
      <td>VBHKTXLEJZIDJF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08657</td>
      <td>2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID</td>
      <td>SSXCWVOQWRUMGN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08580</td>
      <td>4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline</td>
      <td>JEGGWFHNKPRKTO-CQSZACIVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08540</td>
      <td>2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER</td>
      <td>AQJQFCRTSWIUCY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08530</td>
      <td>7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE</td>
      <td>QFSMMXJBEBXTJP-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08514</td>
      <td>6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>IQKMJWDYMFWZRF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07945</td>
      <td>5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid</td>
      <td>GKBQRPKZHUFGOB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08485</td>
      <td>(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID</td>
      <td>QMNMNSINKIFYBV-LMMKCTJWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08470</td>
      <td>3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole</td>
      <td>KMGPJKOKSYGMJD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08179</td>
      <td>methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate</td>
      <td>BLXSEOJIXHWXQJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07962</td>
      <td>METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE</td>
      <td>ZMRRBWRMQPQQAN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12523</td>
      <td>Mizolastine</td>
      <td>PVLJETXTTWAYEW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06588</td>
      <td>Triphendiol</td>
      <td>KQCJZAUNKSGEFM-UNMCSNQZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08307</td>
      <td>2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE</td>
      <td>PMHVFNYNPNKNRO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB07994</td>
      <td>N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>KMBPJSHPAXOXBT-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06620</td>
      <td>Aplindore</td>
      <td>DYJIKHYBKVODAC-ZDUSSCGKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12558</td>
      <td>AEE-788</td>
      <td>OONFNUWBHFSNBT-HXUWFJFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06899</td>
      <td>N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE</td>
      <td>RMEVNJZCKDVVND-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08208</td>
      <td>2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE</td>
      <td>AMNKRBRQQAMACZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06460</td>
      <td>Enrasentan</td>
      <td>GLCKXJLCYIJMRB-UPRLRBBYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB02651</td>
      <td>{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)</td>
      <td>BTAGTGWPDROBMG-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB02647</td>
      <td>N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide</td>
      <td>LUCORKWTQSQFFU-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB04888</td>
      <td>Bifeprunox</td>
      <td>CYGODHVAJQTCBG-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07287</td>
      <td>2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL</td>
      <td>AOVDSWPGWPRTSR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07234</td>
      <td>3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione</td>
      <td>MCBPNFWHHNJTGN-LLVKDONJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07211</td>
      <td>(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE</td>
      <td>YMJHMJLNQLVUAV-GHYUOPHCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07295</td>
      <td>2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID</td>
      <td>IGOULVZYQKJJKC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07198</td>
      <td>5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE</td>
      <td>GGEKOZPXKBYLNK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB13307</td>
      <td>Proscillaridin</td>
      <td>MYEJFUXQJGHEQK-ALRJYLEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07405</td>
      <td>1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</td>
      <td>GIZYIOOBBUHOBS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07154</td>
      <td>(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE</td>
      <td>SWKGZJAAGSVROJ-MWLCHTKSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07146</td>
      <td>2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE</td>
      <td>QUIQCYFSBGOBKE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07278</td>
      <td>2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE</td>
      <td>ACEFOQMQINFMRW-DYCFVMESSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07403</td>
      <td>4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE</td>
      <td>DTDZLJHKVNTQGZ-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07123</td>
      <td>N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE</td>
      <td>DVOLWKZEIDCCES-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07457</td>
      <td>3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE</td>
      <td>APYXQTXFRIDSGE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07469</td>
      <td>(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</td>
      <td>KAJFGRLMKVNMLH-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB13499</td>
      <td>Cefsulodin</td>
      <td>SYLKGLMBLAAGSC-QLVMHMETSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08285</td>
      <td>(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol</td>
      <td>SQUNOCMDMIQIQK-OAHLLOKOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB13606</td>
      <td>Phenazocine</td>
      <td>ZQHYKVKNPWDQSL-KNXBSLHKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB13927</td>
      <td>anle138b</td>
      <td>RCQIIBJSUWYYFU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08300</td>
      <td>1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>UOKGZPYGRJDACN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07540</td>
      <td>4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE</td>
      <td>AKFVRSQELXTCFW-JYRVWZFOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07409</td>
      <td>(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID</td>
      <td>MPBUFKZCEBTBSK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07283</td>
      <td>9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid</td>
      <td>VDOXYKGIKBUISK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07422</td>
      <td>(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide</td>
      <td>MMNRWNREMUMYQG-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB04862</td>
      <td>Merimepodib</td>
      <td>JBPUGFODGPKTDW-SFHVURJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12848</td>
      <td>PF-04217903</td>
      <td>PDMUGYOXRHVNMO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07148</td>
      <td>(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one</td>
      <td>HPAFVLDARQIHPU-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB13003</td>
      <td>Cortivazol</td>
      <td>RKHQGWMMUURILY-UHRZLXHJSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07561</td>
      <td>(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide</td>
      <td>RPILZQUCBKIPAZ-AQTBWJFISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07547</td>
      <td>5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>RYXAHMSZLLIPRO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07534</td>
      <td>4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE</td>
      <td>BKUMVXIXUVYKDQ-GHXNOFRVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07533</td>
      <td>4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE</td>
      <td>FJJJERLTHDXEPT-JYRVWZFOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07522</td>
      <td>N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE</td>
      <td>QSSWSEQPKCCATQ-VQTJNVASSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07456</td>
      <td>3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-QGZVFWFLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07504</td>
      <td>(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol</td>
      <td>MEIJADBULOETOV-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12877</td>
      <td>Oxatomide</td>
      <td>BAINIUMDFURPJM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07489</td>
      <td>4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium</td>
      <td>WWGPTHOMFHDEEC-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07450</td>
      <td>(R)-minalrestat</td>
      <td>BMHZAHGTGIZZCT-LJQANCHMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12988</td>
      <td>LY-518674</td>
      <td>PNHFDVSKDSLUFH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07227</td>
      <td>4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE</td>
      <td>JNUGFGAVPBYSHF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12998</td>
      <td>PF-00217830</td>
      <td>QGNOXTFZOLDODX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12999</td>
      <td>MK-6186</td>
      <td>FZBAOOQVQXATRL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB02615</td>
      <td>Compound 19</td>
      <td>UZOOIPXOYYJULJ-BLIZRMSTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07322</td>
      <td>2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID</td>
      <td>RRXVUYHFDBLTEL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB07290</td>
      <td>(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE</td>
      <td>LUCFRFDOOYLALP-CYBMUJFWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12426</td>
      <td>Bitopertin</td>
      <td>YUUGYIUSCYNSQR-LBPRGKRZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06967</td>
      <td>6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE</td>
      <td>MLSVRCGEBXIIQO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06346</td>
      <td>Fiboflapon</td>
      <td>DFQGDHBGRSTTHX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07917</td>
      <td>4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE</td>
      <td>TZQGXAHOROZEKN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04614</td>
      <td>(R)-tacrine(10)-hupyridone</td>
      <td>ROTFGKJJMRTWBD-HHHXNRCGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12015</td>
      <td>Alpelisib</td>
      <td>STUWGJZDJHPWGZ-LBPRGKRZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12293</td>
      <td>Nefopam</td>
      <td>RGPDEAGGEXEMMM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12275</td>
      <td>Seviteronel</td>
      <td>ZBRAJOQFSNYJMF-SFHVURJKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04652</td>
      <td>Corticosterone</td>
      <td>OMFXVFTZEKFJBZ-HJTSIMOOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12254</td>
      <td>ABT-751</td>
      <td>URCVCIZFVQDVPM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04794</td>
      <td>Bifonazole</td>
      <td>OCAPBUJLXMYKEJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07642</td>
      <td>5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>GYKIQIOWVKCVBP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12443</td>
      <td>Sonedenoson</td>
      <td>WUCQGGOGHZRELS-LSCFUAHRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04796</td>
      <td>Inecalcitol</td>
      <td>HHGRMHMXKPQNGF-WNSNRMDMSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12230</td>
      <td>Bunazosin</td>
      <td>RHLJLALHBZGAFM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12036</td>
      <td>Naquotinib</td>
      <td>QKDCLUARMDUUKN-XMMPIXPASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12204</td>
      <td>Terbogrel</td>
      <td>XUTLOCQNGLJNSA-RGVLZGJSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07651</td>
      <td>N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE</td>
      <td>KPMMESISHWWXNM-ROUUACIJSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12161</td>
      <td>Deutetrabenazine</td>
      <td>MKJIEFSOBYUXJB-WEZHFFAMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07676</td>
      <td>3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one</td>
      <td>CKLAPOFDFZKCPB-LBPRGKRZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12072</td>
      <td>Orantinib</td>
      <td>NHFDRBXTEDBWCZ-ZROIWOOFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12070</td>
      <td>Letermovir</td>
      <td>FWYSMLBETOMXAG-QHCPKHFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12039</td>
      <td>Epicatechin</td>
      <td>PFTAWBLQPZVEMU-UKRRQHHQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12233</td>
      <td>Iguratimod</td>
      <td>ANMATWQYLIFGOK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB11990</td>
      <td>MK-0812</td>
      <td>UNVWTBOGMHPKJM-CWKRKGSWSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11995</td>
      <td>Avatrombopag</td>
      <td>OFZJKCQENFPZBH-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04194</td>
      <td>Chitotriose</td>
      <td>WZZVUHWLNMNWLW-VFCSDQTKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13132</td>
      <td>Artemisinin</td>
      <td>BLUAFEHZUWYNDE-NNWCWBAJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13125</td>
      <td>Lusutrombopag</td>
      <td>NOZIJMHMKORZBA-KJCUYJGMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB03507</td>
      <td>6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One</td>
      <td>UXGUZFZBZPPZGL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07459</td>
      <td>4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE</td>
      <td>HVLSCZSVTCNAQX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13083</td>
      <td>Talarozole</td>
      <td>SNFYYXUGUBUECJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB03598</td>
      <td>Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]</td>
      <td>XSUAVPPTKHUTDX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11844</td>
      <td>Pritelivir</td>
      <td>IVZKZONQVYTCKC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11878</td>
      <td>Filibuvir</td>
      <td>SLVAPEZTBDBAPI-GDLZYMKVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07793</td>
      <td>(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE</td>
      <td>ACSGSLPOHKRZCY-GXTWGEPZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12545</td>
      <td>Indobufen</td>
      <td>AYDXAULLCROVIT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12921</td>
      <td>Chlorsulfaquinoxaline</td>
      <td>CTSNHMQGVWXIEG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12896</td>
      <td>PSI-352938</td>
      <td>PVRFQJIRERYGTQ-DSQUMVBZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04022</td>
      <td>Guanosine-5',3'-Tetraphosphate</td>
      <td>BUFLLCUFNHESEH-UUOKFMHZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB07514</td>
      <td>3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one</td>
      <td>LHLGUOHREUTYTO-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12846</td>
      <td>Reproterol</td>
      <td>WVLAAKXASPCBGT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04038</td>
      <td>Ergosterol</td>
      <td>DNVPQKQSNYMLRS-APGDWVJJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04097</td>
      <td>Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose</td>
      <td>OAPPZHVTNHJVAL-JZMIEXBBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12774</td>
      <td>AZD-8055</td>
      <td>KVLFRAWTRWDEDF-IRXDYDNUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11978</td>
      <td>Glasdegib</td>
      <td>SFNSLLSYNZWZQG-VQIMIIECSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB12675</td>
      <td>PF-04995274</td>
      <td>WLLOFQROROXOMO-GOSISDBHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04014</td>
      <td>Alsterpaullone</td>
      <td>OLUKILHGKRVDCT-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB11966</td>
      <td>BMS-986094</td>
      <td>YFXGICNMLCGLHJ-RSKRLRQZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB11961</td>
      <td>AZD-1236</td>
      <td>SFJFBTPHDHUUPU-OAHLLOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12050</td>
      <td>LY-3039478</td>
      <td>YCBAQKQAINQRFW-UGSOOPFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB09201</td>
      <td>Ciglitazone</td>
      <td>YZFWTZACSRHJQD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07839</td>
      <td>N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE</td>
      <td>VFNWTXUFNNOQHD-QFIPXVFZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB05532</td>
      <td>BMS-488043</td>
      <td>DBPMWRYLTBNCCE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB09179</td>
      <td>R-30490</td>
      <td>GARXJOUQUSNOGK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB09173</td>
      <td>Butyrfentanyl</td>
      <td>QQOMYEQLWQJRKK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08990</td>
      <td>Eprazinone</td>
      <td>BSHWLCACYCVCJE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12361</td>
      <td>Piclozotan</td>
      <td>URMTUEWUIGOJBW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB07872</td>
      <td>5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide</td>
      <td>IYGIXVNAMZPBDK-CQSZACIVSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB05738</td>
      <td>Vapitadine</td>
      <td>VQWGYPVNVICKFC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB09262</td>
      <td>Imidafenacin</td>
      <td>SQKXYSGRELMAAU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08873</td>
      <td>Boceprevir</td>
      <td>LHHCSNFAOIFYRV-DOVBMPENSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12388</td>
      <td>Evocalcet</td>
      <td>RZNUIYPHQFXBAN-XLIONFOSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06235</td>
      <td>Vadimezan</td>
      <td>XGOYIMQSIKSOBS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08761</td>
      <td>(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione</td>
      <td>NGPCLOGFGKJCBP-HOTGVXAUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06274</td>
      <td>Alvimopan</td>
      <td>UPNUIXSCZBYVBB-JVFUWBCBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08743</td>
      <td>2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE</td>
      <td>XJNKUWDMCBZMTG-OAHLLOKOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08736</td>
      <td>S,R-Warfarin alcohol</td>
      <td>ZUJMMGHIYSAEOU-DOMZBBRYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07638</td>
      <td>(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</td>
      <td>QJSMFUTULGSHNQ-ZOBUZTSGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08702</td>
      <td>2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID</td>
      <td>QPKYPOMZPFDBEZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12410</td>
      <td>Sabarubicin</td>
      <td>VQHRZZISQVWPLK-UIRGBLDSSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB06157</td>
      <td>Istaroxime</td>
      <td>MPYLDWFDPHRTEG-PAAYLBSLSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB09274</td>
      <td>Artesunate</td>
      <td>FIHJKUPKCHIPAT-AHIGJZGOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB09285</td>
      <td>Morniflumate</td>
      <td>LDXSPUSKBDTEKA-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12325</td>
      <td>Idasanutlin</td>
      <td>TVTXCJFHQKSQQM-LJQIRTBHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12064</td>
      <td>BMS-777607</td>
      <td>VNBRGSXVFBYQNN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07728</td>
      <td>2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>XJJYJNMNYDNXNO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04885</td>
      <td>Cilansetron</td>
      <td>NCNFDKWULDWJDS-OAHLLOKOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04898</td>
      <td>Ximelagatran</td>
      <td>ZXIBCJHYVWYIKI-PZJWPPBQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12114</td>
      <td>Poziotinib</td>
      <td>LPFWVDIFUFFKJU-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12128</td>
      <td>Ulimorelin</td>
      <td>WGYPAJVJMXQXTR-ABNZCKJZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB04983</td>
      <td>Denufosol</td>
      <td>FPNPSEMJLALQSA-MIYUEGBISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB11774</td>
      <td>Pazufloxacin</td>
      <td>XAGMUUZPGZWTRP-ZETCQYMHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB11764</td>
      <td>Spebrutinib</td>
      <td>KXBDTLQSDKGAEB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB11763</td>
      <td>Momelotinib</td>
      <td>ZVHNDZWQTBEVRY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB05016</td>
      <td>Ataluren</td>
      <td>OOUGLTULBSNHNF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB11739</td>
      <td>Vonoprazan</td>
      <td>BFDBKMOZYNOTPK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB11721</td>
      <td>Mitoglitazone</td>
      <td>IRNJSRAGRIZIHD-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12149</td>
      <td>S-3304</td>
      <td>YWCLDDLVLSQGSZ-JOCHJYFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07779</td>
      <td>N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE</td>
      <td>ANQHSFFUNMTTRS-MOPGFXCFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB05105</td>
      <td>Pleconaril</td>
      <td>KQOXLKOJHVFTRN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12198</td>
      <td>Fosdagrocorat</td>
      <td>BVXLAHSJXXSWFF-KEKPKEOLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07787</td>
      <td>5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE</td>
      <td>PNPFDRCIGCUCMN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12289</td>
      <td>Darexaban</td>
      <td>IJNIQYINMSGIPS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB09488</td>
      <td>Acrivastine</td>
      <td>PWACSDKDOHSSQD-IUTFFREVSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB12306</td>
      <td>Cipargamin</td>
      <td>CKLPLPZSUQEDRT-WPCRTTGESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB08670</td>
      <td>METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE</td>
      <td>WIWZNHHLFMPGGO-PIKADFDJSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06899</td>
      <td>N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE</td>
      <td>RMEVNJZCKDVVND-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06873</td>
      <td>1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE</td>
      <td>CSXNPJKDZKLDET-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06870</td>
      <td>17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE</td>
      <td>OXHNQTSIKGHVBH-ANULTFPQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01588</td>
      <td>Prazepam</td>
      <td>MWQCHHACWWAQLJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01535</td>
      <td>Carfentanil</td>
      <td>YDSDEBIZUNNPOB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01497</td>
      <td>Etorphine</td>
      <td>CAHCBJPUTCKATP-HBDRVVKHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01450</td>
      <td>Dihydroetorphine</td>
      <td>BRTSNYPDACNMIP-FAWZKKEFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB06590</td>
      <td>Ceftaroline fosamil</td>
      <td>ZCCUWMICIWSJIX-NQJJCJBVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01393</td>
      <td>Bezafibrate</td>
      <td>IIBYAHWJQTYFKB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08561</td>
      <td>BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE</td>
      <td>PLBINCOCFGQAJM-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01238</td>
      <td>Aripiprazole</td>
      <td>CEUORZQYGODEFX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB08912</td>
      <td>Dabrafenib</td>
      <td>BFSMGDJOXZAERB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08519</td>
      <td>N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>SQQAPOSROFWHIB-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01215</td>
      <td>Estazolam</td>
      <td>CDCHDCWJMGXXRH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01183</td>
      <td>Naloxone</td>
      <td>UZHSEJADLWPNLE-GRGSLBFTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01165</td>
      <td>Ofloxacin</td>
      <td>GSDSWSVVBLHKDQ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08572</td>
      <td>4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE</td>
      <td>YBKLJTXDSBEVRV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08582</td>
      <td>N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide</td>
      <td>DELARNBPJXTDBD-IYBDPMFKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01059</td>
      <td>Norfloxacin</td>
      <td>OGJPXUAPXNRGGI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00991</td>
      <td>Oxaprozin</td>
      <td>OFPXSFXSNFPTHF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB00490</td>
      <td>Buspirone</td>
      <td>QWCRAEMEVRGPNT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00969</td>
      <td>Alosetron</td>
      <td>JSWZEAMFRNKZNL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00962</td>
      <td>Zaleplon</td>
      <td>HUNXMJYCHXQEGX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08930</td>
      <td>Dolutegravir</td>
      <td>RHWKPHLQXYSBKR-BMIGLBTASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08980</td>
      <td>Fendiline</td>
      <td>NMKSAYKQLCHXDK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08833</td>
      <td>Taurochenodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-BJLOMENOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08513</td>
      <td>[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID</td>
      <td>PAIQRYUOBBCBSE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02427</td>
      <td>2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline</td>
      <td>YBJANOUTWRTBDK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02367</td>
      <td>(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine</td>
      <td>ULDXUWXTVRRUND-SWLSCSKDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB15396</td>
      <td>PF-114</td>
      <td>SLIVDYMORZGPLW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02363</td>
      <td>2'-Monophosphoadenosine-5'-Diphosphate</td>
      <td>YPTPYQSAVGGMFN-KQYNXXCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08233</td>
      <td>6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE</td>
      <td>RFSDQDHHBKYQOD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02307</td>
      <td>N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine</td>
      <td>FOJUHLDAXGNCIP-FHWLQOOXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB15407</td>
      <td>Acalisib</td>
      <td>DOCINCLJNAXZQF-LBPRGKRZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02205</td>
      <td>6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One</td>
      <td>JCDLLLXYAICSQV-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB04760</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)</td>
      <td>PYFRREJCFXFNRR-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01622</td>
      <td>Thioproperazine</td>
      <td>VZYCZNZBPPHOFY-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02082</td>
      <td>Phosphoaminophosphonic Acid Guanylate Ester</td>
      <td>UQABYHGXWYXDTK-UUOKFMHZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08345</td>
      <td>4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>IWUUKHQIKFHWIW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB04759</td>
      <td>PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)</td>
      <td>GTBUZLPQANSGGE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02014</td>
      <td>5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid</td>
      <td>QKHWJUMLYAYZFS-ONEGZZNKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01960</td>
      <td>7n-Methyl-8-Hydroguanosine-5'-Diphosphate</td>
      <td>QQODJOAVWUWVHJ-KQYNXXCUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB15435</td>
      <td>BMS-986158</td>
      <td>KGERZPVQIRYWRK-GDLZYMKVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB06809</td>
      <td>Plerixafor</td>
      <td>YIQPUIGJQJDJOS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB00153</td>
      <td>Ergocalciferol</td>
      <td>MECHNRXZTMCUDQ-RKHKHRCZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB01720</td>
      <td>(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid</td>
      <td>WLPJLQNKCJWAFL-RGEXLXHISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB00213</td>
      <td>Pantoprazole</td>
      <td>IQPSEEYGBUAQFF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02071</td>
      <td>WAY-151693</td>
      <td>AINJYWXKBKRQSX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB00496</td>
      <td>Darifenacin</td>
      <td>HXGBXQDTNZMWGS-RUZDIDTESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00842</td>
      <td>Oxazepam</td>
      <td>ADIMAYPTOBDMTL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00839</td>
      <td>Tolazamide</td>
      <td>OUDSBRTVNLOZBN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00425</td>
      <td>Zolpidem</td>
      <td>ZAFYATHCZYHLPB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB09073</td>
      <td>Palbociclib</td>
      <td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB09079</td>
      <td>Nintedanib</td>
      <td>XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB09079</td>
      <td>Nintedanib</td>
      <td>XZXHXSATPCNXJR-ZIADKAODSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00348</td>
      <td>Nitisinone</td>
      <td>OUBCNLGXQFSTLU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08878</td>
      <td>Aminopterin</td>
      <td>TVZGACDUOSZQKY-LBPRGKRZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00328</td>
      <td>Indometacin</td>
      <td>CGIGDMFJXJATDK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00298</td>
      <td>Dapiprazole</td>
      <td>RFWZESUMWJKKRN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00229</td>
      <td>Cefotiam</td>
      <td>QYQDKDWGWDOFFU-IUODEOHRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08860</td>
      <td>Pitavastatin</td>
      <td>VGYFMXBACGZSIL-MCBHFWOFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08915</td>
      <td>Aleglitazar</td>
      <td>DAYKLWSKQJBGCS-NRFANRHFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB09166</td>
      <td>Etizolam</td>
      <td>VMZUTJCNQWMAGF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB15325</td>
      <td>ONO-8539</td>
      <td>ALLLQQUASFFEKP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB15316</td>
      <td>Florasulam</td>
      <td>QZXATCCPQKOEIH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB15246</td>
      <td>Salvianolic acid A</td>
      <td>YMGFTDKNIWPMGF-UCPJVGPRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB15204</td>
      <td>Fosravuconazole</td>
      <td>SYTNEMZCCLUTNX-NPMXOYFQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB15170</td>
      <td>Evobrutinib</td>
      <td>QUIWHXQETADMGN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB06272</td>
      <td>Maxacalcitol</td>
      <td>DTXXSJZBSTYZKE-ZDQKKZTESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB00901</td>
      <td>Bitolterol</td>
      <td>FZGVEKPRDOIXJY-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB15449</td>
      <td>Citarinostat</td>
      <td>VLIUIBXPEDFJRF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08820</td>
      <td>Ivacaftor</td>
      <td>PURKAOJPTOLRMP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08794</td>
      <td>Ethyl biscoumacetate</td>
      <td>JCLHQFUTFHUXNN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00486</td>
      <td>Nabilone</td>
      <td>GECBBEABIDMGGL-RTBURBONSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00817</td>
      <td>Rosoxacin</td>
      <td>XBPZXDSZHPDXQU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08701</td>
      <td>2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE</td>
      <td>JZCUVYNOSDWORZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB02388</td>
      <td>Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine</td>
      <td>UQFRSHRWRKYNDE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00808</td>
      <td>Indapamide</td>
      <td>NDDAHWYSQHTHNT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08705</td>
      <td>6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE</td>
      <td>SVSYJTYGPLVUOZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08742</td>
      <td>1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)</td>
      <td>CEEUUHVULXTFGS-BQXVGYHGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00701</td>
      <td>Amprenavir</td>
      <td>YMARZQAQMVYCKC-OEMFJLHTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB00497</td>
      <td>Oxycodone</td>
      <td>BRUQQQPBMZOVGD-XFKAJCMBSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00674</td>
      <td>Galantamine</td>
      <td>ASUTZQLVASHGKV-JDFRZJQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00665</td>
      <td>Nilutamide</td>
      <td>XWXYUMMDTVBTOU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00643</td>
      <td>Mebendazole</td>
      <td>OPXLLQIJSORQAM-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00613</td>
      <td>Amodiaquine</td>
      <td>OVCDSSHSILBFBN-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB09017</td>
      <td>Brotizolam</td>
      <td>UMSGKTJDUHERQW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06875</td>
      <td>3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE</td>
      <td>NSSOSHDCWCMNDM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB09020</td>
      <td>Bisacodyl</td>
      <td>KHOITXIGCFIULA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00587</td>
      <td>Cinalukast</td>
      <td>BZMKNPGKXJAIDV-VAWYXSNFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB00578</td>
      <td>Carbenicillin</td>
      <td>FPPNZSSZRUTDAP-UWFZAAFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB09034</td>
      <td>Suvorexant</td>
      <td>JYTNQNCOQXFQPK-MRXNPFEDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB04724</td>
      <td>(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE</td>
      <td>COVPLULNDBDXTN-KYJUHHDHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB09042</td>
      <td>Tedizolid phosphate</td>
      <td>QCGUSIANLFXSGE-GFCCVEGCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08761</td>
      <td>(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione</td>
      <td>NGPCLOGFGKJCBP-HOTGVXAUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08153</td>
      <td>(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE</td>
      <td>VZTAZMSAAIUZJV-HWKANZROSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02559</td>
      <td>6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine</td>
      <td>HDQIGGQUKAQTGU-SZTTVXCBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08095</td>
      <td>3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA</td>
      <td>ZWYFTKPEHRQCCW-HNNXBMFYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02596</td>
      <td>Alpha,Beta-Methyleneadenosine-5'-Triphosphate</td>
      <td>CAWZRIXWFRFUQB-IOSLPCCCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB05482</td>
      <td>7-ethyl-10-hydroxycamptothecin</td>
      <td>FJHBVJOVLFPMQE-QFIPXVFZSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB05421</td>
      <td>CP-122721</td>
      <td>ZIWFCOIGUNPHPM-HKUYNNGSSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB14878</td>
      <td>Liafensine</td>
      <td>VCIBGDSRPUOBOG-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07776</td>
      <td>Flavone</td>
      <td>VHBFFQKBGNRLFZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB05035</td>
      <td>Eprotirome</td>
      <td>VPCSYAVXDAUHLT-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB05015</td>
      <td>Belinostat</td>
      <td>NCNRHFGMJRPRSK-MDZDMXLPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08489</td>
      <td>N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE</td>
      <td>GCBPAPVOMPJQHK-NQIIRXRSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07783</td>
      <td>1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>GUYYFMCFEPDDFL-OAQYLSRUSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB04960</td>
      <td>Tipifarnib</td>
      <td>PLHJCIYEEKOWNM-HHHXNRCGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08463</td>
      <td>(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol</td>
      <td>HOCBJBNQIQQQGT-LJQANCHMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08500</td>
      <td>(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</td>
      <td>ZCJBDRSKHARECB-PYTCMNEWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07261</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE</td>
      <td>NVKDOURNRJCKJE-INIZCTEOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB04833</td>
      <td>Methaqualone</td>
      <td>JEYCTXHKTXCGPB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB14935</td>
      <td>Serabelisib</td>
      <td>BLGWHBSBBJNKJO-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB14942</td>
      <td>BMS-986141</td>
      <td>KEEBLYWBELVGPQ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB04772</td>
      <td>1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE</td>
      <td>DSVCYWOHJLRGMK-PMACEKPBSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB04768</td>
      <td>Pyrithiamine Pyrophosphate</td>
      <td>ZHKSTKOYQKNDSJ-UHFFFAOYSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB04750</td>
      <td>OREGON GREEN 488 CARBOXYLATE</td>
      <td>BRJCLSQFZSHLRL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB08531</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CVYWYUAQFJMLEO-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08531</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CVYWYUAQFJMLEO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB08504</td>
      <td>6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM</td>
      <td>ZNHVIJAGMFQGMS-IHPCNDPISA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB05695</td>
      <td>NPS-2143</td>
      <td>PZUJQWHTIRWCID-HXUWFJFHSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07333</td>
      <td>N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE</td>
      <td>KRGKAARWVPUWSY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07702</td>
      <td>17alpha-Estriol</td>
      <td>PROQIPRRNZUXQM-PNVOZDDCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06866</td>
      <td>6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID</td>
      <td>NMOUMGFCBOWPAB-RZUBCFFCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06834</td>
      <td>N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide</td>
      <td>XZRYCTLOGNCQDG-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06766</td>
      <td>Alcaftadine</td>
      <td>MWTBKTRZPHJQLH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06685</td>
      <td>Laquinimod</td>
      <td>GKWPCEFFIHSJOE-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB13993</td>
      <td>MRK-409</td>
      <td>GOIFCXRIFSYPFG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07612</td>
      <td>6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE</td>
      <td>XQKJVNGGVLHNLA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07638</td>
      <td>(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</td>
      <td>QJSMFUTULGSHNQ-ZOBUZTSGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06471</td>
      <td>Naxifylline</td>
      <td>NJYNSYQBNSDGIQ-RDDCQWBRSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07643</td>
      <td>5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>XVLUVRFYGVJKGJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06313</td>
      <td>BNC105</td>
      <td>MYDHDVLPMRNDAZ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB14029</td>
      <td>Furafylline</td>
      <td>HMZQULPVMKITSP-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06266</td>
      <td>Lonidamine</td>
      <td>WDRYRZXSPDWGEB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB14217</td>
      <td>Quinaprilat</td>
      <td>FLSLEGPOVLMJMN-YSSFQJQWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06207</td>
      <td>Silodosin</td>
      <td>PNCPYILNMDWPEY-QGZVFWFLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08429</td>
      <td>N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide</td>
      <td>QRGBOABBMKYMLG-UXHICEINSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06153</td>
      <td>Pizotifen</td>
      <td>FIADGNVRKBPQEU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB06133</td>
      <td>Dimethylcurcumin</td>
      <td>ZMGUKFHHNQMKJI-CIOHCNBKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07362</td>
      <td>1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>UOLCZAFAGDOUFX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB00783</td>
      <td>Estradiol</td>
      <td>VOXZDWNPVJITMN-ZBRFXRBCSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07360</td>
      <td>1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>JJHXPDTVQKWKHA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08534</td>
      <td>5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>ZAIYYXVHGBMLEC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13317</td>
      <td>Flunoxaprofen</td>
      <td>ARPYQKTVRGFPIS-VIFPVBQESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB08538</td>
      <td>N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>HQPVGVSQPQVZLD-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07816</td>
      <td>N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID</td>
      <td>KGHMYJFHUHFOGL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB08683</td>
      <td>REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE</td>
      <td>OTPNDVKVEAIXTI-IYBDPMFKSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07988</td>
      <td>2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE</td>
      <td>HZAXNPDJVFUGDS-BYPYZUCNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03124</td>
      <td>5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid</td>
      <td>LBAHOXPDTNUYCX-INIZCTEOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03121</td>
      <td>(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid</td>
      <td>ZEKCBTQHDTUHRJ-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08001</td>
      <td>5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID</td>
      <td>DQSRCEFDWMQCCV-GQCTYLIASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03039</td>
      <td>4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide</td>
      <td>KEGUALXMKQVDIO-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03010</td>
      <td>Patupilone</td>
      <td>QXRSDHAAWVKZLJ-PVYNADRNSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB06908</td>
      <td>(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID</td>
      <td>PAWOPJKHTZCKMT-QFIPXVFZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08042</td>
      <td>N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>FLXGQDHYCWXTAI-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB15187</td>
      <td>Dubermatinib</td>
      <td>YUAALFPUEOYPNX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB06907</td>
      <td>2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID</td>
      <td>XVNRKPCHMYOPPL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB08706</td>
      <td>(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID</td>
      <td>RNEACARJKXYVND-MZLJFPOFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02848</td>
      <td>{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol</td>
      <td>ZJESXGUODSBHSK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08056</td>
      <td>N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine</td>
      <td>KKYYLKPGILUPOA-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02833</td>
      <td>[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine</td>
      <td>DYTKVFHLKPDNRW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02812</td>
      <td>(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide</td>
      <td>VXDAVYUFYPFGDX-SNPRPXQTSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB15346</td>
      <td>GLPG-1205</td>
      <td>IRBAWVGZNJIROV-SFHVURJKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02766</td>
      <td>(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium</td>
      <td>VLIGBVLLNSWVMI-MRXNPFEDSA-O</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02666</td>
      <td>(C8-R)-Hydantocidin 5'-Phosphate</td>
      <td>MAXSFYCTFIBEAR-OJMIUMIFSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02611</td>
      <td>Balanol Analog 1</td>
      <td>FZJQHARRQUNVGZ-QZTJIDSGSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB02887</td>
      <td>2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate</td>
      <td>ODSQODTUNULBHF-JGVFFNPUSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07983</td>
      <td>1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID</td>
      <td>CXBFZYKAVCAPSV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03247</td>
      <td>Flavin mononucleotide</td>
      <td>FVTCRASFADXXNN-SCRDCRAPSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07831</td>
      <td>2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE</td>
      <td>SHSORWZDEKFFLP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07834</td>
      <td>N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide</td>
      <td>FOHZGCHKLPIBBX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07249</td>
      <td>N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine</td>
      <td>QHIMVPIOWKYPSO-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB15031</td>
      <td>Nemorexant</td>
      <td>NBGABHGMJVIVBW-QHCPKHFHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB04460</td>
      <td>(C8-S)-Hydantocidin 5'-Phosphate</td>
      <td>MAXSFYCTFIBEAR-FUIMDIGMSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB04430</td>
      <td>3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile</td>
      <td>FLPLCJJGNZGOAW-QXMHVHEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07204</td>
      <td>(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</td>
      <td>DQIXTEDFNFZMCM-SFHVURJKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07872</td>
      <td>5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide</td>
      <td>IYGIXVNAMZPBDK-CQSZACIVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB04215</td>
      <td>CRA_9076</td>
      <td>BVTBOJXEAPSOEB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07882</td>
      <td>4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID</td>
      <td>VFIZFTGABDUGCF-UPVHCHBVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03987</td>
      <td>2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine</td>
      <td>XWCCXDBXMCTZPW-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07072</td>
      <td>(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</td>
      <td>CNKRZILQBKJWDS-WMFXKJRFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03980</td>
      <td>4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole</td>
      <td>DFEYXQGDDCDXJK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB02505</td>
      <td>N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)</td>
      <td>JJVQUUYZGJWBPW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB07949</td>
      <td>({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID</td>
      <td>BFQRPTKOSYMPOL-LALPNIDTSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03656</td>
      <td>Tribenuron Methyl</td>
      <td>VLCQZHSMCYCDJL-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03626</td>
      <td>5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione</td>
      <td>JRPJCFILHCLEJI-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB02498</td>
      <td>Carba-Nicotinamide-Adenine-Dinucleotide</td>
      <td>DGPLSUKWXXSBCU-VGXGLJSLSA-O</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03472</td>
      <td>Cyclohexyl-Hexyl-Beta-D-Maltoside</td>
      <td>WUCWJXGMSXTDAV-QKMCSOCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03467</td>
      <td>Naringenin</td>
      <td>FTVWIRXFELQLPI-ZDUSSCGKSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB03376</td>
      <td>'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine</td>
      <td>CWWYMWDIYBJVLP-YTMOPEAISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07250</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>HMKLUOPMOJOUDZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB15071</td>
      <td>Omidenepag isopropyl</td>
      <td>VIQCWEGEHRBLAC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13333</td>
      <td>Efloxate</td>
      <td>ZVXBAHLOGZCFTP-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11824</td>
      <td>Tofogliflozin</td>
      <td>VWVKUNOPTJGDOB-BDHVOXNPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12705</td>
      <td>Cenerimod</td>
      <td>KJKKMMMRWISKRF-FQEVSTJZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12725</td>
      <td>TD-8954</td>
      <td>MZOITCJKGUIQEI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12744</td>
      <td>CGI-1842</td>
      <td>ZXBFYBLSJMEBEP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08834</td>
      <td>Tauroursodeoxycholic acid</td>
      <td>BHTRKEVKTKCXOH-LBSADWJPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12781</td>
      <td>Balaglitazone</td>
      <td>IETKPTYAGKZLKY-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12794</td>
      <td>p-Quaterphenyl</td>
      <td>GPRIERYVMZVKTC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12796</td>
      <td>MRX-I</td>
      <td>SULYVXZZUMRQAX-NSHDSACASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06721</td>
      <td>Gimatecan</td>
      <td>UIVFUQKYVFCEKJ-OPTOVBNMSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB05932</td>
      <td>Denibulin</td>
      <td>GAOHLWCIAJNSEE-JTQLQIEISA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB14676</td>
      <td>Fagrocorat</td>
      <td>QJJBNCHSWFGXML-KEKPKEOLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB13791</td>
      <td>Penfluridol</td>
      <td>MDLAAYDRRZXJIF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12857</td>
      <td>NVP-LEQ-506</td>
      <td>POERAARDVFVDLO-QGZVFWFLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07528</td>
      <td>3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one</td>
      <td>HXUZQEYFKAZBPX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB03337</td>
      <td>1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea</td>
      <td>ZHCAYBOLUMAUQX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08739</td>
      <td>2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione</td>
      <td>ZSXNPAWXICXNGZ-HNNXBMFYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08738</td>
      <td>1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one</td>
      <td>KWCKZIJGKMCYCI-QFIPXVFZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB13499</td>
      <td>Cefsulodin</td>
      <td>SYLKGLMBLAAGSC-QLVMHMETSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB13685</td>
      <td>Quingestanol</td>
      <td>PCJFRMOEZQQSAX-AIOSZGMZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB13791</td>
      <td>Penfluridol</td>
      <td>MDLAAYDRRZXJIF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07783</td>
      <td>1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>GUYYFMCFEPDDFL-OAQYLSRUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12832</td>
      <td>Prednimustine</td>
      <td>HFVNWDWLWUCIHC-GUPDPFMOSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB13939</td>
      <td>RAD-140</td>
      <td>XMBUPPIEVAFYHO-KPZWWZAWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07456</td>
      <td>3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione</td>
      <td>LBFDERUQORUFIN-QGZVFWFLSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB14725</td>
      <td>Cefamandole nafate</td>
      <td>RRJHESVQVSRQEX-SUYBPPKGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB15273</td>
      <td>VS-4718</td>
      <td>IGUBBWJDMLCRIK-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12477</td>
      <td>Perfluoro tert-butylcyclohexane</td>
      <td>VLTXBOGHSBHSAC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB15266</td>
      <td>TAK-580</td>
      <td>VWMJHAFYPMOMGF-ZCFIWIBFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB15257</td>
      <td>Milademetan</td>
      <td>RYAYYVTWKAOAJF-QISPRATLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB15254</td>
      <td>RO-5126766 free base</td>
      <td>LMMJFBMMJUMSJS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12479</td>
      <td>Zabofloxacin</td>
      <td>ZNPOCLHDJCAZAH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06652</td>
      <td>Vicriviroc</td>
      <td>CNPVJJQCETWNEU-CYFREDJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB15192</td>
      <td>ABT-288</td>
      <td>GNIRITULTPTAQW-KNQAVFIVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB15190</td>
      <td>GLPG-0259</td>
      <td>YBFGSJUVEOYPIS-OALUTQOASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB14723</td>
      <td>Larotrectinib</td>
      <td>NYNZQNWKBKUAII-KBXCAEBGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB15189</td>
      <td>Birabresib</td>
      <td>GNMUEVRJHCWKTO-FQEVSTJZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB15137</td>
      <td>VK-2809</td>
      <td>LGGPZDRLTDGYSQ-JADSYQMUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12523</td>
      <td>Mizolastine</td>
      <td>PVLJETXTTWAYEW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07405</td>
      <td>1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE</td>
      <td>GIZYIOOBBUHOBS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12597</td>
      <td>ABL-001</td>
      <td>VOVZXURTCKPRDQ-CQSZACIVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07434</td>
      <td>HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE</td>
      <td>TZWQPWGUQCSKDW-GUYCJALGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB14889</td>
      <td>Derazantinib</td>
      <td>KPJDVVCDVBFRMU-AREMUKBSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12658</td>
      <td>AFN-1252</td>
      <td>QXTWSUQCXCWEHF-JXMROGBWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12500</td>
      <td>Fedratinib</td>
      <td>JOOXLOJCABQBSG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12854</td>
      <td>BMS-908662</td>
      <td>MMNNTJYFHUDSKL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12848</td>
      <td>PF-04217903</td>
      <td>PDMUGYOXRHVNMO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB13953</td>
      <td>Estradiol benzoate</td>
      <td>UYIFTLBWAOGQBI-BZDYCCQFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12116</td>
      <td>Epigallocatechin gallate</td>
      <td>WMBWREPUVVBILR-WIYYLYMNSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12002</td>
      <td>AZD-4818</td>
      <td>HVTUHSABWJPWNK-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB11987</td>
      <td>GSK-2018682</td>
      <td>NFIGDBFIDKDNIG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08607</td>
      <td>(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE</td>
      <td>GXPHKUHSUJUWKP-NTKDMRAZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07832</td>
      <td>4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde</td>
      <td>VKQPTVJDZIILPG-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB11943</td>
      <td>Delafloxacin</td>
      <td>DYDCPNMLZGFQTM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB14929</td>
      <td>Elsulfavirine</td>
      <td>ULTDEARCBRNRGR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07936</td>
      <td>N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine</td>
      <td>BACSZMCLZIDTIO-IBGZPJMESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB11818</td>
      <td>Retosiban</td>
      <td>PLVGDGRBPMVYPB-FDUHJNRSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12130</td>
      <td>Lorlatinib</td>
      <td>IIXWYSCJSQVBQM-LLVKDONJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB11796</td>
      <td>Fostemsavir</td>
      <td>SWMDAPWAQQTBOG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB11769</td>
      <td>Funapide</td>
      <td>NEBUOXBYNAHKFV-NRFANRHFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB15031</td>
      <td>Nemorexant</td>
      <td>NBGABHGMJVIVBW-QHCPKHFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08542</td>
      <td>3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione</td>
      <td>YUHVBHDSVLKFNI-NJSLBKSFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06888</td>
      <td>(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE</td>
      <td>KBLPHMRCKHFBJB-OLZOCXBDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08534</td>
      <td>5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>ZAIYYXVHGBMLEC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB11275</td>
      <td>Epicriptine</td>
      <td>SBFXHXZNBNFPHV-PXXBSISHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07991</td>
      <td>N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE</td>
      <td>APLJSSOXDWUNGV-GOSISDBHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB11176</td>
      <td>Zeaxanthin</td>
      <td>JKQXZKUSFCKOGQ-QAYBQHTQSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB09231</td>
      <td>Benidipine</td>
      <td>QZVNQOLPLYWLHQ-ZEQKJWHPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB15009</td>
      <td>PF-04937319</td>
      <td>MASKQITXHVYVFL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12141</td>
      <td>Gilteritinib</td>
      <td>GYQYAJJFPNQOOW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB00430</td>
      <td>Cefpiramide</td>
      <td>PWAUCHMQEXVFJR-PMAPCBKXSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06847</td>
      <td>5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>YYCPXVRHQUEVAW-CQSZACIVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12706</td>
      <td>Seletalisib</td>
      <td>LNLJHGXOFYUARS-OAQYLSRUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12635</td>
      <td>Aleplasinin</td>
      <td>HSXLMAFNWCSZGP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12588</td>
      <td>AZD-1480</td>
      <td>PDOQBOJDRPLBQU-QMMMGPOBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12535</td>
      <td>AC-430</td>
      <td>DCRWIATZWHLIPN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12522</td>
      <td>Toreforant</td>
      <td>FCRFVPZAXGJLPW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12491</td>
      <td>Fasiglifam</td>
      <td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12474</td>
      <td>Lynestrenol</td>
      <td>YNVGQYHLRCDXFQ-XGXHKTLJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB14029</td>
      <td>Furafylline</td>
      <td>HMZQULPVMKITSP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07811</td>
      <td>N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide</td>
      <td>UBVTVSINEVHYSY-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07817</td>
      <td>1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea</td>
      <td>NJPVZSIGDRLLTD-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB14581</td>
      <td>CPI-1205</td>
      <td>HPODOLXTMDHLLC-QGZVFWFLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12339</td>
      <td>Radezolid</td>
      <td>BTTNOGHPGJANSW-IBGZPJMESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB14625</td>
      <td>Meprednisone acetate</td>
      <td>RZAMUHXEOMZXET-ABQXZQTJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06831</td>
      <td>2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE</td>
      <td>UMMYTDJYDSTEMB-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12297</td>
      <td>GLPG-0187</td>
      <td>CXHCNOMGODVIKB-VWLOTQADSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12272</td>
      <td>Vidupiprant</td>
      <td>PFWVGKROPKKEDW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12222</td>
      <td>Lurtotecan</td>
      <td>RVFGKBWWUQOIOU-NDEPHWFRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12207</td>
      <td>Verdinexor</td>
      <td>OPAKEJZFFCECPN-XQRVVYSFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB15282</td>
      <td>Fluorofuranylnorprogesterone F-18</td>
      <td>VJKRBRUNEOHPBS-JQKUZGBFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08521</td>
      <td>4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE</td>
      <td>CDMGBJANTYXAIV-HHHXNRCGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12465</td>
      <td>Ketanserin</td>
      <td>FPCCSQOGAWCVBH-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB05959</td>
      <td>ENMD-1198</td>
      <td>YQJWOUQGXATDAE-ACNBBOPNSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB05482</td>
      <td>7-ethyl-10-hydroxycamptothecin</td>
      <td>FJHBVJOVLFPMQE-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB09209</td>
      <td>Pholcodine</td>
      <td>GPFAJKDEDBRFOS-FKQDBXSBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11871</td>
      <td>PF-00610355</td>
      <td>YPHDIMUXXABSSO-YTTGMZPUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB05039</td>
      <td>Indacaterol</td>
      <td>QZZUEBNBZAPZLX-QFIPXVFZSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB05038</td>
      <td>Anatibant</td>
      <td>XUHBBTKJWIBQMY-MHZLTWQESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06995</td>
      <td>N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide</td>
      <td>USBSTVPJNQLYEM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB04960</td>
      <td>Tipifarnib</td>
      <td>PLHJCIYEEKOWNM-HHHXNRCGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB04908</td>
      <td>Flibanserin</td>
      <td>PPRRDFIXUUSXRA-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11951</td>
      <td>Lemborexant</td>
      <td>MUGXRYIUWFITCP-PGRDOPGGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB05590</td>
      <td>Bedoradrine</td>
      <td>OANCEOSLKSTLTA-REWPJTCUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11984</td>
      <td>Letaxaban</td>
      <td>GEHAEMCVKDPMKO-HXUWFJFHSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12001</td>
      <td>Abemaciclib</td>
      <td>UZWDCWONPYILKI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB04575</td>
      <td>Quinestrol</td>
      <td>PWZUUYSISTUNDW-VAFBSOEGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB04432</td>
      <td>ZK-805623</td>
      <td>ZXIHYCYAQUQHSG-UHFFFAOYSA-O</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12036</td>
      <td>Naquotinib</td>
      <td>QKDCLUARMDUUKN-XMMPIXPASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB04392</td>
      <td>Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]</td>
      <td>HIZKPJUTKKJDGA-BETUJISGSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB00590</td>
      <td>Doxazosin</td>
      <td>RUZYUOTYCVRMRZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06347</td>
      <td>Cenisertib</td>
      <td>KSOVGRCOLZZTPF-QMKUDKLTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12041</td>
      <td>Mapracorat</td>
      <td>VJGFOYBQOIPQFY-XMMPIXPASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07002</td>
      <td>4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile</td>
      <td>SZUVGMCKKLJAFX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12048</td>
      <td>Savolitinib</td>
      <td>XYDNMOZJKOGZLS-NSHDSACASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB05608</td>
      <td>MKC-1</td>
      <td>OVSKGTONMLKNPZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11845</td>
      <td>Lucitanib</td>
      <td>CUDVHEFYRIWYQD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06831</td>
      <td>2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE</td>
      <td>UMMYTDJYDSTEMB-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11262</td>
      <td>Bisoctrizole</td>
      <td>FQUNFJULCYSSOP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06673</td>
      <td>Almorexant</td>
      <td>DKMACHNQISHMDN-RPLLCQBOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11622</td>
      <td>Dehydrocholic acid</td>
      <td>OHXPGWPVLFPUSM-KLRNGDHRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11645</td>
      <td>PF-4191834</td>
      <td>DVNQWYLVSNPCJZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06472</td>
      <td>Fradafiban</td>
      <td>IKZACQMAVUIGPY-HOTGVXAUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06942</td>
      <td>N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide</td>
      <td>RNZKCCPFUWHBFY-IBGZPJMESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11730</td>
      <td>Ribociclib</td>
      <td>RHXHGRAEPCAFML-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06420</td>
      <td>Annamycin</td>
      <td>CIDNKDMVSINJCG-GKXONYSUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11865</td>
      <td>Brivanib alaninate</td>
      <td>LTEJRLHKIYCEOX-OCCSQVGLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11740</td>
      <td>MK-1775</td>
      <td>BKWJAKQVGHWELA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11751</td>
      <td>Cabotegravir</td>
      <td>WCWSTNLSLKSJPK-LKFCYVNXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11794</td>
      <td>Berzosertib</td>
      <td>JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB09272</td>
      <td>Eluxadoline</td>
      <td>QFNHIDANIVGXPE-FNZWTVRRSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06090</td>
      <td>Bradanicline</td>
      <td>OXKRFEWMSWPKKV-GHTZIAJQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB03507</td>
      <td>6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One</td>
      <td>UXGUZFZBZPPZGL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06011</td>
      <td>AMG-222</td>
      <td>NVSWJKWHLUTHLP-CPJSRVTESA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11805</td>
      <td>Saracatinib</td>
      <td>OUKYUETWWIPKQR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11824</td>
      <td>Tofogliflozin</td>
      <td>VWVKUNOPTJGDOB-BDHVOXNPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB05936</td>
      <td>CVT-6883</td>
      <td>KOYXXLLNCXWUNF-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB06314</td>
      <td>SGX-523</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB04023</td>
      <td>Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester</td>
      <td>DNBSDUDYNPJVCN-ZXTXFPBHSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB03944</td>
      <td>5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One</td>
      <td>IZLRMTJLQCLMKF-CYBMUJFWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB06367</td>
      <td>Relacatib</td>
      <td>BWYBBMQLUKXECQ-GIVPXCGWSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06497</td>
      <td>Aplaviroc</td>
      <td>GWNOTCOIYUNTQP-FQLXRVMXSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07229</td>
      <td>3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE</td>
      <td>MINVOLKUPZPDNX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB06510</td>
      <td>Muraglitazar</td>
      <td>IRLWJILLXJGJTD-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12355</td>
      <td>Netazepide</td>
      <td>YDZYKNJZCVIKPP-VWLOTQADSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB01764</td>
      <td>Dalfopristin</td>
      <td>SUYRLXYYZQTJHF-VMBLUXKRSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB01349</td>
      <td>Tasosartan</td>
      <td>ADXGNEYLLLSOAR-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07247</td>
      <td>[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA</td>
      <td>SRPOHNDQBDHONJ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06533</td>
      <td>Ragaglitazar</td>
      <td>WMUIIGVAWPWQAW-XMMPIXPASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12385</td>
      <td>10-hydroxycamptothecin</td>
      <td>HAWSQZCWOQZXHI-FQEVSTJZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB01184</td>
      <td>Domperidone</td>
      <td>FGXWKSZFVQUSTL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB00972</td>
      <td>Azelastine</td>
      <td>MBUVEWMHONZEQD-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12391</td>
      <td>Sagopilone</td>
      <td>BFZKMNSQCNVFGM-UCEYFQQTSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12394</td>
      <td>Eleclazine</td>
      <td>YNUAEEJQYHYLMS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12436</td>
      <td>Vofopitant</td>
      <td>XILNRORTJVDYRH-HKUYNNGSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB00823</td>
      <td>Ethynodiol diacetate</td>
      <td>ONKUMRGIYFNPJW-KIEAKMPYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB00820</td>
      <td>Tadalafil</td>
      <td>WOXKDUGGOYFFRN-IIBYNOLFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB00694</td>
      <td>Daunorubicin</td>
      <td>STQGQHZAVUOBTE-VGBVRHCVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB00673</td>
      <td>Aprepitant</td>
      <td>ATALOFNDEOCMKK-OITMNORJSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB06595</td>
      <td>Midostaurin</td>
      <td>BMGQWWVMWDBQGC-IIFHNQTCSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB01067</td>
      <td>Glipizide</td>
      <td>ZJJXGWJIGJFDTL-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB09048</td>
      <td>Netupitant</td>
      <td>WAXQNWCZJDTGBU-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02010</td>
      <td>Staurosporine</td>
      <td>HKSZLNNOFSGOKW-FYTWVXJKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07014</td>
      <td>2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole</td>
      <td>TUTZKAQTSPMEBI-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB03758</td>
      <td>Radicicol</td>
      <td>WYZWZEOGROVVHK-GTMNPGAYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB09078</td>
      <td>Lenvatinib</td>
      <td>WOSKHXYHFSIKNG-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB03478</td>
      <td>2'-O-Acetyl Adenosine-5-Diphosphoribose</td>
      <td>BFNOPXRXIQJDHO-DLFWLGJNSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12063</td>
      <td>CERC-301</td>
      <td>RECBFDWSXWAXHY-IAGOWNOFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06134</td>
      <td>SNS-314</td>
      <td>FAYAUAZLLLJJGH-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB03124</td>
      <td>5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid</td>
      <td>LBAHOXPDTNUYCX-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02759</td>
      <td>4-Methylumbelliferyl Chitobiose</td>
      <td>UPSFMJHZUCSEHU-JYGUBCOQSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12128</td>
      <td>Ulimorelin</td>
      <td>WGYPAJVJMXQXTR-ABNZCKJZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12130</td>
      <td>Lorlatinib</td>
      <td>IIXWYSCJSQVBQM-LLVKDONJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02554</td>
      <td>Sulfoquinovose-Uridine-C1,5'-Diphosphate</td>
      <td>FQANCGQCBCUSMI-JZMIEXBBSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02547</td>
      <td>Guanosine-5'-Diphosphate-Rhamnose</td>
      <td>LQEBEXMHBLQMDB-GDJBGNAASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02545</td>
      <td>Fexaramine</td>
      <td>VLQTUNDJHLEFEQ-KGENOOAVSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB12221</td>
      <td>Canrenone</td>
      <td>UJVLDDZCTMKXJK-WNHSNXHDSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02505</td>
      <td>N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)</td>
      <td>JJVQUUYZGJWBPW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB14765</td>
      <td>Rivoceranib</td>
      <td>WPEWQEMJFLWMLV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02491</td>
      <td>4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine</td>
      <td>CJSSYVIHFXDFFC-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02432</td>
      <td>RU90395</td>
      <td>RLLAUERCSKPFGD-VMPREFPWSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB07084</td>
      <td>N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</td>
      <td>YHKGWOJTUMJPNW-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB02059</td>
      <td>Adenosine-5-Diphosphoribose</td>
      <td>SRNWOUGRCWSEMX-ZQSHOCFMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB00288</td>
      <td>Amcinonide</td>
      <td>ILKJAFIWWBXGDU-MOGDOJJUSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB15108</td>
      <td>Tipranavir C-14</td>
      <td>SUJUHGSWHZTSEU-MWQIXQBFSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB15121</td>
      <td>AT-001</td>
      <td>YRGPAXAVTDMKDK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB09073</td>
      <td>Palbociclib</td>
      <td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08091</td>
      <td>3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE</td>
      <td>HIUFYIOMUILESI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB05465</td>
      <td>Tandutinib</td>
      <td>UXXQOJXBIDBUAC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01481</td>
      <td>1-Testosterone</td>
      <td>OKJCFMUGMSVJBG-ABEVXSGRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB00948</td>
      <td>Mezlocillin</td>
      <td>YPBATNHYBCGSSN-VWPFQQQWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07159</td>
      <td>Tamatinib</td>
      <td>NHHQJBCNYHBUSI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB00700</td>
      <td>Eplerenone</td>
      <td>JUKPWJGBANNWMW-VWBFHTRKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB00693</td>
      <td>Fluorescein</td>
      <td>GNBHRKFJIUUOQI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB00606</td>
      <td>Cyclothiazide</td>
      <td>BOCUKUHCLICSIY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB00549</td>
      <td>Zafirlukast</td>
      <td>YEEZWCHGZNKEEK-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB00430</td>
      <td>Cefpiramide</td>
      <td>PWAUCHMQEXVFJR-PMAPCBKXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB15425</td>
      <td>CYC-065</td>
      <td>DLPIYBKBHMZCJI-WBVHZDCISA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01544</td>
      <td>Flunitrazepam</td>
      <td>PPTYJKAXVCCBDU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01569</td>
      <td>Formebolone</td>
      <td>AMVODTGMYSRMNP-GNIMZFFESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB15360</td>
      <td>Carfentanil, C-11</td>
      <td>YDSDEBIZUNNPOB-JVVVGQRLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB15338</td>
      <td>Rovatirelin</td>
      <td>WTXWDXWZGJGIHV-URBCHYCLSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB08864</td>
      <td>Rilpivirine</td>
      <td>YIBOMRUWOWDFLG-ONEGZZNKSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB15324</td>
      <td>ORM-13070 C-11</td>
      <td>VGIYMYGMVXPMKV-GWDMYEQXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01623</td>
      <td>Thiothixene</td>
      <td>GFBKORZTTCHDGY-UWVJOHFNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB15316</td>
      <td>Florasulam</td>
      <td>QZXATCCPQKOEIH-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB00157</td>
      <td>NADH</td>
      <td>BOPGDPNILDQYTO-NNYOXOHSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB15126</td>
      <td>IMG-7289</td>
      <td>KQKBMHGOHXOHTD-KKUQBAQOSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB01167</td>
      <td>Itraconazole</td>
      <td>VHVPQPYKVGDNFY-ZPGVKDDISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB01830</td>
      <td>{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid</td>
      <td>SPSGYTWOIGAABK-DQEYMECFSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB03642</td>
      <td>Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</td>
      <td>VBPPNJCVXGAZDD-PMACEKPBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB03476</td>
      <td>Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine</td>
      <td>NQRIWXVAIWPBEM-OALUTQOASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB03447</td>
      <td>Uridylyl-2'-5'-Phospho-Adenosine</td>
      <td>QARCCHXXGAIRFS-KPKSGTNCSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB03358</td>
      <td>7n-Methyl-8-Hydroguanosine-5'-Triphosphate</td>
      <td>BUJQMJUTTBGELS-KQYNXXCUSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01342</td>
      <td>Forasartan</td>
      <td>YONOBYIBNBCDSJ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB07107</td>
      <td>(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE</td>
      <td>SGHXFHRRWFLILP-XJDXJNMNSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB03082</td>
      <td>6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide</td>
      <td>CSWQJKHBMACTGB-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08092</td>
      <td>3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide</td>
      <td>VMLSXFMXUNVCSK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01418</td>
      <td>Acenocoumarol</td>
      <td>VABCILAOYCMVPS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB02705</td>
      <td>6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>DARQQJKHXPXSRO-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB03076</td>
      <td>AHA047</td>
      <td>CGBDAHCDSVOMCF-FYZVQMPESA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB02338</td>
      <td>Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate</td>
      <td>ACFIXJIJDZMPPO-NNYOXOHSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB07124</td>
      <td>(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>CCIACUJJBPSOHE-KRWDZBQOSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07125</td>
      <td>4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid</td>
      <td>KKZYGUVAFJCULH-CYBMUJFWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB02258</td>
      <td>SR11254</td>
      <td>RNZIUDLOJHVHLZ-VYIQYICTSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB02194</td>
      <td>8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One</td>
      <td>ULLMMKZQNNBLRN-SANMLTNESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB02164</td>
      <td>N-Sulfo-Flavin Mononucleotide</td>
      <td>ZLPUGFBBLGQWBS-SCRDCRAPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB01861</td>
      <td>Uridine diphosphate glucose</td>
      <td>HSCJRCZFDFQWRP-JZMIEXBBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB02473</td>
      <td>6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>XRHANBWAKSYPEN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB07253</td>
      <td>N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine</td>
      <td>QTFCKBFCXDAZIU-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB07255</td>
      <td>N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE</td>
      <td>PNEWIQAEGKQNCE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB15052</td>
      <td>Ansofaxine</td>
      <td>QKYBZJLEMOZFFU-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB02319</td>
      <td>5,6-Dihydroxy-Nadp</td>
      <td>LRAVAOPKUBJONV-IVCJQJMGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB02358</td>
      <td>LY374571</td>
      <td>SZHRIPFGZWWRKW-VIFPVBQESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13821</td>
      <td>Ceftezole</td>
      <td>DZMVCVMFETWNIU-LDYMZIIASA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11591</td>
      <td>Bilastine</td>
      <td>ACCMWZWAEFYUGZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB02485</td>
      <td>Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid</td>
      <td>TXCIAUNLDRJGJZ-BILDWYJOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07965</td>
      <td>6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile</td>
      <td>OGODDSLNRULSMM-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB02656</td>
      <td>LY-294002</td>
      <td>CZQHHVNHHHRRDU-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13605</td>
      <td>Phenoperidine</td>
      <td>IPOPQVVNCFQFRK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB05294</td>
      <td>Vandetanib</td>
      <td>UHTHHESEBZOYNR-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11431</td>
      <td>Moxidectin</td>
      <td>YZBLFMPOMVTDJY-LSGXYNIPSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11775</td>
      <td>PF-03758309</td>
      <td>AYCPARAPKDAOEN-LJQANCHMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07415</td>
      <td>4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine</td>
      <td>RFLOFHKRBGKCOB-AWEZNQCLSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13553</td>
      <td>Carumonam</td>
      <td>UIMOJFJSJSIGLV-JNHMLNOCSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07847</td>
      <td>6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE</td>
      <td>ICLOZQFWTRAYPX-LIRRHRJNSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13482</td>
      <td>Dimefline</td>
      <td>ZXFQRFXLFWWKLX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13463</td>
      <td>Oxetorone</td>
      <td>VZVRZTZPHOHSCK-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11794</td>
      <td>Berzosertib</td>
      <td>JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11806</td>
      <td>VTP-194204</td>
      <td>BOOOLEGQBVUTKC-NVQSDHBMSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB03161</td>
      <td>Thymidine-5'-Diphospho-Beta-D-Xylose</td>
      <td>AJUADKZRQSBUAK-KDGZBOQCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB03199</td>
      <td>4-Methoxy-E-Rhodomycin T</td>
      <td>XSSVYBYWQBNYOH-QJIXERIWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13579</td>
      <td>Mepixanox</td>
      <td>PYSOHOOUXFWCFF-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB02128</td>
      <td>[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester</td>
      <td>QCUBCTPTNWPFBC-ZEQRLZLVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB13988</td>
      <td>SB-269970</td>
      <td>HWKROQUZSKPIKQ-MRXNPFEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB05450</td>
      <td>Smilagenin</td>
      <td>GMBQZIIUCVWOCD-UQHLGXRBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01708</td>
      <td>Prasterone</td>
      <td>FMGSKLZLMKYGDP-USOAJAOKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB03672</td>
      <td>9-N-Phenylmethylamino-Tacrine</td>
      <td>JYJAEHAURXXPSD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01774</td>
      <td>Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester</td>
      <td>WFPZSXYXPSUOPY-ROYWQJLOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB05424</td>
      <td>Canertinib</td>
      <td>OMZCMEYTWSXEPZ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB09073</td>
      <td>Palbociclib</td>
      <td>AHJRHEGDXFFMBM-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB02021</td>
      <td>Fidarestat</td>
      <td>WAAPEIZFCHNLKK-UFBFGSQYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB14672</td>
      <td>Oxazepam acetate</td>
      <td>FYRWUTOZBRWYCS-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB14668</td>
      <td>Dienestrol diacetate</td>
      <td>YWLLGDVBTLPARJ-OXAZHYLESA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB09075</td>
      <td>Edoxaban</td>
      <td>HGVDHZBSSITLCT-JLJPHGGASA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB14544</td>
      <td>Hydrocortisone valerate</td>
      <td>FZCHYNWYXKICIO-FZNHGJLXSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07334</td>
      <td>N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE</td>
      <td>HTIZPBXCJPQDEM-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB14543</td>
      <td>Hydrocortisone probutate</td>
      <td>FOGXJPFPZOHSQS-AYVLZSQQSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB14232</td>
      <td>Deacetylbisacodyl</td>
      <td>LJROKJGQSPMTKB-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB14213</td>
      <td>Perindoprilat</td>
      <td>ODAIHABQVKJNIY-PEDHHIEDSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB02102</td>
      <td>DMP450</td>
      <td>KYRSNWPSSXSNEP-ZRTHHSRSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB02115</td>
      <td>Daidzin</td>
      <td>KYQZWONCHDNPDP-QNDFHXLGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m3m</td>
      <td>DB14008</td>
      <td>Hispidulin</td>
      <td>IHFBPDAQLQOCBX-UHFFFAOYSA-N</td>
      <td>nucleocapsid protein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB09298</td>
      <td>Silibinin</td>
      <td>SEBFKMXJBCUCAI-HKTJVKLFSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB03797</td>
      <td>3-Aminomethyl-Pyridinium-Adenine-Dinucleotide</td>
      <td>HMCRLFVYYFBZEZ-PLEFRAQWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01198</td>
      <td>Zopiclone</td>
      <td>GBBSUAFBMRNDJC-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB03944</td>
      <td>5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One</td>
      <td>IZLRMTJLQCLMKF-CYBMUJFWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB04011</td>
      <td>2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole</td>
      <td>VMCOQLKKSNQANE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB15431</td>
      <td>M-2698</td>
      <td>HXAUJHZZPCBFPN-QGZVFWFLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB06948</td>
      <td>2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE</td>
      <td>XWWRLKIBRPJQJX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08031</td>
      <td>N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE</td>
      <td>LNQWELVSNCYKDU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08000</td>
      <td>2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE</td>
      <td>ZTJGXDGAXGWOGR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07991</td>
      <td>N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE</td>
      <td>APLJSSOXDWUNGV-GOSISDBHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07978</td>
      <td>2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID</td>
      <td>ULMUPVXFUDHRGH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB15446</td>
      <td>Vidofludimus</td>
      <td>XPRDUGXOWVXZLL-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08400</td>
      <td>4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid</td>
      <td>KUEKMTNOUPAOBS-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07800</td>
      <td>N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE</td>
      <td>MIJGLXFQYBTIFY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00180</td>
      <td>Flunisolide</td>
      <td>XSFJVAJPIHIPKU-XWCQMRHXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07728</td>
      <td>2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE</td>
      <td>XJJYJNMNYDNXNO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07460</td>
      <td>2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE</td>
      <td>UYJNQQDJUOUFQJ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07457</td>
      <td>3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE</td>
      <td>APYXQTXFRIDSGE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00267</td>
      <td>Cefmenoxime</td>
      <td>HJJDBAOLQAWBMH-YCRCPZNHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07406</td>
      <td>(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE</td>
      <td>QWFFPYQWUWLDBV-NSHDSACASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07396</td>
      <td>1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid</td>
      <td>KAJJGOCSAXKXBD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB08341</td>
      <td>4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide</td>
      <td>CAUFYHKGKDJMQG-HZPDHXFCSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07848</td>
      <td>5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide</td>
      <td>BHNMMFGOJRIAEZ-LRDDRELGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08499</td>
      <td>N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide</td>
      <td>DQXBKUVWJSZHSI-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB08068</td>
      <td>N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-</td>
      <td>YQJVDUKATDECHF-ICSRJNTNSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08237</td>
      <td>2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)</td>
      <td>COMPKRGNHXOXMN-GVDBMIGSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB09048</td>
      <td>Netupitant</td>
      <td>WAXQNWCZJDTGBU-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08896</td>
      <td>Regorafenib</td>
      <td>FNHKPVJBJVTLMP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08883</td>
      <td>Perampanel</td>
      <td>PRMWGUBFXWROHD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08827</td>
      <td>Lomitapide</td>
      <td>MBBCVAKAJPKAKM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08822</td>
      <td>Azilsartan medoxomil</td>
      <td>QJFSABGVXDWMIW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08747</td>
      <td>(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one</td>
      <td>JJTPPGUNMJMPLY-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB08064</td>
      <td>N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA</td>
      <td>NTMADESEDXKNFZ-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB15191</td>
      <td>MAX-40279</td>
      <td>AVIOBQFPAGEICQ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08657</td>
      <td>2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID</td>
      <td>SSXCWVOQWRUMGN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08584</td>
      <td>6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08500</td>
      <td>(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol</td>
      <td>ZCJBDRSKHARECB-PYTCMNEWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08546</td>
      <td>4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE</td>
      <td>CETLUACQMGBMFH-ZALSBGIRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB15219</td>
      <td>Tomivosertib</td>
      <td>HKTBYUWLRDZAJK-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08454</td>
      <td>N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE</td>
      <td>JYCUVOXSZBECAY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08437</td>
      <td>Puromycin</td>
      <td>RXWNCPJZOCPEPQ-NVWDDTSBSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08426</td>
      <td>THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE</td>
      <td>PLXOQMHGHDZMSX-AWEZNQCLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB05678</td>
      <td>SLx-4090</td>
      <td>AZUIUVJESCFSLJ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08299</td>
      <td>4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid</td>
      <td>QTNUWEKKZHSUQO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB08248</td>
      <td>3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE</td>
      <td>BKDUVKJYBJDZQW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07360</td>
      <td>1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>JJHXPDTVQKWKHA-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB03247</td>
      <td>Flavin mononucleotide</td>
      <td>FVTCRASFADXXNN-SCRDCRAPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00358</td>
      <td>Mefloquine</td>
      <td>XEEQGYMUWCZPDN-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08309</td>
      <td>3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL</td>
      <td>AMFGILNPFBVREA-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB05812</td>
      <td>Abiraterone</td>
      <td>GZOSMCIZMLWJML-VJLLXTKPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB08448</td>
      <td>(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol</td>
      <td>PCBWLKUEKANDCL-INIZCTEOSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00846</td>
      <td>Flurandrenolide</td>
      <td>POPFMWWJOGLOIF-XWCQMRHXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00894</td>
      <td>Testolactone</td>
      <td>BPEWUONYVDABNZ-DZBHQSCQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08125</td>
      <td>4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE</td>
      <td>BOMPRXSVSIPRDT-PTNGSMBKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00957</td>
      <td>Norgestimate</td>
      <td>KIQQMECNKUGGKA-NMYWJIRASA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07063</td>
      <td>{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID</td>
      <td>KYHVTMFADJNSGS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07065</td>
      <td>5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>AHPKUZJCNHGFQA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB05944</td>
      <td>Varlitinib</td>
      <td>UWXSAYUXVSFDBQ-CYBMUJFWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08112</td>
      <td>N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID</td>
      <td>IRJUSGUHNFMVCK-OAQYLSRUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01100</td>
      <td>Pimozide</td>
      <td>YVUQSNJEYSNKRX-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB08584</td>
      <td>6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB04698</td>
      <td>N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE</td>
      <td>HJWYZPGYPZNDTN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB04612</td>
      <td>N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE</td>
      <td>QKPXPZYQPBWDHS-MCJAPYMPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07072</td>
      <td>(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE</td>
      <td>CNKRZILQBKJWDS-WMFXKJRFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07074</td>
      <td>6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER</td>
      <td>OUBRALHIKGRAMA-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB04424</td>
      <td>RPR128515</td>
      <td>XFKVLKLCLYJKNF-MZNJEOGPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01184</td>
      <td>Domperidone</td>
      <td>FGXWKSZFVQUSTL-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB04038</td>
      <td>Ergosterol</td>
      <td>DNVPQKQSNYMLRS-APGDWVJJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB01070</td>
      <td>Dihydrotachysterol</td>
      <td>ILYCWAKSDCYMBB-OPCMSESCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00801</td>
      <td>Halazepam</td>
      <td>WYCLKVQLVUQKNZ-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00741</td>
      <td>Hydrocortisone</td>
      <td>JYGXADMDTFJGBT-VWUMJDOOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB08446</td>
      <td>3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile</td>
      <td>OHQMEDBYNUAVNE-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07152</td>
      <td>N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide</td>
      <td>TYPILNNEZPSNTI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07142</td>
      <td>5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>ATFDKOLABYIYCC-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07127</td>
      <td>{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID</td>
      <td>SXDBFKLPNPUPRI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07126</td>
      <td>O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE</td>
      <td>OWXORKPNCHJYOF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07042</td>
      <td>7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide</td>
      <td>XESUNWBIAADLPI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07000</td>
      <td>N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide</td>
      <td>ILXJWLWSYAWJKZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB06997</td>
      <td>2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide</td>
      <td>BMPOCDJEXAXXEZ-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00402</td>
      <td>Eszopiclone</td>
      <td>GBBSUAFBMRNDJC-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00436</td>
      <td>Bendroflumethiazide</td>
      <td>HDWIHXWEUNVBIY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00438</td>
      <td>Ceftazidime</td>
      <td>ORFOPKXBNMVMKC-DWVKKRMSSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB06886</td>
      <td>N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL</td>
      <td>MACLRJNEKXUAJK-YDLSIGKMSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB06746</td>
      <td>ginkgolide-J</td>
      <td>LMEHVEUFNRJAAV-UKWFQYJJSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB08240</td>
      <td>N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE</td>
      <td>RQAQWBFHPMSXKR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxs</td>
      <td>DB08400</td>
      <td>4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid</td>
      <td>KUEKMTNOUPAOBS-UHFFFAOYSA-N</td>
      <td>ribose phosphatase of NSP3</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB03157</td>
      <td>N,O-Didansyl-L-Tyrosine</td>
      <td>LUBOPDUYHWABFG-NDEPHWFRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB00673</td>
      <td>Aprepitant</td>
      <td>ATALOFNDEOCMKK-OITMNORJSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB06521</td>
      <td>Ertiprotafib</td>
      <td>FONCZICQWCUXEB-RUZDIDTESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB06393</td>
      <td>Xaliproden</td>
      <td>WJJYZXPHLSLMGE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB06314</td>
      <td>SGX-523</td>
      <td>BCZUAADEACICHN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB07039</td>
      <td>(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide</td>
      <td>RXSZCFAPSDTELY-SFHVURJKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB07041</td>
      <td>N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide</td>
      <td>FDJWFDQRPKKBFA-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m71</td>
      <td>DB07321</td>
      <td>2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE</td>
      <td>KOKQLKWXOFRTHE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB15033</td>
      <td>Flortaucipir</td>
      <td>GETAAWDSFUCLBS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB08746</td>
      <td>1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE</td>
      <td>ZOSSOFIFNGGDKG-GIJQJNRQSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14941</td>
      <td>BMS-817399</td>
      <td>GTDPZONCGOCXOD-JPYJTQIMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15031</td>
      <td>Nemorexant</td>
      <td>NBGABHGMJVIVBW-QHCPKHFHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15009</td>
      <td>PF-04937319</td>
      <td>MASKQITXHVYVFL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB04764</td>
      <td>[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE</td>
      <td>CCLHROFBSWWOQO-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB11883</td>
      <td>SB-705498</td>
      <td>JYILLRHXRVTRSH-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12914</td>
      <td>MGL-3196</td>
      <td>FDBYIYFVSAHJLY-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB14918</td>
      <td>Branaplam</td>
      <td>STWTUEAWRAIWJG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB11885</td>
      <td>Anlotinib</td>
      <td>KSMZEXLVHXZPEF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01765</td>
      <td>(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid</td>
      <td>INSBKYCYLCEBOD-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15138</td>
      <td>AZD-9496</td>
      <td>DFBDRVGWBHBJNR-BBNFHIFMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB07837</td>
      <td>[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid</td>
      <td>SWXKLXXVFMYMDP-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB08386</td>
      <td>2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline</td>
      <td>VRWJZGHUCOFGPZ-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB11399</td>
      <td>Dirlotapide</td>
      <td>TUOSYWCFRFNJBS-BHVANESWSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB11691</td>
      <td>Naldemedine</td>
      <td>AXQACEQYCPKDMV-RZAWKFBISA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB14664</td>
      <td>Difluocortolone pivalate</td>
      <td>UWGRWFCLGQWKPR-GSTUPEFVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB14662</td>
      <td>Flunisolide acetate</td>
      <td>WEGNFRKBIKYVLC-XTLNBZDDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12949</td>
      <td>PF-03382792</td>
      <td>AGMOFKKOVMRGAK-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB14654</td>
      <td>Bisoxatin acetate</td>
      <td>ZCBJDQBSLZREAA-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB14636</td>
      <td>Triciribine phosphate</td>
      <td>URLYINUFLXOMHP-HTVVRFAVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB11852</td>
      <td>Tegobuvir</td>
      <td>XBEQSQDCBSKCHJ-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB08384</td>
      <td>2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline</td>
      <td>RQDDHVVAAJVVKM-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB04330</td>
      <td>Bilh 434</td>
      <td>KNRVCCXHLSHTFW-HGPRPZRGSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15156</td>
      <td>ABT-072</td>
      <td>XMZSTQYSBYEENY-RMKNXTFCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB03962</td>
      <td>Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate</td>
      <td>MDKMTCCUJSRQGW-NAJQWHGHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB00324</td>
      <td>Fluorometholone</td>
      <td>FAOZLTXFLGPHNG-KNAQIMQKSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB00762</td>
      <td>Irinotecan</td>
      <td>UWKQSNNFCGGAFS-XIFFEERXSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB00450</td>
      <td>Droperidol</td>
      <td>RMEDXOLNCUSCGS-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB01126</td>
      <td>Dutasteride</td>
      <td>JWJOTENAMICLJG-QWBYCMEYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB02112</td>
      <td>Zk-806450</td>
      <td>DZLGSWPXZYDHBD-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08974</td>
      <td>Flubendazole</td>
      <td>CPEUVMUXAHMANV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12836</td>
      <td>Grapiprant</td>
      <td>HZVLFTCYCLXTGV-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB00158</td>
      <td>Folic acid</td>
      <td>OVBPIULPVIDEAO-LBPRGKRZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15163</td>
      <td>Selatogrel</td>
      <td>FYXHWMQPCJOJCH-GMAHTHKFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15456</td>
      <td>Vericiguat</td>
      <td>QZFHIXARHDBPBY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01948</td>
      <td>1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One</td>
      <td>VXIYTVJEIXMAQF-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15401</td>
      <td>Danicopan</td>
      <td>PIBARDGJJAGJAJ-NQIIRXRSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12867</td>
      <td>Benperidol</td>
      <td>FEBOTPHFXYHVPL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB11844</td>
      <td>Pritelivir</td>
      <td>IVZKZONQVYTCKC-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15356</td>
      <td>SLV-334</td>
      <td>LOFDNSDPZTVIIO-VPUSJEBWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15287</td>
      <td>Elismetrep</td>
      <td>CWEFDWIKLABKBX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB03591</td>
      <td>RU82209</td>
      <td>LVZDQVATAQEMCX-NSOVKSMOSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15275</td>
      <td>GDC-0077</td>
      <td>SGEUNORSOZVTOL-CABZTGNLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB15265</td>
      <td>USL-311</td>
      <td>XNUNVQKARNSSEO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB09383</td>
      <td>Meprednisone</td>
      <td>PIDANAQULIKBQS-RNUIGHNZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08954</td>
      <td>Ifenprodil</td>
      <td>UYNVMODNBIQBMV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB13814</td>
      <td>Talampicillin</td>
      <td>SOROUYSPFADXSN-SUWVAFIASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12972</td>
      <td>Sepranolone</td>
      <td>AURFZBICLPNKBZ-FZCSVUEKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12658</td>
      <td>AFN-1252</td>
      <td>QXTWSUQCXCWEHF-JXMROGBWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12561</td>
      <td>WNT-974</td>
      <td>XXYGTCZJJLTAGH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12491</td>
      <td>Fasiglifam</td>
      <td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12465</td>
      <td>Ketanserin</td>
      <td>FPCCSQOGAWCVBH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12459</td>
      <td>Belotecan</td>
      <td>LNHWXBUNXOXMRL-VWLOTQADSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01395</td>
      <td>Drospirenone</td>
      <td>METQSPRSQINEEU-HXCATZOESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB13506</td>
      <td>Carfecillin</td>
      <td>NZDASSHFKWDBBU-KVMCETHSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12380</td>
      <td>GDC-0152</td>
      <td>WZRFLSDVFPIXOV-LRQRDZAKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB04232</td>
      <td>N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide</td>
      <td>DNGGPLKVDUPXFN-GOSISDBHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB00398</td>
      <td>Sorafenib</td>
      <td>MLDQJTXFUGDVEO-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB13586</td>
      <td>Metandienone</td>
      <td>XWALNWXLMVGSFR-HLXURNFRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB13988</td>
      <td>SB-269970</td>
      <td>HWKROQUZSKPIKQ-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB14208</td>
      <td>Ramiprilat</td>
      <td>KEDYTOTWMPBSLG-HILJTLORSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB14541</td>
      <td>Hydrocortisone cypionate</td>
      <td>DLVOSEUFIRPIRM-KAQKJVHQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12180</td>
      <td>Apitolisib</td>
      <td>YOVVNQKCSKSHKT-HNNXBMFYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12158</td>
      <td>Filorexant</td>
      <td>NPFDWHQSDBWQLH-QZTJIDSGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01339</td>
      <td>Vecuronium</td>
      <td>BGSZAXLLHYERSY-XQIGCQGXSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12064</td>
      <td>BMS-777607</td>
      <td>VNBRGSXVFBYQNN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12048</td>
      <td>Savolitinib</td>
      <td>XYDNMOZJKOGZLS-NSHDSACASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB15057</td>
      <td>NUC-1031</td>
      <td>NHTKGYOMICWFQZ-KKQYNPQSSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB13596</td>
      <td>Oxycinchophen</td>
      <td>XAPRFLSJBSXESP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB11977</td>
      <td>Golvatinib</td>
      <td>UQRCJCNVNUFYDX-UHFFFAOYSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB04258</td>
      <td>Seocalcitol</td>
      <td>LVLLALCJVJNGQQ-SEODYNFXSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB12966</td>
      <td>Falnidamol</td>
      <td>FTFRZXFNZVCRSK-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB13556</td>
      <td>Sulfamazone</td>
      <td>BGLHAKAJGYLSOX-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB11979</td>
      <td>Elagolix</td>
      <td>HEAUOKZIVMZVQL-VWLOTQADSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB12054</td>
      <td>BQ-123</td>
      <td>VYCMAAOURFJIHD-PJNXIOHISA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB12655</td>
      <td>Patidegib</td>
      <td>HZLFFNCLTRVYJG-WWGOJCOQSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB12367</td>
      <td>Selurampanel</td>
      <td>MCECSFFXUPEPDB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01669</td>
      <td>Virginiamycin M1</td>
      <td>DAIKHDNSXMZDCU-FQTGFAPKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB13059</td>
      <td>PF-03814735</td>
      <td>RYYNGWLOYLRZLK-RBUKOAKNSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB13055</td>
      <td>Oteseconazole</td>
      <td>IDUYJRXRDSPPRC-NRFANRHFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB12400</td>
      <td>Voxtalisib</td>
      <td>RGHYDLZMTYDBDT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12724</td>
      <td>AZD-7295</td>
      <td>MAQDQJWCSSCURR-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB12442</td>
      <td>Alvespimycin</td>
      <td>KUFRQPKVAWMTJO-LMZWQJSESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6wiq</td>
      <td>DB15328</td>
      <td>Ubrogepant</td>
      <td>DDOOFTLHJSMHLN-ZQHRPCGSSA-N</td>
      <td>nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01405</td>
      <td>Temafloxacin</td>
      <td>QKDHBVNJCZBTMR-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12899</td>
      <td>TT-301</td>
      <td>ZPJGUEPHFXPAQF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12887</td>
      <td>Tazemetostat</td>
      <td>NSQSAUGJQHDYNO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12877</td>
      <td>Oxatomide</td>
      <td>BAINIUMDFURPJM-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12812</td>
      <td>Palomid 529</td>
      <td>YEAHTLOYHVWAKW-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12776</td>
      <td>E-6005</td>
      <td>BBTFKAOFCSOZMB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB12937</td>
      <td>Quercetin-3'-O-phosphate</td>
      <td>UWJBYNLLMAPJMM-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12756</td>
      <td>TAK-901</td>
      <td>WKDACQVEJIVHMZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12952</td>
      <td>Methylprednisone</td>
      <td>SVYCRJXQZUCUND-PQXSVQADSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12780</td>
      <td>Quinfamide</td>
      <td>SBJGFIXQRZOVTO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB00691</td>
      <td>Moexipril</td>
      <td>UWWDHYUMIORJTA-HSQYWUDLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB00719</td>
      <td>Azatadine</td>
      <td>SEBMTIQKRHYNIT-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB11799</td>
      <td>Bictegravir</td>
      <td>SOLUWJRYJLAZCX-LYOVBCGYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB04424</td>
      <td>RPR128515</td>
      <td>XFKVLKLCLYJKNF-MZNJEOGPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB12200</td>
      <td>Tivantinib</td>
      <td>UCEQXRCJXIVODC-PMACEKPBSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08491</td>
      <td>N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE</td>
      <td>ARIRIZBKMKMEBD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB00908</td>
      <td>Quinidine</td>
      <td>LOUPRKONTZGTKE-LHHVKLHASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB02615</td>
      <td>Compound 19</td>
      <td>UZOOIPXOYYJULJ-BLIZRMSTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB12303</td>
      <td>Motolimod</td>
      <td>QSPOQCXMGPDIHI-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB01708</td>
      <td>Prasterone</td>
      <td>FMGSKLZLMKYGDP-USOAJAOKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB02738</td>
      <td>Adenosine-5'-Pentaphosphate</td>
      <td>WYJWVZZCMBUPSP-KQYNXXCUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12591</td>
      <td>BMS-911543</td>
      <td>JCINBYQJBYJGDM-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB12535</td>
      <td>AC-430</td>
      <td>DCRWIATZWHLIPN-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB12673</td>
      <td>ATX-914</td>
      <td>ALANRBCCCQEPFZ-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08519</td>
      <td>N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine</td>
      <td>SQQAPOSROFWHIB-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB02008</td>
      <td>1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine</td>
      <td>JHSHXKJSPVHPCJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01975</td>
      <td>AMPCPR</td>
      <td>ZPZRETFSCSWNDT-DBXCYWGHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01946</td>
      <td>3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione</td>
      <td>UQHKJRCFSLMWIA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01941</td>
      <td>6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid</td>
      <td>SLXTWXQUEZSSTJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB12784</td>
      <td>NS-018</td>
      <td>UQTPDWDAYHAZNT-AWEZNQCLSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08504</td>
      <td>6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM</td>
      <td>ZNHVIJAGMFQGMS-IHPCNDPISA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB02510</td>
      <td>'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine</td>
      <td>LKVJEMXWEODCAY-JVEUSOJLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08470</td>
      <td>3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole</td>
      <td>KMGPJKOKSYGMJD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB02848</td>
      <td>{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol</td>
      <td>ZJESXGUODSBHSK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03534</td>
      <td>3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide</td>
      <td>AWTBJNJPBKTHEV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03523</td>
      <td>Brequinar</td>
      <td>PHEZJEYUWHETKO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB04434</td>
      <td>Naphthyridine Inhibitor</td>
      <td>YRBHUKMLAGQYHS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03509</td>
      <td>2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide</td>
      <td>FLYGLPYJEQPCFY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03488</td>
      <td>Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose</td>
      <td>NGTCPFGWXMBZEP-NQQHDEILSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12491</td>
      <td>Fasiglifam</td>
      <td>BZCALJIHZVNMGJ-HSZRJFAPSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03451</td>
      <td>1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3</td>
      <td>KLZOTDOJMRMLDX-YBBVPDDNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12505</td>
      <td>E-7820</td>
      <td>LWGUASZLXHYWIV-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB08995</td>
      <td>Diosmin</td>
      <td>GZSOSUNBTXMUFQ-YFAPSIMESA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB02836</td>
      <td>Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate</td>
      <td>NGYWTCOGOZELRS-UUOKFMHZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08442</td>
      <td>4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol</td>
      <td>TWODFUZHWYZBHZ-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB09074</td>
      <td>Olaparib</td>
      <td>FDLYAMZZIXQODN-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB11526</td>
      <td>Masitinib</td>
      <td>WJEOLQLKVOPQFV-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03239</td>
      <td>3',5'-Dinitro-N-Acetyl-L-Thyronine</td>
      <td>VZSQTOXQXPKQJX-ZDUSSCGKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03181</td>
      <td>2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione</td>
      <td>RXQAVKWRCZYGMV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB02976</td>
      <td>Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester</td>
      <td>NGTCPFGWXMBZEP-KBQKSTHMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB02639</td>
      <td>4-methylumbelliferyl ??-D-glucoside</td>
      <td>YUDPTGPSBJVHCN-JZYAIQKZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08448</td>
      <td>(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol</td>
      <td>PCBWLKUEKANDCL-INIZCTEOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB11775</td>
      <td>PF-03758309</td>
      <td>AYCPARAPKDAOEN-LJQANCHMSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12540</td>
      <td>Lecozotan</td>
      <td>NRPQELCNMADTOZ-OAQYLSRUSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03336</td>
      <td>BIA</td>
      <td>KVIVJQWOYSWCCZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB13138</td>
      <td>Neladenoson bialanate</td>
      <td>WESNEIGKOAXSGX-VXKWHMMOSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08828</td>
      <td>Vismodegib</td>
      <td>BPQMGSKTAYIVFO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB04405</td>
      <td>2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid</td>
      <td>AQYSXARQCHHHLK-NRFANRHFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08883</td>
      <td>Perampanel</td>
      <td>PRMWGUBFXWROHD-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01134</td>
      <td>Desoxycorticosterone pivalate</td>
      <td>VVOIQBFMTVCINR-WWMZEODYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB02331</td>
      <td>(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid</td>
      <td>YBULOUKTPCHXAL-DEOSSOPVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01095</td>
      <td>Fluvastatin</td>
      <td>FJLGEFLZQAZZCD-JUFISIKESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12720</td>
      <td>Nivocasan</td>
      <td>VYFGDLGHHBUDTQ-ZLGUVYLKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB15068</td>
      <td>Agerafenib</td>
      <td>DKNUPRMJNUQNHR-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB15137</td>
      <td>VK-2809</td>
      <td>LGGPZDRLTDGYSQ-JADSYQMUSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12725</td>
      <td>TD-8954</td>
      <td>MZOITCJKGUIQEI-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12729</td>
      <td>ASP-3026</td>
      <td>MGGBYMDAPCCKCT-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB00502</td>
      <td>Haloperidol</td>
      <td>LNEPOXFFQSENCJ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB15233</td>
      <td>Avapritinib</td>
      <td>DWYRIWUZIJHQKQ-SANMLTNESA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB00957</td>
      <td>Norgestimate</td>
      <td>KIQQMECNKUGGKA-NMYWJIRASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12742</td>
      <td>Amuvatinib</td>
      <td>FOFDIMHVKGYHRU-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB02255</td>
      <td>GM6001</td>
      <td>NITYDPDXAAFEIT-DYVFJYSZSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB00896</td>
      <td>Rimexolone</td>
      <td>QTTRZHGPGKRAFB-OOKHYKNYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB00873</td>
      <td>Loteprednol</td>
      <td>YPZVAYHNBBHPTO-MXRBDKCISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB00844</td>
      <td>Nalbuphine</td>
      <td>NETZHAKZCGBWSS-CEDHKZHLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08911</td>
      <td>Trametinib</td>
      <td>LIRYPHYGHXZJBZ-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12764</td>
      <td>ABC-294640</td>
      <td>CAOTVXGYTWCKQE-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB15382</td>
      <td>SAR-125844</td>
      <td>ODIUNTQOXRXOIV-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB00967</td>
      <td>Desloratadine</td>
      <td>JAUOIFJMECXRGI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01224</td>
      <td>Quetiapine</td>
      <td>URKOMYMAXPYINW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB14943</td>
      <td>LGH-447</td>
      <td>VRQXRVAKPDCRCI-ZNMIVQPWSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01720</td>
      <td>(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid</td>
      <td>WLPJLQNKCJWAFL-RGEXLXHISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01705</td>
      <td>Bis(5-Amidino-Benzimidazolyl)Methane</td>
      <td>QZKOOEFIMWKZPK-UHFFFAOYSA-Q</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12651</td>
      <td>Bardoxolone</td>
      <td>TXGZJQLMVSIZEI-UQMAOPSPSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12659</td>
      <td>SJ-733</td>
      <td>VKCPFWKTFZAOTO-LEWJYISDSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB13947</td>
      <td>Testosterone enantate benzilic acid hydrazone</td>
      <td>PTVXYACXDYZNID-JKXGKYMWSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01591</td>
      <td>Solifenacin</td>
      <td>FBOUYBDGKBSUES-VXKWHMMOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01570</td>
      <td>Ohmefentanyl</td>
      <td>FRPRNNRJTCONEC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01569</td>
      <td>Formebolone</td>
      <td>AMVODTGMYSRMNP-GNIMZFFESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01564</td>
      <td>Calusterone</td>
      <td>IVFYLRMMHVYGJH-PVPPCFLZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB13953</td>
      <td>Estradiol benzoate</td>
      <td>UYIFTLBWAOGQBI-BZDYCCQFSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01540</td>
      <td>17alpha-methyl-4-hydroxynandrolone</td>
      <td>CLNUZOCYKSHICX-FAHHUNKHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01532</td>
      <td>??-Methylacetylfentanyl</td>
      <td>OKTLVZBUKMRPLL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01513</td>
      <td>17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane</td>
      <td>QGKQXZFZOIQFBI-UYEYMFBJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01450</td>
      <td>Dihydroetorphine</td>
      <td>BRTSNYPDACNMIP-FAWZKKEFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01430</td>
      <td>Almitrine</td>
      <td>OBDOVFRMEYHSQB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08865</td>
      <td>Crizotinib</td>
      <td>KTEIFNKAUNYNJU-GFCCVEGCSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01405</td>
      <td>Temafloxacin</td>
      <td>QKDHBVNJCZBTMR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01357</td>
      <td>Mestranol</td>
      <td>IMSSROKUHAOUJS-MJCUULBUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB02341</td>
      <td>Mdl 101,146</td>
      <td>XQAMVCHQGHAELT-YPAWHYETSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB01326</td>
      <td>Cefamandole</td>
      <td>OLVCFLKTBJRLHI-AXAPSJFSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB13113</td>
      <td>JNJ-38877605</td>
      <td>JRWCBEOAFGHNNU-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB12025</td>
      <td>Triptolide</td>
      <td>DFBIRQPKNDILPW-CIVMWXNOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB02164</td>
      <td>N-Sulfo-Flavin Mononucleotide</td>
      <td>ZLPUGFBBLGQWBS-SCRDCRAPSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB11901</td>
      <td>Apalutamide</td>
      <td>HJBWBFZLDZWPHF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB03367</td>
      <td>PF-00356231</td>
      <td>VMTJQZUZINLEKC-JOCHJYFZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB11759</td>
      <td>Pevonedistat</td>
      <td>MPUQHZXIXSTTDU-QXGSTGNESA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB03104</td>
      <td>RU82129</td>
      <td>NKMPOVPTYDXGEC-MNRBYUMSSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB03076</td>
      <td>AHA047</td>
      <td>CGBDAHCDSVOMCF-FYZVQMPESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB08674</td>
      <td>(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE</td>
      <td>USPFJPDEADLGIG-HSZRJFAPSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB02691</td>
      <td>Glycocholic acid</td>
      <td>RFDAIACWWDREDC-FRVQLJSFSA-M</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB08708</td>
      <td>N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine</td>
      <td>XYYDXQCAYXOGQT-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB02545</td>
      <td>Fexaramine</td>
      <td>VLQTUNDJHLEFEQ-KGENOOAVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB11794</td>
      <td>Berzosertib</td>
      <td>JZCWLJDSIRUGIN-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB13422</td>
      <td>Nicofuranose</td>
      <td>FUWFSXZKBMCSKF-ZASNTINBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB11796</td>
      <td>Fostemsavir</td>
      <td>SWMDAPWAQQTBOG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB02259</td>
      <td>3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide</td>
      <td>VSYGXLAJQDAWCZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB02123</td>
      <td>Glycochenodeoxycholic Acid</td>
      <td>GHCZAUBVMUEKKP-GYPHWSFCSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB02033</td>
      <td>N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide</td>
      <td>GDRNWAKVNIROCG-DEOSSOPVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB09030</td>
      <td>Vorapaxar</td>
      <td>ZBGXUVOIWDMMJE-QHNZEKIYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB01908</td>
      <td>RU85493</td>
      <td>MWEWSHNGVWABKG-SVBPBHIXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB09195</td>
      <td>Lorpiprazole</td>
      <td>BNRMWKUVWLKDQJ-YJBOKZPZSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB12267</td>
      <td>Brigatinib</td>
      <td>AILRADAXUVEEIR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB15034</td>
      <td>PRI-724</td>
      <td>VHOZWHQPEJGPCC-AZXNYEMZSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB11832</td>
      <td>Crenolanib</td>
      <td>DYNHJHQFHQTFTP-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB01640</td>
      <td>(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One</td>
      <td>QNURTFDBHAQRSI-OAHLLOKOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB00275</td>
      <td>Olmesartan</td>
      <td>VTRAEEWXHOVJFV-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB08036</td>
      <td>6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one</td>
      <td>MEXUTNIFSHFQRG-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB07794</td>
      <td>5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE</td>
      <td>XVECMUKVOMUNLE-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB04852</td>
      <td>Implitapide</td>
      <td>AMNXBQPRODZJQR-DITALETJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB07622</td>
      <td>1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA</td>
      <td>KRKQVGZXTNLQSV-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB08001</td>
      <td>5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID</td>
      <td>DQSRCEFDWMQCCV-GQCTYLIASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB04716</td>
      <td>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</td>
      <td>VNDWQCSOSCCWIP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB04612</td>
      <td>N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE</td>
      <td>QKPXPZYQPBWDHS-MCJAPYMPSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB04608</td>
      <td>9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</td>
      <td>IAUZTOZLTFSMIE-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB04591</td>
      <td>N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE</td>
      <td>VYJOAYZRCNHDNG-GOSISDBHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB04575</td>
      <td>Quinestrol</td>
      <td>PWZUUYSISTUNDW-VAFBSOEGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB08749</td>
      <td>3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE</td>
      <td>KTRFBFMYAJOXLG-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB04452</td>
      <td>Aminoquinuride</td>
      <td>HOUSDILKOJMENG-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB07970</td>
      <td>5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide</td>
      <td>SAAYRHKJHDIDPH-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB04190</td>
      <td>Inhibitor Bea425</td>
      <td>AHAVBKNGKPWROK-UMFPTGFGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB08303</td>
      <td>(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide</td>
      <td>CUMKMTBOHBENJI-SFHVURJKSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB08345</td>
      <td>4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>IWUUKHQIKFHWIW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB08406</td>
      <td>[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE</td>
      <td>NXCCIJQEAKMFGW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB00288</td>
      <td>Amcinonide</td>
      <td>ILKJAFIWWBXGDU-MOGDOJJUSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB00276</td>
      <td>Amsacrine</td>
      <td>XCPGHVQEEXUHNC-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB04421</td>
      <td>Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct</td>
      <td>BZJFKYRGSZWSLT-YLIVDTKOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB01586</td>
      <td>Ursodeoxycholic acid</td>
      <td>RUDATBOHQWOJDD-UZVSRGJWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB11697</td>
      <td>Pacritinib</td>
      <td>HWXVIOGONBBTBY-ONEGZZNKSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB01501</td>
      <td>Difenoxin</td>
      <td>UFIVBRCCIRTJTN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB12966</td>
      <td>Falnidamol</td>
      <td>FTFRZXFNZVCRSK-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB15440</td>
      <td>GSK-3117391</td>
      <td>AFDPFLDWOXXHQM-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB15360</td>
      <td>Carfentanil, C-11</td>
      <td>YDSDEBIZUNNPOB-JVVVGQRLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB15324</td>
      <td>ORM-13070 C-11</td>
      <td>VGIYMYGMVXPMKV-GWDMYEQXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB14703</td>
      <td>Dexamethasone metasulfobenzoate</td>
      <td>TWQWRHIQRAZHPR-XNXCGYEVSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB13384</td>
      <td>Melitracen</td>
      <td>GWWLWDURRGNSRS-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB12513</td>
      <td>Omaveloxolone</td>
      <td>RJCWBNBKOKFWNY-IDPLTSGASA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB15224</td>
      <td>Lisavanbulin</td>
      <td>NIPZLALJRAHABJ-IBGZPJMESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB13520</td>
      <td>Metergoline</td>
      <td>WZHJKEUHNJHDLS-QTGUNEKASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB12221</td>
      <td>Canrenone</td>
      <td>UJVLDDZCTMKXJK-WNHSNXHDSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB15186</td>
      <td>GDC-0084</td>
      <td>LGWACEZVCMBSKW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB12703</td>
      <td>Omipalisib</td>
      <td>CGBJSGAELGCMKE-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB14017</td>
      <td>H3B-8800</td>
      <td>YOIQWBAHJZGRFW-WVRLKXNASA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB15096</td>
      <td>18-methoxycoronaridine</td>
      <td>DTJQBBHYRQYDEG-SVBQBFEESA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB14860</td>
      <td>Ensartinib</td>
      <td>GLYMPHUVMRFTFV-QLFBSQMISA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB15075</td>
      <td>4-demethyl-4-cholesteryloxycarbonylpenclomedine</td>
      <td>ZJUUIXYKTPSIOH-LEZJFEBPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB00197</td>
      <td>Troglitazone</td>
      <td>GXPHKUHSUJUWKP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB14993</td>
      <td>Pyrotinib</td>
      <td>SADXACCFNXBCFY-IYNHSRRRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB13649</td>
      <td>Proquazone</td>
      <td>JTIGKVIOEQASGT-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB14995</td>
      <td>NP-G2-044</td>
      <td>XLLRLAABUFOJPC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6crv</td>
      <td>DB15169</td>
      <td>H3B-6527</td>
      <td>MBWRLLRCTIYXDW-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB14792</td>
      <td>AZD-5991</td>
      <td>KBQCEQAXHPIRTF-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB12154</td>
      <td>Itacitinib</td>
      <td>KTBSXLIQKWEBRB-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB12910</td>
      <td>Emicerfont</td>
      <td>JFHJGXQFESYQGY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB01411</td>
      <td>Pranlukast</td>
      <td>NBQKINXMPLXUET-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB01406</td>
      <td>Danazol</td>
      <td>POZRVZJJTULAOH-LHZXLZLDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB14989</td>
      <td>Umbralisib</td>
      <td>IUVCFHHAEHNCFT-INIZCTEOSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB11786</td>
      <td>Pefcalcitol</td>
      <td>SVCSMAZYWOQCBW-NVJMFHFGSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB01336</td>
      <td>Metocurine</td>
      <td>JFXBEKISTKFVAB-AJQTZOPKSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB01267</td>
      <td>Paliperidone</td>
      <td>PMXMIIMHBWHSKN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB11851</td>
      <td>Bafetinib</td>
      <td>ZGBAJMQHJDFTQJ-DEOSSOPVSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB14883</td>
      <td>Lorecivivint</td>
      <td>AQDWDWAYVBQMAM-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB00997</td>
      <td>Doxorubicin</td>
      <td>AOJJSUZBOXZQNB-TZSSRYMLSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB00977</td>
      <td>Ethinylestradiol</td>
      <td>BFPYWIDHMRZLRN-SLHNCBLASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB14882</td>
      <td>CEP-9722</td>
      <td>CTLOSZHDGZLOQE-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB12781</td>
      <td>Balaglitazone</td>
      <td>IETKPTYAGKZLKY-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB00846</td>
      <td>Flurandrenolide</td>
      <td>POPFMWWJOGLOIF-XWCQMRHXSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB00845</td>
      <td>Clofazimine</td>
      <td>WDQPAMHFFCXSNU-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB00836</td>
      <td>Loperamide</td>
      <td>RDOIQAHITMMDAJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB00796</td>
      <td>Candesartan cilexetil</td>
      <td>GHOSNRCGJFBJIB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB14822</td>
      <td>SB-649868</td>
      <td>ZJXIUGNEAIHSBI-IBGZPJMESA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB12858</td>
      <td>LY-377604</td>
      <td>RBSGUQYXRDKPAE-QFIPXVFZSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB00496</td>
      <td>Darifenacin</td>
      <td>HXGBXQDTNZMWGS-RUZDIDTESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB12888</td>
      <td>Ezutromid</td>
      <td>KSGCNXAZROJSNW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB00421</td>
      <td>Spironolactone</td>
      <td>LXMSZDCAJNLERA-ZHYRCANASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB05016</td>
      <td>Ataluren</td>
      <td>OOUGLTULBSNHNF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12477</td>
      <td>Perfluoro tert-butylcyclohexane</td>
      <td>VLTXBOGHSBHSAC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB00377</td>
      <td>Palonosetron</td>
      <td>CPZBLNMUGSZIPR-NVXWUHKLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB07537</td>
      <td>N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide</td>
      <td>CLEGTVIMOPPIBR-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08391</td>
      <td>6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE</td>
      <td>UBIIFKJMNRPNMT-CQSZACIVSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08366</td>
      <td>3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid</td>
      <td>XADCWKSMHQPTGH-OFBLZTNGSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08350</td>
      <td>5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE</td>
      <td>GYQRHHQPEMOLKH-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08339</td>
      <td>6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE</td>
      <td>ZIQFYVPVJZEOFS-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB15222</td>
      <td>GS-6620</td>
      <td>YAAQYJCOIFNMKX-RSTNYOGXSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08191</td>
      <td>4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid</td>
      <td>KSFDVNIKNYXUIP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB03944</td>
      <td>5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One</td>
      <td>IZLRMTJLQCLMKF-CYBMUJFWSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08080</td>
      <td>LATRUNCULIN B</td>
      <td>NSHPHXHGRHSMIK-JRIKCGFMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08073</td>
      <td>(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE</td>
      <td>YWTBGJGMTBHQTM-IBGZPJMESA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01047</td>
      <td>Fluocinonide</td>
      <td>WJOHZNCJWYWUJD-IUGZLZTKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08044</td>
      <td>ABT-341</td>
      <td>NVVSPGQEXMJZIR-BMIGLBTASA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07977</td>
      <td>3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>CGNHUSCKOHDSMR-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB04006</td>
      <td>[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone</td>
      <td>WUGJIPFLBOATGL-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07941</td>
      <td>PH-797804</td>
      <td>KCAJXIDMCNPGHZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB13276</td>
      <td>Idanpramine</td>
      <td>HVYGXNYMNHSBGD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07830</td>
      <td>(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE</td>
      <td>DIRIFWIKLRTNMB-DYVFJYSZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07827</td>
      <td>4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID</td>
      <td>FLTYDFYSVZBKOB-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07786</td>
      <td>1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>SMFRBBHLVBWHGB-DJJJIMSYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07778</td>
      <td>FAMOXADONE</td>
      <td>PCCSBWNGDMYFCW-QFIPXVFZSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB00482</td>
      <td>Celecoxib</td>
      <td>RZEKVGVHFLEQIL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB04006</td>
      <td>[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone</td>
      <td>WUGJIPFLBOATGL-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08557</td>
      <td>2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide</td>
      <td>XQKFKSJUBJPOLY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08903</td>
      <td>Bedaquiline</td>
      <td>QUIJNHUBAXPXFS-XLJNKUFUSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01327</td>
      <td>Cefazolin</td>
      <td>MLYYVTUWGNIJIB-BXKDBHETSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB02197</td>
      <td>4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide</td>
      <td>NKORVPQBJCGYEC-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB11830</td>
      <td>Mocetinostat</td>
      <td>HRNLUBSXIHFDHP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB02519</td>
      <td>Indirubin-5-Sulphonate</td>
      <td>IHBOEHLUIBMBMY-YPKPFQOOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB02524</td>
      <td>2',3'-O-{4-[Hydroxy(oxido)-??5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)</td>
      <td>XFMMHXLUHKBKQE-UHEGPQQHSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB11795</td>
      <td>GSK-2636771</td>
      <td>XTKLTGBKIDQGQL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB11789</td>
      <td>Hyodeoxycholic Acid</td>
      <td>DGABKXLVXPYZII-SIBKNCMHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB15168</td>
      <td>Cilofexor</td>
      <td>KZSKGLFYQAYZCO-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB11745</td>
      <td>Otenabant</td>
      <td>UNAZAADNBYXMIV-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB08875</td>
      <td>Cabozantinib</td>
      <td>ONIQOQHATWINJY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB11732</td>
      <td>Lasmiditan</td>
      <td>XEDHVZKDSYZQBF-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB11430</td>
      <td>Monensin</td>
      <td>GAOZTHIDHYLHMS-KEOBGNEYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB11424</td>
      <td>Lufenuron</td>
      <td>PWPJGUXAGUPAHP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB11176</td>
      <td>Zeaxanthin</td>
      <td>JKQXZKUSFCKOGQ-QAYBQHTQSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB02704</td>
      <td>(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide</td>
      <td>GQKBYZPVKVXMJL-LAFNQVRVSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01212</td>
      <td>Ceftriaxone</td>
      <td>VAAUVRVFOQPIGI-SPQHTLEESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB03124</td>
      <td>5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid</td>
      <td>LBAHOXPDTNUYCX-INIZCTEOSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB03159</td>
      <td>CRA_8696</td>
      <td>GAVRMVQHHVMXFD-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB09034</td>
      <td>Suvorexant</td>
      <td>JYTNQNCOQXFQPK-MRXNPFEDSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB03186</td>
      <td>U-Pi-a-Pi</td>
      <td>JIAJERGOUFOENU-LNAOLWRRSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB01326</td>
      <td>Cefamandole</td>
      <td>OLVCFLKTBJRLHI-AXAPSJFSSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07729</td>
      <td>3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide</td>
      <td>GAKOBKPDJJGRIL-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB04575</td>
      <td>Quinestrol</td>
      <td>PWZUUYSISTUNDW-VAFBSOEGSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07630</td>
      <td>N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE</td>
      <td>ARPFWVKYXJZULB-IAGOWNOFSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB07117</td>
      <td>5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE</td>
      <td>FMKQJGOROFNCGM-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB06777</td>
      <td>Chenodeoxycholic acid</td>
      <td>RUDATBOHQWOJDD-BSWAIDMHSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB06746</td>
      <td>ginkgolide-J</td>
      <td>LMEHVEUFNRJAAV-UKWFQYJJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB07126</td>
      <td>O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE</td>
      <td>OWXORKPNCHJYOF-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB00637</td>
      <td>Astemizole</td>
      <td>GXDALQBWZGODGZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB07144</td>
      <td>5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine</td>
      <td>XZXVRKHUCSXVBM-AWEZNQCLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB06882</td>
      <td>1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea</td>
      <td>HJWMLCDGRWWLAQ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB06680</td>
      <td>Asoprisnil</td>
      <td>GJMNAFGEUJBOCE-MEQIQULJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB06945</td>
      <td>N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide</td>
      <td>FOSWRYKPHVPIDJ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB06677</td>
      <td>Clazosentan</td>
      <td>LFWCJABOXHSRGC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB07175</td>
      <td>N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide</td>
      <td>CXQRKICWSCAUGW-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB06367</td>
      <td>Relacatib</td>
      <td>BWYBBMQLUKXECQ-GIVPXCGWSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB06350</td>
      <td>Elinogrel</td>
      <td>LGSDFTPAICUONK-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB06938</td>
      <td>4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide</td>
      <td>ZJLSMLDOCGOURY-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB00471</td>
      <td>Montelukast</td>
      <td>UCHDWCPVSPXUMX-TZIWLTJVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB05990</td>
      <td>Obeticholic acid</td>
      <td>ZXERDUOLZKYMJM-ZWECCWDJSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB05838</td>
      <td>OPC-51803</td>
      <td>INGXCNVWWKKWOO-LJQANCHMSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB05490</td>
      <td>AMG-131</td>
      <td>NMRWDFUZLLQSBN-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB05424</td>
      <td>Canertinib</td>
      <td>OMZCMEYTWSXEPZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB06558</td>
      <td>Tezosentan</td>
      <td>TUYWTLTWNJOZNY-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB06955</td>
      <td>3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid</td>
      <td>OAMCCJASDLMTOO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB00699</td>
      <td>Nicergoline</td>
      <td>YSEXMKHXIOCEJA-FVFQAYNVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB06240</td>
      <td>Tariquidar</td>
      <td>LGGHDPFKSSRQNS-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07605</td>
      <td>2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE</td>
      <td>DHDQMXPAANQKDC-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB04608</td>
      <td>9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</td>
      <td>IAUZTOZLTFSMIE-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB02269</td>
      <td>[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium</td>
      <td>UFKJQTGPBFWMGT-UHFFFAOYSA-O</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB00932</td>
      <td>Tipranavir</td>
      <td>SUJUHGSWHZTSEU-FYBSXPHGSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07493</td>
      <td>(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE</td>
      <td>IEQQJQHHJMQETK-YPKPFQOOSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB05129</td>
      <td>Elsamitrucin</td>
      <td>MGQRRMONVLMKJL-KWJIQSIXSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07453</td>
      <td>2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE</td>
      <td>VFMMPHCGEFXGIP-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB05327</td>
      <td>Ranirestat</td>
      <td>QCVNMNYRNIMDKV-QGZVFWFLSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07410</td>
      <td>[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID</td>
      <td>BYVXAUZOTGITQZ-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB03044</td>
      <td>1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea</td>
      <td>MVCOAUNKQVWQHZ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB03231</td>
      <td>3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide</td>
      <td>IXDQOBDHBWEZOH-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB05552</td>
      <td>TG100-115</td>
      <td>UJIAQDJKSXQLIT-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB06532</td>
      <td>Pafuramidine</td>
      <td>UKOQVLAXCBRRGH-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07395</td>
      <td>4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid</td>
      <td>NWQGDIBCFLDHDO-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB04238</td>
      <td>N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid</td>
      <td>GNANSBQAIRJZPA-XZOQPEGZSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB04727</td>
      <td>N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA</td>
      <td>FGZIONRFHVNRJB-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07159</td>
      <td>Tamatinib</td>
      <td>NHHQJBCNYHBUSI-UHFFFAOYSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lxt</td>
      <td>DB07145</td>
      <td>(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE</td>
      <td>YDMIPBHQKFOFQW-NSYGIPOTSA-N</td>
      <td>S2 unit</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB06733</td>
      <td>Bafilomycin A1</td>
      <td>XDHNQDDQEHDUTM-JQWOJBOSSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>7bv1</td>
      <td>DB07076</td>
      <td>6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE</td>
      <td>FWTQOPWAMQXIMI-UHFFFAOYSA-N</td>
      <td>nsp12-nsp7-nsp8</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB05263</td>
      <td>Caprospinol</td>
      <td>VMOZFSWFUBLCNN-AAPULDEBSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4b</td>
      <td>DB07586</td>
      <td>5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE</td>
      <td>DOPFUKKMSDUVTQ-UHFFFAOYSA-N</td>
      <td>nsp9</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03619</td>
      <td>Deoxycholic Acid</td>
      <td>KXGVEGMKQFWNSR-LLQZFEROSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB11372</td>
      <td>Altrenogest</td>
      <td>VWAUPFMBXBWEQY-ANULTFPQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08422</td>
      <td>[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE</td>
      <td>GEIDRYBJURDUSW-MOPGFXCFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB09383</td>
      <td>Meprednisone</td>
      <td>PIDANAQULIKBQS-RNUIGHNZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB11753</td>
      <td>Rifamycin</td>
      <td>HJYYPODYNSCCOU-ODRIEIDWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12743</td>
      <td>Z-160</td>
      <td>VCPMZDWBEWTGNW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB09226</td>
      <td>RP-5063</td>
      <td>PMKMNTBZJOXTJW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB11772</td>
      <td>Pilaralisib</td>
      <td>QINPEPAQOBZPOF-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB09200</td>
      <td>Rivoglitazone</td>
      <td>XMSXOLDPMGMWTH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB09172</td>
      <td>Brifentanil</td>
      <td>KKMGCTVJCQYQPV-WBVHZDCISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB09119</td>
      <td>Eslicarbazepine acetate</td>
      <td>QIALRBLEEWJACW-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB09083</td>
      <td>Ivabradine</td>
      <td>ACRHBAYQBXXRTO-OAQYLSRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB03666</td>
      <td>3'-Azido-3'-Deoxythymidine-5'-Monophosphate</td>
      <td>OIFWQOKDSPDILA-XLPZGREQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12802</td>
      <td>Picropodophyllin</td>
      <td>YJGVMLPVUAXIQN-HAEOHBJNSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB02081</td>
      <td>Bis-Benzamidine</td>
      <td>BXYGSMRTHHSAHZ-PMACEKPBSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB09070</td>
      <td>Tibolone</td>
      <td>WZDGZWOAQTVYBX-XOINTXKNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB00897</td>
      <td>Triazolam</td>
      <td>JOFWLTCLBGQGBO-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12858</td>
      <td>LY-377604</td>
      <td>RBSGUQYXRDKPAE-QFIPXVFZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12939</td>
      <td>Nikkomycin Z</td>
      <td>WWJFFVUVFNBJTN-VHDFTHOZSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08950</td>
      <td>Indoramin</td>
      <td>JXZZEXZZKAWDSP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08927</td>
      <td>Amperozide</td>
      <td>NNAIYOXJNVGUOM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB03714</td>
      <td>4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid</td>
      <td>OWWCIKSGGKYNHT-ZDUSSCGKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB03718</td>
      <td>6-Aza-Ump</td>
      <td>LRVZOSYMNMNQFR-SHUUEZRQSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12823</td>
      <td>Tecarfarin</td>
      <td>QFLNTQDOVCLQKW-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB11822</td>
      <td>TMC-647055</td>
      <td>UOBYJVFBFSLCTQ-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB11743</td>
      <td>Ipatasertib</td>
      <td>GRZXWCHAXNAUHY-NSISKUIASA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12670</td>
      <td>Rolofylline</td>
      <td>PJBFVWGQFLYWCB-QUYAXPHCSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB11663</td>
      <td>Pictilisib</td>
      <td>LHNIIDJUOCFXAP-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11818</td>
      <td>Retosiban</td>
      <td>PLVGDGRBPMVYPB-FDUHJNRSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11793</td>
      <td>Niraparib</td>
      <td>PCHKPVIQAHNQLW-CQSZACIVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11792</td>
      <td>Mirodenafil</td>
      <td>MIJFNYMSCFYZNY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11789</td>
      <td>Hyodeoxycholic Acid</td>
      <td>DGABKXLVXPYZII-SIBKNCMHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11753</td>
      <td>Rifamycin</td>
      <td>HJYYPODYNSCCOU-ODRIEIDWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB11686</td>
      <td>Iferanserin</td>
      <td>UXIPFQUBOVWAQW-UEBLJOKOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB11692</td>
      <td>Pavinetant</td>
      <td>QYTBBBAHNIWFOD-NRFANRHFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB03186</td>
      <td>U-Pi-a-Pi</td>
      <td>JIAJERGOUFOENU-LNAOLWRRSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12675</td>
      <td>PF-04995274</td>
      <td>WLLOFQROROXOMO-GOSISDBHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12279</td>
      <td>OBP-801</td>
      <td>XFLBOEMFLGLWFF-HDXRNPEWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB04632</td>
      <td>4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE</td>
      <td>JHHBGNIRSUTQAS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11650</td>
      <td>HT-0712</td>
      <td>ABEJDMOBAFLQNJ-NHCUHLMSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB03234</td>
      <td>(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone</td>
      <td>YATCZCSDJCQNAL-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11591</td>
      <td>Bilastine</td>
      <td>ACCMWZWAEFYUGZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11521</td>
      <td>Imidocarb</td>
      <td>SCEVFJUWLLRELN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11440</td>
      <td>Norgestomet</td>
      <td>IWSXBCZCPVUWHT-VIFKTUCRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB03235</td>
      <td>N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide</td>
      <td>UEIGEWJJVQHIAX-MKQKURRLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB03601</td>
      <td>5-deoxyflavanone</td>
      <td>FURUXTVZLHCCNA-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12663</td>
      <td>Letrazuril</td>
      <td>XQKYUBTUOHHNDV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB02152</td>
      <td>K-252a</td>
      <td>KOZFSFOOLUUIGY-SOLYNIJKSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11859</td>
      <td>Brexanolone</td>
      <td>AURFZBICLPNKBZ-SYBPFIFISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB04608</td>
      <td>9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE</td>
      <td>IAUZTOZLTFSMIE-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB04867</td>
      <td>Lintitript</td>
      <td>ILNRQFBVVQUOLP-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB13579</td>
      <td>Mepixanox</td>
      <td>PYSOHOOUXFWCFF-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB04432</td>
      <td>ZK-805623</td>
      <td>ZXIHYCYAQUQHSG-UHFFFAOYSA-O</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08037</td>
      <td>(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide</td>
      <td>MYBGWENAVMIGMM-GIFXNVAJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08023</td>
      <td>N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine</td>
      <td>HYNNWLVWJXWXFO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07993</td>
      <td>N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE</td>
      <td>LPQUIIHPUGDHJK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07988</td>
      <td>2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE</td>
      <td>HZAXNPDJVFUGDS-BYPYZUCNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07984</td>
      <td>2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide</td>
      <td>GKJWXEORYGBJFS-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07981</td>
      <td>2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide</td>
      <td>GKJWXEORYGBJFS-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB13651</td>
      <td>Lorajmine</td>
      <td>LAHDERDHXJFFJU-ZWNKPRIXSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB05399</td>
      <td>Succinobucol</td>
      <td>RKSMVPNZHBRNNS-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB05616</td>
      <td>4'-Methylene-5,8,10-trideazaaminopterin</td>
      <td>NAWXUBYGYWOOIX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB13866</td>
      <td>Etynodiol</td>
      <td>JYILPERKVHXLNF-QMNUTNMBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB05804</td>
      <td>Prasterone sulfate</td>
      <td>CZWCKYRVOZZJNM-USOAJAOKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB05884</td>
      <td>HCV-086</td>
      <td>VBRUONUESYTIDA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB05903</td>
      <td>KOS-1584</td>
      <td>XAYAKDZVINDZGB-BMVMHAJPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12010</td>
      <td>Fostamatinib</td>
      <td>GKDRMWXFWHEQQT-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB04040</td>
      <td>N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide</td>
      <td>MCMWCTMAKPQTPI-WGNYYXNJSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07815</td>
      <td>GIBBERELLIN A4</td>
      <td>RSQSQJNRHICNNH-NFMPGMCNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12027</td>
      <td>Serdemetan</td>
      <td>CEGSUKYESLWKJP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB14210</td>
      <td>Moexiprilat</td>
      <td>CMPAGYDKASJORH-YSSFQJQWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07934</td>
      <td>[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE</td>
      <td>KMUXFASJKPVMGU-HXUWFJFHSA-O</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08807</td>
      <td>Bopindolol</td>
      <td>UUOJIACWOAYWEZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB05294</td>
      <td>Vandetanib</td>
      <td>UHTHHESEBZOYNR-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08130</td>
      <td>N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine</td>
      <td>FPDWDLAITHFTTP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB04158</td>
      <td>6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin</td>
      <td>ZKRKFZJAQKKHKL-SUGPNEFASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB13327</td>
      <td>Picotamide</td>
      <td>KYWCWBXGRWWINE-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB13374</td>
      <td>Vincamine</td>
      <td>RXPRRQLKFXBCSJ-GIVPXCGWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08609</td>
      <td>(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide</td>
      <td>SHEIQJGQDUYUBE-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08582</td>
      <td>N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide</td>
      <td>DELARNBPJXTDBD-IYBDPMFKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB13386</td>
      <td>Epimestrol</td>
      <td>UHQGCIIQUZBJAE-RRQVMCLOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB04204</td>
      <td>[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid</td>
      <td>SRHSAABKYJDBDV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08560</td>
      <td>3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE</td>
      <td>GULUFDCOGAXLEP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08539</td>
      <td>3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>CCDIUVLNHCGSMH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB11952</td>
      <td>Duvelisib</td>
      <td>SJVQHLPISAIATJ-ZDUSSCGKSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB04862</td>
      <td>Merimepodib</td>
      <td>JBPUGFODGPKTDW-SFHVURJKSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08383</td>
      <td>4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole</td>
      <td>XBMULXNXJLWLLD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08379</td>
      <td>6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one</td>
      <td>NOVPOXGMADEKPP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB11912</td>
      <td>Lanopepden</td>
      <td>SWHNZGMQMGFQGW-MSOLQXFVSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08345</td>
      <td>4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE</td>
      <td>IWUUKHQIKFHWIW-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB11923</td>
      <td>Decoglurant</td>
      <td>DMJHZVARRXJSEG-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08240</td>
      <td>N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE</td>
      <td>RQAQWBFHPMSXKR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB03742</td>
      <td>Compound 4-D</td>
      <td>TWZNCTCQAGRUGQ-RRPNLBNLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08223</td>
      <td>N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE</td>
      <td>IKOPFHKAECNGQI-VQTJNVASSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08137</td>
      <td>(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide</td>
      <td>ZMWYSLJBNJUCRK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB08487</td>
      <td>3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE</td>
      <td>PRMSFVUWLBPPLY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12238</td>
      <td>MK-0777</td>
      <td>QKIWQBLNTSQOLY-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11890</td>
      <td>Cilengitide</td>
      <td>AMLYAMJWYAIXIA-VWNVYAMZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11910</td>
      <td>MK-0249</td>
      <td>DDDZBLNULGDPGA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11491</td>
      <td>Sarafloxacin</td>
      <td>XBHBWNFJWIASRO-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB06011</td>
      <td>AMG-222</td>
      <td>NVSWJKWHLUTHLP-CPJSRVTESA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13739</td>
      <td>Penamecillin</td>
      <td>NLOOMWLTUVBWAW-HLLBOEOZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11582</td>
      <td>Thiocolchicoside</td>
      <td>LEQAKWQJCITZNK-AXHKHJLKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13571</td>
      <td>Pentamycin</td>
      <td>AGJUUQSLGVCRQA-SWOUQTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13563</td>
      <td>Norgestrienone</td>
      <td>GVDMJXQHPUYPHP-FYQPLNBISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13520</td>
      <td>Metergoline</td>
      <td>WZHJKEUHNJHDLS-QTGUNEKASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13484</td>
      <td>Quinbolone</td>
      <td>IUVKMZGDUIUOCP-BTNSXGMBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13461</td>
      <td>Cefcapene</td>
      <td>HJJRIJDTIPFROI-NVKITGPLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13936</td>
      <td>JNJ-28330835</td>
      <td>RYBKPGYFXRNMMU-LBPRGKRZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB01708</td>
      <td>Prasterone</td>
      <td>FMGSKLZLMKYGDP-USOAJAOKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13418</td>
      <td>Moxestrol</td>
      <td>MTMZZIPTQITGCY-OLGWUGKESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13393</td>
      <td>Emetine</td>
      <td>AUVVAXYIELKVAI-CKBKHPSWSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11622</td>
      <td>Dehydrocholic acid</td>
      <td>OHXPGWPVLFPUSM-KLRNGDHRSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13371</td>
      <td>Difenpiramide</td>
      <td>PWHROYKAGRUWDQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11636</td>
      <td>Nomegestrol</td>
      <td>KZUIYQJTUIACIG-YBZCJVABSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11665</td>
      <td>BMS-690514</td>
      <td>CSGQVNMSRKWUSH-IAGOWNOFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11687</td>
      <td>E-6201</td>
      <td>MWUFVYLAWAXDHQ-HMNLTAHHSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11703</td>
      <td>Acalabrutinib</td>
      <td>WDENQIQQYWYTPO-IBGZPJMESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11725</td>
      <td>Latrepirdine</td>
      <td>JNODQFNWMXFMEV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13432</td>
      <td>Lonazolac</td>
      <td>XVUQHFRQHBLHQD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB11176</td>
      <td>Zeaxanthin</td>
      <td>JKQXZKUSFCKOGQ-QAYBQHTQSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB13954</td>
      <td>Estradiol cypionate</td>
      <td>UOACKFBJUYNSLK-XRKIENNPSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB01320</td>
      <td>Fosphenytoin</td>
      <td>XWLUWCNOOVRFPX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14914</td>
      <td>Flortaucipir F-18</td>
      <td>GETAAWDSFUCLBS-SJPDSGJFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB09076</td>
      <td>Umeclidinium</td>
      <td>FVTWTVQXNAJTQP-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB02336</td>
      <td>RU83876</td>
      <td>WCMLXBUNHNAMNH-UIOOFZCWSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14802</td>
      <td>ONO-2952</td>
      <td>ZBQMTQGDBFZUBG-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14799</td>
      <td>PF-06821497</td>
      <td>RXCVUHMIWHRLDF-HXUWFJFHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB00910</td>
      <td>Paricalcitol</td>
      <td>BPKAHTKRCLCHEA-UBFJEZKGSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB09209</td>
      <td>Pholcodine</td>
      <td>GPFAJKDEDBRFOS-FKQDBXSBSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB00920</td>
      <td>Ketotifen</td>
      <td>ZCVMWBYGMWKGHF-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB09274</td>
      <td>Artesunate</td>
      <td>FIHJKUPKCHIPAT-AHIGJZGOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11398</td>
      <td>Diclazuril</td>
      <td>ZSZFUDFOPOMEET-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14769</td>
      <td>Pamiparib</td>
      <td>DENYZIUJOTUUNY-MRXNPFEDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB01192</td>
      <td>Oxymorphone</td>
      <td>UQCNKQCJZOAFTQ-ISWURRPUSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14659</td>
      <td>Melengestrol acetate</td>
      <td>UDKABVSQKJNZBH-DWNQPYOZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB01195</td>
      <td>Flecainide</td>
      <td>DJBNUMBKLMJRSA-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14653</td>
      <td>Clocortolone caproate</td>
      <td>MMTRTBFDFNRBQO-ANHDKODLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB09292</td>
      <td>Sacubitril</td>
      <td>PYNXFZCZUAOOQC-UTKZUKDTSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14633</td>
      <td>Prednisolone hemisuccinate</td>
      <td>APGDTXUMTIZLCJ-CGVGKPPMSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14624</td>
      <td>Nandrolone hydrogen sulfate</td>
      <td>SKZMVWBZTQNCKW-IZPLOLCNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB09319</td>
      <td>Carindacillin</td>
      <td>JIRBAUWICKGBFE-MNRDOXJOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11395</td>
      <td>Deracoxib</td>
      <td>WAZQAZKAZLXFMK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB14765</td>
      <td>Rivoceranib</td>
      <td>WPEWQEMJFLWMLV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB01752</td>
      <td>S-adenosyl-L-homocysteine</td>
      <td>ZJUKTBDSGOFHSH-WFMPWKQPSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12985</td>
      <td>Quisinostat</td>
      <td>PAWIYAYFNXQGAP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12974</td>
      <td>Roniciclib</td>
      <td>UELYDGOOJPRWGF-SRQXXRKNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12492</td>
      <td>Piritramide</td>
      <td>IHEHEFLXQFOQJO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12419</td>
      <td>HSD-016</td>
      <td>ZWASRJHIEFYJGL-BFUOFWGJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB11431</td>
      <td>Moxidectin</td>
      <td>YZBLFMPOMVTDJY-LSGXYNIPSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12367</td>
      <td>Selurampanel</td>
      <td>MCECSFFXUPEPDB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12283</td>
      <td>Balapiravir</td>
      <td>VKXWOLCNTHXCLF-DXEZIKHYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12081</td>
      <td>Anecortave</td>
      <td>BCFCRXOJOFDUMZ-ONKRVSLGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12218</td>
      <td>AZD-5363</td>
      <td>JDUBGYFRJFOXQC-KRWDZBQOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12204</td>
      <td>Terbogrel</td>
      <td>XUTLOCQNGLJNSA-RGVLZGJSSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12095</td>
      <td>Telotristat ethyl</td>
      <td>MDSQOJYHHZBZKA-GBXCKJPGSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12068</td>
      <td>T-900607</td>
      <td>FSXLOWIFSZNIMV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB11511</td>
      <td>Difloxacin</td>
      <td>NOCJXYPHIIZEHN-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12124</td>
      <td>Namitecan</td>
      <td>IBTISPLPBBHVSU-UVOOVGFISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12092</td>
      <td>Naftopidil</td>
      <td>HRRBJVNMSRJFHQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12129</td>
      <td>Tideglusib</td>
      <td>PMJIHLSCWIDGMD-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB02197</td>
      <td>4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide</td>
      <td>NKORVPQBJCGYEC-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB05197</td>
      <td>Sofalcone</td>
      <td>GFWRVVCDTLRWPK-KPKJPENVSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11987</td>
      <td>GSK-2018682</td>
      <td>NFIGDBFIDKDNIG-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB11611</td>
      <td>Lifitegrast</td>
      <td>JFOZKMSJYSPYLN-QHCPKHFHSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB11964</td>
      <td>Ilaprazole</td>
      <td>HRRXCXABAPSOCP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB12207</td>
      <td>Verdinexor</td>
      <td>OPAKEJZFFCECPN-XQRVVYSFSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB05327</td>
      <td>Ranirestat</td>
      <td>QCVNMNYRNIMDKV-QGZVFWFLSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12507</td>
      <td>Atecegatran metoxil</td>
      <td>XSNMGLZVFNDDPW-ZWKOTPCHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12511</td>
      <td>Imiglitazar</td>
      <td>ULVDFHLHKNJICZ-QCWLDUFUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB04645</td>
      <td>5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID</td>
      <td>NJJIFGCFUDDBSP-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12972</td>
      <td>Sepranolone</td>
      <td>AURFZBICLPNKBZ-FZCSVUEKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11765</td>
      <td>PF-04991532</td>
      <td>GKMLFBRLRVQVJO-ZDUSSCGKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11784</td>
      <td>NRX-1074</td>
      <td>DVBUEXCIEIAXPM-PJUQSVSOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB11274</td>
      <td>Dihydro-alpha-ergocryptine</td>
      <td>PBUNVLRHZGSROC-VTIMJTGVSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB04669</td>
      <td>TRIAZOLOPYRIMIDINE</td>
      <td>YWBFPKPWMSWWEA-UHFFFAOYSA-O</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB05616</td>
      <td>4'-Methylene-5,8,10-trideazaaminopterin</td>
      <td>NAWXUBYGYWOOIX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12740</td>
      <td>CC-115</td>
      <td>GMYLVKUGJMYTFB-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12732</td>
      <td>Firategrast</td>
      <td>YLFZHHDVRSYTKT-NRFANRHFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12707</td>
      <td>AR-42</td>
      <td>LAMIXXKAWNLXOC-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB11363</td>
      <td>Alectinib</td>
      <td>KDGFLJKFZUIJMX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB02621</td>
      <td>Latrunculin A</td>
      <td>DDVBPZROPPMBLW-IZGXTMSKSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11824</td>
      <td>Tofogliflozin</td>
      <td>VWVKUNOPTJGDOB-BDHVOXNPSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12645</td>
      <td>Givinostat</td>
      <td>YALNUENQHAQXEA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12643</td>
      <td>Nelivaptan</td>
      <td>NJXZWIIMWNEOGJ-WEWKHQNJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12622</td>
      <td>Lupeol</td>
      <td>MQYXUWHLBZFQQO-QGTGJCAVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12612</td>
      <td>Ozanimod</td>
      <td>XRVDGNKRPOAQTN-FQEVSTJZSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB02712</td>
      <td>Sorbinil</td>
      <td>LXANPKRCLVQAOG-NSHDSACASA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12590</td>
      <td>Indiplon</td>
      <td>CBIAWPMZSFFRGN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB12579</td>
      <td>JNJ-37822681</td>
      <td>UVUYWJWYRLJHEN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11886</td>
      <td>Infigratinib</td>
      <td>QADPYRIHXKWUSV-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB11912</td>
      <td>Lanopepden</td>
      <td>SWHNZGMQMGFQGW-MSOLQXFVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB14626</td>
      <td>Pregnenolone acetate</td>
      <td>CRRKVZVYZQXICQ-RJJCNJEVSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07788</td>
      <td>(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE</td>
      <td>NEQZWEXWOFPKOT-QHSZRYGNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB11939</td>
      <td>Henagliflozin</td>
      <td>HYTPDMFFHVZBOR-VNXMGFANSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07787</td>
      <td>5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE</td>
      <td>PNPFDRCIGCUCMN-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06533</td>
      <td>Ragaglitazar</td>
      <td>WMUIIGVAWPWQAW-XMMPIXPASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06457</td>
      <td>Tecastemizole</td>
      <td>SFOVDSLXFUGAIV-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB03712</td>
      <td>RU85053</td>
      <td>CEKLBQMULVLLTD-VMPREFPWSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12280</td>
      <td>AZD-5423</td>
      <td>FCNQMDSJHADDFT-WNSKOXEYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB03966</td>
      <td>Clorobiocin</td>
      <td>FJAQNRBDVKIIKK-LFLQOBSNSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06345</td>
      <td>AR-9281</td>
      <td>HUDQLWBKJOMXSZ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07540</td>
      <td>4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE</td>
      <td>AKFVRSQELXTCFW-JYRVWZFOSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB03325</td>
      <td>Tyrosyladenylate</td>
      <td>MJZAZMKENKZBAJ-QTOWJTHWSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB03571</td>
      <td>3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide</td>
      <td>JMQTXEWNXSPEKX-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12289</td>
      <td>Darexaban</td>
      <td>IJNIQYINMSGIPS-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06250</td>
      <td>Fluasterone</td>
      <td>VHZXNQKVFDBFIK-NBBHSKLNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06249</td>
      <td>Arzoxifene</td>
      <td>MCGDSOGUHLTADD-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06160</td>
      <td>Garenoxacin</td>
      <td>NJDRXTDGYFKORP-LLVKDONJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06134</td>
      <td>SNS-314</td>
      <td>FAYAUAZLLLJJGH-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB05990</td>
      <td>Obeticholic acid</td>
      <td>ZXERDUOLZKYMJM-ZWECCWDJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB03247</td>
      <td>Flavin mononucleotide</td>
      <td>FVTCRASFADXXNN-SCRDCRAPSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB05936</td>
      <td>CVT-6883</td>
      <td>KOYXXLLNCXWUNF-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB05884</td>
      <td>HCV-086</td>
      <td>VBRUONUESYTIDA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB05738</td>
      <td>Vapitadine</td>
      <td>VQWGYPVNVICKFC-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06257</td>
      <td>HE-2200</td>
      <td>OEVZKEVBDIDVOI-YSZCXEEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB05590</td>
      <td>Bedoradrine</td>
      <td>OANCEOSLKSTLTA-REWPJTCUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12247</td>
      <td>AZD-4547</td>
      <td>VRQMAABPASPXMW-HDICACEKSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06670</td>
      <td>Odanacatib</td>
      <td>FWIVDMJALNEADT-SFTDATJTSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB01988</td>
      <td>6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine</td>
      <td>WFSFNKVFXLIZIY-MHZLTWQESA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12174</td>
      <td>CUDC-101</td>
      <td>PLIVFNIUGLLCEK-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07159</td>
      <td>Tamatinib</td>
      <td>NHHQJBCNYHBUSI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07161</td>
      <td>5-phenyl-1H-indazol-3-amine</td>
      <td>ZCUSNQPYUNLATP-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB02551</td>
      <td>6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine</td>
      <td>LVNMYQLXKMSQTG-AWEZNQCLSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07021</td>
      <td>(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine</td>
      <td>SOSYXEPELJIJHZ-RNCFNFMXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07015</td>
      <td>(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine</td>
      <td>XDSKICAQKGYYJF-OLZOCXBDSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06977</td>
      <td>(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine</td>
      <td>CAASENZOSQYNPX-HSTJUUNISA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB02581</td>
      <td>5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid</td>
      <td>VNZHOIDQBPFEJU-OAQYLSRUSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06634</td>
      <td>Casopitant</td>
      <td>XGGTZCKQRWXCHW-WMTVXVAQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06955</td>
      <td>3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid</td>
      <td>OAMCCJASDLMTOO-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06932</td>
      <td>10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine</td>
      <td>NVINUNQBDNEMSY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07192</td>
      <td>(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE</td>
      <td>MVPIURCUINFSAB-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB03072</td>
      <td>2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone</td>
      <td>LOFDUAJQRUYHBR-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06899</td>
      <td>N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE</td>
      <td>RMEVNJZCKDVVND-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB03082</td>
      <td>6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide</td>
      <td>CSWQJKHBMACTGB-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06856</td>
      <td>6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE</td>
      <td>HUYQYLFFFNSAAX-BUXKBTBVSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07210</td>
      <td>3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine</td>
      <td>JECHSYMSTXETFI-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB03466</td>
      <td>BMS184394</td>
      <td>AYAJZQYENGWICE-QHCPKHFHSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB06710</td>
      <td>Methyltestosterone</td>
      <td>GCKMFJBGXUYNAG-HLXURNFRSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12211</td>
      <td>PSI-697</td>
      <td>DIEPFYNZGUUVHD-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB01879</td>
      <td>(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid</td>
      <td>JOAALZBSMWLOPQ-LJAQVGFWSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB03213</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-P</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12339</td>
      <td>Radezolid</td>
      <td>BTTNOGHPGJANSW-IBGZPJMESA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04642</td>
      <td>7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID</td>
      <td>XQTOWNDCHQJXOQ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB02917</td>
      <td>N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide</td>
      <td>LFGYSFPVLMPUPE-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04596</td>
      <td>4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-??-D-mannopyranosyl}-D-glucopyranuronic acid</td>
      <td>GZJXZKGVHLWBOW-AISSFXTFSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04583</td>
      <td>5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid</td>
      <td>LAZPCGBRHLARSI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04582</td>
      <td>IMAZAQUIN</td>
      <td>CABMTIJINOIHOD-QGZVFWFLSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08054</td>
      <td>1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine</td>
      <td>GEZALMMCQYDFML-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12415</td>
      <td>Galeterone</td>
      <td>PAFKTGFSEFKSQG-PAASFTFBSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB07834</td>
      <td>N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide</td>
      <td>FOHZGCHKLPIBBX-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB07975</td>
      <td>2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID</td>
      <td>VTGXLCZUWFYELR-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04643</td>
      <td>4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID</td>
      <td>FYQVFMLCZJZZEM-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB08010</td>
      <td>(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime</td>
      <td>DDHASJXGNUWZTM-ZLEWNXFRSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB02759</td>
      <td>4-Methylumbelliferyl Chitobiose</td>
      <td>UPSFMJHZUCSEHU-JYGUBCOQSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB02723</td>
      <td>4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide</td>
      <td>DHTSUHWLPAEEQB-OALUTQOASA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08382</td>
      <td>Gosogliptin</td>
      <td>QWEWGXUTRTXFRF-KBPBESRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB08268</td>
      <td>6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE</td>
      <td>SPVJRTJUEVXOMS-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08390</td>
      <td>(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE</td>
      <td>AKNIHFDXRAOPAI-NRFANRHFSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04086</td>
      <td>2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside</td>
      <td>WFVCNOHOODVBQK-IUBYCILNSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04064</td>
      <td>Nogalaviketone</td>
      <td>QHNJNOBWURJIEK-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04037</td>
      <td>N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine</td>
      <td>UOUXILZUBDIWQU-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB08512</td>
      <td>6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one</td>
      <td>MCEZMMDIEXECTI-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB02915</td>
      <td>4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine</td>
      <td>MEZFDQUDLQCVNX-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB05524</td>
      <td>Pelitinib</td>
      <td>WVUNYSQLFKLYNI-AATRIKPKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12401</td>
      <td>Bromperidol</td>
      <td>RKLNONIVDFXQRX-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04716</td>
      <td>2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE</td>
      <td>VNDWQCSOSCCWIP-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB05288</td>
      <td>Anecortave acetate</td>
      <td>YUWPMEXLKGOSBF-GACAOOTBSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07588</td>
      <td>3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID</td>
      <td>FZDVNXHYGMEEDT-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12355</td>
      <td>Netazepide</td>
      <td>YDZYKNJZCVIKPP-VWLOTQADSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07664</td>
      <td>5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE</td>
      <td>ARIOBGGRZJITQX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07676</td>
      <td>3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one</td>
      <td>CKLAPOFDFZKCPB-LBPRGKRZSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04971</td>
      <td>Reglitazar</td>
      <td>QBQLYIISSRXYKL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB07084</td>
      <td>N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide</td>
      <td>YHKGWOJTUMJPNW-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04886</td>
      <td>Calanolide A</td>
      <td>NIDRYBLTWYFCFV-FMTVUPSXSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04885</td>
      <td>Cilansetron</td>
      <td>NCNFDKWULDWJDS-OAHLLOKOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08046</td>
      <td>2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide</td>
      <td>JIVPVXMEBJLZRO-AWEZNQCLSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB03916</td>
      <td>4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine</td>
      <td>RHOOHUMOHVIXEF-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07976</td>
      <td>3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID</td>
      <td>GIUMGVUBDBDTDX-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12379</td>
      <td>Indirubin</td>
      <td>CRDNMYFJWFXOCH-BUHFOSPRSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB03041</td>
      <td>UDP-alpha-D-glucuronic acid</td>
      <td>HDYANYHVCAPMJV-LXQIFKJMSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB07362</td>
      <td>1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea</td>
      <td>UOLCZAFAGDOUFX-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB07397</td>
      <td>(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide</td>
      <td>ITADELAVAWJACR-NSHDSACASA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04792</td>
      <td>2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL</td>
      <td>CDEVHSIVANGYRI-XMTFNYHQSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB08008</td>
      <td>5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine</td>
      <td>LRHHXKBKRNNFRV-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB04791</td>
      <td>2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL</td>
      <td>DKBAWRNTUZFJKV-BSDSXHPESA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB07691</td>
      <td>2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid</td>
      <td>GYILVHHTCYNIOS-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12371</td>
      <td>Siponimod</td>
      <td>KIHYPELVXPAIDH-HNSNBQBZSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB01405</td>
      <td>Temafloxacin</td>
      <td>QKDHBVNJCZBTMR-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB03336</td>
      <td>BIA</td>
      <td>KVIVJQWOYSWCCZ-UHFFFAOYSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB12096</td>
      <td>PF-05175157</td>
      <td>BDXXSFOJPYSYOC-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB15046</td>
      <td>LY-2881835</td>
      <td>FHRWHNJJQGSCQC-LJAQVGFWSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07403</td>
      <td>4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE</td>
      <td>DTDZLJHKVNTQGZ-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB03907</td>
      <td>N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide</td>
      <td>UHHBFOLQOQSPLU-WGRQDFERSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07473</td>
      <td>(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER</td>
      <td>JYIHODAXBBPFQF-MAUKXSAKSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07698</td>
      <td>3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine</td>
      <td>JDNMRPIWJIDDAY-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB15393</td>
      <td>Telatinib</td>
      <td>QFCXANHHBCGMAS-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6lzg</td>
      <td>DB01876</td>
      <td>Bis(5-Amidino-2-Benzimidazolyl)Methanone</td>
      <td>VVVXDHROXQUONB-UHFFFAOYSA-N</td>
      <td>ACE2 - CoV spike complex</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07242</td>
      <td>(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile</td>
      <td>XGUIMGJMQKZRGM-LLVKDONJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB14857</td>
      <td>Avadomide</td>
      <td>RSNPAKAFCAAMBH-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07584</td>
      <td>N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine</td>
      <td>OKGCSZUKOGMZAL-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12108</td>
      <td>Taselisib</td>
      <td>BEUQXVWXFDOSAQ-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB06834</td>
      <td>N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide</td>
      <td>XZRYCTLOGNCQDG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB01830</td>
      <td>{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid</td>
      <td>SPSGYTWOIGAABK-DQEYMECFSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12050</td>
      <td>LY-3039478</td>
      <td>YCBAQKQAINQRFW-UGSOOPFHSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07493</td>
      <td>(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE</td>
      <td>IEQQJQHHJMQETK-YPKPFQOOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07394</td>
      <td>AUROVERTIN B</td>
      <td>QXCOFYWOWZJFEA-YJMRODJJSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07269</td>
      <td>(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID</td>
      <td>SFUOOKBZBVUDBC-VQTJNVASSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB14717</td>
      <td>Nitrazolam</td>
      <td>OYRPNABWTHDOFK-UHFFFAOYSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB14867</td>
      <td>Parsaclisib</td>
      <td>ZQPDJCIXJHUERQ-QWRGUYRKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07519</td>
      <td>(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one</td>
      <td>VDFBMQAUECXNKR-OAQYLSRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07217</td>
      <td>N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide</td>
      <td>YVYPYORTKAIUGJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07763</td>
      <td>(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE</td>
      <td>OZZFJGCAYWBVBI-INIZCTEOSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB15333</td>
      <td>AZD-1386</td>
      <td>FPGNKXCEPARJDI-ZDUSSCGKSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB01051</td>
      <td>Novobiocin</td>
      <td>YJQPYGGHQPGBLI-KGSXXDOSSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07138</td>
      <td>Neflamapimod</td>
      <td>VEPKQEUBKLEPRA-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w4h</td>
      <td>DB03642</td>
      <td>Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide</td>
      <td>VBPPNJCVXGAZDD-PMACEKPBSA-N</td>
      <td>nsp16 - nsp10</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07638</td>
      <td>(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL</td>
      <td>QJSMFUTULGSHNQ-ZOBUZTSGSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07468</td>
      <td>(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one</td>
      <td>NJBBBRZNBVLTRZ-GOSISDBHSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07783</td>
      <td>1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE</td>
      <td>GUYYFMCFEPDDFL-OAQYLSRUSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07435</td>
      <td>1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE</td>
      <td>GFANZDFKCCJYRF-NSISKUIASA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB01938</td>
      <td>L-Histidine Beta Naphthylamide</td>
      <td>DKDILZBBFKZMRO-OAHLLOKOSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07643</td>
      <td>5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine</td>
      <td>XVLUVRFYGVJKGJ-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07764</td>
      <td>FLUORESCIN</td>
      <td>MURGITYSBWUQTI-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB14810</td>
      <td>AZD-1656</td>
      <td>FJEJHJINOKKDCW-INIZCTEOSA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB06678</td>
      <td>Esmirtazapine</td>
      <td>RONZAEMNMFQXRA-MRXNPFEDSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB07146</td>
      <td>2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE</td>
      <td>QUIQCYFSBGOBKE-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB14660</td>
      <td>Trenbolone acetate</td>
      <td>CMRJPMODSSEAPL-FYQPLNBISA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9q</td>
      <td>DB01251</td>
      <td>Gliquidone</td>
      <td>LLJFMFZYVVLQKT-UHFFFAOYSA-N</td>
      <td>nsp9 RNA-replicase</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6vxx</td>
      <td>DB06848</td>
      <td>1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine</td>
      <td>VCUDZTCDUDDJGG-UHFFFAOYSA-N</td>
      <td>spike glycoprotein</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6w9c</td>
      <td>DB15406</td>
      <td>GLPG-0974</td>
      <td>MPMKMQHJHDHPBE-RUZDIDTESA-N</td>
      <td>PL pro</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6cs2</td>
      <td>DB12141</td>
      <td>Gilteritinib</td>
      <td>GYQYAJJFPNQOOW-UHFFFAOYSA-N</td>
      <td>ACE2 area for S-protein binding</td>
    </tr>
    <tr>
      <td>-8.5</td>
      <td>6m2n</td>
      <td>DB07546</td>
      <td>[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid</td>
      <td>BBYRUZKRFAIQSR-UHFFFAOYSA-N</td>
      <td>3CL pro</td>
    </tr>
  </tbody>
</table>